data_1ah1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ah1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.542 0.687 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -149.6 118.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 128.45 54.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.547 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -149.83 143.64 16.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.85 136.24 32.26 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.323 1.17 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.63 69.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -144.83 165.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.755 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 8.3 t -139.33 130.56 33.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 121.753 0.787 . . . . 0.0 111.181 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 3.6 mm? -87.59 129.9 34.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.41 154.77 20.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.815 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.0 m -75.2 172.47 12.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.727 -0.608 . . . . 0.0 109.732 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 m -59.79 -40.08 87.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.422 ' HG2' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.01 -29.58 69.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.486 -0.759 . . . . 0.0 110.029 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 41.49 1.41 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 16' ' ' ILE . 1.5 mp -100.5 102.11 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.672 -0.899 . . . . 0.0 108.85 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.75 114.16 27.72 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -130.8 131.72 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.554 0.692 . . . . 0.0 110.886 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.4 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 38.5 p90 -150.07 163.97 36.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.781 -0.574 . . . . 0.0 109.476 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.6 t -123.45 122.36 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 5' ' ' GLN . 42.3 t -103.84 108.5 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.66 162.57 22.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.19 -0.944 . . . . 0.0 110.867 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -140.13 176.36 8.82 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 130.85 45.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.795 -0.566 . . . . 0.0 110.409 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.5 p -132.77 155.94 80.62 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.558 -0.714 . . . . 0.0 110.081 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.15 -16.89 45.21 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.391 1.206 . . . . 0.0 111.216 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -171.99 37.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -100.63 137.3 39.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.598 -0.942 . . . . 0.0 110.127 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.96 170.67 15.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.537 -0.727 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.076 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -81.15 -8.64 59.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.583 -0.698 . . . . 0.0 112.494 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 18.6 mm-40 -129.46 108.26 10.13 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.944 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 78.0 t -125.89 80.45 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.76 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 67.8 ttt180 -59.97 124.59 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 111.427 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.73 153.98 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.45 ' HB ' ' CE ' ' A' ' 95' ' ' LYS . 20.3 m -144.0 141.41 30.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 85.6 t -116.86 124.07 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 14.6 mt -120.07 153.36 36.2 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.518 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HG3' ' CG2' ' A' ' 47' ' ' VAL . 69.0 mtm180 -111.28 123.96 51.26 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 44' ' ' VAL . 20.0 tt0 -96.25 139.99 31.6 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.853 0.835 . . . . 0.0 110.937 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.04 156.98 47.27 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.83 -43.86 94.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.4 m -70.0 -47.28 62.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.648 -0.657 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -165.15 169.48 16.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 111.241 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 39' ' ' GLN . 63.3 t -116.73 140.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -130.03 160.58 33.25 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.326 -0.859 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 96.9 mt-10 -80.03 154.85 27.9 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.574 HG13 ' SG ' ' A' ' 48' ' ' CYS . 45.8 t -130.89 -83.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.705 -0.622 . . . . 0.0 111.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.574 ' SG ' HG13 ' A' ' 47' ' ' VAL . 83.2 m -110.14 149.45 30.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.076 -1.015 . . . . 0.0 110.925 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.04 141.41 15.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.538 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.79 163.35 18.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 109.842 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.772 HG23 ' SD ' ' A' ' 53' ' ' MET . 5.5 m -97.45 116.31 29.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.703 ' CZ ' ' SD ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -72.9 91.94 1.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 1.076 ' SD ' ' O ' ' A' ' 30' ' ' THR . 35.8 mmm -85.0 129.96 34.7 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.703 ' SD ' ' CZ ' ' A' ' 52' ' ' TYR . 18.0 mmt -59.43 -27.98 66.54 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.618 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.66 43.41 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -149.8 -179.99 7.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.0 -1.294 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.61 156.39 19.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.656 -0.653 . . . . 0.0 110.65 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 139.93 52.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.972 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 p -104.55 118.33 36.32 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.718 . . . . 0.0 110.102 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.87 37.85 2.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.472 -0.768 . . . . 0.0 110.307 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.436 -0.79 . . . . 0.0 110.662 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -85.7 127.12 34.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.355 -0.841 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 52.24 47.52 24.56 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.318 -0.864 . . . . 0.0 109.932 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -57.53 -106.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.983 -0.448 . . . . 0.0 110.823 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.8 mt 52.04 22.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.342 -1.473 . . . . 0.0 110.534 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.05 158.21 24.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.988 . . . . 0.0 110.339 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -132.75 139.95 47.83 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.82 154.12 25.09 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.411 -1.376 . . . . 0.0 111.066 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.2 m -130.04 163.51 26.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 32.8 t -143.39 130.02 20.24 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.773 -0.58 . . . . 0.0 109.961 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -142.42 133.85 26.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -0.783 . . . . 0.0 109.744 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.5 -123.99 27.54 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -105.9 16.43 25.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.674 -0.897 . . . . 0.0 110.441 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.87 123.94 44.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 111.013 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -99.49 130.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -107.97 118.38 36.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 111.459 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 74.0 mt -108.95 132.05 54.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -121.14 132.2 54.71 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 0.0 110.173 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.9 mt -116.38 130.16 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.642 -0.661 . . . . 0.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.418 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.5 mt-30 -124.54 120.86 33.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.648 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.28 48.68 0.69 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.0 108.41 20.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.488 -1.007 . . . . 0.0 111.308 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -82.85 -176.62 6.4 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.21 92.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.8 -38.84 83.85 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.117 0.484 . . . . 0.0 111.103 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -60.0 -35.39 74.95 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.544 -0.723 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 m -51.46 135.96 26.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.97 -144.03 7.83 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.908 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 93' ' ' ILE . 2.1 tm? -106.62 139.42 41.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.779 -0.836 . . . . 0.0 110.816 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CD2' HG13 ' A' ' 115' ' ' ILE . 42.3 m-85 -124.53 125.3 43.97 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.503 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.6 mp -97.94 120.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.365 -0.834 . . . . 0.0 111.949 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.695 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 30.8 p -84.15 122.4 28.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' CE ' ' HB ' ' A' ' 35' ' ' THR . 10.5 mtmt -113.9 150.59 33.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.304 -0.873 . . . . 0.0 109.986 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.39 103.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -132.03 117.34 18.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 8.7 mp -75.6 75.35 2.61 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.76 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 22.9 ttm -78.39 -38.31 42.04 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.932 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.452 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 92.8 m-85 -67.51 -44.96 46.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 55.7 Cg_endo -80.8 137.18 11.06 Favored 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 120.463 0.776 . . . . 0.0 110.469 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 73.6 Cg_endo -89.98 143.81 4.17 Favored 'Trans proline' 2 CA--C 1.708 9.188 0 CA-C-O 112.032 -3.403 . . . . 0.0 110.923 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.305 51.0 Cg_endo -114.41 64.67 0.26 Allowed 'Cis proline' 2 C--N 1.443 5.526 1 C-N-CA 93.233 -14.07 . . . . 0.0 113.31 5.111 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' PRO . 4.3 t80 48.14 111.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.092 -2.255 . . . . 0.0 111.8 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 106' ' ' LEU . 28.9 t80 -160.64 107.99 1.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.83 1.3 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.45 -142.83 0.11 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.562 -179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.99 167.41 32.23 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.0 mm -119.82 157.15 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.946 -0.737 . . . . 0.0 109.082 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.695 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -86.32 141.55 18.3 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.01 -36.24 76.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.995 . . . . 0.0 110.11 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 129.64 143.14 5.4 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.866 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.1 m -111.42 131.94 54.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 8' ' ' VAL . 32.8 tp60 -79.97 131.88 35.91 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.423 HG13 ' CD2' ' A' ' 92' ' ' TYR . 22.1 mm -99.74 121.17 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.135 . . . . 0.0 108.61 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.513 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 13.2 m-30 -101.37 147.15 26.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.794 -0.566 . . . . 0.0 110.555 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.89 0.852 . . . . 0.0 110.008 178.277 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.7 m80 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 121.269 0.557 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.1 t -150.15 132.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.66 -0.65 . . . . 0.0 109.279 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.02 130.69 55.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.405 -0.809 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.43 124.99 21.46 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 111.07 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.63 139.87 31.75 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 N-CA-C 109.053 -1.172 . . . . 0.0 109.053 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.16 64.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.503 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -154.33 162.86 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.445 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.68 155.92 25.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -114.32 131.9 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.08 -163.82 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -128.87 -178.8 4.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.518 -0.739 . . . . 0.0 110.566 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.31 -39.53 87.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.413 ' HB3' HG12 ' A' ' 16' ' ' ILE . 21.6 tpp180 -59.15 -21.48 59.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.729 -0.607 . . . . 0.0 109.656 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.64 35.03 17.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 14' ' ' ARG . 5.1 mm -114.69 109.91 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 127.35 52.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.755 -0.591 . . . . 0.0 110.221 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.1 t -127.07 129.96 49.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.08 160.16 40.11 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' CG1' ' CG ' ' A' ' 76' ' ' GLN . 61.5 t -125.67 123.32 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.297 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -105.52 109.94 22.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.6 pt-20 -82.77 149.49 27.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 111.419 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -131.89 164.0 27.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.32 133.4 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.399 -0.813 . . . . 0.0 111.19 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -139.9 150.46 62.57 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.648 -0.658 . . . . 0.0 110.717 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.77 -10.09 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.688 1.362 . . . . 0.0 111.852 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.48 -178.77 22.12 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.383 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -121.87 150.06 42.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.676 -0.896 . . . . 0.0 110.599 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.51 162.63 39.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.604 -0.685 . . . . 0.0 109.795 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 53' ' ' MET . 71.0 p -80.25 -46.09 16.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.46 -0.775 . . . . 0.0 110.647 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 5.7 mm-40 -80.26 112.04 17.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.999 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.23 95.75 3.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.845 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 68.9 ttt180 -75.78 115.3 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.431 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.5 m -118.78 138.91 47.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 85.2 m -129.6 143.73 50.96 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.474 0.654 . . . . 0.0 110.338 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.1 t -114.32 139.48 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 9.5 mt -130.22 172.33 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.049 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -126.72 123.6 37.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -106.32 132.01 52.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.939 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.87 -172.31 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 -43.6 96.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 110.791 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.0 p -132.06 0.06 3.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.331 -0.855 . . . . 0.0 111.878 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -137.3 154.98 49.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.031 -1.043 . . . . 0.0 110.816 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.21 145.16 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.9 p -129.8 156.06 44.95 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.343 -0.848 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 50.8 mp0 -86.34 159.99 19.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 63.9 t -122.25 -80.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.822 -0.549 . . . . 0.0 110.194 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.66 156.6 45.56 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.979 -1.076 . . . . 0.0 110.834 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.03 121.8 3.23 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.462 -0.774 . . . . 0.0 111.275 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 60' ' ' PHE . . . -158.29 143.02 16.24 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.4 -0.812 . . . . 0.0 110.196 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 3.0 m -92.7 119.95 32.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.285 -0.884 . . . . 0.0 108.728 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' CE1' ' CE ' ' A' ' 54' ' ' MET . 46.0 p90 -110.06 146.87 34.63 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.967 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 1.05 ' SD ' ' N ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -75.99 160.78 29.5 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.45 ' CE ' ' CE1' ' A' ' 52' ' ' TYR . 31.7 mmt -70.66 127.45 32.73 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.893 -1.129 . . . . 0.0 110.131 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.85 27.77 23.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -150.03 175.77 11.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.213 -1.169 . . . . 0.0 111.163 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.31 152.01 48.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.8 -0.562 . . . . 0.0 109.859 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 52' ' ' TYR . 96.3 mt -136.42 -171.82 2.99 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.157 0.979 . . . . 0.0 112.136 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.7 p -109.48 159.97 16.61 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.416 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 95.0 m-85 -111.35 127.89 55.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.382 -0.824 . . . . 0.0 109.418 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.94 -44.07 94.6 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.587 -0.695 . . . . 0.0 112.344 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -94.88 131.44 40.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.921 . . . . 0.0 109.898 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 67' ' ' ILE . 81.9 m-20 53.05 57.77 5.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m -60.86 64.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.362 0.601 . . . . 0.0 112.098 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 63' ' ' ASP . 67.3 mt -140.98 16.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.419 -0.801 . . . . 0.0 109.134 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.1 m -104.09 130.03 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.059 -1.026 . . . . 0.0 110.593 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -139.94 150.08 44.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.58 -172.04 41.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.277 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 93.8 m -115.63 167.32 11.02 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.884 -0.774 . . . . 0.0 109.703 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.433 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 97.3 p -145.22 151.26 38.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.786 -0.571 . . . . 0.0 109.632 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -132.03 -175.73 3.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.649 -0.657 . . . . 0.0 109.757 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -52.92 -66.19 2.86 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -111.57 9.53 21.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.425 -1.044 . . . . 0.0 111.699 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.3 tt0 -130.0 129.41 43.69 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.996 -1.065 . . . . 0.0 110.609 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.18 134.52 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -110.99 112.58 24.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.844 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 95.7 mt -107.31 129.66 54.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -124.05 136.69 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.249 -0.907 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -103.52 137.29 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.675 . . . . 0.0 109.957 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HA ' HD11 ' A' ' 16' ' ' ILE . 30.7 mt-30 -119.97 120.71 37.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.041 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.03 40.07 1.74 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.3 mt -80.37 137.83 36.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.996 . . . . 0.0 111.445 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -117.03 176.15 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.9 93.04 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.31 -39.07 93.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.738 -0.601 . . . . 0.0 110.748 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.11 -23.94 64.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.566 -0.709 . . . . 0.0 111.195 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -52.43 137.77 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.96 -164.26 32.2 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 14.6 tp -88.42 126.22 35.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.884 . . . . 0.0 112.733 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 31.5 m-85 -106.89 158.13 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.9 mp -123.7 140.18 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.887 . . . . 0.0 111.723 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.579 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 13.9 p -98.64 133.54 42.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.7 tttt -135.95 123.11 21.65 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.36 118.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.8 mm-40 -139.58 142.68 37.11 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.273 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.467 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.5 mt -90.44 81.87 5.95 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.845 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 2.8 ttm -80.13 -48.99 12.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.264 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.46 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 80.6 m-85 -70.87 -41.92 12.23 Favored Pre-proline 0 N--CA 1.508 2.467 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 60.4 Cg_endo -86.58 119.82 1.69 Allowed 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.558 1.505 . . . . 0.0 109.34 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.408 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 65.5 Cg_endo -84.77 161.71 12.18 Favored 'Trans proline' 2 CA--C 1.685 8.042 0 CA-C-O 113.188 -2.921 . . . . 0.0 106.18 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 38.6 Cg_endo -86.45 174.8 30.84 Favored 'Cis proline' 1 C--N 1.423 4.468 1 C-N-CA 98.673 -11.803 . . . . 0.0 114.9 -11.624 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' GLU 0.313 3.0 t80 -80.16 133.0 36.02 Favored 'General case' 0 N--CA 1.529 3.513 0 O-C-N 118.319 -2.738 . . . . 0.0 115.727 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 14.0 p90 -162.47 107.7 1.19 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.149 -1.595 . . . . 0.0 111.695 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 tp -157.59 -147.11 0.17 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.623 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -160.66 169.57 36.41 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 118.689 -1.719 . . . . 0.0 112.102 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.4 mp -117.16 159.76 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.537 -0.978 . . . . 0.0 109.576 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.579 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -103.39 143.57 15.78 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -59.92 -39.71 86.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -1.089 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 137.01 158.67 8.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.257 -1.449 . . . . 0.0 113.004 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.1 m -125.77 139.96 53.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.469 ' O ' HG21 ' A' ' 8' ' ' VAL . 27.5 tt0 -85.24 142.36 29.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.162 -1.415 . . . . 0.0 108.251 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 76.4 mt -109.18 130.03 62.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.503 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 15.1 m-30 -110.87 150.35 29.3 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.914 -0.491 . . . . 0.0 110.391 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 75.6 m80 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.47 0.652 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.6 t -142.22 132.6 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.95 134.43 53.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.318 -0.864 . . . . 0.0 111.165 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.133 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 65.5 mt-30 -146.81 147.95 31.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.653 -0.655 . . . . 0.0 110.697 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.02 140.7 42.33 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.438 1.23 . . . . 0.0 109.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.18 71.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.55 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -155.49 161.41 2.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.35 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 19' ' ' PHE . 8.5 t -137.94 156.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.529 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.79 124.23 42.85 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.07 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 141.3 38.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.509 -0.744 . . . . 0.0 109.32 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -80.3 -59.78 2.57 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.221 -0.924 . . . . 0.0 111.884 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 16' ' ' ILE . 15.2 t -152.32 165.93 33.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.535 -0.728 . . . . 0.0 109.462 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.419 ' O ' HD12 ' A' ' 16' ' ' ILE . 6.3 ttt180 57.67 19.51 5.56 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.544 -0.722 . . . . 0.0 110.733 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.65 44.31 91.18 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 82' ' ' GLN . 29.1 mm -106.78 104.66 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.75 120.67 42.89 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.335 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 m -116.28 121.93 43.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' HB3' HG22 ' A' ' 9' ' ' VAL . 47.5 p90 -132.03 163.96 27.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.683 . . . . 0.0 110.392 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.3 t -122.03 130.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.171 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.069 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 48.7 t -117.9 131.92 56.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -102.53 136.36 42.5 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 111.821 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CD2' HG13 ' A' ' 96' ' ' VAL . 40.2 p90 -127.3 179.53 5.41 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.47 127.29 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.719 -0.613 . . . . 0.0 110.477 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.35 149.9 59.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.594 -0.691 . . . . 0.0 109.97 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.81 -16.11 45.33 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.362 1.191 . . . . 0.0 111.446 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.96 -171.92 37.4 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -108.05 130.1 55.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.602 -0.94 . . . . 0.0 109.959 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.62 -178.63 5.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 110.623 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.088 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -79.96 -14.19 58.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 112.266 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 3.1 mm-40 -128.82 130.73 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.497 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.0 t -139.68 84.91 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -64.49 115.24 4.96 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.458 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -117.3 147.41 20.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.7 m -147.12 140.03 25.1 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.339 0.59 . . . . 0.0 111.101 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.1 t -102.66 132.1 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -121.91 170.3 9.94 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.847 -1.158 . . . . 0.0 112.019 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.424 ' HD3' ' CE1' ' A' ' 92' ' ' TYR . 15.6 mmm180 -116.0 115.66 26.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.457 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 7.4 tt0 -103.01 140.02 37.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.206 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 155.34 46.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.16 -44.0 92.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.355 -0.841 . . . . 0.0 110.263 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.0 m -70.1 -44.04 69.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.656 -0.652 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 44' ' ' VAL . 12.4 tp60 -162.65 161.33 26.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 111.078 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.438 ' N ' ' HG3' ' A' ' 43' ' ' GLN . 62.1 t -118.25 141.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 160.31 33.99 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.161 -0.962 . . . . 0.0 111.885 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 80.4 mt-10 -87.97 158.53 18.63 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.702 -0.624 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.0 t -139.17 -83.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.609 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 1.118 ' SG ' ' N ' ' A' ' 68' ' ' CYS . 83.4 m -105.21 149.52 25.88 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.085 -1.01 . . . . 0.0 111.792 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -163.94 145.34 8.87 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . . . -171.79 158.0 4.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 100' ' ' TYR . 3.0 m -97.62 109.92 22.59 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.327 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 72' ' ' SER . 29.1 t80 -68.97 123.99 22.52 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 1.088 ' SD ' ' O ' ' A' ' 30' ' ' THR . 40.0 mmm -111.92 39.23 2.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.414 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 16.4 mmt 59.9 35.57 21.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.58 174.66 28.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.03 -18.93 45.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.597 -0.943 . . . . 0.0 112.126 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.95 124.65 28.27 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.312 0.577 . . . . 0.0 112.027 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 75.7 mt -131.9 151.82 51.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.589 -0.695 . . . . 0.0 109.139 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 p -87.12 95.63 10.02 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.967 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD1' ' CG2' ' A' ' 67' ' ' ILE . 20.6 m-85 -115.06 99.54 7.52 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.42 ' N ' HG13 ' A' ' 67' ' ' ILE . 96.0 mt -135.01 -0.13 2.81 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.63 -1.294 . . . . 0.0 114.155 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 56.6 t0 -110.65 130.17 55.64 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.51 -1.369 . . . . 0.0 112.872 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 53.12 44.28 30.53 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.761 -1.212 . . . . 0.0 111.333 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 t 72.15 -42.25 0.53 Allowed 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.417 -0.802 . . . . 0.0 112.43 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.927 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 25.8 mm 61.13 168.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.874 -1.142 . . . . 0.0 110.592 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 1.118 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 4.1 m -110.25 -179.74 3.86 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -130.22 149.79 51.76 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.3 -172.66 40.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.97 -1.586 . . . . 0.0 111.369 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' ASN . 59.7 m -131.85 168.88 17.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 122.157 -0.614 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 19.0 t -140.24 129.83 24.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -130.99 131.99 44.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.55 -123.78 24.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -99.75 11.53 38.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.769 -0.842 . . . . 0.0 110.919 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -114.34 131.92 56.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 11.4 m -111.52 118.2 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.1 m120 -89.9 114.21 25.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.545 -0.722 . . . . 0.0 110.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.422 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 69.7 mt -114.24 124.32 51.74 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.1 m -115.31 132.41 56.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.34 -0.85 . . . . 0.0 110.703 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.697 HG12 ' SG ' ' A' ' 68' ' ' CYS . 62.3 mt -107.06 135.78 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.294 -0.879 . . . . 0.0 110.17 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.503 ' HA ' HD11 ' A' ' 16' ' ' ILE . 82.9 mt-30 -119.97 120.32 36.01 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.204 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.02 51.74 0.72 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.7 mt -92.32 113.53 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.682 -0.893 . . . . 0.0 111.439 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -81.32 166.16 20.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.02 -28.48 57.51 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.215 -0.928 . . . . 0.0 109.066 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.91 -36.07 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.507 0.67 . . . . 0.0 110.005 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.13 -25.74 65.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.799 -0.563 . . . . 0.0 111.397 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.1 m -51.2 132.01 28.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.43 -165.72 31.99 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.457 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 12.9 tp -86.8 130.07 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.705 -0.879 . . . . 0.0 112.798 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.424 ' CD2' HD11 ' A' ' 115' ' ' ILE . 59.1 m-85 -111.58 140.09 46.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.6 mp -110.14 122.95 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.133 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -79.67 120.17 23.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 175.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.0 tttt -103.47 143.97 32.02 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 23' ' ' TYR . 20.3 t -140.77 106.62 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.768 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 59.0 mt-10 -140.17 122.21 15.68 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.908 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 9.5 mp -72.94 83.7 1.23 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.2 mmt -79.28 -50.92 10.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.86 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 97.6 m-85 -69.17 -40.3 15.05 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.407 -0.808 . . . . 0.0 112.618 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 14.8 Cg_endo -88.8 119.6 1.06 Allowed 'Trans proline' 0 C--O 1.177 -2.551 0 C-N-CA 122.14 1.893 . . . . 0.0 109.881 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.724 ' CB ' ' HA ' ' A' ' 103' ' ' PRO 0.479 88.9 Cg_endo -100.46 173.7 0.34 Allowed 'Trans proline' 2 C--O 1.08 -7.38 0 CA-C-O 114.3 -2.459 . . . . 0.0 113.482 173.563 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.724 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.408 52.0 Cg_endo -72.69 176.64 39.37 Favored 'Cis proline' 3 N--CA 1.586 6.96 1 C-N-CA 96.736 -12.61 . . . . 0.0 112.6 -5.491 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 14.7 t80 -79.55 135.72 36.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 116.327 -3.983 . . . . 0.0 111.352 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.33 30.4 t80 -158.73 91.76 1.08 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.104 0.411 . . . . 0.0 111.464 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.413 ' CD1' ' CD1' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -159.35 -157.29 0.57 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.119 -1.432 . . . . 0.0 112.57 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.01 36.82 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.966 -1.112 . . . . 0.0 111.295 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.2 mp -121.29 153.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 5' ' ' GLN . . . -92.99 165.2 27.91 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -62.54 -34.03 76.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -1.094 . . . . 0.0 111.694 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.54 160.57 11.52 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.688 -1.244 . . . . 0.0 111.921 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.6 m -120.04 145.04 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.484 ' O ' HG21 ' A' ' 8' ' ' VAL . 30.5 tt0 -88.98 145.56 25.43 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.612 -1.235 . . . . 0.0 107.954 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.424 HD11 ' CD2' ' A' ' 92' ' ' TYR . 45.6 mt -117.99 131.31 71.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.55 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 23.0 m-85 -113.93 155.97 24.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.83 -0.544 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.826 0.822 . . . . 0.0 110.047 178.631 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.5 m170 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.288 0.566 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.13 137.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.745 -0.597 . . . . 0.0 109.895 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.12 135.69 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.538 -0.726 . . . . 0.0 110.72 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 41.5 mt-30 -148.51 150.07 32.95 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.526 -0.734 . . . . 0.0 111.694 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.02 139.97 37.0 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.284 -1.468 . . . . 0.0 108.284 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.21 -27.5 67.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.497 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -152.34 171.99 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 118.491 -1.284 . . . . 0.0 110.983 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.1 t -149.85 155.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.567 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -112.12 131.95 55.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.05 135.93 39.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.529 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -69.88 173.46 6.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.688 -0.632 . . . . 0.0 110.256 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.4 p -60.32 -30.53 69.57 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.555 -0.715 . . . . 0.0 109.992 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -60.07 -30.13 69.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.68 26.01 8.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -109.72 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.565 -0.962 . . . . 0.0 110.507 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.41 128.88 55.8 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t -126.59 134.83 50.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 111.728 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.07 163.99 31.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.92 124.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.468 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' O ' HG21 ' A' ' 77' ' ' VAL . 51.2 t -100.81 117.12 34.26 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 60.0 tt0 -90.75 137.56 32.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 111.282 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -131.29 180.0 5.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.85 123.57 18.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.707 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -134.53 143.39 46.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.558 -0.714 . . . . 0.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.13 144.24 29.59 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.296 1.156 . . . . 0.0 110.742 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.87 30.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 150.05 51.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.881 . . . . 0.0 109.92 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.77 154.75 37.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 110.41 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.5 p -92.62 10.46 30.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.603 -0.685 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -132.19 84.92 2.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.279 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.35 89.13 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.6 tpt85 -53.72 102.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -110.17 131.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.86 0.838 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 99.9 m -135.56 148.15 49.0 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 95.9 t -116.08 133.83 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 12.8 mt -121.35 170.18 9.87 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.231 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -123.21 119.91 31.6 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.427 ' NE2' HD21 ' A' ' 91' ' ' LEU . 14.2 tt0 -97.15 148.56 22.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 110.166 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.43 -175.66 3.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.848 -0.533 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.74 -40.47 88.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.67 -0.643 . . . . 0.0 111.385 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.0 m -126.8 -21.55 4.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.19 -0.944 . . . . 0.0 112.57 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -131.96 163.98 27.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.06 -1.025 . . . . 0.0 111.775 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.84 143.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.2 p -129.99 160.18 34.44 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 58.2 tt0 -80.15 157.31 26.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 109.876 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.75 -64.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.782 -0.574 . . . . 0.0 110.392 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.3 m -140.1 141.08 36.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.105 -0.997 . . . . 0.0 109.846 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.1 135.1 16.64 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.698 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -172.01 149.57 2.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -81.17 111.24 17.42 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.06 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 72' ' ' SER . 23.3 t80 -74.92 112.99 11.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.769 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 mtp -82.63 161.54 22.17 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 35.6 mmt -61.04 -23.91 65.79 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.659 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.37 41.49 0.75 Allowed Glycine 0 N--CA 1.501 3.027 0 C-N-CA 119.042 -1.551 . . . . 0.0 112.658 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 79.6 m-20 -135.55 160.06 39.67 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 119.067 1.434 . . . . 0.0 110.241 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -89.12 135.63 33.46 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.492 -0.755 . . . . 0.0 110.283 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.3 mm? -103.04 156.12 17.91 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.492 -0.755 . . . . 0.0 110.086 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 p -102.2 123.15 45.53 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.388 -0.82 . . . . 0.0 111.706 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CE1' ' HB1' ' A' ' 50' ' ' ALA . 42.3 m-85 -114.12 30.5 7.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -53.72 -44.03 69.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.532 -0.73 . . . . 0.0 111.899 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -66.54 145.45 55.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.264 -0.897 . . . . 0.0 110.749 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 52.13 55.58 9.0 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.388 -0.82 . . . . 0.0 110.498 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 60.17 163.87 0.06 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.798 -0.564 . . . . 0.0 109.938 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -99.92 142.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.591 0.71 . . . . 0.0 111.229 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.4 m -121.99 153.77 38.11 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -132.63 150.08 52.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.95 -172.01 43.52 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.41 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 78' ' ' ASN . 92.5 m -129.1 168.78 15.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.0 -0.706 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.432 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 70.1 m -159.98 127.39 4.59 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -155.83 155.93 33.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 110.344 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.76 -124.04 25.67 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -109.32 11.05 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.774 -0.839 . . . . 0.0 110.914 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.1 mt-30 -118.46 124.76 48.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 21' ' ' CYS . 4.0 m -107.17 124.01 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.924 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' THR . 46.6 t-20 -101.97 116.21 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.71 . . . . 0.0 111.077 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 96.6 mt -115.98 131.98 56.78 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.297 -0.877 . . . . 0.0 109.164 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.3 m -124.47 147.21 48.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.184 -0.948 . . . . 0.0 111.075 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 62.3 mt -113.53 131.53 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.711 -0.618 . . . . 0.0 110.072 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HG2' HG13 ' A' ' 16' ' ' ILE . 10.5 mt-30 -110.22 120.76 43.48 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.667 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.58 0.99 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.76 125.55 33.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.656 -0.908 . . . . 0.0 111.082 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -107.44 175.85 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.21 94.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.302 -0.873 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.1 ttm -62.14 -36.06 80.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.756 -0.59 . . . . 0.0 110.169 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -66.97 -26.92 67.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.647 . . . . 0.0 111.143 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.9 m -51.4 132.07 29.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.5 -143.96 8.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD21 ' NE2' ' A' ' 39' ' ' GLN . 10.6 tp -110.04 131.94 54.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.737 -0.861 . . . . 0.0 111.611 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 74.1 m-85 -113.28 132.03 55.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.492 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.4 mp -107.97 129.36 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.728 -0.607 . . . . 0.0 112.144 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.077 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 20.1 p -79.88 161.99 25.27 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.3 tttt -152.34 77.49 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.1 113.63 29.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 68.2 mt-10 -130.16 129.65 43.72 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.426 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.1 mt -76.99 76.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.4 tpp -80.63 -50.15 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.034 -0.667 . . . . 0.0 112.45 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 89.1 m-85 -68.6 -41.21 21.41 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 112.926 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 46.9 Cg_endo -86.25 109.44 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-O 117.875 -0.969 . . . . 0.0 111.098 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 100' ' ' TYR . 57.3 Cg_endo -77.39 158.02 32.93 Favored 'Trans proline' 1 CA--C 1.609 4.236 0 CA-C-O 113.892 -2.628 . . . . 0.0 110.001 177.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -88.54 -177.68 12.56 Favored 'Cis proline' 1 C--N 1.484 7.662 1 C-N-CA 93.031 -14.154 . . . . 0.0 114.475 -10.125 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 4.6 t80 -88.04 125.51 34.59 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-O 122.76 1.267 . . . . 0.0 109.888 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -149.7 74.42 1.22 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 120.943 -1.098 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -142.48 -150.68 0.32 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.352 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.1 -173.04 34.99 Favored Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.902 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.7 mt -110.96 149.18 13.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.847 -0.796 . . . . 0.0 109.938 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 1.077 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -74.53 144.14 32.47 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.07 -30.34 69.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.398 -1.06 . . . . 0.0 110.283 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.0 140.03 7.08 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.319 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.3 m -113.53 149.97 33.64 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.501 ' O ' HG21 ' A' ' 8' ' ' VAL . 13.7 tp60 -89.87 137.29 32.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 mt -109.92 128.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.519 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 14.3 m-30 -101.95 139.86 37.02 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.646 0.736 . . . . 0.0 111.748 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 C--N 1.304 -1.399 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.287 0.565 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.69 131.47 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.564 -0.71 . . . . 0.0 109.382 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 131.78 56.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.449 -0.782 . . . . 0.0 110.56 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.7 134.7 18.42 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.649 . . . . 0.0 110.475 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.48 136.57 24.01 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.11 1.058 . . . . 0.0 109.696 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.43 -32.95 64.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.484 -0.76 . . . . 0.0 109.666 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.0 157.35 6.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.992 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.72 153.36 23.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.45 0.643 . . . . 0.0 110.038 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.83 124.1 51.38 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.71 140.77 46.24 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.496 -0.752 . . . . 0.0 110.724 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -91.61 -168.99 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.598 -0.689 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -49.98 159.04 0.45 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.48 -0.763 . . . . 0.0 110.529 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 16' ' ' ILE . 40.8 tpt85 62.43 13.27 5.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.556 -0.715 . . . . 0.0 110.655 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.07 46.01 93.17 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 82' ' ' GLN . 34.6 mm -104.92 106.7 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.729 -0.865 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.08 123.58 48.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.803 -0.56 . . . . 0.0 109.772 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -130.0 130.95 45.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.663 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 27.2 p90 -142.39 164.06 31.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.807 -0.558 . . . . 0.0 109.724 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.66 116.21 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.852 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.449 ' O ' HG21 ' A' ' 77' ' ' VAL . 42.3 t -100.12 103.77 15.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 90.1 mt-10 -79.67 165.11 23.21 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 111.933 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.43 ' CG ' HG13 ' A' ' 96' ' ' VAL . 43.8 p90 -148.07 178.14 8.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 130.34 32.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.689 -0.632 . . . . 0.0 110.009 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -139.95 150.11 61.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.405 -0.809 . . . . 0.0 110.45 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 140.06 33.81 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.44 1.232 . . . . 0.0 110.299 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.65 -145.71 23.28 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -130.11 149.92 51.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.937 . . . . 0.0 110.141 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 147.69 45.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.617 -0.677 . . . . 0.0 109.926 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.093 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 32.8 p -79.97 -59.65 2.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.712 0.767 . . . . 0.0 111.679 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 2.0 mt-10 -80.99 80.52 7.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' HB ' ' CZ ' ' A' ' 52' ' ' TYR . 97.0 t -88.5 96.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -70.53 124.25 23.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.572 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.1 142.14 38.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -135.32 142.35 45.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.726 -0.608 . . . . 0.0 110.625 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.3 t -112.77 131.23 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 14.0 mt -120.94 173.76 7.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 110.958 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.42 121.28 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.478 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 24.4 tt0 -97.9 148.65 23.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 111.151 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.15 168.65 17.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.47 -28.24 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 110.722 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -108.49 -53.14 2.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.474 -0.766 . . . . 0.0 112.153 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -136.64 170.01 16.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.12 -0.988 . . . . 0.0 111.997 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.4 ' CG2' ' HG3' ' A' ' 39' ' ' GLN . 62.0 t -122.56 147.96 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -127.65 160.42 31.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.341 -0.849 . . . . 0.0 110.678 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 40.1 mt-10 -80.4 145.58 31.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 110.651 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.0 t -117.18 -75.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.305 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.896 ' SG ' ' HB3' ' A' ' 63' ' ' ASP . 70.2 m -139.83 149.15 43.11 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.88 145.48 23.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.488 -0.757 . . . . 0.0 111.294 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.28 148.02 8.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.618 -0.677 . . . . 0.0 109.714 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.2 m -98.42 130.19 45.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.476 ' CZ ' ' HB ' ' A' ' 32' ' ' VAL . 52.1 p90 -102.09 133.44 46.93 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.521 -1.272 . . . . 0.0 110.631 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 mmt -78.41 168.17 20.21 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.104 ' SD ' ' N ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -66.96 90.03 0.17 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.673 -1.267 . . . . 0.0 109.2 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.39 -117.48 0.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -129.9 137.77 50.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.307 -1.113 . . . . 0.0 110.379 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -178.73 138.33 0.16 Allowed 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.14 87.72 2.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 46.1 p -89.58 72.2 7.85 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.425 -0.797 . . . . 0.0 111.384 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.89 109.76 20.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.36 -37.3 82.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.425 -0.797 . . . . 0.0 110.48 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -139.98 172.19 13.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.634 -0.666 . . . . 0.0 110.026 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.896 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 84.5 m-20 52.6 49.95 19.24 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -53.91 -21.11 7.1 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.659 -0.651 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.97 -20.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.264 -0.897 . . . . 0.0 110.627 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 30.7 m -86.07 137.78 32.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 110.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -129.95 131.01 45.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.63 116.8 2.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.2 m -103.87 159.0 16.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.726 -0.867 . . . . 0.0 108.673 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 63.0 m -148.15 129.97 15.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.969 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 122.04 25.88 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.04 -124.07 34.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.93 16.59 25.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.964 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 35.7 mt-30 -116.46 122.25 44.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.197 -0.939 . . . . 0.0 110.502 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 21' ' ' CYS . 1.9 m -103.74 122.2 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.866 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -104.21 109.96 21.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 0.0 111.462 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 mt -98.06 130.02 44.88 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.9 m -123.75 145.44 49.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.5 mt -119.91 135.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.83 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HA ' HD11 ' A' ' 16' ' ' ILE . 76.5 mt-30 -120.02 120.31 35.94 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.927 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.66 40.5 1.1 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.81 121.19 31.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.952 . . . . 0.0 111.464 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -103.32 179.66 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.85 93.91 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.926 0.869 . . . . 0.0 109.872 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.7 -34.66 78.34 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.331 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.54 -19.96 66.14 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.479 -0.763 . . . . 0.0 111.238 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -50.65 136.88 20.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.84 -159.99 32.85 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.59 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.478 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 13.8 tp -110.2 130.05 55.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.7 -0.882 . . . . 0.0 111.961 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 115' ' ' ILE . 83.9 m-85 -116.29 146.98 41.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.9 mp -103.53 139.96 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.44 -0.788 . . . . 0.0 111.683 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.77 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.7 p -98.16 127.59 44.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -120.39 141.72 49.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 109.916 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.43 HG13 ' CG ' ' A' ' 23' ' ' TYR . 4.8 t -138.05 108.85 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -134.4 128.26 33.24 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.841 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 98' ' ' LEU 0.26 2.8 mm? -76.51 87.68 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 104' ' ' TYR . 2.7 mmt -81.15 -58.45 3.06 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.498 -1.281 . . . . 0.0 111.687 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.6 m-85 -71.7 -40.45 8.4 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 48.6 Cg_endo -82.05 117.36 2.88 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.229 0.594 . . . . 0.0 110.658 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.443 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 73.0 Cg_endo -92.41 156.97 3.05 Favored 'Trans proline' 1 CA--C 1.701 8.859 0 CA-C-O 114.534 -2.361 . . . . 0.0 109.835 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 55.7 Cg_endo -87.65 178.62 19.91 Favored 'Cis proline' 2 C--N 1.46 6.408 1 C-N-CA 96.668 -12.638 . . . . 0.0 116.727 -8.039 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.455 ' CZ ' ' HE3' ' A' ' 99' ' ' MET . 13.3 t80 -85.93 119.68 26.5 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.043 2.09 . . . . 0.0 113.12 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -162.16 107.74 1.25 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.272 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.411 HD22 ' CG1' ' A' ' 96' ' ' VAL . 1.4 tp -157.16 -143.49 0.11 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.921 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.73 178.55 35.77 Favored Glycine 0 N--CA 1.504 3.227 0 O-C-N 120.682 -1.261 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.17 160.82 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.987 . . . . 0.0 109.814 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.77 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 143.47 16.68 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -60.43 -36.08 77.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.479 -1.013 . . . . 0.0 110.271 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 131.56 158.4 9.1 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.017 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.0 m -123.33 127.67 48.84 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.478 ' O ' HG21 ' A' ' 8' ' ' VAL . 36.1 tp60 -73.64 137.12 43.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 92' ' ' TYR . 75.4 mt -110.0 129.19 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.894 -1.129 . . . . 0.0 108.422 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.542 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 14.9 m-85 -110.15 142.67 41.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.874 -0.516 . . . . 0.0 111.044 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.055 0.455 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -135.78 132.48 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.68 131.09 57.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.581 -0.699 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.089 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 87.0 mm-40 -140.0 139.69 22.12 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.224 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.33 147.66 42.16 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.284 1.15 . . . . 0.0 109.835 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.5 -29.61 25.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG23 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.44 156.99 4.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.017 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.98 157.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -111.04 130.18 55.68 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.702 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.71 147.78 23.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.863 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -78.27 168.85 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.647 -0.658 . . . . 0.0 110.153 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -59.76 -37.91 80.35 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.446 -0.783 . . . . 0.0 109.969 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -57.46 -24.06 53.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.535 -0.728 . . . . 0.0 110.397 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.02 8.6 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.2 mp -103.63 101.67 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -105.56 124.35 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.0 p -136.37 150.03 48.62 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.875 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 22.2 p90 -154.62 161.48 41.57 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 79.8 t -118.79 117.69 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.499 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.089 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 53.6 t -100.1 107.42 19.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.51 144.95 29.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.911 . . . . 0.0 111.186 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.417 ' CG ' HG13 ' A' ' 96' ' ' VAL . 50.0 p90 -131.64 -179.97 5.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.75 131.92 39.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.691 -0.631 . . . . 0.0 110.093 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.4 t -127.29 150.42 72.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.475 -0.766 . . . . 0.0 111.101 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.34 -14.77 37.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.735 1.387 . . . . 0.0 111.362 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.89 -165.43 16.79 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -110.1 132.16 54.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.97 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 153.76 39.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.1 p -80.03 -35.08 37.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -79.89 97.07 6.55 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.3 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -113.56 85.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 99' ' ' MET . 72.1 ttt-85 -61.25 116.19 4.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.114 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 28.4 m -122.46 133.98 67.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.712 0.767 . . . . 0.0 110.157 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.3 m -120.06 123.98 44.75 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.086 0.469 . . . . 0.0 109.967 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 93.7 t -100.54 130.23 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 71.2 mt -124.76 167.66 14.28 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.351 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -127.71 124.04 36.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -109.13 132.01 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.954 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.01 162.6 24.17 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.03 -42.98 95.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.2 m -70.09 -55.92 8.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.727 . . . . 0.0 110.694 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -150.42 -177.27 5.86 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.964 0.888 . . . . 0.0 111.399 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.8 136.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -134.27 161.6 34.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 75.5 mt-10 -80.2 155.54 27.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.77 -95.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.869 -0.519 . . . . 0.0 110.089 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.424 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 99.2 m -120.14 145.12 47.24 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.705 -1.247 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.76 138.57 14.28 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.38 -0.825 . . . . 0.0 111.796 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -175.4 157.06 2.1 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -80.1 119.88 23.49 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 72' ' ' SER . 19.6 t80 -80.83 109.98 15.91 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.445 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.16 146.06 33.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -15.81 63.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.07 -1.018 . . . . 0.0 110.661 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.83 -15.03 5.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -130.02 160.06 34.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -1.221 . . . . 0.0 110.911 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -123.2 125.2 44.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.506 -0.746 . . . . 0.0 110.052 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.2 170.17 13.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.474 -0.766 . . . . 0.0 111.349 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -110.2 159.95 16.93 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.473 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.8 m-85 -99.93 132.08 45.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.492 -0.755 . . . . 0.0 109.696 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.87 -44.13 94.35 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -140.82 -165.76 2.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.028 -1.045 . . . . 0.0 111.995 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 56.0 57.15 5.32 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.221 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.3 m 56.61 167.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.322 0.582 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -91.39 84.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 110.018 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 59.7 m -68.08 151.39 47.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -132.62 149.96 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.1 176.49 39.33 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.9 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 94.3 m -131.96 166.41 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 122.005 -0.703 . . . . 0.0 109.721 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 34.7 t -151.16 80.32 1.31 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.706 -0.621 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -129.97 145.11 51.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.486 -0.759 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.01 37.75 87.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.5 m120 56.96 24.22 9.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.609 -0.936 . . . . 0.0 110.387 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -127.37 124.1 37.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.552 -0.717 . . . . 0.0 109.17 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 21' ' ' CYS . 3.2 m -102.19 117.55 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.553 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 57.4 t-20 -99.76 104.77 16.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.322 -0.861 . . . . 0.0 111.156 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.406 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 75.1 mt -93.27 131.86 37.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 0.0 109.819 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.9 m -121.89 139.93 53.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.02 138.82 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.711 . . . . 0.0 109.905 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.404 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.0 mt-30 -124.92 121.24 33.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.983 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.38 25.1 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 75.7 mt -81.67 129.99 34.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -1.044 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -104.19 179.93 4.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.05 94.55 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.835 0.826 . . . . 0.0 109.614 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.9 mmt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -67.75 -16.93 64.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.761 . . . . 0.0 111.807 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.3 m -52.96 139.96 26.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.31 -164.96 37.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 18.0 tp -94.12 132.01 39.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.752 -0.852 . . . . 0.0 112.483 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 115' ' ' ILE . 72.9 m-85 -118.39 134.58 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.5 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 4.0 mp -99.95 139.91 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 111.762 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.851 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.8 p -108.07 107.98 18.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 37' ' ' LEU . 17.1 mttt -105.17 141.39 36.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 109.202 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 23' ' ' TYR . 9.8 t -135.96 111.42 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.947 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 86.6 mt-10 -131.98 131.7 42.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.539 -0.725 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 11.2 mt -85.43 80.01 9.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 33' ' ' ARG . 2.5 ttm -80.65 -39.67 26.92 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.631 -173.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.439 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 68.6 m-85 -70.8 -45.7 16.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.401 -0.92 . . . . 0.0 112.773 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 71.9 Cg_endo -80.29 133.42 9.72 Favored 'Trans proline' 0 CA--C 1.597 3.648 0 O-C-N 122.877 0.935 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 86.0 Cg_endo -90.88 143.11 3.32 Favored 'Trans proline' 1 N--CA 1.54 4.207 1 CA-C-O 110.185 -4.173 . . . . 0.0 114.945 177.088 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 104' ' ' TYR . 21.2 Cg_endo -110.7 57.07 0.77 Allowed 'Cis proline' 2 C--N 1.453 6.051 1 C-N-CA 97.123 -12.449 . . . . 0.0 110.505 11.41 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.469 ' O ' ' O ' ' A' ' 103' ' ' PRO . 5.1 t80 50.72 120.95 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.836 0 O-C-N 120.556 -1.34 . . . . 0.0 111.843 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -160.18 106.98 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.428 -2.045 . . . . 0.0 107.378 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tp -159.41 -148.91 0.19 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.979 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.46 -176.38 30.44 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -126.63 162.75 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.355 -1.086 . . . . 0.0 110.978 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.851 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 134.81 11.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -59.8 -35.89 75.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -1.17 . . . . 0.0 110.64 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 130.6 136.73 4.02 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.68 -1.248 . . . . 0.0 111.874 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 96.3 m -108.63 139.09 43.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 14.5 tt0 -89.56 120.2 30.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.207 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.413 HD11 ' CD1' ' A' ' 92' ' ' TYR . 97.0 mt -81.48 123.66 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CE2' HG23 ' A' ' 8' ' ' VAL . 2.8 m-30 -94.93 161.66 14.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.633 0.73 . . . . 0.0 111.531 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 77.8 m80 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.434 0.635 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.77 132.03 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . . . -110.2 132.74 53.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.377 -0.827 . . . . 0.0 110.606 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -138.75 138.79 22.34 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.814 -0.554 . . . . 0.0 110.503 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.48 133.89 27.19 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.259 1.137 . . . . 0.0 109.535 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.49 76.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.563 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -149.16 155.96 7.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.118 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 19' ' ' PHE . 8.6 t -137.62 155.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.989 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -116.01 132.72 56.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.07 131.76 35.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.384 -0.823 . . . . 0.0 110.974 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -60.64 172.73 0.85 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.62 -0.675 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -59.83 -35.94 75.77 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.577 -0.702 . . . . 0.0 110.088 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -24.95 15.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.97 24.97 13.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -112.6 111.64 37.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.69 119.72 37.9 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 t -122.31 131.1 53.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.21 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB3' HG22 ' A' ' 9' ' ' VAL . 46.2 p90 -139.92 164.03 31.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.481 ' CG1' ' HG2' ' A' ' 76' ' ' GLN . 55.3 t -131.6 130.77 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.956 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.461 ' SG ' ' CG ' ' A' ' 5' ' ' GLN . 29.5 t -112.84 110.75 21.05 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.9 pt-20 -82.06 151.73 26.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.723 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 96' ' ' VAL . 19.6 p90 -134.36 169.44 17.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.63 134.72 43.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.583 -0.698 . . . . 0.0 110.898 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 t -140.2 149.47 58.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.634 . . . . 0.0 110.651 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.67 -20.44 52.99 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.727 1.383 . . . . 0.0 111.54 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.02 165.91 25.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.61 133.54 55.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.573 -0.957 . . . . 0.0 110.548 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.93 163.0 29.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 109.536 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' MET . 25.6 p -80.1 -38.03 32.49 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.39 -0.818 . . . . 0.0 110.201 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' HE2' ' A' ' 53' ' ' MET . 10.5 mm-40 -79.35 93.11 5.26 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.225 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -109.76 102.6 14.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 71.8 ttt180 -82.83 106.37 14.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.343 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 34.0 m -106.04 141.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.487 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -132.0 156.88 45.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.728 0.775 . . . . 0.0 110.175 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 98.4 t -125.57 136.24 61.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 7.7 mt -131.92 160.1 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.058 -1.026 . . . . 0.0 111.216 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -112.66 113.79 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.431 ' NE2' ' CD1' ' A' ' 93' ' ' ILE . 26.3 mt-30 -93.67 131.82 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.895 . . . . 0.0 110.818 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.9 158.69 39.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.65 85.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 110.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.7 p -73.71 -56.09 5.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.615 -0.678 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -154.15 171.99 18.28 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.302 -0.874 . . . . 0.0 111.353 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -122.35 142.11 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.0 p -128.22 160.16 32.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.206 -0.934 . . . . 0.0 111.603 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 59.1 mt-10 -80.25 162.04 24.83 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.67 -0.643 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 38.7 t -130.25 -64.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.342 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.776 ' SG ' ' O ' ' A' ' 64' ' ' SER . 57.9 m -149.56 151.89 34.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.441 -0.787 . . . . 0.0 110.153 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.59 137.89 2.84 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.148 -0.97 . . . . 0.0 112.387 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.1 148.11 3.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.529 -0.732 . . . . 0.0 109.917 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -95.87 115.3 27.23 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.137 -0.977 . . . . 0.0 108.784 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CE1' ' CE ' ' A' ' 54' ' ' MET . 46.1 p90 -109.57 145.31 36.57 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.388 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 1.068 ' SD ' ' N ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -73.23 158.71 34.67 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.449 ' CE ' ' CE1' ' A' ' 52' ' ' TYR . 27.5 mmt -67.14 130.46 43.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.837 -1.164 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.5 30.46 18.84 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -149.26 175.61 11.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -1.124 . . . . 0.0 110.909 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -137.84 150.07 46.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.819 -0.551 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 51' ' ' THR . 80.1 mt -134.15 179.63 6.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.304 -0.873 . . . . 0.0 111.577 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.7 p -113.8 159.81 19.38 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.963 -0.461 . . . . 0.0 110.081 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 36.2 m-85 -110.2 123.38 49.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.63 -35.87 75.63 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.48 -0.762 . . . . 0.0 112.359 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -67.15 -147.75 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.241 -0.912 . . . . 0.0 111.187 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -46.57 -19.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.896 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.776 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 29.0 m 57.51 -132.62 1.32 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.654 -0.654 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.5 mt 56.56 22.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.77 -1.206 . . . . 0.0 110.27 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 64' ' ' SER . 20.7 m -137.36 155.18 49.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -120.31 140.06 51.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.43 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.58 96.1 1.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 m -123.79 156.03 36.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.538 -0.978 . . . . 0.0 109.024 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.2 p -156.52 160.24 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.177 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -140.36 107.92 5.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.15 32.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -93.69 9.71 35.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.454 -1.027 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.481 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 36.5 tt0 -111.7 136.07 51.44 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.239 -0.913 . . . . 0.0 110.226 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 11.3 m -112.77 141.85 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.008 -1.058 . . . . 0.0 111.287 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -112.76 118.01 33.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.769 . . . . 0.0 110.784 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.22 129.97 56.08 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.719 . . . . 0.0 109.376 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.8 m -130.65 154.52 47.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.272 -0.892 . . . . 0.0 110.808 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 91.0 mt -120.43 139.41 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.78 -0.575 . . . . 0.0 109.846 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.408 ' CG ' HG13 ' A' ' 16' ' ' ILE . 40.2 mt-30 -119.48 123.22 43.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.143 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.57 56.84 0.76 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.85 126.03 30.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.792 -0.828 . . . . 0.0 111.805 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -105.93 170.14 8.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.22 90.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -65.64 -37.72 87.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.755 -0.591 . . . . 0.0 110.325 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.28 -36.47 75.61 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.619 -0.676 . . . . 0.0 111.228 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -51.11 133.75 27.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.6 -143.69 9.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.23 123.71 49.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.733 -0.863 . . . . 0.0 111.709 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CD1' HD11 ' A' ' 115' ' ' ILE . 53.7 m-85 -110.18 115.87 30.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.469 -0.769 . . . . 0.0 110.05 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 112' ' ' GLY . 40.8 mm -78.21 133.51 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.6 -0.687 . . . . 0.0 111.984 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.3 p -85.47 149.82 25.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.2 tttt -147.31 127.93 14.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 108.495 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 23' ' ' TYR . 2.4 p -134.95 113.11 15.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.614 0.721 . . . . 0.0 109.297 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 74.3 mm-40 -134.56 132.2 38.83 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 1.6 mm? -81.54 85.2 6.55 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 51.0 tpp -82.52 -46.92 12.77 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.779 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 59.0 m-85 -71.42 -42.98 11.9 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 49.1 Cg_endo -81.76 113.06 2.47 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 121.194 1.263 . . . . 0.0 112.576 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.44 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 50.5 Cg_endo -77.02 166.87 26.05 Favored 'Trans proline' 1 CA--C 1.642 5.913 0 CA-C-O 111.834 -3.486 . . . . 0.0 108.246 177.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.43 68.2 Cg_endo -81.95 -171.97 10.0 Favored 'Cis proline' 1 C--N 1.47 6.944 1 C-N-CA 98.741 -11.774 . . . . 0.0 116.704 -15.862 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.1 t80 -99.19 125.16 44.7 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 118.365 -2.709 . . . . 0.0 109.243 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 106' ' ' LEU . 22.5 p90 -169.42 108.1 0.42 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.005 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -152.91 -148.02 0.24 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.1 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.8 165.35 32.06 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.357 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.6 mp -122.25 149.18 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.14 -177.68 47.46 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.84 21.33 17.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -1.19 . . . . 0.0 111.803 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 93' ' ' ILE . . . 83.53 146.89 7.17 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-O 122.793 1.218 . . . . 0.0 114.074 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 57.7 m -116.16 128.88 56.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG21 ' A' ' 8' ' ' VAL . 35.3 tp60 -68.36 136.59 53.6 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 118.354 -1.339 . . . . 0.0 107.86 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' ' 92' ' ' TYR . 61.6 mt -113.67 125.1 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.957 -1.09 . . . . 0.0 108.635 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.563 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 24.8 m-85 -109.69 159.79 16.85 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 N--CA 1.492 1.641 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.331 177.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.301 0.572 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.4 t -102.06 134.97 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.773 -0.58 . . . . 0.0 110.114 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.02 131.36 54.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.508 -0.745 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -157.57 156.05 28.15 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.572 -0.705 . . . . 0.0 111.277 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.57 46.75 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.55 1.29 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.13 -23.66 23.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.582 -0.699 . . . . 0.0 109.731 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.512 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.2 156.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.567 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.86 156.8 35.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.86 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.61 127.77 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.629 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.93 165.14 18.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.456 -0.778 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 160.02 43.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.255 -0.903 . . . . 0.0 111.1 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t 55.5 -132.87 1.66 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.509 -0.745 . . . . 0.0 110.737 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' A' ' 16' ' ' ILE . 6.1 ttt180 -52.02 -23.84 5.77 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.764 -1.21 . . . . 0.0 111.461 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.56 46.19 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.8 mp -103.78 113.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.93 0.872 . . . . 0.0 109.893 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -112.92 126.48 55.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.3 p -123.49 139.99 53.46 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.59 0.709 . . . . 0.0 110.902 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -150.15 162.24 40.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -125.29 121.03 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.713 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -100.04 103.72 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -80.04 142.43 34.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.817 . . . . 0.0 111.0 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CG ' HG13 ' A' ' 96' ' ' VAL . 38.3 p90 -121.96 176.36 5.83 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.64 137.01 41.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.661 -0.649 . . . . 0.0 110.584 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.4 p -142.95 152.91 59.88 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.649 -0.657 . . . . 0.0 110.43 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.23 -13.47 36.07 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.461 1.242 . . . . 0.0 110.929 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.13 -179.84 33.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -117.98 140.08 50.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -1.035 . . . . 0.0 110.602 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.54 172.27 13.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.0 109.486 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 p -80.06 -46.55 16.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.09 109.96 15.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.795 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 82.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -60.22 103.58 0.24 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -114.44 143.66 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.325 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.422 ' H ' ' HB3' ' A' ' 95' ' ' LYS . 69.1 m -140.03 132.9 29.22 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.217 0.532 . . . . 0.0 111.04 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.3 t -98.99 130.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 13.6 mt -119.97 160.01 23.59 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.749 -1.219 . . . . 0.0 111.735 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -117.03 129.68 56.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -106.81 149.31 27.51 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.712 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.62 -172.6 2.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.858 -0.526 . . . . 0.0 109.761 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.18 -44.4 95.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.502 -0.749 . . . . 0.0 111.138 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.1 m -132.73 -13.74 2.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.295 -0.878 . . . . 0.0 112.294 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -122.88 142.7 50.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 111.168 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.03 133.81 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -131.17 165.84 22.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -79.98 149.91 30.63 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.441 0.638 . . . . 0.0 110.55 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 1.073 HG13 ' SG ' ' A' ' 68' ' ' CYS . 95.4 t -112.33 -67.99 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 63' ' ' ASP . 57.0 m -133.34 150.08 51.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.547 -0.721 . . . . 0.0 109.526 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.87 135.27 2.71 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.378 -0.929 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -172.02 157.54 4.4 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.422 HG22 ' CD1' ' A' ' 100' ' ' TYR . 2.9 m -85.69 124.81 32.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 72' ' ' SER . 28.7 t80 -87.82 110.41 20.48 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.592 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.425 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 2.2 mmt -80.04 165.58 22.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.2 mmt -59.54 -30.34 68.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.6 -1.312 . . . . 0.0 109.604 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.16 -139.75 7.9 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.68 133.75 55.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -1.154 . . . . 0.0 110.668 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 178.02 159.22 0.48 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 38.3 mt 51.04 78.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.977 . . . . 0.0 111.308 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -96.79 163.26 13.06 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.728 -0.608 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.437 ' CG ' ' HB3' ' A' ' 48' ' ' CYS . 8.6 m-30 -90.53 10.01 27.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.565 -0.709 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.71 -30.21 68.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.273 -0.892 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.07 -28.55 62.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.396 -0.815 . . . . 0.0 111.019 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.702 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 26.3 m-20 -84.11 -6.58 59.43 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 122.082 -0.386 . . . . 0.0 111.667 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p 42.25 28.5 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.8 mt -137.04 -47.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.306 -0.871 . . . . 0.0 110.79 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 1.073 ' SG ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -118.76 131.41 56.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 0.0 111.486 -179.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -139.85 147.49 40.75 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.99 -171.74 37.26 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.275 -1.441 . . . . 0.0 111.16 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 78' ' ' ASN . 59.9 m -130.08 169.6 15.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 122.019 -0.695 . . . . 0.0 109.821 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.426 ' HB3' ' CD2' ' A' ' 52' ' ' TYR . 31.0 t -134.74 130.02 35.56 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -135.07 129.95 34.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 50.61 -122.84 14.09 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.421 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 27.4 m120 -100.03 12.07 37.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.759 -0.847 . . . . 0.0 110.46 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -116.27 128.49 55.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 109.853 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.42 118.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.399 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' THR . 58.8 t-20 -89.31 110.05 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 111.112 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.08 131.96 54.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -131.26 144.08 51.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' A' ' 92' ' ' TYR . 62.5 mt -124.02 140.02 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.502 -0.749 . . . . 0.0 110.481 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -120.34 122.56 41.06 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.402 0.62 . . . . 0.0 109.589 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.92 37.75 1.65 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 94.9 mt -80.12 85.72 5.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.893 . . . . 0.0 110.77 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.96 168.38 20.14 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -41.73 67.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.234 -0.917 . . . . 0.0 109.732 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.76 -36.07 79.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.393 0.616 . . . . 0.0 109.78 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.25 -23.48 67.07 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 110.859 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -53.43 139.98 29.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.23 -146.8 10.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.004 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 93' ' ' ILE . 1.6 tm? -107.33 134.93 49.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.859 -0.789 . . . . 0.0 110.752 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 57.2 m-85 -121.1 125.07 46.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.6 mp -98.75 123.97 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.396 -0.815 . . . . 0.0 112.578 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.898 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.6 p -85.11 111.29 19.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' H ' ' A' ' 35' ' ' THR . 7.8 tttt -103.56 139.99 38.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.536 -0.727 . . . . 0.0 109.076 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 23' ' ' TYR . 21.2 t -140.13 105.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.41 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.929 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 36.8 mt-10 -131.93 130.69 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.238 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.62 78.84 9.77 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.929 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -80.03 -41.67 25.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.195 -0.941 . . . . 0.0 113.016 -174.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.443 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 62.8 m-85 -65.17 -46.84 72.83 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.884 -1.135 . . . . 0.0 113.145 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.0 110.1 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.204 1.107 . . . . 0.0 111.349 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 100' ' ' TYR . 44.6 Cg_endo -89.24 145.92 5.18 Favored 'Trans proline' 0 CA--C 1.598 3.724 0 CA-C-O 110.666 -3.972 . . . . 0.0 110.432 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 37.6 Cg_endo -88.3 -168.37 4.44 Favored 'Cis proline' 2 N--CA 1.629 9.478 2 C-N-CA 92.29 -14.463 . . . . 0.0 111.927 -0.064 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -88.17 137.79 32.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.644 -1.285 . . . . 0.0 113.975 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 12.4 p90 -153.59 92.71 1.6 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.496 -0.752 . . . . 0.0 111.905 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tp -160.13 -149.67 0.2 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.616 -0.678 . . . . 0.0 110.446 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.02 176.35 40.03 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.339 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.0 mp -117.55 158.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.718 -0.872 . . . . 0.0 109.338 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.898 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -87.45 146.82 20.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.31 78.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.439 -1.036 . . . . 0.0 110.135 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.4 129.96 3.74 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.101 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.8 m -94.63 129.98 41.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.987 -0.713 . . . . 0.0 109.089 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' VAL . 21.4 tp60 -79.87 132.01 36.0 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 81.3 mt -98.85 125.06 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.865 -1.147 . . . . 0.0 108.767 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.512 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 11.9 m-30 -103.44 151.21 23.08 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.108 0.48 . . . . 0.0 111.122 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.135 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.144 0.497 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 97.6 t -149.25 147.73 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 109.679 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.425 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . . . -111.71 130.6 55.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.443 -0.785 . . . . 0.0 110.607 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.591 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 13.1 mm100 -143.5 139.97 17.0 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.668 -0.645 . . . . 0.0 111.49 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.63 139.92 38.29 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.82 66.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -154.03 162.41 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.679 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -141.94 153.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -107.91 129.78 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 143.98 25.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.483 -0.761 . . . . 0.0 110.624 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -75.87 170.05 16.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.655 -0.653 . . . . 0.0 110.13 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -60.14 -34.63 73.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.712 . . . . 0.0 110.124 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 5.6 ttt180 -60.17 -26.63 66.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.0 110.034 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.93 30.67 6.63 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.1 mp -105.3 103.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.646 -0.914 . . . . 0.0 109.32 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -108.85 124.07 50.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.9 p -136.26 149.83 48.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.738 0.78 . . . . 0.0 111.243 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.95 164.1 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.66 123.98 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.596 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 36.8 t -102.89 108.07 19.14 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 17.1 pt-20 -79.79 160.03 26.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 111.296 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.422 ' HB3' HG12 ' A' ' 96' ' ' VAL . 50.6 p90 -139.96 179.89 6.35 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.68 125.76 29.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.702 . . . . 0.0 110.961 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -149.73 158.81 37.11 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.653 . . . . 0.0 109.966 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.81 124.91 11.52 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.354 1.186 . . . . 0.0 110.168 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.98 -131.38 52.02 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -126.03 143.31 51.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.617 -0.931 . . . . 0.0 109.956 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.18 145.17 42.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 110.04 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.401 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 2.7 p -80.9 -59.74 2.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 112.067 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.27 75.82 10.17 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.279 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 52' ' ' TYR . 15.4 m -85.78 87.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -55.97 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.53 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.6 m -103.56 129.59 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.819 0.819 . . . . 0.0 111.046 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.5 m -131.45 145.83 51.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.611 -0.68 . . . . 0.0 109.655 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 94.5 t -114.04 132.39 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.25 167.16 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.979 -1.076 . . . . 0.0 111.293 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -127.61 120.86 29.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -105.9 130.28 53.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.395 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.78 156.12 41.73 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.24 -43.62 95.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.443 -0.786 . . . . 0.0 110.644 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -68.33 -49.95 56.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.549 -0.719 . . . . 0.0 111.145 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -155.47 164.02 39.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.382 -0.824 . . . . 0.0 111.084 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.77 137.27 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -139.96 166.11 25.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.494 -0.754 . . . . 0.0 110.959 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 62.5 tt0 -79.99 157.42 26.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 109.47 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG11 ' SG ' ' A' ' 48' ' ' CYS . 97.3 t -121.03 -72.17 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.843 -0.536 . . . . 0.0 110.445 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.519 ' SG ' HG11 ' A' ' 47' ' ' VAL . 81.0 m -129.95 148.08 51.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.339 -0.85 . . . . 0.0 109.411 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.47 13.24 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.17 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -173.84 149.58 1.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.587 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -94.33 119.94 33.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.214 -0.928 . . . . 0.0 109.278 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 53' ' ' MET . 25.6 t80 -77.91 116.7 18.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.077 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -84.23 169.93 14.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.5 mmt -65.44 -28.26 69.1 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.687 -1.258 . . . . 0.0 111.27 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.76 44.3 0.83 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.218 -1.468 . . . . 0.0 112.361 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 74.1 m-20 -132.73 162.14 32.21 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 118.867 1.333 . . . . 0.0 110.158 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -104.68 126.54 51.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.561 -0.712 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -98.29 139.98 33.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.009 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.6 p -100.18 142.87 31.07 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.676 -0.64 . . . . 0.0 110.581 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 96.0 m-85 -103.72 133.64 48.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.51 -0.743 . . . . 0.0 109.25 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.83 -44.27 94.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.516 -0.74 . . . . 0.0 112.762 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -168.39 -149.45 0.09 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.909 -1.119 . . . . 0.0 111.21 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 59.01 54.27 5.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.462 -0.774 . . . . 0.0 110.242 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p 65.47 9.72 6.02 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.899 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.0 mt 48.27 68.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.16 -0.962 . . . . 0.0 111.354 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.413 ' O ' ' CE1' ' A' ' 60' ' ' PHE . 11.5 m -59.89 133.41 56.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.401 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 9.1 t -80.08 128.93 34.09 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.286 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.68 107.69 2.75 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.48 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -113.8 149.69 34.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.737 -0.861 . . . . 0.0 108.943 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 69.3 m -150.71 131.42 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -139.98 138.53 35.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.664 -0.648 . . . . 0.0 109.265 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.54 -123.92 33.31 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -108.92 16.68 22.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.905 . . . . 0.0 110.544 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 36.8 mt-30 -121.8 128.8 52.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.218 -0.926 . . . . 0.0 111.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 2.8 m -100.5 128.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.133 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.02 118.12 35.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 86.7 mt -112.13 129.96 56.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.525 -0.734 . . . . 0.0 109.541 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.401 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 61.3 m -125.89 138.98 53.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.296 -0.878 . . . . 0.0 110.641 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.419 HD12 ' CE2' ' A' ' 92' ' ' TYR . 72.9 mt -113.7 139.74 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.734 -0.604 . . . . 0.0 110.273 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HG2' HG13 ' A' ' 16' ' ' ILE . 63.3 mt-30 -124.81 121.98 36.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.259 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.61 36.99 1.49 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.401 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 80.3 mt -92.81 121.09 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.986 . . . . 0.0 111.33 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -98.02 176.96 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.08 84.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 16.9 tpt -67.89 -34.54 76.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.514 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -67.53 -16.34 64.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.665 -0.647 . . . . 0.0 111.465 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -50.36 135.5 21.81 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.213 -0.929 . . . . 0.0 110.439 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.55 -159.43 24.02 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.871 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -109.55 128.65 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.676 -0.897 . . . . 0.0 111.531 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.458 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 62.1 m-85 -109.94 139.94 44.48 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.2 mp -115.31 130.22 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.608 -0.683 . . . . 0.0 111.881 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.107 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.8 p -80.1 146.87 31.66 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 6.8 tttt -142.55 77.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 23' ' ' TYR . 3.6 p -98.84 113.99 35.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.783 0.801 . . . . 0.0 110.482 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG2' ' OH ' ' A' ' 104' ' ' TYR . 54.9 mt-10 -128.19 129.14 46.02 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.721 -0.612 . . . . 0.0 110.63 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.64 76.16 4.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.6 tpp -81.8 -44.21 17.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.431 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 90.3 m-85 -70.19 -42.1 15.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.405 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 58.7 Cg_endo -87.51 111.76 0.81 Allowed 'Trans proline' 0 CA--C 1.561 1.868 0 CA-C-O 117.362 -1.183 . . . . 0.0 111.324 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 76.0 Cg_endo -85.23 155.15 10.95 Favored 'Trans proline' 0 CA--C 1.597 3.629 0 CA-C-O 111.592 -3.587 . . . . 0.0 110.249 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.286 48.0 Cg_endo -86.46 -178.99 17.33 Favored 'Cis proline' 2 C--N 1.5 8.512 1 C-N-CA 91.179 -14.925 . . . . 0.0 115.914 -5.951 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.402 ' OH ' ' HG2' ' A' ' 97' ' ' GLU . 1.6 t80 -85.28 128.43 34.69 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.399 -1.438 . . . . 0.0 110.33 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -145.09 69.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.385 0.612 . . . . 0.0 111.552 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 tp -144.9 -154.87 0.56 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.74 -171.22 33.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.063 -1.541 . . . . 0.0 111.838 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.2 mp -115.15 150.03 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.7 -0.882 . . . . 0.0 109.639 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 1.107 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -79.91 148.65 30.45 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -59.82 -38.63 82.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.351 -1.087 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 125.42 148.5 7.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.8 m -119.79 134.57 55.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.485 ' O ' HG21 ' A' ' 8' ' ' VAL . 38.3 tp60 -80.38 129.51 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 75.5 mt -98.2 120.82 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.0 108.537 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.542 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 9.5 m-30 -97.02 132.36 42.9 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.095 0.474 . . . . 0.0 111.414 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.413 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.073 0.463 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.5 t -129.89 126.04 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.609 -0.682 . . . . 0.0 109.607 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 130.81 56.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.506 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -135.02 131.29 19.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 110.601 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.78 136.03 24.69 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.064 1.034 . . . . 0.0 109.515 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.1 -28.78 57.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.813 . . . . 0.0 110.209 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -153.01 163.01 2.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.045 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -138.51 151.63 24.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.57 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.9 mt -119.19 121.26 39.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.603 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 140.08 45.53 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -110.12 -69.38 0.87 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.226 -0.921 . . . . 0.0 112.647 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 m -120.03 151.32 39.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.241 -0.912 . . . . 0.0 111.075 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.478 ' HG2' HD12 ' A' ' 16' ' ' ILE . 4.0 tpt180 56.9 18.8 4.09 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.606 -0.684 . . . . 0.0 110.577 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.64 44.02 53.91 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.478 HD12 ' HG2' ' A' ' 14' ' ' ARG . 21.6 mm -110.25 108.97 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 121.606 -0.938 . . . . 0.0 108.941 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.79 126.11 48.59 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.793 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -133.17 135.0 44.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 26.7 p90 -146.23 161.33 40.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.77 -0.581 . . . . 0.0 109.796 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.72 119.06 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.225 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.453 ' O ' HG21 ' A' ' 77' ' ' VAL . 42.2 t -100.18 103.18 14.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 85.1 mt-10 -80.4 164.3 23.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 111.789 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CG ' HG12 ' A' ' 96' ' ' VAL . 44.0 p90 -147.9 178.46 8.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.489 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.59 27.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.636 . . . . 0.0 109.891 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -131.44 147.82 67.65 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 0.0 110.585 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.44 142.53 26.69 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.379 1.199 . . . . 0.0 110.372 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.61 -150.34 38.62 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.07 140.91 50.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.924 . . . . 0.0 110.21 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.81 144.82 31.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.273 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.096 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 82.7 p -78.6 -46.83 18.42 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.952 0.882 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HA ' ' HE2' ' A' ' 53' ' ' MET . 2.2 mm-40 -79.04 112.56 16.37 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.538 0.685 . . . . 0.0 112.847 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 52' ' ' TYR . 94.2 t -124.04 96.09 3.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -77.89 124.03 27.5 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.75 141.81 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.5 m -129.92 130.1 44.7 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.238 0.542 . . . . 0.0 110.536 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 95.6 t -103.77 132.02 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 18.7 mt -127.34 169.03 14.0 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.185 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -122.1 115.66 22.85 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 9.5 tt0 -83.95 150.37 25.71 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.733 0.778 . . . . 0.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.86 -162.05 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.18 -46.15 90.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.444 -0.785 . . . . 0.0 110.392 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.1 p -134.77 -3.88 2.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.473 -0.767 . . . . 0.0 112.031 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.32 161.52 36.05 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.007 -1.058 . . . . 0.0 111.133 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.17 156.0 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.1 p -124.13 157.67 34.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.386 -0.822 . . . . 0.0 110.628 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 50.2 mt-10 -87.31 143.18 27.38 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.608 0.718 . . . . 0.0 111.017 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG13 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -116.3 -71.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.932 -0.48 . . . . 0.0 109.98 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' HG13 ' A' ' 47' ' ' VAL . 30.8 m -140.06 153.38 46.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.381 -0.824 . . . . 0.0 110.589 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 135.27 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.492 -0.755 . . . . 0.0 110.912 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' CB ' ' C ' ' A' ' 59' ' ' THR . . . -171.15 155.96 4.57 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.424 -0.797 . . . . 0.0 110.212 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -102.17 131.04 48.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 32' ' ' VAL . 55.4 p90 -110.05 141.12 43.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.669 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.977 ' SD ' ' N ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -77.0 164.1 26.08 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.096 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -71.29 79.96 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.904 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.05 -134.27 2.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -99.16 135.67 40.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.293 -1.122 . . . . 0.0 110.573 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -177.08 174.94 1.62 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.07 137.76 46.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.107 -0.996 . . . . 0.0 110.055 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 73.4 p -90.77 8.27 35.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.976 -0.452 . . . . 0.0 110.046 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 59' ' ' THR . 13.5 m-85 -131.59 113.54 13.76 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.57 -35.91 81.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.537 -0.727 . . . . 0.0 109.521 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -141.16 -169.92 2.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.792 -0.567 . . . . 0.0 109.684 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.695 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 81.6 m-20 54.33 58.15 5.22 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.344 -0.848 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 t -49.26 -21.53 0.84 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.749 -0.595 . . . . 0.0 112.013 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -49.1 -26.72 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 63' ' ' ASP . 4.2 p -95.57 129.62 42.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -0.764 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -139.08 148.41 43.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.787 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.92 -173.77 38.94 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.5 m -130.12 163.92 25.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.951 -0.734 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 62.8 m -148.08 127.16 12.84 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -155.93 140.0 16.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 110.589 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.86 -124.19 33.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -107.76 16.14 23.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.741 -0.858 . . . . 0.0 110.824 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.5 mt-30 -119.83 120.09 35.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.209 -0.932 . . . . 0.0 110.958 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -103.96 124.33 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -103.0 111.25 23.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 111.946 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -100.52 135.87 41.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.297 -0.877 . . . . 0.0 109.011 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.1 m -135.81 144.5 45.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.313 -0.867 . . . . 0.0 110.812 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.1 mt -119.12 131.45 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 96.9 mt-30 -113.78 119.42 37.29 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.155 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.07 47.85 0.86 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.11 129.82 35.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.958 . . . . 0.0 111.755 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -119.21 179.99 4.01 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.88 82.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.188 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -65.4 -32.93 74.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.982 -0.449 . . . . 0.0 111.74 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.23 -20.02 64.78 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.345 -0.847 . . . . 0.0 111.4 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.4 m -51.79 136.46 27.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.61 29.93 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.631 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 58.4 tp -109.9 133.12 53.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.912 . . . . 0.0 111.775 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 115' ' ' ILE . 46.8 m-85 -116.5 128.79 55.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.3 mp -95.37 127.02 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.612 -0.68 . . . . 0.0 112.112 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.05 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 29.9 p -93.13 112.25 24.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.401 ' HE3' ' CD1' ' A' ' 37' ' ' LEU . 5.6 mttt -105.55 146.62 29.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.419 HG12 ' CG ' ' A' ' 23' ' ' TYR . 21.9 t -141.75 106.3 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.54 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.682 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 85.9 mt-10 -132.69 127.4 34.74 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.057 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 1.7 mm? -77.53 83.73 3.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.682 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 5.0 mmm -80.58 -51.3 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.578 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 78.0 m-85 -66.29 -41.25 41.14 Favored Pre-proline 0 N--CA 1.503 2.195 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 56.4 Cg_endo -86.48 114.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.442 1.233 . . . . 0.0 111.927 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.545 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 90.3 Cg_endo -91.96 151.38 3.28 Favored 'Trans proline' 2 CA--C 1.675 7.545 0 CA-C-O 113.269 -2.888 . . . . 0.0 112.679 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 22.3 Cg_endo -84.95 177.39 27.9 Favored 'Cis proline' 1 N--CA 1.579 6.526 1 C-N-CA 92.828 -14.238 . . . . 0.0 114.271 -1.203 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -85.53 128.06 34.63 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -160.21 111.19 1.9 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.522 -1.361 . . . . 0.0 109.708 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.4 ' HG ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.15 -144.67 0.14 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.693 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.98 175.82 31.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.24 165.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.367 -1.078 . . . . 0.0 109.79 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 1.05 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -96.12 139.33 14.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -60.09 -26.25 66.05 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.633 -0.922 . . . . 0.0 110.558 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 110.89 135.65 6.93 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.0 m -107.63 129.82 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.888 -0.772 . . . . 0.0 109.993 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG21 ' A' ' 8' ' ' VAL . 37.0 tp60 -79.05 146.46 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 92' ' ' TYR . 40.9 mt -117.46 129.91 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.526 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 23.0 m-85 -109.95 140.21 44.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.689 -0.632 . . . . 0.0 111.3 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.42 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.132 0.492 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.69 151.29 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.618 -0.676 . . . . 0.0 109.604 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . . . -130.55 133.86 46.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.449 -0.782 . . . . 0.0 111.562 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.122 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 49.1 mt-30 -150.69 149.92 27.01 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.597 . . . . 0.0 111.141 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.91 139.99 37.41 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 N-CA-C 108.337 -1.447 . . . . 0.0 108.337 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.47 66.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.271 -0.893 . . . . 0.0 110.891 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.586 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.8 p -155.93 166.61 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.1 154.72 28.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.319 0.581 . . . . 0.0 109.513 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.24 130.04 55.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.24 132.69 46.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.733 . . . . 0.0 110.789 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.07 175.5 4.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.786 -0.571 . . . . 0.0 109.527 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -60.18 -35.23 74.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -60.37 -32.63 71.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.6 -0.687 . . . . 0.0 110.163 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.92 5.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.3 mp -105.34 101.78 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.921 . . . . 0.0 109.247 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.39 122.98 47.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.6 t -131.92 131.72 42.93 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.381 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -144.42 159.99 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.73 125.47 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.699 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.754 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 49.6 t -107.02 105.81 16.01 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 16.7 pt-20 -80.22 152.15 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.05 . . . . 0.0 111.098 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.403 ' CB ' HG12 ' A' ' 96' ' ' VAL . 43.8 p90 -139.94 178.86 6.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.47 127.79 38.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.664 -0.648 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.9 p -139.86 148.68 56.28 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.548 -0.72 . . . . 0.0 110.206 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.88 140.03 28.26 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.392 1.207 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.54 -156.92 8.83 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -129.97 149.93 51.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.938 . . . . 0.0 110.127 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 155.48 40.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.526 -0.734 . . . . 0.0 109.98 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.7 p -80.46 -43.17 21.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.456 -0.777 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' CB ' ' HB2' ' A' ' 100' ' ' TYR . 33.2 mm-40 -80.4 114.4 19.27 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.597 0.713 . . . . 0.0 112.334 -176.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.3 t -128.48 87.2 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 52.6 ttt85 -58.67 110.99 1.11 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.389 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.1 m -113.91 127.59 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.628 0.728 . . . . 0.0 110.178 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 93.2 m -128.75 140.45 51.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.713 -0.617 . . . . 0.0 109.574 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.7 t -109.79 136.94 44.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.9 mt -122.94 159.94 27.22 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.853 -1.154 . . . . 0.0 111.31 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -120.85 118.09 29.07 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -99.93 132.64 45.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.435 -0.791 . . . . 0.0 111.33 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.42 161.82 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.69 -41.31 90.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.503 -0.748 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 m -70.58 -57.19 4.99 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 110.83 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -154.29 169.57 23.36 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.4 -0.813 . . . . 0.0 110.734 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.35 137.53 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.655 -0.653 . . . . 0.0 109.28 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.2 p -132.55 162.4 31.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.472 -0.767 . . . . 0.0 110.89 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 36.9 tt0 -80.02 158.1 26.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.582 -0.699 . . . . 0.0 109.937 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 93.8 t -119.38 -82.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.675 ' SG ' ' O ' ' A' ' 64' ' ' SER . 92.8 m -120.15 154.09 35.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.909 -1.119 . . . . 0.0 109.978 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.23 132.89 5.61 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.397 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.38 159.67 4.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -93.4 110.2 21.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 109.869 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 23.7 t80 -72.67 124.44 25.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.384 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.409 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.4 mmt -86.07 144.51 27.51 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 34.1 mmt -59.79 -28.09 67.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.82 -22.59 9.31 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.694 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -129.9 158.21 40.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.177 -1.19 . . . . 0.0 111.467 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -113.57 135.47 53.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.031 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.6 mp -96.32 167.43 11.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.729 0.776 . . . . 0.0 111.742 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -114.79 160.0 19.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.9 m-85 -96.36 124.43 40.36 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.6 tp -59.81 -44.19 94.12 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -144.04 -166.44 2.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.0 111.705 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 55.82 59.27 3.89 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.46 0.648 . . . . 0.0 110.12 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.675 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 70.1 m 57.39 105.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.408 0.623 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.78 92.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.783 -0.573 . . . . 0.0 110.287 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.446 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 76.1 m -69.99 163.34 26.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -138.24 150.38 46.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.414 -0.804 . . . . 0.0 109.218 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.92 43.24 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.872 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.4 m -130.1 166.41 20.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.045 -0.679 . . . . 0.0 109.476 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 65.5 m -152.87 122.77 6.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.755 -0.591 . . . . 0.0 109.554 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.6 p -148.94 148.15 29.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.96 -125.53 27.49 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.23 19.06 20.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.909 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.8 mt-30 -123.98 122.72 38.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.237 -0.915 . . . . 0.0 110.876 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 21' ' ' CYS . 5.4 m -105.57 123.78 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -99.61 114.03 26.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.185 -0.947 . . . . 0.0 111.225 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.81 129.53 48.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.7 m -119.55 132.58 55.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -110.16 129.89 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -122.1 121.87 37.93 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.808 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.62 45.75 0.89 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.9 mt -79.86 133.55 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.788 0.804 . . . . 0.0 111.836 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -120.05 167.54 12.09 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.39 84.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.268 -0.895 . . . . 0.0 109.842 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -68.09 -39.14 82.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.708 -0.62 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.2 -22.6 66.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.536 -0.728 . . . . 0.0 111.345 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -51.52 136.48 26.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.41 -164.81 34.68 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.575 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 26.9 tp -84.27 131.7 34.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.723 -0.869 . . . . 0.0 112.784 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 72.1 m-85 -113.55 127.15 55.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.4 mp -110.09 130.33 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.617 -0.677 . . . . 0.0 112.792 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.173 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -80.06 148.64 30.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.8 tttt -142.79 82.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.419 ' CG2' HD22 ' A' ' 106' ' ' LEU . 3.2 p -93.95 115.28 32.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 122.181 0.991 . . . . 0.0 111.078 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 62.0 mt-10 -131.9 131.04 42.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -80.99 75.78 7.96 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 ttm -80.26 -34.58 36.94 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.471 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 16.8 m-85 -69.0 -44.36 28.54 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 119.389 -0.924 . . . . 0.0 113.144 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -90.42 105.49 0.32 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 N-CA-C 114.958 1.099 . . . . 0.0 114.958 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.88 155.82 43.54 Favored 'Trans proline' 1 CA--C 1.659 6.759 0 CA-C-O 112.825 -3.073 . . . . 0.0 109.081 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -87.98 172.81 30.98 Favored 'Cis proline' 3 C--N 1.494 8.196 1 C-N-CA 90.435 -15.235 . . . . 0.0 116.032 -12.051 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 2.7 t80 -90.8 134.98 34.03 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.518 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -160.5 113.5 2.05 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.679 1.191 . . . . 0.0 109.583 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 96' ' ' VAL . 2.8 tp -158.26 -146.32 0.15 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.014 -1.054 . . . . 0.0 110.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.17 170.66 32.72 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.979 -1.581 . . . . 0.0 112.389 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.69 152.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 122.189 -0.595 . . . . 0.0 109.69 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 1.173 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -80.53 148.41 29.24 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -60.46 -38.65 84.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.988 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.96 136.62 5.94 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.295 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.2 m -119.93 141.75 49.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.474 ' O ' HG21 ' A' ' 8' ' ' VAL . 33.3 tt0 -89.88 124.04 34.35 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.596 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.425 ' HB ' ' CE2' ' A' ' 92' ' ' TYR . 23.9 mm -87.85 123.98 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.586 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 4.4 m-30 -95.02 151.08 19.49 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.854 0.835 . . . . 0.0 111.536 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.613 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.085 0.469 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.46 125.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.637 -0.664 . . . . 0.0 109.246 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.08 137.73 54.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.444 -0.785 . . . . 0.0 110.651 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -150.55 144.47 17.4 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.667 . . . . 0.0 111.117 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.87 147.58 50.17 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.324 1.171 . . . . 0.0 109.745 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.86 -26.55 29.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 109.45 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.8 p -153.61 155.99 5.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.043 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.05 151.45 25.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.222 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.6 mt -105.32 126.61 52.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 154.11 42.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.47 -0.769 . . . . 0.0 110.561 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 m -97.37 -179.93 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.802 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 m -53.36 160.97 1.04 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.83 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 58.8 18.12 5.79 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.747 -0.596 . . . . 0.0 111.401 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.71 39.06 86.38 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.163 -0.96 . . . . 0.0 111.213 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.4 mp -99.52 99.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.152 -1.205 . . . . 0.0 108.854 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 108.907 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.6 p -135.56 149.98 49.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.672 0.748 . . . . 0.0 111.237 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.17 163.95 38.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.06 113.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.548 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.3 t -100.08 109.95 22.24 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.2 pt-20 -80.77 164.03 23.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.958 . . . . 0.0 111.77 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CG ' ' CG1' ' A' ' 96' ' ' VAL . 46.5 p90 -145.83 178.28 8.29 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.12 131.31 53.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.4 p -142.34 160.65 53.78 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.747 -0.596 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.06 -10.37 28.17 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.46 1.242 . . . . 0.0 111.503 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.44 27.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt 52.01 -155.01 0.17 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.265 -1.138 . . . . 0.0 110.063 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.6 117.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 53' ' ' MET . 47.7 p -79.91 -35.69 37.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -80.04 120.09 23.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.091 0.948 . . . . 0.0 112.779 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.1 t -132.05 83.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.731 ' HD3' ' SD ' ' A' ' 99' ' ' MET . 12.4 ttt180 -59.04 114.9 2.81 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.384 0.611 . . . . 0.0 111.664 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.16 152.8 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 95' ' ' LYS . 59.0 m -147.64 140.09 24.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.7 -0.625 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 93.7 t -115.96 131.64 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 15.2 mt -121.98 160.02 25.75 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.696 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp-105 -116.93 129.94 56.38 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -102.92 140.02 37.73 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.27 155.25 49.73 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.09 -43.98 95.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.82 -44.09 67.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.549 -0.72 . . . . 0.0 111.055 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -164.43 167.92 19.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.4 -0.813 . . . . 0.0 110.95 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.16 137.27 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.1 p -130.04 168.23 17.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.29 -0.881 . . . . 0.0 111.224 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 52.5 mt-10 -79.92 154.07 28.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.706 -0.621 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 89.8 t -118.05 -75.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.765 -0.585 . . . . 0.0 110.391 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.977 ' SG ' ' CG ' ' A' ' 63' ' ' ASP . 85.2 m -130.31 165.66 22.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.387 -0.821 . . . . 0.0 110.622 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.11 3.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.218 -0.926 . . . . 0.0 111.677 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -174.19 140.49 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -85.52 105.65 16.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 72' ' ' SER . 32.1 t80 -60.23 127.93 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.596 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.3 mmt -95.72 134.31 38.79 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 34.8 mmt -56.96 -20.38 23.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.101 -0.999 . . . . 0.0 111.077 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.11 -12.83 8.06 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.249 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -129.98 159.94 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.985 -1.303 . . . . 0.0 111.223 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -109.85 131.95 54.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.698 -0.626 . . . . 0.0 110.264 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -93.95 153.88 17.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.486 -0.759 . . . . 0.0 110.861 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.6 p -101.72 140.62 35.77 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.545 0.688 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 72.0 m-85 -100.2 30.97 3.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -60.0 -35.83 75.89 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.531 -0.731 . . . . 0.0 111.331 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -52.08 -25.93 9.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.977 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 2.8 p30 -113.66 11.54 18.21 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.611 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 59.0 137.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.057 0.932 . . . . 0.0 111.877 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 mt 58.86 -131.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.306 -0.872 . . . . 0.0 110.315 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 69.1 m 51.61 67.82 0.9 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.248 -1.533 . . . . 0.0 111.31 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -132.72 149.89 52.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.1 -140.02 4.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 m -129.01 164.92 22.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.723 -0.869 . . . . 0.0 110.499 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 22.0 m -166.38 120.15 1.1 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -158.25 153.51 25.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.22 -124.36 35.61 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.26 12.09 26.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.748 -0.854 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 37.6 mt-30 -120.8 122.09 39.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.182 -0.949 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 3.5 m -107.41 123.74 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.422 -0.799 . . . . 0.0 109.713 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.54 113.43 27.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 111.194 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.422 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 91.5 mt -105.7 129.23 53.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.454 -0.779 . . . . 0.0 109.217 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.1 m -124.53 137.67 54.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 110.738 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.5 mt -111.62 139.58 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.707 -0.621 . . . . 0.0 110.144 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.428 ' HG2' HG13 ' A' ' 16' ' ' ILE . 82.1 mt-30 -120.02 120.53 36.6 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.997 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.68 51.91 0.73 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 80.9 mt -99.69 130.03 45.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.987 . . . . 0.0 111.504 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -105.39 179.97 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.07 87.33 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.776 0.798 . . . . 0.0 109.533 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.7 mtp -60.37 -39.94 89.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.147 0.498 . . . . 0.0 110.82 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -57.95 -27.11 63.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.6 -0.688 . . . . 0.0 111.018 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -50.0 140.02 12.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.555 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.62 -161.85 33.0 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.635 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.8 tm? -88.68 139.91 29.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.888 0.852 . . . . 0.0 112.086 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.412 ' CD2' HD11 ' A' ' 115' ' ' ILE . 42.3 m-85 -127.58 128.19 45.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.7 mp -100.77 129.9 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.302 -0.874 . . . . 0.0 112.182 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.925 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.2 p -91.07 126.24 36.1 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 5.5 mtmt -116.72 145.75 43.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.137 -0.977 . . . . 0.0 110.145 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 ' CG1' ' CG ' ' A' ' 23' ' ' TYR . 26.6 t -142.6 104.57 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.964 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.5 mm-40 -133.23 140.09 47.32 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.599 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.0 mt -93.01 81.14 4.56 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 103.779 -2.675 . . . . 0.0 103.779 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.731 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 1.4 mtt -80.51 -30.58 37.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.411 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.445 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 71.5 m-85 -75.45 -49.08 3.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.29 -0.881 . . . . 0.0 111.853 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 100' ' ' TYR . 41.3 Cg_endo -74.76 120.74 6.27 Favored 'Trans proline' 0 N--CA 1.518 2.924 0 C-N-CA 121.841 1.694 . . . . 0.0 114.813 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.41 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 63.1 Cg_endo -82.2 148.13 14.83 Favored 'Trans proline' 1 CA--C 1.659 6.758 0 CA-C-O 114.187 -2.505 . . . . 0.0 111.06 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.329 58.0 Cg_endo -116.39 58.25 0.38 Allowed 'Cis proline' 0 C--N 1.398 3.156 1 C-N-CA 95.048 -13.313 . . . . 0.0 109.053 10.955 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.2 t80 55.67 118.85 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.093 0 O-C-N 120.942 -1.099 . . . . 0.0 112.629 172.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 4.3 p90 -165.71 105.55 0.72 Allowed 'General case' 0 N--CA 1.529 3.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tp -158.87 -149.38 0.21 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 118.692 0.678 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.22 174.13 34.08 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.281 -1.438 . . . . 0.0 110.753 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 95' ' ' LYS . 48.8 mm -120.26 163.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.954 -0.733 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.925 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -94.04 140.04 14.85 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.99 -38.26 82.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.479 -1.013 . . . . 0.0 110.393 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 128.87 148.53 6.68 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.011 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.0 m -118.15 140.01 50.42 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.437 ' O ' HG21 ' A' ' 8' ' ' VAL . 23.3 tt0 -89.28 129.99 35.75 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.221 -1.392 . . . . 0.0 108.741 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.412 HD11 ' CD2' ' A' ' 92' ' ' TYR . 88.8 mt -94.35 131.95 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.553 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 7.9 m-30 -106.71 149.92 26.8 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.139 0.495 . . . . 0.0 111.491 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.597 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.373 0.606 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 5' ' ' GLN . 71.0 t -125.76 129.68 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.8 132.14 52.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 110.558 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.402 ' NE2' ' CG1' ' A' ' 3' ' ' VAL . 17.2 mp0 -135.82 131.93 19.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.641 -0.662 . . . . 0.0 110.851 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.52 139.86 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.132 1.069 . . . . 0.0 109.799 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.18 -32.28 64.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.808 . . . . 0.0 109.443 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.51 157.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.916 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 t -139.91 136.64 38.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.666 0.746 . . . . 0.0 110.594 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 2.8 mm? -97.63 125.13 42.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.4 151.25 23.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.425 -0.797 . . . . 0.0 110.245 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -75.82 172.24 13.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.552 -0.717 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -59.65 -29.0 67.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.01 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -59.93 -27.78 67.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.597 -0.689 . . . . 0.0 109.867 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.41 23.36 12.65 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -110.25 109.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 O-C-N 121.5 -1.0 . . . . 0.0 110.534 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.47 118.32 36.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 81.7 p -123.95 140.58 52.84 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.531 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -149.92 164.86 34.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.891 -0.505 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.65 114.16 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.134 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.442 ' O ' HG21 ' A' ' 77' ' ' VAL . 42.2 t -100.05 107.49 19.42 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 82.9 mt-10 -79.98 165.03 23.0 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 111.678 -176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.43 ' CG ' HG13 ' A' ' 96' ' ' VAL . 43.4 p90 -149.88 -179.95 7.55 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.9 128.52 43.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -112.6 150.42 42.66 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.425 -0.797 . . . . 0.0 111.116 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.27 -19.31 38.65 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.712 1.375 . . . . 0.0 111.34 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.13 -165.81 29.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.77 126.5 38.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.638 -0.919 . . . . 0.0 110.728 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.65 38.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.682 -0.636 . . . . 0.0 109.588 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 53' ' ' MET . 62.8 p -79.9 -37.88 33.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 110.675 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 6.4 mm-40 -79.93 112.48 17.27 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.861 -0.735 . . . . 0.0 112.331 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.97 82.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ttp85 -60.17 121.42 11.9 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.392 0.615 . . . . 0.0 111.43 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -124.34 132.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.6 m -125.55 131.27 52.79 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.236 0.541 . . . . 0.0 110.66 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 87.9 t -104.54 139.15 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 19.6 mt -125.12 164.02 21.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 111.587 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -116.51 91.64 3.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.463 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 6.5 tt0 -93.63 140.05 30.07 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.29 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 154.53 37.77 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.1 -42.88 91.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 96.4 p -70.21 -43.61 70.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.599 -0.688 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -156.88 160.69 39.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.385 -0.822 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.35 130.39 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.3 p -139.91 165.88 26.14 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.452 -0.78 . . . . 0.0 111.416 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 72.0 mt-10 -81.07 160.3 24.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.631 -0.668 . . . . 0.0 109.832 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 60.1 t -123.75 -85.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.621 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 1.217 ' SG ' ' CG ' ' A' ' 60' ' ' PHE . 18.5 t -118.79 152.69 35.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.959 -1.088 . . . . 0.0 110.112 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.81 128.52 1.41 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.391 -0.818 . . . . 0.0 112.654 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . . . -172.0 161.42 5.66 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -83.11 119.98 25.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.017 -1.052 . . . . 0.0 109.596 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 72' ' ' SER . 12.8 t80 -78.99 109.58 13.43 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.243 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 53' ' ' MET . 6.1 mmm -84.82 138.61 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.1 mmt -58.15 -20.2 38.8 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.16 -0.963 . . . . 0.0 110.921 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.73 -93.17 1.67 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -80.43 164.18 23.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.526 -0.985 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 40.3 tp10 -110.12 130.11 55.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.812 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.03 169.49 18.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.465 -0.772 . . . . 0.0 110.467 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 p -96.53 164.27 12.68 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 1.217 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 49.4 m-85 -116.16 92.61 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.532 -0.73 . . . . 0.0 110.218 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.66 -28.79 67.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.3 -42.0 97.92 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.567 -0.708 . . . . 0.0 111.38 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.885 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . 23.9 t0 -100.02 11.99 37.98 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 122.038 -0.414 . . . . 0.0 112.035 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t 62.02 -67.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.998 -0.439 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 63' ' ' ASP . 89.1 mt -132.1 73.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.98 . . . . 0.0 111.668 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 1.115 ' SG ' ' CB ' ' A' ' 60' ' ' PHE . 1.8 p -113.07 158.08 20.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.208 -0.932 . . . . 0.0 109.176 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -130.65 150.03 52.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.491 -0.756 . . . . 0.0 109.836 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.66 148.95 19.54 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.777 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 75.3 m -129.86 160.29 33.97 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 32.9 t -146.96 108.31 4.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -120.17 123.78 44.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.614 -0.678 . . . . 0.0 109.46 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 -120.55 23.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.88 19.21 20.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.982 . . . . 0.0 110.682 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.8 mt-30 -116.78 120.16 37.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -104.52 123.94 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.05 -1.031 . . . . 0.0 109.416 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 54.2 t-20 -103.79 108.03 19.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 111.372 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 68.0 mt -104.49 139.95 38.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.451 -0.78 . . . . 0.0 109.536 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.6 m -140.84 152.02 44.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 62.5 mt -120.01 139.87 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.402 ' CG ' HG13 ' A' ' 16' ' ' ILE . 38.7 mt-30 -115.79 121.54 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.658 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 51.96 0.7 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.7 mt -97.2 117.34 31.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.609 -0.936 . . . . 0.0 111.246 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -102.44 -179.73 4.06 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.05 92.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -38.52 89.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.724 -0.61 . . . . 0.0 110.523 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.38 -26.91 66.69 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.644 -0.66 . . . . 0.0 110.735 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 m -51.51 134.27 29.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.863 . . . . 0.0 110.557 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.8 -150.29 13.83 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.406 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.463 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 13.6 tp -107.57 134.48 50.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.664 -0.903 . . . . 0.0 111.833 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.459 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 74.9 m-85 -116.24 145.31 43.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 4.7 mp -112.68 129.73 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.357 -0.839 . . . . 0.0 111.96 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.3 p -92.46 123.99 36.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.4 tttt -117.79 138.79 51.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -0.802 . . . . 0.0 108.9 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.457 ' CG1' HD22 ' A' ' 106' ' ' LEU . 4.6 t -135.96 112.81 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.584 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 77.4 mt-10 -138.56 123.94 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.864 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 8.9 mp -76.2 81.85 3.0 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 40.5 tpp -79.03 -52.17 8.6 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 88.5 m-85 -69.09 -38.24 10.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.37 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 29.1 Cg_endo -83.08 112.02 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 CA-C-N 119.832 0.976 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 58.9 Cg_endo -83.25 150.77 13.62 Favored 'Trans proline' 1 CA--C 1.665 7.065 1 CA-C-O 110.57 -4.012 . . . . 0.0 113.244 176.023 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.253 37.4 Cg_endo -89.69 174.38 23.49 Favored 'Cis proline' 0 C--N 1.403 3.396 1 C-N-CA 95.287 -13.214 . . . . 0.0 118.711 -8.782 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.9 t80 -82.05 127.49 33.15 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.562 -2.563 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -160.79 105.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.375 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.457 HD22 ' CG1' ' A' ' 96' ' ' VAL . 3.4 tp -158.23 -144.17 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.29 174.44 39.55 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.726 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.2 mp -123.85 168.76 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 122.082 -0.658 . . . . 0.0 109.732 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.18 144.93 17.88 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.76 -38.99 87.07 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.605 1.202 . . . . 0.0 110.345 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 138.86 163.73 9.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.025 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.3 m -124.01 133.84 53.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 8' ' ' VAL . 34.5 tp60 -75.98 139.76 41.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 52.3 mt -116.21 124.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.897 -1.127 . . . . 0.0 108.642 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.545 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 28.8 m-85 -104.42 140.13 38.37 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.831 178.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.1 m170 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.339 0.59 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.1 t -147.95 144.84 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.01 117.7 30.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 111.552 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.02 ' OE1' ' SG ' ' A' ' 94' ' ' CYS . 1.2 mm-40 -142.34 141.36 20.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.617 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.27 138.11 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.216 1.114 . . . . 0.0 109.549 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.35 -30.21 67.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.547 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -149.57 156.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.951 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.18 151.27 21.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.31 0.576 . . . . 0.0 109.457 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.8 mt -110.06 130.03 55.6 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 135.34 33.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.507 -0.746 . . . . 0.0 110.595 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.02 173.34 6.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.714 -0.616 . . . . 0.0 110.513 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -60.12 -29.4 68.59 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.631 -0.668 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.33 -29.73 69.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.547 -0.721 . . . . 0.0 109.905 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 25.28 10.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.8 mp -114.18 115.61 50.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.97 . . . . 0.0 110.271 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.03 127.4 53.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -127.22 133.59 50.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 111.617 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -143.63 167.02 23.24 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -128.89 124.38 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.475 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.551 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 42.3 t -99.99 109.04 21.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 60.2 tt0 -86.49 140.56 29.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.479 -0.763 . . . . 0.0 110.939 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -129.62 161.94 29.41 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.16 130.54 18.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.0 p -159.99 160.0 27.04 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 0.0 110.388 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.13 148.23 49.89 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.391 1.206 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.6 167.47 8.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.98 149.58 51.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.943 . . . . 0.0 110.318 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 149.96 33.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 43.3 p -79.99 -33.4 39.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.38 -0.825 . . . . 0.0 110.76 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 23.2 mm-40 -80.17 74.29 6.98 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.268 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 52' ' ' TYR . 14.5 m -91.98 87.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.551 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 72.3 ttt-85 -53.1 105.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.693 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -107.55 131.21 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.79 0.805 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.6 m -135.94 150.21 49.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 0.0 109.409 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 94.2 t -117.51 140.03 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 17.4 mt -127.87 164.51 22.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.887 -1.133 . . . . 0.0 110.915 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -127.4 117.28 21.87 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -105.24 123.96 48.73 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.612 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.44 154.28 39.28 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.74 -43.8 94.07 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.467 -0.771 . . . . 0.0 110.422 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.3 m -68.0 -49.79 59.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.579 -0.7 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -154.5 160.75 41.74 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 111.096 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.97 134.23 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.592 -0.692 . . . . 0.0 109.294 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -140.76 164.02 31.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 30.5 tt0 -79.91 156.9 27.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 109.841 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -113.64 -89.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.895 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.446 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 93.4 m -122.68 149.94 43.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.801 -1.187 . . . . 0.0 110.28 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.22 140.01 21.78 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.819 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -172.0 153.54 3.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -91.89 120.62 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 53' ' ' MET . 16.1 t80 -79.16 109.15 13.21 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.983 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.46 169.96 17.0 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.423 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 34.4 mmt -67.63 -28.77 68.01 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.001 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.91 35.63 1.48 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.297 -1.43 . . . . 0.0 112.57 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 81.6 m-20 -130.32 159.95 35.42 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 119.151 1.476 . . . . 0.0 110.272 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -83.41 139.98 32.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.434 HD12 ' CD2' ' A' ' 52' ' ' TYR . 6.6 mp -89.17 129.97 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 110.242 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 p -99.98 135.57 41.2 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.494 -0.754 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 95.2 m-85 -107.99 114.91 29.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.26 -43.72 95.91 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.565 -0.709 . . . . 0.0 112.833 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -149.38 -161.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.024 -1.047 . . . . 0.0 111.632 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 56.75 58.07 4.33 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.473 0.654 . . . . 0.0 110.088 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 57.74 164.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.62 85.75 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 110.465 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 60' ' ' PHE . 97.5 m -68.07 153.24 44.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.577 -0.702 . . . . 0.0 109.462 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -140.0 150.01 43.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 109.305 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.9 179.98 43.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.1 m -130.19 169.25 15.61 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.12 -0.635 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 52' ' ' TYR . 44.5 m -155.04 124.57 6.43 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.2 p -141.09 145.53 35.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.464 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.8 -122.37 16.35 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -105.72 11.98 31.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.801 -0.823 . . . . 0.0 111.016 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.5 mt-30 -116.69 126.68 53.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.873 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.89 123.48 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.899 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -100.61 118.62 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.0 111.435 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 76.1 mt -111.84 137.22 50.09 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.2 m -128.32 140.21 51.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.253 -0.905 . . . . 0.0 110.927 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 92' ' ' TYR . 88.5 mt -116.85 132.79 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.638 -0.664 . . . . 0.0 110.102 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.4 ' CG ' HG13 ' A' ' 16' ' ' ILE . 19.7 mt-30 -118.94 121.39 39.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.589 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.86 54.19 0.57 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.85 120.01 31.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.601 -0.941 . . . . 0.0 110.953 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -98.07 178.95 4.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.66 90.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.281 -0.887 . . . . 0.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -66.79 -37.44 84.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.696 -0.627 . . . . 0.0 110.565 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.88 -33.5 71.9 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -51.99 130.92 30.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.27 -142.02 7.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 tp -109.05 129.19 55.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.672 -0.899 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 73.3 m-85 -109.99 132.06 54.5 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.0 mp -110.07 130.05 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.732 -0.605 . . . . 0.0 111.731 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.077 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 19.9 p -79.9 155.78 27.59 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 5.3 tptm -147.15 79.09 1.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 108.759 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.407 ' CG2' HD22 ' A' ' 106' ' ' LEU . 3.6 p -95.79 115.24 34.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.147 0.975 . . . . 0.0 110.614 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 67.8 mm-40 -135.17 137.24 42.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.787 -0.571 . . . . 0.0 111.703 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.453 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 13.8 mt -83.98 75.46 10.13 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.4 ttm -79.9 -32.42 40.25 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.472 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.2 m-85 -87.03 -39.55 0.52 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.332 -0.855 . . . . 0.0 112.426 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 59.0 Cg_endo -92.59 118.71 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-O 121.556 0.565 . . . . 0.0 110.698 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.592 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 60.7 Cg_endo -91.13 156.01 3.84 Favored 'Trans proline' 1 CA--C 1.655 6.562 0 CA-C-O 113.372 -2.845 . . . . 0.0 111.123 177.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 44.2 Cg_endo -89.94 175.47 21.15 Favored 'Cis proline' 3 N--CA 1.644 10.334 1 C-N-CA 91.289 -14.88 . . . . 0.0 116.263 1.059 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 4.0 t80 -82.58 129.57 34.96 Favored 'General case' 0 C--N 1.266 -3.025 0 O-C-N 119.626 -1.921 . . . . 0.0 109.167 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -166.7 104.9 0.6 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.426 -1.421 . . . . 0.0 108.376 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.407 HD22 ' CG2' ' A' ' 96' ' ' VAL . 4.3 tp -157.71 -147.96 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.484 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.48 170.96 34.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.249 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.22 146.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -1.087 . . . . 0.0 109.187 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 1.077 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -73.63 141.58 29.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -60.07 -30.59 69.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -1.046 . . . . 0.0 109.709 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.72 138.77 5.93 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.492 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.5 m -111.64 139.78 46.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.545 ' O ' HG21 ' A' ' 8' ' ' VAL . 34.1 tp60 -83.45 120.72 26.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.258 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 53.8 mt -96.79 114.23 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.619 -1.301 . . . . 0.0 108.592 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.547 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 12.4 m-85 -87.81 139.11 30.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.389 0.614 . . . . 0.0 111.552 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.4 t . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.603 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.293 0.568 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 128.11 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.329 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.21 128.83 56.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.453 -0.78 . . . . 0.0 110.737 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.087 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 27.1 mm100 -139.45 131.95 15.27 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.729 -0.607 . . . . 0.0 111.214 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.51 139.21 25.39 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.119 1.063 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -33.41 71.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.789 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG23 ' CE2' ' A' ' 116' ' ' TYR . 3.1 p -152.72 156.26 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.529 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.84 155.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.33 129.99 56.11 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.928 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.03 27.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.616 -0.677 . . . . 0.0 110.29 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.3 t -89.58 176.93 6.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.554 -0.716 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -59.97 -28.77 67.94 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.076 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.29 22.59 21.84 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.8 mp -114.73 114.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.501 -0.999 . . . . 0.0 109.877 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.02 49.92 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -132.8 150.01 52.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.008 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 32.4 p90 -152.06 163.11 40.0 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -119.4 122.71 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.087 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 41.4 t -100.78 100.54 11.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.95 149.97 30.66 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.318 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -132.68 173.56 11.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.04 120.59 22.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.391 -0.818 . . . . 0.0 111.154 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.7 t -151.62 149.95 25.32 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 111.053 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.84 147.95 31.52 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.694 1.365 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.51 -176.15 0.44 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.89 160.05 36.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.845 . . . . 0.0 109.73 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 1.018 ' O ' ' SD ' ' A' ' 54' ' ' MET . . . -148.4 171.94 15.23 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.312 -0.867 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.833 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.8 p -86.26 -5.39 59.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.611 -0.681 . . . . 0.0 112.622 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 6.4 mm-40 -129.16 76.44 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.914 -1.514 . . . . 0.0 112.91 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 52' ' ' TYR . 92.0 t -91.94 86.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -63.16 123.33 18.35 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.366 0.603 . . . . 0.0 111.618 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.99 161.24 34.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.6 m -152.73 138.95 18.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 88.2 t -108.84 128.9 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -124.82 165.01 18.79 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.491 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -128.3 121.25 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -103.3 131.96 49.93 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.974 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.74 -174.17 2.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.94 -0.475 . . . . 0.0 109.814 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.43 -43.69 96.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 m -130.08 -3.28 4.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.814 . . . . 0.0 111.88 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -132.31 152.35 51.43 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.061 -1.024 . . . . 0.0 110.988 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.33 138.62 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.617 . . . . 0.0 109.864 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.1 p -136.9 162.8 32.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.584 -0.697 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -79.91 153.73 28.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.605 -0.684 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.966 HG13 ' SG ' ' A' ' 48' ' ' CYS . 86.5 t -120.72 -50.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.636 -0.665 . . . . 0.0 110.646 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.966 ' SG ' HG13 ' A' ' 47' ' ' VAL . 1.3 m -155.96 132.29 10.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.239 -0.913 . . . . 0.0 110.201 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.61 138.46 36.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.444 -0.785 . . . . 0.0 111.188 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.63 156.48 6.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.644 -0.66 . . . . 0.0 109.656 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.611 HG23 ' SD ' ' A' ' 53' ' ' MET . 3.0 m -90.64 124.08 34.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 109.575 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD2' ' CB ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -69.89 90.06 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.833 ' SD ' ' O ' ' A' ' 30' ' ' THR . 61.8 mmm -88.13 122.52 31.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 1.018 ' SD ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -59.83 -27.96 67.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.035 -1.04 . . . . 0.0 110.265 -178.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.45 -42.1 7.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -110.48 151.02 28.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.245 -1.15 . . . . 0.0 111.554 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -77.04 150.23 35.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.58 -0.7 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -71.15 136.93 48.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.514 -0.741 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.1 p -118.28 139.61 51.06 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.525 -0.734 . . . . 0.0 110.999 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 75.2 m-85 -107.63 112.0 24.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -68.0 -43.39 78.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.448 -0.782 . . . . 0.0 112.031 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -142.51 -158.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.262 -0.899 . . . . 0.0 111.339 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.65 57.01 4.5 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.412 0.625 . . . . 0.0 110.271 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p 57.13 166.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.325 0.583 . . . . 0.0 110.95 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.95 131.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.739 -0.601 . . . . 0.0 110.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 82.8 m -130.05 165.42 22.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.709 -0.619 . . . . 0.0 109.667 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 t -136.05 141.37 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.2 153.74 25.25 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.8 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.2 m -139.99 157.36 45.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD2' ' A' ' 52' ' ' TYR . 15.3 t -146.0 108.04 4.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.772 . . . . 0.0 110.512 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.7 t -148.28 148.1 30.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.831 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.74 38.58 96.7 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.06 27.42 13.3 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.692 -0.887 . . . . 0.0 110.227 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -132.12 128.62 38.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.591 -0.693 . . . . 0.0 109.814 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 2.9 m -104.45 120.29 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.34 -0.85 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -100.97 110.1 22.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -0.899 . . . . 0.0 111.175 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 86.9 mt -103.01 131.98 49.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.726 . . . . 0.0 109.242 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.8 m -130.88 150.33 52.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.335 -0.853 . . . . 0.0 111.188 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 62.4 mt -124.47 141.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.809 -0.557 . . . . 0.0 109.977 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.401 ' CG ' HG13 ' A' ' 16' ' ' ILE . 24.0 mt-30 -120.01 122.06 40.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.745 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.46 41.38 1.14 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.1 mt -89.35 129.95 35.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.956 . . . . 0.0 111.421 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -116.15 179.81 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.03 81.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.5 ttp -68.14 -35.86 78.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.64 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.522 -0.736 . . . . 0.0 111.387 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -49.65 142.51 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.357 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.24 35.02 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 21.1 tp -98.76 131.37 44.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.959 . . . . 0.0 112.75 -178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.425 ' CE1' HD11 ' A' ' 115' ' ' ILE . 86.1 m-85 -114.23 139.2 49.59 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.0 mp -108.91 141.45 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.386 -0.822 . . . . 0.0 111.818 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.038 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 17.3 p -104.66 112.72 25.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HG2' HG22 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -100.87 143.08 31.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.22 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.74 106.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.465 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CG ' ' OH ' ' A' ' 104' ' ' TYR . 22.1 mp0 -131.32 130.13 42.35 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.566 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.1 mt -84.61 80.36 9.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.7 tpp -79.74 -52.85 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.186 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.0 m-85 -68.75 -44.25 30.85 Favored Pre-proline 0 N--CA 1.508 2.464 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 60.3 Cg_endo -79.14 110.46 2.74 Favored 'Trans proline' 0 N--CA 1.518 2.932 0 C-N-CA 121.136 1.224 . . . . 0.0 110.885 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -83.18 155.22 14.63 Favored 'Trans proline' 1 CA--C 1.676 7.599 0 CA-C-O 111.686 -3.548 . . . . 0.0 105.643 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.07 -179.08 15.31 Favored 'Cis proline' 1 C--N 1.492 8.082 1 C-N-CA 95.527 -13.114 . . . . 0.0 116.297 -10.356 . . . . . . . . 3 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' OH ' ' CG ' ' A' ' 97' ' ' GLU . 4.4 t80 -87.37 132.15 34.06 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 117.469 -3.27 . . . . 0.0 110.467 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -163.43 92.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.042 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -148.36 0.24 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.074 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.1 179.0 38.58 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.468 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.8 mp -119.81 158.79 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 O-C-N 121.67 -0.9 . . . . 0.0 109.109 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.81 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -85.52 145.22 20.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.15 -34.54 73.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.297 -1.119 . . . . 0.0 110.727 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 122.95 135.27 4.56 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m -106.78 130.99 54.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 44.7 tt0 -85.11 123.99 31.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.835 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.425 HD11 ' CE1' ' A' ' 92' ' ' TYR . 82.3 mt -85.85 125.59 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.731 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CE2' HG23 ' A' ' 8' ' ' VAL . 4.6 m-30 -95.84 158.87 15.25 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.209 0.528 . . . . 0.0 110.38 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.596 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.1 m80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.363 0.601 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -149.26 137.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.826 -0.546 . . . . 0.0 110.043 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.47 127.33 53.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.557 -0.714 . . . . 0.0 109.876 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.004 ' CD ' ' SG ' ' A' ' 94' ' ' CYS . 14.0 mm-40 -139.95 131.52 14.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.658 -0.651 . . . . 0.0 111.745 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.65 139.93 28.79 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.141 1.074 . . . . 0.0 109.434 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.77 -33.81 74.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.725 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.69 HG23 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.68 155.77 7.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.615 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 t -133.01 148.2 31.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.52 127.48 52.25 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.684 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.81 175.18 6.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.465 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -109.45 175.81 5.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.42 -37.54 81.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.745 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -59.63 -30.22 68.56 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.682 -0.636 . . . . 0.0 110.312 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.14 27.03 9.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.3 mp -102.74 100.4 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.65 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.22 118.4 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.7 t -131.19 132.58 44.8 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.924 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -131.92 163.95 27.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.47 122.67 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.685 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.737 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 42.3 t -101.12 108.1 19.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -85.51 141.13 30.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.815 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' CG ' HG12 ' A' ' 96' ' ' VAL . 45.1 p90 -125.57 178.22 5.78 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.54 123.87 25.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.705 -0.622 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -116.18 132.71 23.13 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 109.941 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.51 -12.17 32.77 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.192 1.101 . . . . 0.0 112.159 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.03 27.2 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.358 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.82 136.47 44.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.694 -0.886 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.06 163.99 38.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.625 -0.672 . . . . 0.0 109.931 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' MET . 64.3 p -86.2 12.38 9.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.511 -0.743 . . . . 0.0 111.308 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 34.0 mm-40 -137.22 97.6 3.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.002 -1.479 . . . . 0.0 113.216 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 40.0 t -122.4 79.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -58.99 131.62 51.59 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.254 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -129.26 164.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.408 ' N ' ' HB3' ' A' ' 95' ' ' LYS . 87.1 m -160.0 157.97 29.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 110.084 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.8 t -122.14 134.06 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 8.4 mt -130.03 163.96 25.37 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.523 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -123.68 119.99 31.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -106.01 129.7 54.08 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.512 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.39 154.97 44.35 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.68 -43.19 94.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 0.0 110.621 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.1 m -68.85 -49.99 53.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -155.0 162.89 40.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.343 -0.848 . . . . 0.0 111.284 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -126.42 135.13 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.2 159.97 38.63 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.462 -0.774 . . . . 0.0 111.626 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 54.9 mt-10 -80.86 161.09 24.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.618 . . . . 0.0 110.71 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 96.1 t -127.64 -67.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.698 -0.626 . . . . 0.0 110.663 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 67.8 m -138.03 154.12 49.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.903 . . . . 0.0 111.77 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.56 136.13 8.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.787 -0.57 . . . . 0.0 110.579 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.38 146.56 22.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.575 -0.703 . . . . 0.0 109.12 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -80.05 127.55 32.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.241 -0.912 . . . . 0.0 110.116 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 1.2 t80 -79.99 103.47 9.9 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.3 mtp -95.81 131.09 42.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 21.0 mmt -59.76 -34.96 73.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.957 . . . . 0.0 110.733 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.18 -51.89 25.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.17 159.95 35.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.428 -1.042 . . . . 0.0 110.724 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -103.86 130.85 51.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -95.41 150.21 20.53 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.518 -0.738 . . . . 0.0 109.656 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 p -104.86 167.39 9.75 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.63 -0.669 . . . . 0.0 110.61 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.708 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 34.8 m-85 -92.9 100.6 13.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.664 -0.648 . . . . 0.0 109.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -103.85 2.35 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.531 -0.731 . . . . 0.0 111.77 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -67.92 -41.78 82.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -109.92 7.49 23.89 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 33.63 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 67' ' ' ILE . 26.8 mm -141.98 10.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 0.0 111.246 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 16.8 p -127.92 138.96 52.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.669 -1.269 . . . . 0.0 111.069 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -139.93 156.14 46.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.19 -179.83 43.33 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.6 m -117.43 163.57 16.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.034 -0.686 . . . . 0.0 109.579 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.416 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.3 p -153.18 113.8 4.05 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.2 m -143.66 146.94 33.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.053 -1.029 . . . . 0.0 110.948 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.63 -123.95 27.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -110.11 19.88 18.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.813 -0.816 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -125.79 129.95 50.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.05 126.95 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.723 . . . . 0.0 109.806 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -107.2 120.78 43.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.926 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.09 132.01 54.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.387 -0.821 . . . . 0.0 109.269 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 m -119.99 139.9 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.248 -0.907 . . . . 0.0 110.907 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.31 132.57 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.425 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.1 mt-30 -120.16 121.12 38.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.218 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.94 39.67 0.95 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.83 120.08 34.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.509 -0.994 . . . . 0.0 111.365 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -102.27 178.86 4.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.09 83.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.232 -0.917 . . . . 0.0 109.819 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 ttm -68.02 -33.76 75.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.74 -0.6 . . . . 0.0 110.824 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.04 -17.3 64.36 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.589 -0.694 . . . . 0.0 111.67 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.5 m -51.16 135.17 26.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.84 -155.26 19.22 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.778 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 15.1 tp -109.77 128.68 55.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.738 -0.86 . . . . 0.0 112.061 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 44.9 m-85 -112.29 144.88 40.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.2 mp -111.59 143.32 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 111.432 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.004 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 17.5 p -105.82 117.23 33.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.5 tptt -102.11 141.15 35.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.505 -0.747 . . . . 0.0 109.652 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.42 HG12 ' CG ' ' A' ' 23' ' ' TYR . 16.5 t -145.14 103.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -136.56 125.46 24.18 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.269 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 7.6 mp -79.73 77.22 6.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.8 tpp -80.47 -51.36 8.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.977 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 92.6 m-85 -67.17 -40.21 26.42 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 111.737 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 39.6 Cg_endo -86.99 120.74 1.66 Allowed 'Trans proline' 0 N--CA 1.504 2.109 0 N-CA-C 110.201 -0.73 . . . . 0.0 110.201 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.419 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 59.5 Cg_endo -97.8 159.21 0.9 Allowed 'Trans proline' 1 CA--C 1.662 6.879 0 CA-C-O 112.144 -3.357 . . . . 0.0 108.086 -177.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 71.9 Cg_endo -92.54 171.11 21.06 Favored 'Cis proline' 2 C--N 1.464 6.616 1 C-N-CA 95.217 -13.243 . . . . 0.0 119.232 -6.178 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -74.31 125.15 27.82 Favored 'General case' 0 N--CA 1.527 3.418 0 O-C-N 120.303 -1.498 . . . . 0.0 111.338 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' CD2' ' O ' ' A' ' 105' ' ' TYR 0.262 52.9 t80 -152.82 59.97 0.8 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.499 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -130.78 -152.8 0.53 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.36 24.98 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.333 -1.413 . . . . 0.0 109.919 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -122.26 154.66 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.574 -0.957 . . . . 0.0 110.391 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.719 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -81.08 138.75 19.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 177.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -60.31 -29.69 69.01 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -1.169 . . . . 0.0 110.285 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.42 145.85 7.28 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.6 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.3 m -114.02 131.54 56.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.461 ' HB3' HG22 ' A' ' 8' ' ' VAL . 11.2 tp60 -80.83 119.94 24.04 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.166 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 86.8 mt -86.86 119.99 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.053 . . . . 0.0 109.112 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 8' ' ' VAL . 7.6 m-30 -91.74 120.09 32.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.145 -0.347 . . . . 0.0 110.328 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.3 t . . . . . 0 N--CA 1.491 1.598 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.834 178.293 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.207 0.527 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.85 134.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.517 -0.74 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.02 131.38 54.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.108 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 25.9 mm100 -137.95 139.95 27.76 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.566 -0.709 . . . . 0.0 111.91 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.1 140.28 25.01 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 O-C-N 123.324 1.17 . . . . 0.0 109.109 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -151.7 159.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.713 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -137.82 156.02 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.374 0.607 . . . . 0.0 109.713 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.08 126.6 53.09 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.705 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.92 138.18 40.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.428 -0.795 . . . . 0.0 109.22 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -75.98 -65.29 0.93 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.422 -0.798 . . . . 0.0 111.547 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -160.02 168.22 26.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.473 -0.767 . . . . 0.0 110.369 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 54.16 21.05 2.83 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.674 -0.641 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.12 35.59 64.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.14 97.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 0.0 108.906 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.27 114.36 28.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -121.07 131.97 54.6 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.689 0.757 . . . . 0.0 111.246 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 24.3 p90 -140.47 161.63 37.25 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 85.4 t -120.4 125.33 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.455 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.108 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.5 t -104.38 130.0 52.27 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -102.83 138.75 39.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 111.378 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.449 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 19.7 p90 -137.32 -177.73 4.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.96 113.93 15.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.585 -0.697 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.5 p -141.75 164.37 34.93 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.542 -0.723 . . . . 0.0 110.151 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.96 155.95 64.02 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.389 1.205 . . . . 0.0 110.095 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.2 19.96 51.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -119.93 32.61 5.97 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.212 -1.17 . . . . 0.0 110.775 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.11 140.04 47.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.652 -0.655 . . . . 0.0 110.342 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' MET . 40.3 p -92.03 10.72 27.9 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.528 -0.732 . . . . 0.0 110.572 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -130.29 122.34 27.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.572 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 95.9 t -138.89 83.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 6.6 ttm180 -63.41 116.88 5.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.767 -0.583 . . . . 0.0 111.343 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 35.9 m -113.85 131.91 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -122.47 131.91 54.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.694 -0.629 . . . . 0.0 110.624 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 97.9 t -109.6 129.71 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 46.9 mt -125.46 165.14 18.98 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HG2' ' CE2' ' A' ' 92' ' ' TYR . 75.0 mtm180 -121.31 119.92 33.59 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.405 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 4.8 tt0 -97.45 141.46 30.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.91 157.03 47.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.79 -40.17 87.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.5 m -75.61 -53.36 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -154.47 174.59 14.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.77 139.93 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -130.1 161.46 30.99 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 49.6 mt-10 -80.1 158.95 26.26 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 110.844 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.448 HG13 ' SG ' ' A' ' 48' ' ' CYS . 46.0 t -135.16 -66.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.226 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 71.3 m -129.93 142.65 50.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.26 -0.9 . . . . 0.0 111.22 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.85 131.97 14.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.657 -0.652 . . . . 0.0 110.278 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.9 157.61 14.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 0.0 110.334 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -102.21 116.01 31.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 72' ' ' SER . 20.6 t80 -77.87 123.96 27.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.225 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 mtp -95.58 157.62 15.82 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.5 mmt -60.03 -27.63 67.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.843 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.04 48.01 0.99 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.971 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -157.81 -179.49 8.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.265 -1.138 . . . . 0.0 110.701 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -115.08 156.03 25.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 110.406 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 52' ' ' TYR . 85.3 mt -72.82 136.16 45.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.561 -0.712 . . . . 0.0 111.136 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.2 p -104.76 129.36 53.02 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.705 -0.622 . . . . 0.0 109.565 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 99.1 m-85 -119.99 66.2 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.761 . . . . 0.0 110.099 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.07 -39.48 90.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.536 -0.727 . . . . 0.0 110.767 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.58 131.27 44.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.434 -0.791 . . . . 0.0 110.728 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 52.17 49.01 21.51 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.492 -0.755 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -59.03 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.908 -0.495 . . . . 0.0 110.43 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm 52.36 22.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.386 -1.446 . . . . 0.0 110.921 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -160.03 160.65 33.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -123.88 139.92 53.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.55 121.72 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.978 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -130.06 155.12 46.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 68.9 m -160.06 137.95 9.94 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.857 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -140.27 140.06 35.65 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.89 -124.02 34.84 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -107.32 11.92 28.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.948 . . . . 0.0 110.927 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.406 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.0 mt-30 -116.65 129.29 56.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.122 -0.986 . . . . 0.0 111.016 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 5.7 m -110.12 126.23 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.433 -0.792 . . . . 0.0 110.221 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -98.64 117.89 34.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 111.585 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 76.4 mt -110.38 130.47 55.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.615 -0.678 . . . . 0.0 109.52 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -129.69 138.15 51.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.388 -0.82 . . . . 0.0 110.803 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 HD12 ' CE2' ' A' ' 92' ' ' TYR . 84.3 mt -108.06 130.1 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.99 119.74 35.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.086 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.84 35.96 3.1 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.35 131.3 45.46 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.689 -0.889 . . . . 0.0 110.105 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -86.26 160.6 19.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 109.921 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -29.03 66.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.52 -30.04 70.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.46 0.648 . . . . 0.0 109.526 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -77.48 -4.03 43.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.751 -0.593 . . . . 0.0 111.387 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.4 m -55.31 140.01 40.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.958 -1.089 . . . . 0.0 109.62 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.63 -148.04 11.55 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.793 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.405 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 17.3 tp -106.93 130.23 54.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.741 -0.858 . . . . 0.0 111.754 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 50.8 m-85 -112.57 135.17 53.6 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.9 mp -100.67 140.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 0.0 111.678 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 1.108 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 13.7 p -106.68 122.6 46.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 17.1 mttt -120.04 146.12 46.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.148 -0.97 . . . . 0.0 110.056 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.449 ' CG1' ' CD2' ' A' ' 23' ' ' TYR . 2.7 t -140.44 107.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.529 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 2.5 mp0 -132.52 125.18 29.98 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.598 -0.841 . . . . 0.0 113.216 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 9.4 mp -74.34 80.2 1.86 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.405 ' HE3' ' CZ ' ' A' ' 104' ' ' TYR . 12.9 mmt -79.58 -48.15 14.29 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.556 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 87.0 m-85 -66.66 -42.92 48.36 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.955 -1.091 . . . . 0.0 113.531 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 51.4 Cg_endo -86.07 113.68 1.27 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 O-C-N 122.657 0.819 . . . . 0.0 112.697 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.06 141.03 10.27 Favored 'Trans proline' 1 CA--C 1.654 6.515 0 CA-C-O 110.774 -3.928 . . . . 0.0 107.861 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . 0.433 55.2 Cg_endo -102.61 179.54 3.91 Favored 'Cis proline' 3 C--N 1.524 9.813 1 C-N-CA 91.932 -14.612 . . . . 0.0 116.815 6.991 . . . . . . . . 4 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.9 t80 -82.2 126.9 32.61 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 116.795 -3.691 . . . . 0.0 108.847 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.25 47.8 t80 -158.63 101.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.985 -0.447 . . . . 0.0 110.374 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.8 tp -160.31 -143.46 0.1 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.542 -0.724 . . . . 0.0 110.454 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.27 -173.79 23.64 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.43 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.402 HG22 ' HE2' ' A' ' 95' ' ' LYS 0.251 46.8 mm -131.46 168.87 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.406 -1.055 . . . . 0.0 110.347 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.823 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -105.95 134.13 11.95 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -36.4 77.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.094 -1.239 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.5 153.1 8.1 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.318 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -121.84 139.42 53.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.489 ' O ' HG21 ' A' ' 8' ' ' VAL . 16.3 tp60 -79.95 138.21 37.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 46.8 mt -110.07 124.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.509 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 16.7 m-30 -100.84 133.63 45.03 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.084 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.0 t . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.063 178.717 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.325 0.583 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -148.29 144.34 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.85 -0.531 . . . . 0.0 109.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.65 127.07 51.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.589 -0.694 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.926 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 15.1 mm100 -142.12 130.65 11.89 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.642 -0.661 . . . . 0.0 111.3 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.64 139.97 31.87 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.175 1.092 . . . . 0.0 109.367 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.01 69.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.23 162.9 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.26 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.74 151.86 19.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.954 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.4 mt -110.61 127.03 55.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.26 148.98 23.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.413 -0.805 . . . . 0.0 110.984 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -69.41 172.16 7.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.603 -0.686 . . . . 0.0 110.521 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -60.1 -36.05 76.57 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.557 -0.714 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -57.16 -25.49 59.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.556 -0.715 . . . . 0.0 110.194 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 26.44 7.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -108.06 112.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 121.626 -0.926 . . . . 0.0 110.52 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.54 124.74 52.39 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.0 m -126.97 140.09 52.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.583 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -148.55 163.5 37.02 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.414 ' CG1' ' CG ' ' A' ' 76' ' ' GLN . 63.2 t -130.31 123.73 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.731 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.779 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 37.6 t -100.01 108.04 20.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 tt0 -84.97 139.45 31.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 0.0 110.519 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -130.6 177.6 7.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 0.0 109.6 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.94 138.1 35.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.85 -0.532 . . . . 0.0 110.157 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.7 p -125.83 149.83 66.95 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.95 -13.98 34.89 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.462 1.243 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.6 -170.13 18.02 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.99 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.542 -0.975 . . . . 0.0 110.52 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.43 151.67 46.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.62 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 53' ' ' MET . 32.4 p -79.9 -43.59 21.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 111.097 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.68 84.77 5.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.021 -0.671 . . . . 0.0 112.713 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 52' ' ' TYR . 48.1 t -97.79 89.38 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 123.42 20.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.915 -0.491 . . . . 0.0 110.703 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -118.48 134.75 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.58 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.4 m -134.41 159.71 40.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.411 -0.805 . . . . 0.0 110.025 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 84.5 t -128.84 139.24 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 6.2 mt -131.16 171.0 13.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.687 -1.258 . . . . 0.0 111.67 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HG3' HG23 ' A' ' 47' ' ' VAL . 89.9 mtt180 -125.72 118.39 25.48 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG3' HD12 ' A' ' 93' ' ' ILE . 21.8 mt-30 -101.78 126.25 48.61 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.391 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.16 -171.57 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.21 -43.81 95.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 111.019 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -131.96 -0.16 3.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 111.949 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -135.1 155.59 50.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.06 -1.025 . . . . 0.0 110.943 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.8 139.73 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.604 -0.685 . . . . 0.0 109.629 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.9 p -127.03 160.1 32.13 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.437 -0.789 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 77.0 mt-10 -86.45 160.04 19.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.647 -0.658 . . . . 0.0 110.742 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 71.5 t -123.41 -71.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.807 -0.558 . . . . 0.0 110.232 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' CB ' ' A' ' 63' ' ' ASP . 80.7 m -147.17 153.71 40.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.31 30.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.508 -0.745 . . . . 0.0 111.258 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -170.44 155.68 5.21 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.601 -0.687 . . . . 0.0 109.658 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -116.27 122.76 45.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 32' ' ' VAL . 55.1 p90 -94.05 124.39 38.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.307 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 mmt -60.62 -44.7 96.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.427 ' HE3' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER 166.44 102.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.46 63.0 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.93 159.86 23.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -1.026 . . . . 0.0 110.472 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -70.72 151.6 44.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -90.16 123.89 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.577 -0.702 . . . . 0.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 p -92.57 131.91 37.3 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 67.9 m-85 -113.86 123.92 50.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.764 . . . . 0.0 110.363 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.74 -36.06 77.93 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.485 -0.759 . . . . 0.0 109.79 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -140.07 174.46 10.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 109.671 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CB ' ' SG ' ' A' ' 48' ' ' CYS . 85.8 m-20 52.65 51.02 16.89 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.1 m -52.36 -21.8 3.95 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.622 -0.674 . . . . 0.0 111.382 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.69 -21.88 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.271 -0.893 . . . . 0.0 110.811 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.3 m -72.43 126.36 29.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.342 -0.849 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 t -139.98 149.93 43.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.99 -171.52 42.95 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.4 m -129.73 168.46 16.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.939 -0.742 . . . . 0.0 109.557 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 97.2 p -138.33 152.51 48.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.505 -0.747 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -133.7 -173.64 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.746 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -49.67 76.09 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.6 3.86 6.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.463 -1.022 . . . . 0.0 111.272 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.2 tt0 -124.27 129.62 51.08 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.09 -1.006 . . . . 0.0 110.851 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -113.23 132.84 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -110.11 115.97 30.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.47 133.05 54.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 109.752 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.5 m -130.87 145.06 51.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.34 -0.85 . . . . 0.0 110.811 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 95.6 mt -119.92 140.08 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.611 -0.681 . . . . 0.0 109.874 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.405 ' HG2' HG13 ' A' ' 16' ' ' ILE . 6.7 mt-30 -123.83 121.93 36.68 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.803 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.36 46.37 1.0 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.03 122.79 33.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.635 -0.92 . . . . 0.0 111.182 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -102.59 178.0 4.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.69 95.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.325 -0.86 . . . . 0.0 109.401 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.8 ttm -63.45 -39.98 95.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.753 -0.592 . . . . 0.0 110.742 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.79 -21.06 62.71 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.598 -0.689 . . . . 0.0 111.025 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -51.84 140.01 20.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.921 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.88 -158.59 31.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.2 123.99 49.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.637 -0.919 . . . . 0.0 111.97 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 51.0 m-85 -103.18 140.02 37.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.2 mp -111.33 130.59 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.665 -0.647 . . . . 0.0 111.775 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.926 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 20.2 p -79.97 157.91 26.71 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 tttt -153.65 97.2 2.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.93 -1.106 . . . . 0.0 109.457 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.17 116.78 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.9 0.857 . . . . 0.0 111.37 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -135.7 124.15 23.46 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.914 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 4.1 mm? -75.47 76.48 2.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.9 ttm -78.73 -40.42 33.56 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 83.4 m-85 -62.97 -45.72 86.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.234 -0.986 . . . . 0.0 112.446 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 56.2 Cg_endo -81.3 129.62 6.79 Favored 'Trans proline' 0 C--O 1.284 2.805 0 O-C-N 122.776 0.882 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 72.1 Cg_endo -83.86 166.14 13.32 Favored 'Trans proline' 1 CA--C 1.656 6.601 0 CA-C-O 113.526 -2.781 . . . . 0.0 108.966 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.349 56.6 Cg_endo -96.47 50.54 1.46 Allowed 'Cis proline' 2 C--N 1.477 7.331 1 C-N-CA 89.174 -15.761 . . . . 0.0 115.439 -7.756 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.0 t80 67.36 122.26 0.02 OUTLIER 'General case' 1 N--CA 1.554 4.727 1 O-C-N 115.783 -4.323 . . . . 0.0 112.965 179.931 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.84 100.3 1.42 Allowed 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.31 -1.494 . . . . 0.0 109.91 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' A' ' 98' ' ' LEU . 1.4 tp -160.24 -146.66 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.71 170.69 35.96 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.049 -1.548 . . . . 0.0 111.254 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.412 ' CD1' ' HG3' ' A' ' 95' ' ' LYS . 22.8 mm -124.18 149.68 28.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.685 -0.891 . . . . 0.0 109.25 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -91.41 144.71 17.34 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -68.12 -24.71 65.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.242 . . . . 0.0 110.592 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 126.53 165.79 12.05 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.137 -1.506 . . . . 0.0 113.849 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.5 m -129.28 127.63 41.58 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.505 ' O ' HG21 ' A' ' 8' ' ' VAL . 8.8 tp-100 -67.98 142.72 55.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.93 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 64.6 mt -118.5 126.38 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.543 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 28.1 m-85 -110.16 139.98 44.74 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.834 -0.541 . . . . 0.0 110.328 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.491 1.585 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.449 178.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.9 m80 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.439 0.638 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.04 148.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.02 135.81 41.63 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.051 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.589 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -140.0 146.49 46.85 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.648 -0.658 . . . . 0.0 110.095 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.87 147.95 63.31 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.254 1.134 . . . . 0.0 109.565 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.93 -20.77 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.528 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.7 p -160.6 160.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.029 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.6 t -137.13 159.6 36.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.155 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.0 130.37 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.289 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.89 133.37 45.46 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -135.81 162.43 32.81 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.289 -0.882 . . . . 0.0 112.476 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t 59.31 -115.87 0.78 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.728 -0.608 . . . . 0.0 110.827 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 16' ' ' ILE . 5.9 mtt180 -59.93 -13.06 9.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 111.346 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.22 43.47 5.91 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 14' ' ' ARG . 8.3 mm -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.59 124.1 43.16 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 t -126.2 131.29 52.01 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.168 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 28.2 p90 -139.73 165.82 26.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.742 -0.599 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 57.5 t -123.92 127.27 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.859 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' CG ' ' A' ' 5' ' ' GLN . 42.3 t -110.03 119.79 40.41 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.9 pt-20 -93.16 154.25 18.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.935 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CG ' HG13 ' A' ' 96' ' ' VAL . 45.8 p90 -134.01 -175.99 4.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.64 116.95 20.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.351 -0.843 . . . . 0.0 111.799 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -161.68 155.89 18.97 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.712 -0.618 . . . . 0.0 109.696 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.97 -19.94 45.4 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.286 1.151 . . . . 0.0 110.733 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.98 35.9 33.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -102.64 26.86 7.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.366 -1.079 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.74 27.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 110.709 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 53' ' ' MET . 16.1 p -80.28 -39.11 29.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.731 0.777 . . . . 0.0 111.655 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' CD1' ' A' ' 100' ' ' TYR . 4.7 mm-40 -80.19 82.85 6.16 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.918 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -93.67 84.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.798 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 60.1 ttt180 -59.98 123.17 16.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.676 -0.64 . . . . 0.0 111.084 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 m -123.4 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.8 m -120.92 131.61 54.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.236 0.541 . . . . 0.0 110.636 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 86.4 t -107.76 130.39 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 78.9 mt -124.62 169.93 11.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.992 -1.068 . . . . 0.0 111.958 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -130.26 121.39 26.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -110.24 131.98 54.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.346 -0.846 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.36 152.77 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.57 -44.21 93.38 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 0.0 110.543 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.44 -44.87 66.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -154.89 160.16 40.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.469 -0.769 . . . . 0.0 111.263 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -126.86 139.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -145.21 160.38 41.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.453 -0.779 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 13.7 mt-10 -80.71 156.16 26.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.691 -0.631 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.4 t -114.49 -83.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' ' OD2' ' A' ' 63' ' ' ASP . 80.8 m -122.0 160.9 23.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 110.866 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.37 135.55 6.03 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.91 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.466 ' CB ' ' OG1' ' A' ' 59' ' ' THR . . . -172.1 165.34 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.419 -0.8 . . . . 0.0 110.594 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -97.9 123.94 42.1 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 57' ' ' GLU . 27.6 t80 -88.31 106.79 18.46 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.135 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -76.17 157.86 32.29 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.4 mmt -59.64 -28.5 67.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.852 -1.155 . . . . 0.0 110.084 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.84 -79.04 0.17 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -154.15 178.49 9.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.39 -1.065 . . . . 0.0 110.665 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 7.2 tp10 -120.07 120.15 35.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.65 -0.656 . . . . 0.0 109.746 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 2.4 mm? -124.28 46.22 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.466 ' OG1' ' CB ' ' A' ' 50' ' ' ALA 0.285 36.8 p -116.4 -132.14 0.32 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.791 -0.568 . . . . 0.0 110.909 -178.016 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 57' ' ' GLU . 39.8 m-85 60.57 25.12 14.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.825 -1.172 . . . . 0.0 109.426 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.72 -36.42 80.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 111.402 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -59.63 -43.28 93.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.413 -0.805 . . . . 0.0 111.812 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 1.045 ' OD2' ' SG ' ' A' ' 48' ' ' CYS . 95.9 m-20 -92.88 -13.2 29.29 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.164 0.507 . . . . 0.0 110.78 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t 42.4 24.93 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -144.85 -43.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.018 -1.051 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 22.9 p -67.82 134.64 51.29 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -0.857 . . . . 0.0 111.344 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -130.02 139.98 50.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.05 158.02 25.08 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.357 -1.401 . . . . 0.0 111.111 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.1 m -130.05 159.92 35.26 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 53.4 m -145.93 127.24 14.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -139.96 129.99 24.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.774 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.84 -124.07 35.08 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -106.45 16.43 24.7 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.933 . . . . 0.0 110.715 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 29.3 mt-30 -119.95 123.92 44.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 111.09 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -104.54 121.82 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.661 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -101.43 107.8 19.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.119 -0.988 . . . . 0.0 111.391 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 mt -97.34 131.92 43.56 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.449 -0.782 . . . . 0.0 109.673 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -124.42 139.2 54.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -113.55 129.94 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.728 -0.608 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -112.54 118.26 34.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.282 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.67 51.37 0.75 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.59 129.79 34.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.546 -0.973 . . . . 0.0 111.381 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -112.21 175.48 5.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.06 94.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.875 0.845 . . . . 0.0 109.855 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.2 mmt -66.17 -32.94 74.68 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.191 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.11 -24.91 67.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.44 -0.787 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -51.88 137.85 25.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.52 -163.83 34.76 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.7 tp -94.77 129.94 41.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.886 . . . . 0.0 112.314 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.424 ' CE2' HD11 ' A' ' 115' ' ' ILE . 78.5 m-85 -113.44 136.35 52.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.524 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.9 mp -104.16 133.05 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.429 -0.795 . . . . 0.0 112.117 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.808 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.6 p -97.49 122.34 40.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 109' ' ' ILE . 17.7 mttt -119.1 143.86 46.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.363 -0.836 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.441 HG13 ' CG ' ' A' ' 23' ' ' TYR . 11.1 t -136.51 111.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.889 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -132.39 130.22 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.34 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 31.7 mt -86.94 82.84 7.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.798 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 3.4 ttm -82.67 -45.92 13.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.904 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.442 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 91.0 m-85 -69.71 -42.89 20.17 Favored Pre-proline 0 N--CA 1.508 2.456 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 60.7 Cg_endo -82.36 143.09 12.25 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.734 -1.295 . . . . 0.0 108.734 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -92.88 173.04 2.04 Favored 'Trans proline' 1 CA--C 1.658 6.72 0 CA-C-O 113.417 -2.826 . . . . 0.0 107.536 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -92.18 49.39 1.24 Allowed 'Cis proline' 2 C--N 1.503 8.698 1 C-N-CA 91.326 -14.864 . . . . 0.0 115.228 -14.585 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 2.3 t80 55.82 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 118.692 -2.505 . . . . 0.0 111.692 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -147.19 105.74 3.8 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 119.617 -1.927 . . . . 0.0 108.777 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HG ' ' HG ' ' A' ' 98' ' ' LEU . 1.7 mt -159.3 -157.97 0.63 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.829 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -151.22 -167.61 14.94 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.417 HG22 ' HE2' ' A' ' 95' ' ' LYS 0.258 46.6 mm -134.93 169.39 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.561 -0.964 . . . . 0.0 110.5 -178.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.808 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -104.48 139.49 14.61 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.26 -36.81 78.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.388 -1.066 . . . . 0.0 110.536 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.81 144.49 5.92 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.3 m -115.5 137.45 52.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.485 ' O ' HG21 ' A' ' 8' ' ' VAL . 12.8 tt0 -89.92 124.05 34.38 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.371 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.424 HD11 ' CE2' ' A' ' 92' ' ' TYR . 82.7 mt -90.45 129.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 7.7 m-30 -100.35 140.0 35.21 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.422 0.63 . . . . 0.0 111.976 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.026 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.142 0.496 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.2 132.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 110.001 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.41 54.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.632 -0.668 . . . . 0.0 109.722 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.079 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 96.3 mm-40 -137.34 148.02 60.35 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.785 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.0 152.83 68.22 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.429 1.226 . . . . 0.0 109.146 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.98 -12.17 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 110.792 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.508 ' CG2' ' HE2' ' A' ' 116' ' ' TYR . 2.3 p -139.95 137.62 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 116' ' ' TYR . 8.9 t -137.85 145.66 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.127 -1.608 . . . . 0.0 110.846 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.84 148.31 38.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.465 -0.772 . . . . 0.0 110.539 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.88 -171.5 1.84 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.513 -0.742 . . . . 0.0 110.413 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 t -123.84 172.87 8.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -60.79 -39.13 87.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.469 -0.769 . . . . 0.0 109.744 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -60.51 -28.04 68.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.0 109.854 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 27.14 8.25 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.3 mp -97.73 99.89 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.3 126.11 51.74 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -133.83 149.55 51.39 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.092 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.11 163.94 39.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 68.9 t -119.91 124.04 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.033 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.079 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.3 t -102.78 107.91 18.94 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -86.96 141.55 28.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 112.358 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -127.38 174.72 8.76 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.34 131.87 21.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.843 . . . . 0.0 111.483 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -164.64 153.05 10.89 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.676 -0.64 . . . . 0.0 110.555 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.86 149.86 48.47 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.654 1.344 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.85 -179.19 5.34 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -132.83 151.06 52.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.71 -0.876 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.07 48.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.599 -0.688 . . . . 0.0 109.615 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.9 p -79.81 -39.06 31.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.335 -0.853 . . . . 0.0 110.649 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -79.76 76.72 6.42 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.447 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.25 82.03 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 18.7 ttp85 -59.5 121.53 11.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.821 -0.549 . . . . 0.0 110.955 -178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -125.35 139.86 50.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.571 0.7 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.1 m -135.22 133.06 38.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.033 -0.417 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 95.4 t -105.11 132.35 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.544 -0.723 . . . . 0.0 109.123 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 83.1 mt -126.41 168.01 14.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.128 -0.982 . . . . 0.0 111.176 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -129.61 128.54 42.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 93' ' ' ILE . 30.8 mt-30 -109.86 132.05 54.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.322 -0.861 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.36 178.76 5.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.932 -0.48 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.33 -40.12 89.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.0 111.514 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.4 m -118.37 -19.96 8.68 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 112.112 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -131.79 179.29 6.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.14 -0.975 . . . . 0.0 112.142 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.5 t -149.88 143.52 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.81 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -138.72 156.13 47.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.455 -0.778 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 68.6 mt-10 -80.16 147.57 31.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 111.54 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG11 ' SG ' ' A' ' 48' ' ' CYS . 96.1 t -102.89 -73.92 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.948 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 14.5 p -159.92 164.65 33.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 110.133 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -169.39 161.01 9.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.205 -0.934 . . . . 0.0 111.603 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 60' ' ' PHE . . . -172.0 157.68 4.47 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -84.58 119.82 25.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.681 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 71' ' ' THR . 44.2 t80 -79.96 99.52 7.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.682 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 mmt -71.78 138.11 48.14 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 8.8 tpp -68.03 -19.99 64.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.73 -21.12 8.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.94 161.3 28.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -1.151 . . . . 0.0 110.701 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -121.75 124.39 44.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.408 -0.808 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.16 166.14 12.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 p -119.75 135.04 55.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.784 -0.572 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.948 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 5.3 m-30 -67.2 136.71 55.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tt -68.97 -42.06 77.1 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -118.25 -172.12 2.2 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.915 -1.115 . . . . 0.0 112.615 -177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 56.18 56.77 5.55 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.444 0.64 . . . . 0.0 110.88 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.1 m 52.09 26.64 3.95 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.551 -0.718 . . . . 0.0 110.705 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt 53.98 76.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.503 -0.748 . . . . 0.0 110.762 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.524 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -64.74 149.98 48.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.29 -0.882 . . . . 0.0 108.735 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -119.11 143.57 47.1 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.57 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -130.17 140.91 12.13 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.435 ' HA ' ' CE2' ' A' ' 52' ' ' TYR . 61.4 m -116.1 160.9 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.856 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 46.4 t -143.75 109.8 5.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.75 -0.594 . . . . 0.0 110.487 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -151.77 140.63 20.98 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.517 -0.74 . . . . 0.0 110.319 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.81 99.67 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.21 21.23 6.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.621 -0.929 . . . . 0.0 110.354 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -124.65 125.68 44.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.584 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -102.7 124.11 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.174 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.431 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 47.7 t-20 -102.41 115.95 31.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.0 111.15 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -100.61 137.95 38.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.509 -0.745 . . . . 0.0 109.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 m -127.72 131.97 49.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.826 . . . . 0.0 110.78 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.68 138.3 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 109.872 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -124.02 122.15 37.14 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.093 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.54 2.83 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.0 mt -87.14 129.93 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.499 -1.001 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -102.6 177.19 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.863 0.839 . . . . 0.0 109.747 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -67.61 -29.96 69.42 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.353 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -66.4 -16.49 64.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 111.451 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.0 m -49.8 150.03 2.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 110.415 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.09 -168.62 32.48 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.4 tp -88.91 130.11 35.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.716 -0.873 . . . . 0.0 112.691 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 115' ' ' ILE . 67.7 m-85 -118.5 140.84 49.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.446 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.5 mp -98.14 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.412 -0.805 . . . . 0.0 111.903 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.89 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 18.7 p -109.02 116.4 31.91 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 15.5 mttt -111.61 142.7 43.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.018 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.406 ' CG1' HD22 ' A' ' 106' ' ' LEU . 8.2 t -142.17 105.62 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -128.76 125.27 37.52 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.948 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 mt -81.65 76.35 8.57 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 ttm -80.89 -52.48 7.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.5 m-85 -62.46 -41.83 76.11 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.091 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 55.9 Cg_endo -85.71 113.79 1.37 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 120.831 1.021 . . . . 0.0 111.233 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.473 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 71.7 Cg_endo -90.72 150.99 4.14 Favored 'Trans proline' 1 CA--C 1.688 8.215 0 C-N-CA 123.042 2.495 . . . . 0.0 108.671 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.302 69.7 Cg_endo -83.56 176.09 34.75 Favored 'Cis proline' 2 C--N 1.469 6.892 1 C-N-CA 95.565 -13.098 . . . . 0.0 118.149 -8.53 . . . . . . . . 5 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.17 127.26 32.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.182 -1.574 . . . . 0.0 109.687 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -148.48 87.61 1.59 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.93 -1.106 . . . . 0.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 96' ' ' VAL . 4.2 tp -155.0 -145.95 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.256 -0.903 . . . . 0.0 110.767 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.37 -172.45 31.86 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.586 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.5 mt -126.87 160.31 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.76 -0.847 . . . . 0.0 110.492 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.89 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.9 130.09 10.11 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.116 -2.393 . . . . 0.0 107.116 177.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.61 -32.39 70.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.324 -1.103 . . . . 0.0 111.051 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 135.14 151.54 6.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.934 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.403 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.5 m -124.76 149.81 46.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 116' ' ' TYR . 58.2 tt0 -97.13 119.83 36.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.446 -1.301 . . . . 0.0 110.004 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 92' ' ' TYR . 96.0 mt -81.28 140.1 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.508 ' HE2' ' CG2' ' A' ' 8' ' ' VAL . 48.4 m-85 -120.92 152.58 38.32 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.318 0.58 . . . . 0.0 112.236 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' A ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.262 0.553 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 mtp 54.04 21.97 3.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.508 -0.745 . . . . 0.0 111.354 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' 1' A ALA . 69.1 m-70 -108.11 26.1 10.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 110.303 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -149.6 118.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.81 128.45 54.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.547 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -149.83 143.64 16.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.85 136.24 32.26 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.323 1.17 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.63 69.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -144.83 165.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.755 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 19' ' ' PHE . 8.3 t -139.33 130.56 33.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 121.753 0.787 . . . . 0.0 111.181 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 3.6 mm? -87.59 129.9 34.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.41 154.77 20.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.815 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.0 m -75.2 172.47 12.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.727 -0.608 . . . . 0.0 109.732 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 m -59.79 -40.08 87.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.422 ' HG2' HD12 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.01 -29.58 69.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.486 -0.759 . . . . 0.0 110.029 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.03 41.49 1.41 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.461 HD11 ' N ' ' A' ' 16' ' ' ILE . 1.5 mp -100.5 102.11 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.672 -0.899 . . . . 0.0 108.85 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.75 114.16 27.72 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 52.8 m -130.8 131.72 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.554 0.692 . . . . 0.0 110.886 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.4 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 38.5 p90 -150.07 163.97 36.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.781 -0.574 . . . . 0.0 109.476 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.6 t -123.45 122.36 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 5' ' ' GLN . 42.3 t -103.84 108.5 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -81.66 162.57 22.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.19 -0.944 . . . . 0.0 110.867 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -140.13 176.36 8.82 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 130.85 45.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.795 -0.566 . . . . 0.0 110.409 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.5 p -132.77 155.94 80.62 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.558 -0.714 . . . . 0.0 110.081 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.15 -16.89 45.21 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.391 1.206 . . . . 0.0 111.216 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -171.99 37.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -100.63 137.3 39.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.598 -0.942 . . . . 0.0 110.127 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.96 170.67 15.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.537 -0.727 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.076 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -81.15 -8.64 59.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.583 -0.698 . . . . 0.0 112.494 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 18.6 mm-40 -129.46 108.26 10.13 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.944 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 78.0 t -125.89 80.45 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.76 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 67.8 ttt180 -59.97 124.59 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 111.427 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.73 153.98 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.45 ' HB ' ' CE ' ' A' ' 95' ' ' LYS . 20.3 m -144.0 141.41 30.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 85.6 t -116.86 124.07 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 14.6 mt -120.07 153.36 36.2 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.518 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HG3' ' CG2' ' A' ' 47' ' ' VAL . 69.0 mtm180 -111.28 123.96 51.26 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 44' ' ' VAL . 20.0 tt0 -96.25 139.99 31.6 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.853 0.835 . . . . 0.0 110.937 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.04 156.98 47.27 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.83 -43.86 94.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.4 m -70.0 -47.28 62.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.648 -0.657 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -165.15 169.48 16.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 111.241 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 39' ' ' GLN . 63.3 t -116.73 140.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -130.03 160.58 33.25 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.326 -0.859 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 96.9 mt-10 -80.03 154.85 27.9 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.574 HG13 ' SG ' ' A' ' 48' ' ' CYS . 45.8 t -130.89 -83.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.705 -0.622 . . . . 0.0 111.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.574 ' SG ' HG13 ' A' ' 47' ' ' VAL . 83.2 m -110.14 149.45 30.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.076 -1.015 . . . . 0.0 110.925 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.04 141.41 15.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.538 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.79 163.35 18.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 109.842 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.772 HG23 ' SD ' ' A' ' 53' ' ' MET . 5.5 m -97.45 116.31 29.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.703 ' CZ ' ' SD ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -72.9 91.94 1.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 1.076 ' SD ' ' O ' ' A' ' 30' ' ' THR . 35.8 mmm -85.0 129.96 34.7 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.703 ' SD ' ' CZ ' ' A' ' 52' ' ' TYR . 18.0 mmt -59.43 -27.98 66.54 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.618 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.66 43.41 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -149.8 -179.99 7.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.0 -1.294 . . . . 0.0 110.846 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.61 156.39 19.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.656 -0.653 . . . . 0.0 110.65 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.4 mt -70.28 139.93 52.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.972 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 p -104.55 118.33 36.32 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.718 . . . . 0.0 110.102 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.87 37.85 2.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.472 -0.768 . . . . 0.0 110.307 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.436 -0.79 . . . . 0.0 110.662 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -85.7 127.12 34.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.355 -0.841 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 52.24 47.52 24.56 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.318 -0.864 . . . . 0.0 109.932 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -57.53 -106.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.983 -0.448 . . . . 0.0 110.823 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.8 mt 52.04 22.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.342 -1.473 . . . . 0.0 110.534 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.05 158.21 24.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.988 . . . . 0.0 110.339 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -132.75 139.95 47.83 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.82 154.12 25.09 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.411 -1.376 . . . . 0.0 111.066 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.2 m -130.04 163.51 26.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 32.8 t -143.39 130.02 20.24 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.773 -0.58 . . . . 0.0 109.961 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -142.42 133.85 26.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -0.783 . . . . 0.0 109.744 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.5 -123.99 27.54 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -105.9 16.43 25.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.674 -0.897 . . . . 0.0 110.441 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.87 123.94 44.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 111.013 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 m -99.49 130.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -107.97 118.38 36.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 111.459 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 74.0 mt -108.95 132.05 54.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -121.14 132.2 54.71 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 0.0 110.173 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.9 mt -116.38 130.16 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.642 -0.661 . . . . 0.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.418 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.5 mt-30 -124.54 120.86 33.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.648 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.28 48.68 0.69 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 81.2 mt -96.0 108.41 20.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.488 -1.007 . . . . 0.0 111.308 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -82.85 -176.62 6.4 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.21 92.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.8 -38.84 83.85 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.117 0.484 . . . . 0.0 111.103 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -60.0 -35.39 74.95 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.544 -0.723 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 35.7 m -51.46 135.96 26.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.97 -144.03 7.83 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.908 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' A' ' 93' ' ' ILE . 2.1 tm? -106.62 139.42 41.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.779 -0.836 . . . . 0.0 110.816 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.423 ' CD2' HG13 ' A' ' 115' ' ' ILE . 42.3 m-85 -124.53 125.3 43.97 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.503 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.6 mp -97.94 120.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.365 -0.834 . . . . 0.0 111.949 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.695 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 30.8 p -84.15 122.4 28.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' CE ' ' HB ' ' A' ' 35' ' ' THR . 10.5 mtmt -113.9 150.59 33.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.304 -0.873 . . . . 0.0 109.986 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.39 103.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.401 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -132.03 117.34 18.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 8.7 mp -75.6 75.35 2.61 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.76 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 22.9 ttm -78.39 -38.31 42.04 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.932 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.452 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 92.8 m-85 -67.51 -44.96 46.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 55.7 Cg_endo -80.8 137.18 11.06 Favored 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 120.463 0.776 . . . . 0.0 110.469 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 73.6 Cg_endo -89.98 143.81 4.17 Favored 'Trans proline' 2 CA--C 1.708 9.188 0 CA-C-O 112.032 -3.403 . . . . 0.0 110.923 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.305 51.0 Cg_endo -114.41 64.67 0.26 Allowed 'Cis proline' 2 C--N 1.443 5.526 1 C-N-CA 93.233 -14.07 . . . . 0.0 113.31 5.111 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' PRO . 4.3 t80 48.14 111.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.092 -2.255 . . . . 0.0 111.8 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' O ' ' CD2' ' A' ' 106' ' ' LEU . 28.9 t80 -160.64 107.99 1.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.83 1.3 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.45 -142.83 0.11 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.562 -179.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.99 167.41 32.23 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.0 mm -119.82 157.15 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.946 -0.737 . . . . 0.0 109.082 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.695 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -86.32 141.55 18.3 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 9.2 m120 -60.01 -36.24 76.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.995 . . . . 0.0 110.11 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 129.64 143.14 5.4 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.866 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.1 m -111.42 131.94 54.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 8' ' ' VAL . 32.8 tp60 -79.97 131.88 35.91 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.423 HG13 ' CD2' ' A' ' 92' ' ' TYR . 22.1 mm -99.74 121.17 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.135 . . . . 0.0 108.61 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.513 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 13.2 m-30 -101.37 147.15 26.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.794 -0.566 . . . . 0.0 110.555 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.91 164.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.89 0.852 . . . . 0.0 110.008 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 118' ' ' ILE 0.258 3.5 mp -111.53 138.62 39.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.206 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.51 108.05 51.31 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.499 -0.751 . . . . 0.0 109.556 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.15 149.85 64.99 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.185 1.097 . . . . 0.0 110.748 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -129.98 139.84 36.85 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.626 -0.671 . . . . 0.0 110.053 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.83 -12.03 31.94 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.215 1.113 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.29 156.17 42.49 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.83 -20.0 46.19 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.392 1.206 . . . . 0.0 110.85 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -139.99 163.97 31.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.861 . . . . 0.0 110.276 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.6 p -100.6 12.03 38.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.717 . . . . 0.0 111.016 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.07 -36.33 77.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.229 -0.919 . . . . 0.0 110.402 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -127.77 148.81 50.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.583 -0.698 . . . . 0.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 61.4 mt-10 52.08 49.98 7.6 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.518 -0.739 . . . . 0.0 111.047 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.8 Cg_endo -69.99 150.06 66.28 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.186 1.098 . . . . 0.0 110.414 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.609 -0.682 . . . . 0.0 110.207 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.402 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.438 ' C8 ' ' H1 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.438 ' H1 ' ' C8 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.496 ' C6 ' ' H1 ' ' A' ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.419 ' C1 ' ' H5 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . 0.496 ' H1 ' ' C6 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.916 0.389 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm 57.03 113.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.467 0.651 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -94.44 22.92 5.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.291 -0.881 . . . . 0.0 111.019 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 67.1 t -150.15 132.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.66 -0.65 . . . . 0.0 109.279 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.02 130.69 55.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.405 -0.809 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.43 124.99 21.46 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 111.07 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.63 139.87 31.75 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 N-CA-C 109.053 -1.172 . . . . 0.0 109.053 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.16 64.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.503 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -154.33 162.86 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.445 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.68 155.92 25.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 92.4 mt -114.32 131.9 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.605 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.08 -163.82 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -128.87 -178.8 4.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.518 -0.739 . . . . 0.0 110.566 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.31 -39.53 87.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.413 ' HB3' HG12 ' A' ' 16' ' ' ILE . 21.6 tpp180 -59.15 -21.48 59.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.729 -0.607 . . . . 0.0 109.656 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.64 35.03 17.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 14' ' ' ARG . 5.1 mm -114.69 109.91 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.55 127.35 52.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.755 -0.591 . . . . 0.0 110.221 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.1 t -127.07 129.96 49.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 110.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.08 160.16 40.11 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' CG1' ' CG ' ' A' ' 76' ' ' GLN . 61.5 t -125.67 123.32 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.297 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -105.52 109.94 22.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.6 pt-20 -82.77 149.49 27.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 111.419 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -131.89 164.0 27.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.32 133.4 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.399 -0.813 . . . . 0.0 111.19 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -139.9 150.46 62.57 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.648 -0.658 . . . . 0.0 110.717 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.77 -10.09 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.688 1.362 . . . . 0.0 111.852 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.48 -178.77 22.12 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.383 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -121.87 150.06 42.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.676 -0.896 . . . . 0.0 110.599 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.51 162.63 39.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.604 -0.685 . . . . 0.0 109.795 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 53' ' ' MET . 71.0 p -80.25 -46.09 16.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.46 -0.775 . . . . 0.0 110.647 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 5.7 mm-40 -80.26 112.04 17.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.999 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.23 95.75 3.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.845 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 68.9 ttt180 -75.78 115.3 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.431 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.5 m -118.78 138.91 47.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 85.2 m -129.6 143.73 50.96 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.474 0.654 . . . . 0.0 110.338 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.1 t -114.32 139.48 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 9.5 mt -130.22 172.33 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.049 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -126.72 123.6 37.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -106.32 132.01 52.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.939 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.87 -172.31 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 -43.6 96.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 110.791 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.0 p -132.06 0.06 3.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.331 -0.855 . . . . 0.0 111.878 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -137.3 154.98 49.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.031 -1.043 . . . . 0.0 110.816 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.21 145.16 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.9 p -129.8 156.06 44.95 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.343 -0.848 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 50.8 mp0 -86.34 159.99 19.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 63.9 t -122.25 -80.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.822 -0.549 . . . . 0.0 110.194 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 85.9 m -131.66 156.6 45.56 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.979 -1.076 . . . . 0.0 110.834 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.03 121.8 3.23 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.462 -0.774 . . . . 0.0 111.275 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HB1' ' CD1' ' A' ' 60' ' ' PHE . . . -158.29 143.02 16.24 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.4 -0.812 . . . . 0.0 110.196 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.406 ' O ' ' CD1' ' A' ' 58' ' ' LEU . 3.0 m -92.7 119.95 32.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.285 -0.884 . . . . 0.0 108.728 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' CE1' ' CE ' ' A' ' 54' ' ' MET . 46.0 p90 -110.06 146.87 34.63 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.967 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 1.05 ' SD ' ' N ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -75.99 160.78 29.5 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.45 ' CE ' ' CE1' ' A' ' 52' ' ' TYR . 31.7 mmt -70.66 127.45 32.73 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.893 -1.129 . . . . 0.0 110.131 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.85 27.77 23.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -150.03 175.77 11.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.213 -1.169 . . . . 0.0 111.163 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.31 152.01 48.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.8 -0.562 . . . . 0.0 109.859 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 52' ' ' TYR . 96.3 mt -136.42 -171.82 2.99 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.157 0.979 . . . . 0.0 112.136 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.7 p -109.48 159.97 16.61 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.416 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 95.0 m-85 -111.35 127.89 55.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.382 -0.824 . . . . 0.0 109.418 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.94 -44.07 94.6 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.587 -0.695 . . . . 0.0 112.344 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -94.88 131.44 40.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.921 . . . . 0.0 109.898 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 67' ' ' ILE . 81.9 m-20 53.05 57.77 5.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m -60.86 64.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.362 0.601 . . . . 0.0 112.098 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 63' ' ' ASP . 67.3 mt -140.98 16.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.419 -0.801 . . . . 0.0 109.134 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.1 m -104.09 130.03 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.059 -1.026 . . . . 0.0 110.593 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.5 t -139.94 150.08 44.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.58 -172.04 41.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.277 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 93.8 m -115.63 167.32 11.02 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.884 -0.774 . . . . 0.0 109.703 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.433 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 97.3 p -145.22 151.26 38.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.786 -0.571 . . . . 0.0 109.632 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -132.03 -175.73 3.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.649 -0.657 . . . . 0.0 109.757 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -52.92 -66.19 2.86 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -111.57 9.53 21.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.425 -1.044 . . . . 0.0 111.699 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.3 tt0 -130.0 129.41 43.69 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.996 -1.065 . . . . 0.0 110.609 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.2 m -115.18 134.52 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -110.99 112.58 24.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.844 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 95.7 mt -107.31 129.66 54.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.6 m -124.05 136.69 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.249 -0.907 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -103.52 137.29 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.675 . . . . 0.0 109.957 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HA ' HD11 ' A' ' 16' ' ' ILE . 30.7 mt-30 -119.97 120.71 37.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.041 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.03 40.07 1.74 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.3 mt -80.37 137.83 36.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.996 . . . . 0.0 111.445 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -117.03 176.15 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.9 93.04 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.31 -39.07 93.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.738 -0.601 . . . . 0.0 110.748 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.11 -23.94 64.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.566 -0.709 . . . . 0.0 111.195 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -52.43 137.77 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.96 -164.26 32.2 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 14.6 tp -88.42 126.22 35.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.884 . . . . 0.0 112.733 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.439 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 31.5 m-85 -106.89 158.13 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.9 mp -123.7 140.18 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.887 . . . . 0.0 111.723 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.579 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 13.9 p -98.64 133.54 42.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.7 tttt -135.95 123.11 21.65 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.36 118.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.8 mm-40 -139.58 142.68 37.11 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.273 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.467 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 6.5 mt -90.44 81.87 5.95 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.845 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 2.8 ttm -80.13 -48.99 12.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.264 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.46 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 80.6 m-85 -70.87 -41.92 12.23 Favored Pre-proline 0 N--CA 1.508 2.467 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 60.4 Cg_endo -86.58 119.82 1.69 Allowed 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.558 1.505 . . . . 0.0 109.34 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.408 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 65.5 Cg_endo -84.77 161.71 12.18 Favored 'Trans proline' 2 CA--C 1.685 8.042 0 CA-C-O 113.188 -2.921 . . . . 0.0 106.18 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 38.6 Cg_endo -86.45 174.8 30.84 Favored 'Cis proline' 1 C--N 1.423 4.468 1 C-N-CA 98.673 -11.803 . . . . 0.0 114.9 -11.624 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' GLU 0.313 3.0 t80 -80.16 133.0 36.02 Favored 'General case' 0 N--CA 1.529 3.513 0 O-C-N 118.319 -2.738 . . . . 0.0 115.727 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 14.0 p90 -162.47 107.7 1.19 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.149 -1.595 . . . . 0.0 111.695 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 105' ' ' TYR . 2.3 tp -157.59 -147.11 0.17 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.623 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -160.66 169.57 36.41 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 118.689 -1.719 . . . . 0.0 112.102 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.4 mp -117.16 159.76 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.537 -0.978 . . . . 0.0 109.576 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.579 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -103.39 143.57 15.78 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -59.92 -39.71 86.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -1.089 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 137.01 158.67 8.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.257 -1.449 . . . . 0.0 113.004 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.1 m -125.77 139.96 53.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.469 ' O ' HG21 ' A' ' 8' ' ' VAL . 27.5 tt0 -85.24 142.36 29.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.162 -1.415 . . . . 0.0 108.251 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.439 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 76.4 mt -109.18 130.03 62.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.503 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 15.1 m-30 -110.87 150.35 29.3 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.914 -0.491 . . . . 0.0 110.391 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -98.65 166.49 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.253 44.2 mm -109.22 134.01 52.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.809 -0.557 . . . . 0.0 110.834 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -131.24 107.13 14.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.667 -0.646 . . . . 0.0 109.557 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.71 139.95 41.66 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.202 1.106 . . . . 0.0 110.899 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.83 140.81 39.8 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.631 -0.668 . . . . 0.0 110.04 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.2 -12.23 33.45 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.256 1.135 . . . . 0.0 111.227 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 42.3 t -91.02 138.33 26.08 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.287 -0.883 . . . . 0.0 110.386 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.5 163.96 36.1 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.279 1.147 . . . . 0.0 110.545 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -104.85 157.63 17.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.718 . . . . 0.0 110.374 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -66.93 -30.08 70.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.631 -0.668 . . . . 0.0 110.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.55 134.3 54.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.588 -0.695 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -130.13 157.02 43.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.618 -0.676 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 86.1 mt-10 52.87 49.89 7.09 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.484 -0.76 . . . . 0.0 111.043 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.3 Cg_endo -69.92 150.04 66.71 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.139 1.073 . . . . 0.0 110.427 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.608 -0.682 . . . . 0.0 110.234 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.445 ' C6 ' ' H5 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.445 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.221 0.534 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm -130.34 -176.29 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.735 . . . . 0.0 109.941 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -97.71 25.1 6.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.743 . . . . 0.0 110.518 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.6 t -142.22 132.6 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.95 134.43 53.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.318 -0.864 . . . . 0.0 111.165 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.133 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 65.5 mt-30 -146.81 147.95 31.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.653 -0.655 . . . . 0.0 110.697 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.02 140.7 42.33 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.438 1.23 . . . . 0.0 109.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.18 71.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -155.49 161.41 2.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.35 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 19' ' ' PHE . 8.5 t -137.94 156.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.529 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.8 mt -122.79 124.23 42.85 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.07 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 141.3 38.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.509 -0.744 . . . . 0.0 109.32 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -80.3 -59.78 2.57 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.221 -0.924 . . . . 0.0 111.884 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 16' ' ' ILE . 15.2 t -152.32 165.93 33.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.535 -0.728 . . . . 0.0 109.462 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' O ' HD12 ' A' ' 16' ' ' ILE . 6.3 ttt180 57.67 19.51 5.56 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.544 -0.722 . . . . 0.0 110.733 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 56.65 44.31 91.18 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 82' ' ' GLN . 29.1 mm -106.78 104.66 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.75 120.67 42.89 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.335 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.7 m -116.28 121.93 43.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' HB3' HG22 ' A' ' 9' ' ' VAL . 47.5 p90 -132.03 163.96 27.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.683 . . . . 0.0 110.392 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.3 t -122.03 130.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.171 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.069 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 48.7 t -117.9 131.92 56.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -102.53 136.36 42.5 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 111.821 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CD2' HG13 ' A' ' 96' ' ' VAL . 40.2 p90 -127.3 179.53 5.41 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.47 127.29 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.719 -0.613 . . . . 0.0 110.477 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.35 149.9 59.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.594 -0.691 . . . . 0.0 109.97 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.81 -16.11 45.33 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.362 1.191 . . . . 0.0 111.446 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.96 -171.92 37.4 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -108.05 130.1 55.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.602 -0.94 . . . . 0.0 109.959 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.62 -178.63 5.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 110.623 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.088 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -79.96 -14.19 58.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 112.266 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.592 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 3.1 mm-40 -128.82 130.73 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.497 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.0 t -139.68 84.91 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -64.49 115.24 4.96 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.458 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -117.3 147.41 20.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.7 m -147.12 140.03 25.1 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.339 0.59 . . . . 0.0 111.101 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.1 t -102.66 132.1 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -121.91 170.3 9.94 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.847 -1.158 . . . . 0.0 112.019 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.424 ' HD3' ' CE1' ' A' ' 92' ' ' TYR . 15.6 mmm180 -116.0 115.66 26.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.457 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 7.4 tt0 -103.01 140.02 37.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.206 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.28 155.34 46.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.16 -44.0 92.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.355 -0.841 . . . . 0.0 110.263 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.0 m -70.1 -44.04 69.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.656 -0.652 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 44' ' ' VAL . 12.4 tp60 -162.65 161.33 26.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 111.078 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.438 ' N ' ' HG3' ' A' ' 43' ' ' GLN . 62.1 t -118.25 141.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 160.31 33.99 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.161 -0.962 . . . . 0.0 111.885 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 80.4 mt-10 -87.97 158.53 18.63 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.702 -0.624 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.0 t -139.17 -83.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.609 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 1.118 ' SG ' ' N ' ' A' ' 68' ' ' CYS . 83.4 m -105.21 149.52 25.88 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.085 -1.01 . . . . 0.0 111.792 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -163.94 145.34 8.87 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . . . -171.79 158.0 4.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.423 HG22 ' CD2' ' A' ' 100' ' ' TYR . 3.0 m -97.62 109.92 22.59 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.327 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 72' ' ' SER . 29.1 t80 -68.97 123.99 22.52 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 1.088 ' SD ' ' O ' ' A' ' 30' ' ' THR . 40.0 mmm -111.92 39.23 2.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.414 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 16.4 mmt 59.9 35.57 21.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.58 174.66 28.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.03 -18.93 45.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.597 -0.943 . . . . 0.0 112.126 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.95 124.65 28.27 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.312 0.577 . . . . 0.0 112.027 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 75.7 mt -131.9 151.82 51.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.589 -0.695 . . . . 0.0 109.139 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 p -87.12 95.63 10.02 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.967 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD1' ' CG2' ' A' ' 67' ' ' ILE . 20.6 m-85 -115.06 99.54 7.52 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.42 ' N ' HG13 ' A' ' 67' ' ' ILE . 96.0 mt -135.01 -0.13 2.81 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.63 -1.294 . . . . 0.0 114.155 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 56.6 t0 -110.65 130.17 55.64 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.51 -1.369 . . . . 0.0 112.872 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 53.12 44.28 30.53 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.761 -1.212 . . . . 0.0 111.333 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 t 72.15 -42.25 0.53 Allowed 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.417 -0.802 . . . . 0.0 112.43 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.927 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 25.8 mm 61.13 168.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.874 -1.142 . . . . 0.0 110.592 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 1.118 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 4.1 m -110.25 -179.74 3.86 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -130.22 149.79 51.76 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.3 -172.66 40.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.97 -1.586 . . . . 0.0 111.369 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' ASN . 59.7 m -131.85 168.88 17.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 122.157 -0.614 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 19.0 t -140.24 129.83 24.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -130.99 131.99 44.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.55 -123.78 24.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -99.75 11.53 38.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.769 -0.842 . . . . 0.0 110.919 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -114.34 131.92 56.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 11.4 m -111.52 118.2 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' THR . 4.1 m120 -89.9 114.21 25.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.545 -0.722 . . . . 0.0 110.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 69.7 mt -114.24 124.32 51.74 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.1 m -115.31 132.41 56.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.34 -0.85 . . . . 0.0 110.703 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.697 HG12 ' SG ' ' A' ' 68' ' ' CYS . 62.3 mt -107.06 135.78 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.294 -0.879 . . . . 0.0 110.17 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.503 ' HA ' HD11 ' A' ' 16' ' ' ILE . 82.9 mt-30 -119.97 120.32 36.01 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.204 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.02 51.74 0.72 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.7 mt -92.32 113.53 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.682 -0.893 . . . . 0.0 111.439 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 71.9 mmt-85 -81.32 166.16 20.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.02 -28.48 57.51 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.215 -0.928 . . . . 0.0 109.066 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 22.2 ptm -69.91 -36.07 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.507 0.67 . . . . 0.0 110.005 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.13 -25.74 65.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.799 -0.563 . . . . 0.0 111.397 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.1 m -51.2 132.01 28.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.43 -165.72 31.99 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.457 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 12.9 tp -86.8 130.07 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.705 -0.879 . . . . 0.0 112.798 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.424 ' CD2' HD11 ' A' ' 115' ' ' ILE . 59.1 m-85 -111.58 140.09 46.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.6 mp -110.14 122.95 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.133 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -79.67 120.17 23.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 175.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.0 tttt -103.47 143.97 32.02 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.428 HG13 ' CD2' ' A' ' 23' ' ' TYR . 20.3 t -140.77 106.62 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.768 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 59.0 mt-10 -140.17 122.21 15.68 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.908 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 9.5 mp -72.94 83.7 1.23 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 13.2 mmt -79.28 -50.92 10.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.86 -176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 97.6 m-85 -69.17 -40.3 15.05 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.407 -0.808 . . . . 0.0 112.618 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 14.8 Cg_endo -88.8 119.6 1.06 Allowed 'Trans proline' 0 C--O 1.177 -2.551 0 C-N-CA 122.14 1.893 . . . . 0.0 109.881 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.724 ' CB ' ' HA ' ' A' ' 103' ' ' PRO 0.479 88.9 Cg_endo -100.46 173.7 0.34 Allowed 'Trans proline' 2 C--O 1.08 -7.38 0 CA-C-O 114.3 -2.459 . . . . 0.0 113.482 173.563 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.724 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.408 52.0 Cg_endo -72.69 176.64 39.37 Favored 'Cis proline' 3 N--CA 1.586 6.96 1 C-N-CA 96.736 -12.61 . . . . 0.0 112.6 -5.491 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 14.7 t80 -79.55 135.72 36.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 116.327 -3.983 . . . . 0.0 111.352 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.33 30.4 t80 -158.73 91.76 1.08 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.104 0.411 . . . . 0.0 111.464 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.413 ' CD1' ' CD1' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -159.35 -157.29 0.57 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.119 -1.432 . . . . 0.0 112.57 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.5 -177.01 36.82 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.966 -1.112 . . . . 0.0 111.295 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.2 mp -121.29 153.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 5' ' ' GLN . . . -92.99 165.2 27.91 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -62.54 -34.03 76.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -1.094 . . . . 0.0 111.694 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 118.54 160.57 11.52 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.688 -1.244 . . . . 0.0 111.921 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.6 m -120.04 145.04 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.484 ' O ' HG21 ' A' ' 8' ' ' VAL . 30.5 tt0 -88.98 145.56 25.43 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.612 -1.235 . . . . 0.0 107.954 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.424 HD11 ' CD2' ' A' ' 92' ' ' TYR . 45.6 mt -117.99 131.31 71.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.55 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 23.0 m-85 -113.93 155.97 24.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.83 -0.544 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.6 t -124.02 163.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.826 0.822 . . . . 0.0 110.047 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 118' ' ' ILE 0.259 3.3 mp -111.44 132.55 59.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.314 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -108.0 109.83 62.1 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.701 . . . . 0.0 109.418 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.74 146.39 60.13 Favored 'Trans proline' 0 N--CA 1.485 1.029 0 O-C-N 123.144 1.076 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -129.85 132.93 24.47 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.37 -18.99 44.09 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.105 1.055 . . . . 0.0 110.911 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.7 m -119.84 153.5 54.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.36 -0.837 . . . . 0.0 110.394 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.91 158.09 57.91 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.39 1.205 . . . . 0.0 110.452 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -148.07 172.08 14.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 110.488 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.6 p -131.96 160.0 37.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.638 -0.664 . . . . 0.0 110.166 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -106.14 120.17 41.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.606 -0.684 . . . . 0.0 110.317 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -121.42 153.61 37.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 85.7 mt-10 53.03 50.12 7.32 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.472 -0.768 . . . . 0.0 111.011 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.8 Cg_endo -70.25 159.66 52.26 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.205 1.108 . . . . 0.0 110.338 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.424 ' C6 ' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.424 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.152 0.501 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp 53.39 22.97 3.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.469 -0.77 . . . . 0.0 110.937 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -129.4 36.63 4.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.469 -0.769 . . . . 0.0 110.151 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.13 137.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.745 -0.597 . . . . 0.0 109.895 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.12 135.69 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.538 -0.726 . . . . 0.0 110.72 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 41.5 mt-30 -148.51 150.07 32.95 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.526 -0.734 . . . . 0.0 111.694 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.02 139.97 37.0 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.284 -1.468 . . . . 0.0 108.284 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.21 -27.5 67.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.497 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.519 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -152.34 171.99 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 118.491 -1.284 . . . . 0.0 110.983 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.1 t -149.85 155.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.567 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -112.12 131.95 55.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.639 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.05 135.93 39.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.529 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -69.88 173.46 6.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.688 -0.632 . . . . 0.0 110.256 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.4 p -60.32 -30.53 69.57 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.555 -0.715 . . . . 0.0 109.992 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -60.07 -30.13 69.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 0.0 109.926 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.68 26.01 8.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -109.72 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.565 -0.962 . . . . 0.0 110.507 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.41 128.88 55.8 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t -126.59 134.83 50.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 111.728 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -140.07 163.99 31.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.92 124.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.468 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' O ' HG21 ' A' ' 77' ' ' VAL . 51.2 t -100.81 117.12 34.26 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 60.0 tt0 -90.75 137.56 32.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 111.282 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -131.29 180.0 5.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.85 123.57 18.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.707 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.8 p -134.53 143.39 46.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.558 -0.714 . . . . 0.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.13 144.24 29.59 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.296 1.156 . . . . 0.0 110.742 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.87 30.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 150.05 51.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.881 . . . . 0.0 109.92 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.77 154.75 37.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 110.41 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.5 p -92.62 10.46 30.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.603 -0.685 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -132.19 84.92 2.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.279 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.8 m -103.35 89.13 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.6 tpt85 -53.72 102.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -110.17 131.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.86 0.838 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 99.9 m -135.56 148.15 49.0 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 95.9 t -116.08 133.83 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 12.8 mt -121.35 170.18 9.87 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.231 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -123.21 119.91 31.6 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.427 ' NE2' HD21 ' A' ' 91' ' ' LEU . 14.2 tt0 -97.15 148.56 22.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 110.166 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.43 -175.66 3.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.848 -0.533 . . . . 0.0 110.055 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.74 -40.47 88.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.67 -0.643 . . . . 0.0 111.385 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.0 m -126.8 -21.55 4.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.19 -0.944 . . . . 0.0 112.57 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -131.96 163.98 27.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.06 -1.025 . . . . 0.0 111.775 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.84 143.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.2 p -129.99 160.18 34.44 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 58.2 tt0 -80.15 157.31 26.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 109.876 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.75 -64.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.782 -0.574 . . . . 0.0 110.392 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.3 m -140.1 141.08 36.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.105 -0.997 . . . . 0.0 109.846 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.1 135.1 16.64 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.698 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.422 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -172.01 149.57 2.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -81.17 111.24 17.42 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.06 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' CE1' ' HB2' ' A' ' 72' ' ' SER . 23.3 t80 -74.92 112.99 11.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.769 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.0 mtp -82.63 161.54 22.17 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 35.6 mmt -61.04 -23.91 65.79 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.659 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.37 41.49 0.75 Allowed Glycine 0 N--CA 1.501 3.027 0 C-N-CA 119.042 -1.551 . . . . 0.0 112.658 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 79.6 m-20 -135.55 160.06 39.67 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 119.067 1.434 . . . . 0.0 110.241 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -89.12 135.63 33.46 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.492 -0.755 . . . . 0.0 110.283 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 1.3 mm? -103.04 156.12 17.91 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.492 -0.755 . . . . 0.0 110.086 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 p -102.2 123.15 45.53 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.388 -0.82 . . . . 0.0 111.706 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.42 ' CE1' ' HB1' ' A' ' 50' ' ' ALA . 42.3 m-85 -114.12 30.5 7.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -53.72 -44.03 69.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.532 -0.73 . . . . 0.0 111.899 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -66.54 145.45 55.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.264 -0.897 . . . . 0.0 110.749 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 52.13 55.58 9.0 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.388 -0.82 . . . . 0.0 110.498 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 60.17 163.87 0.06 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.798 -0.564 . . . . 0.0 109.938 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -99.92 142.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.591 0.71 . . . . 0.0 111.229 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.4 m -121.99 153.77 38.11 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -132.63 150.08 52.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.95 -172.01 43.52 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.41 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 78' ' ' ASN . 92.5 m -129.1 168.78 15.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.0 -0.706 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.432 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 70.1 m -159.98 127.39 4.59 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -155.83 155.93 33.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 110.344 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.76 -124.04 25.67 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -109.32 11.05 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.774 -0.839 . . . . 0.0 110.914 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.1 mt-30 -118.46 124.76 48.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 21' ' ' CYS . 4.0 m -107.17 124.01 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.924 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' THR . 46.6 t-20 -101.97 116.21 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.71 . . . . 0.0 111.077 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 96.6 mt -115.98 131.98 56.78 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.297 -0.877 . . . . 0.0 109.164 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.3 m -124.47 147.21 48.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.184 -0.948 . . . . 0.0 111.075 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 62.3 mt -113.53 131.53 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.711 -0.618 . . . . 0.0 110.072 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.4 ' HG2' HG13 ' A' ' 16' ' ' ILE . 10.5 mt-30 -110.22 120.76 43.48 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.667 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.58 0.99 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt -85.76 125.55 33.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.656 -0.908 . . . . 0.0 111.082 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -107.44 175.85 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.21 94.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.302 -0.873 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.1 ttm -62.14 -36.06 80.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.756 -0.59 . . . . 0.0 110.169 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -66.97 -26.92 67.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.647 . . . . 0.0 111.143 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.9 m -51.4 132.07 29.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.5 -143.96 8.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD21 ' NE2' ' A' ' 39' ' ' GLN . 10.6 tp -110.04 131.94 54.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.737 -0.861 . . . . 0.0 111.611 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 74.1 m-85 -113.28 132.03 55.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.492 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.4 mp -107.97 129.36 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.728 -0.607 . . . . 0.0 112.144 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.077 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 20.1 p -79.88 161.99 25.27 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.3 tttt -152.34 77.49 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.4 p -95.1 113.63 29.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 68.2 mt-10 -130.16 129.65 43.72 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.426 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.1 mt -76.99 76.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 176.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.4 tpp -80.63 -50.15 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.034 -0.667 . . . . 0.0 112.45 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 89.1 m-85 -68.6 -41.21 21.41 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 112.926 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 46.9 Cg_endo -86.25 109.44 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-O 117.875 -0.969 . . . . 0.0 111.098 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 100' ' ' TYR . 57.3 Cg_endo -77.39 158.02 32.93 Favored 'Trans proline' 1 CA--C 1.609 4.236 0 CA-C-O 113.892 -2.628 . . . . 0.0 110.001 177.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -88.54 -177.68 12.56 Favored 'Cis proline' 1 C--N 1.484 7.662 1 C-N-CA 93.031 -14.154 . . . . 0.0 114.475 -10.125 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 4.6 t80 -88.04 125.51 34.59 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-O 122.76 1.267 . . . . 0.0 109.888 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -149.7 74.42 1.22 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 120.943 -1.098 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -142.48 -150.68 0.32 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.352 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.1 -173.04 34.99 Favored Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.902 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.451 ' CG2' ' C8 ' ' A' ' 132' ' ' NAG . 71.7 mt -110.96 149.18 13.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.847 -0.796 . . . . 0.0 109.938 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 1.077 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -74.53 144.14 32.47 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.07 -30.34 69.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.398 -1.06 . . . . 0.0 110.283 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.0 140.03 7.08 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.319 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.3 m -113.53 149.97 33.64 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.501 ' O ' HG21 ' A' ' 8' ' ' VAL . 13.7 tp60 -89.87 137.29 32.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 mt -109.92 128.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.519 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 14.3 m-30 -101.95 139.86 37.02 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.646 0.736 . . . . 0.0 111.748 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t -125.64 166.12 22.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 27.1 mm -100.06 120.01 48.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.477 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -146.33 141.03 15.93 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.11 159.98 51.21 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.243 1.128 . . . . 0.0 110.322 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -86.68 114.84 59.98 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.547 -0.72 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.0 -11.92 31.44 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.2 1.105 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -100.51 135.77 20.1 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.6 -12.06 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.224 1.118 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -148.05 172.19 14.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.5 p -136.43 159.91 40.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.239 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.58 132.03 41.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.555 -0.716 . . . . 0.0 110.269 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.599 -0.688 . . . . 0.0 110.24 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 65.7 mm-40 52.3 50.17 7.77 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.407 -0.808 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.9 Cg_endo -70.22 148.14 61.43 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.197 1.104 . . . . 0.0 110.306 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.501 2.12 0 O-C-N 121.363 -0.836 . . . . 0.0 110.957 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.451 ' C8 ' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.407 ' C8 ' ' H62' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.425 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.428 ' C6 ' ' H5 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.428 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.121 0.486 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 mtt -134.2 156.96 47.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.225 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -110.26 132.02 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.644 -0.66 . . . . 0.0 110.783 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.69 131.47 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.564 -0.71 . . . . 0.0 109.382 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 131.78 56.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.449 -0.782 . . . . 0.0 110.56 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.7 134.7 18.42 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.649 . . . . 0.0 110.475 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.48 136.57 24.01 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.11 1.058 . . . . 0.0 109.696 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.43 -32.95 64.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.484 -0.76 . . . . 0.0 109.666 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.0 157.35 6.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.992 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 t -139.72 153.36 23.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.45 0.643 . . . . 0.0 110.038 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.0 mt -110.83 124.1 51.38 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.71 140.77 46.24 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.496 -0.752 . . . . 0.0 110.724 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -91.61 -168.99 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.598 -0.689 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -49.98 159.04 0.45 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.48 -0.763 . . . . 0.0 110.529 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.458 ' O ' HD12 ' A' ' 16' ' ' ILE . 40.8 tpt85 62.43 13.27 5.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.556 -0.715 . . . . 0.0 110.655 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.07 46.01 93.17 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 82' ' ' GLN . 34.6 mm -104.92 106.7 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.729 -0.865 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.08 123.58 48.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.803 -0.56 . . . . 0.0 109.772 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -130.0 130.95 45.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.663 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 27.2 p90 -142.39 164.06 31.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.807 -0.558 . . . . 0.0 109.724 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.66 116.21 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.852 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' O ' HG21 ' A' ' 77' ' ' VAL . 42.3 t -100.12 103.77 15.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 90.1 mt-10 -79.67 165.11 23.21 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 111.933 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.43 ' CG ' HG13 ' A' ' 96' ' ' VAL . 43.8 p90 -148.07 178.14 8.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 130.34 32.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.689 -0.632 . . . . 0.0 110.009 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -139.95 150.11 61.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.405 -0.809 . . . . 0.0 110.45 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 140.06 33.81 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.44 1.232 . . . . 0.0 110.299 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.65 -145.71 23.28 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -130.11 149.92 51.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.937 . . . . 0.0 110.141 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 147.69 45.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.617 -0.677 . . . . 0.0 109.926 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.093 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 32.8 p -79.97 -59.65 2.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.712 0.767 . . . . 0.0 111.679 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 2.0 mt-10 -80.99 80.52 7.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' HB ' ' CZ ' ' A' ' 52' ' ' TYR . 97.0 t -88.5 96.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.6 ttt85 -70.53 124.25 23.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.572 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.1 142.14 38.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 88.8 m -135.32 142.35 45.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.726 -0.608 . . . . 0.0 110.625 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.3 t -112.77 131.23 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 14.0 mt -120.94 173.76 7.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 110.958 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.42 121.28 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.478 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 24.4 tt0 -97.9 148.65 23.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 111.151 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -132.15 168.65 17.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.47 -28.24 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 110.722 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -108.49 -53.14 2.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.474 -0.766 . . . . 0.0 112.153 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -136.64 170.01 16.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.12 -0.988 . . . . 0.0 111.997 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.4 ' CG2' ' HG3' ' A' ' 39' ' ' GLN . 62.0 t -122.56 147.96 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -127.65 160.42 31.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.341 -0.849 . . . . 0.0 110.678 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 40.1 mt-10 -80.4 145.58 31.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 110.651 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.0 t -117.18 -75.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.305 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.896 ' SG ' ' HB3' ' A' ' 63' ' ' ASP . 70.2 m -139.83 149.15 43.11 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.88 145.48 23.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.488 -0.757 . . . . 0.0 111.294 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.28 148.02 8.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.618 -0.677 . . . . 0.0 109.714 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.2 m -98.42 130.19 45.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' CZ ' ' HB ' ' A' ' 32' ' ' VAL . 52.1 p90 -102.09 133.44 46.93 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.521 -1.272 . . . . 0.0 110.631 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 6.6 mmt -78.41 168.17 20.21 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.104 ' SD ' ' N ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -66.96 90.03 0.17 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.673 -1.267 . . . . 0.0 109.2 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.39 -117.48 0.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -129.9 137.77 50.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.307 -1.113 . . . . 0.0 110.379 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -178.73 138.33 0.16 Allowed 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.14 87.72 2.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 46.1 p -89.58 72.2 7.85 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.425 -0.797 . . . . 0.0 111.384 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.89 109.76 20.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.36 -37.3 82.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.425 -0.797 . . . . 0.0 110.48 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -139.98 172.19 13.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.634 -0.666 . . . . 0.0 110.026 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.896 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 84.5 m-20 52.6 49.95 19.24 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -53.91 -21.11 7.1 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.659 -0.651 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.97 -20.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.264 -0.897 . . . . 0.0 110.627 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 30.7 m -86.07 137.78 32.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 110.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -129.95 131.01 45.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -125.63 116.8 2.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.471 HG22 ' O4 ' ' A' ' 138' ' ' FUC . 59.2 m -103.87 159.0 16.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.726 -0.867 . . . . 0.0 108.673 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 63.0 m -148.15 129.97 15.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.969 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 122.04 25.88 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.04 -124.07 34.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.93 16.59 25.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.964 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 35.7 mt-30 -116.46 122.25 44.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.197 -0.939 . . . . 0.0 110.502 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 21' ' ' CYS . 1.9 m -103.74 122.2 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.866 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -104.21 109.96 21.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 0.0 111.462 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 mt -98.06 130.02 44.88 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.9 m -123.75 145.44 49.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.0 110.41 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.5 mt -119.91 135.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.83 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HA ' HD11 ' A' ' 16' ' ' ILE . 76.5 mt-30 -120.02 120.31 35.94 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.927 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.66 40.5 1.1 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.81 121.19 31.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.952 . . . . 0.0 111.464 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -103.32 179.66 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.85 93.91 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.926 0.869 . . . . 0.0 109.872 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.7 -34.66 78.34 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.331 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.54 -19.96 66.14 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.479 -0.763 . . . . 0.0 111.238 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.0 m -50.65 136.88 20.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.6 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.84 -159.99 32.85 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.59 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.478 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 13.8 tp -110.2 130.05 55.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.7 -0.882 . . . . 0.0 111.961 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.425 ' CD2' HD11 ' A' ' 115' ' ' ILE . 83.9 m-85 -116.29 146.98 41.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.9 mp -103.53 139.96 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.44 -0.788 . . . . 0.0 111.683 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.77 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.7 p -98.16 127.59 44.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -120.39 141.72 49.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 109.916 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.43 HG13 ' CG ' ' A' ' 23' ' ' TYR . 4.8 t -138.05 108.85 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -134.4 128.26 33.24 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.841 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 98' ' ' LEU 0.26 2.8 mm? -76.51 87.68 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HE3' ' CZ ' ' A' ' 104' ' ' TYR . 2.7 mmt -81.15 -58.45 3.06 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.498 -1.281 . . . . 0.0 111.687 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.6 m-85 -71.7 -40.45 8.4 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 48.6 Cg_endo -82.05 117.36 2.88 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.229 0.594 . . . . 0.0 110.658 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 73.0 Cg_endo -92.41 156.97 3.05 Favored 'Trans proline' 1 CA--C 1.701 8.859 0 CA-C-O 114.534 -2.361 . . . . 0.0 109.835 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 55.7 Cg_endo -87.65 178.62 19.91 Favored 'Cis proline' 2 C--N 1.46 6.408 1 C-N-CA 96.668 -12.638 . . . . 0.0 116.727 -8.039 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.455 ' CZ ' ' HE3' ' A' ' 99' ' ' MET . 13.3 t80 -85.93 119.68 26.5 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.043 2.09 . . . . 0.0 113.12 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -162.16 107.74 1.25 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.272 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD22 ' CG1' ' A' ' 96' ' ' VAL . 1.4 tp -157.16 -143.49 0.11 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.921 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.73 178.55 35.77 Favored Glycine 0 N--CA 1.504 3.227 0 O-C-N 120.682 -1.261 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.435 ' CG2' ' C8 ' ' A' ' 132' ' ' NAG . 97.4 mt -126.17 160.82 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.987 . . . . 0.0 109.814 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.77 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 143.47 16.68 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -60.43 -36.08 77.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.479 -1.013 . . . . 0.0 110.271 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 131.56 158.4 9.1 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.017 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 97.0 m -123.33 127.67 48.84 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.478 ' O ' HG21 ' A' ' 8' ' ' VAL . 36.1 tp60 -73.64 137.12 43.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 92' ' ' TYR . 75.4 mt -110.0 129.19 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.894 -1.129 . . . . 0.0 108.422 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.542 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 14.9 m-85 -110.15 142.67 41.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.874 -0.516 . . . . 0.0 111.044 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.6 t -96.02 166.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.96 134.29 47.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.843 -0.536 . . . . 0.0 110.592 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.33 141.57 66.4 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 109.858 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.82 148.07 63.89 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -91.75 126.06 55.18 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.69 -12.2 32.53 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.117 1.061 . . . . 0.0 111.043 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 1.06 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 49.3 t -138.73 156.38 72.94 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 109.863 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 1.06 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 41.9 Cg_endo -66.57 -17.79 53.4 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.344 1.181 . . . . 0.0 111.551 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.96 -175.07 5.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.6 t -89.81 129.87 36.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.453 -0.78 . . . . 0.0 110.299 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -67.87 -35.95 79.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.71 . . . . 0.0 110.188 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -101.48 143.79 31.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.616 -0.678 . . . . 0.0 110.119 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 64.9 mm-40 52.72 49.74 6.96 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.767 . . . . 0.0 111.161 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 45.1 Cg_endo -69.75 154.05 68.25 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.194 1.102 . . . . 0.0 110.546 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.435 ' C8 ' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.458 ' C6 ' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.458 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.471 ' O4 ' HG22 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt -99.23 21.44 11.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.59 -0.694 . . . . 0.0 110.517 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -110.04 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.455 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -135.78 132.48 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.68 131.09 57.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.581 -0.699 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.089 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 87.0 mm-40 -140.0 139.69 22.12 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.224 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.33 147.66 42.16 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.284 1.15 . . . . 0.0 109.835 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.5 -29.61 25.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG23 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.44 156.99 4.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.017 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 t -134.98 157.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 66.1 mt -111.04 130.18 55.68 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.702 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.71 147.78 23.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.863 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -78.27 168.85 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.647 -0.658 . . . . 0.0 110.153 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -59.76 -37.91 80.35 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.446 -0.783 . . . . 0.0 109.969 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -57.46 -24.06 53.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.535 -0.728 . . . . 0.0 110.397 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.8 28.02 8.6 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.2 mp -103.63 101.67 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -105.56 124.35 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.0 p -136.37 150.03 48.62 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.875 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 22.2 p90 -154.62 161.48 41.57 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 79.8 t -118.79 117.69 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.499 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.089 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 53.6 t -100.1 107.42 19.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.51 144.95 29.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.911 . . . . 0.0 111.186 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.417 ' CG ' HG13 ' A' ' 96' ' ' VAL . 50.0 p90 -131.64 -179.97 5.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.75 131.92 39.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.691 -0.631 . . . . 0.0 110.093 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.4 t -127.29 150.42 72.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.475 -0.766 . . . . 0.0 111.101 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.34 -14.77 37.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.735 1.387 . . . . 0.0 111.362 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.89 -165.43 16.79 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -110.1 132.16 54.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.97 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 153.76 39.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.1 p -80.03 -35.08 37.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -79.89 97.07 6.55 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.3 -175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.5 t -113.56 85.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 99' ' ' MET . 72.1 ttt-85 -61.25 116.19 4.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.114 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 28.4 m -122.46 133.98 67.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.712 0.767 . . . . 0.0 110.157 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.3 m -120.06 123.98 44.75 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.086 0.469 . . . . 0.0 109.967 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 93.7 t -100.54 130.23 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 71.2 mt -124.76 167.66 14.28 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.351 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -127.71 124.04 36.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -109.13 132.01 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.954 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.01 162.6 24.17 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.03 -42.98 95.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.2 m -70.09 -55.92 8.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.727 . . . . 0.0 110.694 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -150.42 -177.27 5.86 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.964 0.888 . . . . 0.0 111.399 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.8 136.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -134.27 161.6 34.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 75.5 mt-10 -80.2 155.54 27.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.77 -95.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.869 -0.519 . . . . 0.0 110.089 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.424 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 99.2 m -120.14 145.12 47.24 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.705 -1.247 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.76 138.57 14.28 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.38 -0.825 . . . . 0.0 111.796 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -175.4 157.06 2.1 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -80.1 119.88 23.49 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 72' ' ' SER . 19.6 t80 -80.83 109.98 15.91 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.445 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.16 146.06 33.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -15.81 63.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.07 -1.018 . . . . 0.0 110.661 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.83 -15.03 5.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -130.02 160.06 34.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -1.221 . . . . 0.0 110.911 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -123.2 125.2 44.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.506 -0.746 . . . . 0.0 110.052 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.2 170.17 13.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.474 -0.766 . . . . 0.0 111.349 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -110.2 159.95 16.93 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.473 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.8 m-85 -99.93 132.08 45.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.492 -0.755 . . . . 0.0 109.696 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.87 -44.13 94.35 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -140.82 -165.76 2.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.028 -1.045 . . . . 0.0 111.995 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 56.0 57.15 5.32 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.221 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.3 m 56.61 167.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.322 0.582 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -91.39 84.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 110.018 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 59.7 m -68.08 151.39 47.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -132.62 149.96 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 109.336 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.1 176.49 39.33 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.9 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 94.3 m -131.96 166.41 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 122.005 -0.703 . . . . 0.0 109.721 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 34.7 t -151.16 80.32 1.31 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.706 -0.621 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -129.97 145.11 51.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.486 -0.759 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.01 37.75 87.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.5 m120 56.96 24.22 9.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.609 -0.936 . . . . 0.0 110.387 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -127.37 124.1 37.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.552 -0.717 . . . . 0.0 109.17 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 21' ' ' CYS . 3.2 m -102.19 117.55 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.553 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.416 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 57.4 t-20 -99.76 104.77 16.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.322 -0.861 . . . . 0.0 111.156 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.406 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 75.1 mt -93.27 131.86 37.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 0.0 109.819 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 58.9 m -121.89 139.93 53.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.2 mt -120.02 138.82 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.711 . . . . 0.0 109.905 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.0 mt-30 -124.92 121.24 33.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.983 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.38 25.1 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 75.7 mt -81.67 129.99 34.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -1.044 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.9 mtp-105 -104.19 179.93 4.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.05 94.55 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.835 0.826 . . . . 0.0 109.614 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.9 mmt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -67.75 -16.93 64.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.761 . . . . 0.0 111.807 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.3 m -52.96 139.96 26.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 166.31 -164.96 37.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 18.0 tp -94.12 132.01 39.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.752 -0.852 . . . . 0.0 112.483 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 115' ' ' ILE . 72.9 m-85 -118.39 134.58 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.5 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 4.0 mp -99.95 139.91 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 111.762 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.851 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.8 p -108.07 107.98 18.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 37' ' ' LEU . 17.1 mttt -105.17 141.39 36.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 109.202 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG13 ' CG ' ' A' ' 23' ' ' TYR . 9.8 t -135.96 111.42 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.947 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 86.6 mt-10 -131.98 131.7 42.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.539 -0.725 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 11.2 mt -85.43 80.01 9.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 33' ' ' ARG . 2.5 ttm -80.65 -39.67 26.92 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.631 -173.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.439 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 68.6 m-85 -70.8 -45.7 16.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.401 -0.92 . . . . 0.0 112.773 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 71.9 Cg_endo -80.29 133.42 9.72 Favored 'Trans proline' 0 CA--C 1.597 3.648 0 O-C-N 122.877 0.935 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 86.0 Cg_endo -90.88 143.11 3.32 Favored 'Trans proline' 1 N--CA 1.54 4.207 1 CA-C-O 110.185 -4.173 . . . . 0.0 114.945 177.088 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 104' ' ' TYR . 21.2 Cg_endo -110.7 57.07 0.77 Allowed 'Cis proline' 2 C--N 1.453 6.051 1 C-N-CA 97.123 -12.449 . . . . 0.0 110.505 11.41 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' O ' ' O ' ' A' ' 103' ' ' PRO . 5.1 t80 50.72 120.95 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.836 0 O-C-N 120.556 -1.34 . . . . 0.0 111.843 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -160.18 106.98 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.428 -2.045 . . . . 0.0 107.378 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tp -159.41 -148.91 0.19 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.979 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.46 -176.38 30.44 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.458 ' CG2' ' C8 ' ' A' ' 132' ' ' NAG . 76.8 mt -126.63 162.75 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.355 -1.086 . . . . 0.0 110.978 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.851 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 134.81 11.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -59.8 -35.89 75.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -1.17 . . . . 0.0 110.64 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 130.6 136.73 4.02 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.68 -1.248 . . . . 0.0 111.874 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 96.3 m -108.63 139.09 43.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.445 ' O ' ' CG2' ' A' ' 8' ' ' VAL . 14.5 tt0 -89.56 120.2 30.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.207 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.413 HD11 ' CD1' ' A' ' 92' ' ' TYR . 97.0 mt -81.48 123.66 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CE2' HG23 ' A' ' 8' ' ' VAL . 2.8 m-30 -94.93 161.66 14.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.633 0.73 . . . . 0.0 111.531 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 118' ' ' ILE . 8.0 p -123.28 148.0 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 118' ' ' ILE . 1.9 mp -79.99 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -132.03 126.4 20.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.769 -0.582 . . . . 0.0 109.711 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.55 150.02 68.99 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.101 1.053 . . . . 0.0 110.748 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.01 150.07 50.26 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.626 -0.671 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.98 -27.93 35.98 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.353 1.186 . . . . 0.0 110.738 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 1.067 ' SG ' ' OD1' ' A' ' 125' ' ' ASP . 42.3 t -140.0 135.64 16.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.463 -0.773 . . . . 0.0 110.202 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.99 -19.3 35.22 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.158 1.083 . . . . 0.0 111.312 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 1.067 ' OD1' ' SG ' ' A' ' 123' ' ' CYS . 56.3 p30 -86.04 -172.1 3.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.008 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.3 p -122.68 150.45 42.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 0.0 109.927 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.11 160.1 40.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.54 -0.725 . . . . 0.0 110.295 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -60.38 -30.42 69.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.595 -0.69 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.03 140.84 88.72 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.617 -0.677 . . . . 0.0 109.974 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.92 149.98 66.62 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.286 1.151 . . . . 0.0 110.495 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 110.262 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.458 ' C8 ' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.52 ' C8 ' ' C1 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.52 ' C1 ' ' C8 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.443 ' H5 ' ' C8 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.443 ' C8 ' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.109 0.481 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm -122.47 -164.04 1.14 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.626 -0.671 . . . . 0.0 109.858 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -96.52 22.92 7.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 110.818 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 61.3 t -149.77 132.03 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . . . -110.2 132.74 53.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.377 -0.827 . . . . 0.0 110.606 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -138.75 138.79 22.34 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.814 -0.554 . . . . 0.0 110.503 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.48 133.89 27.19 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.259 1.137 . . . . 0.0 109.535 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.49 76.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -149.16 155.96 7.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.118 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 19' ' ' PHE . 8.6 t -137.62 155.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.989 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.1 mt -116.01 132.72 56.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.07 131.76 35.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.384 -0.823 . . . . 0.0 110.974 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -60.64 172.73 0.85 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.62 -0.675 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -59.83 -35.94 75.77 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.577 -0.702 . . . . 0.0 110.088 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -24.95 15.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.97 24.97 13.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -112.6 111.64 37.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.69 119.72 37.9 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.4 t -122.31 131.1 53.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.21 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.419 ' HB3' HG22 ' A' ' 9' ' ' VAL . 46.2 p90 -139.92 164.03 31.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.481 ' CG1' ' HG2' ' A' ' 76' ' ' GLN . 55.3 t -131.6 130.77 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.956 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.461 ' SG ' ' CG ' ' A' ' 5' ' ' GLN . 29.5 t -112.84 110.75 21.05 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.9 pt-20 -82.06 151.73 26.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.723 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.418 ' CD2' HG22 ' A' ' 96' ' ' VAL . 19.6 p90 -134.36 169.44 17.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.63 134.72 43.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.583 -0.698 . . . . 0.0 110.898 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 t -140.2 149.47 58.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.634 . . . . 0.0 110.651 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.67 -20.44 52.99 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.727 1.383 . . . . 0.0 111.54 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.02 165.91 25.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.61 133.54 55.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.573 -0.957 . . . . 0.0 110.548 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.93 163.0 29.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 109.536 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' MET . 25.6 p -80.1 -38.03 32.49 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.39 -0.818 . . . . 0.0 110.201 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' HE2' ' A' ' 53' ' ' MET . 10.5 mm-40 -79.35 93.11 5.26 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.225 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.4 t -109.76 102.6 14.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 71.8 ttt180 -82.83 106.37 14.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.343 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 34.0 m -106.04 141.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.487 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.0 m -132.0 156.88 45.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.728 0.775 . . . . 0.0 110.175 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' O ' ' HB ' ' A' ' 47' ' ' VAL . 98.4 t -125.57 136.24 61.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 7.7 mt -131.92 160.1 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.058 -1.026 . . . . 0.0 111.216 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -112.66 113.79 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.431 ' NE2' ' CD1' ' A' ' 93' ' ' ILE . 26.3 mt-30 -93.67 131.82 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.895 . . . . 0.0 110.818 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.9 158.69 39.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.65 85.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 110.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.7 p -73.71 -56.09 5.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.615 -0.678 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -154.15 171.99 18.28 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.302 -0.874 . . . . 0.0 111.353 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 63.8 t -122.35 142.11 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.0 p -128.22 160.16 32.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.206 -0.934 . . . . 0.0 111.603 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 59.1 mt-10 -80.25 162.04 24.83 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.67 -0.643 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 38.7 t -130.25 -64.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.342 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.776 ' SG ' ' O ' ' A' ' 64' ' ' SER . 57.9 m -149.56 151.89 34.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.441 -0.787 . . . . 0.0 110.153 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.59 137.89 2.84 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.148 -0.97 . . . . 0.0 112.387 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.1 148.11 3.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.529 -0.732 . . . . 0.0 109.917 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -95.87 115.3 27.23 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.137 -0.977 . . . . 0.0 108.784 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CE1' ' CE ' ' A' ' 54' ' ' MET . 46.1 p90 -109.57 145.31 36.57 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.388 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 1.068 ' SD ' ' N ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -73.23 158.71 34.67 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.449 ' CE ' ' CE1' ' A' ' 52' ' ' TYR . 27.5 mmt -67.14 130.46 43.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.837 -1.164 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.5 30.46 18.84 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -149.26 175.61 11.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -1.124 . . . . 0.0 110.909 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -137.84 150.07 46.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.819 -0.551 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 51' ' ' THR . 80.1 mt -134.15 179.63 6.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.304 -0.873 . . . . 0.0 111.577 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.7 p -113.8 159.81 19.38 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.963 -0.461 . . . . 0.0 110.081 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 36.2 m-85 -110.2 123.38 49.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.63 -35.87 75.63 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.48 -0.762 . . . . 0.0 112.359 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -67.15 -147.75 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.241 -0.912 . . . . 0.0 111.187 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -46.57 -19.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.896 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.776 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 29.0 m 57.51 -132.62 1.32 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.654 -0.654 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.5 mt 56.56 22.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.77 -1.206 . . . . 0.0 110.27 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 64' ' ' SER . 20.7 m -137.36 155.18 49.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -120.31 140.06 51.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.43 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.58 96.1 1.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 m -123.79 156.03 36.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.538 -0.978 . . . . 0.0 109.024 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.2 p -156.52 160.24 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.177 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -140.36 107.92 5.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.15 32.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -93.69 9.71 35.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.454 -1.027 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.481 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 36.5 tt0 -111.7 136.07 51.44 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.239 -0.913 . . . . 0.0 110.226 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 11.3 m -112.77 141.85 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.008 -1.058 . . . . 0.0 111.287 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -112.76 118.01 33.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.769 . . . . 0.0 110.784 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.22 129.97 56.08 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.719 . . . . 0.0 109.376 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.8 m -130.65 154.52 47.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.272 -0.892 . . . . 0.0 110.808 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 91.0 mt -120.43 139.41 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.78 -0.575 . . . . 0.0 109.846 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.408 ' CG ' HG13 ' A' ' 16' ' ' ILE . 40.2 mt-30 -119.48 123.22 43.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.143 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.57 56.84 0.76 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.85 126.03 30.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.792 -0.828 . . . . 0.0 111.805 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -105.93 170.14 8.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.22 90.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -65.64 -37.72 87.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.755 -0.591 . . . . 0.0 110.325 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.28 -36.47 75.61 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.619 -0.676 . . . . 0.0 111.228 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -51.11 133.75 27.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.6 -143.69 9.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.23 123.71 49.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.733 -0.863 . . . . 0.0 111.709 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.426 ' CD1' HD11 ' A' ' 115' ' ' ILE . 53.7 m-85 -110.18 115.87 30.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.469 -0.769 . . . . 0.0 110.05 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 112' ' ' GLY . 40.8 mm -78.21 133.51 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.6 -0.687 . . . . 0.0 111.984 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.3 p -85.47 149.82 25.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.2 tttt -147.31 127.93 14.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 108.495 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.418 HG22 ' CD2' ' A' ' 23' ' ' TYR . 2.4 p -134.95 113.11 15.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.614 0.721 . . . . 0.0 109.297 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 74.3 mm-40 -134.56 132.2 38.83 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.511 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 1.6 mm? -81.54 85.2 6.55 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 51.0 tpp -82.52 -46.92 12.77 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.779 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 59.0 m-85 -71.42 -42.98 11.9 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 49.1 Cg_endo -81.76 113.06 2.47 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 121.194 1.263 . . . . 0.0 112.576 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.44 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 50.5 Cg_endo -77.02 166.87 26.05 Favored 'Trans proline' 1 CA--C 1.642 5.913 0 CA-C-O 111.834 -3.486 . . . . 0.0 108.246 177.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.43 68.2 Cg_endo -81.95 -171.97 10.0 Favored 'Cis proline' 1 C--N 1.47 6.944 1 C-N-CA 98.741 -11.774 . . . . 0.0 116.704 -15.862 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.1 t80 -99.19 125.16 44.7 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 118.365 -2.709 . . . . 0.0 109.243 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.43 ' O ' ' CD2' ' A' ' 106' ' ' LEU . 22.5 p90 -169.42 108.1 0.42 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.005 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -152.91 -148.02 0.24 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.1 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.8 165.35 32.06 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.357 -176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.6 mp -122.25 149.18 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -88.14 -177.68 47.46 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.84 21.33 17.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -1.19 . . . . 0.0 111.803 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.504 ' N ' HD11 ' A' ' 93' ' ' ILE . . . 83.53 146.89 7.17 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-O 122.793 1.218 . . . . 0.0 114.074 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 57.7 m -116.16 128.88 56.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG21 ' A' ' 8' ' ' VAL . 35.3 tp60 -68.36 136.59 53.6 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 118.354 -1.339 . . . . 0.0 107.86 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' ' 92' ' ' TYR . 61.6 mt -113.67 125.1 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.957 -1.09 . . . . 0.0 108.635 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.563 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 24.8 m-85 -109.69 159.79 16.85 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.4 t -103.61 164.71 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.331 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.272 38.8 mm -117.95 140.07 42.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.156 0.503 . . . . 0.0 110.672 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -105.98 116.09 60.22 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.619 -0.676 . . . . 0.0 109.276 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.81 140.07 41.58 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.101 1.053 . . . . 0.0 110.76 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.0 142.15 44.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 110.112 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.64 -12.11 32.43 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.244 1.129 . . . . 0.0 111.241 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.611 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 42.3 t -128.03 144.48 51.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.94 . . . . 0.0 110.389 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.611 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 49.1 Cg_endo -69.08 161.92 43.87 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.38 1.2 . . . . 0.0 110.691 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -80.22 -173.7 4.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.457 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -60.12 -29.98 68.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.0 110.785 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -84.14 119.96 25.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.452 -0.78 . . . . 0.0 110.427 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -120.67 142.05 49.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.05 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 52.37 49.49 6.76 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.492 -0.755 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 47.4 Cg_endo -69.34 149.94 70.17 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.24 1.126 . . . . 0.0 110.663 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 110.073 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.434 ' C6 ' ' H5 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.429 ' H1 ' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.434 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.068 0.461 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt 56.09 166.63 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.695 -0.628 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -124.08 37.08 4.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.4 t -102.06 134.97 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.773 -0.58 . . . . 0.0 110.114 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.02 131.36 54.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.508 -0.745 . . . . 0.0 110.217 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -157.57 156.05 28.15 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.572 -0.705 . . . . 0.0 111.277 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.57 46.75 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.55 1.29 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.13 -23.66 23.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.582 -0.699 . . . . 0.0 109.731 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.512 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.2 156.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.567 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.86 156.8 35.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.86 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 86.8 mt -114.61 127.77 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.629 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.93 165.14 18.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.456 -0.778 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 160.02 43.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.255 -0.903 . . . . 0.0 111.1 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t 55.5 -132.87 1.66 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.509 -0.745 . . . . 0.0 110.737 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.423 ' HB3' ' CD1' ' A' ' 16' ' ' ILE . 6.1 ttt180 -52.02 -23.84 5.77 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.764 -1.21 . . . . 0.0 111.461 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 119.56 46.19 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.44 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.8 mp -103.78 113.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.93 0.872 . . . . 0.0 109.893 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -112.92 126.48 55.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.3 p -123.49 139.99 53.46 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.59 0.709 . . . . 0.0 110.902 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -150.15 162.24 40.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.9 t -125.29 121.03 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.713 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -100.04 103.72 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -80.04 142.43 34.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.817 . . . . 0.0 111.0 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CG ' HG13 ' A' ' 96' ' ' VAL . 38.3 p90 -121.96 176.36 5.83 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.64 137.01 41.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.661 -0.649 . . . . 0.0 110.584 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.4 p -142.95 152.91 59.88 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.649 -0.657 . . . . 0.0 110.43 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.23 -13.47 36.07 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.461 1.242 . . . . 0.0 110.929 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.13 -179.84 33.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -117.98 140.08 50.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -1.035 . . . . 0.0 110.602 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.54 172.27 13.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.0 109.486 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 p -80.06 -46.55 16.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -80.09 109.96 15.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.795 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 96.7 t -119.83 82.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -60.22 103.58 0.24 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -114.44 143.66 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.325 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.422 ' H ' ' HB3' ' A' ' 95' ' ' LYS . 69.1 m -140.03 132.9 29.22 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.217 0.532 . . . . 0.0 111.04 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.3 t -98.99 130.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 13.6 mt -119.97 160.01 23.59 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.749 -1.219 . . . . 0.0 111.735 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -117.03 129.68 56.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -106.81 149.31 27.51 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.712 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.62 -172.6 2.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.858 -0.526 . . . . 0.0 109.761 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.18 -44.4 95.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.502 -0.749 . . . . 0.0 111.138 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.1 m -132.73 -13.74 2.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.295 -0.878 . . . . 0.0 112.294 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -122.88 142.7 50.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 111.168 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -132.03 133.81 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -131.17 165.84 22.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -79.98 149.91 30.63 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.441 0.638 . . . . 0.0 110.55 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 1.073 HG13 ' SG ' ' A' ' 68' ' ' CYS . 95.4 t -112.33 -67.99 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 63' ' ' ASP . 57.0 m -133.34 150.08 51.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.547 -0.721 . . . . 0.0 109.526 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -166.87 135.27 2.71 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.378 -0.929 . . . . 0.0 112.007 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -172.02 157.54 4.4 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.422 HG22 ' CD1' ' A' ' 100' ' ' TYR . 2.9 m -85.69 124.81 32.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 72' ' ' SER . 28.7 t80 -87.82 110.41 20.48 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.592 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.425 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 2.2 mmt -80.04 165.58 22.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 31.2 mmt -59.54 -30.34 68.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.6 -1.312 . . . . 0.0 109.604 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.16 -139.75 7.9 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.68 133.75 55.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -1.154 . . . . 0.0 110.668 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 178.02 159.22 0.48 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HB3' ' CB ' ' A' ' 50' ' ' ALA . 38.3 mt 51.04 78.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.977 . . . . 0.0 111.308 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -96.79 163.26 13.06 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.728 -0.608 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.437 ' CG ' ' HB3' ' A' ' 48' ' ' CYS . 8.6 m-30 -90.53 10.01 27.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.565 -0.709 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.71 -30.21 68.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.273 -0.892 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.07 -28.55 62.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.396 -0.815 . . . . 0.0 111.019 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.702 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 26.3 m-20 -84.11 -6.58 59.43 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 122.082 -0.386 . . . . 0.0 111.667 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p 42.25 28.5 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.8 mt -137.04 -47.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.306 -0.871 . . . . 0.0 110.79 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 1.073 ' SG ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -118.76 131.41 56.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 0.0 111.486 -179.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -139.85 147.49 40.75 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.99 -171.74 37.26 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.275 -1.441 . . . . 0.0 111.16 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 78' ' ' ASN . 59.9 m -130.08 169.6 15.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 122.019 -0.695 . . . . 0.0 109.821 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.426 ' HB3' ' CD2' ' A' ' 52' ' ' TYR . 31.0 t -134.74 130.02 35.56 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -135.07 129.95 34.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 50.61 -122.84 14.09 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.421 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 27.4 m120 -100.03 12.07 37.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.759 -0.847 . . . . 0.0 110.46 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -116.27 128.49 55.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 109.853 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.42 118.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.399 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' THR . 58.8 t-20 -89.31 110.05 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 111.112 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.08 131.96 54.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -131.26 144.08 51.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.418 HD12 ' CE2' ' A' ' 92' ' ' TYR . 62.5 mt -124.02 140.02 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.502 -0.749 . . . . 0.0 110.481 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -120.34 122.56 41.06 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.402 0.62 . . . . 0.0 109.589 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.92 37.75 1.65 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 94.9 mt -80.12 85.72 5.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.893 . . . . 0.0 110.77 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.96 168.38 20.14 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -41.73 67.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.234 -0.917 . . . . 0.0 109.732 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.76 -36.07 79.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.393 0.616 . . . . 0.0 109.78 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.25 -23.48 67.07 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 110.859 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -53.43 139.98 29.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.23 -146.8 10.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.004 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 93' ' ' ILE . 1.6 tm? -107.33 134.93 49.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.859 -0.789 . . . . 0.0 110.752 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 57.2 m-85 -121.1 125.07 46.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.6 mp -98.75 123.97 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.396 -0.815 . . . . 0.0 112.578 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.898 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.6 p -85.11 111.29 19.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' H ' ' A' ' 35' ' ' THR . 7.8 tttt -103.56 139.99 38.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.536 -0.727 . . . . 0.0 109.076 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.424 HG13 ' CG ' ' A' ' 23' ' ' TYR . 21.2 t -140.13 105.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.41 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.929 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 36.8 mt-10 -131.93 130.69 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.238 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.5 mt -84.62 78.84 9.77 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.929 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -80.03 -41.67 25.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.195 -0.941 . . . . 0.0 113.016 -174.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.443 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 62.8 m-85 -65.17 -46.84 72.83 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.884 -1.135 . . . . 0.0 113.145 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.0 110.1 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.204 1.107 . . . . 0.0 111.349 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 100' ' ' TYR . 44.6 Cg_endo -89.24 145.92 5.18 Favored 'Trans proline' 0 CA--C 1.598 3.724 0 CA-C-O 110.666 -3.972 . . . . 0.0 110.432 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 37.6 Cg_endo -88.3 -168.37 4.44 Favored 'Cis proline' 2 N--CA 1.629 9.478 2 C-N-CA 92.29 -14.463 . . . . 0.0 111.927 -0.064 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -88.17 137.79 32.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.644 -1.285 . . . . 0.0 113.975 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.458 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 12.4 p90 -153.59 92.71 1.6 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.496 -0.752 . . . . 0.0 111.905 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.6 tp -160.13 -149.67 0.2 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.616 -0.678 . . . . 0.0 110.446 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.02 176.35 40.03 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.339 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.0 mp -117.55 158.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.718 -0.872 . . . . 0.0 109.338 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.898 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -87.45 146.82 20.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.31 78.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.439 -1.036 . . . . 0.0 110.135 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.4 129.96 3.74 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.101 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.8 m -94.63 129.98 41.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.987 -0.713 . . . . 0.0 109.089 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.497 ' O ' HG21 ' A' ' 8' ' ' VAL . 21.4 tp60 -79.87 132.01 36.0 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 81.3 mt -98.85 125.06 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.865 -1.147 . . . . 0.0 108.767 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.512 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 11.9 m-30 -103.44 151.21 23.08 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.108 0.48 . . . . 0.0 111.122 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.8 t -100.13 166.43 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.8 mm -101.67 120.22 50.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.848 -0.533 . . . . 0.0 111.035 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -119.97 148.41 46.63 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 0.0 109.824 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.89 147.99 63.23 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.346 1.182 . . . . 0.0 110.437 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -129.91 144.24 52.28 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.31 160.07 50.83 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.341 1.18 . . . . 0.0 110.365 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.6 m -81.35 140.03 48.59 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.528 -0.732 . . . . 0.0 109.92 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.05 -35.97 10.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.237 1.125 . . . . 0.0 110.975 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.89 -39.84 87.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.44 -0.787 . . . . 0.0 110.637 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.2 p -65.1 -31.98 73.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -107.99 124.11 49.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.55 -0.719 . . . . 0.0 110.446 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -73.69 155.29 39.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 54.0 mt-10 53.48 50.17 7.06 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.443 -0.785 . . . . 0.0 110.741 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.4 Cg_endo -69.98 167.6 24.26 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 123.273 1.144 . . . . 0.0 110.541 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? . . . . . 0 N--CA 1.499 2.018 0 O-C-N 121.562 -0.711 . . . . 0.0 110.557 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.433 ' C8 ' ' H2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.433 ' H2 ' ' C8 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.55 ' C6 ' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.55 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.063 0.459 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt -137.3 78.45 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.67 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -100.1 118.73 37.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.292 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 97.6 t -149.25 147.73 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 109.679 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.425 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . . . -111.71 130.6 55.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.443 -0.785 . . . . 0.0 110.607 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.591 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 13.1 mm100 -143.5 139.97 17.0 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.668 -0.645 . . . . 0.0 111.49 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.63 139.92 38.29 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.82 66.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -154.03 162.41 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.679 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -141.94 153.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.6 mt -107.91 129.78 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 143.98 25.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.483 -0.761 . . . . 0.0 110.624 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -75.87 170.05 16.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.655 -0.653 . . . . 0.0 110.13 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -60.14 -34.63 73.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.712 . . . . 0.0 110.124 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 5.6 ttt180 -60.17 -26.63 66.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.0 110.034 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.93 30.67 6.63 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.1 mp -105.3 103.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.646 -0.914 . . . . 0.0 109.32 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -108.85 124.07 50.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 92.9 p -136.26 149.83 48.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.738 0.78 . . . . 0.0 111.243 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -155.95 164.1 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.1 t -126.66 123.98 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.596 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 36.8 t -102.89 108.07 19.14 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 17.1 pt-20 -79.79 160.03 26.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 111.296 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.422 ' HB3' HG12 ' A' ' 96' ' ' VAL . 50.6 p90 -139.96 179.89 6.35 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.68 125.76 29.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.702 . . . . 0.0 110.961 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -149.73 158.81 37.11 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.653 . . . . 0.0 109.966 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.81 124.91 11.52 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.354 1.186 . . . . 0.0 110.168 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.98 -131.38 52.02 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -126.03 143.31 51.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.617 -0.931 . . . . 0.0 109.956 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.18 145.17 42.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 110.04 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.401 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 2.7 p -80.9 -59.74 2.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 112.067 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -84.27 75.82 10.17 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.279 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG2' ' HB3' ' A' ' 52' ' ' TYR . 15.4 m -85.78 87.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.2 ttp85 -55.97 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.53 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.6 m -103.56 129.59 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.819 0.819 . . . . 0.0 111.046 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.5 m -131.45 145.83 51.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.611 -0.68 . . . . 0.0 109.655 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 94.5 t -114.04 132.39 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.25 167.16 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.979 -1.076 . . . . 0.0 111.293 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -127.61 120.86 29.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -105.9 130.28 53.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.395 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -126.78 156.12 41.73 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.24 -43.62 95.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.443 -0.786 . . . . 0.0 110.644 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -68.33 -49.95 56.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.549 -0.719 . . . . 0.0 111.145 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -155.47 164.02 39.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.382 -0.824 . . . . 0.0 111.084 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.9 t -124.77 137.27 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -139.96 166.11 25.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.494 -0.754 . . . . 0.0 110.959 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 62.5 tt0 -79.99 157.42 26.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 109.47 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG11 ' SG ' ' A' ' 48' ' ' CYS . 97.3 t -121.03 -72.17 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.843 -0.536 . . . . 0.0 110.445 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.519 ' SG ' HG11 ' A' ' 47' ' ' VAL . 81.0 m -129.95 148.08 51.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.339 -0.85 . . . . 0.0 109.411 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -155.95 136.47 13.24 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.17 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -173.84 149.58 1.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.587 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -94.33 119.94 33.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.214 -0.928 . . . . 0.0 109.278 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 53' ' ' MET . 25.6 t80 -77.91 116.7 18.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.077 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -84.23 169.93 14.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.401 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.5 mmt -65.44 -28.26 69.1 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.687 -1.258 . . . . 0.0 111.27 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.76 44.3 0.83 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.218 -1.468 . . . . 0.0 112.361 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 74.1 m-20 -132.73 162.14 32.21 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 118.867 1.333 . . . . 0.0 110.158 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -104.68 126.54 51.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.561 -0.712 . . . . 0.0 110.13 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -98.29 139.98 33.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.009 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.6 p -100.18 142.87 31.07 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.676 -0.64 . . . . 0.0 110.581 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 96.0 m-85 -103.72 133.64 48.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.51 -0.743 . . . . 0.0 109.25 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.83 -44.27 94.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.516 -0.74 . . . . 0.0 112.762 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -168.39 -149.45 0.09 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.909 -1.119 . . . . 0.0 111.21 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 59.01 54.27 5.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.462 -0.774 . . . . 0.0 110.242 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p 65.47 9.72 6.02 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.899 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.0 mt 48.27 68.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.16 -0.962 . . . . 0.0 111.354 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.413 ' O ' ' CE1' ' A' ' 60' ' ' PHE . 11.5 m -59.89 133.41 56.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 9.1 t -80.08 128.93 34.09 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.286 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -106.68 107.69 2.75 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.48 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -113.8 149.69 34.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.737 -0.861 . . . . 0.0 108.943 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 69.3 m -150.71 131.42 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -139.98 138.53 35.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.664 -0.648 . . . . 0.0 109.265 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.54 -123.92 33.31 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -108.92 16.68 22.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.905 . . . . 0.0 110.544 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 36.8 mt-30 -121.8 128.8 52.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.218 -0.926 . . . . 0.0 111.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 2.8 m -100.5 128.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.133 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -108.02 118.12 35.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 86.7 mt -112.13 129.96 56.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.525 -0.734 . . . . 0.0 109.541 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.401 ' HB ' ' CG2' ' A' ' 69' ' ' THR . 61.3 m -125.89 138.98 53.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.296 -0.878 . . . . 0.0 110.641 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.419 HD12 ' CE2' ' A' ' 92' ' ' TYR . 72.9 mt -113.7 139.74 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.734 -0.604 . . . . 0.0 110.273 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.41 ' HG2' HG13 ' A' ' 16' ' ' ILE . 63.3 mt-30 -124.81 121.98 36.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.259 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.61 36.99 1.49 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.401 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 80.3 mt -92.81 121.09 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.986 . . . . 0.0 111.33 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 73.4 mmt-85 -98.02 176.96 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.08 84.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 16.9 tpt -67.89 -34.54 76.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.514 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -67.53 -16.34 64.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.665 -0.647 . . . . 0.0 111.465 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -50.36 135.5 21.81 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.213 -0.929 . . . . 0.0 110.439 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.55 -159.43 24.02 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.871 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 tp -109.55 128.65 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.676 -0.897 . . . . 0.0 111.531 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.458 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 62.1 m-85 -109.94 139.94 44.48 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.2 mp -115.31 130.22 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.608 -0.683 . . . . 0.0 111.881 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.107 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.8 p -80.1 146.87 31.66 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 6.8 tttt -142.55 77.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 23' ' ' TYR . 3.6 p -98.84 113.99 35.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.783 0.801 . . . . 0.0 110.482 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HG2' ' OH ' ' A' ' 104' ' ' TYR . 54.9 mt-10 -128.19 129.14 46.02 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.721 -0.612 . . . . 0.0 110.63 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.4 mt -77.64 76.16 4.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.6 tpp -81.8 -44.21 17.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.431 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 90.3 m-85 -70.19 -42.1 15.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.405 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 58.7 Cg_endo -87.51 111.76 0.81 Allowed 'Trans proline' 0 CA--C 1.561 1.868 0 CA-C-O 117.362 -1.183 . . . . 0.0 111.324 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.484 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 76.0 Cg_endo -85.23 155.15 10.95 Favored 'Trans proline' 0 CA--C 1.597 3.629 0 CA-C-O 111.592 -3.587 . . . . 0.0 110.249 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.286 48.0 Cg_endo -86.46 -178.99 17.33 Favored 'Cis proline' 2 C--N 1.5 8.512 1 C-N-CA 91.179 -14.925 . . . . 0.0 115.914 -5.951 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.402 ' OH ' ' HG2' ' A' ' 97' ' ' GLU . 1.6 t80 -85.28 128.43 34.69 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.399 -1.438 . . . . 0.0 110.33 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -145.09 69.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.385 0.612 . . . . 0.0 111.552 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 tp -144.9 -154.87 0.56 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.74 -171.22 33.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.063 -1.541 . . . . 0.0 111.838 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.464 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.2 mp -115.15 150.03 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.7 -0.882 . . . . 0.0 109.639 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 1.107 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -79.91 148.65 30.45 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -59.82 -38.63 82.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.351 -1.087 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 125.42 148.5 7.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.8 m -119.79 134.57 55.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.485 ' O ' HG21 ' A' ' 8' ' ' VAL . 38.3 tp60 -80.38 129.51 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 75.5 mt -98.2 120.82 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.0 108.537 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.542 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 9.5 m-30 -97.02 132.36 42.9 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.095 0.474 . . . . 0.0 111.414 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -98.82 166.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.03 116.7 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -140.09 125.06 11.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.581 -0.7 . . . . 0.0 110.08 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.72 149.94 67.78 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.075 1.04 . . . . 0.0 110.513 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -123.92 145.52 48.08 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.506 -0.746 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.35 -17.44 44.35 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.418 1.22 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.1 m -125.91 148.91 64.38 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.346 -0.846 . . . . 0.0 110.343 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.8 -11.94 31.8 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.463 1.244 . . . . 0.0 111.36 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -147.95 179.24 7.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.223 -0.923 . . . . 0.0 110.645 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.8 p -132.44 163.95 27.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.146 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.18 122.2 27.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.38 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -89.87 169.77 10.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.642 -0.661 . . . . 0.0 110.331 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 53.67 50.67 7.53 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.471 -0.768 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.5 Cg_endo -70.13 159.99 51.18 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.209 1.11 . . . . 0.0 110.224 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.502 2.162 0 O-C-N 121.454 -0.779 . . . . 0.0 110.613 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.432 ' C8 ' ' H1 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.432 ' H1 ' ' C8 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.041 0.448 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.611 ' SD ' ' HE1' ' A' ' 105' ' ' TYR . 66.3 mtt -93.94 95.29 8.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.562 -0.711 . . . . 0.0 110.283 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.92 132.02 54.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.586 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.5 t -129.89 126.04 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.609 -0.682 . . . . 0.0 109.607 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 130.81 56.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.506 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -135.02 131.29 19.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 110.601 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.78 136.03 24.69 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.064 1.034 . . . . 0.0 109.515 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.1 -28.78 57.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.813 . . . . 0.0 110.209 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -153.01 163.01 2.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.045 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 t -138.51 151.63 24.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.57 178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.9 mt -119.19 121.26 39.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.603 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 140.08 45.53 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -110.12 -69.38 0.87 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.226 -0.921 . . . . 0.0 112.647 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 m -120.03 151.32 39.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.241 -0.912 . . . . 0.0 111.075 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.478 ' HG2' HD12 ' A' ' 16' ' ' ILE . 4.0 tpt180 56.9 18.8 4.09 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.606 -0.684 . . . . 0.0 110.577 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.64 44.02 53.91 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.478 HD12 ' HG2' ' A' ' 14' ' ' ARG . 21.6 mm -110.25 108.97 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 121.606 -0.938 . . . . 0.0 108.941 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.79 126.11 48.59 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.793 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.3 t -133.17 135.0 44.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.92 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 26.7 p90 -146.23 161.33 40.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.77 -0.581 . . . . 0.0 109.796 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.72 119.06 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.225 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.453 ' O ' HG21 ' A' ' 77' ' ' VAL . 42.2 t -100.18 103.18 14.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 85.1 mt-10 -80.4 164.3 23.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 111.789 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CG ' HG12 ' A' ' 96' ' ' VAL . 44.0 p90 -147.9 178.46 8.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.489 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.59 27.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.636 . . . . 0.0 109.891 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -131.44 147.82 67.65 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 0.0 110.585 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.44 142.53 26.69 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.379 1.199 . . . . 0.0 110.372 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.61 -150.34 38.62 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.07 140.91 50.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.924 . . . . 0.0 110.21 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.81 144.82 31.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.273 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.096 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 82.7 p -78.6 -46.83 18.42 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.952 0.882 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HA ' ' HE2' ' A' ' 53' ' ' MET . 2.2 mm-40 -79.04 112.56 16.37 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.538 0.685 . . . . 0.0 112.847 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 52' ' ' TYR . 94.2 t -124.04 96.09 3.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -77.89 124.03 27.5 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 0.0 111.184 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 m -121.75 141.81 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.58 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.5 m -129.92 130.1 44.7 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.238 0.542 . . . . 0.0 110.536 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 95.6 t -103.77 132.02 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 18.7 mt -127.34 169.03 14.0 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.185 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -122.1 115.66 22.85 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 9.5 tt0 -83.95 150.37 25.71 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.733 0.778 . . . . 0.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.86 -162.05 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.18 -46.15 90.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.444 -0.785 . . . . 0.0 110.392 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.1 p -134.77 -3.88 2.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.473 -0.767 . . . . 0.0 112.031 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -137.32 161.52 36.05 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.007 -1.058 . . . . 0.0 111.133 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.17 156.0 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.1 p -124.13 157.67 34.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.386 -0.822 . . . . 0.0 110.628 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 50.2 mt-10 -87.31 143.18 27.38 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.608 0.718 . . . . 0.0 111.017 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG13 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -116.3 -71.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.932 -0.48 . . . . 0.0 109.98 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.51 ' SG ' HG13 ' A' ' 47' ' ' VAL . 30.8 m -140.06 153.38 46.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.381 -0.824 . . . . 0.0 110.589 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 135.27 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.492 -0.755 . . . . 0.0 110.912 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' CB ' ' C ' ' A' ' 59' ' ' THR . . . -171.15 155.96 4.57 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.424 -0.797 . . . . 0.0 110.212 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.6 m -102.17 131.04 48.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.446 ' CZ ' ' HB ' ' A' ' 32' ' ' VAL . 55.4 p90 -110.05 141.12 43.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.669 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.977 ' SD ' ' N ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -77.0 164.1 26.08 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.096 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -71.29 79.96 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.904 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.05 -134.27 2.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -99.16 135.67 40.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.293 -1.122 . . . . 0.0 110.573 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -177.08 174.94 1.62 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.07 137.76 46.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.107 -0.996 . . . . 0.0 110.055 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.472 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 73.4 p -90.77 8.27 35.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.976 -0.452 . . . . 0.0 110.046 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 59' ' ' THR . 13.5 m-85 -131.59 113.54 13.76 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.57 -35.91 81.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.537 -0.727 . . . . 0.0 109.521 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -141.16 -169.92 2.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.792 -0.567 . . . . 0.0 109.684 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.695 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 81.6 m-20 54.33 58.15 5.22 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.344 -0.848 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 t -49.26 -21.53 0.84 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.749 -0.595 . . . . 0.0 112.013 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -49.1 -26.72 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 63' ' ' ASP . 4.2 p -95.57 129.62 42.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -0.764 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -139.08 148.41 43.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.787 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.92 -173.77 38.94 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.5 m -130.12 163.92 25.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.951 -0.734 . . . . 0.0 109.842 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 62.8 m -148.08 127.16 12.84 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -155.93 140.0 16.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 110.589 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.86 -124.19 33.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -107.76 16.14 23.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.741 -0.858 . . . . 0.0 110.824 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.424 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.5 mt-30 -119.83 120.09 35.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.209 -0.932 . . . . 0.0 110.958 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -103.96 124.33 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -103.0 111.25 23.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 111.946 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -100.52 135.87 41.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.297 -0.877 . . . . 0.0 109.011 177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.1 m -135.81 144.5 45.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.313 -0.867 . . . . 0.0 110.812 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.1 mt -119.12 131.45 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.415 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 96.9 mt-30 -113.78 119.42 37.29 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.155 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.07 47.85 0.86 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.2 mt -89.11 129.82 35.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.958 . . . . 0.0 111.755 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -119.21 179.99 4.01 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.88 82.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.188 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -65.4 -32.93 74.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.982 -0.449 . . . . 0.0 111.74 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.23 -20.02 64.78 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.345 -0.847 . . . . 0.0 111.4 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.4 m -51.79 136.46 27.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.61 29.93 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.631 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 58.4 tp -109.9 133.12 53.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.912 . . . . 0.0 111.775 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 115' ' ' ILE . 46.8 m-85 -116.5 128.79 55.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.3 mp -95.37 127.02 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.612 -0.68 . . . . 0.0 112.112 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.05 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 29.9 p -93.13 112.25 24.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.401 ' HE3' ' CD1' ' A' ' 37' ' ' LEU . 5.6 mttt -105.55 146.62 29.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.419 HG12 ' CG ' ' A' ' 23' ' ' TYR . 21.9 t -141.75 106.3 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.54 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.682 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 85.9 mt-10 -132.69 127.4 34.74 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.057 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 1.7 mm? -77.53 83.73 3.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.682 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 5.0 mmm -80.58 -51.3 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.578 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 78.0 m-85 -66.29 -41.25 41.14 Favored Pre-proline 0 N--CA 1.503 2.195 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 56.4 Cg_endo -86.48 114.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.442 1.233 . . . . 0.0 111.927 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.545 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 90.3 Cg_endo -91.96 151.38 3.28 Favored 'Trans proline' 2 CA--C 1.675 7.545 0 CA-C-O 113.269 -2.888 . . . . 0.0 112.679 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 22.3 Cg_endo -84.95 177.39 27.9 Favored 'Cis proline' 1 N--CA 1.579 6.526 1 C-N-CA 92.828 -14.238 . . . . 0.0 114.271 -1.203 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -85.53 128.06 34.63 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.611 ' HE1' ' SD ' ' A' ' 1' ' ' MET . 43.2 t80 -160.21 111.19 1.9 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.522 -1.361 . . . . 0.0 109.708 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.4 ' HG ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.15 -144.67 0.14 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.693 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.98 175.82 31.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.9 mm -124.24 165.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.367 -1.078 . . . . 0.0 109.79 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 1.05 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -96.12 139.33 14.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -60.09 -26.25 66.05 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.633 -0.922 . . . . 0.0 110.558 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 110.89 135.65 6.93 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.0 m -107.63 129.82 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.888 -0.772 . . . . 0.0 109.993 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.494 ' O ' HG21 ' A' ' 8' ' ' VAL . 37.0 tp60 -79.05 146.46 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.422 HD11 ' CD2' ' A' ' 92' ' ' TYR . 40.9 mt -117.46 129.91 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.526 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 23.0 m-85 -109.95 140.21 44.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.689 -0.632 . . . . 0.0 111.3 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 118' ' ' ILE . 96.9 t -96.9 147.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.431 ' N ' HG11 ' A' ' 117' ' ' VAL . 36.6 mm -78.57 131.66 34.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.221 0.534 . . . . 0.0 110.45 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.27 126.33 40.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.708 -0.62 . . . . 0.0 110.145 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.88 151.91 68.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.083 1.044 . . . . 0.0 110.495 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -120.06 149.89 49.99 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.27 -10.09 28.03 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.392 1.206 . . . . 0.0 111.323 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.915 ' SG ' ' CG ' ' A' ' 125' ' ' ASP . 42.3 t -85.54 131.19 48.48 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 0.0 110.084 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.68 -12.99 37.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.185 1.097 . . . . 0.0 111.384 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.915 ' CG ' ' SG ' ' A' ' 123' ' ' CYS . 56.9 p-10 -76.54 169.92 17.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.7 p -70.92 159.88 33.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.553 -0.717 . . . . 0.0 110.198 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -63.47 -35.92 82.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.592 -0.692 . . . . 0.0 110.305 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -142.24 162.13 36.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.73 . . . . 0.0 109.981 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 54.69 50.42 6.45 Favored Pre-proline 0 N--CA 1.502 2.156 0 O-C-N 121.36 -0.838 . . . . 0.0 110.798 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.3 Cg_endo -70.63 157.52 58.45 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.198 1.104 . . . . 0.0 110.135 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.623 -0.673 . . . . 0.0 110.171 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.43 ' C6 ' ' H2 ' ' A' ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . 0.43 ' H2 ' ' C6 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.457 ' C6 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.457 ' H1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.408 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . 0.432 ' H1 ' ' C6 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' A ALA . . . . . 0.406 ' HB2' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.096 0.474 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 106' ' ' LEU . 22.1 mmt 52.7 82.57 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.415 -0.803 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 1' A ALA . 97.9 m-70 -109.98 130.1 55.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.513 -0.742 . . . . 0.0 110.437 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 90.9 t -147.69 151.29 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.618 -0.676 . . . . 0.0 109.604 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' A' ' 22' ' ' GLU . . . -130.55 133.86 46.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.449 -0.782 . . . . 0.0 111.562 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.122 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 49.1 mt-30 -150.69 149.92 27.01 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.597 . . . . 0.0 111.141 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.91 139.99 37.41 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 N-CA-C 108.337 -1.447 . . . . 0.0 108.337 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.47 66.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.271 -0.893 . . . . 0.0 110.891 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.586 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.8 p -155.93 166.61 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.1 154.72 28.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.319 0.581 . . . . 0.0 109.513 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.24 130.04 55.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.24 132.69 46.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.733 . . . . 0.0 110.789 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.07 175.5 4.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.786 -0.571 . . . . 0.0 109.527 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -60.18 -35.23 74.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -60.37 -32.63 71.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.6 -0.687 . . . . 0.0 110.163 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.92 5.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.3 mp -105.34 101.78 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.921 . . . . 0.0 109.247 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.39 122.98 47.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.6 t -131.92 131.72 42.93 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.381 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -144.42 159.99 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.73 125.47 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.699 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.754 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 49.6 t -107.02 105.81 16.01 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 16.7 pt-20 -80.22 152.15 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.05 . . . . 0.0 111.098 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.403 ' CB ' HG12 ' A' ' 96' ' ' VAL . 43.8 p90 -139.94 178.86 6.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.47 127.79 38.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.664 -0.648 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.9 p -139.86 148.68 56.28 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.548 -0.72 . . . . 0.0 110.206 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.88 140.03 28.26 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.392 1.207 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.54 -156.92 8.83 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -129.97 149.93 51.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.938 . . . . 0.0 110.127 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 155.48 40.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.526 -0.734 . . . . 0.0 109.98 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.7 p -80.46 -43.17 21.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.456 -0.777 . . . . 0.0 110.513 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' CB ' ' HB2' ' A' ' 100' ' ' TYR . 33.2 mm-40 -80.4 114.4 19.27 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.597 0.713 . . . . 0.0 112.334 -176.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.3 t -128.48 87.2 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 52.6 ttt85 -58.67 110.99 1.11 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.389 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.1 m -113.91 127.59 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.628 0.728 . . . . 0.0 110.178 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 93.2 m -128.75 140.45 51.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.713 -0.617 . . . . 0.0 109.574 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.7 t -109.79 136.94 44.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 92' ' ' TYR . 12.9 mt -122.94 159.94 27.22 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.853 -1.154 . . . . 0.0 111.31 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -120.85 118.09 29.07 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -99.93 132.64 45.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.435 -0.791 . . . . 0.0 111.33 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.42 161.82 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.69 -41.31 90.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.503 -0.748 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 m -70.58 -57.19 4.99 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 110.83 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -154.29 169.57 23.36 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.4 -0.813 . . . . 0.0 110.734 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 80.9 t -117.35 137.53 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.655 -0.653 . . . . 0.0 109.28 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.2 p -132.55 162.4 31.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.472 -0.767 . . . . 0.0 110.89 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 36.9 tt0 -80.02 158.1 26.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.582 -0.699 . . . . 0.0 109.937 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 93.8 t -119.38 -82.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.675 ' SG ' ' O ' ' A' ' 64' ' ' SER . 92.8 m -120.15 154.09 35.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.909 -1.119 . . . . 0.0 109.978 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -161.23 132.89 5.61 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.397 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -172.38 159.67 4.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -93.4 110.2 21.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 109.869 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 23.7 t80 -72.67 124.44 25.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.384 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.409 ' O ' ' CE1' ' A' ' 52' ' ' TYR . 1.4 mmt -86.07 144.51 27.51 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 34.1 mmt -59.79 -28.09 67.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.82 -22.59 9.31 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.694 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -129.9 158.21 40.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.177 -1.19 . . . . 0.0 111.467 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -113.57 135.47 53.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.031 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.6 mp -96.32 167.43 11.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.729 0.776 . . . . 0.0 111.742 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -114.79 160.0 19.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.9 m-85 -96.36 124.43 40.36 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.6 tp -59.81 -44.19 94.12 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -144.04 -166.44 2.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.0 111.705 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 55.82 59.27 3.89 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.46 0.648 . . . . 0.0 110.12 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.675 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 70.1 m 57.39 105.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.408 0.623 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.78 92.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.783 -0.573 . . . . 0.0 110.287 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.446 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 76.1 m -69.99 163.34 26.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -138.24 150.38 46.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.414 -0.804 . . . . 0.0 109.218 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.92 43.24 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.872 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.4 m -130.1 166.41 20.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.045 -0.679 . . . . 0.0 109.476 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 65.5 m -152.87 122.77 6.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.755 -0.591 . . . . 0.0 109.554 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.6 p -148.94 148.15 29.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.96 -125.53 27.49 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.23 19.06 20.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.909 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.8 mt-30 -123.98 122.72 38.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.237 -0.915 . . . . 0.0 110.876 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 21' ' ' CYS . 5.4 m -105.57 123.78 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -99.61 114.03 26.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.185 -0.947 . . . . 0.0 111.225 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.81 129.53 48.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.7 m -119.55 132.58 55.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.0 mt -110.16 129.89 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.449 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -122.1 121.87 37.93 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.808 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.62 45.75 0.89 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 75.9 mt -79.86 133.55 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.788 0.804 . . . . 0.0 111.836 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -120.05 167.54 12.09 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.39 84.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.268 -0.895 . . . . 0.0 109.842 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -68.09 -39.14 82.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.708 -0.62 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.2 -22.6 66.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.536 -0.728 . . . . 0.0 111.345 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -51.52 136.48 26.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.41 -164.81 34.68 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.575 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 26.9 tp -84.27 131.7 34.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.723 -0.869 . . . . 0.0 112.784 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 72.1 m-85 -113.55 127.15 55.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.4 mp -110.09 130.33 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.617 -0.677 . . . . 0.0 112.792 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.173 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -80.06 148.64 30.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.8 tttt -142.79 82.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.419 ' CG2' HD22 ' A' ' 106' ' ' LEU . 3.2 p -93.95 115.28 32.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 122.181 0.991 . . . . 0.0 111.078 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 62.0 mt-10 -131.9 131.04 42.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.1 mt -80.99 75.78 7.96 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.5 ttm -80.26 -34.58 36.94 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.471 -175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 16.8 m-85 -69.0 -44.36 28.54 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 119.389 -0.924 . . . . 0.0 113.144 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -90.42 105.49 0.32 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 N-CA-C 114.958 1.099 . . . . 0.0 114.958 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.88 155.82 43.54 Favored 'Trans proline' 1 CA--C 1.659 6.759 0 CA-C-O 112.825 -3.073 . . . . 0.0 109.081 177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -87.98 172.81 30.98 Favored 'Cis proline' 3 C--N 1.494 8.196 1 C-N-CA 90.435 -15.235 . . . . 0.0 116.032 -12.051 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 2.7 t80 -90.8 134.98 34.03 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.518 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -160.5 113.5 2.05 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.679 1.191 . . . . 0.0 109.583 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.554 ' O ' ' SD ' ' A' ' 1' ' ' MET . 2.8 tp -158.26 -146.32 0.15 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.014 -1.054 . . . . 0.0 110.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.17 170.66 32.72 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.979 -1.581 . . . . 0.0 112.389 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.8 mm -109.69 152.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 122.189 -0.595 . . . . 0.0 109.69 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 1.173 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -80.53 148.41 29.24 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -60.46 -38.65 84.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.988 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.96 136.62 5.94 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.295 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.2 m -119.93 141.75 49.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.474 ' O ' HG21 ' A' ' 8' ' ' VAL . 33.3 tt0 -89.88 124.04 34.35 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.596 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.425 ' HB ' ' CE2' ' A' ' 92' ' ' TYR . 23.9 mm -87.85 123.98 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.586 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 4.4 m-30 -95.02 151.08 19.49 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.854 0.835 . . . . 0.0 111.536 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.1 t -131.98 166.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.9 114.89 39.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.787 -0.571 . . . . 0.0 110.311 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -139.96 128.5 13.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.58 -0.7 . . . . 0.0 110.548 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.41 164.01 34.32 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.097 1.051 . . . . 0.0 110.025 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -79.66 128.27 75.22 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.0 110.283 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.9 -15.2 36.47 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.192 1.101 . . . . 0.0 111.298 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.3 m -104.09 119.99 52.46 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 110.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.9 -11.44 29.35 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 123.1 1.053 . . . . 0.0 111.424 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -75.91 170.03 17.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.677 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -92.05 3.8 54.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.65 -0.656 . . . . 0.0 111.22 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -64.09 136.61 57.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.122 -0.986 . . . . 0.0 110.187 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -117.66 143.76 45.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.67 . . . . 0.0 110.209 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 65.6 mm-40 52.44 49.91 7.33 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.423 -0.798 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.0 Cg_endo -69.95 150.06 66.52 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.203 1.107 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.549 -0.719 . . . . 0.0 110.172 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.423 ' C6 ' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.423 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.431 ' H5 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.431 ' H1 ' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . 0.424 ' H1 ' ' C6 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.945 0.402 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm -87.38 -79.86 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.785 . . . . 0.0 110.485 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -123.5 119.98 31.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.258 -0.901 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.46 125.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.637 -0.664 . . . . 0.0 109.246 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.08 137.73 54.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.444 -0.785 . . . . 0.0 110.651 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -150.55 144.47 17.4 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.667 . . . . 0.0 111.117 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.87 147.58 50.17 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.324 1.171 . . . . 0.0 109.745 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.86 -26.55 29.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 109.45 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.8 p -153.61 155.99 5.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.043 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.1 t -138.05 151.45 25.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.222 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.6 mt -105.32 126.61 52.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 154.11 42.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.47 -0.769 . . . . 0.0 110.561 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 m -97.37 -179.93 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.802 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 m -53.36 160.97 1.04 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.83 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 58.8 18.12 5.79 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.747 -0.596 . . . . 0.0 111.401 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.71 39.06 86.38 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.163 -0.96 . . . . 0.0 111.213 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.4 mp -99.52 99.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.152 -1.205 . . . . 0.0 108.854 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 108.907 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.6 p -135.56 149.98 49.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.672 0.748 . . . . 0.0 111.237 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -157.17 163.95 38.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.0 t -125.06 113.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.548 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.3 t -100.08 109.95 22.24 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.2 pt-20 -80.77 164.03 23.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.958 . . . . 0.0 111.77 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CG ' ' CG1' ' A' ' 96' ' ' VAL . 46.5 p90 -145.83 178.28 8.29 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.12 131.31 53.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.4 p -142.34 160.65 53.78 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.747 -0.596 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.06 -10.37 28.17 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.46 1.242 . . . . 0.0 111.503 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.44 27.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt 52.01 -155.01 0.17 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.265 -1.138 . . . . 0.0 110.063 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.6 117.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 53' ' ' MET . 47.7 p -79.91 -35.69 37.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -80.04 120.09 23.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.091 0.948 . . . . 0.0 112.779 -175.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.1 t -132.05 83.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.731 ' HD3' ' SD ' ' A' ' 99' ' ' MET . 12.4 ttt180 -59.04 114.9 2.81 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.384 0.611 . . . . 0.0 111.664 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.16 152.8 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 95' ' ' LYS . 59.0 m -147.64 140.09 24.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.7 -0.625 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 93.7 t -115.96 131.64 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 15.2 mt -121.98 160.02 25.75 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.696 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp-105 -116.93 129.94 56.38 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -102.92 140.02 37.73 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.3 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -133.27 155.25 49.73 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.09 -43.98 95.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.82 -44.09 67.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.549 -0.72 . . . . 0.0 111.055 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -164.43 167.92 19.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.4 -0.813 . . . . 0.0 110.95 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.16 137.27 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.1 p -130.04 168.23 17.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.29 -0.881 . . . . 0.0 111.224 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 52.5 mt-10 -79.92 154.07 28.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.706 -0.621 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 89.8 t -118.05 -75.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.765 -0.585 . . . . 0.0 110.391 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.977 ' SG ' ' CG ' ' A' ' 63' ' ' ASP . 85.2 m -130.31 165.66 22.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.387 -0.821 . . . . 0.0 110.622 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.11 3.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.218 -0.926 . . . . 0.0 111.677 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -174.19 140.49 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -85.52 105.65 16.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 72' ' ' SER . 32.1 t80 -60.23 127.93 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.596 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.449 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.3 mmt -95.72 134.31 38.79 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 34.8 mmt -56.96 -20.38 23.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.101 -0.999 . . . . 0.0 111.077 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.11 -12.83 8.06 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.249 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -129.98 159.94 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.985 -1.303 . . . . 0.0 111.223 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -109.85 131.95 54.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.698 -0.626 . . . . 0.0 110.264 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -93.95 153.88 17.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.486 -0.759 . . . . 0.0 110.861 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.6 p -101.72 140.62 35.77 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.545 0.688 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 72.0 m-85 -100.2 30.97 3.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -60.0 -35.83 75.89 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.531 -0.731 . . . . 0.0 111.331 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -52.08 -25.93 9.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.977 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 2.8 p30 -113.66 11.54 18.21 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.611 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 59.0 137.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.057 0.932 . . . . 0.0 111.877 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.0 mt 58.86 -131.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.306 -0.872 . . . . 0.0 110.315 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 69.1 m 51.61 67.82 0.9 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.248 -1.533 . . . . 0.0 111.31 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 t -132.72 149.89 52.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.1 -140.02 4.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 71.2 m -129.01 164.92 22.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.723 -0.869 . . . . 0.0 110.499 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 22.0 m -166.38 120.15 1.1 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -158.25 153.51 25.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.22 -124.36 35.61 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.26 12.09 26.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.748 -0.854 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 37.6 mt-30 -120.8 122.09 39.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.182 -0.949 . . . . 0.0 110.63 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 3.5 m -107.41 123.74 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.422 -0.799 . . . . 0.0 109.713 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.54 113.43 27.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 111.194 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 91.5 mt -105.7 129.23 53.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.454 -0.779 . . . . 0.0 109.217 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.1 m -124.53 137.67 54.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 110.738 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.5 mt -111.62 139.58 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.707 -0.621 . . . . 0.0 110.144 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.428 ' HG2' HG13 ' A' ' 16' ' ' ILE . 82.1 mt-30 -120.02 120.53 36.6 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.997 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.68 51.91 0.73 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.409 ' CD1' ' CB ' ' A' ' 17' ' ' ALA . 80.9 mt -99.69 130.03 45.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.987 . . . . 0.0 111.504 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -105.39 179.97 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.07 87.33 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.776 0.798 . . . . 0.0 109.533 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.7 mtp -60.37 -39.94 89.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.147 0.498 . . . . 0.0 110.82 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -57.95 -27.11 63.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.6 -0.688 . . . . 0.0 111.018 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -50.0 140.02 12.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.555 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.62 -161.85 33.0 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.635 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' CD1' ' N ' ' A' ' 92' ' ' TYR . 1.8 tm? -88.68 139.91 29.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.888 0.852 . . . . 0.0 112.086 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.412 ' CD2' HD11 ' A' ' 115' ' ' ILE . 42.3 m-85 -127.58 128.19 45.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.7 mp -100.77 129.9 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.302 -0.874 . . . . 0.0 112.182 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.925 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.2 p -91.07 126.24 36.1 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 35' ' ' THR . 5.5 mtmt -116.72 145.75 43.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.137 -0.977 . . . . 0.0 110.145 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 ' CG1' ' CG ' ' A' ' 23' ' ' TYR . 26.6 t -142.6 104.57 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.964 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.5 mm-40 -133.23 140.09 47.32 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.599 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.486 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 8.0 mt -93.01 81.14 4.56 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 103.779 -2.675 . . . . 0.0 103.779 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.731 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 1.4 mtt -80.51 -30.58 37.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.411 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.445 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 71.5 m-85 -75.45 -49.08 3.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.29 -0.881 . . . . 0.0 111.853 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 100' ' ' TYR . 41.3 Cg_endo -74.76 120.74 6.27 Favored 'Trans proline' 0 N--CA 1.518 2.924 0 C-N-CA 121.841 1.694 . . . . 0.0 114.813 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.41 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 63.1 Cg_endo -82.2 148.13 14.83 Favored 'Trans proline' 1 CA--C 1.659 6.758 0 CA-C-O 114.187 -2.505 . . . . 0.0 111.06 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.329 58.0 Cg_endo -116.39 58.25 0.38 Allowed 'Cis proline' 0 C--N 1.398 3.156 1 C-N-CA 95.048 -13.313 . . . . 0.0 109.053 10.955 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.2 t80 55.67 118.85 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.093 0 O-C-N 120.942 -1.099 . . . . 0.0 112.629 172.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' O ' ' A' ' 105' ' ' TYR . 4.3 p90 -165.71 105.55 0.72 Allowed 'General case' 0 N--CA 1.529 3.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.0 tp -158.87 -149.38 0.21 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 118.692 0.678 . . . . 0.0 111.415 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.22 174.13 34.08 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.281 -1.438 . . . . 0.0 110.753 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 95' ' ' LYS . 48.8 mm -120.26 163.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.954 -0.733 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.925 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -94.04 140.04 14.85 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.99 -38.26 82.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.479 -1.013 . . . . 0.0 110.393 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 128.87 148.53 6.68 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.011 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.0 m -118.15 140.01 50.42 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.437 ' O ' HG21 ' A' ' 8' ' ' VAL . 23.3 tt0 -89.28 129.99 35.75 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.221 -1.392 . . . . 0.0 108.741 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.412 HD11 ' CD2' ' A' ' 92' ' ' TYR . 88.8 mt -94.35 131.95 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.553 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 7.9 m-30 -106.71 149.92 26.8 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.139 0.495 . . . . 0.0 111.491 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -83.23 168.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.3 mm -102.72 140.04 22.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.783 0.801 . . . . 0.0 111.289 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -117.56 145.49 36.41 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 149.95 88.8 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.107 1.056 . . . . 0.0 110.164 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -66.61 142.24 97.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 111.167 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 123' ' ' CYS . 52.1 Cg_endo -77.03 0.23 9.91 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 123.492 1.259 . . . . 0.0 111.43 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 1.085 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 0.5 OUTLIER 76.17 173.52 0.09 OUTLIER Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.001 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 1.085 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 44.2 Cg_endo -69.95 -8.9 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.367 1.193 . . . . 0.0 112.157 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -65.77 -13.09 58.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.115 -0.99 . . . . 0.0 110.969 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -114.13 155.42 26.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.181 -0.949 . . . . 0.0 110.173 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -69.93 139.94 52.99 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.55 -0.719 . . . . 0.0 110.514 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -118.13 151.1 38.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 53.3 mt-10 53.25 50.19 7.25 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.414 -0.804 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.1 Cg_endo -67.8 -20.01 46.3 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.241 1.127 . . . . 0.0 111.0 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.392 -0.817 . . . . 0.0 110.163 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.447 ' H5 ' ' C8 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.447 ' C8 ' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.148 0.499 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.06 -148.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.578 -0.701 . . . . 0.0 109.587 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -97.02 30.21 2.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.063 -1.023 . . . . 0.0 110.594 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.402 ' CG1' ' NE2' ' A' ' 5' ' ' GLN . 71.0 t -125.76 129.68 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.8 132.14 52.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 110.558 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.402 ' NE2' ' CG1' ' A' ' 3' ' ' VAL . 17.2 mp0 -135.82 131.93 19.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.641 -0.662 . . . . 0.0 110.851 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.52 139.86 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.132 1.069 . . . . 0.0 109.799 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.18 -32.28 64.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.808 . . . . 0.0 109.443 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.51 157.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.916 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 t -139.91 136.64 38.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.666 0.746 . . . . 0.0 110.594 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 2.8 mm? -97.63 125.13 42.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.4 151.25 23.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.425 -0.797 . . . . 0.0 110.245 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -75.82 172.24 13.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.552 -0.717 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -59.65 -29.0 67.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.01 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -59.93 -27.78 67.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.597 -0.689 . . . . 0.0 109.867 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.41 23.36 12.65 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -110.25 109.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 O-C-N 121.5 -1.0 . . . . 0.0 110.534 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.47 118.32 36.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 81.7 p -123.95 140.58 52.84 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.531 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -149.92 164.86 34.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.891 -0.505 . . . . 0.0 109.895 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.1 t -122.65 114.16 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.134 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.442 ' O ' HG21 ' A' ' 77' ' ' VAL . 42.2 t -100.05 107.49 19.42 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.441 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 82.9 mt-10 -79.98 165.03 23.0 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 111.678 -176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.43 ' CG ' HG13 ' A' ' 96' ' ' VAL . 43.4 p90 -149.88 -179.95 7.55 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.9 128.52 43.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -112.6 150.42 42.66 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.425 -0.797 . . . . 0.0 111.116 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.27 -19.31 38.65 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.712 1.375 . . . . 0.0 111.34 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.13 -165.81 29.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.77 126.5 38.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.638 -0.919 . . . . 0.0 110.728 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.65 38.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.682 -0.636 . . . . 0.0 109.588 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 53' ' ' MET . 62.8 p -79.9 -37.88 33.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 110.675 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 6.4 mm-40 -79.93 112.48 17.27 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.861 -0.735 . . . . 0.0 112.331 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.97 82.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ttp85 -60.17 121.42 11.9 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.392 0.615 . . . . 0.0 111.43 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -124.34 132.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.6 m -125.55 131.27 52.79 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.236 0.541 . . . . 0.0 110.66 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 87.9 t -104.54 139.15 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 19.6 mt -125.12 164.02 21.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 111.587 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -116.51 91.64 3.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.463 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 6.5 tt0 -93.63 140.05 30.07 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.29 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.53 154.53 37.77 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.1 -42.88 91.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 96.4 p -70.21 -43.61 70.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.599 -0.688 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -156.88 160.69 39.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.385 -0.822 . . . . 0.0 111.09 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.35 130.39 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.3 p -139.91 165.88 26.14 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.452 -0.78 . . . . 0.0 111.416 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 72.0 mt-10 -81.07 160.3 24.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.631 -0.668 . . . . 0.0 109.832 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 60.1 t -123.75 -85.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.621 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 1.217 ' SG ' ' CG ' ' A' ' 60' ' ' PHE . 18.5 t -118.79 152.69 35.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.959 -1.088 . . . . 0.0 110.112 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -167.81 128.52 1.41 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.391 -0.818 . . . . 0.0 112.654 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . . . -172.0 161.42 5.66 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -83.11 119.98 25.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.017 -1.052 . . . . 0.0 109.596 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.444 ' CE1' ' HB3' ' A' ' 72' ' ' SER . 12.8 t80 -78.99 109.58 13.43 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.243 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 53' ' ' MET . 6.1 mmm -84.82 138.61 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 32.1 mmt -58.15 -20.2 38.8 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.16 -0.963 . . . . 0.0 110.921 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.73 -93.17 1.67 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -80.43 164.18 23.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.526 -0.985 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 40.3 tp10 -110.12 130.11 55.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.812 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.5 mt -76.03 169.49 18.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.465 -0.772 . . . . 0.0 110.467 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 p -96.53 164.27 12.68 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 1.217 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 49.4 m-85 -116.16 92.61 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.532 -0.73 . . . . 0.0 110.218 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.66 -28.79 67.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -61.3 -42.0 97.92 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.567 -0.708 . . . . 0.0 111.38 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.885 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . 23.9 t0 -100.02 11.99 37.98 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 122.038 -0.414 . . . . 0.0 112.035 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t 62.02 -67.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.998 -0.439 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 63' ' ' ASP . 89.1 mt -132.1 73.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.98 . . . . 0.0 111.668 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 1.115 ' SG ' ' CB ' ' A' ' 60' ' ' PHE . 1.8 p -113.07 158.08 20.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.208 -0.932 . . . . 0.0 109.176 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -130.65 150.03 52.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.491 -0.756 . . . . 0.0 109.836 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.66 148.95 19.54 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.777 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 75.3 m -129.86 160.29 33.97 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 32.9 t -146.96 108.31 4.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -120.17 123.78 44.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.614 -0.678 . . . . 0.0 109.46 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 -120.55 23.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.88 19.21 20.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.982 . . . . 0.0 110.682 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.8 mt-30 -116.78 120.16 37.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -104.52 123.94 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.05 -1.031 . . . . 0.0 109.416 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 54.2 t-20 -103.79 108.03 19.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 111.372 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 68.0 mt -104.49 139.95 38.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.451 -0.78 . . . . 0.0 109.536 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.461 ' HB ' ' C8 ' ' A' ' 137' ' ' NAG . 59.6 m -140.84 152.02 44.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 62.5 mt -120.01 139.87 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.402 ' CG ' HG13 ' A' ' 16' ' ' ILE . 38.7 mt-30 -115.79 121.54 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.658 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 51.96 0.7 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 77.7 mt -97.2 117.34 31.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.609 -0.936 . . . . 0.0 111.246 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -102.44 -179.73 4.06 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.05 92.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -38.52 89.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.724 -0.61 . . . . 0.0 110.523 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.38 -26.91 66.69 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.644 -0.66 . . . . 0.0 110.735 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.2 m -51.51 134.27 29.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.863 . . . . 0.0 110.557 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.8 -150.29 13.83 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.406 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 13.6 tp -107.57 134.48 50.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.664 -0.903 . . . . 0.0 111.833 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.459 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 74.9 m-85 -116.24 145.31 43.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 4.7 mp -112.68 129.73 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.357 -0.839 . . . . 0.0 111.96 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 94' ' ' CYS . 31.3 p -92.46 123.99 36.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.4 tttt -117.79 138.79 51.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -0.802 . . . . 0.0 108.9 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.457 ' CG1' HD22 ' A' ' 106' ' ' LEU . 4.6 t -135.96 112.81 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.584 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 77.4 mt-10 -138.56 123.94 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.864 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 8.9 mp -76.2 81.85 3.0 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 40.5 tpp -79.03 -52.17 8.6 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 88.5 m-85 -69.09 -38.24 10.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.37 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 29.1 Cg_endo -83.08 112.02 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 CA-C-N 119.832 0.976 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 58.9 Cg_endo -83.25 150.77 13.62 Favored 'Trans proline' 1 CA--C 1.665 7.065 1 CA-C-O 110.57 -4.012 . . . . 0.0 113.244 176.023 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.253 37.4 Cg_endo -89.69 174.38 23.49 Favored 'Cis proline' 0 C--N 1.403 3.396 1 C-N-CA 95.287 -13.214 . . . . 0.0 118.711 -8.782 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.9 t80 -82.05 127.49 33.15 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.562 -2.563 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -160.79 105.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.375 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.457 HD22 ' CG1' ' A' ' 96' ' ' VAL . 3.4 tp -158.23 -144.17 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.29 174.44 39.55 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.726 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.461 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.2 mp -123.85 168.76 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 122.082 -0.658 . . . . 0.0 109.732 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -112.18 144.93 17.88 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.76 -38.99 87.07 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.605 1.202 . . . . 0.0 110.345 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 138.86 163.73 9.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.025 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 98.3 m -124.01 133.84 53.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.486 ' O ' HG21 ' A' ' 8' ' ' VAL . 34.5 tp60 -75.98 139.76 41.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.459 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 52.3 mt -116.21 124.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.897 -1.127 . . . . 0.0 108.642 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.545 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 28.8 m-85 -104.42 140.13 38.37 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.8 t -109.95 157.09 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.831 178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.27 43.9 mm -103.94 140.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -116.81 97.53 50.61 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.429 -0.794 . . . . 0.0 109.95 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.03 147.26 60.71 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.349 1.184 . . . . 0.0 110.697 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -130.06 155.08 81.25 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.679 -0.638 . . . . 0.0 110.18 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.85 -20.34 51.9 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.398 1.209 . . . . 0.0 111.358 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.44 146.85 51.45 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.36 -0.837 . . . . 0.0 109.904 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.12 -21.46 42.52 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.363 1.191 . . . . 0.0 110.934 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -151.93 150.14 29.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.426 -0.796 . . . . 0.0 110.052 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.8 p -152.88 157.79 41.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.459 -0.776 . . . . 0.0 110.357 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -139.97 83.62 1.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 110.039 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -137.93 144.46 41.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.712 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 85.8 mt-10 51.56 49.68 7.41 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.527 -0.733 . . . . 0.0 111.563 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 45.9 Cg_endo -69.26 150.07 70.84 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.171 1.09 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.72 . . . . 0.0 110.148 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.446 ' C6 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.461 ' C8 ' ' HB ' ' A' ' 80' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.435 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.041 0.448 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm -64.4 138.4 58.4 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -110.27 129.91 55.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 0.0 110.83 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.1 t -147.95 144.84 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.01 117.7 30.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 111.552 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.02 ' OE1' ' SG ' ' A' ' 94' ' ' CYS . 1.2 mm-40 -142.34 141.36 20.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.617 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.27 138.11 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.216 1.114 . . . . 0.0 109.549 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.35 -30.21 67.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.547 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -149.57 156.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.951 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.18 151.27 21.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.31 0.576 . . . . 0.0 109.457 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.8 mt -110.06 130.03 55.6 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 135.34 33.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.507 -0.746 . . . . 0.0 110.595 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.02 173.34 6.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.714 -0.616 . . . . 0.0 110.513 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -60.12 -29.4 68.59 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.631 -0.668 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 23.6 tpp180 -60.33 -29.73 69.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.547 -0.721 . . . . 0.0 109.905 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 25.28 10.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.8 mp -114.18 115.61 50.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.97 . . . . 0.0 110.271 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.03 127.4 53.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -127.22 133.59 50.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 111.617 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -143.63 167.02 23.24 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -128.89 124.38 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.475 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.551 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 42.3 t -99.99 109.04 21.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 60.2 tt0 -86.49 140.56 29.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.479 -0.763 . . . . 0.0 110.939 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -129.62 161.94 29.41 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.16 130.54 18.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.0 p -159.99 160.0 27.04 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 0.0 110.388 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.13 148.23 49.89 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.391 1.206 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.6 167.47 8.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.98 149.58 51.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.943 . . . . 0.0 110.318 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 149.96 33.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.423 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 43.3 p -79.99 -33.4 39.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.38 -0.825 . . . . 0.0 110.76 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 23.2 mm-40 -80.17 74.29 6.98 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.268 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 52' ' ' TYR . 14.5 m -91.98 87.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.551 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 72.3 ttt-85 -53.1 105.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.693 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -107.55 131.21 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.79 0.805 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.6 m -135.94 150.21 49.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 0.0 109.409 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 94.2 t -117.51 140.03 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 17.4 mt -127.87 164.51 22.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.887 -1.133 . . . . 0.0 110.915 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -127.4 117.28 21.87 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -105.24 123.96 48.73 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.612 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.44 154.28 39.28 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.74 -43.8 94.07 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.467 -0.771 . . . . 0.0 110.422 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.3 m -68.0 -49.79 59.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.579 -0.7 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -154.5 160.75 41.74 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 111.096 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.97 134.23 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.592 -0.692 . . . . 0.0 109.294 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -140.76 164.02 31.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 30.5 tt0 -79.91 156.9 27.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 109.841 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -113.64 -89.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.895 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.446 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 93.4 m -122.68 149.94 43.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.801 -1.187 . . . . 0.0 110.28 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.22 140.01 21.78 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.819 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 58' ' ' LEU . . . -172.0 153.54 3.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -91.89 120.62 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 53' ' ' MET . 16.1 t80 -79.16 109.15 13.21 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.983 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.469 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.46 169.96 17.0 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.423 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 34.4 mmt -67.63 -28.77 68.01 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.001 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.91 35.63 1.48 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.297 -1.43 . . . . 0.0 112.57 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 81.6 m-20 -130.32 159.95 35.42 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 119.151 1.476 . . . . 0.0 110.272 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -83.41 139.98 32.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.434 HD12 ' CD2' ' A' ' 52' ' ' TYR . 6.6 mp -89.17 129.97 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 110.242 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 p -99.98 135.57 41.2 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.494 -0.754 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 95.2 m-85 -107.99 114.91 29.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.26 -43.72 95.91 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.565 -0.709 . . . . 0.0 112.833 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -149.38 -161.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.024 -1.047 . . . . 0.0 111.632 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 56.75 58.07 4.33 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.473 0.654 . . . . 0.0 110.088 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 57.74 164.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.62 85.75 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 110.465 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 60' ' ' PHE . 97.5 m -68.07 153.24 44.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.577 -0.702 . . . . 0.0 109.462 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -140.0 150.01 43.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 109.305 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.9 179.98 43.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.1 m -130.19 169.25 15.61 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.12 -0.635 . . . . 0.0 109.444 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 52' ' ' TYR . 44.5 m -155.04 124.57 6.43 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.2 p -141.09 145.53 35.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.464 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.8 -122.37 16.35 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -105.72 11.98 31.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.801 -0.823 . . . . 0.0 111.016 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.5 mt-30 -116.69 126.68 53.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.873 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -107.89 123.48 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.899 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -100.61 118.62 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.0 111.435 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 76.1 mt -111.84 137.22 50.09 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.2 m -128.32 140.21 51.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.253 -0.905 . . . . 0.0 110.927 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 92' ' ' TYR . 88.5 mt -116.85 132.79 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.638 -0.664 . . . . 0.0 110.102 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.4 ' CG ' HG13 ' A' ' 16' ' ' ILE . 19.7 mt-30 -118.94 121.39 39.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.589 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.86 54.19 0.57 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.2 mt -90.85 120.01 31.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.601 -0.941 . . . . 0.0 110.953 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -98.07 178.95 4.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.66 90.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.281 -0.887 . . . . 0.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -66.79 -37.44 84.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.696 -0.627 . . . . 0.0 110.565 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.88 -33.5 71.9 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -51.99 130.92 30.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.27 -142.02 7.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 tp -109.05 129.19 55.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.672 -0.899 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 73.3 m-85 -109.99 132.06 54.5 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 93' ' ' ILE . 4.0 mp -110.07 130.05 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.732 -0.605 . . . . 0.0 111.731 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.077 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 19.9 p -79.9 155.78 27.59 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 5.3 tptm -147.15 79.09 1.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 108.759 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.407 ' CG2' HD22 ' A' ' 106' ' ' LEU . 3.6 p -95.79 115.24 34.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.147 0.975 . . . . 0.0 110.614 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 67.8 mm-40 -135.17 137.24 42.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.787 -0.571 . . . . 0.0 111.703 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.453 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 13.8 mt -83.98 75.46 10.13 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.4 ttm -79.9 -32.42 40.25 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.472 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.2 m-85 -87.03 -39.55 0.52 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.332 -0.855 . . . . 0.0 112.426 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 59.0 Cg_endo -92.59 118.71 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-O 121.556 0.565 . . . . 0.0 110.698 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.592 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 60.7 Cg_endo -91.13 156.01 3.84 Favored 'Trans proline' 1 CA--C 1.655 6.562 0 CA-C-O 113.372 -2.845 . . . . 0.0 111.123 177.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 44.2 Cg_endo -89.94 175.47 21.15 Favored 'Cis proline' 3 N--CA 1.644 10.334 1 C-N-CA 91.289 -14.88 . . . . 0.0 116.263 1.059 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 4.0 t80 -82.58 129.57 34.96 Favored 'General case' 0 C--N 1.266 -3.025 0 O-C-N 119.626 -1.921 . . . . 0.0 109.167 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -166.7 104.9 0.6 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.426 -1.421 . . . . 0.0 108.376 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.407 HD22 ' CG2' ' A' ' 96' ' ' VAL . 4.3 tp -157.71 -147.96 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.484 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.48 170.96 34.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.249 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.22 146.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -1.087 . . . . 0.0 109.187 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 1.077 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -73.63 141.58 29.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.428 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 11.1 t-20 -60.07 -30.59 69.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -1.046 . . . . 0.0 109.709 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.72 138.77 5.93 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.492 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.5 m -111.64 139.78 46.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.545 ' O ' HG21 ' A' ' 8' ' ' VAL . 34.1 tp60 -83.45 120.72 26.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.258 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 53.8 mt -96.79 114.23 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.619 -1.301 . . . . 0.0 108.592 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.547 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 12.4 m-85 -87.81 139.11 30.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.389 0.614 . . . . 0.0 111.552 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.45 165.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.2 mm -99.98 119.88 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.954 -0.466 . . . . 0.0 110.323 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -137.65 126.52 14.78 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 110.203 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.03 159.99 51.22 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.09 1.048 . . . . 0.0 110.314 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.9 150.19 43.72 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 110.273 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.28 -19.81 43.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.38 1.2 . . . . 0.0 110.863 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.7 m -102.83 123.59 41.77 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 109.991 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.43 -17.66 38.98 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.129 1.068 . . . . 0.0 111.394 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -90.0 178.68 6.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.24 -0.912 . . . . 0.0 110.831 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -83.41 169.93 15.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.623 -0.673 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -89.68 106.35 18.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.599 -0.688 . . . . 0.0 110.104 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -130.03 160.02 34.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.251 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 80.9 mm-40 53.01 50.05 7.24 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.414 -0.804 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.3 Cg_endo -69.95 149.93 66.34 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.214 1.113 . . . . 0.0 110.435 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.217 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.428 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.408 ' H62' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.408 ' C1 ' ' H62' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.4 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.105 0.478 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt 52.85 77.35 0.17 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.445 -0.784 . . . . 0.0 110.739 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -110.04 130.55 55.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 110.888 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 128.11 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.329 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.21 128.83 56.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.453 -0.78 . . . . 0.0 110.737 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.087 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 27.1 mm100 -139.45 131.95 15.27 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.729 -0.607 . . . . 0.0 111.214 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.51 139.21 25.39 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.119 1.063 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -33.41 71.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.789 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG23 ' CE2' ' A' ' 116' ' ' TYR . 3.1 p -152.72 156.26 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.529 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -131.84 155.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.9 mt -112.33 129.99 56.11 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.928 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.03 27.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.616 -0.677 . . . . 0.0 110.29 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.3 t -89.58 176.93 6.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.554 -0.716 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 7.8 tpm_? -59.97 -28.77 67.94 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.076 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.29 22.59 21.84 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.8 mp -114.73 114.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.501 -0.999 . . . . 0.0 109.877 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.02 49.92 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -132.8 150.01 52.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.008 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 19' ' ' PHE . 32.4 p90 -152.06 163.11 40.0 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -119.4 122.71 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.301 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.087 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 41.4 t -100.78 100.54 11.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -79.95 149.97 30.66 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.318 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -132.68 173.56 11.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.04 120.59 22.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.391 -0.818 . . . . 0.0 111.154 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.7 t -151.62 149.95 25.32 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 111.053 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.84 147.95 31.52 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.694 1.365 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.51 -176.15 0.44 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.89 160.05 36.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.845 . . . . 0.0 109.73 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 1.018 ' O ' ' SD ' ' A' ' 54' ' ' MET . . . -148.4 171.94 15.23 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.312 -0.867 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.833 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.8 p -86.26 -5.39 59.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.611 -0.681 . . . . 0.0 112.622 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HA ' ' SD ' ' A' ' 53' ' ' MET . 6.4 mm-40 -129.16 76.44 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.914 -1.514 . . . . 0.0 112.91 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 52' ' ' TYR . 92.0 t -91.94 86.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -63.16 123.33 18.35 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.366 0.603 . . . . 0.0 111.618 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.99 161.24 34.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.6 m -152.73 138.95 18.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 88.2 t -108.84 128.9 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.0 mt -124.82 165.01 18.79 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.491 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -128.3 121.25 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -103.3 131.96 49.93 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.974 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.74 -174.17 2.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.94 -0.475 . . . . 0.0 109.814 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.43 -43.69 96.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 m -130.08 -3.28 4.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.814 . . . . 0.0 111.88 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -132.31 152.35 51.43 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.061 -1.024 . . . . 0.0 110.988 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.33 138.62 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.617 . . . . 0.0 109.864 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.1 p -136.9 162.8 32.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.584 -0.697 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -79.91 153.73 28.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.605 -0.684 . . . . 0.0 110.146 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.966 HG13 ' SG ' ' A' ' 48' ' ' CYS . 86.5 t -120.72 -50.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.636 -0.665 . . . . 0.0 110.646 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.966 ' SG ' HG13 ' A' ' 47' ' ' VAL . 1.3 m -155.96 132.29 10.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.239 -0.913 . . . . 0.0 110.201 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -139.61 138.46 36.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.444 -0.785 . . . . 0.0 111.188 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.63 156.48 6.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.644 -0.66 . . . . 0.0 109.656 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.611 HG23 ' SD ' ' A' ' 53' ' ' MET . 3.0 m -90.64 124.08 34.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 109.575 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD2' ' CB ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -69.89 90.06 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.833 ' SD ' ' O ' ' A' ' 30' ' ' THR . 61.8 mmm -88.13 122.52 31.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 1.018 ' SD ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -59.83 -27.96 67.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.035 -1.04 . . . . 0.0 110.265 -178.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.45 -42.1 7.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -110.48 151.02 28.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.245 -1.15 . . . . 0.0 111.554 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -77.04 150.23 35.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.58 -0.7 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.7 mp -71.15 136.93 48.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.514 -0.741 . . . . 0.0 110.388 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.1 p -118.28 139.61 51.06 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.525 -0.734 . . . . 0.0 110.999 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 75.2 m-85 -107.63 112.0 24.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 tt -68.0 -43.39 78.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.448 -0.782 . . . . 0.0 112.031 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -142.51 -158.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.262 -0.899 . . . . 0.0 111.339 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.65 57.01 4.5 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.412 0.625 . . . . 0.0 110.271 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p 57.13 166.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.325 0.583 . . . . 0.0 110.95 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.95 131.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.739 -0.601 . . . . 0.0 110.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 82.8 m -130.05 165.42 22.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.709 -0.619 . . . . 0.0 109.667 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 t -136.05 141.37 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.2 153.74 25.25 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.8 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.456 HG22 ' O4 ' ' A' ' 138' ' ' FUC . 59.2 m -139.99 157.36 45.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD2' ' A' ' 52' ' ' TYR . 15.3 t -146.0 108.04 4.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.772 . . . . 0.0 110.512 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.7 t -148.28 148.1 30.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.831 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.74 38.58 96.7 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.06 27.42 13.3 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.692 -0.887 . . . . 0.0 110.227 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -132.12 128.62 38.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.591 -0.693 . . . . 0.0 109.814 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 2.9 m -104.45 120.29 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.34 -0.85 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -100.97 110.1 22.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -0.899 . . . . 0.0 111.175 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 86.9 mt -103.01 131.98 49.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.726 . . . . 0.0 109.242 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.8 m -130.88 150.33 52.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.335 -0.853 . . . . 0.0 111.188 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 62.4 mt -124.47 141.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.809 -0.557 . . . . 0.0 109.977 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.401 ' CG ' HG13 ' A' ' 16' ' ' ILE . 24.0 mt-30 -120.01 122.06 40.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.745 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.46 41.38 1.14 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.1 mt -89.35 129.95 35.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.956 . . . . 0.0 111.421 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -116.15 179.81 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.03 81.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.5 ttp -68.14 -35.86 78.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.64 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.522 -0.736 . . . . 0.0 111.387 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.7 m -49.65 142.51 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.357 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.24 35.02 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 21.1 tp -98.76 131.37 44.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.959 . . . . 0.0 112.75 -178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.425 ' CE1' HD11 ' A' ' 115' ' ' ILE . 86.1 m-85 -114.23 139.2 49.59 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.0 mp -108.91 141.45 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.386 -0.822 . . . . 0.0 111.818 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.038 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 17.3 p -104.66 112.72 25.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HG2' HG22 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -100.87 143.08 31.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.22 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.74 106.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.465 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CG ' ' OH ' ' A' ' 104' ' ' TYR . 22.1 mp0 -131.32 130.13 42.35 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.566 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.1 mt -84.61 80.36 9.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.7 tpp -79.74 -52.85 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.186 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.421 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.0 m-85 -68.75 -44.25 30.85 Favored Pre-proline 0 N--CA 1.508 2.464 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 60.3 Cg_endo -79.14 110.46 2.74 Favored 'Trans proline' 0 N--CA 1.518 2.932 0 C-N-CA 121.136 1.224 . . . . 0.0 110.885 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -83.18 155.22 14.63 Favored 'Trans proline' 1 CA--C 1.676 7.599 0 CA-C-O 111.686 -3.548 . . . . 0.0 105.643 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.07 -179.08 15.31 Favored 'Cis proline' 1 C--N 1.492 8.082 1 C-N-CA 95.527 -13.114 . . . . 0.0 116.297 -10.356 . . . . . . . . 3 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' OH ' ' CG ' ' A' ' 97' ' ' GLU . 4.4 t80 -87.37 132.15 34.06 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 117.469 -3.27 . . . . 0.0 110.467 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -163.43 92.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.042 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -148.36 0.24 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.074 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.1 179.0 38.58 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.468 ' N ' ' CD1' ' A' ' 109' ' ' ILE . 3.8 mp -119.81 158.79 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 O-C-N 121.67 -0.9 . . . . 0.0 109.109 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.81 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -85.52 145.22 20.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.15 -34.54 73.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.297 -1.119 . . . . 0.0 110.727 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 122.95 135.27 4.56 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.7 m -106.78 130.99 54.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 91' ' ' LEU . 44.7 tt0 -85.11 123.99 31.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.835 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.425 HD11 ' CE1' ' A' ' 92' ' ' TYR . 82.3 mt -85.85 125.59 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.731 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CE2' HG23 ' A' ' 8' ' ' VAL . 4.6 m-30 -95.84 158.87 15.25 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.209 0.528 . . . . 0.0 110.38 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -110.55 167.01 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.7 mm -99.54 115.14 39.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.303 0.573 . . . . 0.0 110.451 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -140.01 125.41 11.53 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.736 -0.603 . . . . 0.0 109.819 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.49 149.99 69.29 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.058 1.031 . . . . 0.0 110.298 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -87.14 129.98 49.78 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.502 -0.749 . . . . 0.0 110.266 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.36 -12.3 33.36 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.184 1.097 . . . . 0.0 111.235 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.892 ' SG ' ' O ' ' A' ' 125' ' ' ASP . 42.3 t -102.44 120.74 52.26 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.237 -0.914 . . . . 0.0 110.194 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.13 -19.88 44.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.12 1.063 . . . . 0.0 110.986 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.892 ' O ' ' SG ' ' A' ' 123' ' ' CYS . 55.0 p-10 -140.59 169.97 16.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.361 -0.837 . . . . 0.0 110.602 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -94.37 170.06 9.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.656 -0.653 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -79.31 124.03 28.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.008 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -67.51 -36.35 80.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.567 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -110.05 124.07 34.46 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 0.0 110.412 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.93 159.91 51.57 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.19 1.1 . . . . 0.0 110.529 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.3 mttm . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.565 -0.709 . . . . 0.0 110.196 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.444 ' C6 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.444 ' H1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.456 ' O4 ' HG22 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.053 0.454 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.01 -32.93 8.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.615 -0.678 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -110.06 31.45 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.551 -0.718 . . . . 0.0 110.293 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -149.26 137.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.826 -0.546 . . . . 0.0 110.043 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.47 127.33 53.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.557 -0.714 . . . . 0.0 109.876 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.004 ' CD ' ' SG ' ' A' ' 94' ' ' CYS . 14.0 mm-40 -139.95 131.52 14.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.658 -0.651 . . . . 0.0 111.745 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.65 139.93 28.79 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.141 1.074 . . . . 0.0 109.434 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.77 -33.81 74.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.725 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.69 HG23 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.68 155.77 7.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.615 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 t -133.01 148.2 31.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.135 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.52 127.48 52.25 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.684 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.81 175.18 6.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.465 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -109.45 175.81 5.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.42 -37.54 81.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.745 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -59.63 -30.22 68.56 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.682 -0.636 . . . . 0.0 110.312 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.14 27.03 9.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.3 mp -102.74 100.4 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.65 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.22 118.4 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.7 t -131.19 132.58 44.8 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.924 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -131.92 163.95 27.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.47 122.67 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.685 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.737 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 42.3 t -101.12 108.1 19.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -85.51 141.13 30.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.815 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' CG ' HG12 ' A' ' 96' ' ' VAL . 45.1 p90 -125.57 178.22 5.78 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.54 123.87 25.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.705 -0.622 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -116.18 132.71 23.13 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 109.941 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.51 -12.17 32.77 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.192 1.101 . . . . 0.0 112.159 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.03 27.2 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.358 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.82 136.47 44.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.694 -0.886 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.06 163.99 38.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.625 -0.672 . . . . 0.0 109.931 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' MET . 64.3 p -86.2 12.38 9.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.511 -0.743 . . . . 0.0 111.308 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' CB ' ' HD3' ' A' ' 101' ' ' PRO . 34.0 mm-40 -137.22 97.6 3.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.002 -1.479 . . . . 0.0 113.216 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 40.0 t -122.4 79.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -58.99 131.62 51.59 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.254 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -129.26 164.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.408 ' N ' ' HB3' ' A' ' 95' ' ' LYS . 87.1 m -160.0 157.97 29.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 110.084 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 96.8 t -122.14 134.06 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 8.4 mt -130.03 163.96 25.37 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.523 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -123.68 119.99 31.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -106.01 129.7 54.08 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.512 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -127.39 154.97 44.35 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.68 -43.19 94.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 0.0 110.621 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.1 m -68.85 -49.99 53.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -155.0 162.89 40.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.343 -0.848 . . . . 0.0 111.284 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.8 t -126.42 135.13 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.2 159.97 38.63 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.462 -0.774 . . . . 0.0 111.626 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 54.9 mt-10 -80.86 161.09 24.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.618 . . . . 0.0 110.71 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 96.1 t -127.64 -67.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.698 -0.626 . . . . 0.0 110.663 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 67.8 m -138.03 154.12 49.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.903 . . . . 0.0 111.77 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.56 136.13 8.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.787 -0.57 . . . . 0.0 110.579 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.38 146.56 22.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.575 -0.703 . . . . 0.0 109.12 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.4 m -80.05 127.55 32.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.241 -0.912 . . . . 0.0 110.116 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 1.2 t80 -79.99 103.47 9.9 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.3 mtp -95.81 131.09 42.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 21.0 mmt -59.76 -34.96 73.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.957 . . . . 0.0 110.733 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.18 -51.89 25.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.17 159.95 35.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.428 -1.042 . . . . 0.0 110.724 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -103.86 130.85 51.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -95.41 150.21 20.53 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.518 -0.738 . . . . 0.0 109.656 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 p -104.86 167.39 9.75 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.63 -0.669 . . . . 0.0 110.61 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.708 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 34.8 m-85 -92.9 100.6 13.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.664 -0.648 . . . . 0.0 109.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -103.85 2.35 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.531 -0.731 . . . . 0.0 111.77 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -67.92 -41.78 82.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -109.92 7.49 23.89 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 33.63 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 67' ' ' ILE . 26.8 mm -141.98 10.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 0.0 111.246 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.708 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 16.8 p -127.92 138.96 52.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.669 -1.269 . . . . 0.0 111.069 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -139.93 156.14 46.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.19 -179.83 43.33 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.6 m -117.43 163.57 16.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.034 -0.686 . . . . 0.0 109.579 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.416 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 1.3 p -153.18 113.8 4.05 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.2 m -143.66 146.94 33.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.053 -1.029 . . . . 0.0 110.948 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.63 -123.95 27.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -110.11 19.88 18.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.813 -0.816 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -125.79 129.95 50.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.05 126.95 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.723 . . . . 0.0 109.806 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -107.2 120.78 43.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.926 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.09 132.01 54.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.387 -0.821 . . . . 0.0 109.269 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.9 m -119.99 139.9 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.248 -0.907 . . . . 0.0 110.907 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.8 mt -117.31 132.57 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.0 110.158 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.425 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.1 mt-30 -120.16 121.12 38.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.218 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.94 39.67 0.95 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.4 mt -94.83 120.08 34.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.509 -0.994 . . . . 0.0 111.365 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 19.1 mmt85 -102.27 178.86 4.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.09 83.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.232 -0.917 . . . . 0.0 109.819 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 ttm -68.02 -33.76 75.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.74 -0.6 . . . . 0.0 110.824 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.04 -17.3 64.36 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.589 -0.694 . . . . 0.0 111.67 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.5 m -51.16 135.17 26.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.84 -155.26 19.22 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.778 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 15.1 tp -109.77 128.68 55.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.738 -0.86 . . . . 0.0 112.061 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 44.9 m-85 -112.29 144.88 40.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.2 mp -111.59 143.32 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 111.432 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.004 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 17.5 p -105.82 117.23 33.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.5 tptt -102.11 141.15 35.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.505 -0.747 . . . . 0.0 109.652 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.42 HG12 ' CG ' ' A' ' 23' ' ' TYR . 16.5 t -145.14 103.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -136.56 125.46 24.18 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.269 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 7.6 mp -79.73 77.22 6.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.8 tpp -80.47 -51.36 8.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.977 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 92.6 m-85 -67.17 -40.21 26.42 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 111.737 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 39.6 Cg_endo -86.99 120.74 1.66 Allowed 'Trans proline' 0 N--CA 1.504 2.109 0 N-CA-C 110.201 -0.73 . . . . 0.0 110.201 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.419 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 59.5 Cg_endo -97.8 159.21 0.9 Allowed 'Trans proline' 1 CA--C 1.662 6.879 0 CA-C-O 112.144 -3.357 . . . . 0.0 108.086 -177.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 71.9 Cg_endo -92.54 171.11 21.06 Favored 'Cis proline' 2 C--N 1.464 6.616 1 C-N-CA 95.217 -13.243 . . . . 0.0 119.232 -6.178 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -74.31 125.15 27.82 Favored 'General case' 0 N--CA 1.527 3.418 0 O-C-N 120.303 -1.498 . . . . 0.0 111.338 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.422 ' CD2' ' O ' ' A' ' 105' ' ' TYR 0.262 52.9 t80 -152.82 59.97 0.8 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.499 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -130.78 -152.8 0.53 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.36 24.98 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.333 -1.413 . . . . 0.0 109.919 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.405 ' CG2' ' C8 ' ' A' ' 132' ' ' NAG . 93.7 mt -122.26 154.66 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.574 -0.957 . . . . 0.0 110.391 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.719 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -81.08 138.75 19.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 177.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 9.7 m120 -60.31 -29.69 69.01 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -1.169 . . . . 0.0 110.285 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.42 145.85 7.28 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.6 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.3 m -114.02 131.54 56.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.461 ' HB3' HG22 ' A' ' 8' ' ' VAL . 11.2 tp60 -80.83 119.94 24.04 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.166 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 86.8 mt -86.86 119.99 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.053 . . . . 0.0 109.112 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 8' ' ' VAL . 7.6 m-30 -91.74 120.09 32.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.145 -0.347 . . . . 0.0 110.328 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.3 t -84.39 166.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.834 178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.3 mm -102.86 139.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.21 0.529 . . . . 0.0 110.607 -179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -111.68 123.12 35.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.724 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.07 149.94 65.61 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.069 1.036 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -124.37 151.21 66.2 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.674 . . . . 0.0 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.95 -27.53 36.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.289 1.152 . . . . 0.0 110.873 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.0 m -136.86 130.04 17.49 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.51 -20.07 27.66 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.143 1.075 . . . . 0.0 111.041 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -99.98 139.53 35.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.875 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -90.03 -0.56 57.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 111.265 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -62.84 -25.79 68.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -87.86 0.5 55.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 111.527 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' N ' ' HD2' ' A' ' 130' ' ' PRO . 77.3 mt-10 -59.52 -46.0 98.78 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.041 -1.037 . . . . 0.0 112.086 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 129' ' ' GLU . 43.9 Cg_endo -71.41 152.92 61.06 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 122.763 0.875 . . . . 0.0 110.692 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.405 ' C8 ' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.441 ' C6 ' ' O2 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.445 ' H61' ' C1 ' ' A' ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.441 ' O2 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . 0.445 ' C1 ' ' H61' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.121 0.486 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt -109.74 160.68 16.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 110.21 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -130.07 74.19 1.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.061 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.85 134.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.517 -0.74 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.02 131.38 54.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.108 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 25.9 mm100 -137.95 139.95 27.76 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.566 -0.709 . . . . 0.0 111.91 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.1 140.28 25.01 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 O-C-N 123.324 1.17 . . . . 0.0 109.109 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.9 p -151.7 159.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.713 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 t -137.82 156.02 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.374 0.607 . . . . 0.0 109.713 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.1 mt -117.08 126.6 53.09 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.705 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.92 138.18 40.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.428 -0.795 . . . . 0.0 109.22 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -75.98 -65.29 0.93 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.422 -0.798 . . . . 0.0 111.547 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -160.02 168.22 26.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.473 -0.767 . . . . 0.0 110.369 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 54.16 21.05 2.83 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.674 -0.641 . . . . 0.0 111.252 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.12 35.59 64.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.14 97.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 0.0 108.906 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.27 114.36 28.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -121.07 131.97 54.6 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.689 0.757 . . . . 0.0 111.246 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 24.3 p90 -140.47 161.63 37.25 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 85.4 t -120.4 125.33 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.455 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.108 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.5 t -104.38 130.0 52.27 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -102.83 138.75 39.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 111.378 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.449 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 19.7 p90 -137.32 -177.73 4.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.96 113.93 15.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.585 -0.697 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.5 p -141.75 164.37 34.93 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.542 -0.723 . . . . 0.0 110.151 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.96 155.95 64.02 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.389 1.205 . . . . 0.0 110.095 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.2 19.96 51.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -119.93 32.61 5.97 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.212 -1.17 . . . . 0.0 110.775 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.11 140.04 47.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.652 -0.655 . . . . 0.0 110.342 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' MET . 40.3 p -92.03 10.72 27.9 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.528 -0.732 . . . . 0.0 110.572 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -130.29 122.34 27.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.572 -176.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 95.9 t -138.89 83.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 6.6 ttm180 -63.41 116.88 5.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.767 -0.583 . . . . 0.0 111.343 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 35.9 m -113.85 131.91 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -122.47 131.91 54.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.694 -0.629 . . . . 0.0 110.624 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 97.9 t -109.6 129.71 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 46.9 mt -125.46 165.14 18.98 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' HG2' ' CE2' ' A' ' 92' ' ' TYR . 75.0 mtm180 -121.31 119.92 33.59 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.405 ' NE2' ' CD2' ' A' ' 91' ' ' LEU . 4.8 tt0 -97.45 141.46 30.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.91 157.03 47.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.79 -40.17 87.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.5 m -75.61 -53.36 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -154.47 174.59 14.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.77 139.93 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -130.1 161.46 30.99 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 49.6 mt-10 -80.1 158.95 26.26 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 110.844 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.448 HG13 ' SG ' ' A' ' 48' ' ' CYS . 46.0 t -135.16 -66.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.226 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 71.3 m -129.93 142.65 50.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.26 -0.9 . . . . 0.0 111.22 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.85 131.97 14.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.657 -0.652 . . . . 0.0 110.278 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.9 157.61 14.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 0.0 110.334 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 2.9 m -102.21 116.01 31.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.43 ' CD2' ' HB2' ' A' ' 72' ' ' SER . 20.6 t80 -77.87 123.96 27.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.225 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 30' ' ' THR . 2.8 mtp -95.58 157.62 15.82 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.5 mmt -60.03 -27.63 67.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.843 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.04 48.01 0.99 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.971 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -157.81 -179.49 8.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.265 -1.138 . . . . 0.0 110.701 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -115.08 156.03 25.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 110.406 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.416 ' CD2' ' N ' ' A' ' 52' ' ' TYR . 85.3 mt -72.82 136.16 45.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.561 -0.712 . . . . 0.0 111.136 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.2 p -104.76 129.36 53.02 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.705 -0.622 . . . . 0.0 109.565 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 99.1 m-85 -119.99 66.2 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.761 . . . . 0.0 110.099 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.07 -39.48 90.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.536 -0.727 . . . . 0.0 110.767 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.58 131.27 44.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.434 -0.791 . . . . 0.0 110.728 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 52.17 49.01 21.51 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.492 -0.755 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -59.03 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.908 -0.495 . . . . 0.0 110.43 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm 52.36 22.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.386 -1.446 . . . . 0.0 110.921 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -160.03 160.65 33.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -123.88 139.92 53.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.55 121.72 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.978 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -130.06 155.12 46.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 68.9 m -160.06 137.95 9.94 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.857 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -140.27 140.06 35.65 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.89 -124.02 34.84 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -107.32 11.92 28.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.948 . . . . 0.0 110.927 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.406 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.0 mt-30 -116.65 129.29 56.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.122 -0.986 . . . . 0.0 111.016 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 72' ' ' SER . 5.7 m -110.12 126.23 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.433 -0.792 . . . . 0.0 110.221 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -98.64 117.89 34.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 111.585 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' CD1' ' CG2' ' A' ' 36' ' ' VAL . 76.4 mt -110.38 130.47 55.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.615 -0.678 . . . . 0.0 109.52 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.1 m -129.69 138.15 51.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.388 -0.82 . . . . 0.0 110.803 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 HD12 ' CE2' ' A' ' 92' ' ' TYR . 84.3 mt -108.06 130.1 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.99 119.74 35.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.086 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.84 35.96 3.1 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.35 131.3 45.46 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.689 -0.889 . . . . 0.0 110.105 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -86.26 160.6 19.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 109.921 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -29.03 66.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.52 -30.04 70.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.46 0.648 . . . . 0.0 109.526 179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -77.48 -4.03 43.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.751 -0.593 . . . . 0.0 111.387 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.4 m -55.31 140.01 40.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.958 -1.089 . . . . 0.0 109.62 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.63 -148.04 11.55 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.793 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.405 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 17.3 tp -106.93 130.23 54.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.741 -0.858 . . . . 0.0 111.754 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 50.8 m-85 -112.57 135.17 53.6 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 3.9 mp -100.67 140.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 0.0 111.678 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 1.108 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 13.7 p -106.68 122.6 46.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 17.1 mttt -120.04 146.12 46.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.148 -0.97 . . . . 0.0 110.056 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.449 ' CG1' ' CD2' ' A' ' 23' ' ' TYR . 2.7 t -140.44 107.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.529 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 2.5 mp0 -132.52 125.18 29.98 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.598 -0.841 . . . . 0.0 113.216 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 9.4 mp -74.34 80.2 1.86 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.405 ' HE3' ' CZ ' ' A' ' 104' ' ' TYR . 12.9 mmt -79.58 -48.15 14.29 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.556 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 87.0 m-85 -66.66 -42.92 48.36 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.955 -1.091 . . . . 0.0 113.531 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 51.4 Cg_endo -86.07 113.68 1.27 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 O-C-N 122.657 0.819 . . . . 0.0 112.697 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -83.06 141.03 10.27 Favored 'Trans proline' 1 CA--C 1.654 6.515 0 CA-C-O 110.774 -3.928 . . . . 0.0 107.861 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . 0.433 55.2 Cg_endo -102.61 179.54 3.91 Favored 'Cis proline' 3 C--N 1.524 9.813 1 C-N-CA 91.932 -14.612 . . . . 0.0 116.815 6.991 . . . . . . . . 4 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.9 t80 -82.2 126.9 32.61 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 116.795 -3.691 . . . . 0.0 108.847 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.25 47.8 t80 -158.63 101.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.985 -0.447 . . . . 0.0 110.374 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.8 tp -160.31 -143.46 0.1 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.542 -0.724 . . . . 0.0 110.454 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.27 -173.79 23.64 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.43 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.402 HG22 ' HE2' ' A' ' 95' ' ' LYS 0.251 46.8 mm -131.46 168.87 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.406 -1.055 . . . . 0.0 110.347 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.823 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -105.95 134.13 11.95 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -36.4 77.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.094 -1.239 . . . . 0.0 110.519 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.5 153.1 8.1 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.318 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 89.1 m -121.84 139.42 53.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.489 ' O ' HG21 ' A' ' 8' ' ' VAL . 16.3 tp60 -79.95 138.21 37.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 46.8 mt -110.07 124.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.509 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 16.7 m-30 -100.84 133.63 45.03 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.084 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.0 t -96.94 165.96 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.063 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.2 mm -105.21 132.01 53.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.993 -0.442 . . . . 0.0 110.048 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -97.35 119.97 61.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.486 -0.759 . . . . 0.0 109.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -74.16 68.03 5.06 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.095 1.05 . . . . 0.0 110.871 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -87.05 132.93 40.23 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.462 -0.773 . . . . 0.0 109.986 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.26 -19.88 43.68 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.136 1.072 . . . . 0.0 111.008 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.4 m -129.92 141.84 43.27 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 110.329 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.03 160.05 51.0 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.293 1.154 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -82.8 120.03 25.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.578 -0.701 . . . . 0.0 110.125 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -66.94 -29.99 70.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.617 -0.677 . . . . 0.0 110.353 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -70.07 132.01 45.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.745 . . . . 0.0 110.233 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -84.54 148.84 26.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 0.0 110.09 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 22.0 mp0 52.5 49.89 7.26 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.406 -0.809 . . . . 0.0 111.005 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.8 Cg_endo -69.79 155.96 64.5 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.203 1.107 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 110.099 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.404 ' C6 ' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . 0.404 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.53 ' C6 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.53 ' H1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.041 0.448 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm 56.09 167.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.73 -0.607 . . . . 0.0 110.844 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -120.08 29.43 7.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.439 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -148.29 144.34 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.85 -0.531 . . . . 0.0 109.862 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.65 127.07 51.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.589 -0.694 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.926 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 15.1 mm100 -142.12 130.65 11.89 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.642 -0.661 . . . . 0.0 111.3 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.64 139.97 31.87 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.175 1.092 . . . . 0.0 109.367 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.01 69.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' CG2' ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.23 162.9 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.26 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.74 151.86 19.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.954 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 89.4 mt -110.61 127.03 55.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.26 148.98 23.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.413 -0.805 . . . . 0.0 110.984 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -69.41 172.16 7.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.603 -0.686 . . . . 0.0 110.521 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -60.1 -36.05 76.57 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.557 -0.714 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -57.16 -25.49 59.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.556 -0.715 . . . . 0.0 110.194 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.14 26.44 7.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 1.8 mp -108.06 112.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 121.626 -0.926 . . . . 0.0 110.52 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -110.54 124.74 52.39 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.0 m -126.97 140.09 52.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.583 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -148.55 163.5 37.02 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' CG1' ' CG ' ' A' ' 76' ' ' GLN . 63.2 t -130.31 123.73 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.731 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.779 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 37.6 t -100.01 108.04 20.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 tt0 -84.97 139.45 31.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 0.0 110.519 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -130.6 177.6 7.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 0.0 109.6 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.94 138.1 35.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.85 -0.532 . . . . 0.0 110.157 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.7 p -125.83 149.83 66.95 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.95 -13.98 34.89 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.462 1.243 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.6 -170.13 18.02 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.99 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.542 -0.975 . . . . 0.0 110.52 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.43 151.67 46.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.62 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 53' ' ' MET . 32.4 p -79.9 -43.59 21.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 111.097 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -79.68 84.77 5.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.021 -0.671 . . . . 0.0 112.713 -175.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 52' ' ' TYR . 48.1 t -97.79 89.38 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 123.42 20.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.915 -0.491 . . . . 0.0 110.703 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -118.48 134.75 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.58 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.4 m -134.41 159.71 40.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.411 -0.805 . . . . 0.0 110.025 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 84.5 t -128.84 139.24 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 6.2 mt -131.16 171.0 13.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.687 -1.258 . . . . 0.0 111.67 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HG3' HG23 ' A' ' 47' ' ' VAL . 89.9 mtt180 -125.72 118.39 25.48 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG3' HD12 ' A' ' 93' ' ' ILE . 21.8 mt-30 -101.78 126.25 48.61 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.391 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.16 -171.57 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.21 -43.81 95.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 111.019 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -131.96 -0.16 3.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 111.949 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -135.1 155.59 50.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.06 -1.025 . . . . 0.0 110.943 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.8 139.73 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.604 -0.685 . . . . 0.0 109.629 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.9 p -127.03 160.1 32.13 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.437 -0.789 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 77.0 mt-10 -86.45 160.04 19.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.647 -0.658 . . . . 0.0 110.742 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 71.5 t -123.41 -71.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.807 -0.558 . . . . 0.0 110.232 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' CB ' ' A' ' 63' ' ' ASP . 80.7 m -147.17 153.71 40.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.31 30.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.508 -0.745 . . . . 0.0 111.258 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -170.44 155.68 5.21 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.601 -0.687 . . . . 0.0 109.658 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -116.27 122.76 45.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.437 ' CE2' HG13 ' A' ' 32' ' ' VAL . 55.1 p90 -94.05 124.39 38.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.307 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' THR . 3.2 mmt -60.62 -44.7 96.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.427 ' HE3' ' CD1' ' A' ' 52' ' ' TYR . 0.0 OUTLIER 166.44 102.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.46 63.0 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.93 159.86 23.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -1.026 . . . . 0.0 110.472 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -70.72 151.6 44.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -90.16 123.89 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.577 -0.702 . . . . 0.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.9 p -92.57 131.91 37.3 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 67.9 m-85 -113.86 123.92 50.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.764 . . . . 0.0 110.363 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.74 -36.06 77.93 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.485 -0.759 . . . . 0.0 109.79 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -140.07 174.46 10.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 109.671 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CB ' ' SG ' ' A' ' 48' ' ' CYS . 85.8 m-20 52.65 51.02 16.89 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.1 m -52.36 -21.8 3.95 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.622 -0.674 . . . . 0.0 111.382 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.69 -21.88 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.271 -0.893 . . . . 0.0 110.811 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.3 m -72.43 126.36 29.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.342 -0.849 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 t -139.98 149.93 43.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.99 -171.52 42.95 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 94.4 m -129.73 168.46 16.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.939 -0.742 . . . . 0.0 109.557 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.42 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 97.2 p -138.33 152.51 48.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.505 -0.747 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -133.7 -173.64 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.746 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -49.67 76.09 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.6 3.86 6.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.463 -1.022 . . . . 0.0 111.272 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.2 tt0 -124.27 129.62 51.08 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.09 -1.006 . . . . 0.0 110.851 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -113.23 132.84 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -110.11 115.97 30.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.47 133.05 54.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 109.752 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.5 m -130.87 145.06 51.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.34 -0.85 . . . . 0.0 110.811 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 95.6 mt -119.92 140.08 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.611 -0.681 . . . . 0.0 109.874 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.405 ' HG2' HG13 ' A' ' 16' ' ' ILE . 6.7 mt-30 -123.83 121.93 36.68 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.803 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.36 46.37 1.0 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.03 122.79 33.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.635 -0.92 . . . . 0.0 111.182 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -102.59 178.0 4.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.69 95.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.325 -0.86 . . . . 0.0 109.401 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.8 ttm -63.45 -39.98 95.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.753 -0.592 . . . . 0.0 110.742 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.79 -21.06 62.71 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.598 -0.689 . . . . 0.0 111.025 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -51.84 140.01 20.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.921 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.88 -158.59 31.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.2 123.99 49.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.637 -0.919 . . . . 0.0 111.97 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CD1' ' CD1' ' A' ' 115' ' ' ILE . 51.0 m-85 -103.18 140.02 37.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 4.2 mp -111.33 130.59 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.665 -0.647 . . . . 0.0 111.775 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.926 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 20.2 p -79.97 157.91 26.71 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 tttt -153.65 97.2 2.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.93 -1.106 . . . . 0.0 109.457 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.17 116.78 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.9 0.857 . . . . 0.0 111.37 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -135.7 124.15 23.46 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.914 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 4.1 mm? -75.47 76.48 2.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.9 ttm -78.73 -40.42 33.56 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 83.4 m-85 -62.97 -45.72 86.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.234 -0.986 . . . . 0.0 112.446 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 56.2 Cg_endo -81.3 129.62 6.79 Favored 'Trans proline' 0 C--O 1.284 2.805 0 O-C-N 122.776 0.882 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 72.1 Cg_endo -83.86 166.14 13.32 Favored 'Trans proline' 1 CA--C 1.656 6.601 0 CA-C-O 113.526 -2.781 . . . . 0.0 108.966 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.349 56.6 Cg_endo -96.47 50.54 1.46 Allowed 'Cis proline' 2 C--N 1.477 7.331 1 C-N-CA 89.174 -15.761 . . . . 0.0 115.439 -7.756 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.0 t80 67.36 122.26 0.02 OUTLIER 'General case' 1 N--CA 1.554 4.727 1 O-C-N 115.783 -4.323 . . . . 0.0 112.965 179.931 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -159.84 100.3 1.42 Allowed 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.31 -1.494 . . . . 0.0 109.91 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' CD2' HD21 ' A' ' 98' ' ' LEU . 1.4 tp -160.24 -146.66 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.71 170.69 35.96 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.049 -1.548 . . . . 0.0 111.254 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.412 ' CD1' ' HG3' ' A' ' 95' ' ' LYS . 22.8 mm -124.18 149.68 28.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.685 -0.891 . . . . 0.0 109.25 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -91.41 144.71 17.34 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HA ' ' HN2' ' A' ' 132' ' ' NAG . 6.8 m120 -68.12 -24.71 65.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.242 . . . . 0.0 110.592 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 126.53 165.79 12.05 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.137 -1.506 . . . . 0.0 113.849 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.5 m -129.28 127.63 41.58 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.505 ' O ' HG21 ' A' ' 8' ' ' VAL . 8.8 tp-100 -67.98 142.72 55.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.93 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 64.6 mt -118.5 126.38 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.543 ' CE2' ' CG2' ' A' ' 8' ' ' VAL . 28.1 m-85 -110.16 139.98 44.74 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.834 -0.541 . . . . 0.0 110.328 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.8 t -99.98 165.14 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.449 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.264 42.4 mm -112.83 130.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.046 0.451 . . . . 0.0 110.53 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -108.07 110.03 62.05 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 109.604 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.02 139.1 38.55 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.693 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -133.9 150.5 74.66 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.679 -0.638 . . . . 0.0 110.138 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.92 -11.49 31.99 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.433 1.228 . . . . 0.0 110.884 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.681 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 42.3 t -112.77 146.65 35.49 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.681 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 41.7 Cg_endo -68.22 147.89 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.325 1.171 . . . . 0.0 110.405 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -89.94 -179.98 5.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.649 -0.657 . . . . 0.0 110.676 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.7 p -92.98 9.87 33.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.627 -0.671 . . . . 0.0 111.015 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.77 139.96 57.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -110.16 149.99 29.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 110.118 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 96.3 mt-10 52.82 49.88 7.1 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.445 -0.784 . . . . 0.0 111.119 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.8 Cg_endo -69.85 150.87 68.22 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.241 1.127 . . . . 0.0 110.54 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.51 -0.744 . . . . 0.0 110.221 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.412 ' O3 ' ' C7 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . 0.428 ' H62' ' C2 ' ' A' ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . 0.428 ' C2 ' ' H62' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.407 ' C6 ' ' H5 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.404 ' C1 ' ' H62' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.407 ' H5 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.144 0.497 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 ttp 53.89 98.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.46 -0.775 . . . . 0.0 110.781 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -104.04 30.88 4.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.56 -0.712 . . . . 0.0 110.27 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.3 t -147.04 148.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.02 135.81 41.63 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.051 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.589 ' CG ' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -140.0 146.49 46.85 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.648 -0.658 . . . . 0.0 110.095 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.87 147.95 63.31 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.254 1.134 . . . . 0.0 109.565 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.93 -20.77 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.528 HG22 ' CZ ' ' A' ' 116' ' ' TYR . 2.7 p -160.6 160.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.029 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.6 t -137.13 159.6 36.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.155 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.0 130.37 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.289 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.89 133.37 45.46 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -135.81 162.43 32.81 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.289 -0.882 . . . . 0.0 112.476 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t 59.31 -115.87 0.78 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.728 -0.608 . . . . 0.0 110.827 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 16' ' ' ILE . 5.9 mtt180 -59.93 -13.06 9.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 111.346 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.22 43.47 5.91 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 HG12 ' HB2' ' A' ' 14' ' ' ARG . 8.3 mm -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -98.59 124.1 43.16 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.998 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.0 t -126.2 131.29 52.01 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.168 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 28.2 p90 -139.73 165.82 26.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.742 -0.599 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 57.5 t -123.92 127.27 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.859 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' CG ' ' A' ' 5' ' ' GLN . 42.3 t -110.03 119.79 40.41 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 14.9 pt-20 -93.16 154.25 18.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.935 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.441 ' CG ' HG13 ' A' ' 96' ' ' VAL . 45.8 p90 -134.01 -175.99 4.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.64 116.95 20.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.351 -0.843 . . . . 0.0 111.799 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.8 m -161.68 155.89 18.97 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.712 -0.618 . . . . 0.0 109.696 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.97 -19.94 45.4 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.286 1.151 . . . . 0.0 110.733 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.98 35.9 33.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -102.64 26.86 7.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.366 -1.079 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.19 144.74 27.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 110.709 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 53' ' ' MET . 16.1 p -80.28 -39.11 29.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.731 0.777 . . . . 0.0 111.655 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' OE1' ' CD1' ' A' ' 100' ' ' TYR . 4.7 mm-40 -80.19 82.85 6.16 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.918 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.8 t -93.67 84.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.798 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 60.1 ttt180 -59.98 123.17 16.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.676 -0.64 . . . . 0.0 111.084 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 m -123.4 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.8 m -120.92 131.61 54.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.236 0.541 . . . . 0.0 110.636 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 86.4 t -107.76 130.39 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.456 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 78.9 mt -124.62 169.93 11.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.992 -1.068 . . . . 0.0 111.958 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -130.26 121.39 26.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -110.24 131.98 54.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.346 -0.846 . . . . 0.0 111.061 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.36 152.77 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.57 -44.21 93.38 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 0.0 110.543 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.44 -44.87 66.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -154.89 160.16 40.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.469 -0.769 . . . . 0.0 111.263 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 92.2 t -126.86 139.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -145.21 160.38 41.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.453 -0.779 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 13.7 mt-10 -80.71 156.16 26.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.691 -0.631 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 85.4 t -114.49 -83.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' ' OD2' ' A' ' 63' ' ' ASP . 80.8 m -122.0 160.9 23.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 110.866 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.37 135.55 6.03 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.91 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.466 ' CB ' ' OG1' ' A' ' 59' ' ' THR . . . -172.1 165.34 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.419 -0.8 . . . . 0.0 110.594 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 m -97.9 123.94 42.1 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 57' ' ' GLU . 27.6 t80 -88.31 106.79 18.46 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.135 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -76.17 157.86 32.29 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.4 mmt -59.64 -28.5 67.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.852 -1.155 . . . . 0.0 110.084 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.84 -79.04 0.17 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -154.15 178.49 9.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.39 -1.065 . . . . 0.0 110.665 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' HB2' ' CD2' ' A' ' 52' ' ' TYR . 7.2 tp10 -120.07 120.15 35.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.65 -0.656 . . . . 0.0 109.746 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 2.4 mm? -124.28 46.22 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.466 ' OG1' ' CB ' ' A' ' 50' ' ' ALA 0.285 36.8 p -116.4 -132.14 0.32 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.791 -0.568 . . . . 0.0 110.909 -178.016 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 57' ' ' GLU . 39.8 m-85 60.57 25.12 14.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.825 -1.172 . . . . 0.0 109.426 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.72 -36.42 80.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 111.402 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -59.63 -43.28 93.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.413 -0.805 . . . . 0.0 111.812 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 1.045 ' OD2' ' SG ' ' A' ' 48' ' ' CYS . 95.9 m-20 -92.88 -13.2 29.29 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.164 0.507 . . . . 0.0 110.78 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t 42.4 24.93 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -144.85 -43.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.018 -1.051 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 22.9 p -67.82 134.64 51.29 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -0.857 . . . . 0.0 111.344 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -130.02 139.98 50.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.05 158.02 25.08 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.357 -1.401 . . . . 0.0 111.111 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.461 ' CG2' ' C6 ' ' A' ' 138' ' ' FUC . 61.1 m -130.05 159.92 35.26 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 53.4 m -145.93 127.24 14.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -139.96 129.99 24.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.774 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.84 -124.07 35.08 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -106.45 16.43 24.7 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.933 . . . . 0.0 110.715 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 29.3 mt-30 -119.95 123.92 44.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 111.09 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -104.54 121.82 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.661 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.429 ' OD1' ' N2 ' ' A' ' 136' ' ' NAG . 55.5 t30 -101.43 107.8 19.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.119 -0.988 . . . . 0.0 111.391 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.6 mt -97.34 131.92 43.56 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.449 -0.782 . . . . 0.0 109.673 178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.2 m -124.42 139.2 54.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 0.0 111.034 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 95.6 mt -113.55 129.94 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.728 -0.608 . . . . 0.0 109.618 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -112.54 118.26 34.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.282 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.67 51.37 0.75 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.59 129.79 34.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.546 -0.973 . . . . 0.0 111.381 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -112.21 175.48 5.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.06 94.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.875 0.845 . . . . 0.0 109.855 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.2 mmt -66.17 -32.94 74.68 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.191 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.11 -24.91 67.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.44 -0.787 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -51.88 137.85 25.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.52 -163.83 34.76 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.7 tp -94.77 129.94 41.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.886 . . . . 0.0 112.314 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.424 ' CE2' HD11 ' A' ' 115' ' ' ILE . 78.5 m-85 -113.44 136.35 52.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.524 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.9 mp -104.16 133.05 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.429 -0.795 . . . . 0.0 112.117 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.808 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.6 p -97.49 122.34 40.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 109' ' ' ILE . 17.7 mttt -119.1 143.86 46.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.363 -0.836 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.441 HG13 ' CG ' ' A' ' 23' ' ' TYR . 11.1 t -136.51 111.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.889 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -132.39 130.22 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.34 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 31.7 mt -86.94 82.84 7.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.798 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 3.4 ttm -82.67 -45.92 13.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.904 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.442 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 91.0 m-85 -69.71 -42.89 20.17 Favored Pre-proline 0 N--CA 1.508 2.456 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 60.7 Cg_endo -82.36 143.09 12.25 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.734 -1.295 . . . . 0.0 108.734 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -92.88 173.04 2.04 Favored 'Trans proline' 1 CA--C 1.658 6.72 0 CA-C-O 113.417 -2.826 . . . . 0.0 107.536 177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -92.18 49.39 1.24 Allowed 'Cis proline' 2 C--N 1.503 8.698 1 C-N-CA 91.326 -14.864 . . . . 0.0 115.228 -14.585 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 2.3 t80 55.82 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 118.692 -2.505 . . . . 0.0 111.692 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -147.19 105.74 3.8 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 119.617 -1.927 . . . . 0.0 108.777 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HG ' ' HG ' ' A' ' 98' ' ' LEU . 1.7 mt -159.3 -157.97 0.63 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.829 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -151.22 -167.61 14.94 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.417 HG22 ' HE2' ' A' ' 95' ' ' LYS 0.258 46.6 mm -134.93 169.39 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.561 -0.964 . . . . 0.0 110.5 -178.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.808 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -104.48 139.49 14.61 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.26 -36.81 78.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.388 -1.066 . . . . 0.0 110.536 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.81 144.49 5.92 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 94.3 m -115.5 137.45 52.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.485 ' O ' HG21 ' A' ' 8' ' ' VAL . 12.8 tt0 -89.92 124.05 34.38 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.371 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.424 HD11 ' CE2' ' A' ' 92' ' ' TYR . 82.7 mt -90.45 129.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CZ ' HG22 ' A' ' 8' ' ' VAL . 7.7 m-30 -100.35 140.0 35.21 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.422 0.63 . . . . 0.0 111.976 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p -94.0 168.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.0 mm -98.9 119.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 110.844 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -136.11 126.84 16.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.68 159.88 51.81 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 123.122 1.064 . . . . 0.0 110.558 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -109.86 143.85 28.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.299 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.91 -20.17 45.48 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.315 1.166 . . . . 0.0 111.336 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.8 m -129.31 140.06 37.51 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 110.425 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.72 -19.48 36.28 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.224 1.118 . . . . 0.0 110.987 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -149.79 175.12 11.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.354 -0.841 . . . . 0.0 110.519 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.0 p -75.83 163.91 26.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.583 -0.698 . . . . 0.0 110.29 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.27 137.58 58.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.13 -35.91 78.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.632 -0.667 . . . . 0.0 110.28 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -109.74 130.34 22.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 110.203 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.56 159.96 51.07 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.151 1.08 . . . . 0.0 110.311 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.599 -0.688 . . . . 0.0 110.243 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.522 ' C6 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.522 ' H1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.461 ' C6 ' ' CG2' ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.218 0.532 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp 52.98 38.59 27.57 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.379 -0.825 . . . . 0.0 110.637 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -110.1 130.14 55.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.694 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.2 132.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 110.001 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.41 54.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.632 -0.668 . . . . 0.0 109.722 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.079 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 96.3 mm-40 -137.34 148.02 60.35 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.785 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.0 152.83 68.22 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.429 1.226 . . . . 0.0 109.146 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.98 -12.17 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 110.792 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.508 ' CG2' ' HE2' ' A' ' 116' ' ' TYR . 2.3 p -139.95 137.62 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 116' ' ' TYR . 8.9 t -137.85 145.66 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.127 -1.608 . . . . 0.0 110.846 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 70.8 mt -114.84 148.31 38.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.465 -0.772 . . . . 0.0 110.539 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.88 -171.5 1.84 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.513 -0.742 . . . . 0.0 110.413 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 t -123.84 172.87 8.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -60.79 -39.13 87.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.469 -0.769 . . . . 0.0 109.744 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -60.51 -28.04 68.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.0 109.854 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 27.14 8.25 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 16' ' ' ILE . 1.3 mp -97.73 99.89 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.3 126.11 51.74 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -133.83 149.55 51.39 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.092 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.11 163.94 39.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 68.9 t -119.91 124.04 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.033 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.079 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.3 t -102.78 107.91 18.94 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -86.96 141.55 28.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 112.358 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -127.38 174.72 8.76 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.34 131.87 21.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.843 . . . . 0.0 111.483 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 t -164.64 153.05 10.89 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.676 -0.64 . . . . 0.0 110.555 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.86 149.86 48.47 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.654 1.344 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.85 -179.19 5.34 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -132.83 151.06 52.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.71 -0.876 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.07 48.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.599 -0.688 . . . . 0.0 109.615 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.9 p -79.81 -39.06 31.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.335 -0.853 . . . . 0.0 110.649 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -79.76 76.72 6.42 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.447 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.25 82.03 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 18.7 ttp85 -59.5 121.53 11.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.821 -0.549 . . . . 0.0 110.955 -178.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -125.35 139.86 50.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.571 0.7 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.1 m -135.22 133.06 38.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.033 -0.417 . . . . 0.0 109.982 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 95.4 t -105.11 132.35 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.544 -0.723 . . . . 0.0 109.123 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' CD2' ' HA ' ' A' ' 46' ' ' GLU . 83.1 mt -126.41 168.01 14.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.128 -0.982 . . . . 0.0 111.176 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -129.61 128.54 42.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' HG3' HD12 ' A' ' 93' ' ' ILE . 30.8 mt-30 -109.86 132.05 54.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.322 -0.861 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.36 178.76 5.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.932 -0.48 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.33 -40.12 89.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.0 111.514 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.4 m -118.37 -19.96 8.68 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 112.112 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -131.79 179.29 6.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.14 -0.975 . . . . 0.0 112.142 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.5 t -149.88 143.52 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.81 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -138.72 156.13 47.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.455 -0.778 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 68.6 mt-10 -80.16 147.57 31.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 111.54 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG11 ' SG ' ' A' ' 48' ' ' CYS . 96.1 t -102.89 -73.92 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.948 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 14.5 p -159.92 164.65 33.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 110.133 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -169.39 161.01 9.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.205 -0.934 . . . . 0.0 111.603 -178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 60' ' ' PHE . . . -172.0 157.68 4.47 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -84.58 119.82 25.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.681 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 71' ' ' THR . 44.2 t80 -79.96 99.52 7.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.682 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 mmt -71.78 138.11 48.14 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 8.8 tpp -68.03 -19.99 64.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.73 -21.12 8.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.94 161.3 28.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -1.151 . . . . 0.0 110.701 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -121.75 124.39 44.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.408 -0.808 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 69.3 mt -93.16 166.14 12.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 p -119.75 135.04 55.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.784 -0.572 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.948 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 5.3 m-30 -67.2 136.71 55.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.4 tt -68.97 -42.06 77.1 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -118.25 -172.12 2.2 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.915 -1.115 . . . . 0.0 112.615 -177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 56.18 56.77 5.55 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.444 0.64 . . . . 0.0 110.88 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.1 m 52.09 26.64 3.95 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.551 -0.718 . . . . 0.0 110.705 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt 53.98 76.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.503 -0.748 . . . . 0.0 110.762 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.524 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -64.74 149.98 48.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.29 -0.882 . . . . 0.0 108.735 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -119.11 143.57 47.1 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.57 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -130.17 140.91 12.13 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.435 ' HA ' ' CE2' ' A' ' 52' ' ' TYR . 61.4 m -116.1 160.9 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.856 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 46.4 t -143.75 109.8 5.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.75 -0.594 . . . . 0.0 110.487 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -151.77 140.63 20.98 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.517 -0.74 . . . . 0.0 110.319 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.81 99.67 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.21 21.23 6.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.621 -0.929 . . . . 0.0 110.354 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -124.65 125.68 44.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.584 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -102.7 124.11 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.174 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.431 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 47.7 t-20 -102.41 115.95 31.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.0 111.15 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -100.61 137.95 38.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.509 -0.745 . . . . 0.0 109.586 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 m -127.72 131.97 49.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.826 . . . . 0.0 110.78 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 69.8 mt -110.68 138.3 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 109.872 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -124.02 122.15 37.14 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.093 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.54 2.83 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.0 mt -87.14 129.93 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.499 -1.001 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -102.6 177.19 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.863 0.839 . . . . 0.0 109.747 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -67.61 -29.96 69.42 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.353 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -66.4 -16.49 64.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 111.451 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.0 m -49.8 150.03 2.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 110.415 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.09 -168.62 32.48 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.4 tp -88.91 130.11 35.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.716 -0.873 . . . . 0.0 112.691 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.42 ' CD1' HD11 ' A' ' 115' ' ' ILE . 67.7 m-85 -118.5 140.84 49.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.446 ' HA ' ' HA2' ' A' ' 112' ' ' GLY . 3.5 mp -98.14 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.412 -0.805 . . . . 0.0 111.903 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.89 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 18.7 p -109.02 116.4 31.91 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 15.5 mttt -111.61 142.7 43.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.018 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' CG1' HD22 ' A' ' 106' ' ' LEU . 8.2 t -142.17 105.62 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -128.76 125.27 37.52 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.948 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 52.7 mt -81.65 76.35 8.57 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 5.8 ttm -80.89 -52.48 7.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.5 m-85 -62.46 -41.83 76.11 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.091 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 55.9 Cg_endo -85.71 113.79 1.37 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 120.831 1.021 . . . . 0.0 111.233 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.473 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 71.7 Cg_endo -90.72 150.99 4.14 Favored 'Trans proline' 1 CA--C 1.688 8.215 0 C-N-CA 123.042 2.495 . . . . 0.0 108.671 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.302 69.7 Cg_endo -83.56 176.09 34.75 Favored 'Cis proline' 2 C--N 1.469 6.892 1 C-N-CA 95.565 -13.098 . . . . 0.0 118.149 -8.53 . . . . . . . . 5 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.17 127.26 32.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.182 -1.574 . . . . 0.0 109.687 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -148.48 87.61 1.59 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.93 -1.106 . . . . 0.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 96' ' ' VAL . 4.2 tp -155.0 -145.95 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.256 -0.903 . . . . 0.0 110.767 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.37 -172.45 31.86 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.586 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.434 HG21 ' C8 ' ' A' ' 132' ' ' NAG . 84.5 mt -126.87 160.31 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.76 -0.847 . . . . 0.0 110.492 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.89 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.9 130.09 10.11 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.116 -2.393 . . . . 0.0 107.116 177.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.61 -32.39 70.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.324 -1.103 . . . . 0.0 111.051 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 135.14 151.54 6.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.934 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.403 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.5 m -124.76 149.81 46.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.428 ' HG2' ' CE1' ' A' ' 116' ' ' TYR . 58.2 tt0 -97.13 119.83 36.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.446 -1.301 . . . . 0.0 110.004 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.42 HD11 ' CD1' ' A' ' 92' ' ' TYR . 96.0 mt -81.28 140.1 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.508 ' HE2' ' CG2' ' A' ' 8' ' ' VAL . 48.4 m-85 -120.92 152.58 38.32 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.318 0.58 . . . . 0.0 112.236 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.403 HG23 ' N ' ' A' ' 118' ' ' ILE . 7.1 p -86.15 168.67 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.403 ' N ' HG23 ' A' ' 117' ' ' VAL . 39.9 mm -96.71 114.29 33.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.34 -0.85 . . . . 0.0 110.891 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -140.05 124.01 10.75 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.831 -0.543 . . . . 0.0 109.766 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.99 158.19 57.49 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.095 1.05 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -99.43 120.05 58.77 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.535 -0.728 . . . . 0.0 110.025 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.9 -19.87 34.89 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.126 1.066 . . . . 0.0 111.184 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 125' ' ' ASP . 42.3 t -111.26 119.95 44.21 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 0.0 110.59 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.64 -12.3 32.83 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.118 1.062 . . . . 0.0 111.086 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.774 ' O ' ' SG ' ' A' ' 123' ' ' CYS . 55.8 p-10 -145.33 -171.06 3.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.2 p -70.14 166.37 20.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.57 -0.706 . . . . 0.0 110.136 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -140.01 159.97 40.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.7 . . . . 0.0 110.325 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -64.63 -34.28 77.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 110.371 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -77.82 130.32 73.61 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.506 -0.747 . . . . 0.0 110.205 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.08 159.97 51.28 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.158 1.083 . . . . 0.0 110.464 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 0.0 110.114 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' NAG . . . . . 0.434 ' C8 ' HG21 ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' NAG . . . . . 0.44 ' H5 ' ' H1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' NAG . . . . . 0.44 ' H1 ' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' FUC . . . . . 0.402 ' H1 ' ' C5 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 3' ' ' VAL . 69.1 m-70 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.542 0.687 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -149.6 118.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -106.81 128.45 54.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.568 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -149.83 143.64 16.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.85 136.24 32.26 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.323 1.17 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.63 69.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.929 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -144.83 165.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.755 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HB ' HD13 ' A' ' 115' ' ' ILE . 8.3 t -139.33 130.56 33.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 121.753 0.787 . . . . 0.0 111.181 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 10' ' ' LEU . 3.6 mm? -87.59 129.9 34.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 117' ' ' VAL . . . -106.41 154.77 20.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.815 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.0 m -75.2 172.47 12.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.727 -0.608 . . . . 0.0 109.732 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 m -59.79 -40.08 87.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.01 -29.58 69.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.486 -0.759 . . . . 0.0 110.029 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.405 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 109.03 41.49 1.41 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.5 mp -100.5 102.11 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.672 -0.899 . . . . 0.0 108.85 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -108.75 114.16 27.72 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.87 ' OG ' HG23 ' A' ' 80' ' ' THR . 52.8 m -130.8 131.72 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.554 0.692 . . . . 0.0 110.886 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' HG21 ' A' ' 9' ' ' VAL . 38.5 p90 -150.07 163.97 36.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.781 -0.574 . . . . 0.0 109.476 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.6 t -123.45 122.36 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.692 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -103.84 108.5 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 15.2 pt-20 -81.66 162.57 22.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.19 -0.944 . . . . 0.0 110.867 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.2 p90 -140.13 176.36 8.82 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 130.85 45.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.795 -0.566 . . . . 0.0 110.409 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.5 p -132.77 155.94 80.62 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.558 -0.714 . . . . 0.0 110.081 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.15 -16.89 45.21 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.391 1.206 . . . . 0.0 111.216 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -171.99 37.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -100.63 137.3 39.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.598 -0.942 . . . . 0.0 110.127 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.96 170.67 15.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.537 -0.727 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.076 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -81.15 -8.64 59.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.583 -0.698 . . . . 0.0 112.494 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 51' ' ' THR . 18.6 mm-40 -129.46 108.26 10.13 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.944 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 78.0 t -125.89 80.45 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.76 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 67.8 ttt180 -59.97 124.59 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 111.427 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -114.73 153.98 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 95' ' ' LYS . 20.3 m -144.0 141.41 30.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 79' ' ' LEU . 85.6 t -116.86 124.07 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.6 mt -120.07 153.36 36.2 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.518 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 47' ' ' VAL . 69.0 mtm180 -111.28 123.96 51.26 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.0 tt0 -96.25 139.99 31.6 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.853 0.835 . . . . 0.0 110.937 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -134.04 156.98 47.27 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.83 -43.86 94.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.4 m -70.0 -47.28 62.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.648 -0.657 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.777 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.2 tt0 -165.15 169.48 16.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 111.241 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.3 t -116.73 140.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -130.03 160.58 33.25 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.326 -0.859 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.822 ' HA ' HD23 ' A' ' 37' ' ' LEU . 96.9 mt-10 -80.03 154.85 27.9 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.9 HG21 ' HG3' ' A' ' 38' ' ' ARG . 45.8 t -130.89 -83.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.705 -0.622 . . . . 0.0 111.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.655 ' SG ' HG12 ' A' ' 47' ' ' VAL . 83.2 m -110.14 149.45 30.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.076 -1.015 . . . . 0.0 110.925 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.04 141.41 15.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.538 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 58' ' ' LEU . . . -165.79 163.35 18.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 109.842 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 31' ' ' GLU . 5.5 m -97.45 116.31 29.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.703 ' CZ ' ' SD ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -72.9 91.94 1.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 1.076 ' SD ' ' O ' ' A' ' 30' ' ' THR . 35.8 mmm -85.0 129.96 34.7 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.703 ' SD ' ' CZ ' ' A' ' 52' ' ' TYR . 18.0 mmt -59.43 -27.98 66.54 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.618 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.66 43.41 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 53' ' ' MET . 11.2 t30 -149.8 -179.99 7.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.0 -1.294 . . . . 0.0 110.846 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.61 156.39 19.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.656 -0.653 . . . . 0.0 110.65 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 50' ' ' ALA . 80.4 mt -70.28 139.93 52.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.972 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 p -104.55 118.33 36.32 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.718 . . . . 0.0 110.102 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.87 37.85 2.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.472 -0.768 . . . . 0.0 110.307 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.436 -0.79 . . . . 0.0 110.662 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -85.7 127.12 34.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.355 -0.841 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 52.24 47.52 24.56 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.318 -0.864 . . . . 0.0 109.932 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -57.53 -106.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.983 -0.448 . . . . 0.0 110.823 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.8 mt 52.04 22.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.342 -1.473 . . . . 0.0 110.534 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.05 158.21 24.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.988 . . . . 0.0 110.339 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.712 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.0 t -132.75 139.95 47.83 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.82 154.12 25.09 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.411 -1.376 . . . . 0.0 111.066 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 72' ' ' SER . 94.2 m -130.04 163.51 26.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 32.8 t -143.39 130.02 20.24 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.773 -0.58 . . . . 0.0 109.961 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -142.42 133.85 26.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -0.783 . . . . 0.0 109.744 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.5 -123.99 27.54 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -105.9 16.43 25.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.674 -0.897 . . . . 0.0 110.441 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.87 123.94 44.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 111.013 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.0 m -99.49 130.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -107.97 118.38 36.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 111.459 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD13 ' CG2' ' A' ' 36' ' ' VAL . 74.0 mt -108.95 132.05 54.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.87 HG23 ' OG ' ' A' ' 18' ' ' SER . 86.6 m -121.14 132.2 54.71 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 0.0 110.173 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.789 HG21 HD21 ' A' ' 84' ' ' LEU . 94.9 mt -116.38 130.16 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.642 -0.661 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.5 mt-30 -124.54 120.86 33.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.648 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.28 48.68 0.69 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 81' ' ' ILE . 81.2 mt -96.0 108.41 20.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.488 -1.007 . . . . 0.0 111.308 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -82.85 -176.62 6.4 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.21 92.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.8 -38.84 83.85 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.117 0.484 . . . . 0.0 111.103 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -60.0 -35.39 74.95 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.544 -0.723 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 115' ' ' ILE . 35.7 m -51.46 135.96 26.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.97 -144.03 7.83 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.908 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 92' ' ' TYR . 2.1 tm? -106.62 139.42 41.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.779 -0.836 . . . . 0.0 110.816 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.868 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -124.53 125.3 43.97 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.741 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -97.94 120.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.365 -0.834 . . . . 0.0 111.949 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 30.8 p -84.15 122.4 28.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.757 ' HD2' HD12 ' A' ' 109' ' ' ILE . 10.5 mtmt -113.9 150.59 33.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.304 -0.873 . . . . 0.0 109.986 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.704 HG11 ' CG ' ' A' ' 23' ' ' TYR . 24.6 t -141.39 103.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.03 117.34 18.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.759 HD13 HD23 ' A' ' 106' ' ' LEU . 8.7 mp -75.6 75.35 2.61 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.76 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 22.9 ttm -78.39 -38.31 42.04 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.932 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.429 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 92.8 m-85 -67.51 -44.96 46.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 55.7 Cg_endo -80.8 137.18 11.06 Favored 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 120.463 0.776 . . . . 0.0 110.469 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 73.6 Cg_endo -89.98 143.81 4.17 Favored 'Trans proline' 2 CA--C 1.708 9.188 0 CA-C-O 112.032 -3.403 . . . . 0.0 110.923 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.305 51.0 Cg_endo -114.41 64.67 0.26 Allowed 'Cis proline' 2 C--N 1.443 5.526 1 C-N-CA 93.233 -14.07 . . . . 0.0 113.31 5.111 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' PRO . 4.3 t80 48.14 111.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.092 -2.255 . . . . 0.0 111.8 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' O ' HD22 ' A' ' 106' ' ' LEU . 28.9 t80 -160.64 107.99 1.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.83 1.3 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.45 -142.83 0.11 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.562 -179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.99 167.41 32.23 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.0 mm -119.82 157.15 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.946 -0.737 . . . . 0.0 109.082 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.701 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -86.32 141.55 18.3 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.01 -36.24 76.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.995 . . . . 0.0 110.11 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.797 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 129.64 143.14 5.4 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.866 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 98.1 m -111.42 131.94 54.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.833 ' HB3' HG23 ' A' ' 8' ' ' VAL . 32.8 tp60 -79.97 131.88 35.91 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.925 HD13 ' HB ' ' A' ' 9' ' ' VAL . 22.1 mm -99.74 121.17 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.135 . . . . 0.0 108.61 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.929 ' CE2' HG21 ' A' ' 8' ' ' VAL . 13.2 m-30 -101.37 147.15 26.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.794 -0.566 . . . . 0.0 110.555 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 11' ' ' ALA . 86.4 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.89 0.852 . . . . 0.0 110.008 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 72.7 m80 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 121.269 0.557 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 2' ' ' HIS . 67.1 t -150.15 132.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.66 -0.65 . . . . 0.0 109.279 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -108.02 130.69 55.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.405 -0.809 . . . . 0.0 110.319 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.43 124.99 21.46 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 111.07 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.63 139.87 31.75 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 N-CA-C 109.053 -1.172 . . . . 0.0 109.053 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.16 64.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.33 162.86 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.445 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 19' ' ' PHE . 10.7 t -139.68 155.92 25.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 116' ' ' TYR . 92.4 mt -114.32 131.9 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.605 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.08 -163.82 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -128.87 -178.8 4.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.518 -0.739 . . . . 0.0 110.566 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.31 -39.53 87.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.567 ' HG3' HD11 ' A' ' 16' ' ' ILE . 21.6 tpp180 -59.15 -21.48 59.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.729 -0.607 . . . . 0.0 109.656 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.606 ' C ' HD13 ' A' ' 16' ' ' ILE . . . 83.64 35.03 17.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' GLY . 5.1 mm -114.69 109.91 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.503 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -104.55 127.35 52.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.755 -0.591 . . . . 0.0 110.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.696 ' HB2' HG23 ' A' ' 80' ' ' THR . 34.1 t -127.07 129.96 49.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.7 p90 -138.08 160.16 40.11 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 77' ' ' VAL . 61.5 t -125.67 123.32 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.297 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -105.52 109.94 22.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.6 pt-20 -82.77 149.49 27.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 111.419 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CD2' HG21 ' A' ' 96' ' ' VAL . 7.6 p90 -131.89 164.0 27.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -131.32 133.4 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.399 -0.813 . . . . 0.0 111.19 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -139.9 150.46 62.57 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.648 -0.658 . . . . 0.0 110.717 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.77 -10.09 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.688 1.362 . . . . 0.0 111.852 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.48 -178.77 22.12 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.383 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -121.87 150.06 42.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.676 -0.896 . . . . 0.0 110.599 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.51 162.63 39.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.604 -0.685 . . . . 0.0 109.795 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 71.0 p -80.25 -46.09 16.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.46 -0.775 . . . . 0.0 110.647 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 51' ' ' THR . 5.7 mm-40 -80.26 112.04 17.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.999 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.23 95.75 3.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.845 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 68.9 ttt180 -75.78 115.3 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.431 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.5 m -118.78 138.91 47.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 85.2 m -129.6 143.73 50.96 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.474 0.654 . . . . 0.0 110.338 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.935 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -114.32 139.48 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' A' ' 46' ' ' GLU . 9.5 mt -130.22 172.33 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.049 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HG3' ' CG2' ' A' ' 47' ' ' VAL . 91.5 mtt180 -126.72 123.6 37.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' HG3' HD11 ' A' ' 93' ' ' ILE . 81.1 mt-30 -106.32 132.01 52.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.939 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -104.87 -172.31 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 -43.6 96.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 110.791 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.0 p -132.06 0.06 3.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.331 -0.855 . . . . 0.0 111.878 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.624 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 74.9 mt-30 -137.3 154.98 49.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.031 -1.043 . . . . 0.0 110.816 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.21 145.16 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.9 p -129.8 156.06 44.95 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.343 -0.848 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.841 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.8 mp0 -86.34 159.99 19.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 63.9 t -122.25 -80.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.822 -0.549 . . . . 0.0 110.194 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 85.9 m -131.66 156.6 45.56 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.979 -1.076 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.03 121.8 3.23 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.462 -0.774 . . . . 0.0 111.275 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -158.29 143.02 16.24 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.4 -0.812 . . . . 0.0 110.196 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.0 m -92.7 119.95 32.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.285 -0.884 . . . . 0.0 108.728 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HE1' ' A' ' 54' ' ' MET . 46.0 p90 -110.06 146.87 34.63 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.967 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 1.05 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -75.99 160.78 29.5 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.459 ' HE1' ' CE1' ' A' ' 52' ' ' TYR . 31.7 mmt -70.66 127.45 32.73 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.893 -1.129 . . . . 0.0 110.131 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.85 27.77 23.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -150.03 175.77 11.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.213 -1.169 . . . . 0.0 111.163 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.31 152.01 48.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.8 -0.562 . . . . 0.0 109.859 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 51' ' ' THR . 96.3 mt -136.42 -171.82 2.99 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.157 0.979 . . . . 0.0 112.136 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.7 p -109.48 159.97 16.61 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 95.0 m-85 -111.35 127.89 55.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.382 -0.824 . . . . 0.0 109.418 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.94 -44.07 94.6 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.587 -0.695 . . . . 0.0 112.344 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -94.88 131.44 40.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.921 . . . . 0.0 109.898 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 67' ' ' ILE . 81.9 m-20 53.05 57.77 5.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m -60.86 64.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.362 0.601 . . . . 0.0 112.098 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 67' ' ' ILE . 67.3 mt -140.98 16.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.419 -0.801 . . . . 0.0 109.134 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.1 m -104.09 130.03 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.059 -1.026 . . . . 0.0 110.593 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.409 HG21 ' OE1' ' A' ' 82' ' ' GLN . 9.5 t -139.94 150.08 44.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.58 -172.04 41.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.277 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 72' ' ' SER . 93.8 m -115.63 167.32 11.02 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.884 -0.774 . . . . 0.0 109.703 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 71' ' ' THR . 97.3 p -145.22 151.26 38.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.786 -0.571 . . . . 0.0 109.632 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -132.03 -175.73 3.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.649 -0.657 . . . . 0.0 109.757 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -52.92 -66.19 2.86 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -111.57 9.53 21.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.425 -1.044 . . . . 0.0 111.699 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.3 tt0 -130.0 129.41 43.69 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.996 -1.065 . . . . 0.0 110.609 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 21' ' ' CYS . 9.2 m -115.18 134.52 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -110.99 112.58 24.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.844 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.935 HD13 ' CG2' ' A' ' 36' ' ' VAL . 95.7 mt -107.31 129.66 54.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 18' ' ' SER . 58.6 m -124.05 136.69 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.249 -0.907 . . . . 0.0 110.777 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.78 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -103.52 137.29 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.675 . . . . 0.0 109.957 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.528 ' HG2' HG23 ' A' ' 16' ' ' ILE . 92.5 mt-30 -119.97 120.71 37.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.041 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.03 40.07 1.74 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.78 HD21 HG21 ' A' ' 81' ' ' ILE . 76.3 mt -80.37 137.83 36.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.996 . . . . 0.0 111.445 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -117.03 176.15 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.9 93.04 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.31 -39.07 93.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.738 -0.601 . . . . 0.0 110.748 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.11 -23.94 64.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.566 -0.709 . . . . 0.0 111.195 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 115' ' ' ILE . 25.3 m -52.43 137.77 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 155.96 -164.26 32.2 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 14.6 tp -88.42 126.22 35.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.884 . . . . 0.0 112.733 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 31.5 m-85 -106.89 158.13 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -123.7 140.18 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.887 . . . . 0.0 111.723 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.581 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 13.9 p -98.64 133.54 42.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.7 tttt -135.95 123.11 21.65 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 106' ' ' LEU . 2.6 p -132.36 118.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.8 mm-40 -139.58 142.68 37.11 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.273 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 106' ' ' LEU . 6.5 mt -90.44 81.87 5.95 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.845 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 2.8 ttm -80.13 -48.99 12.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.264 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.46 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 80.6 m-85 -70.87 -41.92 12.23 Favored Pre-proline 0 N--CA 1.508 2.467 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.4 Cg_endo -86.58 119.82 1.69 Allowed 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.558 1.505 . . . . 0.0 109.34 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 65.5 Cg_endo -84.77 161.71 12.18 Favored 'Trans proline' 2 CA--C 1.685 8.042 0 CA-C-O 113.188 -2.921 . . . . 0.0 106.18 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 38.6 Cg_endo -86.45 174.8 30.84 Favored 'Cis proline' 1 C--N 1.423 4.468 1 C-N-CA 98.673 -11.803 . . . . 0.0 114.9 -11.624 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' GLU 0.313 3.0 t80 -80.16 133.0 36.02 Favored 'General case' 0 N--CA 1.529 3.513 0 O-C-N 118.319 -2.738 . . . . 0.0 115.727 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 14.0 p90 -162.47 107.7 1.19 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.149 -1.595 . . . . 0.0 111.695 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 96' ' ' VAL . 2.3 tp -157.59 -147.11 0.17 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.623 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.548 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -160.66 169.57 36.41 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 118.689 -1.719 . . . . 0.0 112.102 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.4 mp -117.16 159.76 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.537 -0.978 . . . . 0.0 109.576 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -103.39 143.57 15.78 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -59.92 -39.71 86.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -1.089 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 137.01 158.67 8.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.257 -1.449 . . . . 0.0 113.004 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.627 HG21 HG23 ' A' ' 9' ' ' VAL . 85.1 m -125.77 139.96 53.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.858 ' HB3' HG23 ' A' ' 8' ' ' VAL . 27.5 tt0 -85.24 142.36 29.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.162 -1.415 . . . . 0.0 108.251 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 76.4 mt -109.18 130.03 62.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 8' ' ' VAL . 15.1 m-30 -110.87 150.35 29.3 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.914 -0.491 . . . . 0.0 110.391 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 75.6 m80 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.47 0.652 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.601 HG11 ' CA ' ' A' ' 110' ' ' GLY . 66.6 t -142.22 132.6 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -123.95 134.43 53.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.318 -0.864 . . . . 0.0 111.165 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.133 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 65.5 mt-30 -146.81 147.95 31.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.653 -0.655 . . . . 0.0 110.697 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.02 140.7 42.33 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.438 1.23 . . . . 0.0 109.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.18 71.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.978 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -155.49 161.41 2.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.35 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.5 t -137.94 156.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.529 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' A' ' 116' ' ' TYR . 84.8 mt -122.79 124.23 42.85 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.07 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 141.3 38.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.509 -0.744 . . . . 0.0 109.32 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -80.3 -59.78 2.57 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.221 -0.924 . . . . 0.0 111.884 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 16' ' ' ILE . 15.2 t -152.32 165.93 33.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.535 -0.728 . . . . 0.0 109.462 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.875 ' HG2' HD11 ' A' ' 16' ' ' ILE . 6.3 ttt180 57.67 19.51 5.56 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.544 -0.722 . . . . 0.0 110.733 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' HD12 ' A' ' 84' ' ' LEU . . . 56.65 44.31 91.18 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.875 HD11 ' HG2' ' A' ' 14' ' ' ARG . 29.1 mm -106.78 104.66 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.75 120.67 42.89 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.335 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.613 ' OG ' HG23 ' A' ' 80' ' ' THR . 13.7 m -116.28 121.93 43.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.763 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.5 p90 -132.03 163.96 27.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.683 . . . . 0.0 110.392 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 78' ' ' ASN . 36.3 t -122.03 130.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.171 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.081 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 48.7 t -117.9 131.92 56.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.4 tt0 -102.53 136.36 42.5 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 111.821 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.78 ' CG ' HG11 ' A' ' 96' ' ' VAL . 40.2 p90 -127.3 179.53 5.41 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' HD21 ' A' ' 106' ' ' LEU . . . -132.47 127.29 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.719 -0.613 . . . . 0.0 110.477 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.35 149.9 59.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.594 -0.691 . . . . 0.0 109.97 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.81 -16.11 45.33 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.362 1.191 . . . . 0.0 111.446 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.96 -171.92 37.4 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -108.05 130.1 55.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.602 -0.94 . . . . 0.0 109.959 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.62 -178.63 5.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 110.623 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.088 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -79.96 -14.19 58.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 112.266 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.717 ' OE1' HG21 ' A' ' 51' ' ' THR . 3.1 mm-40 -128.82 130.73 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.497 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.0 t -139.68 84.91 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -64.49 115.24 4.96 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.458 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -117.3 147.41 20.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 49' ' ' ALA . 90.7 m -147.12 140.03 25.1 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.339 0.59 . . . . 0.0 111.101 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.882 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -102.66 132.1 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -121.91 170.3 9.94 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.847 -1.158 . . . . 0.0 112.019 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 47' ' ' VAL . 15.6 mmm180 -116.0 115.66 26.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HA ' HG13 ' A' ' 44' ' ' VAL . 37.9 tt0 -103.01 140.02 37.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.206 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.774 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -141.28 155.34 46.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.16 -44.0 92.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.355 -0.841 . . . . 0.0 110.263 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.0 m -70.1 -44.04 69.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.656 -0.652 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.774 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 12.4 tp60 -162.65 161.33 26.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 111.078 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 39' ' ' GLN . 62.1 t -118.25 141.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 160.31 33.99 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.161 -0.962 . . . . 0.0 111.885 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.922 ' HA ' HD23 ' A' ' 37' ' ' LEU . 80.4 mt-10 -87.97 158.53 18.63 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.702 -0.624 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 38' ' ' ARG . 94.0 t -139.17 -83.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.609 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 1.118 ' SG ' ' N ' ' A' ' 68' ' ' CYS . 83.4 m -105.21 149.52 25.88 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.085 -1.01 . . . . 0.0 111.792 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -163.94 145.34 8.87 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB2' ' CD1' ' A' ' 60' ' ' PHE . . . -171.79 158.0 4.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.717 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -97.62 109.92 22.59 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.327 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.633 ' CD1' HD21 ' A' ' 58' ' ' LEU . 29.1 t80 -68.97 123.99 22.52 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 1.088 ' SD ' ' O ' ' A' ' 30' ' ' THR . 40.0 mmm -111.92 39.23 2.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.414 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 16.4 mmt 59.9 35.57 21.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.58 174.66 28.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.03 -18.93 45.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.597 -0.943 . . . . 0.0 112.126 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.95 124.65 28.27 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.312 0.577 . . . . 0.0 112.027 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' A' ' 52' ' ' TYR . 75.7 mt -131.9 151.82 51.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.589 -0.695 . . . . 0.0 109.139 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 p -87.12 95.63 10.02 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.967 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 67' ' ' ILE . 20.6 m-85 -115.06 99.54 7.52 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.441 ' N ' HG13 ' A' ' 67' ' ' ILE . 96.0 mt -135.01 -0.13 2.81 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.63 -1.294 . . . . 0.0 114.155 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 56.6 t0 -110.65 130.17 55.64 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.51 -1.369 . . . . 0.0 112.872 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 53.12 44.28 30.53 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.761 -1.212 . . . . 0.0 111.333 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 5.8 t 72.15 -42.25 0.53 Allowed 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.417 -0.802 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.966 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 25.8 mm 61.13 168.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.874 -1.142 . . . . 0.0 110.592 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.118 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 4.1 m -110.25 -179.74 3.86 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -130.22 149.79 51.76 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.3 -172.66 40.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.97 -1.586 . . . . 0.0 111.369 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 72' ' ' SER . 59.7 m -131.85 168.88 17.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 122.157 -0.614 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 71' ' ' THR . 19.0 t -140.24 129.83 24.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -130.99 131.99 44.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.55 -123.78 24.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 78.7 m-20 -99.75 11.53 38.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.769 -0.842 . . . . 0.0 110.919 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -114.34 131.92 56.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 21' ' ' CYS . 11.4 m -111.52 118.2 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.614 ' CG ' HG22 ' A' ' 20' ' ' VAL . 4.1 m120 -89.9 114.21 25.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.545 -0.722 . . . . 0.0 110.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 36' ' ' VAL . 69.7 mt -114.24 124.32 51.74 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.613 HG23 ' OG ' ' A' ' 18' ' ' SER . 88.1 m -115.31 132.41 56.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.34 -0.85 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -107.06 135.78 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.294 -0.879 . . . . 0.0 110.17 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.849 ' HG2' HD12 ' A' ' 16' ' ' ILE . 82.9 mt-30 -119.97 120.32 36.01 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.204 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.02 51.74 0.72 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 81' ' ' ILE . 80.7 mt -92.32 113.53 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.682 -0.893 . . . . 0.0 111.439 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' HB2' ' HG2' ' A' ' 87' ' ' MET . 71.9 mmt-85 -81.32 166.16 20.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.02 -28.48 57.51 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.215 -0.928 . . . . 0.0 109.066 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 22.2 ptm -69.91 -36.07 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.507 0.67 . . . . 0.0 110.005 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.13 -25.74 65.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.799 -0.563 . . . . 0.0 111.397 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.1 m -51.2 132.01 28.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.43 -165.72 31.99 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 12.9 tp -86.8 130.07 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.705 -0.879 . . . . 0.0 112.798 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 115' ' ' ILE . 59.1 m-85 -111.58 140.09 46.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.704 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.6 mp -110.14 122.95 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.133 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -79.67 120.17 23.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 175.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HE3' HD11 ' A' ' 109' ' ' ILE . 8.0 tttt -103.47 143.97 32.02 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.78 HG11 ' CG ' ' A' ' 23' ' ' TYR . 20.3 t -140.77 106.62 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.768 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG2' ' OH ' ' A' ' 104' ' ' TYR . 59.0 mt-10 -140.17 122.21 15.68 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.908 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.5 mp -72.94 83.7 1.23 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 13.2 mmt -79.28 -50.92 10.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 97.6 m-85 -69.17 -40.3 15.05 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.407 -0.808 . . . . 0.0 112.618 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 14.8 Cg_endo -88.8 119.6 1.06 Allowed 'Trans proline' 0 C--O 1.177 -2.551 0 C-N-CA 122.14 1.893 . . . . 0.0 109.881 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.885 ' CB ' ' HA ' ' A' ' 103' ' ' PRO 0.479 88.9 Cg_endo -100.46 173.7 0.34 Allowed 'Trans proline' 2 C--O 1.08 -7.38 0 CA-C-O 114.3 -2.459 . . . . 0.0 113.482 173.563 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.885 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.408 52.0 Cg_endo -72.69 176.64 39.37 Favored 'Cis proline' 3 N--CA 1.586 6.96 1 C-N-CA 96.736 -12.61 . . . . 0.0 112.6 -5.491 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.422 ' OH ' ' HG2' ' A' ' 97' ' ' GLU . 14.7 t80 -79.55 135.72 36.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 116.327 -3.983 . . . . 0.0 111.352 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.33 30.4 t80 -158.73 91.76 1.08 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.104 0.411 . . . . 0.0 111.464 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -159.35 -157.29 0.57 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.119 -1.432 . . . . 0.0 112.57 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.715 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.5 -177.01 36.82 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.966 -1.112 . . . . 0.0 111.295 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.715 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -121.29 153.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.601 ' CA ' HG11 ' A' ' 3' ' ' VAL . . . -92.99 165.2 27.91 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -62.54 -34.03 76.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -1.094 . . . . 0.0 111.694 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.54 160.57 11.52 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.688 -1.244 . . . . 0.0 111.921 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.563 HG21 HG23 ' A' ' 9' ' ' VAL . 60.6 m -120.04 145.04 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.978 ' HB3' HG23 ' A' ' 8' ' ' VAL . 30.5 tt0 -88.98 145.56 25.43 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.612 -1.235 . . . . 0.0 107.954 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 92' ' ' TYR . 45.6 mt -117.99 131.31 71.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.87 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -113.93 155.97 24.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.83 -0.544 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.826 0.822 . . . . 0.0 110.047 178.631 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.5 m170 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.288 0.566 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG11 ' HA2' ' A' ' 110' ' ' GLY . 83.8 t -80.13 137.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.745 -0.597 . . . . 0.0 109.895 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -122.12 135.69 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.538 -0.726 . . . . 0.0 110.72 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 41.5 mt-30 -148.51 150.07 32.95 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.526 -0.734 . . . . 0.0 111.694 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 113' ' ' THR . 41.7 Cg_endo -71.02 139.97 37.0 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.284 -1.468 . . . . 0.0 108.284 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.21 -27.5 67.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.497 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.926 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -152.34 171.99 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 118.491 -1.284 . . . . 0.0 110.983 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -149.85 155.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.567 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -112.12 131.95 55.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.05 135.93 39.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.529 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -69.88 173.46 6.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.688 -0.632 . . . . 0.0 110.256 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.4 p -60.32 -30.53 69.57 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.555 -0.715 . . . . 0.0 109.992 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.69 ' CG ' HD13 ' A' ' 16' ' ' ILE . 7.7 tpm_? -60.07 -30.13 69.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 0.0 109.926 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.648 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.68 26.01 8.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.69 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -109.72 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.565 -0.962 . . . . 0.0 110.507 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -110.41 128.88 55.8 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t -126.59 134.83 50.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 111.728 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -140.07 163.99 31.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 93.5 t -124.92 124.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.468 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 77' ' ' VAL . 51.2 t -100.81 117.12 34.26 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.0 tt0 -90.75 137.56 32.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 111.282 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.695 ' HB3' HG11 ' A' ' 96' ' ' VAL . 31.8 p90 -131.29 180.0 5.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.85 123.57 18.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.707 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 98' ' ' LEU . 92.8 p -134.53 143.39 46.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.558 -0.714 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.13 144.24 29.59 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.296 1.156 . . . . 0.0 110.742 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.87 30.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 150.05 51.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.881 . . . . 0.0 109.92 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.77 154.75 37.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 110.41 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.5 p -92.62 10.46 30.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.603 -0.685 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' OE1' HG21 ' A' ' 51' ' ' THR . 13.1 mm-40 -132.19 84.92 2.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.279 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 34' ' ' VAL . 11.8 m -103.35 89.13 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 19.6 tpt85 -53.72 102.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.3 m -110.17 131.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.86 0.838 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 99.9 m -135.56 148.15 49.0 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.828 ' CG2' HD13 ' A' ' 79' ' ' LEU . 95.9 t -116.08 133.83 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.8 mt -121.35 170.18 9.87 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.231 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.2 ttt180 -123.21 119.91 31.6 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.607 ' HA ' HG22 ' A' ' 44' ' ' VAL . 46.2 tt0 -97.15 148.56 22.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 110.166 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.43 -175.66 3.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.848 -0.533 . . . . 0.0 110.055 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.74 -40.47 88.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.67 -0.643 . . . . 0.0 111.385 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.0 m -126.8 -21.55 4.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.19 -0.944 . . . . 0.0 112.57 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 98.1 mt-30 -131.96 163.98 27.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.06 -1.025 . . . . 0.0 111.775 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 39' ' ' GLN . 61.0 t -134.84 143.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.2 p -129.99 160.18 34.44 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.842 ' HA ' HD23 ' A' ' 37' ' ' LEU . 58.2 tt0 -80.15 157.31 26.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 109.876 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.75 -64.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.782 -0.574 . . . . 0.0 110.392 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.3 m -140.1 141.08 36.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.105 -0.997 . . . . 0.0 109.846 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -151.1 135.1 16.64 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.698 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.01 149.57 2.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.564 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -81.17 111.24 17.42 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.06 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.606 ' O ' HG22 ' A' ' 32' ' ' VAL . 23.3 t80 -74.92 112.99 11.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.769 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 2.0 mtp -82.63 161.54 22.17 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 35.6 mmt -61.04 -23.91 65.79 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.659 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.37 41.49 0.75 Allowed Glycine 0 N--CA 1.501 3.027 0 C-N-CA 119.042 -1.551 . . . . 0.0 112.658 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 79.6 m-20 -135.55 160.06 39.67 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 119.067 1.434 . . . . 0.0 110.241 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -89.12 135.63 33.46 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.492 -0.755 . . . . 0.0 110.283 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.677 HD22 ' N ' ' A' ' 58' ' ' LEU . 1.3 mm? -103.04 156.12 17.91 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.492 -0.755 . . . . 0.0 110.086 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 p -102.2 123.15 45.53 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.388 -0.82 . . . . 0.0 111.706 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 42.3 m-85 -114.12 30.5 7.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -53.72 -44.03 69.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.532 -0.73 . . . . 0.0 111.899 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -66.54 145.45 55.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.264 -0.897 . . . . 0.0 110.749 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 52.13 55.58 9.0 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.388 -0.82 . . . . 0.0 110.498 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 60.17 163.87 0.06 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.798 -0.564 . . . . 0.0 109.938 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -99.92 142.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.591 0.71 . . . . 0.0 111.229 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.4 m -121.99 153.77 38.11 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -132.63 150.08 52.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.95 -172.01 43.52 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.41 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 72' ' ' SER . 92.5 m -129.1 168.78 15.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.0 -0.706 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 71' ' ' THR . 70.1 m -159.98 127.39 4.59 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -155.83 155.93 33.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 110.344 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.76 -124.04 25.67 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -109.32 11.05 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.774 -0.839 . . . . 0.0 110.914 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.1 mt-30 -118.46 124.76 48.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 21' ' ' CYS . 4.0 m -107.17 124.01 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.924 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' THR . 46.6 t-20 -101.97 116.21 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.71 . . . . 0.0 111.077 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.828 HD13 ' CG2' ' A' ' 36' ' ' VAL . 96.6 mt -115.98 131.98 56.78 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.297 -0.877 . . . . 0.0 109.164 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.3 m -124.47 147.21 48.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.184 -0.948 . . . . 0.0 111.075 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.635 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -113.53 131.53 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.711 -0.618 . . . . 0.0 110.072 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG2' HG13 ' A' ' 16' ' ' ILE . 52.6 mt-30 -110.22 120.76 43.48 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.667 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.58 0.99 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -85.76 125.55 33.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.656 -0.908 . . . . 0.0 111.082 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -107.44 175.85 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.21 94.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.302 -0.873 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.1 ttm -62.14 -36.06 80.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.756 -0.59 . . . . 0.0 110.169 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -66.97 -26.92 67.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.647 . . . . 0.0 111.143 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.9 m -51.4 132.07 29.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.5 -143.96 8.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 113' ' ' THR . 10.6 tp -110.04 131.94 54.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.737 -0.861 . . . . 0.0 111.611 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.876 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.1 m-85 -113.28 132.03 55.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -107.97 129.36 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.728 -0.607 . . . . 0.0 112.144 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.076 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 20.1 p -79.88 161.99 25.27 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.3 tttt -152.34 77.49 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 23' ' ' TYR . 7.4 p -95.1 113.63 29.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 68.2 mt-10 -130.16 129.65 43.72 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.426 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.658 ' CD2' HD22 ' A' ' 106' ' ' LEU . 19.1 mt -76.99 76.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.4 tpp -80.63 -50.15 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.034 -0.667 . . . . 0.0 112.45 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 89.1 m-85 -68.6 -41.21 21.41 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 112.926 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 46.9 Cg_endo -86.25 109.44 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-O 117.875 -0.969 . . . . 0.0 111.098 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.3 Cg_endo -77.39 158.02 32.93 Favored 'Trans proline' 1 CA--C 1.609 4.236 0 CA-C-O 113.892 -2.628 . . . . 0.0 110.001 177.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 56.3 Cg_endo -88.54 -177.68 12.56 Favored 'Cis proline' 1 C--N 1.484 7.662 1 C-N-CA 93.031 -14.154 . . . . 0.0 114.475 -10.125 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 4.6 t80 -88.04 125.51 34.59 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-O 122.76 1.267 . . . . 0.0 109.888 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -149.7 74.42 1.22 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 120.943 -1.098 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.3 tp -142.48 -150.68 0.32 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.352 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.1 -173.04 34.99 Favored Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.902 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 94' ' ' CYS . 71.7 mt -110.96 149.18 13.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.847 -0.796 . . . . 0.0 109.938 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 1.076 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -74.53 144.14 32.47 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -60.07 -30.34 69.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.398 -1.06 . . . . 0.0 110.283 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.0 140.03 7.08 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.319 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.3 m -113.53 149.97 33.64 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.843 ' HB3' HG23 ' A' ' 8' ' ' VAL . 13.7 tp60 -89.87 137.29 32.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.876 HD12 ' CD1' ' A' ' 92' ' ' TYR . 56.4 mt -109.92 128.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.926 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.3 m-30 -101.95 139.86 37.02 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.646 0.736 . . . . 0.0 111.748 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 C--N 1.304 -1.399 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.287 0.565 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG12 ' OE1' ' A' ' 5' ' ' GLN . 74.8 t -129.69 131.47 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.564 -0.71 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 131.78 56.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.449 -0.782 . . . . 0.0 110.56 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.7 134.7 18.42 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.649 . . . . 0.0 110.475 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.48 136.57 24.01 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.11 1.058 . . . . 0.0 109.696 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.43 -32.95 64.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.484 -0.76 . . . . 0.0 109.666 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.0 157.35 6.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.992 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.8 t -139.72 153.36 23.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.45 0.643 . . . . 0.0 110.038 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.0 mt -110.83 124.1 51.38 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.71 140.77 46.24 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.496 -0.752 . . . . 0.0 110.724 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -91.61 -168.99 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.598 -0.689 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -49.98 159.04 0.45 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.48 -0.763 . . . . 0.0 110.529 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.817 ' HG3' HD11 ' A' ' 16' ' ' ILE . 40.8 tpt85 62.43 13.27 5.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.556 -0.715 . . . . 0.0 110.655 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.07 46.01 93.17 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' HG2' ' A' ' 82' ' ' GLN . 34.6 mm -104.92 106.7 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.729 -0.865 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.08 123.58 48.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.803 -0.56 . . . . 0.0 109.772 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -130.0 130.95 45.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.663 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.678 ' HB3' HG21 ' A' ' 9' ' ' VAL . 27.2 p90 -142.39 164.06 31.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.807 -0.558 . . . . 0.0 109.724 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 99.5 t -120.66 116.21 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.852 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.8 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -100.12 103.77 15.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 90.1 mt-10 -79.67 165.11 23.21 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 111.933 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.7 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.8 p90 -148.07 178.14 8.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 130.34 32.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.689 -0.632 . . . . 0.0 110.009 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -139.95 150.11 61.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.405 -0.809 . . . . 0.0 110.45 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 140.06 33.81 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.44 1.232 . . . . 0.0 110.299 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.65 -145.71 23.28 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -130.11 149.92 51.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.937 . . . . 0.0 110.141 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 147.69 45.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.617 -0.677 . . . . 0.0 109.926 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.142 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 32.8 p -79.97 -59.65 2.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.712 0.767 . . . . 0.0 111.679 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.0 mt-10 -80.99 80.52 7.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG11 ' OH ' ' A' ' 52' ' ' TYR . 97.0 t -88.5 96.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 51' ' ' THR . 55.6 ttt85 -70.53 124.25 23.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.572 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 50' ' ' ALA . 27.3 m -121.1 142.14 38.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 49' ' ' ALA . 88.8 m -135.32 142.35 45.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.726 -0.608 . . . . 0.0 110.625 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.897 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -112.77 131.23 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.0 mt -120.94 173.76 7.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 110.958 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.651 ' O ' HG13 ' A' ' 44' ' ' VAL . 39.5 ttm180 -122.42 121.28 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 44' ' ' VAL . 46.0 tt0 -97.9 148.65 23.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 111.151 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -132.15 168.65 17.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.47 -28.24 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 110.722 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -108.49 -53.14 2.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.474 -0.766 . . . . 0.0 112.153 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.747 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 63.3 mt-30 -136.64 170.01 16.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.12 -0.988 . . . . 0.0 111.997 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 39' ' ' GLN . 62.0 t -122.56 147.96 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -127.65 160.42 31.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.341 -0.849 . . . . 0.0 110.678 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.1 mt-10 -80.4 145.58 31.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 110.651 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -117.18 -75.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.305 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.922 ' SG ' ' HB3' ' A' ' 63' ' ' ASP . 70.2 m -139.83 149.15 43.11 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -153.88 145.48 23.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.488 -0.757 . . . . 0.0 111.294 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -165.28 148.02 8.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.618 -0.677 . . . . 0.0 109.714 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.568 HG21 ' HB3' ' A' ' 31' ' ' GLU . 6.2 m -98.42 130.19 45.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.685 ' OH ' HG11 ' A' ' 32' ' ' VAL . 52.1 p90 -102.09 133.44 46.93 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.521 -1.272 . . . . 0.0 110.631 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.477 ' HE1' ' HG2' ' A' ' 31' ' ' GLU . 6.6 mmt -78.41 168.17 20.21 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.142 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.96 90.03 0.17 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.673 -1.267 . . . . 0.0 109.2 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.39 -117.48 0.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -129.9 137.77 50.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.307 -1.113 . . . . 0.0 110.379 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 58' ' ' LEU . 17.6 tt0 -178.73 138.33 0.16 Allowed 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 70' ' ' GLY . 94.3 mt -142.14 87.72 2.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.435 ' N ' ' HB1' ' A' ' 50' ' ' ALA . 46.1 p -89.58 72.2 7.85 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.425 -0.797 . . . . 0.0 111.384 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.482 ' HE2' HD22 ' A' ' 58' ' ' LEU . 78.4 m-85 -89.89 109.76 20.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.36 -37.3 82.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.425 -0.797 . . . . 0.0 110.48 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -139.98 172.19 13.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.634 -0.666 . . . . 0.0 110.026 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.922 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 84.5 m-20 52.6 49.95 19.24 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -53.91 -21.11 7.1 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.659 -0.651 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.97 -20.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.264 -0.897 . . . . 0.0 110.627 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 30.7 m -86.07 137.78 32.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 110.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 80' ' ' THR . 9.0 t -129.95 131.01 45.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.705 ' CA ' HD23 ' A' ' 79' ' ' LEU . . . -125.63 116.8 2.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.2 m -103.87 159.0 16.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.726 -0.867 . . . . 0.0 108.673 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 63.0 m -148.15 129.97 15.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.969 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 122.04 25.88 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.04 -124.07 34.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.93 16.59 25.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.964 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 35.7 mt-30 -116.46 122.25 44.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.197 -0.939 . . . . 0.0 110.502 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 21' ' ' CYS . 1.9 m -103.74 122.2 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.866 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -104.21 109.96 21.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 0.0 111.462 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.897 HD13 HG22 ' A' ' 36' ' ' VAL . 53.1 mt -98.06 130.02 44.88 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 69' ' ' THR . 93.9 m -123.75 145.44 49.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.0 110.41 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 84' ' ' LEU . 95.5 mt -119.91 135.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.83 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.851 ' HG2' HD12 ' A' ' 16' ' ' ILE . 76.5 mt-30 -120.02 120.31 35.94 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.927 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.66 40.5 1.1 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 81' ' ' ILE . 80.8 mt -89.81 121.19 31.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.952 . . . . 0.0 111.464 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -103.32 179.66 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.85 93.91 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.926 0.869 . . . . 0.0 109.872 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.7 -34.66 78.34 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.331 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.54 -19.96 66.14 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.479 -0.763 . . . . 0.0 111.238 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 115' ' ' ILE . 30.0 m -50.65 136.88 20.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.84 -159.99 32.85 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.59 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 113' ' ' THR . 13.8 tp -110.2 130.05 55.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.7 -0.882 . . . . 0.0 111.961 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.699 ' CD2' HD12 ' A' ' 115' ' ' ILE . 83.9 m-85 -116.29 146.98 41.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -103.53 139.96 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.44 -0.788 . . . . 0.0 111.683 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.769 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.7 p -98.16 127.59 44.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 109' ' ' ILE . 4.6 tttm -120.39 141.72 49.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.741 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.8 t -138.05 108.85 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 99' ' ' MET . 5.9 mm-40 -134.4 128.26 33.24 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.841 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.79 HD23 HD13 ' A' ' 106' ' ' LEU 0.26 2.8 mm? -76.51 87.68 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.456 ' HE1' ' HB3' ' A' ' 97' ' ' GLU . 2.7 mmt -81.15 -58.45 3.06 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.498 -1.281 . . . . 0.0 111.687 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.6 m-85 -71.7 -40.45 8.4 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 48.6 Cg_endo -82.05 117.36 2.88 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.229 0.594 . . . . 0.0 110.658 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 73.0 Cg_endo -92.41 156.97 3.05 Favored 'Trans proline' 1 CA--C 1.701 8.859 0 CA-C-O 114.534 -2.361 . . . . 0.0 109.835 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 55.7 Cg_endo -87.65 178.62 19.91 Favored 'Cis proline' 2 C--N 1.46 6.408 1 C-N-CA 96.668 -12.638 . . . . 0.0 116.727 -8.039 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 13.3 t80 -85.93 119.68 26.5 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.043 2.09 . . . . 0.0 113.12 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 106' ' ' LEU . 25.7 t80 -162.16 107.74 1.25 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.272 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.79 HD13 HD23 ' A' ' 98' ' ' LEU . 1.4 tp -157.16 -143.49 0.11 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.921 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.73 178.55 35.77 Favored Glycine 0 N--CA 1.504 3.227 0 O-C-N 120.682 -1.261 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 95' ' ' LYS . 97.4 mt -126.17 160.82 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.987 . . . . 0.0 109.814 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.769 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 143.47 16.68 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -60.43 -36.08 77.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.479 -1.013 . . . . 0.0 110.271 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 131.56 158.4 9.1 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.017 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.553 ' C ' HD12 ' A' ' 91' ' ' LEU . 97.0 m -123.33 127.67 48.84 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 1.002 ' HB3' HG23 ' A' ' 8' ' ' VAL . 36.1 tp60 -73.64 137.12 43.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.699 HD12 ' CD2' ' A' ' 92' ' ' TYR . 75.4 mt -110.0 129.19 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.894 -1.129 . . . . 0.0 108.422 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.808 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.9 m-85 -110.15 142.67 41.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.874 -0.516 . . . . 0.0 111.044 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.055 0.455 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -135.78 132.48 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.68 131.09 57.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.581 -0.699 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.089 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 87.0 mm-40 -140.0 139.69 22.12 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.224 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.33 147.66 42.16 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.284 1.15 . . . . 0.0 109.835 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.5 -29.61 25.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.44 156.99 4.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.017 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.0 t -134.98 157.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 116' ' ' TYR . 66.1 mt -111.04 130.18 55.68 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.702 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.71 147.78 23.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.863 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -78.27 168.85 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.647 -0.658 . . . . 0.0 110.153 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -59.76 -37.91 80.35 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.446 -0.783 . . . . 0.0 109.969 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -57.46 -24.06 53.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.535 -0.728 . . . . 0.0 110.397 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.8 28.02 8.6 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.2 mp -103.63 101.67 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.56 124.35 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.0 p -136.37 150.03 48.62 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.922 ' HB3' HG21 ' A' ' 9' ' ' VAL . 22.2 p90 -154.62 161.48 41.57 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 79.8 t -118.79 117.69 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.499 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.089 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 53.6 t -100.1 107.42 19.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.51 144.95 29.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.911 . . . . 0.0 111.186 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CG ' HG11 ' A' ' 96' ' ' VAL . 50.0 p90 -131.64 -179.97 5.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.75 131.92 39.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.691 -0.631 . . . . 0.0 110.093 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.4 t -127.29 150.42 72.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.475 -0.766 . . . . 0.0 111.101 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.34 -14.77 37.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.735 1.387 . . . . 0.0 111.362 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.89 -165.43 16.79 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -110.1 132.16 54.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.97 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 153.76 39.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.1 p -80.03 -35.08 37.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.794 ' OE1' HG21 ' A' ' 51' ' ' THR . 42.7 mm-40 -79.89 97.07 6.55 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.3 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 34' ' ' VAL . 97.5 t -113.56 85.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 99' ' ' MET . 72.1 ttt-85 -61.25 116.19 4.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.114 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 32' ' ' VAL . 28.4 m -122.46 133.98 67.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.712 0.767 . . . . 0.0 110.157 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.483 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 61.3 m -120.06 123.98 44.75 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.086 0.469 . . . . 0.0 109.967 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.689 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -100.54 130.23 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 95' ' ' LYS . 71.2 mt -124.76 167.66 14.28 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.351 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.3 ttt180 -127.71 124.04 36.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.564 ' NE2' HD23 ' A' ' 91' ' ' LEU . 22.0 mt-30 -109.13 132.01 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.954 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -125.01 162.6 24.17 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.03 -42.98 95.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.2 m -70.09 -55.92 8.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.727 . . . . 0.0 110.694 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 58.7 mm-40 -150.42 -177.27 5.86 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.964 0.888 . . . . 0.0 111.399 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.8 136.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -134.27 161.6 34.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 37' ' ' LEU . 75.5 mt-10 -80.2 155.54 27.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 48' ' ' CYS . 96.3 t -118.77 -95.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.869 -0.519 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 47' ' ' VAL . 99.2 m -120.14 145.12 47.24 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.705 -1.247 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.76 138.57 14.28 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.38 -0.825 . . . . 0.0 111.796 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -175.4 157.06 2.1 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.794 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -80.1 119.88 23.49 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 72' ' ' SER . 19.6 t80 -80.83 109.98 15.91 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.445 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.16 146.06 33.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -15.81 63.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.07 -1.018 . . . . 0.0 110.661 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.83 -15.03 5.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -130.02 160.06 34.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -1.221 . . . . 0.0 110.911 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -123.2 125.2 44.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.506 -0.746 . . . . 0.0 110.052 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 51' ' ' THR . 79.8 mt -85.2 170.17 13.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.474 -0.766 . . . . 0.0 111.349 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -110.2 159.95 16.93 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.8 m-85 -99.93 132.08 45.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.492 -0.755 . . . . 0.0 109.696 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.87 -44.13 94.35 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -140.82 -165.76 2.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.028 -1.045 . . . . 0.0 111.995 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 56.0 57.15 5.32 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.221 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.3 m 56.61 167.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.322 0.582 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -91.39 84.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 110.018 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 59.7 m -68.08 151.39 47.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.1 t -132.62 149.96 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 109.336 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.1 176.49 39.33 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.9 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 94.3 m -131.96 166.41 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 122.005 -0.703 . . . . 0.0 109.721 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 34.7 t -151.16 80.32 1.31 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.706 -0.621 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -129.97 145.11 51.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.486 -0.759 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.01 37.75 87.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.5 m120 56.96 24.22 9.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.609 -0.936 . . . . 0.0 110.387 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -127.37 124.1 37.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.552 -0.717 . . . . 0.0 109.17 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -102.19 117.55 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.553 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 57.4 t-20 -99.76 104.77 16.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.322 -0.861 . . . . 0.0 111.156 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.689 HD13 ' CG2' ' A' ' 36' ' ' VAL . 75.1 mt -93.27 131.86 37.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 0.0 109.819 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.577 ' HB ' HG23 ' A' ' 69' ' ' THR . 58.9 m -121.89 139.93 53.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 84' ' ' LEU . 72.2 mt -120.02 138.82 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.711 . . . . 0.0 109.905 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.0 mt-30 -124.92 121.24 33.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.983 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.38 25.1 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 81' ' ' ILE . 75.7 mt -81.67 129.99 34.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -1.044 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 85' ' ' ARG . 22.9 mtp-105 -104.19 179.93 4.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.05 94.55 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.835 0.826 . . . . 0.0 109.614 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.9 mmt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -67.75 -16.93 64.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.761 . . . . 0.0 111.807 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.3 m -52.96 139.96 26.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 166.31 -164.96 37.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.564 HD23 ' NE2' ' A' ' 39' ' ' GLN . 18.0 tp -94.12 132.01 39.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.752 -0.852 . . . . 0.0 112.483 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.798 ' CD1' HD12 ' A' ' 115' ' ' ILE . 72.9 m-85 -118.39 134.58 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -99.95 139.91 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 111.762 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.859 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.8 p -108.07 107.98 18.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.712 ' HE3' HD12 ' A' ' 37' ' ' LEU . 17.1 mttt -105.17 141.39 36.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 109.202 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.6 ' O ' HD23 ' A' ' 106' ' ' LEU . 9.8 t -135.96 111.42 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.947 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 86.6 mt-10 -131.98 131.7 42.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.539 -0.725 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.717 ' CD2' HD22 ' A' ' 106' ' ' LEU . 11.2 mt -85.43 80.01 9.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 33' ' ' ARG . 2.5 ttm -80.65 -39.67 26.92 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.631 -173.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 68.6 m-85 -70.8 -45.7 16.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.401 -0.92 . . . . 0.0 112.773 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 71.9 Cg_endo -80.29 133.42 9.72 Favored 'Trans proline' 0 CA--C 1.597 3.648 0 O-C-N 122.877 0.935 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 86.0 Cg_endo -90.88 143.11 3.32 Favored 'Trans proline' 1 N--CA 1.54 4.207 1 CA-C-O 110.185 -4.173 . . . . 0.0 114.945 177.088 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.2 Cg_endo -110.7 57.07 0.77 Allowed 'Cis proline' 2 C--N 1.453 6.051 1 C-N-CA 97.123 -12.449 . . . . 0.0 110.505 11.41 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.469 ' O ' ' O ' ' A' ' 103' ' ' PRO . 5.1 t80 50.72 120.95 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.836 0 O-C-N 120.556 -1.34 . . . . 0.0 111.843 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -160.18 106.98 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.428 -2.045 . . . . 0.0 107.378 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD22 ' CD2' ' A' ' 98' ' ' LEU . 3.2 tp -159.41 -148.91 0.19 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.979 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.46 -176.38 30.44 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 ' HD3' ' A' ' 95' ' ' LYS . 76.8 mt -126.63 162.75 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.355 -1.086 . . . . 0.0 110.978 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.859 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 134.81 11.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -59.8 -35.89 75.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -1.17 . . . . 0.0 110.64 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 130.6 136.73 4.02 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.68 -1.248 . . . . 0.0 111.874 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.492 HG21 HG23 ' A' ' 9' ' ' VAL . 96.3 m -108.63 139.09 43.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.564 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.5 tt0 -89.56 120.2 30.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.207 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.798 HD12 ' CD1' ' A' ' 92' ' ' TYR . 97.0 mt -81.48 123.66 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.609 ' CE2' HG21 ' A' ' 8' ' ' VAL . 2.8 m-30 -94.93 161.66 14.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.633 0.73 . . . . 0.0 111.531 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.653 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.44 ' C ' HG23 ' A' ' 3' ' ' VAL . 77.8 m80 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.434 0.635 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.468 HG12 ' OE1' ' A' ' 5' ' ' GLN . 61.3 t -149.77 132.03 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -110.2 132.74 53.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.377 -0.827 . . . . 0.0 110.606 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.75 138.79 22.34 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.814 -0.554 . . . . 0.0 110.503 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.48 133.89 27.19 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.259 1.137 . . . . 0.0 109.535 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.49 76.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.994 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -149.16 155.96 7.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.118 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.6 t -137.62 155.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.989 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 116' ' ' TYR . 82.1 mt -116.01 132.72 56.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.07 131.76 35.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.384 -0.823 . . . . 0.0 110.974 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -60.64 172.73 0.85 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.62 -0.675 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -59.83 -35.94 75.77 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.577 -0.702 . . . . 0.0 110.088 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.762 ' CG ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -53.55 -24.95 15.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.97 24.97 13.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.762 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -112.6 111.64 37.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 84' ' ' LEU . . . -98.69 119.72 37.9 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.503 ' HB2' HG23 ' A' ' 80' ' ' THR . 46.4 t -122.31 131.1 53.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.21 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.725 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.2 p90 -139.92 164.03 31.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 77' ' ' VAL . 55.3 t -131.6 130.77 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.956 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' VAL . 29.5 t -112.84 110.75 21.05 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -82.06 151.73 26.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.723 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CD2' HG21 ' A' ' 96' ' ' VAL . 19.6 p90 -134.36 169.44 17.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.63 134.72 43.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.583 -0.698 . . . . 0.0 110.898 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 t -140.2 149.47 58.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.634 . . . . 0.0 110.651 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.67 -20.44 52.99 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.727 1.383 . . . . 0.0 111.54 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.02 165.91 25.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.61 133.54 55.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.573 -0.957 . . . . 0.0 110.548 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -131.93 163.0 29.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 109.536 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' MET . 25.6 p -80.1 -38.03 32.49 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.39 -0.818 . . . . 0.0 110.201 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 10.5 mm-40 -79.35 93.11 5.26 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.225 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 34' ' ' VAL . 96.4 t -109.76 102.6 14.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -82.83 106.37 14.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.343 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 34.0 m -106.04 141.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.487 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.0 m -132.0 156.88 45.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.728 0.775 . . . . 0.0 110.175 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 79' ' ' LEU . 98.4 t -125.57 136.24 61.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 46' ' ' GLU . 7.7 mt -131.92 160.1 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.058 -1.026 . . . . 0.0 111.216 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 47' ' ' VAL . 77.4 mtt180 -112.66 113.79 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.771 ' OE1' HD11 ' A' ' 93' ' ' ILE . 84.8 mt-30 -93.67 131.82 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.895 . . . . 0.0 110.818 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -130.9 158.69 39.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.65 85.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 110.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.7 p -73.71 -56.09 5.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.615 -0.678 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.663 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.6 mt-30 -154.15 171.99 18.28 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.302 -0.874 . . . . 0.0 111.353 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.8 t -122.35 142.11 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.0 p -128.22 160.16 32.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.206 -0.934 . . . . 0.0 111.603 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.87 ' HA ' HD23 ' A' ' 37' ' ' LEU . 59.1 mt-10 -80.25 162.04 24.83 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.67 -0.643 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 48' ' ' CYS . 38.7 t -130.25 -64.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.342 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.776 ' SG ' ' O ' ' A' ' 64' ' ' SER . 57.9 m -149.56 151.89 34.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.441 -0.787 . . . . 0.0 110.153 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -167.59 137.89 2.84 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.148 -0.97 . . . . 0.0 112.387 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -169.1 148.11 3.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.529 -0.732 . . . . 0.0 109.917 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.437 ' HG1' ' HE1' ' A' ' 100' ' ' TYR . 2.9 m -95.87 115.3 27.23 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.137 -0.977 . . . . 0.0 108.784 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 54' ' ' MET . 46.1 p90 -109.57 145.31 36.57 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.388 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 1.068 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -73.23 158.71 34.67 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.464 ' HE2' ' CD1' ' A' ' 52' ' ' TYR . 27.5 mmt -67.14 130.46 43.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.837 -1.164 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.5 30.46 18.84 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -149.26 175.61 11.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -1.124 . . . . 0.0 110.909 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -137.84 150.07 46.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.819 -0.551 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 51' ' ' THR . 80.1 mt -134.15 179.63 6.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.304 -0.873 . . . . 0.0 111.577 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.7 p -113.8 159.81 19.38 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.963 -0.461 . . . . 0.0 110.081 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 36.2 m-85 -110.2 123.38 49.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.63 -35.87 75.63 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.48 -0.762 . . . . 0.0 112.359 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -67.15 -147.75 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.241 -0.912 . . . . 0.0 111.187 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -46.57 -19.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.896 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.776 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 29.0 m 57.51 -132.62 1.32 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.654 -0.654 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.5 mt 56.56 22.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.77 -1.206 . . . . 0.0 110.27 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 64' ' ' SER . 20.7 m -137.36 155.18 49.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.413 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 9.9 t -120.31 140.06 51.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.43 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.58 96.1 1.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 m -123.79 156.03 36.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.538 -0.978 . . . . 0.0 109.024 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.2 p -156.52 160.24 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.177 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -140.36 107.92 5.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.15 32.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -93.69 9.71 35.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.454 -1.027 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.528 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 36.5 tt0 -111.7 136.07 51.44 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.239 -0.913 . . . . 0.0 110.226 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 20' ' ' VAL . 11.3 m -112.77 141.85 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.008 -1.058 . . . . 0.0 111.287 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' CG ' HG22 ' A' ' 20' ' ' VAL . 64.1 t-20 -112.76 118.01 33.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.769 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD13 HG22 ' A' ' 36' ' ' VAL . 90.4 mt -112.22 129.97 56.08 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.719 . . . . 0.0 109.376 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 18' ' ' SER . 81.8 m -130.65 154.52 47.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.272 -0.892 . . . . 0.0 110.808 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 91.0 mt -120.43 139.41 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.78 -0.575 . . . . 0.0 109.846 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 67' ' ' ILE . 40.2 mt-30 -119.48 123.22 43.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.143 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.57 56.84 0.76 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 17' ' ' ALA . 91.4 mt -80.85 126.03 30.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.792 -0.828 . . . . 0.0 111.805 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -105.93 170.14 8.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.22 90.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -65.64 -37.72 87.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.755 -0.591 . . . . 0.0 110.325 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.28 -36.47 75.61 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.619 -0.676 . . . . 0.0 111.228 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 115' ' ' ILE . 20.3 m -51.11 133.75 27.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.6 -143.69 9.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 112' ' ' GLY . 34.8 tp -109.23 123.71 49.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.733 -0.863 . . . . 0.0 111.709 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.767 ' CD1' HD12 ' A' ' 115' ' ' ILE . 53.7 m-85 -110.18 115.87 30.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.469 -0.769 . . . . 0.0 110.05 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.771 HD11 ' OE1' ' A' ' 39' ' ' GLN . 40.8 mm -78.21 133.51 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.6 -0.687 . . . . 0.0 111.984 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.3 p -85.47 149.82 25.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.2 tttt -147.31 127.93 14.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 108.495 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.704 HG21 ' CD2' ' A' ' 23' ' ' TYR . 2.4 p -134.95 113.11 15.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.614 0.721 . . . . 0.0 109.297 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 74.3 mm-40 -134.56 132.2 38.83 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.553 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.6 mm? -81.54 85.2 6.55 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 51.0 tpp -82.52 -46.92 12.77 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.779 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 59.0 m-85 -71.42 -42.98 11.9 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 49.1 Cg_endo -81.76 113.06 2.47 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 121.194 1.263 . . . . 0.0 112.576 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 50.5 Cg_endo -77.02 166.87 26.05 Favored 'Trans proline' 1 CA--C 1.642 5.913 0 CA-C-O 111.834 -3.486 . . . . 0.0 108.246 177.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.43 68.2 Cg_endo -81.95 -171.97 10.0 Favored 'Cis proline' 1 C--N 1.47 6.944 1 C-N-CA 98.741 -11.774 . . . . 0.0 116.704 -15.862 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.1 t80 -99.19 125.16 44.7 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 118.365 -2.709 . . . . 0.0 109.243 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.536 ' O ' HD22 ' A' ' 106' ' ' LEU . 22.5 p90 -169.42 108.1 0.42 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.005 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.553 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.91 -148.02 0.24 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.1 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.65 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -154.8 165.35 32.06 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.357 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -122.25 149.18 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' HA2' ' OE1' ' A' ' 5' ' ' GLN . . . -88.14 -177.68 47.46 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.84 21.33 17.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -1.19 . . . . 0.0 111.803 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.682 ' CA ' HD13 ' A' ' 93' ' ' ILE . . . 83.53 146.89 7.17 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-O 122.793 1.218 . . . . 0.0 114.074 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.593 HG21 HG23 ' A' ' 9' ' ' VAL . 57.7 m -116.16 128.88 56.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 8' ' ' VAL . 35.3 tp60 -68.36 136.59 53.6 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 118.354 -1.339 . . . . 0.0 107.86 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 92' ' ' TYR . 61.6 mt -113.67 125.1 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.957 -1.09 . . . . 0.0 108.635 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.819 ' CE2' HG21 ' A' ' 8' ' ' VAL . 24.8 m-85 -109.69 159.79 16.85 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 88.4 t . . . . . 0 N--CA 1.492 1.641 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.331 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.301 0.572 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 22' ' ' GLU . 95.4 t -102.06 134.97 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.773 -0.58 . . . . 0.0 110.114 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.36 54.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.508 -0.745 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.417 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.3 pt20 -157.57 156.05 28.15 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.572 -0.705 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.57 46.75 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.55 1.29 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.13 -23.66 23.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.582 -0.699 . . . . 0.0 109.731 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.2 156.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.567 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.711 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -136.86 156.8 35.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.86 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 116' ' ' TYR . 86.8 mt -114.61 127.77 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.629 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.93 165.14 18.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.456 -0.778 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 160.02 43.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.255 -0.903 . . . . 0.0 111.1 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t 55.5 -132.87 1.66 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.509 -0.745 . . . . 0.0 110.737 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 16' ' ' ILE . 6.1 ttt180 -52.02 -23.84 5.77 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.764 -1.21 . . . . 0.0 111.461 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.576 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 119.56 46.19 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.8 mp -103.78 113.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.93 0.872 . . . . 0.0 109.893 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -112.92 126.48 55.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.3 p -123.49 139.99 53.46 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.59 0.709 . . . . 0.0 110.902 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.711 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.7 p90 -150.15 162.24 40.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 71.9 t -125.29 121.03 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.713 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.864 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.04 103.72 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 3' ' ' VAL . 57.2 tt0 -80.04 142.43 34.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.817 . . . . 0.0 111.0 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.3 p90 -121.96 176.36 5.83 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.64 137.01 41.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.661 -0.649 . . . . 0.0 110.584 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 106' ' ' LEU . 95.4 p -142.95 152.91 59.88 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.649 -0.657 . . . . 0.0 110.43 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HG2' ' CE2' ' A' ' 105' ' ' TYR . 44.0 Cg_endo -69.23 -13.47 36.07 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.461 1.242 . . . . 0.0 110.929 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.13 -179.84 33.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -117.98 140.08 50.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -1.035 . . . . 0.0 110.602 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.54 172.27 13.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.0 109.486 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 p -80.06 -46.55 16.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.638 ' OE1' HG21 ' A' ' 51' ' ' THR . 5.3 mm-40 -80.09 109.96 15.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.795 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 34' ' ' VAL . 96.7 t -119.83 82.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -60.22 103.58 0.24 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.739 HG23 ' HZ ' ' A' ' 60' ' ' PHE . 27.2 m -114.44 143.66 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.325 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 49' ' ' ALA . 69.1 m -140.03 132.9 29.22 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.217 0.532 . . . . 0.0 111.04 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -98.99 130.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -119.97 160.01 23.59 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.749 -1.219 . . . . 0.0 111.735 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -117.03 129.68 56.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.406 ' HG3' ' CG2' ' A' ' 44' ' ' VAL . 15.8 tt0 -106.81 149.31 27.51 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.712 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.62 -172.6 2.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.858 -0.526 . . . . 0.0 109.761 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.18 -44.4 95.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.502 -0.749 . . . . 0.0 111.138 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.1 m -132.73 -13.74 2.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.295 -0.878 . . . . 0.0 112.294 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.746 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 tt0 -122.88 142.7 50.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 111.168 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 39' ' ' GLN . 50.7 t -132.03 133.81 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -131.17 165.84 22.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HA ' HD23 ' A' ' 37' ' ' LEU . 64.3 mt-10 -79.98 149.91 30.63 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.441 0.638 . . . . 0.0 110.55 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.314 HG12 ' SG ' ' A' ' 68' ' ' CYS . 95.4 t -112.33 -67.99 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 63' ' ' ASP . 57.0 m -133.34 150.08 51.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.547 -0.721 . . . . 0.0 109.526 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.853 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -166.87 135.27 2.71 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.378 -0.929 . . . . 0.0 112.007 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.02 157.54 4.4 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.638 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -85.69 124.81 32.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 72' ' ' SER . 28.7 t80 -87.82 110.41 20.48 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.592 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.425 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 2.2 mmt -80.04 165.58 22.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 54' ' ' MET . 31.2 mmt -59.54 -30.34 68.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.6 -1.312 . . . . 0.0 109.604 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.16 -139.75 7.9 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.68 133.75 55.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -1.154 . . . . 0.0 110.668 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 178.02 159.22 0.48 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 38.3 mt 51.04 78.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.977 . . . . 0.0 111.308 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -96.79 163.26 13.06 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.728 -0.608 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.739 ' HZ ' HG23 ' A' ' 34' ' ' VAL . 8.6 m-30 -90.53 10.01 27.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.565 -0.709 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.71 -30.21 68.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.273 -0.892 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.07 -28.55 62.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.396 -0.815 . . . . 0.0 111.019 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.724 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 26.3 m-20 -84.11 -6.58 59.43 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 122.082 -0.386 . . . . 0.0 111.667 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p 42.25 28.5 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.8 mt -137.04 -47.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.306 -0.871 . . . . 0.0 110.79 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.314 ' SG ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -118.76 131.41 56.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 0.0 111.486 -179.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -139.85 147.49 40.75 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.99 -171.74 37.26 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.275 -1.441 . . . . 0.0 111.16 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 72' ' ' SER . 59.9 m -130.08 169.6 15.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 122.019 -0.695 . . . . 0.0 109.821 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 71' ' ' THR . 31.0 t -134.74 130.02 35.56 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -135.07 129.95 34.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 50.61 -122.84 14.09 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 27.4 m120 -100.03 12.07 37.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.759 -0.847 . . . . 0.0 110.46 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -116.27 128.49 55.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 109.853 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 21' ' ' CYS . 16.7 m -105.42 118.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.399 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.31 110.05 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 111.112 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 HG22 ' A' ' 36' ' ' VAL . 77.4 mt -111.08 131.96 54.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -131.26 144.08 51.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -124.02 140.02 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.502 -0.749 . . . . 0.0 110.481 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 16' ' ' ILE . 30.4 mt-30 -120.34 122.56 41.06 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.402 0.62 . . . . 0.0 109.589 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.92 37.75 1.65 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 94.9 mt -80.12 85.72 5.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.893 . . . . 0.0 110.77 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.96 168.38 20.14 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -41.73 67.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.234 -0.917 . . . . 0.0 109.732 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.76 -36.07 79.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.393 0.616 . . . . 0.0 109.78 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.25 -23.48 67.07 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 110.859 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 115' ' ' ILE . 50.7 m -53.43 139.98 29.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.23 -146.8 10.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.004 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.6 tm? -107.33 134.93 49.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.859 -0.789 . . . . 0.0 110.752 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.813 ' N ' HD13 ' A' ' 91' ' ' LEU . 57.2 m-85 -121.1 125.07 46.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.744 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -98.75 123.97 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.396 -0.815 . . . . 0.0 112.578 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.9 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.6 p -85.11 111.29 19.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HB3' ' H ' ' A' ' 35' ' ' THR . 7.8 tttt -103.56 139.99 38.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.536 -0.727 . . . . 0.0 109.076 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' HD23 ' A' ' 106' ' ' LEU . 21.2 t -140.13 105.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.41 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.937 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 36.8 mt-10 -131.93 130.69 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.238 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.728 ' HG ' HD22 ' A' ' 106' ' ' LEU . 13.5 mt -84.62 78.84 9.77 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.937 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -80.03 -41.67 25.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.195 -0.941 . . . . 0.0 113.016 -174.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.475 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 62.8 m-85 -65.17 -46.84 72.83 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.884 -1.135 . . . . 0.0 113.145 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 61.3 Cg_endo -77.0 110.1 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.204 1.107 . . . . 0.0 111.349 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 44.6 Cg_endo -89.24 145.92 5.18 Favored 'Trans proline' 0 CA--C 1.598 3.724 0 CA-C-O 110.666 -3.972 . . . . 0.0 110.432 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 37.6 Cg_endo -88.3 -168.37 4.44 Favored 'Cis proline' 2 N--CA 1.629 9.478 2 C-N-CA 92.29 -14.463 . . . . 0.0 111.927 -0.064 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -88.17 137.79 32.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.644 -1.285 . . . . 0.0 113.975 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 12.4 p90 -153.59 92.71 1.6 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.496 -0.752 . . . . 0.0 111.905 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.6 tp -160.13 -149.67 0.2 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.616 -0.678 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.695 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.02 176.35 40.03 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.339 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.0 mp -117.55 158.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.718 -0.872 . . . . 0.0 109.338 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.9 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -87.45 146.82 20.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -59.68 -37.31 78.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.439 -1.036 . . . . 0.0 110.135 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 121.4 129.96 3.74 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.101 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.706 HG21 HG23 ' A' ' 9' ' ' VAL . 94.8 m -94.63 129.98 41.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.987 -0.713 . . . . 0.0 109.089 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.774 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 tp60 -79.87 132.01 36.0 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 89' ' ' THR . 81.3 mt -98.85 125.06 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.865 -1.147 . . . . 0.0 108.767 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.888 ' CE2' HG21 ' A' ' 8' ' ' VAL . 11.9 m-30 -103.44 151.21 23.08 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.108 0.48 . . . . 0.0 111.122 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.516 HG23 ' OG1' ' A' ' 89' ' ' THR . 95.8 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.459 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.144 0.497 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 97.6 t -149.25 147.73 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 109.679 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.71 130.6 55.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.443 -0.785 . . . . 0.0 110.607 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.591 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 13.1 mm100 -143.5 139.97 17.0 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.668 -0.645 . . . . 0.0 111.49 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.63 139.92 38.29 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.82 66.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.909 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.03 162.41 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.679 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG23 HG21 ' A' ' 113' ' ' THR . 8.9 t -141.94 153.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -107.91 129.78 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 143.98 25.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.483 -0.761 . . . . 0.0 110.624 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -75.87 170.05 16.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.655 -0.653 . . . . 0.0 110.13 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -60.14 -34.63 73.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.712 . . . . 0.0 110.124 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.444 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 5.6 ttt180 -60.17 -26.63 66.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.0 110.034 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.93 30.67 6.63 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.1 mp -105.3 103.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.646 -0.914 . . . . 0.0 109.32 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.85 124.07 50.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.763 ' HB3' HG23 ' A' ' 80' ' ' THR . 92.9 p -136.26 149.83 48.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.738 0.78 . . . . 0.0 111.243 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -155.95 164.1 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 89.1 t -126.66 123.98 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.596 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' VAL . 36.8 t -102.89 108.07 19.14 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.895 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 17.1 pt-20 -79.79 160.03 26.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 111.296 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.96 179.89 6.35 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.68 125.76 29.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.702 . . . . 0.0 110.961 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -149.73 158.81 37.11 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.653 . . . . 0.0 109.966 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.81 124.91 11.52 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.354 1.186 . . . . 0.0 110.168 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.98 -131.38 52.02 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -126.03 143.31 51.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.617 -0.931 . . . . 0.0 109.956 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.18 145.17 42.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 110.04 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 2.7 p -80.9 -59.74 2.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 112.067 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 51' ' ' THR . 9.8 mm-40 -84.27 75.82 10.17 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.279 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 34' ' ' VAL . 15.4 m -85.78 87.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.613 ' N ' HG23 ' A' ' 51' ' ' THR . 7.2 ttp85 -55.97 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.53 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.6 m -103.56 129.59 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.819 0.819 . . . . 0.0 111.046 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.5 m -131.45 145.83 51.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.611 -0.68 . . . . 0.0 109.655 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.883 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.5 t -114.04 132.39 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.821 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.25 167.16 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.979 -1.076 . . . . 0.0 111.293 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.9 ttt-85 -127.61 120.86 29.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HA ' HG22 ' A' ' 44' ' ' VAL . 80.4 mt-30 -105.9 130.28 53.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.395 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -126.78 156.12 41.73 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.24 -43.62 95.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.443 -0.786 . . . . 0.0 110.644 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -68.33 -49.95 56.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.549 -0.719 . . . . 0.0 111.145 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 71.2 mt-30 -155.47 164.02 39.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.382 -0.824 . . . . 0.0 111.084 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.9 t -124.77 137.27 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -139.96 166.11 25.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.494 -0.754 . . . . 0.0 110.959 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.821 ' HA ' HD23 ' A' ' 37' ' ' LEU . 62.5 tt0 -79.99 157.42 26.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 109.47 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 38' ' ' ARG . 97.3 t -121.03 -72.17 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.843 -0.536 . . . . 0.0 110.445 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 47' ' ' VAL . 81.0 m -129.95 148.08 51.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.339 -0.85 . . . . 0.0 109.411 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -155.95 136.47 13.24 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.17 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -173.84 149.58 1.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.587 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 ' N ' ' A' ' 33' ' ' ARG . 3.2 m -94.33 119.94 33.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.214 -0.928 . . . . 0.0 109.278 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 53' ' ' MET . 25.6 t80 -77.91 116.7 18.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.077 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -84.23 169.93 14.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.5 mmt -65.44 -28.26 69.1 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.687 -1.258 . . . . 0.0 111.27 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.76 44.3 0.83 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.218 -1.468 . . . . 0.0 112.361 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 74.1 m-20 -132.73 162.14 32.21 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 118.867 1.333 . . . . 0.0 110.158 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' HD22 ' A' ' 58' ' ' LEU . 59.0 tt0 -104.68 126.54 51.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.561 -0.712 . . . . 0.0 110.13 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.804 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mm? -98.29 139.98 33.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.009 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.6 p -100.18 142.87 31.07 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.676 -0.64 . . . . 0.0 110.581 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 96.0 m-85 -103.72 133.64 48.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.51 -0.743 . . . . 0.0 109.25 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.83 -44.27 94.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.516 -0.74 . . . . 0.0 112.762 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -168.39 -149.45 0.09 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.909 -1.119 . . . . 0.0 111.21 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 47' ' ' VAL . 76.8 m-20 59.01 54.27 5.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.462 -0.774 . . . . 0.0 110.242 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p 65.47 9.72 6.02 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.899 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.0 mt 48.27 68.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.16 -0.962 . . . . 0.0 111.354 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.413 ' O ' ' CE1' ' A' ' 60' ' ' PHE . 11.5 m -59.89 133.41 56.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 80' ' ' THR . 9.1 t -80.08 128.93 34.09 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.286 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.68 ' HA2' HD23 ' A' ' 79' ' ' LEU . . . -106.68 107.69 2.75 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.48 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -113.8 149.69 34.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.737 -0.861 . . . . 0.0 108.943 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 69.3 m -150.71 131.42 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -139.98 138.53 35.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.664 -0.648 . . . . 0.0 109.265 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.54 -123.92 33.31 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -108.92 16.68 22.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.905 . . . . 0.0 110.544 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 36.8 mt-30 -121.8 128.8 52.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.218 -0.926 . . . . 0.0 111.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -100.5 128.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.133 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 20' ' ' VAL . 51.0 t-20 -108.02 118.12 35.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' CG2' ' A' ' 36' ' ' VAL . 86.7 mt -112.13 129.96 56.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.525 -0.734 . . . . 0.0 109.541 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.763 HG23 ' HB3' ' A' ' 18' ' ' SER . 61.3 m -125.89 138.98 53.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.296 -0.878 . . . . 0.0 110.641 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.705 HG21 HD21 ' A' ' 84' ' ' LEU . 72.9 mt -113.7 139.74 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.734 -0.604 . . . . 0.0 110.273 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.431 ' HG2' HG13 ' A' ' 16' ' ' ILE . 63.3 mt-30 -124.81 121.98 36.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.259 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.61 36.99 1.49 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.705 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -92.81 121.09 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.986 . . . . 0.0 111.33 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' O ' HG21 ' A' ' 117' ' ' VAL . 73.4 mmt-85 -98.02 176.96 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.08 84.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 16.9 tpt -67.89 -34.54 76.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.514 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -67.53 -16.34 64.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.665 -0.647 . . . . 0.0 111.465 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 115' ' ' ILE . 22.8 m -50.36 135.5 21.81 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.213 -0.929 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.55 -159.43 24.02 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.871 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 113' ' ' THR . 15.6 tp -109.55 128.65 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.676 -0.897 . . . . 0.0 111.531 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 62.1 m-85 -109.94 139.94 44.48 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -115.31 130.22 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.608 -0.683 . . . . 0.0 111.881 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.114 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.8 p -80.1 146.87 31.66 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 6.8 tttt -142.55 77.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.776 HG22 HD23 ' A' ' 106' ' ' LEU . 3.6 p -98.84 113.99 35.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.783 0.801 . . . . 0.0 110.482 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.661 ' OE2' HD11 ' A' ' 109' ' ' ILE . 54.9 mt-10 -128.19 129.14 46.02 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.721 -0.612 . . . . 0.0 110.63 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 106' ' ' LEU . 67.4 mt -77.64 76.16 4.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.6 tpp -81.8 -44.21 17.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.431 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 90.3 m-85 -70.19 -42.1 15.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.405 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 58.7 Cg_endo -87.51 111.76 0.81 Allowed 'Trans proline' 0 CA--C 1.561 1.868 0 CA-C-O 117.362 -1.183 . . . . 0.0 111.324 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.591 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 76.0 Cg_endo -85.23 155.15 10.95 Favored 'Trans proline' 0 CA--C 1.597 3.629 0 CA-C-O 111.592 -3.587 . . . . 0.0 110.249 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.591 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.286 48.0 Cg_endo -86.46 -178.99 17.33 Favored 'Cis proline' 2 C--N 1.5 8.512 1 C-N-CA 91.179 -14.925 . . . . 0.0 115.914 -5.951 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.28 128.43 34.69 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.399 -1.438 . . . . 0.0 110.33 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -145.09 69.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.385 0.612 . . . . 0.0 111.552 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.776 HD23 HG22 ' A' ' 96' ' ' VAL . 3.5 tp -144.9 -154.87 0.56 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -167.74 -171.22 33.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.063 -1.541 . . . . 0.0 111.838 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.2 mp -115.15 150.03 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.7 -0.882 . . . . 0.0 109.639 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 1.114 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -79.91 148.65 30.45 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -59.82 -38.63 82.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.351 -1.087 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 125.42 148.5 7.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.549 HG21 HG23 ' A' ' 9' ' ' VAL . 98.8 m -119.79 134.57 55.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.813 ' HB3' HG23 ' A' ' 8' ' ' VAL . 38.3 tp60 -80.38 129.51 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 75.5 mt -98.2 120.82 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.0 108.537 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 8' ' ' VAL . 9.5 m-30 -97.02 132.36 42.9 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.095 0.474 . . . . 0.0 111.414 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 85' ' ' ARG . 96.4 t . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.073 0.463 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.48 HG12 ' OE1' ' A' ' 5' ' ' GLN . 66.5 t -129.89 126.04 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.609 -0.682 . . . . 0.0 109.607 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 130.81 56.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.506 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' OE1' HG12 ' A' ' 3' ' ' VAL . 2.7 mp0 -135.02 131.29 19.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 110.601 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.78 136.03 24.69 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.064 1.034 . . . . 0.0 109.515 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.1 -28.78 57.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.813 . . . . 0.0 110.209 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.97 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -153.01 163.01 2.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.045 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.4 t -138.51 151.63 24.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.57 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 116' ' ' TYR . 85.9 mt -119.19 121.26 39.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.603 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 140.08 45.53 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -110.12 -69.38 0.87 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.226 -0.921 . . . . 0.0 112.647 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 m -120.03 151.32 39.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.241 -0.912 . . . . 0.0 111.075 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HG2' HD11 ' A' ' 16' ' ' ILE . 4.0 tpt180 56.9 18.8 4.09 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.606 -0.684 . . . . 0.0 110.577 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.64 44.02 53.91 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.618 HD11 ' HG2' ' A' ' 14' ' ' ARG . 21.6 mm -110.25 108.97 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 121.606 -0.938 . . . . 0.0 108.941 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -101.79 126.11 48.59 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.793 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' HG23 ' A' ' 80' ' ' THR . 38.3 t -133.17 135.0 44.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' VAL . 26.7 p90 -146.23 161.33 40.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.77 -0.581 . . . . 0.0 109.796 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 96.1 t -117.72 119.06 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.225 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.881 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.18 103.18 14.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 85.1 mt-10 -80.4 164.3 23.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 111.789 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.662 ' CG ' HG11 ' A' ' 96' ' ' VAL . 44.0 p90 -147.9 178.46 8.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.489 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.59 27.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.636 . . . . 0.0 109.891 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -131.44 147.82 67.65 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 0.0 110.585 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.44 142.53 26.69 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.379 1.199 . . . . 0.0 110.372 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.61 -150.34 38.62 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.07 140.91 50.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.924 . . . . 0.0 110.21 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.81 144.82 31.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.273 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 1.149 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 82.7 p -78.6 -46.83 18.42 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.952 0.882 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.686 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.2 mm-40 -79.04 112.56 16.37 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.538 0.685 . . . . 0.0 112.847 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.684 HG11 ' OH ' ' A' ' 52' ' ' TYR . 94.2 t -124.04 96.09 3.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 99' ' ' MET . 24.0 ttt180 -77.89 124.03 27.5 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 0.0 111.184 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 28.3 m -121.75 141.81 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.58 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.5 m -129.92 130.1 44.7 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.238 0.542 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD13 ' A' ' 79' ' ' LEU . 95.6 t -103.77 132.02 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 46' ' ' GLU . 18.7 mt -127.34 169.03 14.0 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.185 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HG3' HG21 ' A' ' 47' ' ' VAL . 87.7 mtm180 -122.1 115.66 22.85 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.791 ' HA ' HG22 ' A' ' 44' ' ' VAL . 44.3 tt0 -83.95 150.37 25.71 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.733 0.778 . . . . 0.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.86 -162.05 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.18 -46.15 90.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.444 -0.785 . . . . 0.0 110.392 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.1 p -134.77 -3.88 2.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.473 -0.767 . . . . 0.0 112.031 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.5 mt-30 -137.32 161.52 36.05 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.007 -1.058 . . . . 0.0 111.133 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 39' ' ' GLN . 94.0 t -125.17 156.0 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.1 p -124.13 157.67 34.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.386 -0.822 . . . . 0.0 110.628 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.806 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.2 mt-10 -87.31 143.18 27.38 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.608 0.718 . . . . 0.0 111.017 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -116.3 -71.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.932 -0.48 . . . . 0.0 109.98 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HG12 ' A' ' 47' ' ' VAL . 30.8 m -140.06 153.38 46.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.381 -0.824 . . . . 0.0 110.589 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 135.27 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.492 -0.755 . . . . 0.0 110.912 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.844 ' HB3' ' C ' ' A' ' 59' ' ' THR . . . -171.15 155.96 4.57 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.424 -0.797 . . . . 0.0 110.212 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.6 m -102.17 131.04 48.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.684 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.4 p90 -110.05 141.12 43.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.669 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.977 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -77.0 164.1 26.08 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.149 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -71.29 79.96 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.904 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.05 -134.27 2.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -99.16 135.67 40.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.293 -1.122 . . . . 0.0 110.573 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -177.08 174.94 1.62 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.07 137.76 46.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.107 -0.996 . . . . 0.0 110.055 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.844 ' C ' ' HB3' ' A' ' 50' ' ' ALA . 73.4 p -90.77 8.27 35.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.976 -0.452 . . . . 0.0 110.046 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 59' ' ' THR . 13.5 m-85 -131.59 113.54 13.76 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.57 -35.91 81.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.537 -0.727 . . . . 0.0 109.521 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -141.16 -169.92 2.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.792 -0.567 . . . . 0.0 109.684 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.695 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 81.6 m-20 54.33 58.15 5.22 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.344 -0.848 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 t -49.26 -21.53 0.84 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.749 -0.595 . . . . 0.0 112.013 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -49.1 -26.72 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 63' ' ' ASP . 4.2 p -95.57 129.62 42.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -0.764 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -139.08 148.41 43.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.787 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.92 -173.77 38.94 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 72' ' ' SER . 94.5 m -130.12 163.92 25.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.951 -0.734 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 62.8 m -148.08 127.16 12.84 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -155.93 140.0 16.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 110.589 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.86 -124.19 33.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -107.76 16.14 23.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.741 -0.858 . . . . 0.0 110.824 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.423 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.5 mt-30 -119.83 120.09 35.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.209 -0.932 . . . . 0.0 110.958 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -103.96 124.33 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -103.0 111.25 23.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 111.946 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.768 HD13 HG22 ' A' ' 36' ' ' VAL . 81.1 mt -100.52 135.87 41.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.297 -0.877 . . . . 0.0 109.011 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 18' ' ' SER . 94.1 m -135.81 144.5 45.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.313 -0.867 . . . . 0.0 110.812 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.821 HG21 HD21 ' A' ' 84' ' ' LEU . 91.1 mt -119.12 131.45 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 96.9 mt-30 -113.78 119.42 37.29 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.155 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.07 47.85 0.86 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.821 HD21 HG21 ' A' ' 81' ' ' ILE . 80.2 mt -89.11 129.82 35.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.958 . . . . 0.0 111.755 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -119.21 179.99 4.01 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.88 82.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.188 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -65.4 -32.93 74.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.982 -0.449 . . . . 0.0 111.74 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.23 -20.02 64.78 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.345 -0.847 . . . . 0.0 111.4 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 115' ' ' ILE . 26.4 m -51.79 136.46 27.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.61 29.93 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.631 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.571 HD11 ' C ' ' A' ' 112' ' ' GLY . 58.4 tp -109.9 133.12 53.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.912 . . . . 0.0 111.775 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD2' HD12 ' A' ' 115' ' ' ILE . 46.8 m-85 -116.5 128.79 55.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.3 mp -95.37 127.02 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.612 -0.68 . . . . 0.0 112.112 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.064 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 29.9 p -93.13 112.25 24.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.867 ' HD3' HD12 ' A' ' 109' ' ' ILE . 5.6 mttt -105.55 146.62 29.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.662 HG11 ' CG ' ' A' ' 23' ' ' TYR . 21.9 t -141.75 106.3 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.54 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.688 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 85.9 mt-10 -132.69 127.4 34.74 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.057 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.539 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.7 mm? -77.53 83.73 3.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 5.0 mmm -80.58 -51.3 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.578 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 78.0 m-85 -66.29 -41.25 41.14 Favored Pre-proline 0 N--CA 1.503 2.195 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 56.4 Cg_endo -86.48 114.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.442 1.233 . . . . 0.0 111.927 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.752 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 90.3 Cg_endo -91.96 151.38 3.28 Favored 'Trans proline' 2 CA--C 1.675 7.545 0 CA-C-O 113.269 -2.888 . . . . 0.0 112.679 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.752 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 22.3 Cg_endo -84.95 177.39 27.9 Favored 'Cis proline' 1 N--CA 1.579 6.526 1 C-N-CA 92.828 -14.238 . . . . 0.0 114.271 -1.203 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -85.53 128.06 34.63 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.475 ' O ' HD22 ' A' ' 106' ' ' LEU . 43.2 t80 -160.21 111.19 1.9 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.522 -1.361 . . . . 0.0 109.708 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.539 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.15 -144.67 0.14 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.693 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.98 175.82 31.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.867 HD12 ' HD3' ' A' ' 95' ' ' LYS . 48.9 mm -124.24 165.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.367 -1.078 . . . . 0.0 109.79 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 1.064 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -96.12 139.33 14.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -60.09 -26.25 66.05 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.633 -0.922 . . . . 0.0 110.558 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.571 ' C ' HD11 ' A' ' 91' ' ' LEU . . . 110.89 135.65 6.93 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 9' ' ' VAL . 94.0 m -107.63 129.82 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.888 -0.772 . . . . 0.0 109.993 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.97 ' HB3' HG23 ' A' ' 8' ' ' VAL . 37.0 tp60 -79.05 146.46 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.709 ' O ' HG23 ' A' ' 89' ' ' THR . 40.9 mt -117.46 129.91 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.848 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -109.95 140.21 44.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.689 -0.632 . . . . 0.0 111.3 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.42 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.448 ' C ' HG23 ' A' ' 3' ' ' VAL . 97.9 m-70 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.132 0.492 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.834 HG11 ' HA2' ' A' ' 110' ' ' GLY . 90.9 t -147.69 151.29 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.618 -0.676 . . . . 0.0 109.604 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.881 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -130.55 133.86 46.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.449 -0.782 . . . . 0.0 111.562 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.122 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 49.1 mt-30 -150.69 149.92 27.01 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.597 . . . . 0.0 111.141 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.91 139.99 37.41 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 N-CA-C 108.337 -1.447 . . . . 0.0 108.337 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.47 66.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.271 -0.893 . . . . 0.0 110.891 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.873 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.93 166.61 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.931 ' HB ' HD13 ' A' ' 115' ' ' ILE . 25.7 t -138.1 154.72 28.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.319 0.581 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.24 130.04 55.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.24 132.69 46.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.733 . . . . 0.0 110.789 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.07 175.5 4.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.786 -0.571 . . . . 0.0 109.527 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -60.18 -35.23 74.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.582 ' CG ' HD13 ' A' ' 16' ' ' ILE . 22.7 tpt180 -60.37 -32.63 71.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.6 -0.687 . . . . 0.0 110.163 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.05 33.92 5.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.582 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.3 mp -105.34 101.78 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.921 . . . . 0.0 109.247 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.852 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -107.39 122.98 47.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.6 t -131.92 131.72 42.93 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.381 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HD11 ' A' ' 115' ' ' ILE . 34.8 p90 -144.42 159.99 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 92.1 t -116.73 125.47 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.699 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.819 ' O ' HG22 ' A' ' 77' ' ' VAL . 49.6 t -107.02 105.81 16.01 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.881 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 16.7 pt-20 -80.22 152.15 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.05 . . . . 0.0 111.098 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -139.94 178.86 6.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.47 127.79 38.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.664 -0.648 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 106' ' ' LEU . 97.9 p -139.86 148.68 56.28 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.548 -0.72 . . . . 0.0 110.206 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.88 140.03 28.26 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.392 1.207 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.54 -156.92 8.83 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -129.97 149.93 51.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.938 . . . . 0.0 110.127 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 155.48 40.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.526 -0.734 . . . . 0.0 109.98 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 70.7 p -80.46 -43.17 21.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.456 -0.777 . . . . 0.0 110.513 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG21 ' A' ' 51' ' ' THR . 33.2 mm-40 -80.4 114.4 19.27 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.597 0.713 . . . . 0.0 112.334 -176.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.634 ' CG1' HG23 ' A' ' 96' ' ' VAL . 93.3 t -128.48 87.2 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 52.6 ttt85 -58.67 110.99 1.11 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.389 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.1 m -113.91 127.59 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.628 0.728 . . . . 0.0 110.178 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 93.2 m -128.75 140.45 51.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.713 -0.617 . . . . 0.0 109.574 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD13 ' A' ' 79' ' ' LEU . 96.7 t -109.79 136.94 44.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.9 mt -122.94 159.94 27.22 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.853 -1.154 . . . . 0.0 111.31 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -120.85 118.09 29.07 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' HG22 ' A' ' 44' ' ' VAL . 28.8 mt-30 -99.93 132.64 45.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.435 -0.791 . . . . 0.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.42 161.82 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.69 -41.31 90.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.503 -0.748 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 m -70.58 -57.19 4.99 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 110.83 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 mt-30 -154.29 169.57 23.36 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.4 -0.813 . . . . 0.0 110.734 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 39' ' ' GLN . 80.9 t -117.35 137.53 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.655 -0.653 . . . . 0.0 109.28 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.2 p -132.55 162.4 31.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.472 -0.767 . . . . 0.0 110.89 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.82 ' HA ' HD23 ' A' ' 37' ' ' LEU . 36.9 tt0 -80.02 158.1 26.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.582 -0.699 . . . . 0.0 109.937 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 93.8 t -119.38 -82.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.675 ' SG ' ' O ' ' A' ' 64' ' ' SER . 92.8 m -120.15 154.09 35.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.909 -1.119 . . . . 0.0 109.978 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -161.23 132.89 5.61 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.397 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.38 159.67 4.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.659 ' O ' HD13 ' A' ' 58' ' ' LEU . 3.0 m -93.4 110.2 21.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 109.869 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 23.7 t80 -72.67 124.44 25.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.384 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 1.4 mmt -86.07 144.51 27.51 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.431 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 34.1 mmt -59.79 -28.09 67.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.82 -22.59 9.31 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.694 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -129.9 158.21 40.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.177 -1.19 . . . . 0.0 111.467 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -113.57 135.47 53.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.031 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 51' ' ' THR . 9.6 mp -96.32 167.43 11.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.729 0.776 . . . . 0.0 111.742 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -114.79 160.0 19.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m-85 -96.36 124.43 40.36 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.6 tp -59.81 -44.19 94.12 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -144.04 -166.44 2.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.0 111.705 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 55.82 59.27 3.89 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.46 0.648 . . . . 0.0 110.12 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.675 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 70.1 m 57.39 105.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.408 0.623 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.78 92.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.783 -0.573 . . . . 0.0 110.287 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 76.1 m -69.99 163.34 26.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.631 HG21 ' NE2' ' A' ' 82' ' ' GLN . 8.8 t -138.24 150.38 46.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.414 -0.804 . . . . 0.0 109.218 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.92 43.24 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.872 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 72' ' ' SER . 99.4 m -130.1 166.41 20.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.045 -0.679 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 65.5 m -152.87 122.77 6.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.755 -0.591 . . . . 0.0 109.554 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.6 p -148.94 148.15 29.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.96 -125.53 27.49 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.23 19.06 20.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.909 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.8 mt-30 -123.98 122.72 38.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.237 -0.915 . . . . 0.0 110.876 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.4 m -105.57 123.78 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -99.61 114.03 26.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.185 -0.947 . . . . 0.0 111.225 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 HG22 ' A' ' 36' ' ' VAL . 81.2 mt -101.81 129.53 48.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' HG23 ' A' ' 69' ' ' THR . 60.7 m -119.55 132.58 55.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 96.0 mt -110.16 129.89 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.449 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.631 ' NE2' HG21 ' A' ' 69' ' ' THR . 76.6 mt-30 -122.1 121.87 37.93 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.62 45.75 0.89 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 75.9 mt -79.86 133.55 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.788 0.804 . . . . 0.0 111.836 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -120.05 167.54 12.09 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.39 84.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.268 -0.895 . . . . 0.0 109.842 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -68.09 -39.14 82.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.708 -0.62 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.2 -22.6 66.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.536 -0.728 . . . . 0.0 111.345 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -51.52 136.48 26.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.41 -164.81 34.68 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.575 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 26.9 tp -84.27 131.7 34.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.723 -0.869 . . . . 0.0 112.784 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 72.1 m-85 -113.55 127.15 55.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -110.09 130.33 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.617 -0.677 . . . . 0.0 112.792 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.194 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -80.06 148.64 30.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.823 ' HD2' HD12 ' A' ' 109' ' ' ILE . 7.8 tttt -142.79 82.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 106' ' ' LEU . 3.2 p -93.95 115.28 32.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 122.181 0.991 . . . . 0.0 111.078 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 62.0 mt-10 -131.9 131.04 42.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.729 ' HG ' HD22 ' A' ' 106' ' ' LEU . 49.1 mt -80.99 75.78 7.96 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.415 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 2.5 ttm -80.26 -34.58 36.94 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.471 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 16.8 m-85 -69.0 -44.36 28.54 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 119.389 -0.924 . . . . 0.0 113.144 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 37.1 Cg_endo -90.42 105.49 0.32 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 N-CA-C 114.958 1.099 . . . . 0.0 114.958 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.7 Cg_endo -74.88 155.82 43.54 Favored 'Trans proline' 1 CA--C 1.659 6.759 0 CA-C-O 112.825 -3.073 . . . . 0.0 109.081 177.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 48.1 Cg_endo -87.98 172.81 30.98 Favored 'Cis proline' 3 C--N 1.494 8.196 1 C-N-CA 90.435 -15.235 . . . . 0.0 116.032 -12.051 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 2.7 t80 -90.8 134.98 34.03 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.518 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -160.5 113.5 2.05 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.679 1.191 . . . . 0.0 109.583 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.729 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.8 tp -158.26 -146.32 0.15 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.014 -1.054 . . . . 0.0 110.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.17 170.66 32.72 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.979 -1.581 . . . . 0.0 112.389 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.823 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.8 mm -109.69 152.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 122.189 -0.595 . . . . 0.0 109.69 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 1.194 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -80.53 148.41 29.24 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -60.46 -38.65 84.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.988 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.96 136.62 5.94 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.295 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.7 HG21 HG23 ' A' ' 9' ' ' VAL . 60.2 m -119.93 141.75 49.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.3 tt0 -89.88 124.04 34.35 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.596 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.931 HD13 ' HB ' ' A' ' 9' ' ' VAL . 23.9 mm -87.85 123.98 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.873 ' CE2' HG21 ' A' ' 8' ' ' VAL . 4.4 m-30 -95.02 151.08 19.49 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.854 0.835 . . . . 0.0 111.536 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.613 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.085 0.469 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.46 125.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.637 -0.664 . . . . 0.0 109.246 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -122.08 137.73 54.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.444 -0.785 . . . . 0.0 110.651 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -150.55 144.47 17.4 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.667 . . . . 0.0 111.117 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.87 147.58 50.17 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.324 1.171 . . . . 0.0 109.745 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.86 -26.55 29.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 109.45 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -153.61 155.99 5.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.043 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.701 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -138.05 151.45 25.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.222 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.6 mt -105.32 126.61 52.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 154.11 42.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.47 -0.769 . . . . 0.0 110.561 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 m -97.37 -179.93 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.802 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 m -53.36 160.97 1.04 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.83 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 58.8 18.12 5.79 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.747 -0.596 . . . . 0.0 111.401 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.71 39.06 86.38 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.163 -0.96 . . . . 0.0 111.213 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG13 ' HG2' ' A' ' 82' ' ' GLN . 1.4 mp -99.52 99.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.152 -1.205 . . . . 0.0 108.854 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 108.907 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.66 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.6 p -135.56 149.98 49.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.672 0.748 . . . . 0.0 111.237 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.701 ' HB3' HG21 ' A' ' 9' ' ' VAL . 35.5 p90 -157.17 163.95 38.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 59.0 t -125.06 113.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.548 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 47.3 t -100.08 109.95 22.24 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.2 pt-20 -80.77 164.03 23.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.958 . . . . 0.0 111.77 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.975 ' CG ' HG11 ' A' ' 96' ' ' VAL . 46.5 p90 -145.83 178.28 8.29 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.12 131.31 53.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.4 p -142.34 160.65 53.78 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.747 -0.596 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.06 -10.37 28.17 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.46 1.242 . . . . 0.0 111.503 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.44 27.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 44.1 mtpt 52.01 -155.01 0.17 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.265 -1.138 . . . . 0.0 110.063 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 28' ' ' LYS . . . 60.6 117.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 53' ' ' MET . 47.7 p -79.91 -35.69 37.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.661 ' OE1' HG21 ' A' ' 51' ' ' THR . 39.1 mm-40 -80.04 120.09 23.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.091 0.948 . . . . 0.0 112.779 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 34' ' ' VAL . 92.1 t -132.05 83.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.724 ' HD3' ' SD ' ' A' ' 99' ' ' MET . 12.4 ttt180 -59.04 114.9 2.81 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.384 0.611 . . . . 0.0 111.664 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 50' ' ' ALA . 35.6 m -112.16 152.8 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 59.0 m -147.64 140.09 24.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.7 -0.625 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.829 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -115.96 131.64 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.98 160.02 25.75 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.696 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp-105 -116.93 129.94 56.38 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HA ' HG13 ' A' ' 44' ' ' VAL . 38.3 tt0 -102.92 140.02 37.73 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.3 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -133.27 155.25 49.73 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.09 -43.98 95.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.82 -44.09 67.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.549 -0.72 . . . . 0.0 111.055 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.83 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.6 tt0 -164.43 167.92 19.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.4 -0.813 . . . . 0.0 110.95 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 39' ' ' GLN . 59.6 t -119.16 137.27 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.1 p -130.04 168.23 17.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.29 -0.881 . . . . 0.0 111.224 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.792 ' HA ' HD23 ' A' ' 37' ' ' LEU . 52.5 mt-10 -79.92 154.07 28.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.706 -0.621 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 48' ' ' CYS . 89.8 t -118.05 -75.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.765 -0.585 . . . . 0.0 110.391 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.977 ' SG ' ' CG ' ' A' ' 63' ' ' ASP . 85.2 m -130.31 165.66 22.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.387 -0.821 . . . . 0.0 110.622 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.11 3.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.218 -0.926 . . . . 0.0 111.677 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -174.19 140.49 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.661 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -85.52 105.65 16.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.579 ' HA ' HD23 ' A' ' 58' ' ' LEU . 32.1 t80 -60.23 127.93 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.596 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.5 ' CG ' HD21 ' A' ' 58' ' ' LEU . 2.3 mmt -95.72 134.31 38.79 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.441 ' CG ' ' HA ' ' A' ' 30' ' ' THR . 34.8 mmt -56.96 -20.38 23.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.101 -0.999 . . . . 0.0 111.077 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.11 -12.83 8.06 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.249 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -129.98 159.94 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.985 -1.303 . . . . 0.0 111.223 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -109.85 131.95 54.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.698 -0.626 . . . . 0.0 110.264 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -93.95 153.88 17.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.486 -0.759 . . . . 0.0 110.861 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.6 p -101.72 140.62 35.77 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.545 0.688 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 50' ' ' ALA . 72.0 m-85 -100.2 30.97 3.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -60.0 -35.83 75.89 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.531 -0.731 . . . . 0.0 111.331 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -52.08 -25.93 9.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.977 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 2.8 p30 -113.66 11.54 18.21 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.611 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 59.0 137.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.057 0.932 . . . . 0.0 111.877 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 68' ' ' CYS . 19.0 mt 58.86 -131.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.306 -0.872 . . . . 0.0 110.315 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.556 ' H ' HG22 ' A' ' 67' ' ' ILE . 69.1 m 51.61 67.82 0.9 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.248 -1.533 . . . . 0.0 111.31 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 80' ' ' THR . 10.0 t -132.72 149.89 52.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.1 -140.02 4.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 72' ' ' SER . 71.2 m -129.01 164.92 22.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.723 -0.869 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 22.0 m -166.38 120.15 1.1 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -158.25 153.51 25.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.22 -124.36 35.61 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.26 12.09 26.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.748 -0.854 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -120.8 122.09 39.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.182 -0.949 . . . . 0.0 110.63 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.5 m -107.41 123.74 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.422 -0.799 . . . . 0.0 109.713 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.54 113.43 27.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 111.194 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 36' ' ' VAL . 91.5 mt -105.7 129.23 53.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.454 -0.779 . . . . 0.0 109.217 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 18' ' ' SER . 62.1 m -124.53 137.67 54.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 110.738 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 84' ' ' LEU . 59.5 mt -111.62 139.58 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.707 -0.621 . . . . 0.0 110.144 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 16' ' ' ILE . 82.1 mt-30 -120.02 120.53 36.6 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.997 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.68 51.91 0.73 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 81' ' ' ILE . 80.9 mt -99.69 130.03 45.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.987 . . . . 0.0 111.504 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -105.39 179.97 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 117' ' ' VAL . . . -59.97 -47.07 87.33 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.776 0.798 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.7 mtp -60.37 -39.94 89.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.147 0.498 . . . . 0.0 110.82 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -57.95 -27.11 63.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.6 -0.688 . . . . 0.0 111.018 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.4 m -50.0 140.02 12.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.62 -161.85 33.0 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.635 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.8 tm? -88.68 139.91 29.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.888 0.852 . . . . 0.0 112.086 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.884 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -127.58 128.19 45.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.73 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.7 mp -100.77 129.9 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.302 -0.874 . . . . 0.0 112.182 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.932 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.2 p -91.07 126.24 36.1 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.76 ' HD2' HD12 ' A' ' 109' ' ' ILE . 5.5 mtmt -116.72 145.75 43.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.137 -0.977 . . . . 0.0 110.145 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' A' ' 23' ' ' TYR . 26.6 t -142.6 104.57 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.964 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.5 mm-40 -133.23 140.09 47.32 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.599 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 106' ' ' LEU . 8.0 mt -93.01 81.14 4.56 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 103.779 -2.675 . . . . 0.0 103.779 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.724 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 1.4 mtt -80.51 -30.58 37.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.411 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.461 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 71.5 m-85 -75.45 -49.08 3.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.29 -0.881 . . . . 0.0 111.853 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 98' ' ' LEU . 41.3 Cg_endo -74.76 120.74 6.27 Favored 'Trans proline' 0 N--CA 1.518 2.924 0 C-N-CA 121.841 1.694 . . . . 0.0 114.813 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.45 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 63.1 Cg_endo -82.2 148.13 14.83 Favored 'Trans proline' 1 CA--C 1.659 6.758 0 CA-C-O 114.187 -2.505 . . . . 0.0 111.06 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.329 58.0 Cg_endo -116.39 58.25 0.38 Allowed 'Cis proline' 0 C--N 1.398 3.156 1 C-N-CA 95.048 -13.313 . . . . 0.0 109.053 10.955 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.2 t80 55.67 118.85 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.093 0 O-C-N 120.942 -1.099 . . . . 0.0 112.629 172.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 4.3 p90 -165.71 105.55 0.72 Allowed 'General case' 0 N--CA 1.529 3.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.0 tp -158.87 -149.38 0.21 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 118.692 0.678 . . . . 0.0 111.415 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.22 174.13 34.08 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.281 -1.438 . . . . 0.0 110.753 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.8 mm -120.26 163.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.954 -0.733 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.932 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -94.04 140.04 14.85 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -59.99 -38.26 82.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.479 -1.013 . . . . 0.0 110.393 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.77 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 128.87 148.53 6.68 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.011 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.626 HG21 HG23 ' A' ' 9' ' ' VAL . 98.0 m -118.15 140.01 50.42 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 8' ' ' VAL . 23.3 tt0 -89.28 129.99 35.75 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.221 -1.392 . . . . 0.0 108.741 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 89' ' ' THR . 88.8 mt -94.35 131.95 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.857 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.9 m-30 -106.71 149.92 26.8 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.139 0.495 . . . . 0.0 111.491 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' A' ' 86' ' ' ALA . 96.4 t . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.373 0.606 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 71.0 t -125.76 129.68 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.8 132.14 52.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 110.558 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.512 ' NE2' HG12 ' A' ' 3' ' ' VAL . 17.2 mp0 -135.82 131.93 19.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.641 -0.662 . . . . 0.0 110.851 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.52 139.86 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.132 1.069 . . . . 0.0 109.799 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.18 -32.28 64.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.808 . . . . 0.0 109.443 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.51 157.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.916 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.3 t -139.91 136.64 38.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.666 0.746 . . . . 0.0 110.594 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 10' ' ' LEU . 2.8 mm? -97.63 125.13 42.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -86.4 151.25 23.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.425 -0.797 . . . . 0.0 110.245 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -75.82 172.24 13.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.552 -0.717 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -59.65 -29.0 67.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.01 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.702 ' CG ' HD13 ' A' ' 16' ' ' ILE . 3.0 tpt180 -59.93 -27.78 67.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.597 -0.689 . . . . 0.0 109.867 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.662 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.41 23.36 12.65 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.702 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -110.25 109.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 O-C-N 121.5 -1.0 . . . . 0.0 110.534 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -100.47 118.32 36.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB3' HG23 ' A' ' 80' ' ' THR . 81.7 p -123.95 140.58 52.84 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.531 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.0 p90 -149.92 164.86 34.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.891 -0.505 . . . . 0.0 109.895 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 97.1 t -122.65 114.16 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.134 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.833 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.05 107.49 19.42 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 3' ' ' VAL . 82.9 mt-10 -79.98 165.03 23.0 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 111.678 -176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.673 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.4 p90 -149.88 -179.95 7.55 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 106' ' ' LEU . . . -128.9 128.52 43.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -112.6 150.42 42.66 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.425 -0.797 . . . . 0.0 111.116 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.27 -19.31 38.65 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.712 1.375 . . . . 0.0 111.34 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.13 -165.81 29.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.77 126.5 38.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.638 -0.919 . . . . 0.0 110.728 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.65 38.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.682 -0.636 . . . . 0.0 109.588 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' MET . 62.8 p -79.9 -37.88 33.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 110.675 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -79.93 112.48 17.27 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.861 -0.735 . . . . 0.0 112.331 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 34' ' ' VAL . 85.3 t -131.97 82.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ttp85 -60.17 121.42 11.9 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.392 0.615 . . . . 0.0 111.43 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -124.34 132.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 49' ' ' ALA . 58.6 m -125.55 131.27 52.79 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.236 0.541 . . . . 0.0 110.66 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.991 HG22 HD13 ' A' ' 79' ' ' LEU . 87.9 t -104.54 139.15 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 46' ' ' GLU . 19.6 mt -125.12 164.02 21.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 111.587 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HG3' HG21 ' A' ' 47' ' ' VAL . 10.4 mtt-85 -116.51 91.64 3.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.606 ' HA ' HG13 ' A' ' 44' ' ' VAL . 34.6 tt0 -93.63 140.05 30.07 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.29 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -150.53 154.53 37.77 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.1 -42.88 91.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 96.4 p -70.21 -43.61 70.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.599 -0.688 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 11.5 mp0 -156.88 160.69 39.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.385 -0.822 . . . . 0.0 111.09 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 39' ' ' GLN . 60.3 t -130.35 130.39 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.3 p -139.91 165.88 26.14 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.452 -0.78 . . . . 0.0 111.416 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.808 ' HA ' HD23 ' A' ' 37' ' ' LEU . 72.0 mt-10 -81.07 160.3 24.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.631 -0.668 . . . . 0.0 109.832 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG12 ' OD2' ' A' ' 63' ' ' ASP . 60.1 t -123.75 -85.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.621 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 1.217 ' SG ' ' CG ' ' A' ' 60' ' ' PHE . 18.5 t -118.79 152.69 35.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.959 -1.088 . . . . 0.0 110.112 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 62' ' ' ASP . . . -167.81 128.52 1.41 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.391 -0.818 . . . . 0.0 112.654 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.0 161.42 5.66 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 58' ' ' LEU . 2.9 m -83.11 119.98 25.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.017 -1.052 . . . . 0.0 109.596 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 72' ' ' SER . 12.8 t80 -78.99 109.58 13.43 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.243 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 53' ' ' MET . 6.1 mmm -84.82 138.61 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.1 mmt -58.15 -20.2 38.8 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.16 -0.963 . . . . 0.0 110.921 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.73 -93.17 1.67 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -80.43 164.18 23.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.526 -0.985 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 40.3 tp10 -110.12 130.11 55.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.812 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 51' ' ' THR . 71.5 mt -76.03 169.49 18.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.465 -0.772 . . . . 0.0 110.467 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 p -96.53 164.27 12.68 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.217 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 49.4 m-85 -116.16 92.61 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.532 -0.73 . . . . 0.0 110.218 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.66 -28.79 67.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 49' ' ' ALA . 82.2 m-20 -61.3 -42.0 97.92 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.567 -0.708 . . . . 0.0 111.38 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.905 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . 23.9 t0 -100.02 11.99 37.98 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 122.038 -0.414 . . . . 0.0 112.035 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t 62.02 -67.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.998 -0.439 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.1 mt -132.1 73.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.98 . . . . 0.0 111.668 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 1.115 ' SG ' ' CB ' ' A' ' 60' ' ' PHE . 1.8 p -113.07 158.08 20.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.208 -0.932 . . . . 0.0 109.176 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 80' ' ' THR . 8.8 t -130.65 150.03 52.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.491 -0.756 . . . . 0.0 109.836 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.66 148.95 19.54 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.777 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 75.3 m -129.86 160.29 33.97 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 32.9 t -146.96 108.31 4.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -120.17 123.78 44.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.614 -0.678 . . . . 0.0 109.46 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 -120.55 23.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.88 19.21 20.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.982 . . . . 0.0 110.682 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.439 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 88.2 mt-30 -116.78 120.16 37.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -104.52 123.94 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.05 -1.031 . . . . 0.0 109.416 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 54.2 t-20 -103.79 108.03 19.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 111.372 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.991 HD13 HG22 ' A' ' 36' ' ' VAL . 68.0 mt -104.49 139.95 38.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.451 -0.78 . . . . 0.0 109.536 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.482 ' HB ' HG23 ' A' ' 69' ' ' THR . 59.6 m -140.84 152.02 44.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.816 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -120.01 139.87 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.441 ' HG2' HG13 ' A' ' 16' ' ' ILE . 38.7 mt-30 -115.79 121.54 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.658 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 51.96 0.7 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.816 HD21 HG21 ' A' ' 81' ' ' ILE . 77.7 mt -97.2 117.34 31.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.609 -0.936 . . . . 0.0 111.246 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -102.44 -179.73 4.06 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.05 92.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -38.52 89.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.724 -0.61 . . . . 0.0 110.523 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.38 -26.91 66.69 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.644 -0.66 . . . . 0.0 110.735 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.2 m -51.51 134.27 29.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.863 . . . . 0.0 110.557 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.8 -150.29 13.83 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.406 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 113' ' ' THR . 13.6 tp -107.57 134.48 50.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.664 -0.903 . . . . 0.0 111.833 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.896 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.9 m-85 -116.24 145.31 43.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.7 mp -112.68 129.73 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.357 -0.839 . . . . 0.0 111.96 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 94' ' ' CYS . 31.3 p -92.46 123.99 36.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HB3' ' H ' ' A' ' 35' ' ' THR . 8.4 tttt -117.79 138.79 51.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -0.802 . . . . 0.0 108.9 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.797 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.6 t -135.96 112.81 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.584 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 77.4 mt-10 -138.56 123.94 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.864 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 106' ' ' LEU . 8.9 mp -76.2 81.85 3.0 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 40.5 tpp -79.03 -52.17 8.6 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 88.5 m-85 -69.09 -38.24 10.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.37 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 29.1 Cg_endo -83.08 112.02 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 CA-C-N 119.832 0.976 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 58.9 Cg_endo -83.25 150.77 13.62 Favored 'Trans proline' 1 CA--C 1.665 7.065 1 CA-C-O 110.57 -4.012 . . . . 0.0 113.244 176.023 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' PRO 0.253 37.4 Cg_endo -89.69 174.38 23.49 Favored 'Cis proline' 0 C--N 1.403 3.396 1 C-N-CA 95.287 -13.214 . . . . 0.0 118.711 -8.782 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.9 t80 -82.05 127.49 33.15 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.562 -2.563 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -160.79 105.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.375 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 98' ' ' LEU . 3.4 tp -158.23 -144.17 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.757 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.29 174.44 39.55 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.726 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -123.85 168.76 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 122.082 -0.658 . . . . 0.0 109.732 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -112.18 144.93 17.88 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.76 -38.99 87.07 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.605 1.202 . . . . 0.0 110.345 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 138.86 163.73 9.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.025 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.537 HG21 HG23 ' A' ' 9' ' ' VAL . 98.3 m -124.01 133.84 53.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.988 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.5 tp60 -75.98 139.76 41.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 92' ' ' TYR . 52.3 mt -116.21 124.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.897 -1.127 . . . . 0.0 108.642 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.84 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.8 m-85 -104.42 140.13 38.37 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 t . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.831 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.438 ' C ' HG23 ' A' ' 3' ' ' VAL . 65.1 m170 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.339 0.59 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.1 t -147.95 144.84 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -117.01 117.7 30.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 111.552 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.02 ' OE1' ' SG ' ' A' ' 94' ' ' CYS . 1.2 mm-40 -142.34 141.36 20.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.617 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.27 138.11 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.216 1.114 . . . . 0.0 109.549 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.35 -30.21 67.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -149.57 156.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.951 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 113' ' ' THR . 13.9 t -140.18 151.27 21.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.31 0.576 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 116' ' ' TYR . 77.8 mt -110.06 130.03 55.6 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.472 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 135.34 33.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.507 -0.746 . . . . 0.0 110.595 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.02 173.34 6.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.714 -0.616 . . . . 0.0 110.513 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -60.12 -29.4 68.59 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.631 -0.668 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.713 ' HG3' HD13 ' A' ' 16' ' ' ILE . 23.6 tpp180 -60.33 -29.73 69.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.547 -0.721 . . . . 0.0 109.905 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.75 25.28 10.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 15' ' ' GLY . 1.8 mp -114.18 115.61 50.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.97 . . . . 0.0 110.271 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.03 127.4 53.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -127.22 133.59 50.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 111.617 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' HB3' HG21 ' A' ' 9' ' ' VAL . 51.1 p90 -143.63 167.02 23.24 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 88.6 t -128.89 124.38 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.475 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.702 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -99.99 109.04 21.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.2 tt0 -86.49 140.56 29.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.479 -0.763 . . . . 0.0 110.939 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -129.62 161.94 29.41 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.16 130.54 18.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.0 p -159.99 160.0 27.04 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 0.0 110.388 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.13 148.23 49.89 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.391 1.206 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.6 167.47 8.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.98 149.58 51.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.943 . . . . 0.0 110.318 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 149.96 33.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HE2' ' A' ' 54' ' ' MET . 43.3 p -79.99 -33.4 39.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.38 -0.825 . . . . 0.0 110.76 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 23.2 mm-40 -80.17 74.29 6.98 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.268 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 34' ' ' VAL . 14.5 m -91.98 87.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.551 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 72.3 ttt-85 -53.1 105.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.693 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -107.55 131.21 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.79 0.805 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.6 m -135.94 150.21 49.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 0.0 109.409 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.959 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.2 t -117.51 140.03 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 46' ' ' GLU . 17.4 mt -127.87 164.51 22.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.887 -1.133 . . . . 0.0 110.915 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -127.4 117.28 21.87 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.443 ' HA ' HG22 ' A' ' 44' ' ' VAL . 81.9 mt-30 -105.24 123.96 48.73 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.44 154.28 39.28 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.74 -43.8 94.07 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.467 -0.771 . . . . 0.0 110.422 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.3 m -68.0 -49.79 59.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.579 -0.7 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.3 mt-30 -154.5 160.75 41.74 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 111.096 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.3 t -125.97 134.23 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.592 -0.692 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -140.76 164.02 31.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.788 ' HA ' HD23 ' A' ' 37' ' ' LEU . 30.5 tt0 -79.91 156.9 27.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 109.841 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 98.4 t -113.64 -89.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.895 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 93.4 m -122.68 149.94 43.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.801 -1.187 . . . . 0.0 110.28 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -150.22 140.01 21.78 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.819 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -172.0 153.54 3.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -91.89 120.62 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.791 ' CA ' HD21 ' A' ' 58' ' ' LEU . 16.1 t80 -79.16 109.15 13.21 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.983 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.46 169.96 17.0 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 30' ' ' THR . 34.4 mmt -67.63 -28.77 68.01 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.001 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.91 35.63 1.48 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.297 -1.43 . . . . 0.0 112.57 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 81.6 m-20 -130.32 159.95 35.42 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 119.151 1.476 . . . . 0.0 110.272 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -83.41 139.98 32.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.791 HD21 ' CA ' ' A' ' 52' ' ' TYR . 6.6 mp -89.17 129.97 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 110.242 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 p -99.98 135.57 41.2 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.494 -0.754 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 95.2 m-85 -107.99 114.91 29.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.26 -43.72 95.91 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.565 -0.709 . . . . 0.0 112.833 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -149.38 -161.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.024 -1.047 . . . . 0.0 111.632 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 56.75 58.07 4.33 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.473 0.654 . . . . 0.0 110.088 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 57.74 164.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.62 85.75 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 110.465 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 60' ' ' PHE . 97.5 m -68.07 153.24 44.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.577 -0.702 . . . . 0.0 109.462 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -140.0 150.01 43.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 109.305 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.9 179.98 43.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 72' ' ' SER . 91.1 m -130.19 169.25 15.61 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.12 -0.635 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.482 ' N ' HG22 ' A' ' 71' ' ' THR . 44.5 m -155.04 124.57 6.43 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.2 p -141.09 145.53 35.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.464 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.8 -122.37 16.35 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -105.72 11.98 31.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.801 -0.823 . . . . 0.0 111.016 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -116.69 126.68 53.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.873 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -107.89 123.48 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.899 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -100.61 118.62 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.0 111.435 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 ' CG2' ' A' ' 36' ' ' VAL . 76.1 mt -111.84 137.22 50.09 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.2 m -128.32 140.21 51.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.253 -0.905 . . . . 0.0 110.927 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 84' ' ' LEU . 88.5 mt -116.85 132.79 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.638 -0.664 . . . . 0.0 110.102 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 16' ' ' ILE . 19.7 mt-30 -118.94 121.39 39.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.589 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.86 54.19 0.57 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 81' ' ' ILE . 76.2 mt -90.85 120.01 31.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.601 -0.941 . . . . 0.0 110.953 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -98.07 178.95 4.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.66 90.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.281 -0.887 . . . . 0.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -66.79 -37.44 84.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.696 -0.627 . . . . 0.0 110.565 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.88 -33.5 71.9 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -51.99 130.92 30.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.27 -142.02 7.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 tp -109.05 129.19 55.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.672 -0.899 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.801 ' CD1' HD12 ' A' ' 115' ' ' ILE . 73.3 m-85 -109.99 132.06 54.5 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -110.07 130.05 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.732 -0.605 . . . . 0.0 111.731 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.088 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 19.9 p -79.9 155.78 27.59 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 5.3 tptm -147.15 79.09 1.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 108.759 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 106' ' ' LEU . 3.6 p -95.79 115.24 34.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.147 0.975 . . . . 0.0 110.614 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 67.8 mm-40 -135.17 137.24 42.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.787 -0.571 . . . . 0.0 111.703 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.768 ' CD2' HD22 ' A' ' 106' ' ' LEU . 13.8 mt -83.98 75.46 10.13 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.4 ttm -79.9 -32.42 40.25 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.472 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.2 m-85 -87.03 -39.55 0.52 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.332 -0.855 . . . . 0.0 112.426 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 59.0 Cg_endo -92.59 118.71 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-O 121.556 0.565 . . . . 0.0 110.698 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.599 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 60.7 Cg_endo -91.13 156.01 3.84 Favored 'Trans proline' 1 CA--C 1.655 6.562 0 CA-C-O 113.372 -2.845 . . . . 0.0 111.123 177.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.599 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 44.2 Cg_endo -89.94 175.47 21.15 Favored 'Cis proline' 3 N--CA 1.644 10.334 1 C-N-CA 91.289 -14.88 . . . . 0.0 116.263 1.059 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 4.0 t80 -82.58 129.57 34.96 Favored 'General case' 0 C--N 1.266 -3.025 0 O-C-N 119.626 -1.921 . . . . 0.0 109.167 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -166.7 104.9 0.6 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.426 -1.421 . . . . 0.0 108.376 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.768 HD22 ' CD2' ' A' ' 98' ' ' LEU . 4.3 tp -157.71 -147.96 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.484 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.48 170.96 34.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.249 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.471 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.0 mm -115.22 146.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -1.087 . . . . 0.0 109.187 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 1.088 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -73.63 141.58 29.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -60.07 -30.59 69.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -1.046 . . . . 0.0 109.709 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.72 138.77 5.93 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.492 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 9' ' ' VAL . 94.5 m -111.64 139.78 46.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 1.012 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.1 tp60 -83.45 120.72 26.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.258 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.801 HD12 ' CD1' ' A' ' 92' ' ' TYR . 53.8 mt -96.79 114.23 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.619 -1.301 . . . . 0.0 108.592 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.78 ' CE2' HG21 ' A' ' 8' ' ' VAL . 12.4 m-85 -87.81 139.11 30.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.389 0.614 . . . . 0.0 111.552 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.4 t . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.603 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.293 0.568 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 128.11 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.329 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.884 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.21 128.83 56.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.453 -0.78 . . . . 0.0 110.737 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.087 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 27.1 mm100 -139.45 131.95 15.27 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.729 -0.607 . . . . 0.0 111.214 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.51 139.21 25.39 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.119 1.063 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -33.41 71.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.789 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 116' ' ' TYR . 3.1 p -152.72 156.26 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.529 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -131.84 155.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.845 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.9 mt -112.33 129.99 56.11 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.928 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.03 27.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.616 -0.677 . . . . 0.0 110.29 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.3 t -89.58 176.93 6.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.554 -0.716 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG3' HD13 ' A' ' 16' ' ' ILE . 7.8 tpm_? -59.97 -28.77 67.94 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.076 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.29 22.59 21.84 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.74 HD13 ' HG3' ' A' ' 14' ' ' ARG . 1.8 mp -114.73 114.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.501 -0.999 . . . . 0.0 109.877 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.76 124.02 49.92 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.642 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.1 p -132.8 150.01 52.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.008 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.685 ' HB3' HG21 ' A' ' 9' ' ' VAL . 32.4 p90 -152.06 163.11 40.0 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 87.2 t -119.4 122.71 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.301 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.087 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 41.4 t -100.78 100.54 11.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.884 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.4 pt-20 -79.95 149.97 30.66 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.318 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -132.68 173.56 11.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.04 120.59 22.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.391 -0.818 . . . . 0.0 111.154 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 106' ' ' LEU . 28.7 t -151.62 149.95 25.32 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 111.053 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.84 147.95 31.52 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.694 1.365 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.51 -176.15 0.44 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.89 160.05 36.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.845 . . . . 0.0 109.73 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 1.018 ' O ' ' SD ' ' A' ' 54' ' ' MET . . . -148.4 171.94 15.23 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.312 -0.867 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.833 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.8 p -86.26 -5.39 59.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.611 -0.681 . . . . 0.0 112.622 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -129.16 76.44 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.914 -1.514 . . . . 0.0 112.91 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HB ' ' CD2' ' A' ' 52' ' ' TYR . 92.0 t -91.94 86.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -63.16 123.33 18.35 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.366 0.603 . . . . 0.0 111.618 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.99 161.24 34.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.6 m -152.73 138.95 18.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.985 HG22 HD13 ' A' ' 79' ' ' LEU . 88.2 t -108.84 128.9 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 46' ' ' GLU . 11.0 mt -124.82 165.01 18.79 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.491 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB2' HG21 ' A' ' 47' ' ' VAL . 62.4 ttp180 -128.3 121.25 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HG2' ' CG1' ' A' ' 44' ' ' VAL . 80.5 mt-30 -103.3 131.96 49.93 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.974 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -99.74 -174.17 2.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.94 -0.475 . . . . 0.0 109.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.43 -43.69 96.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 m -130.08 -3.28 4.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.814 . . . . 0.0 111.88 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.632 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 37.2 mt-30 -132.31 152.35 51.43 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.061 -1.024 . . . . 0.0 110.988 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 89.4 t -135.33 138.62 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.617 . . . . 0.0 109.864 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.1 p -136.9 162.8 32.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.584 -0.697 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.879 ' HA ' HD23 ' A' ' 37' ' ' LEU . 85.8 mt-10 -79.91 153.73 28.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.605 -0.684 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.189 HG12 ' SG ' ' A' ' 48' ' ' CYS . 86.5 t -120.72 -50.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.636 -0.665 . . . . 0.0 110.646 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 1.189 ' SG ' HG12 ' A' ' 47' ' ' VAL . 1.3 m -155.96 132.29 10.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.239 -0.913 . . . . 0.0 110.201 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -139.61 138.46 36.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.444 -0.785 . . . . 0.0 111.188 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.63 156.48 6.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.644 -0.66 . . . . 0.0 109.656 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -90.64 124.08 34.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 109.575 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.582 ' HA ' HD11 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.89 90.06 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.833 ' SD ' ' O ' ' A' ' 30' ' ' THR . 61.8 mmm -88.13 122.52 31.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 1.018 ' SD ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -59.83 -27.96 67.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.035 -1.04 . . . . 0.0 110.265 -178.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.45 -42.1 7.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -110.48 151.02 28.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.245 -1.15 . . . . 0.0 111.554 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -77.04 150.23 35.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.58 -0.7 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' TYR . 4.7 mp -71.15 136.93 48.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.514 -0.741 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.1 p -118.28 139.61 51.06 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.525 -0.734 . . . . 0.0 110.999 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 75.2 m-85 -107.63 112.0 24.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -68.0 -43.39 78.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.448 -0.782 . . . . 0.0 112.031 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' HB3' HD23 ' A' ' 61' ' ' LEU . 55.3 p-10 -142.51 -158.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.262 -0.899 . . . . 0.0 111.339 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.65 57.01 4.5 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.412 0.625 . . . . 0.0 110.271 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p 57.13 166.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.325 0.583 . . . . 0.0 110.95 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.95 131.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.739 -0.601 . . . . 0.0 110.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 82.8 m -130.05 165.42 22.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.709 -0.619 . . . . 0.0 109.667 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 80' ' ' THR . 8.2 t -136.05 141.37 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.2 153.74 25.25 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.8 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 59.2 m -139.99 157.36 45.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD2' ' A' ' 52' ' ' TYR . 15.3 t -146.0 108.04 4.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.772 . . . . 0.0 110.512 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.7 t -148.28 148.1 30.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.831 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.74 38.58 96.7 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.06 27.42 13.3 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.692 -0.887 . . . . 0.0 110.227 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -132.12 128.62 38.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.591 -0.693 . . . . 0.0 109.814 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.9 m -104.45 120.29 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.34 -0.85 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -100.97 110.1 22.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -0.899 . . . . 0.0 111.175 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.985 HD13 HG22 ' A' ' 36' ' ' VAL . 86.9 mt -103.01 131.98 49.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.726 . . . . 0.0 109.242 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.642 HG23 ' HB3' ' A' ' 18' ' ' SER . 94.8 m -130.88 150.33 52.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.335 -0.853 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 HD21 ' A' ' 84' ' ' LEU . 62.4 mt -124.47 141.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.809 -0.557 . . . . 0.0 109.977 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' CG ' HG13 ' A' ' 16' ' ' ILE . 24.0 mt-30 -120.01 122.06 40.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.745 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.46 41.38 1.14 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 81' ' ' ILE . 80.1 mt -89.35 129.95 35.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.956 . . . . 0.0 111.421 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -116.15 179.81 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.03 81.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.5 ttp -68.14 -35.86 78.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.64 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.522 -0.736 . . . . 0.0 111.387 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 115' ' ' ILE . 19.7 m -49.65 142.51 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.7 -165.24 35.02 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 21.1 tp -98.76 131.37 44.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.959 . . . . 0.0 112.75 -178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CE1' HD12 ' A' ' 115' ' ' ILE . 86.1 m-85 -114.23 139.2 49.59 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -108.91 141.45 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.386 -0.822 . . . . 0.0 111.818 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.038 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 17.3 p -104.66 112.72 25.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -100.87 143.08 31.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.22 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.74 106.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.465 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CG ' ' OH ' ' A' ' 104' ' ' TYR . 22.1 mp0 -131.32 130.13 42.35 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.566 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.7 ' CD1' HD23 ' A' ' 106' ' ' LEU . 12.1 mt -84.61 80.36 9.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.7 tpp -79.74 -52.85 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.186 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.451 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 94.0 m-85 -68.75 -44.25 30.85 Favored Pre-proline 0 N--CA 1.508 2.464 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.3 Cg_endo -79.14 110.46 2.74 Favored 'Trans proline' 0 N--CA 1.518 2.932 0 C-N-CA 121.136 1.224 . . . . 0.0 110.885 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.4 Cg_endo -83.18 155.22 14.63 Favored 'Trans proline' 1 CA--C 1.676 7.599 0 CA-C-O 111.686 -3.548 . . . . 0.0 105.643 -177.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 52.4 Cg_endo -88.07 -179.08 15.31 Favored 'Cis proline' 1 C--N 1.492 8.082 1 C-N-CA 95.527 -13.114 . . . . 0.0 116.297 -10.356 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' OH ' ' CG ' ' A' ' 97' ' ' GLU . 4.4 t80 -87.37 132.15 34.06 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 117.469 -3.27 . . . . 0.0 110.467 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 106' ' ' LEU . 51.4 t80 -163.43 92.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.042 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.7 HD23 ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -145.57 -148.36 0.24 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.074 -179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.61 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.1 179.0 38.58 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.8 mp -119.81 158.79 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 O-C-N 121.67 -0.9 . . . . 0.0 109.109 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.81 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -85.52 145.22 20.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.15 -34.54 73.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.297 -1.119 . . . . 0.0 110.727 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 122.95 135.27 4.56 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 9' ' ' VAL . 94.7 m -106.78 130.99 54.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' VAL . 44.7 tt0 -85.11 123.99 31.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.835 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 92' ' ' TYR . 82.3 mt -85.85 125.59 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.731 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.845 ' HB2' HD23 ' A' ' 10' ' ' LEU . 4.6 m-30 -95.84 158.87 15.25 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.209 0.528 . . . . 0.0 110.38 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.596 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 71.1 m80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.363 0.601 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.2 t -149.26 137.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.826 -0.546 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.47 127.33 53.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.557 -0.714 . . . . 0.0 109.876 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.004 ' CD ' ' SG ' ' A' ' 94' ' ' CYS . 5.5 mm100 -139.95 131.52 14.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.658 -0.651 . . . . 0.0 111.745 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.65 139.93 28.79 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.141 1.074 . . . . 0.0 109.434 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.77 -33.81 74.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.725 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.68 155.77 7.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.615 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.64 HG23 HG21 ' A' ' 113' ' ' THR . 8.6 t -133.01 148.2 31.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.135 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.1 mt -104.52 127.48 52.25 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.81 175.18 6.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.465 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -109.45 175.81 5.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.42 -37.54 81.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.745 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HB3' HD13 ' A' ' 16' ' ' ILE . 19.8 mmt85 -59.63 -30.22 68.56 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.682 -0.636 . . . . 0.0 110.312 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.14 27.03 9.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.3 mp -102.74 100.4 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.65 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.22 118.4 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.676 ' HB2' HG23 ' A' ' 80' ' ' THR . 45.7 t -131.19 132.58 44.8 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.5 p90 -131.92 163.95 27.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.547 HG22 ' CG ' ' A' ' 78' ' ' ASN . 58.0 t -118.47 122.67 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.685 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.634 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -101.12 108.1 19.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -85.51 141.13 30.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.815 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.914 ' CB ' HG11 ' A' ' 96' ' ' VAL . 45.1 p90 -125.57 178.22 5.78 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -133.54 123.87 25.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.705 -0.622 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -116.18 132.71 23.13 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 109.941 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.51 -12.17 32.77 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.192 1.101 . . . . 0.0 112.159 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.03 27.2 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.358 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.82 136.47 44.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.694 -0.886 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.06 163.99 38.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.625 -0.672 . . . . 0.0 109.931 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 64.3 p -86.2 12.38 9.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.511 -0.743 . . . . 0.0 111.308 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' HG21 ' A' ' 51' ' ' THR . 34.0 mm-40 -137.22 97.6 3.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.002 -1.479 . . . . 0.0 113.216 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 40.0 t -122.4 79.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -58.99 131.62 51.59 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.254 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -129.26 164.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 49' ' ' ALA . 87.1 m -160.0 157.97 29.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 110.084 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.001 HG22 HD13 ' A' ' 79' ' ' LEU . 96.8 t -122.14 134.06 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.876 HD23 ' HA ' ' A' ' 46' ' ' GLU . 8.4 mt -130.03 163.96 25.37 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.523 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.724 ' HG3' HG21 ' A' ' 47' ' ' VAL . 39.0 mtm105 -123.68 119.99 31.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 44' ' ' VAL . 90.0 mt-30 -106.01 129.7 54.08 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.512 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.39 154.97 44.35 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.68 -43.19 94.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 0.0 110.621 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.1 m -68.85 -49.99 53.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.9 mt-30 -155.0 162.89 40.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.343 -0.848 . . . . 0.0 111.284 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 39' ' ' GLN . 87.8 t -126.42 135.13 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.2 159.97 38.63 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.462 -0.774 . . . . 0.0 111.626 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.876 ' HA ' HD23 ' A' ' 37' ' ' LEU . 54.9 mt-10 -80.86 161.09 24.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.618 . . . . 0.0 110.71 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.724 HG21 ' HG3' ' A' ' 38' ' ' ARG . 96.1 t -127.64 -67.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.698 -0.626 . . . . 0.0 110.663 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 67.8 m -138.03 154.12 49.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.903 . . . . 0.0 111.77 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -160.56 136.13 8.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.787 -0.57 . . . . 0.0 110.579 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -155.38 146.56 22.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.575 -0.703 . . . . 0.0 109.12 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.554 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.4 m -80.05 127.55 32.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.241 -0.912 . . . . 0.0 110.116 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 1.2 t80 -79.99 103.47 9.9 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.3 mtp -95.81 131.09 42.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 21.0 mmt -59.76 -34.96 73.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.957 . . . . 0.0 110.733 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.18 -51.89 25.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.17 159.95 35.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.428 -1.042 . . . . 0.0 110.724 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -103.86 130.85 51.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 51' ' ' THR . 60.9 tp -95.41 150.21 20.53 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.518 -0.738 . . . . 0.0 109.656 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 p -104.86 167.39 9.75 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.63 -0.669 . . . . 0.0 110.61 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 34.8 m-85 -92.9 100.6 13.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.664 -0.648 . . . . 0.0 109.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -103.85 2.35 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.531 -0.731 . . . . 0.0 111.77 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -67.92 -41.78 82.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -109.92 7.49 23.89 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 33.63 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 67' ' ' ILE . 26.8 mm -141.98 10.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 0.0 111.246 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 16.8 p -127.92 138.96 52.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.669 -1.269 . . . . 0.0 111.069 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -139.93 156.14 46.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.19 -179.83 43.33 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 72' ' ' SER . 94.6 m -117.43 163.57 16.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.034 -0.686 . . . . 0.0 109.579 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 71' ' ' THR . 1.3 p -153.18 113.8 4.05 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.2 m -143.66 146.94 33.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.053 -1.029 . . . . 0.0 110.948 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.63 -123.95 27.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -110.11 19.88 18.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.813 -0.816 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -125.79 129.95 50.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.7 m -110.05 126.95 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.723 . . . . 0.0 109.806 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.547 ' CG ' HG22 ' A' ' 20' ' ' VAL . 39.4 t-20 -107.2 120.78 43.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.926 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.001 HD13 HG22 ' A' ' 36' ' ' VAL . 80.6 mt -108.09 132.01 54.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.387 -0.821 . . . . 0.0 109.269 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.676 HG23 ' HB2' ' A' ' 18' ' ' SER . 60.9 m -119.99 139.9 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.248 -0.907 . . . . 0.0 110.907 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.718 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -117.31 132.57 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.0 110.158 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.1 mt-30 -120.16 121.12 38.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.218 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.94 39.67 0.95 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 81' ' ' ILE . 80.4 mt -94.83 120.08 34.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.509 -0.994 . . . . 0.0 111.365 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' O ' HG21 ' A' ' 117' ' ' VAL . 19.1 mmt85 -102.27 178.86 4.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.09 83.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.232 -0.917 . . . . 0.0 109.819 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 ttm -68.02 -33.76 75.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.74 -0.6 . . . . 0.0 110.824 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.04 -17.3 64.36 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.589 -0.694 . . . . 0.0 111.67 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 115' ' ' ILE . 24.5 m -51.16 135.17 26.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.84 -155.26 19.22 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.778 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.77 128.68 55.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.738 -0.86 . . . . 0.0 112.061 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.941 ' CD1' HD12 ' A' ' 115' ' ' ILE . 44.9 m-85 -112.29 144.88 40.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -111.59 143.32 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 111.432 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.004 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 17.5 p -105.82 117.23 33.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.5 tptt -102.11 141.15 35.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.505 -0.747 . . . . 0.0 109.652 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.914 HG11 ' CB ' ' A' ' 23' ' ' TYR . 16.5 t -145.14 103.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -136.56 125.46 24.18 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.269 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 HD23 ' A' ' 106' ' ' LEU . 7.6 mp -79.73 77.22 6.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.8 tpp -80.47 -51.36 8.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.977 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 92.6 m-85 -67.17 -40.21 26.42 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 111.737 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 39.6 Cg_endo -86.99 120.74 1.66 Allowed 'Trans proline' 0 N--CA 1.504 2.109 0 N-CA-C 110.201 -0.73 . . . . 0.0 110.201 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -97.8 159.21 0.9 Allowed 'Trans proline' 1 CA--C 1.662 6.879 0 CA-C-O 112.144 -3.357 . . . . 0.0 108.086 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 71.9 Cg_endo -92.54 171.11 21.06 Favored 'Cis proline' 2 C--N 1.464 6.616 1 C-N-CA 95.217 -13.243 . . . . 0.0 119.232 -6.178 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -74.31 125.15 27.82 Favored 'General case' 0 N--CA 1.527 3.418 0 O-C-N 120.303 -1.498 . . . . 0.0 111.338 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 105' ' ' TYR 0.262 52.9 t80 -152.82 59.97 0.8 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.499 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.834 HD23 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -130.78 -152.8 0.53 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.36 24.98 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.333 -1.413 . . . . 0.0 109.919 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -122.26 154.66 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.574 -0.957 . . . . 0.0 110.391 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.726 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -81.08 138.75 19.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 177.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -60.31 -29.69 69.01 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -1.169 . . . . 0.0 110.285 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.42 145.85 7.28 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.6 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.64 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -114.02 131.54 56.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.2 tp60 -80.83 119.94 24.04 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.166 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.941 HD12 ' CD1' ' A' ' 92' ' ' TYR . 86.8 mt -86.86 119.99 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.053 . . . . 0.0 109.112 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' HD23 ' A' ' 10' ' ' LEU . 7.6 m-30 -91.74 120.09 32.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.145 -0.347 . . . . 0.0 110.328 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 85' ' ' ARG . 96.3 t . . . . . 0 N--CA 1.491 1.598 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.834 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.207 0.527 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' GLU . 93.3 t -123.85 134.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.517 -0.74 . . . . 0.0 110.075 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.38 54.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.108 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 25.9 mm100 -137.95 139.95 27.76 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.566 -0.709 . . . . 0.0 111.91 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.1 140.28 25.01 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 O-C-N 123.324 1.17 . . . . 0.0 109.109 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -151.7 159.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.713 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -137.82 156.02 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.374 0.607 . . . . 0.0 109.713 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.1 mt -117.08 126.6 53.09 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.705 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.92 138.18 40.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.428 -0.795 . . . . 0.0 109.22 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -75.98 -65.29 0.93 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.422 -0.798 . . . . 0.0 111.547 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -160.02 168.22 26.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.473 -0.767 . . . . 0.0 110.369 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.414 ' HB2' HD13 ' A' ' 16' ' ' ILE . 6.2 mtt180 54.16 21.05 2.83 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.674 -0.641 . . . . 0.0 111.252 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.12 35.59 64.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 16' ' ' ILE . 1.2 mp -99.14 97.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 0.0 108.906 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.27 114.36 28.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 80' ' ' THR . 32.8 t -121.07 131.97 54.6 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.689 0.757 . . . . 0.0 111.246 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.855 ' HB3' HG21 ' A' ' 9' ' ' VAL . 24.3 p90 -140.47 161.63 37.25 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 85.4 t -120.4 125.33 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.455 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.108 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.5 t -104.38 130.0 52.27 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.1 tt0 -102.83 138.75 39.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 111.378 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.873 ' CD2' HG11 ' A' ' 96' ' ' VAL . 19.7 p90 -137.32 -177.73 4.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.96 113.93 15.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.585 -0.697 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.5 p -141.75 164.37 34.93 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.542 -0.723 . . . . 0.0 110.151 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.678 ' HD2' HD21 ' A' ' 98' ' ' LEU . 43.4 Cg_endo -69.96 155.95 64.02 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.389 1.205 . . . . 0.0 110.095 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.2 19.96 51.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -119.93 32.61 5.97 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.212 -1.17 . . . . 0.0 110.775 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.11 140.04 47.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.652 -0.655 . . . . 0.0 110.342 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.512 ' O ' ' HE2' ' A' ' 53' ' ' MET . 40.3 p -92.03 10.72 27.9 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.528 -0.732 . . . . 0.0 110.572 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' OE1' HG21 ' A' ' 51' ' ' THR . 16.1 mm-40 -130.29 122.34 27.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.572 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 95.9 t -138.89 83.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 6.6 ttm180 -63.41 116.88 5.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.767 -0.583 . . . . 0.0 111.343 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 35.9 m -113.85 131.91 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.1 m -122.47 131.91 54.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.694 -0.629 . . . . 0.0 110.624 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.936 HG22 HD13 ' A' ' 79' ' ' LEU . 97.9 t -109.6 129.71 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.771 HD12 ' HE3' ' A' ' 95' ' ' LYS . 46.9 mt -125.46 165.14 18.98 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.87 ' HG3' HG21 ' A' ' 47' ' ' VAL . 75.0 mtm180 -121.31 119.92 33.59 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.718 ' HA ' HG22 ' A' ' 44' ' ' VAL . 34.0 tt0 -97.45 141.46 30.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -136.91 157.03 47.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.79 -40.17 87.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.5 m -75.61 -53.36 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.776 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.2 mt-30 -154.47 174.59 14.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.718 HG22 ' HA ' ' A' ' 39' ' ' GLN . 99.8 t -128.77 139.93 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -130.1 161.46 30.99 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.706 ' HA ' HD23 ' A' ' 37' ' ' LEU . 49.6 mt-10 -80.1 158.95 26.26 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 110.844 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 ' HG3' ' A' ' 38' ' ' ARG . 46.0 t -135.16 -66.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.226 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.683 ' SG ' HG12 ' A' ' 47' ' ' VAL . 71.3 m -129.93 142.65 50.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.26 -0.9 . . . . 0.0 111.22 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.85 131.97 14.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.657 -0.652 . . . . 0.0 110.278 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.9 157.61 14.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 0.0 110.334 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.579 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -102.21 116.01 31.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.578 ' N ' HD21 ' A' ' 58' ' ' LEU . 20.6 t80 -77.87 123.96 27.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.225 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 30' ' ' THR . 2.8 mtp -95.58 157.62 15.82 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.5 mmt -60.03 -27.63 67.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.843 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.04 48.01 0.99 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.971 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' A' ' 53' ' ' MET . 9.0 t-20 -157.81 -179.49 8.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.265 -1.138 . . . . 0.0 110.701 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -115.08 156.03 25.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 110.406 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' N ' ' A' ' 52' ' ' TYR . 85.3 mt -72.82 136.16 45.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.561 -0.712 . . . . 0.0 111.136 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.2 p -104.76 129.36 53.02 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.705 -0.622 . . . . 0.0 109.565 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 99.1 m-85 -119.99 66.2 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.761 . . . . 0.0 110.099 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.07 -39.48 90.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.536 -0.727 . . . . 0.0 110.767 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.58 131.27 44.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.434 -0.791 . . . . 0.0 110.728 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 52.17 49.01 21.51 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.492 -0.755 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -59.03 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.908 -0.495 . . . . 0.0 110.43 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 67' ' ' ILE . 49.0 mm 52.36 22.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.386 -1.446 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -160.03 160.65 33.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -123.88 139.92 53.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.55 121.72 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.978 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -130.06 155.12 46.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 68.9 m -160.06 137.95 9.94 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.857 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -140.27 140.06 35.65 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.89 -124.02 34.84 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -107.32 11.92 28.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.948 . . . . 0.0 110.927 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.0 mt-30 -116.65 129.29 56.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.122 -0.986 . . . . 0.0 111.016 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.7 m -110.12 126.23 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.433 -0.792 . . . . 0.0 110.221 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -98.64 117.89 34.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 111.585 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 36' ' ' VAL . 76.4 mt -110.38 130.47 55.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.615 -0.678 . . . . 0.0 109.52 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.488 HG23 ' HB2' ' A' ' 18' ' ' SER . 60.1 m -129.69 138.15 51.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.388 -0.82 . . . . 0.0 110.803 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 92' ' ' TYR . 84.3 mt -108.06 130.1 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 75.4 mt-30 -118.99 119.74 35.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.086 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.84 35.96 3.1 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.571 HD11 ' CG2' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -99.35 131.3 45.46 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.689 -0.889 . . . . 0.0 110.105 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 84' ' ' LEU . 72.3 mtt85 -86.26 160.6 19.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 109.921 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -29.03 66.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 26.1 ptm -66.52 -30.04 70.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.46 0.648 . . . . 0.0 109.526 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -77.48 -4.03 43.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.751 -0.593 . . . . 0.0 111.387 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 115' ' ' ILE . 59.4 m -55.31 140.01 40.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.958 -1.089 . . . . 0.0 109.62 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.63 -148.04 11.55 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.793 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 113' ' ' THR . 17.3 tp -106.93 130.23 54.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.741 -0.858 . . . . 0.0 111.754 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.866 ' CD1' HD12 ' A' ' 115' ' ' ILE . 50.8 m-85 -112.57 135.17 53.6 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -100.67 140.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 0.0 111.678 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 1.108 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 13.7 p -106.68 122.6 46.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.925 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.1 mttt -120.04 146.12 46.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.148 -0.97 . . . . 0.0 110.056 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 23' ' ' TYR . 2.7 t -140.44 107.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.529 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 99' ' ' MET . 2.5 mp0 -132.52 125.18 29.98 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.598 -0.841 . . . . 0.0 113.216 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 106' ' ' LEU . 9.4 mp -74.34 80.2 1.86 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 12.9 mmt -79.58 -48.15 14.29 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.556 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 87.0 m-85 -66.66 -42.92 48.36 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.955 -1.091 . . . . 0.0 113.531 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 51.4 Cg_endo -86.07 113.68 1.27 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 O-C-N 122.657 0.819 . . . . 0.0 112.697 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 60.1 Cg_endo -83.06 141.03 10.27 Favored 'Trans proline' 1 CA--C 1.654 6.515 0 CA-C-O 110.774 -3.928 . . . . 0.0 107.861 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.433 55.2 Cg_endo -102.61 179.54 3.91 Favored 'Cis proline' 3 C--N 1.524 9.813 1 C-N-CA 91.932 -14.612 . . . . 0.0 116.815 6.991 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.402 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 5.9 t80 -82.2 126.9 32.61 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 116.795 -3.691 . . . . 0.0 108.847 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.25 47.8 t80 -158.63 101.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.985 -0.447 . . . . 0.0 110.374 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 98' ' ' LEU . 2.8 tp -160.31 -143.46 0.1 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.542 -0.724 . . . . 0.0 110.454 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.27 -173.79 23.64 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.43 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.925 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.251 46.8 mm -131.46 168.87 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.406 -1.055 . . . . 0.0 110.347 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.833 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -105.95 134.13 11.95 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -60.1 -36.4 77.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.094 -1.239 . . . . 0.0 110.519 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.5 153.1 8.1 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.318 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.757 HG21 HG23 ' A' ' 9' ' ' VAL . 89.1 m -121.84 139.42 53.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.906 ' HB3' HG23 ' A' ' 8' ' ' VAL . 16.3 tp60 -79.95 138.21 37.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.866 HD12 ' CD1' ' A' ' 92' ' ' TYR . 46.8 mt -110.07 124.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CE2' HG21 ' A' ' 8' ' ' VAL . 16.7 m-30 -100.84 133.63 45.03 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.084 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 84' ' ' LEU . 98.0 t . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.063 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.453 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.325 0.583 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -148.29 144.34 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.85 -0.531 . . . . 0.0 109.862 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.65 127.07 51.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.589 -0.694 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.926 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 15.1 mm100 -142.12 130.65 11.89 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.642 -0.661 . . . . 0.0 111.3 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.64 139.97 31.87 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.175 1.092 . . . . 0.0 109.367 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.01 69.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.954 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -154.23 162.9 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.26 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' A' ' 113' ' ' THR . 8.3 t -141.74 151.86 19.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.954 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.4 mt -110.61 127.03 55.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.26 148.98 23.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.413 -0.805 . . . . 0.0 110.984 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -69.41 172.16 7.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.603 -0.686 . . . . 0.0 110.521 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -60.1 -36.05 76.57 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.557 -0.714 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.653 ' CG ' HD13 ' A' ' 16' ' ' ILE . 27.1 tpt180 -57.16 -25.49 59.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.556 -0.715 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.603 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 101.14 26.44 7.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.653 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -108.06 112.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 121.626 -0.926 . . . . 0.0 110.52 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -110.54 124.74 52.39 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.794 ' OG ' HG23 ' A' ' 80' ' ' THR . 53.0 m -126.97 140.09 52.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.583 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.6 p90 -148.55 163.5 37.02 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 77' ' ' VAL . 63.2 t -130.31 123.73 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.731 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 77' ' ' VAL . 37.6 t -100.01 108.04 20.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 tt0 -84.97 139.45 31.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 0.0 110.519 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 96' ' ' VAL . 41.1 p90 -130.6 177.6 7.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 0.0 109.6 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.94 138.1 35.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.85 -0.532 . . . . 0.0 110.157 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.7 p -125.83 149.83 66.95 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.95 -13.98 34.89 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.462 1.243 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.6 -170.13 18.02 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.99 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.542 -0.975 . . . . 0.0 110.52 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -139.43 151.67 46.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.62 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' MET . 32.4 p -79.9 -43.59 21.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 111.097 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.4 mm-40 -79.68 84.77 5.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.021 -0.671 . . . . 0.0 112.713 -175.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.719 HG11 ' OH ' ' A' ' 52' ' ' TYR . 48.1 t -97.79 89.38 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.705 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -67.15 123.42 20.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.915 -0.491 . . . . 0.0 110.703 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -118.48 134.75 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.58 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.4 m -134.41 159.71 40.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.411 -0.805 . . . . 0.0 110.025 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.97 HG22 HD13 ' A' ' 79' ' ' LEU . 84.5 t -128.84 139.24 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 46' ' ' GLU . 6.2 mt -131.16 171.0 13.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.687 -1.258 . . . . 0.0 111.67 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 47' ' ' VAL . 89.9 mtt180 -125.72 118.39 25.48 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -101.78 126.25 48.61 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.391 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -97.16 -171.57 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.21 -43.81 95.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 111.019 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -131.96 -0.16 3.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 111.949 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 62.8 mt-30 -135.1 155.59 50.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.06 -1.025 . . . . 0.0 110.943 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.8 139.73 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.604 -0.685 . . . . 0.0 109.629 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.9 p -127.03 160.1 32.13 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.437 -0.789 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 37' ' ' LEU . 77.0 mt-10 -86.45 160.04 19.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.647 -0.658 . . . . 0.0 110.742 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 71.5 t -123.41 -71.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.807 -0.558 . . . . 0.0 110.232 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' CB ' ' A' ' 63' ' ' ASP . 80.7 m -147.17 153.71 40.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.31 30.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.508 -0.745 . . . . 0.0 111.258 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 59' ' ' THR . . . -170.44 155.68 5.21 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.601 -0.687 . . . . 0.0 109.658 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' N ' ' A' ' 33' ' ' ARG . 2.8 m -116.27 122.76 45.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.719 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.1 p90 -94.05 124.39 38.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.307 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 3.2 mmt -60.62 -44.7 96.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 166.44 102.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.46 63.0 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.93 159.86 23.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -1.026 . . . . 0.0 110.472 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -70.72 151.6 44.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -90.16 123.89 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.577 -0.702 . . . . 0.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 53.9 p -92.57 131.91 37.3 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 67.9 m-85 -113.86 123.92 50.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.764 . . . . 0.0 110.363 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.74 -36.06 77.93 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.485 -0.759 . . . . 0.0 109.79 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -140.07 174.46 10.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 109.671 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CB ' ' SG ' ' A' ' 48' ' ' CYS . 85.8 m-20 52.65 51.02 16.89 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.1 m -52.36 -21.8 3.95 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.622 -0.674 . . . . 0.0 111.382 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.69 -21.88 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.271 -0.893 . . . . 0.0 110.811 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.3 m -72.43 126.36 29.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.342 -0.849 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.43 HG21 ' OE1' ' A' ' 82' ' ' GLN . 9.2 t -139.98 149.93 43.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.99 -171.52 42.95 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 72' ' ' SER . 94.4 m -129.73 168.46 16.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.939 -0.742 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 71' ' ' THR . 97.2 p -138.33 152.51 48.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.505 -0.747 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -133.7 -173.64 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.746 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -49.67 76.09 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.6 3.86 6.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.463 -1.022 . . . . 0.0 111.272 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 19.2 tt0 -124.27 129.62 51.08 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.09 -1.006 . . . . 0.0 110.851 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.8 m -113.23 132.84 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 64.8 t-20 -110.11 115.97 30.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.97 HD13 HG22 ' A' ' 36' ' ' VAL . 86.6 mt -111.47 133.05 54.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 109.752 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.794 HG23 ' OG ' ' A' ' 18' ' ' SER . 94.5 m -130.87 145.06 51.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.34 -0.85 . . . . 0.0 110.811 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -119.92 140.08 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.611 -0.681 . . . . 0.0 109.874 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.7 mt-30 -123.83 121.93 36.68 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.803 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.36 46.37 1.0 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.813 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -90.03 122.79 33.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.635 -0.92 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -102.59 178.0 4.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.69 95.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.325 -0.86 . . . . 0.0 109.401 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.8 ttm -63.45 -39.98 95.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.753 -0.592 . . . . 0.0 110.742 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.79 -21.06 62.71 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.598 -0.689 . . . . 0.0 111.025 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.9 m -51.84 140.01 20.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.921 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.88 -158.59 31.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 113' ' ' THR . 17.2 tp -108.2 123.99 49.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.637 -0.919 . . . . 0.0 111.97 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.938 ' CD1' HD12 ' A' ' 115' ' ' ILE . 51.0 m-85 -103.18 140.02 37.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.862 HG23 ' O ' ' A' ' 110' ' ' GLY . 4.2 mp -111.33 130.59 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.665 -0.647 . . . . 0.0 111.775 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.926 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 20.2 p -79.97 157.91 26.71 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.782 ' HG3' HD12 ' A' ' 109' ' ' ILE . 7.9 tttt -153.65 97.2 2.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.93 -1.106 . . . . 0.0 109.457 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.868 HG22 ' CD2' ' A' ' 106' ' ' LEU . 4.0 p -111.17 116.78 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.9 0.857 . . . . 0.0 111.37 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -135.7 124.15 23.46 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.914 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.858 HD23 HD13 ' A' ' 106' ' ' LEU . 4.1 mm? -75.47 76.48 2.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.9 ttm -78.73 -40.42 33.56 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 83.4 m-85 -62.97 -45.72 86.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.234 -0.986 . . . . 0.0 112.446 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 56.2 Cg_endo -81.3 129.62 6.79 Favored 'Trans proline' 0 C--O 1.284 2.805 0 O-C-N 122.776 0.882 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 72.1 Cg_endo -83.86 166.14 13.32 Favored 'Trans proline' 1 CA--C 1.656 6.601 0 CA-C-O 113.526 -2.781 . . . . 0.0 108.966 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.349 56.6 Cg_endo -96.47 50.54 1.46 Allowed 'Cis proline' 2 C--N 1.477 7.331 1 C-N-CA 89.174 -15.761 . . . . 0.0 115.439 -7.756 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.0 t80 67.36 122.26 0.02 OUTLIER 'General case' 1 N--CA 1.554 4.727 1 O-C-N 115.783 -4.323 . . . . 0.0 112.965 179.931 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.476 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.1 p90 -159.84 100.3 1.42 Allowed 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.31 -1.494 . . . . 0.0 109.91 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.868 ' CD2' HG22 ' A' ' 96' ' ' VAL . 1.4 tp -160.24 -146.66 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' O ' HD13 ' A' ' 109' ' ' ILE . . . -159.71 170.69 35.96 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.049 -1.548 . . . . 0.0 111.254 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.782 HD12 ' HG3' ' A' ' 95' ' ' LYS . 22.8 mm -124.18 149.68 28.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.685 -0.891 . . . . 0.0 109.25 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.862 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -91.41 144.71 17.34 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -68.12 -24.71 65.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.242 . . . . 0.0 110.592 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 126.53 165.79 12.05 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.137 -1.506 . . . . 0.0 113.849 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 59.5 m -129.28 127.63 41.58 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.954 ' HB3' HG23 ' A' ' 8' ' ' VAL . 8.8 tp-100 -67.98 142.72 55.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.93 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.938 HD12 ' CD1' ' A' ' 92' ' ' TYR . 64.6 mt -118.5 126.38 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.85 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.1 m-85 -110.16 139.98 44.74 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.834 -0.541 . . . . 0.0 110.328 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 84.8 t . . . . . 0 N--CA 1.491 1.585 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.449 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.9 m80 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.439 0.638 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.833 HG12 ' OE1' ' A' ' 5' ' ' GLN . 53.3 t -147.04 148.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -135.02 135.81 41.63 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.051 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.833 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -140.0 146.49 46.85 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.648 -0.658 . . . . 0.0 110.095 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 42.6 Cg_endo -69.87 147.95 63.31 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.254 1.134 . . . . 0.0 109.565 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.93 -20.77 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.835 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.7 p -160.6 160.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.029 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 113' ' ' THR . 33.6 t -137.13 159.6 36.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.155 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.698 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.8 mt -120.0 130.37 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.289 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -100.89 133.37 45.46 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -135.81 162.43 32.81 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.289 -0.882 . . . . 0.0 112.476 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t 59.31 -115.87 0.78 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.728 -0.608 . . . . 0.0 110.827 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 16' ' ' ILE . 5.9 mtt180 -59.93 -13.06 9.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 111.346 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.22 43.47 5.91 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.3 mm -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -98.59 124.1 43.16 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.998 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 80' ' ' THR . 15.0 t -126.2 131.29 52.01 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 28.2 p90 -139.73 165.82 26.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.742 -0.599 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 57.5 t -123.92 127.27 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.859 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.675 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -110.03 119.79 40.41 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -93.16 154.25 18.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.935 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' HG11 ' A' ' 96' ' ' VAL . 45.8 p90 -134.01 -175.99 4.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.64 116.95 20.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.351 -0.843 . . . . 0.0 111.799 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 106' ' ' LEU . 69.8 m -161.68 155.89 18.97 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.712 -0.618 . . . . 0.0 109.696 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.97 -19.94 45.4 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.286 1.151 . . . . 0.0 110.733 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.98 35.9 33.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -102.64 26.86 7.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.366 -1.079 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -148.19 144.74 27.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 53' ' ' MET . 16.1 p -80.28 -39.11 29.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.731 0.777 . . . . 0.0 111.655 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.694 ' OE1' HG21 ' A' ' 51' ' ' THR . 4.7 mm-40 -80.19 82.85 6.16 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.918 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 86.8 t -93.67 84.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.798 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 60.1 ttt180 -59.98 123.17 16.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.676 -0.64 . . . . 0.0 111.084 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 32' ' ' VAL . 31.9 m -123.4 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.8 m -120.92 131.61 54.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.236 0.541 . . . . 0.0 110.636 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.837 HG22 HD13 ' A' ' 79' ' ' LEU . 86.4 t -107.76 130.39 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD12 ' HE3' ' A' ' 95' ' ' LYS . 78.9 mt -124.62 169.93 11.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.992 -1.068 . . . . 0.0 111.958 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -130.26 121.39 26.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' HG2' ' CG1' ' A' ' 44' ' ' VAL . 83.2 mt-30 -110.24 131.98 54.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.346 -0.846 . . . . 0.0 111.061 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.36 152.77 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.57 -44.21 93.38 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 0.0 110.543 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.44 -44.87 66.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.3 mt-30 -154.89 160.16 40.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.469 -0.769 . . . . 0.0 111.263 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 92.2 t -126.86 139.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -145.21 160.38 41.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.453 -0.779 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 13.7 mt-10 -80.71 156.16 26.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.691 -0.631 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 48' ' ' CYS . 85.4 t -114.49 -83.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.345 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' ' OD2' ' A' ' 63' ' ' ASP . 80.8 m -122.0 160.9 23.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 110.866 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.37 135.55 6.03 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.91 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 59' ' ' THR . . . -172.1 165.34 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.419 -0.8 . . . . 0.0 110.594 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.694 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.9 m -97.9 123.94 42.1 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 27.6 t80 -88.31 106.79 18.46 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.135 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -76.17 157.86 32.29 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.4 mmt -59.64 -28.5 67.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.852 -1.155 . . . . 0.0 110.084 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.84 -79.04 0.17 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 58' ' ' LEU . 25.1 t30 -154.15 178.49 9.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.39 -1.065 . . . . 0.0 110.665 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.715 ' C ' HD22 ' A' ' 58' ' ' LEU . 7.2 tp10 -120.07 120.15 35.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.65 -0.656 . . . . 0.0 109.746 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 58' ' ' LEU . 2.4 mm? -124.28 46.22 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.571 HG21 ' HB1' ' A' ' 50' ' ' ALA 0.285 36.8 p -116.4 -132.14 0.32 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.791 -0.568 . . . . 0.0 110.909 -178.016 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 57' ' ' GLU . 39.8 m-85 60.57 25.12 14.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.825 -1.172 . . . . 0.0 109.426 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.72 -36.42 80.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 111.402 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -59.63 -43.28 93.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.413 -0.805 . . . . 0.0 111.812 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 1.045 ' OD2' ' SG ' ' A' ' 48' ' ' CYS . 95.9 m-20 -92.88 -13.2 29.29 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.164 0.507 . . . . 0.0 110.78 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t 42.4 24.93 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -144.85 -43.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.018 -1.051 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 22.9 p -67.82 134.64 51.29 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -0.857 . . . . 0.0 111.344 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -130.02 139.98 50.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA3' HD23 ' A' ' 79' ' ' LEU . . . -139.05 158.02 25.08 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.357 -1.401 . . . . 0.0 111.111 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.1 m -130.05 159.92 35.26 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 53.4 m -145.93 127.24 14.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -139.96 129.99 24.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.774 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.84 -124.07 35.08 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -106.45 16.43 24.7 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.933 . . . . 0.0 110.715 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.3 mt-30 -119.95 123.92 44.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 111.09 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -104.54 121.82 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.661 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' HG22 ' A' ' 20' ' ' VAL . 55.5 t30 -101.43 107.8 19.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.119 -0.988 . . . . 0.0 111.391 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.837 HD13 HG22 ' A' ' 36' ' ' VAL . 61.6 mt -97.34 131.92 43.56 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.449 -0.782 . . . . 0.0 109.673 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 18' ' ' SER . 59.2 m -124.42 139.2 54.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 0.0 111.034 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.622 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -113.55 129.94 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.728 -0.608 . . . . 0.0 109.618 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 16' ' ' ILE . 35.2 mt-30 -112.54 118.26 34.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.282 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.67 51.37 0.75 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 81' ' ' ILE . 76.6 mt -84.59 129.79 34.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.546 -0.973 . . . . 0.0 111.381 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -112.21 175.48 5.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.06 94.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.875 0.845 . . . . 0.0 109.855 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.2 mmt -66.17 -32.94 74.68 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.191 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.11 -24.91 67.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.44 -0.787 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 115' ' ' ILE . 42.4 m -51.88 137.85 25.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.52 -163.83 34.76 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 15.7 tp -94.77 129.94 41.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.886 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CD2' HD12 ' A' ' 115' ' ' ILE . 78.5 m-85 -113.44 136.35 52.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -104.16 133.05 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.429 -0.795 . . . . 0.0 112.117 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.822 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.6 p -97.49 122.34 40.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.907 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.7 mttt -119.1 143.86 46.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.363 -0.836 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' CD1' ' A' ' 106' ' ' LEU . 11.1 t -136.51 111.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.889 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -132.39 130.22 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.34 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 31.7 mt -86.94 82.84 7.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.798 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 3.4 ttm -82.67 -45.92 13.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.904 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 91.0 m-85 -69.71 -42.89 20.17 Favored Pre-proline 0 N--CA 1.508 2.456 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HG3' ' HB1' ' A' ' 29' ' ' ALA . 60.7 Cg_endo -82.36 143.09 12.25 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.734 -1.295 . . . . 0.0 108.734 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.431 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 53.1 Cg_endo -92.88 173.04 2.04 Favored 'Trans proline' 1 CA--C 1.658 6.72 0 CA-C-O 113.417 -2.826 . . . . 0.0 107.536 177.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 88.5 Cg_endo -92.18 49.39 1.24 Allowed 'Cis proline' 2 C--N 1.503 8.698 1 C-N-CA 91.326 -14.864 . . . . 0.0 115.228 -14.585 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 2.3 t80 55.82 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 118.692 -2.505 . . . . 0.0 111.692 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -147.19 105.74 3.8 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 119.617 -1.927 . . . . 0.0 108.777 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.731 ' CD1' HG12 ' A' ' 96' ' ' VAL . 1.7 mt -159.3 -157.97 0.63 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.829 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -151.22 -167.61 14.94 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.907 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.258 46.6 mm -134.93 169.39 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.561 -0.964 . . . . 0.0 110.5 -178.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.822 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -104.48 139.49 14.61 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.26 -36.81 78.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.388 -1.066 . . . . 0.0 110.536 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.81 144.49 5.92 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.691 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -115.5 137.45 52.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.589 ' HB3' HG23 ' A' ' 8' ' ' VAL . 12.8 tt0 -89.92 124.05 34.38 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.371 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.697 HD12 ' CD2' ' A' ' 92' ' ' TYR . 82.7 mt -90.45 129.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.835 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.7 m-30 -100.35 140.0 35.21 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.422 0.63 . . . . 0.0 111.976 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.026 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.142 0.496 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.2 132.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 110.001 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.41 54.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.632 -0.668 . . . . 0.0 109.722 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 1.079 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 96.3 mm-40 -137.34 148.02 60.35 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.785 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.0 152.83 68.22 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.429 1.226 . . . . 0.0 109.146 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.98 -12.17 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 110.792 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' HE2' ' A' ' 116' ' ' TYR . 2.3 p -139.95 137.62 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.67 ' CG2' HG21 ' A' ' 113' ' ' THR . 8.9 t -137.85 145.66 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.127 -1.608 . . . . 0.0 110.846 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 116' ' ' TYR . 70.8 mt -114.84 148.31 38.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.465 -0.772 . . . . 0.0 110.539 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.88 -171.5 1.84 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.513 -0.742 . . . . 0.0 110.413 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 t -123.84 172.87 8.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -60.79 -39.13 87.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.469 -0.769 . . . . 0.0 109.744 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.471 ' CB ' HD13 ' A' ' 16' ' ' ILE . 22.4 mmt85 -60.51 -28.04 68.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.0 109.854 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 27.14 8.25 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' CB ' ' A' ' 14' ' ' ARG . 1.3 mp -97.73 99.89 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.3 126.11 51.74 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -133.83 149.55 51.39 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.092 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.11 163.94 39.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 68.9 t -119.91 124.04 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.033 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.079 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.3 t -102.78 107.91 18.94 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -86.96 141.55 28.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 112.358 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -127.38 174.72 8.76 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.34 131.87 21.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.843 . . . . 0.0 111.483 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 106' ' ' LEU . 6.4 t -164.64 153.05 10.89 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.676 -0.64 . . . . 0.0 110.555 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.86 149.86 48.47 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.654 1.344 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.85 -179.19 5.34 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -132.83 151.06 52.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.71 -0.876 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.07 48.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.599 -0.688 . . . . 0.0 109.615 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 54' ' ' MET . 57.9 p -79.81 -39.06 31.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.335 -0.853 . . . . 0.0 110.649 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 38.0 mm-40 -79.76 76.72 6.42 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.447 -175.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 34' ' ' VAL . 91.3 t -94.25 82.03 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HE ' ' HE3' ' A' ' 99' ' ' MET . 18.7 ttp85 -59.5 121.53 11.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.821 -0.549 . . . . 0.0 110.955 -178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -125.35 139.86 50.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.571 0.7 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 72.1 m -135.22 133.06 38.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.033 -0.417 . . . . 0.0 109.982 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 79' ' ' LEU . 95.4 t -105.11 132.35 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.544 -0.723 . . . . 0.0 109.123 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.751 HD12 ' HE3' ' A' ' 95' ' ' LYS . 83.1 mt -126.41 168.01 14.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.128 -0.982 . . . . 0.0 111.176 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -129.61 128.54 42.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -109.86 132.05 54.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.322 -0.861 . . . . 0.0 111.397 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.36 178.76 5.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.932 -0.48 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.33 -40.12 89.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.0 111.514 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.4 m -118.37 -19.96 8.68 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 112.112 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' C ' HG23 ' A' ' 44' ' ' VAL . 83.9 mm-40 -131.79 179.29 6.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.14 -0.975 . . . . 0.0 112.142 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.464 HG23 ' C ' ' A' ' 43' ' ' GLN . 84.5 t -149.88 143.52 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.81 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -138.72 156.13 47.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.455 -0.778 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 68.6 mt-10 -80.16 147.57 31.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 111.54 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.1 t -102.89 -73.92 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.952 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 14.5 p -159.92 164.65 33.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 110.133 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -169.39 161.01 9.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.205 -0.934 . . . . 0.0 111.603 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . . . -172.0 157.68 4.47 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -84.58 119.82 25.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.681 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 71' ' ' THR . 44.2 t80 -79.96 99.52 7.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.682 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 mmt -71.78 138.11 48.14 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 8.8 tpp -68.03 -19.99 64.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.73 -21.12 8.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.94 161.3 28.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -1.151 . . . . 0.0 110.701 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -121.75 124.39 44.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.408 -0.808 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 51' ' ' THR . 69.3 mt -93.16 166.14 12.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 p -119.75 135.04 55.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.784 -0.572 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.952 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 5.3 m-30 -67.2 136.71 55.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.4 tt -68.97 -42.06 77.1 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -118.25 -172.12 2.2 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.915 -1.115 . . . . 0.0 112.615 -177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 56.18 56.77 5.55 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.444 0.64 . . . . 0.0 110.88 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.1 m 52.09 26.64 3.95 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.551 -0.718 . . . . 0.0 110.705 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt 53.98 76.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.503 -0.748 . . . . 0.0 110.762 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.524 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -64.74 149.98 48.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.29 -0.882 . . . . 0.0 108.735 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -119.11 143.57 47.1 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.57 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -130.17 140.91 12.13 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 61.4 m -116.1 160.9 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.856 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 46.4 t -143.75 109.8 5.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.75 -0.594 . . . . 0.0 110.487 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -151.77 140.63 20.98 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.517 -0.74 . . . . 0.0 110.319 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.81 99.67 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.21 21.23 6.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.621 -0.929 . . . . 0.0 110.354 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -124.65 125.68 44.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.584 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -102.7 124.11 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.174 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 47.7 t-20 -102.41 115.95 31.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.0 111.15 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 36' ' ' VAL . 84.2 mt -100.61 137.95 38.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.509 -0.745 . . . . 0.0 109.586 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 m -127.72 131.97 49.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.826 . . . . 0.0 110.78 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -110.68 138.3 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 109.872 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 62.6 mt-30 -124.02 122.15 37.14 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.093 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.54 2.83 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 76.0 mt -87.14 129.93 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.499 -1.001 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -102.6 177.19 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.863 0.839 . . . . 0.0 109.747 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -67.61 -29.96 69.42 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.353 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -66.4 -16.49 64.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 111.451 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 115' ' ' ILE . 23.0 m -49.8 150.03 2.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 110.415 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.09 -168.62 32.48 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.4 tp -88.91 130.11 35.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.716 -0.873 . . . . 0.0 112.691 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 115' ' ' ILE . 67.7 m-85 -118.5 140.84 49.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.5 mp -98.14 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.412 -0.805 . . . . 0.0 111.903 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.896 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 18.7 p -109.02 116.4 31.91 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.751 ' HE3' HD12 ' A' ' 37' ' ' LEU . 15.5 mttt -111.61 142.7 43.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.018 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.622 HG12 ' CD2' ' A' ' 106' ' ' LEU . 8.2 t -142.17 105.62 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -128.76 125.27 37.52 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.948 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.727 ' HG ' HD22 ' A' ' 106' ' ' LEU . 52.7 mt -81.65 76.35 8.57 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.437 ' HE3' ' HE ' ' A' ' 33' ' ' ARG . 5.8 ttm -80.89 -52.48 7.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.5 m-85 -62.46 -41.83 76.11 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.091 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 55.9 Cg_endo -85.71 113.79 1.37 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 120.831 1.021 . . . . 0.0 111.233 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 71.7 Cg_endo -90.72 150.99 4.14 Favored 'Trans proline' 1 CA--C 1.688 8.215 0 C-N-CA 123.042 2.495 . . . . 0.0 108.671 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.302 69.7 Cg_endo -83.56 176.09 34.75 Favored 'Cis proline' 2 C--N 1.469 6.892 1 C-N-CA 95.565 -13.098 . . . . 0.0 118.149 -8.53 . . . . . . . . 5 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.17 127.26 32.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.182 -1.574 . . . . 0.0 109.687 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -148.48 87.61 1.59 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.93 -1.106 . . . . 0.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.727 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.2 tp -155.0 -145.95 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.256 -0.903 . . . . 0.0 110.767 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.37 -172.45 31.86 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.586 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 95' ' ' LYS . 84.5 mt -126.87 160.31 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.76 -0.847 . . . . 0.0 110.492 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.896 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.9 130.09 10.11 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.116 -2.393 . . . . 0.0 107.116 177.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.61 -32.39 70.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.324 -1.103 . . . . 0.0 111.051 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 135.14 151.54 6.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.934 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.67 HG21 ' CG2' ' A' ' 9' ' ' VAL . 65.5 m -124.76 149.81 46.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.423 ' HG2' ' CE1' ' A' ' 116' ' ' TYR . 58.2 tt0 -97.13 119.83 36.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.446 -1.301 . . . . 0.0 110.004 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 92' ' ' TYR . 96.0 mt -81.28 140.1 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.685 ' HB2' HD23 ' A' ' 10' ' ' LEU . 48.4 m-85 -120.92 152.58 38.32 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.318 0.58 . . . . 0.0 112.236 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.73 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.262 0.553 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 mtp 54.04 21.97 3.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.508 -0.745 . . . . 0.0 111.354 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 3' ' ' VAL . 35.9 m80 -108.11 26.1 10.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 110.303 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -149.6 118.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -106.81 128.45 54.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.568 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -149.83 143.64 16.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.85 136.24 32.26 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.323 1.17 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.63 69.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.929 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -144.83 165.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.755 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HB ' HD13 ' A' ' 115' ' ' ILE . 8.3 t -139.33 130.56 33.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 121.753 0.787 . . . . 0.0 111.181 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 10' ' ' LEU . 3.6 mm? -87.59 129.9 34.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' O ' HD13 ' A' ' 118' ' ' ILE . . . -106.41 154.77 20.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.815 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.0 m -75.2 172.47 12.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.727 -0.608 . . . . 0.0 109.732 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 m -59.79 -40.08 87.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.01 -29.58 69.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.486 -0.759 . . . . 0.0 110.029 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 109.03 41.49 1.41 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.5 mp -100.5 102.11 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.672 -0.899 . . . . 0.0 108.85 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -108.75 114.16 27.72 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.87 ' OG ' HG23 ' A' ' 80' ' ' THR . 52.8 m -130.8 131.72 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.554 0.692 . . . . 0.0 110.886 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' HG21 ' A' ' 9' ' ' VAL . 38.5 p90 -150.07 163.97 36.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.781 -0.574 . . . . 0.0 109.476 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.6 t -123.45 122.36 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.692 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -103.84 108.5 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 15.2 pt-20 -81.66 162.57 22.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.19 -0.944 . . . . 0.0 110.867 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.2 p90 -140.13 176.36 8.82 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 130.85 45.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.795 -0.566 . . . . 0.0 110.409 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.5 p -132.77 155.94 80.62 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.558 -0.714 . . . . 0.0 110.081 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.15 -16.89 45.21 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.391 1.206 . . . . 0.0 111.216 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -171.99 37.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -100.63 137.3 39.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.598 -0.942 . . . . 0.0 110.127 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.96 170.67 15.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.537 -0.727 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.076 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -81.15 -8.64 59.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.583 -0.698 . . . . 0.0 112.494 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 51' ' ' THR . 18.6 mm-40 -129.46 108.26 10.13 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.944 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 78.0 t -125.89 80.45 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.76 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 67.8 ttt180 -59.97 124.59 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 111.427 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -114.73 153.98 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 95' ' ' LYS . 20.3 m -144.0 141.41 30.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 79' ' ' LEU . 85.6 t -116.86 124.07 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.6 mt -120.07 153.36 36.2 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.518 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 47' ' ' VAL . 69.0 mtm180 -111.28 123.96 51.26 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.0 tt0 -96.25 139.99 31.6 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.853 0.835 . . . . 0.0 110.937 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -134.04 156.98 47.27 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.83 -43.86 94.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.4 m -70.0 -47.28 62.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.648 -0.657 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.777 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.2 tt0 -165.15 169.48 16.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 111.241 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.3 t -116.73 140.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -130.03 160.58 33.25 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.326 -0.859 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.822 ' HA ' HD23 ' A' ' 37' ' ' LEU . 96.9 mt-10 -80.03 154.85 27.9 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.9 HG21 ' HG3' ' A' ' 38' ' ' ARG . 45.8 t -130.89 -83.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.705 -0.622 . . . . 0.0 111.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.655 ' SG ' HG12 ' A' ' 47' ' ' VAL . 83.2 m -110.14 149.45 30.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.076 -1.015 . . . . 0.0 110.925 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.04 141.41 15.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.538 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 58' ' ' LEU . . . -165.79 163.35 18.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 109.842 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 31' ' ' GLU . 5.5 m -97.45 116.31 29.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.703 ' CZ ' ' SD ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -72.9 91.94 1.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 1.076 ' SD ' ' O ' ' A' ' 30' ' ' THR . 35.8 mmm -85.0 129.96 34.7 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.703 ' SD ' ' CZ ' ' A' ' 52' ' ' TYR . 18.0 mmt -59.43 -27.98 66.54 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.618 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.66 43.41 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 53' ' ' MET . 11.2 t30 -149.8 -179.99 7.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.0 -1.294 . . . . 0.0 110.846 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.61 156.39 19.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.656 -0.653 . . . . 0.0 110.65 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 50' ' ' ALA . 80.4 mt -70.28 139.93 52.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.972 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 p -104.55 118.33 36.32 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.718 . . . . 0.0 110.102 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.87 37.85 2.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.472 -0.768 . . . . 0.0 110.307 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.436 -0.79 . . . . 0.0 110.662 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -85.7 127.12 34.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.355 -0.841 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 52.24 47.52 24.56 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.318 -0.864 . . . . 0.0 109.932 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -57.53 -106.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.983 -0.448 . . . . 0.0 110.823 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.8 mt 52.04 22.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.342 -1.473 . . . . 0.0 110.534 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.05 158.21 24.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.988 . . . . 0.0 110.339 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.712 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.0 t -132.75 139.95 47.83 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.82 154.12 25.09 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.411 -1.376 . . . . 0.0 111.066 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 72' ' ' SER . 94.2 m -130.04 163.51 26.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 32.8 t -143.39 130.02 20.24 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.773 -0.58 . . . . 0.0 109.961 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -142.42 133.85 26.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -0.783 . . . . 0.0 109.744 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.5 -123.99 27.54 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -105.9 16.43 25.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.674 -0.897 . . . . 0.0 110.441 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.87 123.94 44.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 111.013 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.0 m -99.49 130.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -107.97 118.38 36.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 111.459 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD13 ' CG2' ' A' ' 36' ' ' VAL . 74.0 mt -108.95 132.05 54.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.87 HG23 ' OG ' ' A' ' 18' ' ' SER . 86.6 m -121.14 132.2 54.71 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 0.0 110.173 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.789 HG21 HD21 ' A' ' 84' ' ' LEU . 94.9 mt -116.38 130.16 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.642 -0.661 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.5 mt-30 -124.54 120.86 33.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.648 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.28 48.68 0.69 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 81' ' ' ILE . 81.2 mt -96.0 108.41 20.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.488 -1.007 . . . . 0.0 111.308 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -82.85 -176.62 6.4 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.21 92.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.8 -38.84 83.85 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.117 0.484 . . . . 0.0 111.103 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -60.0 -35.39 74.95 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.544 -0.723 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 115' ' ' ILE . 35.7 m -51.46 135.96 26.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.97 -144.03 7.83 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.908 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 92' ' ' TYR . 2.1 tm? -106.62 139.42 41.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.779 -0.836 . . . . 0.0 110.816 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.868 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -124.53 125.3 43.97 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.741 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -97.94 120.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.365 -0.834 . . . . 0.0 111.949 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 30.8 p -84.15 122.4 28.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.757 ' HD2' HD12 ' A' ' 109' ' ' ILE . 10.5 mtmt -113.9 150.59 33.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.304 -0.873 . . . . 0.0 109.986 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.704 HG11 ' CG ' ' A' ' 23' ' ' TYR . 24.6 t -141.39 103.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.03 117.34 18.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.759 HD13 HD23 ' A' ' 106' ' ' LEU . 8.7 mp -75.6 75.35 2.61 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.76 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 22.9 ttm -78.39 -38.31 42.04 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.932 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.429 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 92.8 m-85 -67.51 -44.96 46.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 55.7 Cg_endo -80.8 137.18 11.06 Favored 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 120.463 0.776 . . . . 0.0 110.469 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 73.6 Cg_endo -89.98 143.81 4.17 Favored 'Trans proline' 2 CA--C 1.708 9.188 0 CA-C-O 112.032 -3.403 . . . . 0.0 110.923 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.305 51.0 Cg_endo -114.41 64.67 0.26 Allowed 'Cis proline' 2 C--N 1.443 5.526 1 C-N-CA 93.233 -14.07 . . . . 0.0 113.31 5.111 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' PRO . 4.3 t80 48.14 111.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.092 -2.255 . . . . 0.0 111.8 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' O ' HD22 ' A' ' 106' ' ' LEU . 28.9 t80 -160.64 107.99 1.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.83 1.3 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.45 -142.83 0.11 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.562 -179.195 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.99 167.41 32.23 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.0 mm -119.82 157.15 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.946 -0.737 . . . . 0.0 109.082 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.701 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -86.32 141.55 18.3 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.424 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 9.2 m120 -60.01 -36.24 76.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.995 . . . . 0.0 110.11 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.797 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 129.64 143.14 5.4 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.866 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 98.1 m -111.42 131.94 54.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.833 ' HB3' HG23 ' A' ' 8' ' ' VAL . 32.8 tp60 -79.97 131.88 35.91 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.925 HD13 ' HB ' ' A' ' 9' ' ' VAL . 22.1 mm -99.74 121.17 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.135 . . . . 0.0 108.61 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.929 ' CE2' HG21 ' A' ' 8' ' ' VAL . 13.2 m-30 -101.37 147.15 26.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.794 -0.566 . . . . 0.0 110.555 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.532 ' C ' HD12 ' A' ' 118' ' ' ILE . 86.4 t -133.91 164.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.89 0.852 . . . . 0.0 110.008 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.655 HD12 ' N ' ' A' ' 118' ' ' ILE 0.258 3.5 mp -111.53 138.62 39.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.206 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.51 108.05 51.31 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.499 -0.751 . . . . 0.0 109.556 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.15 149.85 64.99 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.185 1.097 . . . . 0.0 110.748 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -129.98 139.84 36.85 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.626 -0.671 . . . . 0.0 110.053 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.83 -12.03 31.94 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.215 1.113 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.29 156.17 42.49 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.83 -20.0 46.19 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.392 1.206 . . . . 0.0 110.85 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -139.99 163.97 31.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.861 . . . . 0.0 110.276 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.6 p -100.6 12.03 38.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.717 . . . . 0.0 111.016 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.07 -36.33 77.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.229 -0.919 . . . . 0.0 110.402 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -127.77 148.81 50.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.583 -0.698 . . . . 0.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 61.4 mt-10 52.08 49.98 7.6 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.518 -0.739 . . . . 0.0 111.047 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.8 Cg_endo -69.99 150.06 66.28 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.186 1.098 . . . . 0.0 110.414 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.609 -0.682 . . . . 0.0 110.207 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.498 ' H83' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.509 ' H82' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.509 ' O2 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.442 ' H61' ' C1 ' ' A' ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 139' ' ' BMA . . . . . 0.442 ' C1 ' ' H61' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.916 0.389 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm 57.03 113.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.467 0.651 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 72.7 m80 -94.44 22.92 5.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.291 -0.881 . . . . 0.0 111.019 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 2' ' ' HIS . 67.1 t -150.15 132.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.66 -0.65 . . . . 0.0 109.279 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -108.02 130.69 55.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.405 -0.809 . . . . 0.0 110.319 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.43 124.99 21.46 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 111.07 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.63 139.87 31.75 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 N-CA-C 109.053 -1.172 . . . . 0.0 109.053 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.16 64.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.33 162.86 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.445 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 19' ' ' PHE . 10.7 t -139.68 155.92 25.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 116' ' ' TYR . 92.4 mt -114.32 131.9 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.605 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.08 -163.82 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -128.87 -178.8 4.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.518 -0.739 . . . . 0.0 110.566 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.31 -39.53 87.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.567 ' HG3' HD11 ' A' ' 16' ' ' ILE . 21.6 tpp180 -59.15 -21.48 59.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.729 -0.607 . . . . 0.0 109.656 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.606 ' C ' HD13 ' A' ' 16' ' ' ILE . . . 83.64 35.03 17.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' GLY . 5.1 mm -114.69 109.91 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.503 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -104.55 127.35 52.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.755 -0.591 . . . . 0.0 110.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.696 ' HB2' HG23 ' A' ' 80' ' ' THR . 34.1 t -127.07 129.96 49.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.7 p90 -138.08 160.16 40.11 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 77' ' ' VAL . 61.5 t -125.67 123.32 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.297 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -105.52 109.94 22.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.6 pt-20 -82.77 149.49 27.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 111.419 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CD2' HG21 ' A' ' 96' ' ' VAL . 7.6 p90 -131.89 164.0 27.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -131.32 133.4 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.399 -0.813 . . . . 0.0 111.19 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -139.9 150.46 62.57 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.648 -0.658 . . . . 0.0 110.717 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.77 -10.09 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.688 1.362 . . . . 0.0 111.852 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.48 -178.77 22.12 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.383 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -121.87 150.06 42.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.676 -0.896 . . . . 0.0 110.599 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.51 162.63 39.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.604 -0.685 . . . . 0.0 109.795 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 71.0 p -80.25 -46.09 16.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.46 -0.775 . . . . 0.0 110.647 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 51' ' ' THR . 5.7 mm-40 -80.26 112.04 17.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.999 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.23 95.75 3.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.845 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 68.9 ttt180 -75.78 115.3 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.431 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.5 m -118.78 138.91 47.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 85.2 m -129.6 143.73 50.96 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.474 0.654 . . . . 0.0 110.338 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.935 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -114.32 139.48 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' A' ' 46' ' ' GLU . 9.5 mt -130.22 172.33 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.049 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HG3' ' CG2' ' A' ' 47' ' ' VAL . 91.5 mtt180 -126.72 123.6 37.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.517 ' HG3' HD11 ' A' ' 93' ' ' ILE . 81.1 mt-30 -106.32 132.01 52.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.939 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -104.87 -172.31 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 -43.6 96.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 110.791 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.0 p -132.06 0.06 3.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.331 -0.855 . . . . 0.0 111.878 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.624 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 74.9 mt-30 -137.3 154.98 49.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.031 -1.043 . . . . 0.0 110.816 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.21 145.16 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.9 p -129.8 156.06 44.95 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.343 -0.848 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.841 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.8 mp0 -86.34 159.99 19.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 63.9 t -122.25 -80.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.822 -0.549 . . . . 0.0 110.194 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 85.9 m -131.66 156.6 45.56 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.979 -1.076 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.03 121.8 3.23 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.462 -0.774 . . . . 0.0 111.275 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -158.29 143.02 16.24 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.4 -0.812 . . . . 0.0 110.196 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.0 m -92.7 119.95 32.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.285 -0.884 . . . . 0.0 108.728 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HE1' ' A' ' 54' ' ' MET . 46.0 p90 -110.06 146.87 34.63 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.967 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 1.05 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -75.99 160.78 29.5 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.459 ' HE1' ' CE1' ' A' ' 52' ' ' TYR . 31.7 mmt -70.66 127.45 32.73 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.893 -1.129 . . . . 0.0 110.131 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.85 27.77 23.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -150.03 175.77 11.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.213 -1.169 . . . . 0.0 111.163 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.31 152.01 48.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.8 -0.562 . . . . 0.0 109.859 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 51' ' ' THR . 96.3 mt -136.42 -171.82 2.99 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.157 0.979 . . . . 0.0 112.136 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.7 p -109.48 159.97 16.61 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 95.0 m-85 -111.35 127.89 55.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.382 -0.824 . . . . 0.0 109.418 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.94 -44.07 94.6 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.587 -0.695 . . . . 0.0 112.344 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -94.88 131.44 40.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.921 . . . . 0.0 109.898 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 67' ' ' ILE . 81.9 m-20 53.05 57.77 5.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m -60.86 64.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.362 0.601 . . . . 0.0 112.098 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 67' ' ' ILE . 67.3 mt -140.98 16.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.419 -0.801 . . . . 0.0 109.134 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.1 m -104.09 130.03 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.059 -1.026 . . . . 0.0 110.593 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.409 HG21 ' OE1' ' A' ' 82' ' ' GLN . 9.5 t -139.94 150.08 44.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.58 -172.04 41.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.277 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 72' ' ' SER . 93.8 m -115.63 167.32 11.02 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.884 -0.774 . . . . 0.0 109.703 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 71' ' ' THR . 97.3 p -145.22 151.26 38.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.786 -0.571 . . . . 0.0 109.632 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -132.03 -175.73 3.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.649 -0.657 . . . . 0.0 109.757 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -52.92 -66.19 2.86 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -111.57 9.53 21.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.425 -1.044 . . . . 0.0 111.699 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.3 tt0 -130.0 129.41 43.69 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.996 -1.065 . . . . 0.0 110.609 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 21' ' ' CYS . 9.2 m -115.18 134.52 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -110.99 112.58 24.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.844 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.935 HD13 ' CG2' ' A' ' 36' ' ' VAL . 95.7 mt -107.31 129.66 54.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 18' ' ' SER . 58.6 m -124.05 136.69 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.249 -0.907 . . . . 0.0 110.777 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.78 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -103.52 137.29 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.675 . . . . 0.0 109.957 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.528 ' HG2' HG23 ' A' ' 16' ' ' ILE . 92.5 mt-30 -119.97 120.71 37.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.041 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.03 40.07 1.74 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.78 HD21 HG21 ' A' ' 81' ' ' ILE . 76.3 mt -80.37 137.83 36.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.996 . . . . 0.0 111.445 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -117.03 176.15 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.9 93.04 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.31 -39.07 93.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.738 -0.601 . . . . 0.0 110.748 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.11 -23.94 64.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.566 -0.709 . . . . 0.0 111.195 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 115' ' ' ILE . 25.3 m -52.43 137.77 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 155.96 -164.26 32.2 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 14.6 tp -88.42 126.22 35.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.884 . . . . 0.0 112.733 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 31.5 m-85 -106.89 158.13 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -123.7 140.18 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.887 . . . . 0.0 111.723 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.581 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 13.9 p -98.64 133.54 42.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.7 tttt -135.95 123.11 21.65 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 106' ' ' LEU . 2.6 p -132.36 118.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.8 mm-40 -139.58 142.68 37.11 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.273 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 106' ' ' LEU . 6.5 mt -90.44 81.87 5.95 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.845 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 2.8 ttm -80.13 -48.99 12.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.264 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.46 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 80.6 m-85 -70.87 -41.92 12.23 Favored Pre-proline 0 N--CA 1.508 2.467 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.4 Cg_endo -86.58 119.82 1.69 Allowed 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.558 1.505 . . . . 0.0 109.34 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 65.5 Cg_endo -84.77 161.71 12.18 Favored 'Trans proline' 2 CA--C 1.685 8.042 0 CA-C-O 113.188 -2.921 . . . . 0.0 106.18 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 38.6 Cg_endo -86.45 174.8 30.84 Favored 'Cis proline' 1 C--N 1.423 4.468 1 C-N-CA 98.673 -11.803 . . . . 0.0 114.9 -11.624 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' GLU 0.313 3.0 t80 -80.16 133.0 36.02 Favored 'General case' 0 N--CA 1.529 3.513 0 O-C-N 118.319 -2.738 . . . . 0.0 115.727 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 14.0 p90 -162.47 107.7 1.19 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.149 -1.595 . . . . 0.0 111.695 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 96' ' ' VAL . 2.3 tp -157.59 -147.11 0.17 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.623 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.548 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -160.66 169.57 36.41 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 118.689 -1.719 . . . . 0.0 112.102 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.4 mp -117.16 159.76 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.537 -0.978 . . . . 0.0 109.576 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -103.39 143.57 15.78 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 5.2 m120 -59.92 -39.71 86.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -1.089 . . . . 0.0 110.188 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 137.01 158.67 8.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.257 -1.449 . . . . 0.0 113.004 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.627 HG21 HG23 ' A' ' 9' ' ' VAL . 85.1 m -125.77 139.96 53.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.858 ' HB3' HG23 ' A' ' 8' ' ' VAL . 27.5 tt0 -85.24 142.36 29.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.162 -1.415 . . . . 0.0 108.251 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 76.4 mt -109.18 130.03 62.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 8' ' ' VAL . 15.1 m-30 -110.87 150.35 29.3 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.914 -0.491 . . . . 0.0 110.391 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 118' ' ' ILE . 95.9 t -98.65 166.49 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 117' ' ' VAL 0.253 44.2 mm -109.22 134.01 52.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.809 -0.557 . . . . 0.0 110.834 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -131.24 107.13 14.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.667 -0.646 . . . . 0.0 109.557 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.71 139.95 41.66 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.202 1.106 . . . . 0.0 110.899 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.83 140.81 39.8 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.631 -0.668 . . . . 0.0 110.04 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.2 -12.23 33.45 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.256 1.135 . . . . 0.0 111.227 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 42.3 t -91.02 138.33 26.08 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.287 -0.883 . . . . 0.0 110.386 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.5 163.96 36.1 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.279 1.147 . . . . 0.0 110.545 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -104.85 157.63 17.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.718 . . . . 0.0 110.374 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -66.93 -30.08 70.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.631 -0.668 . . . . 0.0 110.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.55 134.3 54.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.588 -0.695 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -130.13 157.02 43.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.618 -0.676 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 86.1 mt-10 52.87 49.89 7.09 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.484 -0.76 . . . . 0.0 111.043 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.3 Cg_endo -69.92 150.04 66.71 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.139 1.073 . . . . 0.0 110.427 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.608 -0.682 . . . . 0.0 110.234 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.627 ' O6 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.627 ' H82' ' O6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.221 0.534 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm -130.34 -176.29 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.735 . . . . 0.0 109.941 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -97.71 25.1 6.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.743 . . . . 0.0 110.518 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.601 HG11 ' CA ' ' A' ' 110' ' ' GLY . 66.6 t -142.22 132.6 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -123.95 134.43 53.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.318 -0.864 . . . . 0.0 111.165 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.133 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 65.5 mt-30 -146.81 147.95 31.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.653 -0.655 . . . . 0.0 110.697 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.02 140.7 42.33 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.438 1.23 . . . . 0.0 109.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.18 71.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.978 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -155.49 161.41 2.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.35 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.5 t -137.94 156.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.529 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' A' ' 116' ' ' TYR . 84.8 mt -122.79 124.23 42.85 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.07 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.7 ' O ' HD13 ' A' ' 118' ' ' ILE . . . -78.49 141.3 38.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.509 -0.744 . . . . 0.0 109.32 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -80.3 -59.78 2.57 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.221 -0.924 . . . . 0.0 111.884 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 16' ' ' ILE . 15.2 t -152.32 165.93 33.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.535 -0.728 . . . . 0.0 109.462 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.875 ' HG2' HD11 ' A' ' 16' ' ' ILE . 6.3 ttt180 57.67 19.51 5.56 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.544 -0.722 . . . . 0.0 110.733 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' HD12 ' A' ' 84' ' ' LEU . . . 56.65 44.31 91.18 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.875 HD11 ' HG2' ' A' ' 14' ' ' ARG . 29.1 mm -106.78 104.66 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.75 120.67 42.89 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.335 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.613 ' OG ' HG23 ' A' ' 80' ' ' THR . 13.7 m -116.28 121.93 43.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.763 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.5 p90 -132.03 163.96 27.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.683 . . . . 0.0 110.392 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 78' ' ' ASN . 36.3 t -122.03 130.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.171 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.081 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 48.7 t -117.9 131.92 56.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.4 tt0 -102.53 136.36 42.5 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 111.821 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.78 ' CG ' HG11 ' A' ' 96' ' ' VAL . 40.2 p90 -127.3 179.53 5.41 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' HD21 ' A' ' 106' ' ' LEU . . . -132.47 127.29 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.719 -0.613 . . . . 0.0 110.477 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.35 149.9 59.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.594 -0.691 . . . . 0.0 109.97 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.81 -16.11 45.33 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.362 1.191 . . . . 0.0 111.446 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.96 -171.92 37.4 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -108.05 130.1 55.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.602 -0.94 . . . . 0.0 109.959 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.62 -178.63 5.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 110.623 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.088 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -79.96 -14.19 58.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 112.266 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.717 ' OE1' HG21 ' A' ' 51' ' ' THR . 3.1 mm-40 -128.82 130.73 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.497 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.0 t -139.68 84.91 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -64.49 115.24 4.96 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.458 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -117.3 147.41 20.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 49' ' ' ALA . 90.7 m -147.12 140.03 25.1 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.339 0.59 . . . . 0.0 111.101 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.882 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -102.66 132.1 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -121.91 170.3 9.94 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.847 -1.158 . . . . 0.0 112.019 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 47' ' ' VAL . 15.6 mmm180 -116.0 115.66 26.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HA ' HG13 ' A' ' 44' ' ' VAL . 37.9 tt0 -103.01 140.02 37.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.206 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.774 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -141.28 155.34 46.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.16 -44.0 92.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.355 -0.841 . . . . 0.0 110.263 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.0 m -70.1 -44.04 69.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.656 -0.652 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.774 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 12.4 tp60 -162.65 161.33 26.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 111.078 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 39' ' ' GLN . 62.1 t -118.25 141.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 160.31 33.99 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.161 -0.962 . . . . 0.0 111.885 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.922 ' HA ' HD23 ' A' ' 37' ' ' LEU . 80.4 mt-10 -87.97 158.53 18.63 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.702 -0.624 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 38' ' ' ARG . 94.0 t -139.17 -83.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.609 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.118 ' SG ' ' N ' ' A' ' 68' ' ' CYS . 83.4 m -105.21 149.52 25.88 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.085 -1.01 . . . . 0.0 111.792 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -163.94 145.34 8.87 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB2' ' CD1' ' A' ' 60' ' ' PHE . . . -171.79 158.0 4.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.717 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -97.62 109.92 22.59 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.327 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.633 ' CD1' HD21 ' A' ' 58' ' ' LEU . 29.1 t80 -68.97 123.99 22.52 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 1.088 ' SD ' ' O ' ' A' ' 30' ' ' THR . 40.0 mmm -111.92 39.23 2.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.414 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 16.4 mmt 59.9 35.57 21.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.58 174.66 28.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.03 -18.93 45.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.597 -0.943 . . . . 0.0 112.126 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.95 124.65 28.27 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.312 0.577 . . . . 0.0 112.027 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' A' ' 52' ' ' TYR . 75.7 mt -131.9 151.82 51.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.589 -0.695 . . . . 0.0 109.139 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 p -87.12 95.63 10.02 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.967 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 67' ' ' ILE . 20.6 m-85 -115.06 99.54 7.52 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' N ' HG13 ' A' ' 67' ' ' ILE . 96.0 mt -135.01 -0.13 2.81 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.63 -1.294 . . . . 0.0 114.155 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 56.6 t0 -110.65 130.17 55.64 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.51 -1.369 . . . . 0.0 112.872 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 53.12 44.28 30.53 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.761 -1.212 . . . . 0.0 111.333 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 5.8 t 72.15 -42.25 0.53 Allowed 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.417 -0.802 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.966 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 25.8 mm 61.13 168.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.874 -1.142 . . . . 0.0 110.592 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.118 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 4.1 m -110.25 -179.74 3.86 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -130.22 149.79 51.76 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.3 -172.66 40.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.97 -1.586 . . . . 0.0 111.369 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 72' ' ' SER . 59.7 m -131.85 168.88 17.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 122.157 -0.614 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 71' ' ' THR . 19.0 t -140.24 129.83 24.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -130.99 131.99 44.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.55 -123.78 24.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 78.7 m-20 -99.75 11.53 38.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.769 -0.842 . . . . 0.0 110.919 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -114.34 131.92 56.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 21' ' ' CYS . 11.4 m -111.52 118.2 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.614 ' CG ' HG22 ' A' ' 20' ' ' VAL . 4.1 m120 -89.9 114.21 25.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.545 -0.722 . . . . 0.0 110.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 36' ' ' VAL . 69.7 mt -114.24 124.32 51.74 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.613 HG23 ' OG ' ' A' ' 18' ' ' SER . 88.1 m -115.31 132.41 56.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.34 -0.85 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -107.06 135.78 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.294 -0.879 . . . . 0.0 110.17 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.849 ' HG2' HD12 ' A' ' 16' ' ' ILE . 82.9 mt-30 -119.97 120.32 36.01 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.204 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.02 51.74 0.72 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 81' ' ' ILE . 80.7 mt -92.32 113.53 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.682 -0.893 . . . . 0.0 111.439 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' HB2' ' HG2' ' A' ' 87' ' ' MET . 71.9 mmt-85 -81.32 166.16 20.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.02 -28.48 57.51 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.215 -0.928 . . . . 0.0 109.066 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 22.2 ptm -69.91 -36.07 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.507 0.67 . . . . 0.0 110.005 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.13 -25.74 65.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.799 -0.563 . . . . 0.0 111.397 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.1 m -51.2 132.01 28.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.43 -165.72 31.99 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 12.9 tp -86.8 130.07 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.705 -0.879 . . . . 0.0 112.798 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 115' ' ' ILE . 59.1 m-85 -111.58 140.09 46.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.704 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.6 mp -110.14 122.95 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.133 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -79.67 120.17 23.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 175.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HE3' HD11 ' A' ' 109' ' ' ILE . 8.0 tttt -103.47 143.97 32.02 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.78 HG11 ' CG ' ' A' ' 23' ' ' TYR . 20.3 t -140.77 106.62 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.768 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG2' ' OH ' ' A' ' 104' ' ' TYR . 59.0 mt-10 -140.17 122.21 15.68 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.908 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.5 mp -72.94 83.7 1.23 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 13.2 mmt -79.28 -50.92 10.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 97.6 m-85 -69.17 -40.3 15.05 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.407 -0.808 . . . . 0.0 112.618 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 14.8 Cg_endo -88.8 119.6 1.06 Allowed 'Trans proline' 0 C--O 1.177 -2.551 0 C-N-CA 122.14 1.893 . . . . 0.0 109.881 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.885 ' CB ' ' HA ' ' A' ' 103' ' ' PRO 0.479 88.9 Cg_endo -100.46 173.7 0.34 Allowed 'Trans proline' 2 C--O 1.08 -7.38 0 CA-C-O 114.3 -2.459 . . . . 0.0 113.482 173.563 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.885 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.408 52.0 Cg_endo -72.69 176.64 39.37 Favored 'Cis proline' 3 N--CA 1.586 6.96 1 C-N-CA 96.736 -12.61 . . . . 0.0 112.6 -5.491 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.422 ' OH ' ' HG2' ' A' ' 97' ' ' GLU . 14.7 t80 -79.55 135.72 36.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 116.327 -3.983 . . . . 0.0 111.352 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.33 30.4 t80 -158.73 91.76 1.08 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.104 0.411 . . . . 0.0 111.464 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -159.35 -157.29 0.57 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.119 -1.432 . . . . 0.0 112.57 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.715 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.5 -177.01 36.82 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.966 -1.112 . . . . 0.0 111.295 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.715 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -121.29 153.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.659 ' O ' ' H83' ' A' ' 132' ' ' NAG . . . -92.99 165.2 27.91 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -62.54 -34.03 76.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -1.094 . . . . 0.0 111.694 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.54 160.57 11.52 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.688 -1.244 . . . . 0.0 111.921 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.563 HG21 HG23 ' A' ' 9' ' ' VAL . 60.6 m -120.04 145.04 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.978 ' HB3' HG23 ' A' ' 8' ' ' VAL . 30.5 tt0 -88.98 145.56 25.43 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.612 -1.235 . . . . 0.0 107.954 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 92' ' ' TYR . 45.6 mt -117.99 131.31 71.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.87 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -113.93 155.97 24.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.83 -0.544 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.568 ' C ' HD12 ' A' ' 118' ' ' ILE . 76.6 t -124.02 163.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.826 0.822 . . . . 0.0 110.047 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 11' ' ' ALA 0.259 3.3 mp -111.44 132.55 59.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.314 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -108.0 109.83 62.1 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.701 . . . . 0.0 109.418 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.74 146.39 60.13 Favored 'Trans proline' 0 N--CA 1.485 1.029 0 O-C-N 123.144 1.076 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -129.85 132.93 24.47 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.37 -18.99 44.09 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.105 1.055 . . . . 0.0 110.911 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.7 m -119.84 153.5 54.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.36 -0.837 . . . . 0.0 110.394 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.91 158.09 57.91 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.39 1.205 . . . . 0.0 110.452 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -148.07 172.08 14.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 110.488 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.6 p -131.96 160.0 37.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.638 -0.664 . . . . 0.0 110.166 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -106.14 120.17 41.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.606 -0.684 . . . . 0.0 110.317 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -121.42 153.61 37.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 85.7 mt-10 53.03 50.12 7.32 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.472 -0.768 . . . . 0.0 111.011 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.8 Cg_endo -70.25 159.66 52.26 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.205 1.108 . . . . 0.0 110.338 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.659 ' H83' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.571 ' H83' ' H2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.571 ' H2 ' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.54 ' H83' HG23 ' A' ' 20' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.424 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.152 0.501 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp 53.39 22.97 3.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.469 -0.77 . . . . 0.0 110.937 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -129.4 36.63 4.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.469 -0.769 . . . . 0.0 110.151 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG11 ' HA2' ' A' ' 110' ' ' GLY . 83.8 t -80.13 137.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.745 -0.597 . . . . 0.0 109.895 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -122.12 135.69 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.538 -0.726 . . . . 0.0 110.72 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 41.5 mt-30 -148.51 150.07 32.95 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.526 -0.734 . . . . 0.0 111.694 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 113' ' ' THR . 41.7 Cg_endo -71.02 139.97 37.0 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.284 -1.468 . . . . 0.0 108.284 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.21 -27.5 67.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.497 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.926 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -152.34 171.99 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 118.491 -1.284 . . . . 0.0 110.983 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -149.85 155.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.567 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -112.12 131.95 55.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.05 135.93 39.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.529 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -69.88 173.46 6.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.688 -0.632 . . . . 0.0 110.256 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.4 p -60.32 -30.53 69.57 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.555 -0.715 . . . . 0.0 109.992 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.69 ' CG ' HD13 ' A' ' 16' ' ' ILE . 7.7 tpm_? -60.07 -30.13 69.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 0.0 109.926 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.648 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.68 26.01 8.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.69 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -109.72 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.565 -0.962 . . . . 0.0 110.507 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -110.41 128.88 55.8 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.433 ' HB3' ' H82' ' A' ' 136' ' ' NAG . 32.7 t -126.59 134.83 50.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 111.728 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -140.07 163.99 31.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 93.5 t -124.92 124.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.468 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 77' ' ' VAL . 51.2 t -100.81 117.12 34.26 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.0 tt0 -90.75 137.56 32.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 111.282 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.695 ' HB3' HG11 ' A' ' 96' ' ' VAL . 31.8 p90 -131.29 180.0 5.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.85 123.57 18.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.707 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 98' ' ' LEU . 92.8 p -134.53 143.39 46.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.558 -0.714 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.13 144.24 29.59 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.296 1.156 . . . . 0.0 110.742 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.87 30.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 150.05 51.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.881 . . . . 0.0 109.92 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.77 154.75 37.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 110.41 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.5 p -92.62 10.46 30.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.603 -0.685 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' OE1' HG21 ' A' ' 51' ' ' THR . 13.1 mm-40 -132.19 84.92 2.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.279 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 34' ' ' VAL . 11.8 m -103.35 89.13 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 19.6 tpt85 -53.72 102.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.3 m -110.17 131.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.86 0.838 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 99.9 m -135.56 148.15 49.0 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.828 ' CG2' HD13 ' A' ' 79' ' ' LEU . 95.9 t -116.08 133.83 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.8 mt -121.35 170.18 9.87 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.231 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.2 ttt180 -123.21 119.91 31.6 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.607 ' HA ' HG22 ' A' ' 44' ' ' VAL . 46.2 tt0 -97.15 148.56 22.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 110.166 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.43 -175.66 3.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.848 -0.533 . . . . 0.0 110.055 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.74 -40.47 88.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.67 -0.643 . . . . 0.0 111.385 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.0 m -126.8 -21.55 4.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.19 -0.944 . . . . 0.0 112.57 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 98.1 mt-30 -131.96 163.98 27.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.06 -1.025 . . . . 0.0 111.775 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 39' ' ' GLN . 61.0 t -134.84 143.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.2 p -129.99 160.18 34.44 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.842 ' HA ' HD23 ' A' ' 37' ' ' LEU . 58.2 tt0 -80.15 157.31 26.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 109.876 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.75 -64.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.782 -0.574 . . . . 0.0 110.392 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.3 m -140.1 141.08 36.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.105 -0.997 . . . . 0.0 109.846 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -151.1 135.1 16.64 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.698 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.01 149.57 2.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.564 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -81.17 111.24 17.42 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.06 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.606 ' O ' HG22 ' A' ' 32' ' ' VAL . 23.3 t80 -74.92 112.99 11.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.769 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 2.0 mtp -82.63 161.54 22.17 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 35.6 mmt -61.04 -23.91 65.79 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.659 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.37 41.49 0.75 Allowed Glycine 0 N--CA 1.501 3.027 0 C-N-CA 119.042 -1.551 . . . . 0.0 112.658 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 79.6 m-20 -135.55 160.06 39.67 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 119.067 1.434 . . . . 0.0 110.241 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -89.12 135.63 33.46 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.492 -0.755 . . . . 0.0 110.283 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.677 HD22 ' N ' ' A' ' 58' ' ' LEU . 1.3 mm? -103.04 156.12 17.91 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.492 -0.755 . . . . 0.0 110.086 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 p -102.2 123.15 45.53 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.388 -0.82 . . . . 0.0 111.706 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 42.3 m-85 -114.12 30.5 7.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -53.72 -44.03 69.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.532 -0.73 . . . . 0.0 111.899 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -66.54 145.45 55.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.264 -0.897 . . . . 0.0 110.749 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 52.13 55.58 9.0 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.388 -0.82 . . . . 0.0 110.498 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 60.17 163.87 0.06 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.798 -0.564 . . . . 0.0 109.938 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -99.92 142.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.591 0.71 . . . . 0.0 111.229 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.4 m -121.99 153.77 38.11 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -132.63 150.08 52.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.95 -172.01 43.52 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.41 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 72' ' ' SER . 92.5 m -129.1 168.78 15.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.0 -0.706 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 71' ' ' THR . 70.1 m -159.98 127.39 4.59 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -155.83 155.93 33.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 110.344 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.76 -124.04 25.67 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -109.32 11.05 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.774 -0.839 . . . . 0.0 110.914 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.1 mt-30 -118.46 124.76 48.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 21' ' ' CYS . 4.0 m -107.17 124.01 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.924 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' THR . 46.6 t-20 -101.97 116.21 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.71 . . . . 0.0 111.077 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.828 HD13 ' CG2' ' A' ' 36' ' ' VAL . 96.6 mt -115.98 131.98 56.78 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.297 -0.877 . . . . 0.0 109.164 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.3 m -124.47 147.21 48.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.184 -0.948 . . . . 0.0 111.075 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.635 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -113.53 131.53 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.711 -0.618 . . . . 0.0 110.072 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG2' HG13 ' A' ' 16' ' ' ILE . 52.6 mt-30 -110.22 120.76 43.48 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.667 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.58 0.99 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -85.76 125.55 33.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.656 -0.908 . . . . 0.0 111.082 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -107.44 175.85 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.21 94.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.302 -0.873 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.1 ttm -62.14 -36.06 80.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.756 -0.59 . . . . 0.0 110.169 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -66.97 -26.92 67.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.647 . . . . 0.0 111.143 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.9 m -51.4 132.07 29.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.5 -143.96 8.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 113' ' ' THR . 10.6 tp -110.04 131.94 54.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.737 -0.861 . . . . 0.0 111.611 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.876 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.1 m-85 -113.28 132.03 55.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -107.97 129.36 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.728 -0.607 . . . . 0.0 112.144 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.076 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 20.1 p -79.88 161.99 25.27 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.3 tttt -152.34 77.49 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 23' ' ' TYR . 7.4 p -95.1 113.63 29.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 68.2 mt-10 -130.16 129.65 43.72 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.426 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.658 ' CD2' HD22 ' A' ' 106' ' ' LEU . 19.1 mt -76.99 76.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.4 tpp -80.63 -50.15 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.034 -0.667 . . . . 0.0 112.45 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 89.1 m-85 -68.6 -41.21 21.41 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 112.926 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 46.9 Cg_endo -86.25 109.44 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-O 117.875 -0.969 . . . . 0.0 111.098 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.3 Cg_endo -77.39 158.02 32.93 Favored 'Trans proline' 1 CA--C 1.609 4.236 0 CA-C-O 113.892 -2.628 . . . . 0.0 110.001 177.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 56.3 Cg_endo -88.54 -177.68 12.56 Favored 'Cis proline' 1 C--N 1.484 7.662 1 C-N-CA 93.031 -14.154 . . . . 0.0 114.475 -10.125 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 4.6 t80 -88.04 125.51 34.59 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-O 122.76 1.267 . . . . 0.0 109.888 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -149.7 74.42 1.22 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 120.943 -1.098 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.3 tp -142.48 -150.68 0.32 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.352 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.1 -173.04 34.99 Favored Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.902 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.533 HG22 ' C8 ' ' A' ' 132' ' ' NAG . 71.7 mt -110.96 149.18 13.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.847 -0.796 . . . . 0.0 109.938 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 1.076 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -74.53 144.14 32.47 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.426 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 4.0 t-20 -60.07 -30.34 69.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.398 -1.06 . . . . 0.0 110.283 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.0 140.03 7.08 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.319 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.3 m -113.53 149.97 33.64 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.843 ' HB3' HG23 ' A' ' 8' ' ' VAL . 13.7 tp60 -89.87 137.29 32.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.876 HD12 ' CD1' ' A' ' 92' ' ' TYR . 56.4 mt -109.92 128.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.926 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.3 m-30 -101.95 139.86 37.02 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.646 0.736 . . . . 0.0 111.748 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 118' ' ' ILE . 97.1 t -125.64 166.12 22.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' N ' HG12 ' A' ' 117' ' ' VAL . 27.1 mm -100.06 120.01 48.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.477 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -146.33 141.03 15.93 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.11 159.98 51.21 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.243 1.128 . . . . 0.0 110.322 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -86.68 114.84 59.98 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.547 -0.72 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.0 -11.92 31.44 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.2 1.105 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -100.51 135.77 20.1 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.6 -12.06 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.224 1.118 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -148.05 172.19 14.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.5 p -136.43 159.91 40.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.239 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.58 132.03 41.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.555 -0.716 . . . . 0.0 110.269 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.599 -0.688 . . . . 0.0 110.24 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 65.7 mm-40 52.3 50.17 7.77 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.407 -0.808 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.9 Cg_endo -70.22 148.14 61.43 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.197 1.104 . . . . 0.0 110.306 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.501 2.12 0 O-C-N 121.363 -0.836 . . . . 0.0 110.957 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.894 ' H61' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.894 ' H83' ' H61' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.425 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.433 ' H82' ' HB3' ' A' ' 18' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.121 0.486 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 57.9 mtt -134.2 156.96 47.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.225 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -110.26 132.02 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.644 -0.66 . . . . 0.0 110.783 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG12 ' OE1' ' A' ' 5' ' ' GLN . 74.8 t -129.69 131.47 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.564 -0.71 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 131.78 56.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.449 -0.782 . . . . 0.0 110.56 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.7 134.7 18.42 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.649 . . . . 0.0 110.475 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.48 136.57 24.01 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.11 1.058 . . . . 0.0 109.696 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.43 -32.95 64.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.484 -0.76 . . . . 0.0 109.666 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.0 157.35 6.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.992 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.8 t -139.72 153.36 23.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.45 0.643 . . . . 0.0 110.038 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.0 mt -110.83 124.1 51.38 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.71 140.77 46.24 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.496 -0.752 . . . . 0.0 110.724 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -91.61 -168.99 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.598 -0.689 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -49.98 159.04 0.45 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.48 -0.763 . . . . 0.0 110.529 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.817 ' HG3' HD11 ' A' ' 16' ' ' ILE . 40.8 tpt85 62.43 13.27 5.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.556 -0.715 . . . . 0.0 110.655 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.07 46.01 93.17 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' HG2' ' A' ' 82' ' ' GLN . 34.6 mm -104.92 106.7 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.729 -0.865 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.08 123.58 48.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.803 -0.56 . . . . 0.0 109.772 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -130.0 130.95 45.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.663 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.678 ' HB3' HG21 ' A' ' 9' ' ' VAL . 27.2 p90 -142.39 164.06 31.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.807 -0.558 . . . . 0.0 109.724 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG23 ' O7 ' ' A' ' 136' ' ' NAG . 99.5 t -120.66 116.21 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.852 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.8 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -100.12 103.77 15.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 90.1 mt-10 -79.67 165.11 23.21 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 111.933 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.7 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.8 p90 -148.07 178.14 8.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -136.4 130.34 32.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.689 -0.632 . . . . 0.0 110.009 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -139.95 150.11 61.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.405 -0.809 . . . . 0.0 110.45 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 140.06 33.81 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.44 1.232 . . . . 0.0 110.299 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.65 -145.71 23.28 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -130.11 149.92 51.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.937 . . . . 0.0 110.141 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 147.69 45.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.617 -0.677 . . . . 0.0 109.926 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.142 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 32.8 p -79.97 -59.65 2.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.712 0.767 . . . . 0.0 111.679 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.0 mt-10 -80.99 80.52 7.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG11 ' OH ' ' A' ' 52' ' ' TYR . 97.0 t -88.5 96.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 51' ' ' THR . 55.6 ttt85 -70.53 124.25 23.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.572 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 50' ' ' ALA . 27.3 m -121.1 142.14 38.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 49' ' ' ALA . 88.8 m -135.32 142.35 45.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.726 -0.608 . . . . 0.0 110.625 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.897 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -112.77 131.23 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.0 mt -120.94 173.76 7.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 110.958 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.651 ' O ' HG13 ' A' ' 44' ' ' VAL . 39.5 ttm180 -122.42 121.28 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 44' ' ' VAL . 46.0 tt0 -97.9 148.65 23.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 111.151 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -132.15 168.65 17.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.47 -28.24 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 110.722 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -108.49 -53.14 2.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.474 -0.766 . . . . 0.0 112.153 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.747 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 63.3 mt-30 -136.64 170.01 16.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.12 -0.988 . . . . 0.0 111.997 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 39' ' ' GLN . 62.0 t -122.56 147.96 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -127.65 160.42 31.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.341 -0.849 . . . . 0.0 110.678 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.1 mt-10 -80.4 145.58 31.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 110.651 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -117.18 -75.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.305 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.922 ' SG ' ' HB3' ' A' ' 63' ' ' ASP . 70.2 m -139.83 149.15 43.11 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -153.88 145.48 23.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.488 -0.757 . . . . 0.0 111.294 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -165.28 148.02 8.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.618 -0.677 . . . . 0.0 109.714 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.568 HG21 ' HB3' ' A' ' 31' ' ' GLU . 6.2 m -98.42 130.19 45.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.685 ' OH ' HG11 ' A' ' 32' ' ' VAL . 52.1 p90 -102.09 133.44 46.93 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.521 -1.272 . . . . 0.0 110.631 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.477 ' HE1' ' HG2' ' A' ' 31' ' ' GLU . 6.6 mmt -78.41 168.17 20.21 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.142 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.96 90.03 0.17 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.673 -1.267 . . . . 0.0 109.2 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.39 -117.48 0.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -129.9 137.77 50.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.307 -1.113 . . . . 0.0 110.379 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 58' ' ' LEU . 17.6 tt0 -178.73 138.33 0.16 Allowed 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 70' ' ' GLY . 94.3 mt -142.14 87.72 2.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.435 ' N ' ' HB1' ' A' ' 50' ' ' ALA . 46.1 p -89.58 72.2 7.85 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.425 -0.797 . . . . 0.0 111.384 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.482 ' HE2' HD22 ' A' ' 58' ' ' LEU . 78.4 m-85 -89.89 109.76 20.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.36 -37.3 82.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.425 -0.797 . . . . 0.0 110.48 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -139.98 172.19 13.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.634 -0.666 . . . . 0.0 110.026 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.922 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 84.5 m-20 52.6 49.95 19.24 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -53.91 -21.11 7.1 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.659 -0.651 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.97 -20.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.264 -0.897 . . . . 0.0 110.627 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 30.7 m -86.07 137.78 32.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 110.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 80' ' ' THR . 9.0 t -129.95 131.01 45.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.705 ' CA ' HD23 ' A' ' 79' ' ' LEU . . . -125.63 116.8 2.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.864 HG21 ' O5 ' ' A' ' 138' ' ' FUC . 59.2 m -103.87 159.0 16.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.726 -0.867 . . . . 0.0 108.673 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 63.0 m -148.15 129.97 15.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.969 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 122.04 25.88 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.04 -124.07 34.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.93 16.59 25.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.964 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 35.7 mt-30 -116.46 122.25 44.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.197 -0.939 . . . . 0.0 110.502 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 21' ' ' CYS . 1.9 m -103.74 122.2 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.866 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -104.21 109.96 21.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 0.0 111.462 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.897 HD13 HG22 ' A' ' 36' ' ' VAL . 53.1 mt -98.06 130.02 44.88 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 69' ' ' THR . 93.9 m -123.75 145.44 49.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.0 110.41 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 84' ' ' LEU . 95.5 mt -119.91 135.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.83 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.851 ' HG2' HD12 ' A' ' 16' ' ' ILE . 76.5 mt-30 -120.02 120.31 35.94 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.927 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.66 40.5 1.1 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 81' ' ' ILE . 80.8 mt -89.81 121.19 31.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.952 . . . . 0.0 111.464 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -103.32 179.66 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.85 93.91 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.926 0.869 . . . . 0.0 109.872 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.7 -34.66 78.34 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.331 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.54 -19.96 66.14 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.479 -0.763 . . . . 0.0 111.238 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 115' ' ' ILE . 30.0 m -50.65 136.88 20.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.84 -159.99 32.85 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.59 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 113' ' ' THR . 13.8 tp -110.2 130.05 55.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.7 -0.882 . . . . 0.0 111.961 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.699 ' CD2' HD12 ' A' ' 115' ' ' ILE . 83.9 m-85 -116.29 146.98 41.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -103.53 139.96 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.44 -0.788 . . . . 0.0 111.683 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.769 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.7 p -98.16 127.59 44.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 109' ' ' ILE . 4.6 tttm -120.39 141.72 49.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.741 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.8 t -138.05 108.85 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 99' ' ' MET . 5.9 mm-40 -134.4 128.26 33.24 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.841 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD23 HD13 ' A' ' 106' ' ' LEU 0.26 2.8 mm? -76.51 87.68 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.456 ' HE1' ' HB3' ' A' ' 97' ' ' GLU . 2.7 mmt -81.15 -58.45 3.06 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.498 -1.281 . . . . 0.0 111.687 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.6 m-85 -71.7 -40.45 8.4 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 48.6 Cg_endo -82.05 117.36 2.88 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.229 0.594 . . . . 0.0 110.658 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 73.0 Cg_endo -92.41 156.97 3.05 Favored 'Trans proline' 1 CA--C 1.701 8.859 0 CA-C-O 114.534 -2.361 . . . . 0.0 109.835 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 55.7 Cg_endo -87.65 178.62 19.91 Favored 'Cis proline' 2 C--N 1.46 6.408 1 C-N-CA 96.668 -12.638 . . . . 0.0 116.727 -8.039 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 13.3 t80 -85.93 119.68 26.5 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.043 2.09 . . . . 0.0 113.12 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 106' ' ' LEU . 25.7 t80 -162.16 107.74 1.25 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.272 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.79 HD13 HD23 ' A' ' 98' ' ' LEU . 1.4 tp -157.16 -143.49 0.11 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.921 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.73 178.55 35.77 Favored Glycine 0 N--CA 1.504 3.227 0 O-C-N 120.682 -1.261 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 95' ' ' LYS . 97.4 mt -126.17 160.82 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.987 . . . . 0.0 109.814 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.769 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 143.47 16.68 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -60.43 -36.08 77.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.479 -1.013 . . . . 0.0 110.271 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 131.56 158.4 9.1 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.017 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.553 ' C ' HD12 ' A' ' 91' ' ' LEU . 97.0 m -123.33 127.67 48.84 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 1.002 ' HB3' HG23 ' A' ' 8' ' ' VAL . 36.1 tp60 -73.64 137.12 43.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.699 HD12 ' CD2' ' A' ' 92' ' ' TYR . 75.4 mt -110.0 129.19 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.894 -1.129 . . . . 0.0 108.422 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.808 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.9 m-85 -110.15 142.67 41.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.874 -0.516 . . . . 0.0 111.044 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.6 t -96.02 166.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 117' ' ' VAL . 46.8 mm -105.96 134.29 47.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.843 -0.536 . . . . 0.0 110.592 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.33 141.57 66.4 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 109.858 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.82 148.07 63.89 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -91.75 126.06 55.18 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.69 -12.2 32.53 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.117 1.061 . . . . 0.0 111.043 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 1.057 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 49.3 t -138.73 156.38 72.94 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 109.863 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 1.057 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 41.9 Cg_endo -66.57 -17.79 53.4 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.344 1.181 . . . . 0.0 111.551 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.96 -175.07 5.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.6 t -89.81 129.87 36.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.453 -0.78 . . . . 0.0 110.299 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -67.87 -35.95 79.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.71 . . . . 0.0 110.188 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -101.48 143.79 31.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.616 -0.678 . . . . 0.0 110.119 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 64.9 mm-40 52.72 49.74 6.96 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.767 . . . . 0.0 111.161 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 45.1 Cg_endo -69.75 154.05 68.25 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.194 1.102 . . . . 0.0 110.546 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.435 ' C8 ' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.489 ' O7 ' HG23 ' A' ' 20' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.458 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.864 ' O5 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt -99.23 21.44 11.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.59 -0.694 . . . . 0.0 110.517 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -110.04 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.455 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -135.78 132.48 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.68 131.09 57.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.581 -0.699 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.089 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 87.0 mm-40 -140.0 139.69 22.12 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.224 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.33 147.66 42.16 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.284 1.15 . . . . 0.0 109.835 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.5 -29.61 25.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.44 156.99 4.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.017 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.0 t -134.98 157.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 116' ' ' TYR . 66.1 mt -111.04 130.18 55.68 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.702 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 118' ' ' ILE . . . -90.71 147.78 23.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.863 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -78.27 168.85 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.647 -0.658 . . . . 0.0 110.153 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -59.76 -37.91 80.35 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.446 -0.783 . . . . 0.0 109.969 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -57.46 -24.06 53.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.535 -0.728 . . . . 0.0 110.397 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.8 28.02 8.6 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.2 mp -103.63 101.67 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.56 124.35 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.0 p -136.37 150.03 48.62 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.922 ' HB3' HG21 ' A' ' 9' ' ' VAL . 22.2 p90 -154.62 161.48 41.57 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 79.8 t -118.79 117.69 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.499 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.089 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 53.6 t -100.1 107.42 19.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.51 144.95 29.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.911 . . . . 0.0 111.186 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CG ' HG11 ' A' ' 96' ' ' VAL . 50.0 p90 -131.64 -179.97 5.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.75 131.92 39.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.691 -0.631 . . . . 0.0 110.093 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.4 t -127.29 150.42 72.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.475 -0.766 . . . . 0.0 111.101 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.34 -14.77 37.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.735 1.387 . . . . 0.0 111.362 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.89 -165.43 16.79 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -110.1 132.16 54.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.97 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 153.76 39.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.1 p -80.03 -35.08 37.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.794 ' OE1' HG21 ' A' ' 51' ' ' THR . 42.7 mm-40 -79.89 97.07 6.55 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.3 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 34' ' ' VAL . 97.5 t -113.56 85.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 99' ' ' MET . 72.1 ttt-85 -61.25 116.19 4.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.114 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 32' ' ' VAL . 28.4 m -122.46 133.98 67.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.712 0.767 . . . . 0.0 110.157 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.483 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 61.3 m -120.06 123.98 44.75 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.086 0.469 . . . . 0.0 109.967 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.689 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -100.54 130.23 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 95' ' ' LYS . 71.2 mt -124.76 167.66 14.28 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.351 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.3 ttt180 -127.71 124.04 36.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.564 ' NE2' HD23 ' A' ' 91' ' ' LEU . 22.0 mt-30 -109.13 132.01 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.954 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -125.01 162.6 24.17 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.03 -42.98 95.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.2 m -70.09 -55.92 8.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.727 . . . . 0.0 110.694 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 58.7 mm-40 -150.42 -177.27 5.86 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.964 0.888 . . . . 0.0 111.399 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.8 136.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -134.27 161.6 34.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 37' ' ' LEU . 75.5 mt-10 -80.2 155.54 27.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 48' ' ' CYS . 96.3 t -118.77 -95.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.869 -0.519 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 47' ' ' VAL . 99.2 m -120.14 145.12 47.24 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.705 -1.247 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.76 138.57 14.28 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.38 -0.825 . . . . 0.0 111.796 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -175.4 157.06 2.1 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.794 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -80.1 119.88 23.49 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 72' ' ' SER . 19.6 t80 -80.83 109.98 15.91 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.445 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.16 146.06 33.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -15.81 63.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.07 -1.018 . . . . 0.0 110.661 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.83 -15.03 5.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -130.02 160.06 34.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -1.221 . . . . 0.0 110.911 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -123.2 125.2 44.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.506 -0.746 . . . . 0.0 110.052 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 51' ' ' THR . 79.8 mt -85.2 170.17 13.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.474 -0.766 . . . . 0.0 111.349 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -110.2 159.95 16.93 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.8 m-85 -99.93 132.08 45.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.492 -0.755 . . . . 0.0 109.696 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.87 -44.13 94.35 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -140.82 -165.76 2.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.028 -1.045 . . . . 0.0 111.995 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 56.0 57.15 5.32 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.221 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.3 m 56.61 167.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.322 0.582 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -91.39 84.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 110.018 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 59.7 m -68.08 151.39 47.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.1 t -132.62 149.96 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 109.336 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.1 176.49 39.33 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.9 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 94.3 m -131.96 166.41 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 122.005 -0.703 . . . . 0.0 109.721 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 34.7 t -151.16 80.32 1.31 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.706 -0.621 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -129.97 145.11 51.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.486 -0.759 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.01 37.75 87.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.5 m120 56.96 24.22 9.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.609 -0.936 . . . . 0.0 110.387 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -127.37 124.1 37.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.552 -0.717 . . . . 0.0 109.17 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -102.19 117.55 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.553 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 57.4 t-20 -99.76 104.77 16.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.322 -0.861 . . . . 0.0 111.156 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.689 HD13 ' CG2' ' A' ' 36' ' ' VAL . 75.1 mt -93.27 131.86 37.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 0.0 109.819 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.644 HG21 ' O7 ' ' A' ' 137' ' ' NAG . 58.9 m -121.89 139.93 53.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 84' ' ' LEU . 72.2 mt -120.02 138.82 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.711 . . . . 0.0 109.905 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.0 mt-30 -124.92 121.24 33.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.983 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.38 25.1 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 81' ' ' ILE . 75.7 mt -81.67 129.99 34.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -1.044 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 85' ' ' ARG . 22.9 mtp-105 -104.19 179.93 4.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.05 94.55 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.835 0.826 . . . . 0.0 109.614 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.9 mmt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -67.75 -16.93 64.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.761 . . . . 0.0 111.807 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.3 m -52.96 139.96 26.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 166.31 -164.96 37.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.564 HD23 ' NE2' ' A' ' 39' ' ' GLN . 18.0 tp -94.12 132.01 39.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.752 -0.852 . . . . 0.0 112.483 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.798 ' CD1' HD12 ' A' ' 115' ' ' ILE . 72.9 m-85 -118.39 134.58 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -99.95 139.91 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 111.762 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.859 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.8 p -108.07 107.98 18.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.712 ' HE3' HD12 ' A' ' 37' ' ' LEU . 17.1 mttt -105.17 141.39 36.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 109.202 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.6 ' O ' HD23 ' A' ' 106' ' ' LEU . 9.8 t -135.96 111.42 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.947 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 86.6 mt-10 -131.98 131.7 42.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.539 -0.725 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.717 ' CD2' HD22 ' A' ' 106' ' ' LEU . 11.2 mt -85.43 80.01 9.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 33' ' ' ARG . 2.5 ttm -80.65 -39.67 26.92 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.631 -173.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 68.6 m-85 -70.8 -45.7 16.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.401 -0.92 . . . . 0.0 112.773 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 71.9 Cg_endo -80.29 133.42 9.72 Favored 'Trans proline' 0 CA--C 1.597 3.648 0 O-C-N 122.877 0.935 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 86.0 Cg_endo -90.88 143.11 3.32 Favored 'Trans proline' 1 N--CA 1.54 4.207 1 CA-C-O 110.185 -4.173 . . . . 0.0 114.945 177.088 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.2 Cg_endo -110.7 57.07 0.77 Allowed 'Cis proline' 2 C--N 1.453 6.051 1 C-N-CA 97.123 -12.449 . . . . 0.0 110.505 11.41 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' O ' ' O ' ' A' ' 103' ' ' PRO . 5.1 t80 50.72 120.95 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.836 0 O-C-N 120.556 -1.34 . . . . 0.0 111.843 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -160.18 106.98 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.428 -2.045 . . . . 0.0 107.378 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD22 ' CD2' ' A' ' 98' ' ' LEU . 3.2 tp -159.41 -148.91 0.19 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.979 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.46 -176.38 30.44 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.55 HG21 ' H81' ' A' ' 132' ' ' NAG . 76.8 mt -126.63 162.75 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.355 -1.086 . . . . 0.0 110.978 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.859 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 134.81 11.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -59.8 -35.89 75.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -1.17 . . . . 0.0 110.64 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 130.6 136.73 4.02 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.68 -1.248 . . . . 0.0 111.874 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.492 HG21 HG23 ' A' ' 9' ' ' VAL . 96.3 m -108.63 139.09 43.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.564 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.5 tt0 -89.56 120.2 30.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.207 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.798 HD12 ' CD1' ' A' ' 92' ' ' TYR . 97.0 mt -81.48 123.66 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.609 ' CE2' HG21 ' A' ' 8' ' ' VAL . 2.8 m-30 -94.93 161.66 14.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.633 0.73 . . . . 0.0 111.531 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.28 148.0 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 118' ' ' ILE . 1.9 mp -79.99 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -132.03 126.4 20.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.769 -0.582 . . . . 0.0 109.711 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.55 150.02 68.99 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.101 1.053 . . . . 0.0 110.748 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.01 150.07 50.26 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.626 -0.671 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.98 -27.93 35.98 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.353 1.186 . . . . 0.0 110.738 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 1.118 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 42.3 t -140.0 135.64 16.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.463 -0.773 . . . . 0.0 110.202 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.99 -19.3 35.22 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.158 1.083 . . . . 0.0 111.312 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 1.118 ' CG ' ' HG ' ' A' ' 123' ' ' CYS . 56.3 p30 -86.04 -172.1 3.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.008 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.3 p -122.68 150.45 42.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 0.0 109.927 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.11 160.1 40.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.54 -0.725 . . . . 0.0 110.295 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -60.38 -30.42 69.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.595 -0.69 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.03 140.84 88.72 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.617 -0.677 . . . . 0.0 109.974 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.92 149.98 66.62 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.286 1.151 . . . . 0.0 110.495 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 110.262 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.55 ' H81' HG21 ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.814 ' H82' ' C1 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.814 ' C1 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.489 ' H5 ' ' C8 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.644 ' O7 ' HG21 ' A' ' 80' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.109 0.481 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm -122.47 -164.04 1.14 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.626 -0.671 . . . . 0.0 109.858 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.44 ' C ' HG23 ' A' ' 3' ' ' VAL . 77.8 m80 -96.52 22.92 7.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 110.818 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.468 HG12 ' OE1' ' A' ' 5' ' ' GLN . 61.3 t -149.77 132.03 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -110.2 132.74 53.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.377 -0.827 . . . . 0.0 110.606 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.75 138.79 22.34 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.814 -0.554 . . . . 0.0 110.503 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.48 133.89 27.19 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.259 1.137 . . . . 0.0 109.535 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.49 76.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.994 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -149.16 155.96 7.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.118 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.6 t -137.62 155.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.989 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 116' ' ' TYR . 82.1 mt -116.01 132.72 56.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.07 131.76 35.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.384 -0.823 . . . . 0.0 110.974 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -60.64 172.73 0.85 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.62 -0.675 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -59.83 -35.94 75.77 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.577 -0.702 . . . . 0.0 110.088 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.762 ' CG ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -53.55 -24.95 15.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.97 24.97 13.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.762 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -112.6 111.64 37.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 84' ' ' LEU . . . -98.69 119.72 37.9 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.503 ' HB2' HG23 ' A' ' 80' ' ' THR . 46.4 t -122.31 131.1 53.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.21 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.725 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.2 p90 -139.92 164.03 31.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 77' ' ' VAL . 55.3 t -131.6 130.77 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.956 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' VAL . 29.5 t -112.84 110.75 21.05 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -82.06 151.73 26.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.723 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CD2' HG21 ' A' ' 96' ' ' VAL . 19.6 p90 -134.36 169.44 17.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.63 134.72 43.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.583 -0.698 . . . . 0.0 110.898 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 t -140.2 149.47 58.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.634 . . . . 0.0 110.651 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.67 -20.44 52.99 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.727 1.383 . . . . 0.0 111.54 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.02 165.91 25.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.61 133.54 55.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.573 -0.957 . . . . 0.0 110.548 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -131.93 163.0 29.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 109.536 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' MET . 25.6 p -80.1 -38.03 32.49 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.39 -0.818 . . . . 0.0 110.201 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 10.5 mm-40 -79.35 93.11 5.26 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.225 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 34' ' ' VAL . 96.4 t -109.76 102.6 14.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -82.83 106.37 14.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.343 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 34.0 m -106.04 141.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.487 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.0 m -132.0 156.88 45.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.728 0.775 . . . . 0.0 110.175 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 79' ' ' LEU . 98.4 t -125.57 136.24 61.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 46' ' ' GLU . 7.7 mt -131.92 160.1 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.058 -1.026 . . . . 0.0 111.216 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 47' ' ' VAL . 77.4 mtt180 -112.66 113.79 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.771 ' OE1' HD11 ' A' ' 93' ' ' ILE . 84.8 mt-30 -93.67 131.82 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.895 . . . . 0.0 110.818 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -130.9 158.69 39.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.65 85.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 110.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.7 p -73.71 -56.09 5.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.615 -0.678 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.663 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.6 mt-30 -154.15 171.99 18.28 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.302 -0.874 . . . . 0.0 111.353 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.8 t -122.35 142.11 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.0 p -128.22 160.16 32.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.206 -0.934 . . . . 0.0 111.603 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.87 ' HA ' HD23 ' A' ' 37' ' ' LEU . 59.1 mt-10 -80.25 162.04 24.83 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.67 -0.643 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 48' ' ' CYS . 38.7 t -130.25 -64.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.342 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.776 ' SG ' ' O ' ' A' ' 64' ' ' SER . 57.9 m -149.56 151.89 34.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.441 -0.787 . . . . 0.0 110.153 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -167.59 137.89 2.84 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.148 -0.97 . . . . 0.0 112.387 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -169.1 148.11 3.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.529 -0.732 . . . . 0.0 109.917 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.437 ' HG1' ' HE1' ' A' ' 100' ' ' TYR . 2.9 m -95.87 115.3 27.23 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.137 -0.977 . . . . 0.0 108.784 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 54' ' ' MET . 46.1 p90 -109.57 145.31 36.57 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.388 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 1.068 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -73.23 158.71 34.67 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.464 ' HE2' ' CD1' ' A' ' 52' ' ' TYR . 27.5 mmt -67.14 130.46 43.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.837 -1.164 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.5 30.46 18.84 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -149.26 175.61 11.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -1.124 . . . . 0.0 110.909 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -137.84 150.07 46.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.819 -0.551 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 51' ' ' THR . 80.1 mt -134.15 179.63 6.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.304 -0.873 . . . . 0.0 111.577 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.7 p -113.8 159.81 19.38 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.963 -0.461 . . . . 0.0 110.081 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 36.2 m-85 -110.2 123.38 49.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.63 -35.87 75.63 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.48 -0.762 . . . . 0.0 112.359 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -67.15 -147.75 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.241 -0.912 . . . . 0.0 111.187 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -46.57 -19.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.896 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.776 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 29.0 m 57.51 -132.62 1.32 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.654 -0.654 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.5 mt 56.56 22.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.77 -1.206 . . . . 0.0 110.27 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 64' ' ' SER . 20.7 m -137.36 155.18 49.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.413 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 9.9 t -120.31 140.06 51.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.43 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.58 96.1 1.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 m -123.79 156.03 36.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.538 -0.978 . . . . 0.0 109.024 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.2 p -156.52 160.24 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.177 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -140.36 107.92 5.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.15 32.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -93.69 9.71 35.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.454 -1.027 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.528 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 36.5 tt0 -111.7 136.07 51.44 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.239 -0.913 . . . . 0.0 110.226 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 20' ' ' VAL . 11.3 m -112.77 141.85 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.008 -1.058 . . . . 0.0 111.287 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' CG ' HG22 ' A' ' 20' ' ' VAL . 64.1 t-20 -112.76 118.01 33.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.769 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD13 HG22 ' A' ' 36' ' ' VAL . 90.4 mt -112.22 129.97 56.08 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.719 . . . . 0.0 109.376 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 18' ' ' SER . 81.8 m -130.65 154.52 47.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.272 -0.892 . . . . 0.0 110.808 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 91.0 mt -120.43 139.41 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.78 -0.575 . . . . 0.0 109.846 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 67' ' ' ILE . 40.2 mt-30 -119.48 123.22 43.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.143 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.57 56.84 0.76 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 17' ' ' ALA . 91.4 mt -80.85 126.03 30.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.792 -0.828 . . . . 0.0 111.805 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -105.93 170.14 8.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.22 90.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -65.64 -37.72 87.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.755 -0.591 . . . . 0.0 110.325 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.28 -36.47 75.61 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.619 -0.676 . . . . 0.0 111.228 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 115' ' ' ILE . 20.3 m -51.11 133.75 27.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.6 -143.69 9.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.478 HD11 ' C ' ' A' ' 112' ' ' GLY . 34.8 tp -109.23 123.71 49.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.733 -0.863 . . . . 0.0 111.709 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.767 ' CD1' HD12 ' A' ' 115' ' ' ILE . 53.7 m-85 -110.18 115.87 30.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.469 -0.769 . . . . 0.0 110.05 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.771 HD11 ' OE1' ' A' ' 39' ' ' GLN . 40.8 mm -78.21 133.51 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.6 -0.687 . . . . 0.0 111.984 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.3 p -85.47 149.82 25.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.2 tttt -147.31 127.93 14.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 108.495 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.704 HG21 ' CD2' ' A' ' 23' ' ' TYR . 2.4 p -134.95 113.11 15.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.614 0.721 . . . . 0.0 109.297 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 74.3 mm-40 -134.56 132.2 38.83 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.553 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.6 mm? -81.54 85.2 6.55 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 51.0 tpp -82.52 -46.92 12.77 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.779 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 59.0 m-85 -71.42 -42.98 11.9 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 49.1 Cg_endo -81.76 113.06 2.47 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 121.194 1.263 . . . . 0.0 112.576 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 50.5 Cg_endo -77.02 166.87 26.05 Favored 'Trans proline' 1 CA--C 1.642 5.913 0 CA-C-O 111.834 -3.486 . . . . 0.0 108.246 177.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.43 68.2 Cg_endo -81.95 -171.97 10.0 Favored 'Cis proline' 1 C--N 1.47 6.944 1 C-N-CA 98.741 -11.774 . . . . 0.0 116.704 -15.862 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.1 t80 -99.19 125.16 44.7 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 118.365 -2.709 . . . . 0.0 109.243 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.536 ' O ' HD22 ' A' ' 106' ' ' LEU . 22.5 p90 -169.42 108.1 0.42 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.005 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.553 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.91 -148.02 0.24 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.1 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.65 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -154.8 165.35 32.06 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.357 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -122.25 149.18 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' HA2' ' OE1' ' A' ' 5' ' ' GLN . . . -88.14 -177.68 47.46 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.84 21.33 17.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -1.19 . . . . 0.0 111.803 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.682 ' CA ' HD13 ' A' ' 93' ' ' ILE . . . 83.53 146.89 7.17 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-O 122.793 1.218 . . . . 0.0 114.074 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.593 HG21 HG23 ' A' ' 9' ' ' VAL . 57.7 m -116.16 128.88 56.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 8' ' ' VAL . 35.3 tp60 -68.36 136.59 53.6 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 118.354 -1.339 . . . . 0.0 107.86 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 92' ' ' TYR . 61.6 mt -113.67 125.1 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.957 -1.09 . . . . 0.0 108.635 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.819 ' CE2' HG21 ' A' ' 8' ' ' VAL . 24.8 m-85 -109.69 159.79 16.85 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 118' ' ' ILE . 88.4 t -103.61 164.71 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.331 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 117' ' ' VAL 0.272 38.8 mm -117.95 140.07 42.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.156 0.503 . . . . 0.0 110.672 -178.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -105.98 116.09 60.22 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.619 -0.676 . . . . 0.0 109.276 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.81 140.07 41.58 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.101 1.053 . . . . 0.0 110.76 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.0 142.15 44.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 110.112 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.64 -12.11 32.43 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.244 1.129 . . . . 0.0 111.241 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 42.3 t -128.03 144.48 51.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.94 . . . . 0.0 110.389 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.61 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 49.1 Cg_endo -69.08 161.92 43.87 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.38 1.2 . . . . 0.0 110.691 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -80.22 -173.7 4.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.457 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -60.12 -29.98 68.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.0 110.785 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -84.14 119.96 25.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.452 -0.78 . . . . 0.0 110.427 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -120.67 142.05 49.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.05 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 52.37 49.49 6.76 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.492 -0.755 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 47.4 Cg_endo -69.34 149.94 70.17 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.24 1.126 . . . . 0.0 110.663 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 110.073 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.068 0.461 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt 56.09 166.63 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.695 -0.628 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -124.08 37.08 4.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 22' ' ' GLU . 95.4 t -102.06 134.97 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.773 -0.58 . . . . 0.0 110.114 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.36 54.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.508 -0.745 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.417 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.3 pt20 -157.57 156.05 28.15 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.572 -0.705 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.57 46.75 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.55 1.29 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.13 -23.66 23.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.582 -0.699 . . . . 0.0 109.731 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.2 156.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.567 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.711 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -136.86 156.8 35.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.86 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 116' ' ' TYR . 86.8 mt -114.61 127.77 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.629 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.93 165.14 18.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.456 -0.778 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 160.02 43.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.255 -0.903 . . . . 0.0 111.1 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t 55.5 -132.87 1.66 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.509 -0.745 . . . . 0.0 110.737 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 16' ' ' ILE . 6.1 ttt180 -52.02 -23.84 5.77 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.764 -1.21 . . . . 0.0 111.461 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.576 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 119.56 46.19 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.8 mp -103.78 113.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.93 0.872 . . . . 0.0 109.893 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -112.92 126.48 55.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.3 p -123.49 139.99 53.46 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.59 0.709 . . . . 0.0 110.902 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.711 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.7 p90 -150.15 162.24 40.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 71.9 t -125.29 121.03 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.713 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.864 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.04 103.72 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 3' ' ' VAL . 57.2 tt0 -80.04 142.43 34.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.817 . . . . 0.0 111.0 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.3 p90 -121.96 176.36 5.83 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.64 137.01 41.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.661 -0.649 . . . . 0.0 110.584 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 106' ' ' LEU . 95.4 p -142.95 152.91 59.88 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.649 -0.657 . . . . 0.0 110.43 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HG2' ' CE2' ' A' ' 105' ' ' TYR . 44.0 Cg_endo -69.23 -13.47 36.07 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.461 1.242 . . . . 0.0 110.929 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.13 -179.84 33.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -117.98 140.08 50.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -1.035 . . . . 0.0 110.602 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.54 172.27 13.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.0 109.486 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 p -80.06 -46.55 16.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.638 ' OE1' HG21 ' A' ' 51' ' ' THR . 5.3 mm-40 -80.09 109.96 15.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.795 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 34' ' ' VAL . 96.7 t -119.83 82.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -60.22 103.58 0.24 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.739 HG23 ' HZ ' ' A' ' 60' ' ' PHE . 27.2 m -114.44 143.66 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.325 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 49' ' ' ALA . 69.1 m -140.03 132.9 29.22 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.217 0.532 . . . . 0.0 111.04 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -98.99 130.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -119.97 160.01 23.59 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.749 -1.219 . . . . 0.0 111.735 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -117.03 129.68 56.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.406 ' HG3' ' CG2' ' A' ' 44' ' ' VAL . 15.8 tt0 -106.81 149.31 27.51 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.712 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.62 -172.6 2.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.858 -0.526 . . . . 0.0 109.761 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.18 -44.4 95.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.502 -0.749 . . . . 0.0 111.138 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.1 m -132.73 -13.74 2.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.295 -0.878 . . . . 0.0 112.294 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.746 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 tt0 -122.88 142.7 50.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 111.168 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 39' ' ' GLN . 50.7 t -132.03 133.81 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -131.17 165.84 22.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HA ' HD23 ' A' ' 37' ' ' LEU . 64.3 mt-10 -79.98 149.91 30.63 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.441 0.638 . . . . 0.0 110.55 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.314 HG12 ' SG ' ' A' ' 68' ' ' CYS . 95.4 t -112.33 -67.99 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 63' ' ' ASP . 57.0 m -133.34 150.08 51.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.547 -0.721 . . . . 0.0 109.526 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.853 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -166.87 135.27 2.71 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.378 -0.929 . . . . 0.0 112.007 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.02 157.54 4.4 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.638 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -85.69 124.81 32.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 72' ' ' SER . 28.7 t80 -87.82 110.41 20.48 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.592 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.425 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 2.2 mmt -80.04 165.58 22.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 54' ' ' MET . 31.2 mmt -59.54 -30.34 68.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.6 -1.312 . . . . 0.0 109.604 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.16 -139.75 7.9 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.68 133.75 55.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -1.154 . . . . 0.0 110.668 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 178.02 159.22 0.48 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 38.3 mt 51.04 78.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.977 . . . . 0.0 111.308 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -96.79 163.26 13.06 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.728 -0.608 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.739 ' HZ ' HG23 ' A' ' 34' ' ' VAL . 8.6 m-30 -90.53 10.01 27.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.565 -0.709 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.71 -30.21 68.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.273 -0.892 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.07 -28.55 62.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.396 -0.815 . . . . 0.0 111.019 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.724 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 26.3 m-20 -84.11 -6.58 59.43 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 122.082 -0.386 . . . . 0.0 111.667 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p 42.25 28.5 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.8 mt -137.04 -47.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.306 -0.871 . . . . 0.0 110.79 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.314 ' SG ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -118.76 131.41 56.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 0.0 111.486 -179.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -139.85 147.49 40.75 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.99 -171.74 37.26 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.275 -1.441 . . . . 0.0 111.16 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.514 HG21 ' H62' ' A' ' 138' ' ' FUC . 59.9 m -130.08 169.6 15.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 122.019 -0.695 . . . . 0.0 109.821 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 71' ' ' THR . 31.0 t -134.74 130.02 35.56 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -135.07 129.95 34.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 50.61 -122.84 14.09 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 27.4 m120 -100.03 12.07 37.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.759 -0.847 . . . . 0.0 110.46 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -116.27 128.49 55.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 109.853 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 21' ' ' CYS . 16.7 m -105.42 118.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.399 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.31 110.05 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 111.112 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 HG22 ' A' ' 36' ' ' VAL . 77.4 mt -111.08 131.96 54.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -131.26 144.08 51.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -124.02 140.02 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.502 -0.749 . . . . 0.0 110.481 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 16' ' ' ILE . 30.4 mt-30 -120.34 122.56 41.06 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.402 0.62 . . . . 0.0 109.589 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.92 37.75 1.65 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 94.9 mt -80.12 85.72 5.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.893 . . . . 0.0 110.77 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.96 168.38 20.14 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -41.73 67.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.234 -0.917 . . . . 0.0 109.732 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.76 -36.07 79.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.393 0.616 . . . . 0.0 109.78 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.25 -23.48 67.07 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 110.859 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 115' ' ' ILE . 50.7 m -53.43 139.98 29.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.23 -146.8 10.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.004 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.6 tm? -107.33 134.93 49.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.859 -0.789 . . . . 0.0 110.752 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.813 ' N ' HD13 ' A' ' 91' ' ' LEU . 57.2 m-85 -121.1 125.07 46.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.744 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -98.75 123.97 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.396 -0.815 . . . . 0.0 112.578 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.9 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.6 p -85.11 111.29 19.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HB3' ' H ' ' A' ' 35' ' ' THR . 7.8 tttt -103.56 139.99 38.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.536 -0.727 . . . . 0.0 109.076 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' HD23 ' A' ' 106' ' ' LEU . 21.2 t -140.13 105.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.41 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.937 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 36.8 mt-10 -131.93 130.69 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.238 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.728 ' HG ' HD22 ' A' ' 106' ' ' LEU . 13.5 mt -84.62 78.84 9.77 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.937 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -80.03 -41.67 25.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.195 -0.941 . . . . 0.0 113.016 -174.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.475 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 62.8 m-85 -65.17 -46.84 72.83 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.884 -1.135 . . . . 0.0 113.145 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 61.3 Cg_endo -77.0 110.1 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.204 1.107 . . . . 0.0 111.349 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 44.6 Cg_endo -89.24 145.92 5.18 Favored 'Trans proline' 0 CA--C 1.598 3.724 0 CA-C-O 110.666 -3.972 . . . . 0.0 110.432 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 37.6 Cg_endo -88.3 -168.37 4.44 Favored 'Cis proline' 2 N--CA 1.629 9.478 2 C-N-CA 92.29 -14.463 . . . . 0.0 111.927 -0.064 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -88.17 137.79 32.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.644 -1.285 . . . . 0.0 113.975 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 12.4 p90 -153.59 92.71 1.6 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.496 -0.752 . . . . 0.0 111.905 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.6 tp -160.13 -149.67 0.2 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.616 -0.678 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.695 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.02 176.35 40.03 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.339 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.0 mp -117.55 158.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.718 -0.872 . . . . 0.0 109.338 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.9 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -87.45 146.82 20.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.31 78.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.439 -1.036 . . . . 0.0 110.135 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 121.4 129.96 3.74 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.101 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.706 HG21 HG23 ' A' ' 9' ' ' VAL . 94.8 m -94.63 129.98 41.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.987 -0.713 . . . . 0.0 109.089 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.774 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 tp60 -79.87 132.01 36.0 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 89' ' ' THR . 81.3 mt -98.85 125.06 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.865 -1.147 . . . . 0.0 108.767 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.888 ' CE2' HG21 ' A' ' 8' ' ' VAL . 11.9 m-30 -103.44 151.21 23.08 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.108 0.48 . . . . 0.0 111.122 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 118' ' ' ILE . 95.8 t -100.13 166.43 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' N ' HG12 ' A' ' 117' ' ' VAL . 45.8 mm -101.67 120.22 50.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.848 -0.533 . . . . 0.0 111.035 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -119.97 148.41 46.63 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 0.0 109.824 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.89 147.99 63.23 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.346 1.182 . . . . 0.0 110.437 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -129.91 144.24 52.28 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.31 160.07 50.83 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.341 1.18 . . . . 0.0 110.365 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.6 m -81.35 140.03 48.59 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.528 -0.732 . . . . 0.0 109.92 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.05 -35.97 10.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.237 1.125 . . . . 0.0 110.975 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.89 -39.84 87.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.44 -0.787 . . . . 0.0 110.637 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.2 p -65.1 -31.98 73.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -107.99 124.11 49.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.55 -0.719 . . . . 0.0 110.446 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -73.69 155.29 39.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 54.0 mt-10 53.48 50.17 7.06 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.443 -0.785 . . . . 0.0 110.741 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.4 Cg_endo -69.98 167.6 24.26 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 123.273 1.144 . . . . 0.0 110.541 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? . . . . . 0 N--CA 1.499 2.018 0 O-C-N 121.562 -0.711 . . . . 0.0 110.557 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.424 ' C8 ' ' H2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.424 ' H2 ' ' C8 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.55 ' C6 ' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.55 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.514 ' H62' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.063 0.459 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt -137.3 78.45 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.67 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.459 ' C ' HG23 ' A' ' 3' ' ' VAL . 95.8 m-70 -100.1 118.73 37.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.292 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 97.6 t -149.25 147.73 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 109.679 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.71 130.6 55.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.443 -0.785 . . . . 0.0 110.607 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.591 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 13.1 mm100 -143.5 139.97 17.0 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.668 -0.645 . . . . 0.0 111.49 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.63 139.92 38.29 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.82 66.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.909 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.03 162.41 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.679 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG23 HG21 ' A' ' 113' ' ' THR . 8.9 t -141.94 153.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -107.91 129.78 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 143.98 25.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.483 -0.761 . . . . 0.0 110.624 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -75.87 170.05 16.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.655 -0.653 . . . . 0.0 110.13 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -60.14 -34.63 73.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.712 . . . . 0.0 110.124 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 5.6 ttt180 -60.17 -26.63 66.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.0 110.034 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.93 30.67 6.63 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.1 mp -105.3 103.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.646 -0.914 . . . . 0.0 109.32 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.85 124.07 50.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.763 ' HB3' HG23 ' A' ' 80' ' ' THR . 92.9 p -136.26 149.83 48.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.738 0.78 . . . . 0.0 111.243 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -155.95 164.1 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 89.1 t -126.66 123.98 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.596 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' VAL . 36.8 t -102.89 108.07 19.14 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.895 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 17.1 pt-20 -79.79 160.03 26.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 111.296 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.96 179.89 6.35 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.68 125.76 29.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.702 . . . . 0.0 110.961 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -149.73 158.81 37.11 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.653 . . . . 0.0 109.966 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.81 124.91 11.52 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.354 1.186 . . . . 0.0 110.168 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.98 -131.38 52.02 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -126.03 143.31 51.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.617 -0.931 . . . . 0.0 109.956 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.18 145.17 42.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 110.04 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 2.7 p -80.9 -59.74 2.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 112.067 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 51' ' ' THR . 9.8 mm-40 -84.27 75.82 10.17 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.279 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 34' ' ' VAL . 15.4 m -85.78 87.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.613 ' N ' HG23 ' A' ' 51' ' ' THR . 7.2 ttp85 -55.97 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.53 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.6 m -103.56 129.59 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.819 0.819 . . . . 0.0 111.046 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.5 m -131.45 145.83 51.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.611 -0.68 . . . . 0.0 109.655 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.883 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.5 t -114.04 132.39 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.821 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.25 167.16 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.979 -1.076 . . . . 0.0 111.293 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.9 ttt-85 -127.61 120.86 29.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HA ' HG22 ' A' ' 44' ' ' VAL . 80.4 mt-30 -105.9 130.28 53.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.395 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -126.78 156.12 41.73 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.24 -43.62 95.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.443 -0.786 . . . . 0.0 110.644 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -68.33 -49.95 56.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.549 -0.719 . . . . 0.0 111.145 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 71.2 mt-30 -155.47 164.02 39.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.382 -0.824 . . . . 0.0 111.084 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.9 t -124.77 137.27 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -139.96 166.11 25.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.494 -0.754 . . . . 0.0 110.959 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.821 ' HA ' HD23 ' A' ' 37' ' ' LEU . 62.5 tt0 -79.99 157.42 26.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 109.47 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 38' ' ' ARG . 97.3 t -121.03 -72.17 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.843 -0.536 . . . . 0.0 110.445 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 47' ' ' VAL . 81.0 m -129.95 148.08 51.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.339 -0.85 . . . . 0.0 109.411 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -155.95 136.47 13.24 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.17 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -173.84 149.58 1.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.587 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 ' N ' ' A' ' 33' ' ' ARG . 3.2 m -94.33 119.94 33.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.214 -0.928 . . . . 0.0 109.278 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 53' ' ' MET . 25.6 t80 -77.91 116.7 18.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.077 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -84.23 169.93 14.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.5 mmt -65.44 -28.26 69.1 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.687 -1.258 . . . . 0.0 111.27 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.76 44.3 0.83 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.218 -1.468 . . . . 0.0 112.361 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 74.1 m-20 -132.73 162.14 32.21 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 118.867 1.333 . . . . 0.0 110.158 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' HD22 ' A' ' 58' ' ' LEU . 59.0 tt0 -104.68 126.54 51.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.561 -0.712 . . . . 0.0 110.13 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.804 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mm? -98.29 139.98 33.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.009 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.6 p -100.18 142.87 31.07 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.676 -0.64 . . . . 0.0 110.581 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 96.0 m-85 -103.72 133.64 48.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.51 -0.743 . . . . 0.0 109.25 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.83 -44.27 94.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.516 -0.74 . . . . 0.0 112.762 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -168.39 -149.45 0.09 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.909 -1.119 . . . . 0.0 111.21 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 47' ' ' VAL . 76.8 m-20 59.01 54.27 5.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.462 -0.774 . . . . 0.0 110.242 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p 65.47 9.72 6.02 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.899 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.0 mt 48.27 68.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.16 -0.962 . . . . 0.0 111.354 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.413 ' O ' ' CE1' ' A' ' 60' ' ' PHE . 11.5 m -59.89 133.41 56.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 80' ' ' THR . 9.1 t -80.08 128.93 34.09 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.286 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.68 ' HA2' HD23 ' A' ' 79' ' ' LEU . . . -106.68 107.69 2.75 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.48 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -113.8 149.69 34.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.737 -0.861 . . . . 0.0 108.943 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 69.3 m -150.71 131.42 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -139.98 138.53 35.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.664 -0.648 . . . . 0.0 109.265 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.54 -123.92 33.31 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -108.92 16.68 22.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.905 . . . . 0.0 110.544 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 36.8 mt-30 -121.8 128.8 52.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.218 -0.926 . . . . 0.0 111.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -100.5 128.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.133 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 20' ' ' VAL . 51.0 t-20 -108.02 118.12 35.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' CG2' ' A' ' 36' ' ' VAL . 86.7 mt -112.13 129.96 56.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.525 -0.734 . . . . 0.0 109.541 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.763 HG23 ' HB3' ' A' ' 18' ' ' SER . 61.3 m -125.89 138.98 53.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.296 -0.878 . . . . 0.0 110.641 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.705 HG21 HD21 ' A' ' 84' ' ' LEU . 72.9 mt -113.7 139.74 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.734 -0.604 . . . . 0.0 110.273 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.431 ' HG2' HG13 ' A' ' 16' ' ' ILE . 63.3 mt-30 -124.81 121.98 36.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.259 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.61 36.99 1.49 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.705 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -92.81 121.09 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.986 . . . . 0.0 111.33 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' O ' HG21 ' A' ' 117' ' ' VAL . 73.4 mmt-85 -98.02 176.96 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.08 84.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 16.9 tpt -67.89 -34.54 76.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.514 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -67.53 -16.34 64.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.665 -0.647 . . . . 0.0 111.465 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 115' ' ' ILE . 22.8 m -50.36 135.5 21.81 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.213 -0.929 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.55 -159.43 24.02 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.871 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 113' ' ' THR . 15.6 tp -109.55 128.65 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.676 -0.897 . . . . 0.0 111.531 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 62.1 m-85 -109.94 139.94 44.48 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -115.31 130.22 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.608 -0.683 . . . . 0.0 111.881 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.114 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.8 p -80.1 146.87 31.66 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 6.8 tttt -142.55 77.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.776 HG22 HD23 ' A' ' 106' ' ' LEU . 3.6 p -98.84 113.99 35.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.783 0.801 . . . . 0.0 110.482 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.661 ' OE2' HD11 ' A' ' 109' ' ' ILE . 54.9 mt-10 -128.19 129.14 46.02 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.721 -0.612 . . . . 0.0 110.63 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 106' ' ' LEU . 67.4 mt -77.64 76.16 4.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.6 tpp -81.8 -44.21 17.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.431 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 90.3 m-85 -70.19 -42.1 15.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.405 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 58.7 Cg_endo -87.51 111.76 0.81 Allowed 'Trans proline' 0 CA--C 1.561 1.868 0 CA-C-O 117.362 -1.183 . . . . 0.0 111.324 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.591 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 76.0 Cg_endo -85.23 155.15 10.95 Favored 'Trans proline' 0 CA--C 1.597 3.629 0 CA-C-O 111.592 -3.587 . . . . 0.0 110.249 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.591 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.286 48.0 Cg_endo -86.46 -178.99 17.33 Favored 'Cis proline' 2 C--N 1.5 8.512 1 C-N-CA 91.179 -14.925 . . . . 0.0 115.914 -5.951 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.28 128.43 34.69 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.399 -1.438 . . . . 0.0 110.33 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -145.09 69.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.385 0.612 . . . . 0.0 111.552 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.776 HD23 HG22 ' A' ' 96' ' ' VAL . 3.5 tp -144.9 -154.87 0.56 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -167.74 -171.22 33.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.063 -1.541 . . . . 0.0 111.838 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.2 mp -115.15 150.03 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.7 -0.882 . . . . 0.0 109.639 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 1.114 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -79.91 148.65 30.45 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.4 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 12.1 t-20 -59.82 -38.63 82.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.351 -1.087 . . . . 0.0 110.227 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 125.42 148.5 7.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.549 HG21 HG23 ' A' ' 9' ' ' VAL . 98.8 m -119.79 134.57 55.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.813 ' HB3' HG23 ' A' ' 8' ' ' VAL . 38.3 tp60 -80.38 129.51 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 75.5 mt -98.2 120.82 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.0 108.537 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 8' ' ' VAL . 9.5 m-30 -97.02 132.36 42.9 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.095 0.474 . . . . 0.0 111.414 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.4 t -98.82 166.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.504 ' N ' HG12 ' A' ' 117' ' ' VAL . 45.6 mm -100.03 116.7 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -140.09 125.06 11.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.581 -0.7 . . . . 0.0 110.08 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.72 149.94 67.78 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.075 1.04 . . . . 0.0 110.513 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -123.92 145.52 48.08 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.506 -0.746 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.35 -17.44 44.35 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.418 1.22 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.1 m -125.91 148.91 64.38 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.346 -0.846 . . . . 0.0 110.343 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.8 -11.94 31.8 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.463 1.244 . . . . 0.0 111.36 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -147.95 179.24 7.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.223 -0.923 . . . . 0.0 110.645 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.8 p -132.44 163.95 27.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.146 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.18 122.2 27.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.38 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -89.87 169.77 10.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.642 -0.661 . . . . 0.0 110.331 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 53.67 50.67 7.53 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.471 -0.768 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.5 Cg_endo -70.13 159.99 51.18 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.209 1.11 . . . . 0.0 110.224 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.502 2.162 0 O-C-N 121.454 -0.779 . . . . 0.0 110.613 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.718 ' H62' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.718 ' H83' ' H62' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' A ALA . . . . . 0.589 ' HB3' ' NE2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.041 0.448 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.611 ' SD ' ' HE1' ' A' ' 105' ' ' TYR . 66.3 mtt -93.94 95.29 8.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.562 -0.711 . . . . 0.0 110.283 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.589 ' NE2' ' HB3' ' A' ' 1' A ALA . 97.7 m-70 -109.92 132.02 54.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.48 HG12 ' OE1' ' A' ' 5' ' ' GLN . 66.5 t -129.89 126.04 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.609 -0.682 . . . . 0.0 109.607 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 130.81 56.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.506 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' OE1' HG12 ' A' ' 3' ' ' VAL . 2.7 mp0 -135.02 131.29 19.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 110.601 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.78 136.03 24.69 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.064 1.034 . . . . 0.0 109.515 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.1 -28.78 57.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.813 . . . . 0.0 110.209 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.97 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -153.01 163.01 2.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.045 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.4 t -138.51 151.63 24.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.57 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 116' ' ' TYR . 85.9 mt -119.19 121.26 39.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.603 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 140.08 45.53 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -110.12 -69.38 0.87 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.226 -0.921 . . . . 0.0 112.647 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 m -120.03 151.32 39.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.241 -0.912 . . . . 0.0 111.075 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HG2' HD11 ' A' ' 16' ' ' ILE . 4.0 tpt180 56.9 18.8 4.09 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.606 -0.684 . . . . 0.0 110.577 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.64 44.02 53.91 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.618 HD11 ' HG2' ' A' ' 14' ' ' ARG . 21.6 mm -110.25 108.97 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 121.606 -0.938 . . . . 0.0 108.941 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -101.79 126.11 48.59 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.793 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' HG23 ' A' ' 80' ' ' THR . 38.3 t -133.17 135.0 44.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' VAL . 26.7 p90 -146.23 161.33 40.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.77 -0.581 . . . . 0.0 109.796 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 96.1 t -117.72 119.06 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.225 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.881 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.18 103.18 14.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 85.1 mt-10 -80.4 164.3 23.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 111.789 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.662 ' CG ' HG11 ' A' ' 96' ' ' VAL . 44.0 p90 -147.9 178.46 8.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.489 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.59 27.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.636 . . . . 0.0 109.891 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -131.44 147.82 67.65 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 0.0 110.585 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.44 142.53 26.69 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.379 1.199 . . . . 0.0 110.372 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.61 -150.34 38.62 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.07 140.91 50.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.924 . . . . 0.0 110.21 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.81 144.82 31.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.273 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 1.149 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 82.7 p -78.6 -46.83 18.42 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.952 0.882 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.686 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.2 mm-40 -79.04 112.56 16.37 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.538 0.685 . . . . 0.0 112.847 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.684 HG11 ' OH ' ' A' ' 52' ' ' TYR . 94.2 t -124.04 96.09 3.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 99' ' ' MET . 24.0 ttt180 -77.89 124.03 27.5 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 0.0 111.184 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 28.3 m -121.75 141.81 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.58 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.5 m -129.92 130.1 44.7 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.238 0.542 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD13 ' A' ' 79' ' ' LEU . 95.6 t -103.77 132.02 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 46' ' ' GLU . 18.7 mt -127.34 169.03 14.0 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.185 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HG3' HG21 ' A' ' 47' ' ' VAL . 87.7 mtm180 -122.1 115.66 22.85 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.791 ' HA ' HG22 ' A' ' 44' ' ' VAL . 44.3 tt0 -83.95 150.37 25.71 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.733 0.778 . . . . 0.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.86 -162.05 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.18 -46.15 90.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.444 -0.785 . . . . 0.0 110.392 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.1 p -134.77 -3.88 2.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.473 -0.767 . . . . 0.0 112.031 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.5 mt-30 -137.32 161.52 36.05 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.007 -1.058 . . . . 0.0 111.133 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 39' ' ' GLN . 94.0 t -125.17 156.0 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.1 p -124.13 157.67 34.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.386 -0.822 . . . . 0.0 110.628 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.806 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.2 mt-10 -87.31 143.18 27.38 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.608 0.718 . . . . 0.0 111.017 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -116.3 -71.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.932 -0.48 . . . . 0.0 109.98 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HG12 ' A' ' 47' ' ' VAL . 30.8 m -140.06 153.38 46.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.381 -0.824 . . . . 0.0 110.589 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 135.27 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.492 -0.755 . . . . 0.0 110.912 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.844 ' HB3' ' C ' ' A' ' 59' ' ' THR . . . -171.15 155.96 4.57 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.424 -0.797 . . . . 0.0 110.212 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.6 m -102.17 131.04 48.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.684 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.4 p90 -110.05 141.12 43.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.669 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.977 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -77.0 164.1 26.08 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.149 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -71.29 79.96 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.904 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.05 -134.27 2.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -99.16 135.67 40.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.293 -1.122 . . . . 0.0 110.573 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -177.08 174.94 1.62 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.07 137.76 46.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.107 -0.996 . . . . 0.0 110.055 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.844 ' C ' ' HB3' ' A' ' 50' ' ' ALA . 73.4 p -90.77 8.27 35.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.976 -0.452 . . . . 0.0 110.046 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 59' ' ' THR . 13.5 m-85 -131.59 113.54 13.76 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.57 -35.91 81.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.537 -0.727 . . . . 0.0 109.521 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -141.16 -169.92 2.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.792 -0.567 . . . . 0.0 109.684 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.695 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 81.6 m-20 54.33 58.15 5.22 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.344 -0.848 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 t -49.26 -21.53 0.84 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.749 -0.595 . . . . 0.0 112.013 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -49.1 -26.72 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 63' ' ' ASP . 4.2 p -95.57 129.62 42.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -0.764 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -139.08 148.41 43.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.787 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.92 -173.77 38.94 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.666 HG21 ' H3 ' ' A' ' 138' ' ' FUC . 94.5 m -130.12 163.92 25.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.951 -0.734 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 62.8 m -148.08 127.16 12.84 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -155.93 140.0 16.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 110.589 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.86 -124.19 33.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -107.76 16.14 23.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.741 -0.858 . . . . 0.0 110.824 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.423 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.5 mt-30 -119.83 120.09 35.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.209 -0.932 . . . . 0.0 110.958 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -103.96 124.33 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -103.0 111.25 23.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 111.946 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.768 HD13 HG22 ' A' ' 36' ' ' VAL . 81.1 mt -100.52 135.87 41.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.297 -0.877 . . . . 0.0 109.011 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 18' ' ' SER . 94.1 m -135.81 144.5 45.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.313 -0.867 . . . . 0.0 110.812 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.821 HG21 HD21 ' A' ' 84' ' ' LEU . 91.1 mt -119.12 131.45 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 96.9 mt-30 -113.78 119.42 37.29 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.155 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.07 47.85 0.86 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.821 HD21 HG21 ' A' ' 81' ' ' ILE . 80.2 mt -89.11 129.82 35.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.958 . . . . 0.0 111.755 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -119.21 179.99 4.01 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.88 82.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.188 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -65.4 -32.93 74.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.982 -0.449 . . . . 0.0 111.74 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.23 -20.02 64.78 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.345 -0.847 . . . . 0.0 111.4 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 115' ' ' ILE . 26.4 m -51.79 136.46 27.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.61 29.93 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.631 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.571 HD11 ' C ' ' A' ' 112' ' ' GLY . 58.4 tp -109.9 133.12 53.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.912 . . . . 0.0 111.775 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD2' HD12 ' A' ' 115' ' ' ILE . 46.8 m-85 -116.5 128.79 55.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.3 mp -95.37 127.02 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.612 -0.68 . . . . 0.0 112.112 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.064 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 29.9 p -93.13 112.25 24.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.867 ' HD3' HD12 ' A' ' 109' ' ' ILE . 5.6 mttt -105.55 146.62 29.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.662 HG11 ' CG ' ' A' ' 23' ' ' TYR . 21.9 t -141.75 106.3 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.54 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.688 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 85.9 mt-10 -132.69 127.4 34.74 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.057 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.539 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.7 mm? -77.53 83.73 3.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 5.0 mmm -80.58 -51.3 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.578 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 78.0 m-85 -66.29 -41.25 41.14 Favored Pre-proline 0 N--CA 1.503 2.195 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 56.4 Cg_endo -86.48 114.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.442 1.233 . . . . 0.0 111.927 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.752 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 90.3 Cg_endo -91.96 151.38 3.28 Favored 'Trans proline' 2 CA--C 1.675 7.545 0 CA-C-O 113.269 -2.888 . . . . 0.0 112.679 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.752 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 22.3 Cg_endo -84.95 177.39 27.9 Favored 'Cis proline' 1 N--CA 1.579 6.526 1 C-N-CA 92.828 -14.238 . . . . 0.0 114.271 -1.203 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -85.53 128.06 34.63 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.611 ' HE1' ' SD ' ' A' ' 1' ' ' MET . 43.2 t80 -160.21 111.19 1.9 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.522 -1.361 . . . . 0.0 109.708 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.539 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.15 -144.67 0.14 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.693 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.98 175.82 31.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.867 HD12 ' HD3' ' A' ' 95' ' ' LYS . 48.9 mm -124.24 165.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.367 -1.078 . . . . 0.0 109.79 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 1.064 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -96.12 139.33 14.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.9 ' OD1' ' H61' ' A' ' 134' ' ' FUL . 10.1 m120 -60.09 -26.25 66.05 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.633 -0.922 . . . . 0.0 110.558 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.571 ' C ' HD11 ' A' ' 91' ' ' LEU . . . 110.89 135.65 6.93 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 9' ' ' VAL . 94.0 m -107.63 129.82 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.888 -0.772 . . . . 0.0 109.993 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.97 ' HB3' HG23 ' A' ' 8' ' ' VAL . 37.0 tp60 -79.05 146.46 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.709 ' O ' HG23 ' A' ' 89' ' ' THR . 40.9 mt -117.46 129.91 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.848 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -109.95 140.21 44.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.689 -0.632 . . . . 0.0 111.3 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.9 147.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.6 mm -78.57 131.66 34.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.221 0.534 . . . . 0.0 110.45 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.27 126.33 40.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.708 -0.62 . . . . 0.0 110.145 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.88 151.91 68.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.083 1.044 . . . . 0.0 110.495 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -120.06 149.89 49.99 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.27 -10.09 28.03 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.392 1.206 . . . . 0.0 111.323 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.915 ' SG ' ' CG ' ' A' ' 125' ' ' ASP . 42.3 t -85.54 131.19 48.48 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 0.0 110.084 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.68 -12.99 37.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.185 1.097 . . . . 0.0 111.384 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.915 ' CG ' ' SG ' ' A' ' 123' ' ' CYS . 56.9 p-10 -76.54 169.92 17.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.7 p -70.92 159.88 33.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.553 -0.717 . . . . 0.0 110.198 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -63.47 -35.92 82.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.592 -0.692 . . . . 0.0 110.305 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -142.24 162.13 36.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.73 . . . . 0.0 109.981 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 54.69 50.42 6.45 Favored Pre-proline 0 N--CA 1.502 2.156 0 O-C-N 121.36 -0.838 . . . . 0.0 110.798 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.3 Cg_endo -70.63 157.52 58.45 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.198 1.104 . . . . 0.0 110.135 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.623 -0.673 . . . . 0.0 110.171 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.482 ' H82' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.444 ' C6 ' ' H2 ' ' A' ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.9 ' H61' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' BMA . . . . . 0.444 ' H2 ' ' C6 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.408 ' H61' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.408 ' C1 ' ' H61' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.666 ' H3 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' A ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.096 0.474 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 106' ' ' LEU . 22.1 mmt 52.7 82.57 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.415 -0.803 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.548 ' CD2' ' HB1' ' A' ' 1' A ALA . 97.9 m-70 -109.98 130.1 55.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.513 -0.742 . . . . 0.0 110.437 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.834 HG11 ' HA2' ' A' ' 110' ' ' GLY . 90.9 t -147.69 151.29 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.618 -0.676 . . . . 0.0 109.604 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.881 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -130.55 133.86 46.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.449 -0.782 . . . . 0.0 111.562 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.122 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 49.1 mt-30 -150.69 149.92 27.01 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.597 . . . . 0.0 111.141 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.91 139.99 37.41 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 N-CA-C 108.337 -1.447 . . . . 0.0 108.337 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.47 66.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.271 -0.893 . . . . 0.0 110.891 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.873 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.93 166.61 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.931 ' HB ' HD13 ' A' ' 115' ' ' ILE . 25.7 t -138.1 154.72 28.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.319 0.581 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.24 130.04 55.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.24 132.69 46.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.733 . . . . 0.0 110.789 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.07 175.5 4.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.786 -0.571 . . . . 0.0 109.527 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -60.18 -35.23 74.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.582 ' CG ' HD13 ' A' ' 16' ' ' ILE . 22.7 tpt180 -60.37 -32.63 71.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.6 -0.687 . . . . 0.0 110.163 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.05 33.92 5.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.582 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.3 mp -105.34 101.78 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.921 . . . . 0.0 109.247 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.852 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -107.39 122.98 47.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.745 ' O ' ' H83' ' A' ' 136' ' ' NAG . 32.6 t -131.92 131.72 42.93 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.381 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HD11 ' A' ' 115' ' ' ILE . 34.8 p90 -144.42 159.99 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 92.1 t -116.73 125.47 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.699 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.819 ' O ' HG22 ' A' ' 77' ' ' VAL . 49.6 t -107.02 105.81 16.01 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.881 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 16.7 pt-20 -80.22 152.15 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.05 . . . . 0.0 111.098 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -139.94 178.86 6.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.47 127.79 38.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.664 -0.648 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 106' ' ' LEU . 97.9 p -139.86 148.68 56.28 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.548 -0.72 . . . . 0.0 110.206 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.88 140.03 28.26 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.392 1.207 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.54 -156.92 8.83 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -129.97 149.93 51.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.938 . . . . 0.0 110.127 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 155.48 40.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.526 -0.734 . . . . 0.0 109.98 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 70.7 p -80.46 -43.17 21.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.456 -0.777 . . . . 0.0 110.513 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG21 ' A' ' 51' ' ' THR . 33.2 mm-40 -80.4 114.4 19.27 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.597 0.713 . . . . 0.0 112.334 -176.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.634 ' CG1' HG23 ' A' ' 96' ' ' VAL . 93.3 t -128.48 87.2 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 52.6 ttt85 -58.67 110.99 1.11 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.389 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.1 m -113.91 127.59 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.628 0.728 . . . . 0.0 110.178 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 93.2 m -128.75 140.45 51.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.713 -0.617 . . . . 0.0 109.574 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD13 ' A' ' 79' ' ' LEU . 96.7 t -109.79 136.94 44.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.9 mt -122.94 159.94 27.22 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.853 -1.154 . . . . 0.0 111.31 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -120.85 118.09 29.07 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' HG22 ' A' ' 44' ' ' VAL . 28.8 mt-30 -99.93 132.64 45.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.435 -0.791 . . . . 0.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.42 161.82 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.69 -41.31 90.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.503 -0.748 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 m -70.58 -57.19 4.99 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 110.83 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 mt-30 -154.29 169.57 23.36 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.4 -0.813 . . . . 0.0 110.734 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 39' ' ' GLN . 80.9 t -117.35 137.53 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.655 -0.653 . . . . 0.0 109.28 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.2 p -132.55 162.4 31.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.472 -0.767 . . . . 0.0 110.89 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.82 ' HA ' HD23 ' A' ' 37' ' ' LEU . 36.9 tt0 -80.02 158.1 26.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.582 -0.699 . . . . 0.0 109.937 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 93.8 t -119.38 -82.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.675 ' SG ' ' O ' ' A' ' 64' ' ' SER . 92.8 m -120.15 154.09 35.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.909 -1.119 . . . . 0.0 109.978 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -161.23 132.89 5.61 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.397 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.38 159.67 4.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.659 ' O ' HD13 ' A' ' 58' ' ' LEU . 3.0 m -93.4 110.2 21.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 109.869 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 23.7 t80 -72.67 124.44 25.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.384 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 1.4 mmt -86.07 144.51 27.51 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.431 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 34.1 mmt -59.79 -28.09 67.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.82 -22.59 9.31 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.694 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -129.9 158.21 40.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.177 -1.19 . . . . 0.0 111.467 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -113.57 135.47 53.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.031 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 51' ' ' THR . 9.6 mp -96.32 167.43 11.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.729 0.776 . . . . 0.0 111.742 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -114.79 160.0 19.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m-85 -96.36 124.43 40.36 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.6 tp -59.81 -44.19 94.12 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -144.04 -166.44 2.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.0 111.705 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 55.82 59.27 3.89 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.46 0.648 . . . . 0.0 110.12 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.675 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 70.1 m 57.39 105.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.408 0.623 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.78 92.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.783 -0.573 . . . . 0.0 110.287 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 76.1 m -69.99 163.34 26.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.631 HG21 ' NE2' ' A' ' 82' ' ' GLN . 8.8 t -138.24 150.38 46.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.414 -0.804 . . . . 0.0 109.218 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.92 43.24 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.872 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.529 HG21 ' H5 ' ' A' ' 138' ' ' FUC . 99.4 m -130.1 166.41 20.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.045 -0.679 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 65.5 m -152.87 122.77 6.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.755 -0.591 . . . . 0.0 109.554 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.6 p -148.94 148.15 29.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.96 -125.53 27.49 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.23 19.06 20.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.909 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.8 mt-30 -123.98 122.72 38.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.237 -0.915 . . . . 0.0 110.876 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.4 m -105.57 123.78 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -99.61 114.03 26.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.185 -0.947 . . . . 0.0 111.225 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 HG22 ' A' ' 36' ' ' VAL . 81.2 mt -101.81 129.53 48.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' HG23 ' A' ' 69' ' ' THR . 60.7 m -119.55 132.58 55.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 96.0 mt -110.16 129.89 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.449 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.631 ' NE2' HG21 ' A' ' 69' ' ' THR . 76.6 mt-30 -122.1 121.87 37.93 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.62 45.75 0.89 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 75.9 mt -79.86 133.55 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.788 0.804 . . . . 0.0 111.836 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -120.05 167.54 12.09 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB1' ' OD2' ' A' ' 119' ' ' ASP . . . -59.84 -39.39 84.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.268 -0.895 . . . . 0.0 109.842 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -68.09 -39.14 82.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.708 -0.62 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.2 -22.6 66.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.536 -0.728 . . . . 0.0 111.345 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -51.52 136.48 26.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.41 -164.81 34.68 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.575 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 26.9 tp -84.27 131.7 34.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.723 -0.869 . . . . 0.0 112.784 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 72.1 m-85 -113.55 127.15 55.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -110.09 130.33 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.617 -0.677 . . . . 0.0 112.792 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.194 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -80.06 148.64 30.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.823 ' HD2' HD12 ' A' ' 109' ' ' ILE . 7.8 tttt -142.79 82.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 106' ' ' LEU . 3.2 p -93.95 115.28 32.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 122.181 0.991 . . . . 0.0 111.078 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 62.0 mt-10 -131.9 131.04 42.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.729 ' HG ' HD22 ' A' ' 106' ' ' LEU . 49.1 mt -80.99 75.78 7.96 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.415 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 2.5 ttm -80.26 -34.58 36.94 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.471 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 16.8 m-85 -69.0 -44.36 28.54 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 119.389 -0.924 . . . . 0.0 113.144 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 37.1 Cg_endo -90.42 105.49 0.32 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 N-CA-C 114.958 1.099 . . . . 0.0 114.958 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.7 Cg_endo -74.88 155.82 43.54 Favored 'Trans proline' 1 CA--C 1.659 6.759 0 CA-C-O 112.825 -3.073 . . . . 0.0 109.081 177.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 48.1 Cg_endo -87.98 172.81 30.98 Favored 'Cis proline' 3 C--N 1.494 8.196 1 C-N-CA 90.435 -15.235 . . . . 0.0 116.032 -12.051 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 2.7 t80 -90.8 134.98 34.03 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.518 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -160.5 113.5 2.05 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.679 1.191 . . . . 0.0 109.583 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.729 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.8 tp -158.26 -146.32 0.15 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.014 -1.054 . . . . 0.0 110.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.17 170.66 32.72 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.979 -1.581 . . . . 0.0 112.389 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.823 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.8 mm -109.69 152.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 122.189 -0.595 . . . . 0.0 109.69 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 1.194 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -80.53 148.41 29.24 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 8.9 t-20 -60.46 -38.65 84.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.988 . . . . 0.0 110.327 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.96 136.62 5.94 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.295 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.7 HG21 HG23 ' A' ' 9' ' ' VAL . 60.2 m -119.93 141.75 49.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.3 tt0 -89.88 124.04 34.35 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.596 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.931 HD13 ' HB ' ' A' ' 9' ' ' VAL . 23.9 mm -87.85 123.98 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.873 ' CE2' HG21 ' A' ' 8' ' ' VAL . 4.4 m-30 -95.02 151.08 19.49 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.854 0.835 . . . . 0.0 111.536 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 118' ' ' ILE . 99.1 t -131.98 166.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.51 ' N ' HG12 ' A' ' 117' ' ' VAL . 26.4 mm -99.9 114.89 39.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.787 -0.571 . . . . 0.0 110.311 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.416 ' OD2' ' HB1' ' A' ' 86' ' ' ALA . 64.3 t0 -139.96 128.5 13.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.58 -0.7 . . . . 0.0 110.548 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.41 164.01 34.32 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.097 1.051 . . . . 0.0 110.025 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -79.66 128.27 75.22 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.0 110.283 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.9 -15.2 36.47 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.192 1.101 . . . . 0.0 111.298 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.3 m -104.09 119.99 52.46 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 110.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.9 -11.44 29.35 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 123.1 1.053 . . . . 0.0 111.424 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -75.91 170.03 17.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.677 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -92.05 3.8 54.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.65 -0.656 . . . . 0.0 111.22 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -64.09 136.61 57.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.122 -0.986 . . . . 0.0 110.187 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -117.66 143.76 45.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.67 . . . . 0.0 110.209 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 65.6 mm-40 52.44 49.91 7.33 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.423 -0.798 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.0 Cg_endo -69.95 150.06 66.52 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.203 1.107 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.549 -0.719 . . . . 0.0 110.172 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.829 ' H61' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.829 ' H83' ' H61' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.423 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.745 ' H83' ' O ' ' A' ' 18' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.529 ' H5 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.945 0.402 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm -87.38 -79.86 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.785 . . . . 0.0 110.485 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -123.5 119.98 31.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.258 -0.901 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.46 125.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.637 -0.664 . . . . 0.0 109.246 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -122.08 137.73 54.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.444 -0.785 . . . . 0.0 110.651 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -150.55 144.47 17.4 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.667 . . . . 0.0 111.117 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.87 147.58 50.17 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.324 1.171 . . . . 0.0 109.745 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.86 -26.55 29.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 109.45 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -153.61 155.99 5.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.043 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.701 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -138.05 151.45 25.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.222 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.6 mt -105.32 126.61 52.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 118' ' ' ILE . . . -67.97 154.11 42.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.47 -0.769 . . . . 0.0 110.561 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 m -97.37 -179.93 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.802 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 m -53.36 160.97 1.04 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.83 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 58.8 18.12 5.79 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.747 -0.596 . . . . 0.0 111.401 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.71 39.06 86.38 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.163 -0.96 . . . . 0.0 111.213 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG13 ' HG2' ' A' ' 82' ' ' GLN . 1.4 mp -99.52 99.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.152 -1.205 . . . . 0.0 108.854 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 108.907 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.66 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.6 p -135.56 149.98 49.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.672 0.748 . . . . 0.0 111.237 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.701 ' HB3' HG21 ' A' ' 9' ' ' VAL . 35.5 p90 -157.17 163.95 38.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 59.0 t -125.06 113.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.548 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 47.3 t -100.08 109.95 22.24 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.2 pt-20 -80.77 164.03 23.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.958 . . . . 0.0 111.77 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.975 ' CG ' HG11 ' A' ' 96' ' ' VAL . 46.5 p90 -145.83 178.28 8.29 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.12 131.31 53.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.4 p -142.34 160.65 53.78 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.747 -0.596 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.06 -10.37 28.17 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.46 1.242 . . . . 0.0 111.503 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.44 27.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 44.1 mtpt 52.01 -155.01 0.17 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.265 -1.138 . . . . 0.0 110.063 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 28' ' ' LYS . . . 60.6 117.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 53' ' ' MET . 47.7 p -79.91 -35.69 37.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.661 ' OE1' HG21 ' A' ' 51' ' ' THR . 39.1 mm-40 -80.04 120.09 23.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.091 0.948 . . . . 0.0 112.779 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 34' ' ' VAL . 92.1 t -132.05 83.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.724 ' HD3' ' SD ' ' A' ' 99' ' ' MET . 12.4 ttt180 -59.04 114.9 2.81 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.384 0.611 . . . . 0.0 111.664 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 50' ' ' ALA . 35.6 m -112.16 152.8 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 59.0 m -147.64 140.09 24.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.7 -0.625 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.829 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -115.96 131.64 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.98 160.02 25.75 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.696 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp-105 -116.93 129.94 56.38 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HA ' HG13 ' A' ' 44' ' ' VAL . 38.3 tt0 -102.92 140.02 37.73 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.3 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -133.27 155.25 49.73 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.09 -43.98 95.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.82 -44.09 67.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.549 -0.72 . . . . 0.0 111.055 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.83 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.6 tt0 -164.43 167.92 19.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.4 -0.813 . . . . 0.0 110.95 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 39' ' ' GLN . 59.6 t -119.16 137.27 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.1 p -130.04 168.23 17.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.29 -0.881 . . . . 0.0 111.224 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.792 ' HA ' HD23 ' A' ' 37' ' ' LEU . 52.5 mt-10 -79.92 154.07 28.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.706 -0.621 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 48' ' ' CYS . 89.8 t -118.05 -75.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.765 -0.585 . . . . 0.0 110.391 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.977 ' SG ' ' CG ' ' A' ' 63' ' ' ASP . 85.2 m -130.31 165.66 22.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.387 -0.821 . . . . 0.0 110.622 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.11 3.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.218 -0.926 . . . . 0.0 111.677 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -174.19 140.49 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.661 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -85.52 105.65 16.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.579 ' HA ' HD23 ' A' ' 58' ' ' LEU . 32.1 t80 -60.23 127.93 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.596 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.5 ' CG ' HD21 ' A' ' 58' ' ' LEU . 2.3 mmt -95.72 134.31 38.79 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.441 ' CG ' ' HA ' ' A' ' 30' ' ' THR . 34.8 mmt -56.96 -20.38 23.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.101 -0.999 . . . . 0.0 111.077 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.11 -12.83 8.06 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.249 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -129.98 159.94 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.985 -1.303 . . . . 0.0 111.223 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -109.85 131.95 54.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.698 -0.626 . . . . 0.0 110.264 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -93.95 153.88 17.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.486 -0.759 . . . . 0.0 110.861 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.6 p -101.72 140.62 35.77 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.545 0.688 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 50' ' ' ALA . 72.0 m-85 -100.2 30.97 3.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -60.0 -35.83 75.89 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.531 -0.731 . . . . 0.0 111.331 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -52.08 -25.93 9.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.977 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 2.8 p30 -113.66 11.54 18.21 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.611 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 59.0 137.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.057 0.932 . . . . 0.0 111.877 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 68' ' ' CYS . 19.0 mt 58.86 -131.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.306 -0.872 . . . . 0.0 110.315 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.556 ' H ' HG22 ' A' ' 67' ' ' ILE . 69.1 m 51.61 67.82 0.9 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.248 -1.533 . . . . 0.0 111.31 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 80' ' ' THR . 10.0 t -132.72 149.89 52.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.1 -140.02 4.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 72' ' ' SER . 71.2 m -129.01 164.92 22.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.723 -0.869 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 22.0 m -166.38 120.15 1.1 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -158.25 153.51 25.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.22 -124.36 35.61 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.26 12.09 26.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.748 -0.854 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -120.8 122.09 39.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.182 -0.949 . . . . 0.0 110.63 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.5 m -107.41 123.74 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.422 -0.799 . . . . 0.0 109.713 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.54 113.43 27.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 111.194 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 36' ' ' VAL . 91.5 mt -105.7 129.23 53.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.454 -0.779 . . . . 0.0 109.217 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 18' ' ' SER . 62.1 m -124.53 137.67 54.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 110.738 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 84' ' ' LEU . 59.5 mt -111.62 139.58 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.707 -0.621 . . . . 0.0 110.144 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 16' ' ' ILE . 82.1 mt-30 -120.02 120.53 36.6 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.997 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.68 51.91 0.73 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 81' ' ' ILE . 80.9 mt -99.69 130.03 45.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.987 . . . . 0.0 111.504 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -105.39 179.97 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 117' ' ' VAL . . . -59.97 -47.07 87.33 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.776 0.798 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.7 mtp -60.37 -39.94 89.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.147 0.498 . . . . 0.0 110.82 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -57.95 -27.11 63.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.6 -0.688 . . . . 0.0 111.018 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.4 m -50.0 140.02 12.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.62 -161.85 33.0 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.635 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.8 tm? -88.68 139.91 29.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.888 0.852 . . . . 0.0 112.086 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.884 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -127.58 128.19 45.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.73 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.7 mp -100.77 129.9 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.302 -0.874 . . . . 0.0 112.182 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.932 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.2 p -91.07 126.24 36.1 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.76 ' HD2' HD12 ' A' ' 109' ' ' ILE . 5.5 mtmt -116.72 145.75 43.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.137 -0.977 . . . . 0.0 110.145 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' A' ' 23' ' ' TYR . 26.6 t -142.6 104.57 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.964 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.5 mm-40 -133.23 140.09 47.32 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.599 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 106' ' ' LEU . 8.0 mt -93.01 81.14 4.56 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 103.779 -2.675 . . . . 0.0 103.779 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.724 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 1.4 mtt -80.51 -30.58 37.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.411 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.461 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 71.5 m-85 -75.45 -49.08 3.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.29 -0.881 . . . . 0.0 111.853 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 98' ' ' LEU . 41.3 Cg_endo -74.76 120.74 6.27 Favored 'Trans proline' 0 N--CA 1.518 2.924 0 C-N-CA 121.841 1.694 . . . . 0.0 114.813 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.45 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 63.1 Cg_endo -82.2 148.13 14.83 Favored 'Trans proline' 1 CA--C 1.659 6.758 0 CA-C-O 114.187 -2.505 . . . . 0.0 111.06 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.329 58.0 Cg_endo -116.39 58.25 0.38 Allowed 'Cis proline' 0 C--N 1.398 3.156 1 C-N-CA 95.048 -13.313 . . . . 0.0 109.053 10.955 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.2 t80 55.67 118.85 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.093 0 O-C-N 120.942 -1.099 . . . . 0.0 112.629 172.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 4.3 p90 -165.71 105.55 0.72 Allowed 'General case' 0 N--CA 1.529 3.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.0 tp -158.87 -149.38 0.21 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 118.692 0.678 . . . . 0.0 111.415 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.22 174.13 34.08 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.281 -1.438 . . . . 0.0 110.753 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.8 mm -120.26 163.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.954 -0.733 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.932 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -94.04 140.04 14.85 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.99 -38.26 82.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.479 -1.013 . . . . 0.0 110.393 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.77 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 128.87 148.53 6.68 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.011 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.626 HG21 HG23 ' A' ' 9' ' ' VAL . 98.0 m -118.15 140.01 50.42 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 8' ' ' VAL . 23.3 tt0 -89.28 129.99 35.75 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.221 -1.392 . . . . 0.0 108.741 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 89' ' ' THR . 88.8 mt -94.35 131.95 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.857 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.9 m-30 -106.71 149.92 26.8 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.139 0.495 . . . . 0.0 111.491 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' A' ' 86' ' ' ALA . 96.4 t -83.23 168.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.533 ' N ' HG12 ' A' ' 117' ' ' VAL . 36.3 mm -102.72 140.04 22.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.783 0.801 . . . . 0.0 111.289 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -117.56 145.49 36.41 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 149.95 88.8 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.107 1.056 . . . . 0.0 110.164 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -66.61 142.24 97.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 111.167 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 123' ' ' CYS . 52.1 Cg_endo -77.03 0.23 9.91 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 123.492 1.259 . . . . 0.0 111.43 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 1.112 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 0.5 OUTLIER 76.17 173.52 0.09 OUTLIER Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.001 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 1.112 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 44.2 Cg_endo -69.95 -8.9 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.367 1.193 . . . . 0.0 112.157 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -65.77 -13.09 58.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.115 -0.99 . . . . 0.0 110.969 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -114.13 155.42 26.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.181 -0.949 . . . . 0.0 110.173 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -69.93 139.94 52.99 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.55 -0.719 . . . . 0.0 110.514 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -118.13 151.1 38.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 53.3 mt-10 53.25 50.19 7.25 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.414 -0.804 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.1 Cg_endo -67.8 -20.01 46.3 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.241 1.127 . . . . 0.0 111.0 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.392 -0.817 . . . . 0.0 110.163 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.744 ' O6 ' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.744 ' H83' ' O6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.596 ' H5 ' ' H83' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.596 ' H83' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.148 0.499 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.06 -148.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.578 -0.701 . . . . 0.0 109.587 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -97.02 30.21 2.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.063 -1.023 . . . . 0.0 110.594 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 71.0 t -125.76 129.68 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.8 132.14 52.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 110.558 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' NE2' HG12 ' A' ' 3' ' ' VAL . 17.2 mp0 -135.82 131.93 19.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.641 -0.662 . . . . 0.0 110.851 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.52 139.86 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.132 1.069 . . . . 0.0 109.799 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.18 -32.28 64.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.808 . . . . 0.0 109.443 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.51 157.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.916 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.3 t -139.91 136.64 38.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.666 0.746 . . . . 0.0 110.594 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 10' ' ' LEU . 2.8 mm? -97.63 125.13 42.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -86.4 151.25 23.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.425 -0.797 . . . . 0.0 110.245 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -75.82 172.24 13.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.552 -0.717 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -59.65 -29.0 67.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.01 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.702 ' CG ' HD13 ' A' ' 16' ' ' ILE . 3.0 tpt180 -59.93 -27.78 67.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.597 -0.689 . . . . 0.0 109.867 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.662 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.41 23.36 12.65 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.702 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -110.25 109.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 O-C-N 121.5 -1.0 . . . . 0.0 110.534 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -100.47 118.32 36.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB3' HG23 ' A' ' 80' ' ' THR . 81.7 p -123.95 140.58 52.84 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.531 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.0 p90 -149.92 164.86 34.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.891 -0.505 . . . . 0.0 109.895 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 97.1 t -122.65 114.16 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.134 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.833 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.05 107.49 19.42 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 3' ' ' VAL . 82.9 mt-10 -79.98 165.03 23.0 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 111.678 -176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.673 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.4 p90 -149.88 -179.95 7.55 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 106' ' ' LEU . . . -128.9 128.52 43.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -112.6 150.42 42.66 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.425 -0.797 . . . . 0.0 111.116 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.27 -19.31 38.65 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.712 1.375 . . . . 0.0 111.34 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.13 -165.81 29.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.77 126.5 38.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.638 -0.919 . . . . 0.0 110.728 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.65 38.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.682 -0.636 . . . . 0.0 109.588 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' MET . 62.8 p -79.9 -37.88 33.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 110.675 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -79.93 112.48 17.27 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.861 -0.735 . . . . 0.0 112.331 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 34' ' ' VAL . 85.3 t -131.97 82.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ttp85 -60.17 121.42 11.9 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.392 0.615 . . . . 0.0 111.43 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -124.34 132.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 49' ' ' ALA . 58.6 m -125.55 131.27 52.79 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.236 0.541 . . . . 0.0 110.66 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.991 HG22 HD13 ' A' ' 79' ' ' LEU . 87.9 t -104.54 139.15 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 46' ' ' GLU . 19.6 mt -125.12 164.02 21.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 111.587 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HG3' HG21 ' A' ' 47' ' ' VAL . 10.4 mtt-85 -116.51 91.64 3.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.606 ' HA ' HG13 ' A' ' 44' ' ' VAL . 34.6 tt0 -93.63 140.05 30.07 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.29 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -150.53 154.53 37.77 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.1 -42.88 91.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 96.4 p -70.21 -43.61 70.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.599 -0.688 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 11.5 mp0 -156.88 160.69 39.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.385 -0.822 . . . . 0.0 111.09 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 39' ' ' GLN . 60.3 t -130.35 130.39 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.3 p -139.91 165.88 26.14 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.452 -0.78 . . . . 0.0 111.416 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.808 ' HA ' HD23 ' A' ' 37' ' ' LEU . 72.0 mt-10 -81.07 160.3 24.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.631 -0.668 . . . . 0.0 109.832 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG12 ' OD2' ' A' ' 63' ' ' ASP . 60.1 t -123.75 -85.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.621 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.217 ' SG ' ' CG ' ' A' ' 60' ' ' PHE . 18.5 t -118.79 152.69 35.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.959 -1.088 . . . . 0.0 110.112 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 62' ' ' ASP . . . -167.81 128.52 1.41 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.391 -0.818 . . . . 0.0 112.654 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.0 161.42 5.66 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 58' ' ' LEU . 2.9 m -83.11 119.98 25.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.017 -1.052 . . . . 0.0 109.596 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 72' ' ' SER . 12.8 t80 -78.99 109.58 13.43 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.243 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 53' ' ' MET . 6.1 mmm -84.82 138.61 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.1 mmt -58.15 -20.2 38.8 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.16 -0.963 . . . . 0.0 110.921 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.73 -93.17 1.67 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -80.43 164.18 23.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.526 -0.985 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 40.3 tp10 -110.12 130.11 55.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.812 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 51' ' ' THR . 71.5 mt -76.03 169.49 18.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.465 -0.772 . . . . 0.0 110.467 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 p -96.53 164.27 12.68 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.217 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 49.4 m-85 -116.16 92.61 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.532 -0.73 . . . . 0.0 110.218 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.66 -28.79 67.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 49' ' ' ALA . 82.2 m-20 -61.3 -42.0 97.92 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.567 -0.708 . . . . 0.0 111.38 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.905 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . 23.9 t0 -100.02 11.99 37.98 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 122.038 -0.414 . . . . 0.0 112.035 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t 62.02 -67.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.998 -0.439 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.1 mt -132.1 73.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.98 . . . . 0.0 111.668 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 1.115 ' SG ' ' CB ' ' A' ' 60' ' ' PHE . 1.8 p -113.07 158.08 20.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.208 -0.932 . . . . 0.0 109.176 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 80' ' ' THR . 8.8 t -130.65 150.03 52.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.491 -0.756 . . . . 0.0 109.836 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.66 148.95 19.54 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.777 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 75.3 m -129.86 160.29 33.97 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 32.9 t -146.96 108.31 4.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -120.17 123.78 44.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.614 -0.678 . . . . 0.0 109.46 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 -120.55 23.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.88 19.21 20.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.982 . . . . 0.0 110.682 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.439 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 88.2 mt-30 -116.78 120.16 37.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -104.52 123.94 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.05 -1.031 . . . . 0.0 109.416 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 54.2 t-20 -103.79 108.03 19.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 111.372 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.991 HD13 HG22 ' A' ' 36' ' ' VAL . 68.0 mt -104.49 139.95 38.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.451 -0.78 . . . . 0.0 109.536 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.517 ' HB ' ' H82' ' A' ' 137' ' ' NAG . 59.6 m -140.84 152.02 44.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.816 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -120.01 139.87 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.441 ' HG2' HG13 ' A' ' 16' ' ' ILE . 38.7 mt-30 -115.79 121.54 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.658 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 51.96 0.7 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.816 HD21 HG21 ' A' ' 81' ' ' ILE . 77.7 mt -97.2 117.34 31.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.609 -0.936 . . . . 0.0 111.246 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -102.44 -179.73 4.06 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.05 92.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -38.52 89.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.724 -0.61 . . . . 0.0 110.523 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.38 -26.91 66.69 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.644 -0.66 . . . . 0.0 110.735 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.2 m -51.51 134.27 29.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.863 . . . . 0.0 110.557 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.8 -150.29 13.83 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.406 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 113' ' ' THR . 13.6 tp -107.57 134.48 50.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.664 -0.903 . . . . 0.0 111.833 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.896 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.9 m-85 -116.24 145.31 43.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.7 mp -112.68 129.73 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.357 -0.839 . . . . 0.0 111.96 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 94' ' ' CYS . 31.3 p -92.46 123.99 36.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HB3' ' H ' ' A' ' 35' ' ' THR . 8.4 tttt -117.79 138.79 51.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -0.802 . . . . 0.0 108.9 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.797 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.6 t -135.96 112.81 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.584 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 77.4 mt-10 -138.56 123.94 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.864 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 106' ' ' LEU . 8.9 mp -76.2 81.85 3.0 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 40.5 tpp -79.03 -52.17 8.6 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 88.5 m-85 -69.09 -38.24 10.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.37 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 29.1 Cg_endo -83.08 112.02 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 CA-C-N 119.832 0.976 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 58.9 Cg_endo -83.25 150.77 13.62 Favored 'Trans proline' 1 CA--C 1.665 7.065 1 CA-C-O 110.57 -4.012 . . . . 0.0 113.244 176.023 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' PRO 0.253 37.4 Cg_endo -89.69 174.38 23.49 Favored 'Cis proline' 0 C--N 1.403 3.396 1 C-N-CA 95.287 -13.214 . . . . 0.0 118.711 -8.782 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.9 t80 -82.05 127.49 33.15 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.562 -2.563 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -160.79 105.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.375 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 98' ' ' LEU . 3.4 tp -158.23 -144.17 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.757 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.29 174.44 39.55 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.726 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -123.85 168.76 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 122.082 -0.658 . . . . 0.0 109.732 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -112.18 144.93 17.88 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.76 -38.99 87.07 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.605 1.202 . . . . 0.0 110.345 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 138.86 163.73 9.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.025 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.537 HG21 HG23 ' A' ' 9' ' ' VAL . 98.3 m -124.01 133.84 53.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.988 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.5 tp60 -75.98 139.76 41.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 92' ' ' TYR . 52.3 mt -116.21 124.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.897 -1.127 . . . . 0.0 108.642 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.84 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.8 m-85 -104.42 140.13 38.37 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 t -109.95 157.09 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.831 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.27 43.9 mm -103.94 140.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -116.81 97.53 50.61 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.429 -0.794 . . . . 0.0 109.95 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.03 147.26 60.71 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.349 1.184 . . . . 0.0 110.697 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -130.06 155.08 81.25 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.679 -0.638 . . . . 0.0 110.18 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.85 -20.34 51.9 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.398 1.209 . . . . 0.0 111.358 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.44 146.85 51.45 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.36 -0.837 . . . . 0.0 109.904 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.12 -21.46 42.52 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.363 1.191 . . . . 0.0 110.934 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -151.93 150.14 29.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.426 -0.796 . . . . 0.0 110.052 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.8 p -152.88 157.79 41.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.459 -0.776 . . . . 0.0 110.357 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -139.97 83.62 1.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 110.039 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -137.93 144.46 41.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.712 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 85.8 mt-10 51.56 49.68 7.41 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.527 -0.733 . . . . 0.0 111.563 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 45.9 Cg_endo -69.26 150.07 70.84 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.171 1.09 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.72 . . . . 0.0 110.148 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.658 ' H61' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.658 ' H82' ' H61' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.467 ' H5 ' ' C7 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.517 ' H82' ' HB ' ' A' ' 80' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.491 ' H5 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.041 0.448 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm -64.4 138.4 58.4 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' C ' HG23 ' A' ' 3' ' ' VAL . 4.5 m-70 -110.27 129.91 55.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.1 t -147.95 144.84 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -117.01 117.7 30.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 111.552 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.02 ' OE1' ' SG ' ' A' ' 94' ' ' CYS . 1.2 mm-40 -142.34 141.36 20.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.617 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.27 138.11 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.216 1.114 . . . . 0.0 109.549 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.35 -30.21 67.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -149.57 156.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.951 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 113' ' ' THR . 13.9 t -140.18 151.27 21.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.31 0.576 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 116' ' ' TYR . 77.8 mt -110.06 130.03 55.6 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.472 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 135.34 33.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.507 -0.746 . . . . 0.0 110.595 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.02 173.34 6.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.714 -0.616 . . . . 0.0 110.513 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -60.12 -29.4 68.59 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.631 -0.668 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.713 ' HG3' HD13 ' A' ' 16' ' ' ILE . 23.6 tpp180 -60.33 -29.73 69.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.547 -0.721 . . . . 0.0 109.905 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.75 25.28 10.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 15' ' ' GLY . 1.8 mp -114.18 115.61 50.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.97 . . . . 0.0 110.271 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.03 127.4 53.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -127.22 133.59 50.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 111.617 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' HB3' HG21 ' A' ' 9' ' ' VAL . 51.1 p90 -143.63 167.02 23.24 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 88.6 t -128.89 124.38 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.475 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.702 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -99.99 109.04 21.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.2 tt0 -86.49 140.56 29.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.479 -0.763 . . . . 0.0 110.939 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -129.62 161.94 29.41 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.16 130.54 18.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.0 p -159.99 160.0 27.04 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 0.0 110.388 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.13 148.23 49.89 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.391 1.206 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.6 167.47 8.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.98 149.58 51.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.943 . . . . 0.0 110.318 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 149.96 33.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HE2' ' A' ' 54' ' ' MET . 43.3 p -79.99 -33.4 39.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.38 -0.825 . . . . 0.0 110.76 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 23.2 mm-40 -80.17 74.29 6.98 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.268 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 34' ' ' VAL . 14.5 m -91.98 87.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.551 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 72.3 ttt-85 -53.1 105.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.693 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -107.55 131.21 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.79 0.805 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.6 m -135.94 150.21 49.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 0.0 109.409 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.959 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.2 t -117.51 140.03 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 46' ' ' GLU . 17.4 mt -127.87 164.51 22.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.887 -1.133 . . . . 0.0 110.915 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -127.4 117.28 21.87 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.443 ' HA ' HG22 ' A' ' 44' ' ' VAL . 81.9 mt-30 -105.24 123.96 48.73 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.44 154.28 39.28 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.74 -43.8 94.07 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.467 -0.771 . . . . 0.0 110.422 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.3 m -68.0 -49.79 59.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.579 -0.7 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.3 mt-30 -154.5 160.75 41.74 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 111.096 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.3 t -125.97 134.23 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.592 -0.692 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -140.76 164.02 31.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.788 ' HA ' HD23 ' A' ' 37' ' ' LEU . 30.5 tt0 -79.91 156.9 27.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 109.841 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 98.4 t -113.64 -89.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.895 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 93.4 m -122.68 149.94 43.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.801 -1.187 . . . . 0.0 110.28 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -150.22 140.01 21.78 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.819 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -172.0 153.54 3.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -91.89 120.62 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.791 ' CA ' HD21 ' A' ' 58' ' ' LEU . 16.1 t80 -79.16 109.15 13.21 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.983 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.46 169.96 17.0 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 30' ' ' THR . 34.4 mmt -67.63 -28.77 68.01 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.001 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.91 35.63 1.48 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.297 -1.43 . . . . 0.0 112.57 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 81.6 m-20 -130.32 159.95 35.42 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 119.151 1.476 . . . . 0.0 110.272 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -83.41 139.98 32.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.791 HD21 ' CA ' ' A' ' 52' ' ' TYR . 6.6 mp -89.17 129.97 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 110.242 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 p -99.98 135.57 41.2 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.494 -0.754 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 95.2 m-85 -107.99 114.91 29.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.26 -43.72 95.91 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.565 -0.709 . . . . 0.0 112.833 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -149.38 -161.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.024 -1.047 . . . . 0.0 111.632 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 56.75 58.07 4.33 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.473 0.654 . . . . 0.0 110.088 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 57.74 164.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.62 85.75 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 110.465 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 60' ' ' PHE . 97.5 m -68.07 153.24 44.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.577 -0.702 . . . . 0.0 109.462 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -140.0 150.01 43.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 109.305 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.9 179.98 43.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 72' ' ' SER . 91.1 m -130.19 169.25 15.61 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.12 -0.635 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.482 ' N ' HG22 ' A' ' 71' ' ' THR . 44.5 m -155.04 124.57 6.43 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.2 p -141.09 145.53 35.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.464 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.8 -122.37 16.35 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -105.72 11.98 31.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.801 -0.823 . . . . 0.0 111.016 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -116.69 126.68 53.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.873 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -107.89 123.48 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.899 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -100.61 118.62 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.0 111.435 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 ' CG2' ' A' ' 36' ' ' VAL . 76.1 mt -111.84 137.22 50.09 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.2 m -128.32 140.21 51.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.253 -0.905 . . . . 0.0 110.927 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 84' ' ' LEU . 88.5 mt -116.85 132.79 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.638 -0.664 . . . . 0.0 110.102 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 16' ' ' ILE . 19.7 mt-30 -118.94 121.39 39.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.589 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.86 54.19 0.57 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 81' ' ' ILE . 76.2 mt -90.85 120.01 31.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.601 -0.941 . . . . 0.0 110.953 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -98.07 178.95 4.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.66 90.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.281 -0.887 . . . . 0.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -66.79 -37.44 84.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.696 -0.627 . . . . 0.0 110.565 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.88 -33.5 71.9 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -51.99 130.92 30.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.27 -142.02 7.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 tp -109.05 129.19 55.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.672 -0.899 . . . . 0.0 111.518 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.801 ' CD1' HD12 ' A' ' 115' ' ' ILE . 73.3 m-85 -109.99 132.06 54.5 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -110.07 130.05 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.732 -0.605 . . . . 0.0 111.731 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.088 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 19.9 p -79.9 155.78 27.59 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 5.3 tptm -147.15 79.09 1.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 108.759 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 106' ' ' LEU . 3.6 p -95.79 115.24 34.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.147 0.975 . . . . 0.0 110.614 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 67.8 mm-40 -135.17 137.24 42.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.787 -0.571 . . . . 0.0 111.703 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' CD2' HD22 ' A' ' 106' ' ' LEU . 13.8 mt -83.98 75.46 10.13 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.4 ttm -79.9 -32.42 40.25 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.472 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.2 m-85 -87.03 -39.55 0.52 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.332 -0.855 . . . . 0.0 112.426 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 59.0 Cg_endo -92.59 118.71 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-O 121.556 0.565 . . . . 0.0 110.698 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.599 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 60.7 Cg_endo -91.13 156.01 3.84 Favored 'Trans proline' 1 CA--C 1.655 6.562 0 CA-C-O 113.372 -2.845 . . . . 0.0 111.123 177.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.599 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 44.2 Cg_endo -89.94 175.47 21.15 Favored 'Cis proline' 3 N--CA 1.644 10.334 1 C-N-CA 91.289 -14.88 . . . . 0.0 116.263 1.059 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 4.0 t80 -82.58 129.57 34.96 Favored 'General case' 0 C--N 1.266 -3.025 0 O-C-N 119.626 -1.921 . . . . 0.0 109.167 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -166.7 104.9 0.6 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.426 -1.421 . . . . 0.0 108.376 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.768 HD22 ' CD2' ' A' ' 98' ' ' LEU . 4.3 tp -157.71 -147.96 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.484 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.48 170.96 34.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.249 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.471 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.0 mm -115.22 146.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -1.087 . . . . 0.0 109.187 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 1.088 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -73.63 141.58 29.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.467 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 11.1 t-20 -60.07 -30.59 69.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -1.046 . . . . 0.0 109.709 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.72 138.77 5.93 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.492 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 9' ' ' VAL . 94.5 m -111.64 139.78 46.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 1.012 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.1 tp60 -83.45 120.72 26.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.258 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.801 HD12 ' CD1' ' A' ' 92' ' ' TYR . 53.8 mt -96.79 114.23 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.619 -1.301 . . . . 0.0 108.592 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.78 ' CE2' HG21 ' A' ' 8' ' ' VAL . 12.4 m-85 -87.81 139.11 30.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.389 0.614 . . . . 0.0 111.552 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 118' ' ' ILE . 89.4 t -125.45 165.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.492 ' N ' HG12 ' A' ' 117' ' ' VAL . 28.2 mm -99.98 119.88 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.954 -0.466 . . . . 0.0 110.323 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -137.65 126.52 14.78 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 110.203 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.03 159.99 51.22 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.09 1.048 . . . . 0.0 110.314 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.9 150.19 43.72 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 110.273 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.28 -19.81 43.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.38 1.2 . . . . 0.0 110.863 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.7 m -102.83 123.59 41.77 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 109.991 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.43 -17.66 38.98 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.129 1.068 . . . . 0.0 111.394 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -90.0 178.68 6.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.24 -0.912 . . . . 0.0 110.831 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -83.41 169.93 15.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.623 -0.673 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -89.68 106.35 18.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.599 -0.688 . . . . 0.0 110.104 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -130.03 160.02 34.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.251 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 80.9 mm-40 53.01 50.05 7.24 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.414 -0.804 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.3 Cg_endo -69.95 149.93 66.34 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.214 1.113 . . . . 0.0 110.435 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.217 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.467 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.428 ' O2 ' ' H62' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.498 ' O3 ' ' H82' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.498 ' H82' ' O3 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' A ALA . . . . . 0.597 ' HB1' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.105 0.478 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt 52.85 77.35 0.17 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.445 -0.784 . . . . 0.0 110.739 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.597 ' CD2' ' HB1' ' A' ' 1' A ALA . 84.8 m-70 -110.04 130.55 55.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 110.888 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 128.11 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.329 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.884 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.21 128.83 56.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.453 -0.78 . . . . 0.0 110.737 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.087 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 27.1 mm100 -139.45 131.95 15.27 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.729 -0.607 . . . . 0.0 111.214 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.51 139.21 25.39 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.119 1.063 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -33.41 71.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.789 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 116' ' ' TYR . 3.1 p -152.72 156.26 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.529 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -131.84 155.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.845 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.9 mt -112.33 129.99 56.11 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.928 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.03 27.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.616 -0.677 . . . . 0.0 110.29 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.3 t -89.58 176.93 6.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.554 -0.716 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG3' HD13 ' A' ' 16' ' ' ILE . 7.8 tpm_? -59.97 -28.77 67.94 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.076 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.29 22.59 21.84 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.74 HD13 ' HG3' ' A' ' 14' ' ' ARG . 1.8 mp -114.73 114.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.501 -0.999 . . . . 0.0 109.877 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.76 124.02 49.92 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.642 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.1 p -132.8 150.01 52.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.008 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.685 ' HB3' HG21 ' A' ' 9' ' ' VAL . 32.4 p90 -152.06 163.11 40.0 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 87.2 t -119.4 122.71 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.301 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.087 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 41.4 t -100.78 100.54 11.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.884 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.4 pt-20 -79.95 149.97 30.66 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.318 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -132.68 173.56 11.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.04 120.59 22.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.391 -0.818 . . . . 0.0 111.154 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 106' ' ' LEU . 28.7 t -151.62 149.95 25.32 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 111.053 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.84 147.95 31.52 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.694 1.365 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.51 -176.15 0.44 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.89 160.05 36.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.845 . . . . 0.0 109.73 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 1.018 ' O ' ' SD ' ' A' ' 54' ' ' MET . . . -148.4 171.94 15.23 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.312 -0.867 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.833 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.8 p -86.26 -5.39 59.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.611 -0.681 . . . . 0.0 112.622 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -129.16 76.44 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.914 -1.514 . . . . 0.0 112.91 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HB ' ' CD2' ' A' ' 52' ' ' TYR . 92.0 t -91.94 86.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -63.16 123.33 18.35 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.366 0.603 . . . . 0.0 111.618 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.99 161.24 34.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.6 m -152.73 138.95 18.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.985 HG22 HD13 ' A' ' 79' ' ' LEU . 88.2 t -108.84 128.9 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 46' ' ' GLU . 11.0 mt -124.82 165.01 18.79 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.491 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB2' HG21 ' A' ' 47' ' ' VAL . 62.4 ttp180 -128.3 121.25 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HG2' ' CG1' ' A' ' 44' ' ' VAL . 80.5 mt-30 -103.3 131.96 49.93 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.974 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -99.74 -174.17 2.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.94 -0.475 . . . . 0.0 109.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.43 -43.69 96.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 m -130.08 -3.28 4.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.814 . . . . 0.0 111.88 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.632 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 37.2 mt-30 -132.31 152.35 51.43 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.061 -1.024 . . . . 0.0 110.988 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 89.4 t -135.33 138.62 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.617 . . . . 0.0 109.864 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.1 p -136.9 162.8 32.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.584 -0.697 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.879 ' HA ' HD23 ' A' ' 37' ' ' LEU . 85.8 mt-10 -79.91 153.73 28.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.605 -0.684 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.189 HG12 ' SG ' ' A' ' 48' ' ' CYS . 86.5 t -120.72 -50.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.636 -0.665 . . . . 0.0 110.646 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.189 ' SG ' HG12 ' A' ' 47' ' ' VAL . 1.3 m -155.96 132.29 10.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.239 -0.913 . . . . 0.0 110.201 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -139.61 138.46 36.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.444 -0.785 . . . . 0.0 111.188 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.63 156.48 6.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.644 -0.66 . . . . 0.0 109.656 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -90.64 124.08 34.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 109.575 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.582 ' HA ' HD11 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.89 90.06 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.833 ' SD ' ' O ' ' A' ' 30' ' ' THR . 61.8 mmm -88.13 122.52 31.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 1.018 ' SD ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -59.83 -27.96 67.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.035 -1.04 . . . . 0.0 110.265 -178.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.45 -42.1 7.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -110.48 151.02 28.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.245 -1.15 . . . . 0.0 111.554 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -77.04 150.23 35.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.58 -0.7 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' TYR . 4.7 mp -71.15 136.93 48.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.514 -0.741 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.1 p -118.28 139.61 51.06 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.525 -0.734 . . . . 0.0 110.999 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 75.2 m-85 -107.63 112.0 24.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -68.0 -43.39 78.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.448 -0.782 . . . . 0.0 112.031 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' HB3' HD23 ' A' ' 61' ' ' LEU . 55.3 p-10 -142.51 -158.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.262 -0.899 . . . . 0.0 111.339 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.65 57.01 4.5 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.412 0.625 . . . . 0.0 110.271 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p 57.13 166.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.325 0.583 . . . . 0.0 110.95 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.95 131.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.739 -0.601 . . . . 0.0 110.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 82.8 m -130.05 165.42 22.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.709 -0.619 . . . . 0.0 109.667 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 80' ' ' THR . 8.2 t -136.05 141.37 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.2 153.74 25.25 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.8 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.829 HG21 ' C6 ' ' A' ' 138' ' ' FUC . 59.2 m -139.99 157.36 45.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD2' ' A' ' 52' ' ' TYR . 15.3 t -146.0 108.04 4.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.772 . . . . 0.0 110.512 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.7 t -148.28 148.1 30.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.831 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.74 38.58 96.7 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.06 27.42 13.3 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.692 -0.887 . . . . 0.0 110.227 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -132.12 128.62 38.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.591 -0.693 . . . . 0.0 109.814 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.9 m -104.45 120.29 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.34 -0.85 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -100.97 110.1 22.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -0.899 . . . . 0.0 111.175 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.985 HD13 HG22 ' A' ' 36' ' ' VAL . 86.9 mt -103.01 131.98 49.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.726 . . . . 0.0 109.242 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.642 HG23 ' HB3' ' A' ' 18' ' ' SER . 94.8 m -130.88 150.33 52.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.335 -0.853 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 HD21 ' A' ' 84' ' ' LEU . 62.4 mt -124.47 141.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.809 -0.557 . . . . 0.0 109.977 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' CG ' HG13 ' A' ' 16' ' ' ILE . 6.9 mt-30 -120.01 122.06 40.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.745 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.46 41.38 1.14 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 81' ' ' ILE . 80.1 mt -89.35 129.95 35.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.956 . . . . 0.0 111.421 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -116.15 179.81 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.03 81.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.5 ttp -68.14 -35.86 78.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.64 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.522 -0.736 . . . . 0.0 111.387 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 115' ' ' ILE . 19.7 m -49.65 142.51 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.7 -165.24 35.02 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 21.1 tp -98.76 131.37 44.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.959 . . . . 0.0 112.75 -178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CE1' HD12 ' A' ' 115' ' ' ILE . 86.1 m-85 -114.23 139.2 49.59 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -108.91 141.45 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.386 -0.822 . . . . 0.0 111.818 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.038 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 17.3 p -104.66 112.72 25.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -100.87 143.08 31.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.22 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.74 106.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.465 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CG ' ' OH ' ' A' ' 104' ' ' TYR . 22.1 mp0 -131.32 130.13 42.35 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.566 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' CD1' HD23 ' A' ' 106' ' ' LEU . 12.1 mt -84.61 80.36 9.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.7 tpp -79.74 -52.85 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.186 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.451 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 94.0 m-85 -68.75 -44.25 30.85 Favored Pre-proline 0 N--CA 1.508 2.464 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.3 Cg_endo -79.14 110.46 2.74 Favored 'Trans proline' 0 N--CA 1.518 2.932 0 C-N-CA 121.136 1.224 . . . . 0.0 110.885 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.4 Cg_endo -83.18 155.22 14.63 Favored 'Trans proline' 1 CA--C 1.676 7.599 0 CA-C-O 111.686 -3.548 . . . . 0.0 105.643 -177.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 52.4 Cg_endo -88.07 -179.08 15.31 Favored 'Cis proline' 1 C--N 1.492 8.082 1 C-N-CA 95.527 -13.114 . . . . 0.0 116.297 -10.356 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' OH ' ' CG ' ' A' ' 97' ' ' GLU . 4.4 t80 -87.37 132.15 34.06 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 117.469 -3.27 . . . . 0.0 110.467 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 106' ' ' LEU . 51.4 t80 -163.43 92.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.042 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.7 HD23 ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -145.57 -148.36 0.24 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.074 -179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.61 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.1 179.0 38.58 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.8 mp -119.81 158.79 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 O-C-N 121.67 -0.9 . . . . 0.0 109.109 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.81 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -85.52 145.22 20.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.15 -34.54 73.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.297 -1.119 . . . . 0.0 110.727 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 122.95 135.27 4.56 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 9' ' ' VAL . 94.7 m -106.78 130.99 54.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' VAL . 44.7 tt0 -85.11 123.99 31.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.835 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 92' ' ' TYR . 82.3 mt -85.85 125.59 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.731 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.845 ' HB2' HD23 ' A' ' 10' ' ' LEU . 4.6 m-30 -95.84 158.87 15.25 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.209 0.528 . . . . 0.0 110.38 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.4 t -110.55 167.01 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.51 ' N ' HG12 ' A' ' 117' ' ' VAL . 30.7 mm -99.54 115.14 39.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.303 0.573 . . . . 0.0 110.451 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -140.01 125.41 11.53 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.736 -0.603 . . . . 0.0 109.819 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.49 149.99 69.29 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.058 1.031 . . . . 0.0 110.298 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -87.14 129.98 49.78 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.502 -0.749 . . . . 0.0 110.266 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.36 -12.3 33.36 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.184 1.097 . . . . 0.0 111.235 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.888 ' SG ' ' O ' ' A' ' 125' ' ' ASP . 42.3 t -102.44 120.74 52.26 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.237 -0.914 . . . . 0.0 110.194 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.13 -19.88 44.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.12 1.063 . . . . 0.0 110.986 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.888 ' O ' ' SG ' ' A' ' 123' ' ' CYS . 55.0 p-10 -140.59 169.97 16.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.361 -0.837 . . . . 0.0 110.602 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -94.37 170.06 9.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.656 -0.653 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -79.31 124.03 28.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.008 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -67.51 -36.35 80.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.567 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -110.05 124.07 34.46 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 0.0 110.412 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.93 159.91 51.57 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.19 1.1 . . . . 0.0 110.529 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.3 mttm . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.565 -0.709 . . . . 0.0 110.196 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.686 ' O6 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.686 ' H82' ' O6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.829 ' C6 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.053 0.454 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.01 -32.93 8.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.615 -0.678 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 71.1 m80 -110.06 31.45 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.551 -0.718 . . . . 0.0 110.293 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.2 t -149.26 137.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.826 -0.546 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.47 127.33 53.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.557 -0.714 . . . . 0.0 109.876 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.004 ' CD ' ' SG ' ' A' ' 94' ' ' CYS . 5.5 mm100 -139.95 131.52 14.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.658 -0.651 . . . . 0.0 111.745 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.65 139.93 28.79 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.141 1.074 . . . . 0.0 109.434 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.77 -33.81 74.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.725 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.68 155.77 7.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.615 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.64 HG23 HG21 ' A' ' 113' ' ' THR . 8.6 t -133.01 148.2 31.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.135 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.1 mt -104.52 127.48 52.25 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.81 175.18 6.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.465 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -109.45 175.81 5.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.42 -37.54 81.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.745 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HB3' HD13 ' A' ' 16' ' ' ILE . 19.8 mmt85 -59.63 -30.22 68.56 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.682 -0.636 . . . . 0.0 110.312 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.14 27.03 9.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.3 mp -102.74 100.4 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.65 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.22 118.4 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.676 ' HB2' HG23 ' A' ' 80' ' ' THR . 45.7 t -131.19 132.58 44.8 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.5 p90 -131.92 163.95 27.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.547 HG22 ' CG ' ' A' ' 78' ' ' ASN . 58.0 t -118.47 122.67 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.685 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.634 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -101.12 108.1 19.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -85.51 141.13 30.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.815 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.914 ' CB ' HG11 ' A' ' 96' ' ' VAL . 45.1 p90 -125.57 178.22 5.78 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -133.54 123.87 25.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.705 -0.622 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -116.18 132.71 23.13 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 109.941 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.51 -12.17 32.77 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.192 1.101 . . . . 0.0 112.159 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.03 27.2 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.358 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.82 136.47 44.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.694 -0.886 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.06 163.99 38.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.625 -0.672 . . . . 0.0 109.931 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 64.3 p -86.2 12.38 9.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.511 -0.743 . . . . 0.0 111.308 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' HG21 ' A' ' 51' ' ' THR . 34.0 mm-40 -137.22 97.6 3.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.002 -1.479 . . . . 0.0 113.216 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 40.0 t -122.4 79.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -58.99 131.62 51.59 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.254 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -129.26 164.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 49' ' ' ALA . 87.1 m -160.0 157.97 29.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 110.084 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.001 HG22 HD13 ' A' ' 79' ' ' LEU . 96.8 t -122.14 134.06 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.876 HD23 ' HA ' ' A' ' 46' ' ' GLU . 8.4 mt -130.03 163.96 25.37 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.523 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.724 ' HG3' HG21 ' A' ' 47' ' ' VAL . 39.0 mtm105 -123.68 119.99 31.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 44' ' ' VAL . 90.0 mt-30 -106.01 129.7 54.08 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.512 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.39 154.97 44.35 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.68 -43.19 94.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 0.0 110.621 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.1 m -68.85 -49.99 53.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.9 mt-30 -155.0 162.89 40.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.343 -0.848 . . . . 0.0 111.284 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 39' ' ' GLN . 87.8 t -126.42 135.13 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.2 159.97 38.63 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.462 -0.774 . . . . 0.0 111.626 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.876 ' HA ' HD23 ' A' ' 37' ' ' LEU . 54.9 mt-10 -80.86 161.09 24.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.618 . . . . 0.0 110.71 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.724 HG21 ' HG3' ' A' ' 38' ' ' ARG . 96.1 t -127.64 -67.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.698 -0.626 . . . . 0.0 110.663 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 67.8 m -138.03 154.12 49.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.903 . . . . 0.0 111.77 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -160.56 136.13 8.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.787 -0.57 . . . . 0.0 110.579 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -155.38 146.56 22.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.575 -0.703 . . . . 0.0 109.12 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.554 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.4 m -80.05 127.55 32.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.241 -0.912 . . . . 0.0 110.116 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 1.2 t80 -79.99 103.47 9.9 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.3 mtp -95.81 131.09 42.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 21.0 mmt -59.76 -34.96 73.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.957 . . . . 0.0 110.733 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.18 -51.89 25.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.17 159.95 35.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.428 -1.042 . . . . 0.0 110.724 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -103.86 130.85 51.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 51' ' ' THR . 60.9 tp -95.41 150.21 20.53 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.518 -0.738 . . . . 0.0 109.656 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 p -104.86 167.39 9.75 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.63 -0.669 . . . . 0.0 110.61 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 34.8 m-85 -92.9 100.6 13.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.664 -0.648 . . . . 0.0 109.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -103.85 2.35 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.531 -0.731 . . . . 0.0 111.77 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -67.92 -41.78 82.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -109.92 7.49 23.89 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 33.63 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 67' ' ' ILE . 26.8 mm -141.98 10.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 0.0 111.246 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 16.8 p -127.92 138.96 52.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.669 -1.269 . . . . 0.0 111.069 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -139.93 156.14 46.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.19 -179.83 43.33 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 72' ' ' SER . 94.6 m -117.43 163.57 16.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.034 -0.686 . . . . 0.0 109.579 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 71' ' ' THR . 1.3 p -153.18 113.8 4.05 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.2 m -143.66 146.94 33.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.053 -1.029 . . . . 0.0 110.948 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.63 -123.95 27.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -110.11 19.88 18.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.813 -0.816 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -125.79 129.95 50.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.7 m -110.05 126.95 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.723 . . . . 0.0 109.806 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.547 ' CG ' HG22 ' A' ' 20' ' ' VAL . 39.4 t-20 -107.2 120.78 43.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.926 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.001 HD13 HG22 ' A' ' 36' ' ' VAL . 80.6 mt -108.09 132.01 54.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.387 -0.821 . . . . 0.0 109.269 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.676 HG23 ' HB2' ' A' ' 18' ' ' SER . 60.9 m -119.99 139.9 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.248 -0.907 . . . . 0.0 110.907 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.718 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -117.31 132.57 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.0 110.158 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.1 mt-30 -120.16 121.12 38.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.218 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.94 39.67 0.95 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 81' ' ' ILE . 80.4 mt -94.83 120.08 34.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.509 -0.994 . . . . 0.0 111.365 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' O ' HG21 ' A' ' 117' ' ' VAL . 19.1 mmt85 -102.27 178.86 4.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.09 83.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.232 -0.917 . . . . 0.0 109.819 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 ttm -68.02 -33.76 75.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.74 -0.6 . . . . 0.0 110.824 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.04 -17.3 64.36 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.589 -0.694 . . . . 0.0 111.67 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 115' ' ' ILE . 24.5 m -51.16 135.17 26.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.84 -155.26 19.22 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.778 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.77 128.68 55.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.738 -0.86 . . . . 0.0 112.061 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.941 ' CD1' HD12 ' A' ' 115' ' ' ILE . 44.9 m-85 -112.29 144.88 40.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -111.59 143.32 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 111.432 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.004 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 17.5 p -105.82 117.23 33.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.5 tptt -102.11 141.15 35.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.505 -0.747 . . . . 0.0 109.652 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.914 HG11 ' CB ' ' A' ' 23' ' ' TYR . 16.5 t -145.14 103.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -136.56 125.46 24.18 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.269 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 HD23 ' A' ' 106' ' ' LEU . 7.6 mp -79.73 77.22 6.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.8 tpp -80.47 -51.36 8.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.977 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 92.6 m-85 -67.17 -40.21 26.42 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 111.737 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 39.6 Cg_endo -86.99 120.74 1.66 Allowed 'Trans proline' 0 N--CA 1.504 2.109 0 N-CA-C 110.201 -0.73 . . . . 0.0 110.201 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -97.8 159.21 0.9 Allowed 'Trans proline' 1 CA--C 1.662 6.879 0 CA-C-O 112.144 -3.357 . . . . 0.0 108.086 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 71.9 Cg_endo -92.54 171.11 21.06 Favored 'Cis proline' 2 C--N 1.464 6.616 1 C-N-CA 95.217 -13.243 . . . . 0.0 119.232 -6.178 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -74.31 125.15 27.82 Favored 'General case' 0 N--CA 1.527 3.418 0 O-C-N 120.303 -1.498 . . . . 0.0 111.338 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 105' ' ' TYR 0.262 52.9 t80 -152.82 59.97 0.8 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.499 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.834 HD23 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -130.78 -152.8 0.53 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.36 24.98 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.333 -1.413 . . . . 0.0 109.919 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.534 ' CG2' ' H81' ' A' ' 132' ' ' NAG . 93.7 mt -122.26 154.66 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.574 -0.957 . . . . 0.0 110.391 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.726 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -81.08 138.75 19.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 177.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 9.7 m120 -60.31 -29.69 69.01 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -1.169 . . . . 0.0 110.285 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.42 145.85 7.28 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.6 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.64 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -114.02 131.54 56.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.2 tp60 -80.83 119.94 24.04 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.166 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.941 HD12 ' CD1' ' A' ' 92' ' ' TYR . 86.8 mt -86.86 119.99 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.053 . . . . 0.0 109.112 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' HD23 ' A' ' 10' ' ' LEU . 7.6 m-30 -91.74 120.09 32.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.145 -0.347 . . . . 0.0 110.328 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.3 t -84.39 166.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.834 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.519 ' N ' HG12 ' A' ' 117' ' ' VAL . 45.3 mm -102.86 139.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.21 0.529 . . . . 0.0 110.607 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -111.68 123.12 35.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.724 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.07 149.94 65.61 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.069 1.036 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -124.37 151.21 66.2 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.674 . . . . 0.0 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.95 -27.53 36.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.289 1.152 . . . . 0.0 110.873 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.0 m -136.86 130.04 17.49 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.51 -20.07 27.66 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.143 1.075 . . . . 0.0 111.041 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -99.98 139.53 35.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.875 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -90.03 -0.56 57.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 111.265 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -62.84 -25.79 68.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -87.86 0.5 55.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 111.527 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' N ' ' HD2' ' A' ' 130' ' ' PRO . 77.3 mt-10 -59.52 -46.0 98.78 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.041 -1.037 . . . . 0.0 112.086 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 129' ' ' GLU . 43.9 Cg_endo -71.41 152.92 61.06 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 122.763 0.875 . . . . 0.0 110.692 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.559 ' H83' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.412 ' H82' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.412 ' O2 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.441 ' C6 ' ' O2 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.472 ' H61' ' C1 ' ' A' ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.441 ' O2 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' BMA . . . . . 0.472 ' C1 ' ' H61' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.121 0.486 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt -109.74 160.68 16.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 110.21 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -130.07 74.19 1.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.061 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' GLU . 93.3 t -123.85 134.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.517 -0.74 . . . . 0.0 110.075 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.38 54.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.108 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 25.9 mm100 -137.95 139.95 27.76 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.566 -0.709 . . . . 0.0 111.91 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.1 140.28 25.01 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 O-C-N 123.324 1.17 . . . . 0.0 109.109 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -151.7 159.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.713 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -137.82 156.02 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.374 0.607 . . . . 0.0 109.713 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.1 mt -117.08 126.6 53.09 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.705 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.92 138.18 40.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.428 -0.795 . . . . 0.0 109.22 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -75.98 -65.29 0.93 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.422 -0.798 . . . . 0.0 111.547 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -160.02 168.22 26.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.473 -0.767 . . . . 0.0 110.369 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.414 ' HB2' HD13 ' A' ' 16' ' ' ILE . 6.2 mtt180 54.16 21.05 2.83 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.674 -0.641 . . . . 0.0 111.252 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.12 35.59 64.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 16' ' ' ILE . 1.2 mp -99.14 97.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 0.0 108.906 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.27 114.36 28.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 80' ' ' THR . 32.8 t -121.07 131.97 54.6 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.689 0.757 . . . . 0.0 111.246 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.855 ' HB3' HG21 ' A' ' 9' ' ' VAL . 24.3 p90 -140.47 161.63 37.25 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 85.4 t -120.4 125.33 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.455 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.108 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.5 t -104.38 130.0 52.27 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.1 tt0 -102.83 138.75 39.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 111.378 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.873 ' CD2' HG11 ' A' ' 96' ' ' VAL . 19.7 p90 -137.32 -177.73 4.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.96 113.93 15.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.585 -0.697 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.5 p -141.75 164.37 34.93 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.542 -0.723 . . . . 0.0 110.151 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.678 ' HD2' HD21 ' A' ' 98' ' ' LEU . 43.4 Cg_endo -69.96 155.95 64.02 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.389 1.205 . . . . 0.0 110.095 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.2 19.96 51.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -119.93 32.61 5.97 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.212 -1.17 . . . . 0.0 110.775 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.11 140.04 47.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.652 -0.655 . . . . 0.0 110.342 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.512 ' O ' ' HE2' ' A' ' 53' ' ' MET . 40.3 p -92.03 10.72 27.9 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.528 -0.732 . . . . 0.0 110.572 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' OE1' HG21 ' A' ' 51' ' ' THR . 16.1 mm-40 -130.29 122.34 27.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.572 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 95.9 t -138.89 83.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 6.6 ttm180 -63.41 116.88 5.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.767 -0.583 . . . . 0.0 111.343 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 35.9 m -113.85 131.91 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.1 m -122.47 131.91 54.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.694 -0.629 . . . . 0.0 110.624 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.936 HG22 HD13 ' A' ' 79' ' ' LEU . 97.9 t -109.6 129.71 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.771 HD12 ' HE3' ' A' ' 95' ' ' LYS . 46.9 mt -125.46 165.14 18.98 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.87 ' HG3' HG21 ' A' ' 47' ' ' VAL . 75.0 mtm180 -121.31 119.92 33.59 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.718 ' HA ' HG22 ' A' ' 44' ' ' VAL . 34.0 tt0 -97.45 141.46 30.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -136.91 157.03 47.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.79 -40.17 87.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.5 m -75.61 -53.36 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.776 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.2 mt-30 -154.47 174.59 14.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.718 HG22 ' HA ' ' A' ' 39' ' ' GLN . 99.8 t -128.77 139.93 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -130.1 161.46 30.99 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.706 ' HA ' HD23 ' A' ' 37' ' ' LEU . 49.6 mt-10 -80.1 158.95 26.26 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 110.844 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 ' HG3' ' A' ' 38' ' ' ARG . 46.0 t -135.16 -66.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.226 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.683 ' SG ' HG12 ' A' ' 47' ' ' VAL . 71.3 m -129.93 142.65 50.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.26 -0.9 . . . . 0.0 111.22 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.85 131.97 14.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.657 -0.652 . . . . 0.0 110.278 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.9 157.61 14.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 0.0 110.334 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.579 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -102.21 116.01 31.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.578 ' N ' HD21 ' A' ' 58' ' ' LEU . 20.6 t80 -77.87 123.96 27.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.225 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 30' ' ' THR . 2.8 mtp -95.58 157.62 15.82 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.5 mmt -60.03 -27.63 67.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.843 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.04 48.01 0.99 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.971 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' A' ' 53' ' ' MET . 9.0 t-20 -157.81 -179.49 8.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.265 -1.138 . . . . 0.0 110.701 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -115.08 156.03 25.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 110.406 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' N ' ' A' ' 52' ' ' TYR . 85.3 mt -72.82 136.16 45.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.561 -0.712 . . . . 0.0 111.136 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.2 p -104.76 129.36 53.02 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.705 -0.622 . . . . 0.0 109.565 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 99.1 m-85 -119.99 66.2 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.761 . . . . 0.0 110.099 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.07 -39.48 90.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.536 -0.727 . . . . 0.0 110.767 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.58 131.27 44.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.434 -0.791 . . . . 0.0 110.728 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 52.17 49.01 21.51 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.492 -0.755 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -59.03 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.908 -0.495 . . . . 0.0 110.43 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 67' ' ' ILE . 49.0 mm 52.36 22.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.386 -1.446 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -160.03 160.65 33.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.549 HG21 ' H81' ' A' ' 137' ' ' NAG . 9.1 t -123.88 139.92 53.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.55 121.72 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.978 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -130.06 155.12 46.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 68.9 m -160.06 137.95 9.94 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.857 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -140.27 140.06 35.65 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.89 -124.02 34.84 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -107.32 11.92 28.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.948 . . . . 0.0 110.927 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.0 mt-30 -116.65 129.29 56.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.122 -0.986 . . . . 0.0 111.016 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.7 m -110.12 126.23 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.433 -0.792 . . . . 0.0 110.221 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -98.64 117.89 34.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 111.585 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 36' ' ' VAL . 76.4 mt -110.38 130.47 55.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.615 -0.678 . . . . 0.0 109.52 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.512 HG21 ' H83' ' A' ' 137' ' ' NAG . 60.1 m -129.69 138.15 51.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.388 -0.82 . . . . 0.0 110.803 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 92' ' ' TYR . 84.3 mt -108.06 130.1 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 75.4 mt-30 -118.99 119.74 35.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.086 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.84 35.96 3.1 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.571 HD11 ' CG2' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -99.35 131.3 45.46 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.689 -0.889 . . . . 0.0 110.105 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 84' ' ' LEU . 72.3 mtt85 -86.26 160.6 19.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 109.921 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -29.03 66.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 26.1 ptm -66.52 -30.04 70.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.46 0.648 . . . . 0.0 109.526 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -77.48 -4.03 43.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.751 -0.593 . . . . 0.0 111.387 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 115' ' ' ILE . 59.4 m -55.31 140.01 40.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.958 -1.089 . . . . 0.0 109.62 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.63 -148.04 11.55 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.793 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 113' ' ' THR . 17.3 tp -106.93 130.23 54.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.741 -0.858 . . . . 0.0 111.754 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.866 ' CD1' HD12 ' A' ' 115' ' ' ILE . 50.8 m-85 -112.57 135.17 53.6 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -100.67 140.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 0.0 111.678 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 1.108 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 13.7 p -106.68 122.6 46.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.925 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.1 mttt -120.04 146.12 46.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.148 -0.97 . . . . 0.0 110.056 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 23' ' ' TYR . 2.7 t -140.44 107.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.529 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 99' ' ' MET . 2.5 mp0 -132.52 125.18 29.98 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.598 -0.841 . . . . 0.0 113.216 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 106' ' ' LEU . 9.4 mp -74.34 80.2 1.86 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 12.9 mmt -79.58 -48.15 14.29 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.556 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 87.0 m-85 -66.66 -42.92 48.36 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.955 -1.091 . . . . 0.0 113.531 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 51.4 Cg_endo -86.07 113.68 1.27 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 O-C-N 122.657 0.819 . . . . 0.0 112.697 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 60.1 Cg_endo -83.06 141.03 10.27 Favored 'Trans proline' 1 CA--C 1.654 6.515 0 CA-C-O 110.774 -3.928 . . . . 0.0 107.861 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.433 55.2 Cg_endo -102.61 179.54 3.91 Favored 'Cis proline' 3 C--N 1.524 9.813 1 C-N-CA 91.932 -14.612 . . . . 0.0 116.815 6.991 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.402 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 5.9 t80 -82.2 126.9 32.61 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 116.795 -3.691 . . . . 0.0 108.847 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.25 47.8 t80 -158.63 101.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.985 -0.447 . . . . 0.0 110.374 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 98' ' ' LEU . 2.8 tp -160.31 -143.46 0.1 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.542 -0.724 . . . . 0.0 110.454 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.27 -173.79 23.64 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.43 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.925 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.251 46.8 mm -131.46 168.87 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.406 -1.055 . . . . 0.0 110.347 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.833 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -105.95 134.13 11.95 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -60.1 -36.4 77.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.094 -1.239 . . . . 0.0 110.519 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.5 153.1 8.1 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.318 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.757 HG21 HG23 ' A' ' 9' ' ' VAL . 89.1 m -121.84 139.42 53.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.906 ' HB3' HG23 ' A' ' 8' ' ' VAL . 16.3 tp60 -79.95 138.21 37.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.866 HD12 ' CD1' ' A' ' 92' ' ' TYR . 46.8 mt -110.07 124.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CE2' HG21 ' A' ' 8' ' ' VAL . 16.7 m-30 -100.84 133.63 45.03 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.084 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 84' ' ' LEU . 98.0 t -96.94 165.96 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.063 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.522 ' N ' HG12 ' A' ' 117' ' ' VAL . 41.2 mm -105.21 132.01 53.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.993 -0.442 . . . . 0.0 110.048 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -97.35 119.97 61.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.486 -0.759 . . . . 0.0 109.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -74.16 68.03 5.06 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.095 1.05 . . . . 0.0 110.871 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -87.05 132.93 40.23 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.462 -0.773 . . . . 0.0 109.986 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.26 -19.88 43.68 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.136 1.072 . . . . 0.0 111.008 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.4 m -129.92 141.84 43.27 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 110.329 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.03 160.05 51.0 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.293 1.154 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -82.8 120.03 25.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.578 -0.701 . . . . 0.0 110.125 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -66.94 -29.99 70.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.617 -0.677 . . . . 0.0 110.353 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -70.07 132.01 45.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.745 . . . . 0.0 110.233 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -84.54 148.84 26.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 0.0 110.09 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 22.0 mp0 52.5 49.89 7.26 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.406 -0.809 . . . . 0.0 111.005 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.8 Cg_endo -69.79 155.96 64.5 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.203 1.107 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 110.099 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.434 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.587 ' H83' ' H3 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.411 ' C1 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.549 ' H81' HG21 ' A' ' 69' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.041 0.448 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm 56.09 167.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.73 -0.607 . . . . 0.0 110.844 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.453 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 -120.08 29.43 7.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -148.29 144.34 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.85 -0.531 . . . . 0.0 109.862 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.65 127.07 51.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.589 -0.694 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.926 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 15.1 mm100 -142.12 130.65 11.89 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.642 -0.661 . . . . 0.0 111.3 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.64 139.97 31.87 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.175 1.092 . . . . 0.0 109.367 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.01 69.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.954 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -154.23 162.9 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.26 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' A' ' 113' ' ' THR . 8.3 t -141.74 151.86 19.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.954 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.4 mt -110.61 127.03 55.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.26 148.98 23.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.413 -0.805 . . . . 0.0 110.984 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -69.41 172.16 7.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.603 -0.686 . . . . 0.0 110.521 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -60.1 -36.05 76.57 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.557 -0.714 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.653 ' CG ' HD13 ' A' ' 16' ' ' ILE . 27.1 tpt180 -57.16 -25.49 59.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.556 -0.715 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.603 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 101.14 26.44 7.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.693 HG21 ' H82' ' A' ' 137' ' ' NAG . 1.8 mp -108.06 112.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 121.626 -0.926 . . . . 0.0 110.52 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -110.54 124.74 52.39 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.794 ' OG ' HG23 ' A' ' 80' ' ' THR . 53.0 m -126.97 140.09 52.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.583 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.6 p90 -148.55 163.5 37.02 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 77' ' ' VAL . 63.2 t -130.31 123.73 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.731 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 77' ' ' VAL . 37.6 t -100.01 108.04 20.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 tt0 -84.97 139.45 31.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 0.0 110.519 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 96' ' ' VAL . 41.1 p90 -130.6 177.6 7.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 0.0 109.6 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.94 138.1 35.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.85 -0.532 . . . . 0.0 110.157 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.7 p -125.83 149.83 66.95 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.95 -13.98 34.89 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.462 1.243 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.6 -170.13 18.02 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.99 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.542 -0.975 . . . . 0.0 110.52 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -139.43 151.67 46.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.62 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' MET . 32.4 p -79.9 -43.59 21.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 111.097 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.4 mm-40 -79.68 84.77 5.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.021 -0.671 . . . . 0.0 112.713 -175.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.719 HG11 ' OH ' ' A' ' 52' ' ' TYR . 48.1 t -97.79 89.38 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.705 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -67.15 123.42 20.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.915 -0.491 . . . . 0.0 110.703 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -118.48 134.75 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.58 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.4 m -134.41 159.71 40.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.411 -0.805 . . . . 0.0 110.025 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.97 HG22 HD13 ' A' ' 79' ' ' LEU . 84.5 t -128.84 139.24 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 46' ' ' GLU . 6.2 mt -131.16 171.0 13.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.687 -1.258 . . . . 0.0 111.67 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 47' ' ' VAL . 89.9 mtt180 -125.72 118.39 25.48 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -101.78 126.25 48.61 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.391 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -97.16 -171.57 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.21 -43.81 95.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 111.019 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -131.96 -0.16 3.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 111.949 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 62.8 mt-30 -135.1 155.59 50.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.06 -1.025 . . . . 0.0 110.943 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.8 139.73 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.604 -0.685 . . . . 0.0 109.629 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.9 p -127.03 160.1 32.13 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.437 -0.789 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 37' ' ' LEU . 77.0 mt-10 -86.45 160.04 19.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.647 -0.658 . . . . 0.0 110.742 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 71.5 t -123.41 -71.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.807 -0.558 . . . . 0.0 110.232 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' CB ' ' A' ' 63' ' ' ASP . 80.7 m -147.17 153.71 40.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.31 30.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.508 -0.745 . . . . 0.0 111.258 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 59' ' ' THR . . . -170.44 155.68 5.21 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.601 -0.687 . . . . 0.0 109.658 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' N ' ' A' ' 33' ' ' ARG . 2.8 m -116.27 122.76 45.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.719 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.1 p90 -94.05 124.39 38.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.307 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 3.2 mmt -60.62 -44.7 96.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 166.44 102.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.46 63.0 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.93 159.86 23.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -1.026 . . . . 0.0 110.472 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -70.72 151.6 44.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -90.16 123.89 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.577 -0.702 . . . . 0.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 53.9 p -92.57 131.91 37.3 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 67.9 m-85 -113.86 123.92 50.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.764 . . . . 0.0 110.363 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.74 -36.06 77.93 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.485 -0.759 . . . . 0.0 109.79 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -140.07 174.46 10.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 109.671 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CB ' ' SG ' ' A' ' 48' ' ' CYS . 85.8 m-20 52.65 51.02 16.89 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.1 m -52.36 -21.8 3.95 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.622 -0.674 . . . . 0.0 111.382 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.69 -21.88 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.271 -0.893 . . . . 0.0 110.811 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.3 m -72.43 126.36 29.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.342 -0.849 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.43 HG21 ' OE1' ' A' ' 82' ' ' GLN . 9.2 t -139.98 149.93 43.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.99 -171.52 42.95 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 72' ' ' SER . 94.4 m -129.73 168.46 16.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.939 -0.742 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 71' ' ' THR . 97.2 p -138.33 152.51 48.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.505 -0.747 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -133.7 -173.64 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.746 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -49.67 76.09 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.6 3.86 6.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.463 -1.022 . . . . 0.0 111.272 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 19.2 tt0 -124.27 129.62 51.08 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.09 -1.006 . . . . 0.0 110.851 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.8 m -113.23 132.84 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 64.8 t-20 -110.11 115.97 30.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.97 HD13 HG22 ' A' ' 36' ' ' VAL . 86.6 mt -111.47 133.05 54.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 109.752 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.794 HG23 ' OG ' ' A' ' 18' ' ' SER . 94.5 m -130.87 145.06 51.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.34 -0.85 . . . . 0.0 110.811 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -119.92 140.08 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.611 -0.681 . . . . 0.0 109.874 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.466 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.7 mt-30 -123.83 121.93 36.68 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.803 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.36 46.37 1.0 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.813 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -90.03 122.79 33.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.635 -0.92 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -102.59 178.0 4.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.69 95.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.325 -0.86 . . . . 0.0 109.401 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.8 ttm -63.45 -39.98 95.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.753 -0.592 . . . . 0.0 110.742 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.79 -21.06 62.71 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.598 -0.689 . . . . 0.0 111.025 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.9 m -51.84 140.01 20.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.921 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.88 -158.59 31.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 113' ' ' THR . 17.2 tp -108.2 123.99 49.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.637 -0.919 . . . . 0.0 111.97 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.938 ' CD1' HD12 ' A' ' 115' ' ' ILE . 51.0 m-85 -103.18 140.02 37.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.862 HG23 ' O ' ' A' ' 110' ' ' GLY . 4.2 mp -111.33 130.59 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.665 -0.647 . . . . 0.0 111.775 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.926 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 20.2 p -79.97 157.91 26.71 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.782 ' HG3' HD12 ' A' ' 109' ' ' ILE . 7.9 tttt -153.65 97.2 2.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.93 -1.106 . . . . 0.0 109.457 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.868 HG22 ' CD2' ' A' ' 106' ' ' LEU . 4.0 p -111.17 116.78 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.9 0.857 . . . . 0.0 111.37 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -135.7 124.15 23.46 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.914 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.858 HD23 HD13 ' A' ' 106' ' ' LEU . 4.1 mm? -75.47 76.48 2.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.9 ttm -78.73 -40.42 33.56 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 83.4 m-85 -62.97 -45.72 86.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.234 -0.986 . . . . 0.0 112.446 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 56.2 Cg_endo -81.3 129.62 6.79 Favored 'Trans proline' 0 C--O 1.284 2.805 0 O-C-N 122.776 0.882 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 72.1 Cg_endo -83.86 166.14 13.32 Favored 'Trans proline' 1 CA--C 1.656 6.601 0 CA-C-O 113.526 -2.781 . . . . 0.0 108.966 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.349 56.6 Cg_endo -96.47 50.54 1.46 Allowed 'Cis proline' 2 C--N 1.477 7.331 1 C-N-CA 89.174 -15.761 . . . . 0.0 115.439 -7.756 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.0 t80 67.36 122.26 0.02 OUTLIER 'General case' 1 N--CA 1.554 4.727 1 O-C-N 115.783 -4.323 . . . . 0.0 112.965 179.931 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.476 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.1 p90 -159.84 100.3 1.42 Allowed 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.31 -1.494 . . . . 0.0 109.91 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.868 ' CD2' HG22 ' A' ' 96' ' ' VAL . 1.4 tp -160.24 -146.66 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' O ' HD13 ' A' ' 109' ' ' ILE . . . -159.71 170.69 35.96 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.049 -1.548 . . . . 0.0 111.254 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.782 HD12 ' HG3' ' A' ' 95' ' ' LYS . 22.8 mm -124.18 149.68 28.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.685 -0.891 . . . . 0.0 109.25 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.862 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -91.41 144.71 17.34 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HA ' ' HN2' ' A' ' 132' ' ' NAG . 6.8 m120 -68.12 -24.71 65.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.242 . . . . 0.0 110.592 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 126.53 165.79 12.05 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.137 -1.506 . . . . 0.0 113.849 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 59.5 m -129.28 127.63 41.58 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.954 ' HB3' HG23 ' A' ' 8' ' ' VAL . 8.8 tp-100 -67.98 142.72 55.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.93 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.938 HD12 ' CD1' ' A' ' 92' ' ' TYR . 64.6 mt -118.5 126.38 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.85 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.1 m-85 -110.16 139.98 44.74 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.834 -0.541 . . . . 0.0 110.328 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 118' ' ' ILE . 84.8 t -99.98 165.14 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.449 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.53 ' N ' HG12 ' A' ' 117' ' ' VAL 0.264 42.4 mm -112.83 130.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.046 0.451 . . . . 0.0 110.53 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -108.07 110.03 62.05 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 109.604 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.02 139.1 38.55 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.693 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -133.9 150.5 74.66 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.679 -0.638 . . . . 0.0 110.138 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.92 -11.49 31.99 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.433 1.228 . . . . 0.0 110.884 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.672 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 42.3 t -112.77 146.65 35.49 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.672 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 41.7 Cg_endo -68.22 147.89 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.325 1.171 . . . . 0.0 110.405 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -89.94 -179.98 5.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.649 -0.657 . . . . 0.0 110.676 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.7 p -92.98 9.87 33.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.627 -0.671 . . . . 0.0 111.015 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.77 139.96 57.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -110.16 149.99 29.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 110.118 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 96.3 mt-10 52.82 49.88 7.1 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.445 -0.784 . . . . 0.0 111.119 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.8 Cg_endo -69.85 150.87 68.22 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.241 1.127 . . . . 0.0 110.54 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.51 -0.744 . . . . 0.0 110.221 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.533 ' H81' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.406 ' H62' ' C2 ' ' A' ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 135' ' ' BMA . . . . . 0.406 ' C2 ' ' H62' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.693 ' H82' HG21 ' A' ' 16' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.144 0.497 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 ttp 53.89 98.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.46 -0.775 . . . . 0.0 110.781 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -104.04 30.88 4.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.56 -0.712 . . . . 0.0 110.27 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.833 HG12 ' OE1' ' A' ' 5' ' ' GLN . 53.3 t -147.04 148.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -135.02 135.81 41.63 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.051 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.833 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -140.0 146.49 46.85 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.648 -0.658 . . . . 0.0 110.095 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 42.6 Cg_endo -69.87 147.95 63.31 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.254 1.134 . . . . 0.0 109.565 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.93 -20.77 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.835 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.7 p -160.6 160.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.029 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 113' ' ' THR . 33.6 t -137.13 159.6 36.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.155 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.698 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.8 mt -120.0 130.37 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.289 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -100.89 133.37 45.46 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -135.81 162.43 32.81 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.289 -0.882 . . . . 0.0 112.476 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t 59.31 -115.87 0.78 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.728 -0.608 . . . . 0.0 110.827 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 16' ' ' ILE . 5.9 mtt180 -59.93 -13.06 9.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 111.346 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.22 43.47 5.91 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.3 mm -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -98.59 124.1 43.16 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.998 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 80' ' ' THR . 15.0 t -126.2 131.29 52.01 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 28.2 p90 -139.73 165.82 26.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.742 -0.599 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.877 HG23 ' H83' ' A' ' 136' ' ' NAG . 57.5 t -123.92 127.27 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.859 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.675 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -110.03 119.79 40.41 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -93.16 154.25 18.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.935 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' HG11 ' A' ' 96' ' ' VAL . 45.8 p90 -134.01 -175.99 4.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.64 116.95 20.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.351 -0.843 . . . . 0.0 111.799 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 106' ' ' LEU . 69.8 m -161.68 155.89 18.97 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.712 -0.618 . . . . 0.0 109.696 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.97 -19.94 45.4 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.286 1.151 . . . . 0.0 110.733 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.98 35.9 33.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -102.64 26.86 7.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.366 -1.079 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -148.19 144.74 27.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 53' ' ' MET . 16.1 p -80.28 -39.11 29.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.731 0.777 . . . . 0.0 111.655 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.694 ' OE1' HG21 ' A' ' 51' ' ' THR . 4.7 mm-40 -80.19 82.85 6.16 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.918 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 86.8 t -93.67 84.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.798 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 60.1 ttt180 -59.98 123.17 16.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.676 -0.64 . . . . 0.0 111.084 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 32' ' ' VAL . 31.9 m -123.4 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.8 m -120.92 131.61 54.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.236 0.541 . . . . 0.0 110.636 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.837 HG22 HD13 ' A' ' 79' ' ' LEU . 86.4 t -107.76 130.39 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD12 ' HE3' ' A' ' 95' ' ' LYS . 78.9 mt -124.62 169.93 11.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.992 -1.068 . . . . 0.0 111.958 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -130.26 121.39 26.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' HG2' ' CG1' ' A' ' 44' ' ' VAL . 83.2 mt-30 -110.24 131.98 54.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.346 -0.846 . . . . 0.0 111.061 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.36 152.77 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.57 -44.21 93.38 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 0.0 110.543 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.44 -44.87 66.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.3 mt-30 -154.89 160.16 40.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.469 -0.769 . . . . 0.0 111.263 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 92.2 t -126.86 139.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -145.21 160.38 41.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.453 -0.779 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 13.7 mt-10 -80.71 156.16 26.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.691 -0.631 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 48' ' ' CYS . 85.4 t -114.49 -83.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.345 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' ' OD2' ' A' ' 63' ' ' ASP . 80.8 m -122.0 160.9 23.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 110.866 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.37 135.55 6.03 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.91 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 59' ' ' THR . . . -172.1 165.34 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.419 -0.8 . . . . 0.0 110.594 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.694 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.9 m -97.9 123.94 42.1 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 27.6 t80 -88.31 106.79 18.46 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.135 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -76.17 157.86 32.29 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.4 mmt -59.64 -28.5 67.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.852 -1.155 . . . . 0.0 110.084 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.84 -79.04 0.17 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 58' ' ' LEU . 25.1 t30 -154.15 178.49 9.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.39 -1.065 . . . . 0.0 110.665 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.715 ' C ' HD22 ' A' ' 58' ' ' LEU . 7.2 tp10 -120.07 120.15 35.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.65 -0.656 . . . . 0.0 109.746 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 58' ' ' LEU . 2.4 mm? -124.28 46.22 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.571 HG21 ' HB1' ' A' ' 50' ' ' ALA 0.285 36.8 p -116.4 -132.14 0.32 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.791 -0.568 . . . . 0.0 110.909 -178.016 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 57' ' ' GLU . 39.8 m-85 60.57 25.12 14.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.825 -1.172 . . . . 0.0 109.426 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.72 -36.42 80.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 111.402 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -59.63 -43.28 93.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.413 -0.805 . . . . 0.0 111.812 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 1.045 ' OD2' ' SG ' ' A' ' 48' ' ' CYS . 95.9 m-20 -92.88 -13.2 29.29 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.164 0.507 . . . . 0.0 110.78 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t 42.4 24.93 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -144.85 -43.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.018 -1.051 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 22.9 p -67.82 134.64 51.29 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -0.857 . . . . 0.0 111.344 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -130.02 139.98 50.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA3' HD23 ' A' ' 79' ' ' LEU . . . -139.05 158.02 25.08 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.357 -1.401 . . . . 0.0 111.111 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.853 HG21 ' H63' ' A' ' 138' ' ' FUC . 61.1 m -130.05 159.92 35.26 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 53.4 m -145.93 127.24 14.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -139.96 129.99 24.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.774 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.84 -124.07 35.08 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -106.45 16.43 24.7 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.933 . . . . 0.0 110.715 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.3 mt-30 -119.95 123.92 44.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 111.09 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -104.54 121.82 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.661 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.429 ' OD1' ' N2 ' ' A' ' 136' ' ' NAG . 55.5 t30 -101.43 107.8 19.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.119 -0.988 . . . . 0.0 111.391 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.837 HD13 HG22 ' A' ' 36' ' ' VAL . 61.6 mt -97.34 131.92 43.56 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.449 -0.782 . . . . 0.0 109.673 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 18' ' ' SER . 59.2 m -124.42 139.2 54.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 0.0 111.034 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.622 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -113.55 129.94 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.728 -0.608 . . . . 0.0 109.618 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 16' ' ' ILE . 35.2 mt-30 -112.54 118.26 34.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.282 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.67 51.37 0.75 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 81' ' ' ILE . 76.6 mt -84.59 129.79 34.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.546 -0.973 . . . . 0.0 111.381 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -112.21 175.48 5.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.06 94.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.875 0.845 . . . . 0.0 109.855 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.2 mmt -66.17 -32.94 74.68 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.191 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.11 -24.91 67.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.44 -0.787 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 115' ' ' ILE . 42.4 m -51.88 137.85 25.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.52 -163.83 34.76 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 15.7 tp -94.77 129.94 41.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.886 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CD2' HD12 ' A' ' 115' ' ' ILE . 78.5 m-85 -113.44 136.35 52.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -104.16 133.05 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.429 -0.795 . . . . 0.0 112.117 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.822 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.6 p -97.49 122.34 40.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.907 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.7 mttt -119.1 143.86 46.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.363 -0.836 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' CD1' ' A' ' 106' ' ' LEU . 11.1 t -136.51 111.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.889 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -132.39 130.22 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.34 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 31.7 mt -86.94 82.84 7.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.798 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 3.4 ttm -82.67 -45.92 13.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.904 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 91.0 m-85 -69.71 -42.89 20.17 Favored Pre-proline 0 N--CA 1.508 2.456 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HG3' ' HB1' ' A' ' 29' ' ' ALA . 60.7 Cg_endo -82.36 143.09 12.25 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.734 -1.295 . . . . 0.0 108.734 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.431 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 53.1 Cg_endo -92.88 173.04 2.04 Favored 'Trans proline' 1 CA--C 1.658 6.72 0 CA-C-O 113.417 -2.826 . . . . 0.0 107.536 177.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 88.5 Cg_endo -92.18 49.39 1.24 Allowed 'Cis proline' 2 C--N 1.503 8.698 1 C-N-CA 91.326 -14.864 . . . . 0.0 115.228 -14.585 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 2.3 t80 55.82 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 118.692 -2.505 . . . . 0.0 111.692 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -147.19 105.74 3.8 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 119.617 -1.927 . . . . 0.0 108.777 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.731 ' CD1' HG12 ' A' ' 96' ' ' VAL . 1.7 mt -159.3 -157.97 0.63 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.829 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -151.22 -167.61 14.94 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.907 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.258 46.6 mm -134.93 169.39 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.561 -0.964 . . . . 0.0 110.5 -178.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.822 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -104.48 139.49 14.61 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 10.8 t-20 -60.26 -36.81 78.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.388 -1.066 . . . . 0.0 110.536 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.81 144.49 5.92 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.691 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -115.5 137.45 52.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.589 ' HB3' HG23 ' A' ' 8' ' ' VAL . 12.8 tt0 -89.92 124.05 34.38 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.371 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.697 HD12 ' CD2' ' A' ' 92' ' ' TYR . 82.7 mt -90.45 129.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.835 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.7 m-30 -100.35 140.0 35.21 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.422 0.63 . . . . 0.0 111.976 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 118' ' ' ILE . 7.2 p -94.0 168.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' N ' HG22 ' A' ' 117' ' ' VAL . 41.0 mm -98.9 119.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 110.844 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -136.11 126.84 16.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.68 159.88 51.81 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 123.122 1.064 . . . . 0.0 110.558 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -109.86 143.85 28.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.299 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.91 -20.17 45.48 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.315 1.166 . . . . 0.0 111.336 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.8 m -129.31 140.06 37.51 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 110.425 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.72 -19.48 36.28 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.224 1.118 . . . . 0.0 110.987 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -149.79 175.12 11.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.354 -0.841 . . . . 0.0 110.519 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.0 p -75.83 163.91 26.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.583 -0.698 . . . . 0.0 110.29 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.27 137.58 58.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.13 -35.91 78.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.632 -0.667 . . . . 0.0 110.28 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -109.74 130.34 22.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 110.203 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.56 159.96 51.07 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.151 1.08 . . . . 0.0 110.311 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.599 -0.688 . . . . 0.0 110.243 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.408 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.787 ' H82' ' O4 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.787 ' O4 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 136' ' ' NAG . . . . . 0.877 ' H83' HG23 ' A' ' 20' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' NAG . . . . . 0.436 ' N2 ' ' H3 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' FUC . . . . . 0.853 ' H63' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.218 0.532 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp 52.98 38.59 27.57 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.379 -0.825 . . . . 0.0 110.637 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -110.1 130.14 55.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.694 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.2 132.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 110.001 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.41 54.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.632 -0.668 . . . . 0.0 109.722 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 1.079 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 96.3 mm-40 -137.34 148.02 60.35 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.785 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.0 152.83 68.22 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.429 1.226 . . . . 0.0 109.146 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.98 -12.17 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 110.792 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' HE2' ' A' ' 116' ' ' TYR . 2.3 p -139.95 137.62 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.67 ' CG2' HG21 ' A' ' 113' ' ' THR . 8.9 t -137.85 145.66 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.127 -1.608 . . . . 0.0 110.846 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 116' ' ' TYR . 70.8 mt -114.84 148.31 38.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.465 -0.772 . . . . 0.0 110.539 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.88 -171.5 1.84 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.513 -0.742 . . . . 0.0 110.413 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 t -123.84 172.87 8.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -60.79 -39.13 87.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.469 -0.769 . . . . 0.0 109.744 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' CB ' HD13 ' A' ' 16' ' ' ILE . 22.4 mmt85 -60.51 -28.04 68.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.0 109.854 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 27.14 8.25 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' CB ' ' A' ' 14' ' ' ARG . 1.3 mp -97.73 99.89 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.3 126.11 51.74 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -133.83 149.55 51.39 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.092 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.11 163.94 39.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 68.9 t -119.91 124.04 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.033 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.079 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.3 t -102.78 107.91 18.94 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -86.96 141.55 28.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 112.358 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -127.38 174.72 8.76 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.34 131.87 21.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.843 . . . . 0.0 111.483 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 106' ' ' LEU . 6.4 t -164.64 153.05 10.89 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.676 -0.64 . . . . 0.0 110.555 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.86 149.86 48.47 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.654 1.344 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.85 -179.19 5.34 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -132.83 151.06 52.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.71 -0.876 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.07 48.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.599 -0.688 . . . . 0.0 109.615 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 54' ' ' MET . 57.9 p -79.81 -39.06 31.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.335 -0.853 . . . . 0.0 110.649 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 38.0 mm-40 -79.76 76.72 6.42 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.447 -175.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 34' ' ' VAL . 91.3 t -94.25 82.03 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HE ' ' HE3' ' A' ' 99' ' ' MET . 18.7 ttp85 -59.5 121.53 11.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.821 -0.549 . . . . 0.0 110.955 -178.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -125.35 139.86 50.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.571 0.7 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 72.1 m -135.22 133.06 38.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.033 -0.417 . . . . 0.0 109.982 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 79' ' ' LEU . 95.4 t -105.11 132.35 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.544 -0.723 . . . . 0.0 109.123 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.751 HD12 ' HE3' ' A' ' 95' ' ' LYS . 83.1 mt -126.41 168.01 14.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.128 -0.982 . . . . 0.0 111.176 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -129.61 128.54 42.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -109.86 132.05 54.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.322 -0.861 . . . . 0.0 111.397 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.36 178.76 5.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.932 -0.48 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.33 -40.12 89.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.0 111.514 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.4 m -118.37 -19.96 8.68 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 112.112 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' C ' HG23 ' A' ' 44' ' ' VAL . 83.9 mm-40 -131.79 179.29 6.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.14 -0.975 . . . . 0.0 112.142 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.464 HG23 ' C ' ' A' ' 43' ' ' GLN . 84.5 t -149.88 143.52 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.81 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -138.72 156.13 47.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.455 -0.778 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 68.6 mt-10 -80.16 147.57 31.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 111.54 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.1 t -102.89 -73.92 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.952 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 14.5 p -159.92 164.65 33.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 110.133 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -169.39 161.01 9.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.205 -0.934 . . . . 0.0 111.603 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . . . -172.0 157.68 4.47 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -84.58 119.82 25.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.681 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 71' ' ' THR . 44.2 t80 -79.96 99.52 7.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.682 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 mmt -71.78 138.11 48.14 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 8.8 tpp -68.03 -19.99 64.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.73 -21.12 8.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.94 161.3 28.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -1.151 . . . . 0.0 110.701 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -121.75 124.39 44.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.408 -0.808 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 51' ' ' THR . 69.3 mt -93.16 166.14 12.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 p -119.75 135.04 55.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.784 -0.572 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.952 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 5.3 m-30 -67.2 136.71 55.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.4 tt -68.97 -42.06 77.1 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -118.25 -172.12 2.2 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.915 -1.115 . . . . 0.0 112.615 -177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 56.18 56.77 5.55 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.444 0.64 . . . . 0.0 110.88 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.1 m 52.09 26.64 3.95 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.551 -0.718 . . . . 0.0 110.705 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt 53.98 76.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.503 -0.748 . . . . 0.0 110.762 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.524 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -64.74 149.98 48.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.29 -0.882 . . . . 0.0 108.735 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -119.11 143.57 47.1 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.57 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -130.17 140.91 12.13 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 61.4 m -116.1 160.9 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.856 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 46.4 t -143.75 109.8 5.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.75 -0.594 . . . . 0.0 110.487 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -151.77 140.63 20.98 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.517 -0.74 . . . . 0.0 110.319 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.81 99.67 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.21 21.23 6.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.621 -0.929 . . . . 0.0 110.354 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -124.65 125.68 44.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.584 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -102.7 124.11 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.174 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 47.7 t-20 -102.41 115.95 31.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.0 111.15 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 36' ' ' VAL . 84.2 mt -100.61 137.95 38.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.509 -0.745 . . . . 0.0 109.586 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 m -127.72 131.97 49.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.826 . . . . 0.0 110.78 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -110.68 138.3 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 109.872 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 62.6 mt-30 -124.02 122.15 37.14 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.093 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.54 2.83 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 76.0 mt -87.14 129.93 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.499 -1.001 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -102.6 177.19 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.863 0.839 . . . . 0.0 109.747 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -67.61 -29.96 69.42 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.353 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -66.4 -16.49 64.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 111.451 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 115' ' ' ILE . 23.0 m -49.8 150.03 2.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 110.415 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.09 -168.62 32.48 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 9.4 tp -88.91 130.11 35.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.716 -0.873 . . . . 0.0 112.691 -178.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 115' ' ' ILE . 67.7 m-85 -118.5 140.84 49.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.5 mp -98.14 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.412 -0.805 . . . . 0.0 111.903 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.896 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 18.7 p -109.02 116.4 31.91 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.751 ' HE3' HD12 ' A' ' 37' ' ' LEU . 15.5 mttt -111.61 142.7 43.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.018 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.622 HG12 ' CD2' ' A' ' 106' ' ' LEU . 8.2 t -142.17 105.62 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -128.76 125.27 37.52 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.948 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.727 ' HG ' HD22 ' A' ' 106' ' ' LEU . 52.7 mt -81.65 76.35 8.57 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.437 ' HE3' ' HE ' ' A' ' 33' ' ' ARG . 5.8 ttm -80.89 -52.48 7.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.5 m-85 -62.46 -41.83 76.11 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.091 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 55.9 Cg_endo -85.71 113.79 1.37 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 120.831 1.021 . . . . 0.0 111.233 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 71.7 Cg_endo -90.72 150.99 4.14 Favored 'Trans proline' 1 CA--C 1.688 8.215 0 C-N-CA 123.042 2.495 . . . . 0.0 108.671 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.302 69.7 Cg_endo -83.56 176.09 34.75 Favored 'Cis proline' 2 C--N 1.469 6.892 1 C-N-CA 95.565 -13.098 . . . . 0.0 118.149 -8.53 . . . . . . . . 5 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.17 127.26 32.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.182 -1.574 . . . . 0.0 109.687 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -148.48 87.61 1.59 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.93 -1.106 . . . . 0.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.727 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.2 tp -155.0 -145.95 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.256 -0.903 . . . . 0.0 110.767 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.37 -172.45 31.86 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.586 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.544 HG22 ' C8 ' ' A' ' 132' ' ' NAG . 84.5 mt -126.87 160.31 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.76 -0.847 . . . . 0.0 110.492 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.896 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.9 130.09 10.11 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.116 -2.393 . . . . 0.0 107.116 177.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HA ' ' H82' ' A' ' 132' ' ' NAG . 3.6 m120 -59.61 -32.39 70.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.324 -1.103 . . . . 0.0 111.051 -178.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 135.14 151.54 6.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.934 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.67 HG21 ' CG2' ' A' ' 9' ' ' VAL . 65.5 m -124.76 149.81 46.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.423 ' HG2' ' CE1' ' A' ' 116' ' ' TYR . 58.2 tt0 -97.13 119.83 36.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.446 -1.301 . . . . 0.0 110.004 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 92' ' ' TYR . 96.0 mt -81.28 140.1 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.685 ' HB2' HD23 ' A' ' 10' ' ' LEU . 48.4 m-85 -120.92 152.58 38.32 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.318 0.58 . . . . 0.0 112.236 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 118' ' ' ILE . 7.1 p -86.15 168.67 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 10' ' ' LEU . 39.9 mm -96.71 114.29 33.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.34 -0.85 . . . . 0.0 110.891 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -140.05 124.01 10.75 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.831 -0.543 . . . . 0.0 109.766 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.99 158.19 57.49 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.095 1.05 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -99.43 120.05 58.77 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.535 -0.728 . . . . 0.0 110.025 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.9 -19.87 34.89 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.126 1.066 . . . . 0.0 111.184 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 125' ' ' ASP . 42.3 t -111.26 119.95 44.21 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 0.0 110.59 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.64 -12.3 32.83 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.118 1.062 . . . . 0.0 111.086 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.774 ' O ' ' SG ' ' A' ' 123' ' ' CYS . 55.8 p-10 -145.33 -171.06 3.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.2 p -70.14 166.37 20.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.57 -0.706 . . . . 0.0 110.136 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -140.01 159.97 40.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.7 . . . . 0.0 110.325 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -64.63 -34.28 77.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 110.371 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -77.82 130.32 73.61 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.506 -0.747 . . . . 0.0 110.205 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.08 159.97 51.28 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.158 1.083 . . . . 0.0 110.464 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 0.0 110.114 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 132' ' ' NAG . . . . . 0.544 ' C8 ' HG22 ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' NAG . . . . . 0.685 ' H82' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' FUL . . . . . 0.685 ' O2 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 3' ' ' VAL . 69.1 m-70 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.542 0.687 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -149.6 118.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -106.81 128.45 54.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.568 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -149.83 143.64 16.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.85 136.24 32.26 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.323 1.17 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.63 69.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.929 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -144.83 165.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.755 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HB ' HD13 ' A' ' 115' ' ' ILE . 8.3 t -139.33 130.56 33.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 121.753 0.787 . . . . 0.0 111.181 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 10' ' ' LEU . 3.6 mm? -87.59 129.9 34.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 117' ' ' VAL . . . -106.41 154.77 20.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.815 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.0 m -75.2 172.47 12.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.727 -0.608 . . . . 0.0 109.732 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 m -59.79 -40.08 87.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.01 -29.58 69.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.486 -0.759 . . . . 0.0 110.029 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.405 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 109.03 41.49 1.41 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.5 mp -100.5 102.11 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.672 -0.899 . . . . 0.0 108.85 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -108.75 114.16 27.72 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.87 ' OG ' HG23 ' A' ' 80' ' ' THR . 52.8 m -130.8 131.72 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.554 0.692 . . . . 0.0 110.886 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' HG21 ' A' ' 9' ' ' VAL . 38.5 p90 -150.07 163.97 36.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.781 -0.574 . . . . 0.0 109.476 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.6 t -123.45 122.36 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.692 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -103.84 108.5 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 15.2 pt-20 -81.66 162.57 22.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.19 -0.944 . . . . 0.0 110.867 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.2 p90 -140.13 176.36 8.82 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 130.85 45.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.795 -0.566 . . . . 0.0 110.409 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.5 p -132.77 155.94 80.62 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.558 -0.714 . . . . 0.0 110.081 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.15 -16.89 45.21 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.391 1.206 . . . . 0.0 111.216 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -171.99 37.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -100.63 137.3 39.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.598 -0.942 . . . . 0.0 110.127 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.96 170.67 15.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.537 -0.727 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.076 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -81.15 -8.64 59.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.583 -0.698 . . . . 0.0 112.494 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 51' ' ' THR . 18.6 mm-40 -129.46 108.26 10.13 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.944 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 78.0 t -125.89 80.45 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.76 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 67.8 ttt180 -59.97 124.59 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 111.427 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -114.73 153.98 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 95' ' ' LYS . 20.3 m -144.0 141.41 30.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 79' ' ' LEU . 85.6 t -116.86 124.07 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.6 mt -120.07 153.36 36.2 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.518 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 47' ' ' VAL . 69.0 mtm180 -111.28 123.96 51.26 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.0 tt0 -96.25 139.99 31.6 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.853 0.835 . . . . 0.0 110.937 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -134.04 156.98 47.27 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.83 -43.86 94.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.4 m -70.0 -47.28 62.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.648 -0.657 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.777 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.2 tt0 -165.15 169.48 16.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 111.241 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.3 t -116.73 140.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -130.03 160.58 33.25 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.326 -0.859 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.822 ' HA ' HD23 ' A' ' 37' ' ' LEU . 96.9 mt-10 -80.03 154.85 27.9 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.9 HG21 ' HG3' ' A' ' 38' ' ' ARG . 45.8 t -130.89 -83.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.705 -0.622 . . . . 0.0 111.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.655 ' SG ' HG12 ' A' ' 47' ' ' VAL . 83.2 m -110.14 149.45 30.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.076 -1.015 . . . . 0.0 110.925 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.04 141.41 15.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.538 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 58' ' ' LEU . . . -165.79 163.35 18.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 109.842 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 31' ' ' GLU . 5.5 m -97.45 116.31 29.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.703 ' CZ ' ' SD ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -72.9 91.94 1.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 1.076 ' SD ' ' O ' ' A' ' 30' ' ' THR . 35.8 mmm -85.0 129.96 34.7 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.703 ' SD ' ' CZ ' ' A' ' 52' ' ' TYR . 18.0 mmt -59.43 -27.98 66.54 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.618 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.66 43.41 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 53' ' ' MET . 11.2 t30 -149.8 -179.99 7.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.0 -1.294 . . . . 0.0 110.846 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.61 156.39 19.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.656 -0.653 . . . . 0.0 110.65 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 50' ' ' ALA . 80.4 mt -70.28 139.93 52.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.972 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 p -104.55 118.33 36.32 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.718 . . . . 0.0 110.102 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.87 37.85 2.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.472 -0.768 . . . . 0.0 110.307 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.436 -0.79 . . . . 0.0 110.662 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -85.7 127.12 34.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.355 -0.841 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 52.24 47.52 24.56 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.318 -0.864 . . . . 0.0 109.932 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -57.53 -106.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.983 -0.448 . . . . 0.0 110.823 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.8 mt 52.04 22.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.342 -1.473 . . . . 0.0 110.534 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.05 158.21 24.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.988 . . . . 0.0 110.339 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.712 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.0 t -132.75 139.95 47.83 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.82 154.12 25.09 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.411 -1.376 . . . . 0.0 111.066 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 72' ' ' SER . 94.2 m -130.04 163.51 26.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 32.8 t -143.39 130.02 20.24 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.773 -0.58 . . . . 0.0 109.961 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -142.42 133.85 26.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -0.783 . . . . 0.0 109.744 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.5 -123.99 27.54 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -105.9 16.43 25.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.674 -0.897 . . . . 0.0 110.441 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.87 123.94 44.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 111.013 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.0 m -99.49 130.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -107.97 118.38 36.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 111.459 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD13 ' CG2' ' A' ' 36' ' ' VAL . 74.0 mt -108.95 132.05 54.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.87 HG23 ' OG ' ' A' ' 18' ' ' SER . 86.6 m -121.14 132.2 54.71 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 0.0 110.173 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.789 HG21 HD21 ' A' ' 84' ' ' LEU . 94.9 mt -116.38 130.16 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.642 -0.661 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.5 mt-30 -124.54 120.86 33.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.648 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.28 48.68 0.69 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 81' ' ' ILE . 81.2 mt -96.0 108.41 20.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.488 -1.007 . . . . 0.0 111.308 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -82.85 -176.62 6.4 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.21 92.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.8 -38.84 83.85 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.117 0.484 . . . . 0.0 111.103 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -60.0 -35.39 74.95 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.544 -0.723 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 115' ' ' ILE . 35.7 m -51.46 135.96 26.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.97 -144.03 7.83 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.908 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 92' ' ' TYR . 2.1 tm? -106.62 139.42 41.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.779 -0.836 . . . . 0.0 110.816 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.868 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -124.53 125.3 43.97 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.741 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -97.94 120.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.365 -0.834 . . . . 0.0 111.949 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 30.8 p -84.15 122.4 28.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.757 ' HD2' HD12 ' A' ' 109' ' ' ILE . 10.5 mtmt -113.9 150.59 33.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.304 -0.873 . . . . 0.0 109.986 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.704 HG11 ' CG ' ' A' ' 23' ' ' TYR . 24.6 t -141.39 103.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.03 117.34 18.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.759 HD13 HD23 ' A' ' 106' ' ' LEU . 8.7 mp -75.6 75.35 2.61 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.76 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 22.9 ttm -78.39 -38.31 42.04 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.932 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.429 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 92.8 m-85 -67.51 -44.96 46.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 55.7 Cg_endo -80.8 137.18 11.06 Favored 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 120.463 0.776 . . . . 0.0 110.469 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 73.6 Cg_endo -89.98 143.81 4.17 Favored 'Trans proline' 2 CA--C 1.708 9.188 0 CA-C-O 112.032 -3.403 . . . . 0.0 110.923 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.305 51.0 Cg_endo -114.41 64.67 0.26 Allowed 'Cis proline' 2 C--N 1.443 5.526 1 C-N-CA 93.233 -14.07 . . . . 0.0 113.31 5.111 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' PRO . 4.3 t80 48.14 111.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.092 -2.255 . . . . 0.0 111.8 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.467 ' O ' HD22 ' A' ' 106' ' ' LEU . 28.9 t80 -160.64 107.99 1.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.83 1.3 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.45 -142.83 0.11 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.562 -179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.99 167.41 32.23 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.0 mm -119.82 157.15 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.946 -0.737 . . . . 0.0 109.082 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.701 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -86.32 141.55 18.3 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.01 -36.24 76.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.995 . . . . 0.0 110.11 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.797 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 129.64 143.14 5.4 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.866 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 98.1 m -111.42 131.94 54.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.833 ' HB3' HG23 ' A' ' 8' ' ' VAL . 32.8 tp60 -79.97 131.88 35.91 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.925 HD13 ' HB ' ' A' ' 9' ' ' VAL . 22.1 mm -99.74 121.17 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.135 . . . . 0.0 108.61 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.929 ' CE2' HG21 ' A' ' 8' ' ' VAL . 13.2 m-30 -101.37 147.15 26.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.794 -0.566 . . . . 0.0 110.555 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 11' ' ' ALA . 86.4 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.89 0.852 . . . . 0.0 110.008 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 72.7 m80 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 121.269 0.557 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 2' ' ' HIS . 67.1 t -150.15 132.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.66 -0.65 . . . . 0.0 109.279 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -108.02 130.69 55.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.405 -0.809 . . . . 0.0 110.319 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.43 124.99 21.46 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 111.07 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.63 139.87 31.75 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 N-CA-C 109.053 -1.172 . . . . 0.0 109.053 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.16 64.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.33 162.86 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.445 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 19' ' ' PHE . 10.7 t -139.68 155.92 25.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 116' ' ' TYR . 92.4 mt -114.32 131.9 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.605 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.08 -163.82 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -128.87 -178.8 4.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.518 -0.739 . . . . 0.0 110.566 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.31 -39.53 87.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.567 ' HG3' HD11 ' A' ' 16' ' ' ILE . 21.6 tpp180 -59.15 -21.48 59.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.729 -0.607 . . . . 0.0 109.656 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.606 ' C ' HD13 ' A' ' 16' ' ' ILE . . . 83.64 35.03 17.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' GLY . 5.1 mm -114.69 109.91 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.503 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -104.55 127.35 52.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.755 -0.591 . . . . 0.0 110.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.696 ' HB2' HG23 ' A' ' 80' ' ' THR . 34.1 t -127.07 129.96 49.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.7 p90 -138.08 160.16 40.11 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 77' ' ' VAL . 61.5 t -125.67 123.32 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.297 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -105.52 109.94 22.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.6 pt-20 -82.77 149.49 27.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 111.419 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CD2' HG21 ' A' ' 96' ' ' VAL . 7.6 p90 -131.89 164.0 27.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -131.32 133.4 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.399 -0.813 . . . . 0.0 111.19 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -139.9 150.46 62.57 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.648 -0.658 . . . . 0.0 110.717 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.77 -10.09 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.688 1.362 . . . . 0.0 111.852 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.48 -178.77 22.12 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.383 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -121.87 150.06 42.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.676 -0.896 . . . . 0.0 110.599 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.51 162.63 39.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.604 -0.685 . . . . 0.0 109.795 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 71.0 p -80.25 -46.09 16.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.46 -0.775 . . . . 0.0 110.647 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 51' ' ' THR . 5.7 mm-40 -80.26 112.04 17.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.999 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.23 95.75 3.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.845 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 68.9 ttt180 -75.78 115.3 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.431 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.5 m -118.78 138.91 47.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 85.2 m -129.6 143.73 50.96 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.474 0.654 . . . . 0.0 110.338 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.935 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -114.32 139.48 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' A' ' 46' ' ' GLU . 9.5 mt -130.22 172.33 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.049 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HG3' ' CG2' ' A' ' 47' ' ' VAL . 91.5 mtt180 -126.72 123.6 37.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' HG3' HD11 ' A' ' 93' ' ' ILE . 24.7 mt-30 -106.32 132.01 52.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.939 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -104.87 -172.31 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 -43.6 96.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 110.791 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.0 p -132.06 0.06 3.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.331 -0.855 . . . . 0.0 111.878 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.624 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 74.9 mt-30 -137.3 154.98 49.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.031 -1.043 . . . . 0.0 110.816 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.21 145.16 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.9 p -129.8 156.06 44.95 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.343 -0.848 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.841 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.8 mp0 -86.34 159.99 19.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 63.9 t -122.25 -80.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.822 -0.549 . . . . 0.0 110.194 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 85.9 m -131.66 156.6 45.56 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.979 -1.076 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.03 121.8 3.23 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.462 -0.774 . . . . 0.0 111.275 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -158.29 143.02 16.24 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.4 -0.812 . . . . 0.0 110.196 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.0 m -92.7 119.95 32.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.285 -0.884 . . . . 0.0 108.728 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HE1' ' A' ' 54' ' ' MET . 46.0 p90 -110.06 146.87 34.63 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.967 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 1.05 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -75.99 160.78 29.5 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.459 ' HE1' ' CE1' ' A' ' 52' ' ' TYR . 31.7 mmt -70.66 127.45 32.73 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.893 -1.129 . . . . 0.0 110.131 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.85 27.77 23.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -150.03 175.77 11.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.213 -1.169 . . . . 0.0 111.163 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.31 152.01 48.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.8 -0.562 . . . . 0.0 109.859 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 51' ' ' THR . 96.3 mt -136.42 -171.82 2.99 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.157 0.979 . . . . 0.0 112.136 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.7 p -109.48 159.97 16.61 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 95.0 m-85 -111.35 127.89 55.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.382 -0.824 . . . . 0.0 109.418 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.94 -44.07 94.6 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.587 -0.695 . . . . 0.0 112.344 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -94.88 131.44 40.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.921 . . . . 0.0 109.898 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 67' ' ' ILE . 81.9 m-20 53.05 57.77 5.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m -60.86 64.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.362 0.601 . . . . 0.0 112.098 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 67' ' ' ILE . 67.3 mt -140.98 16.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.419 -0.801 . . . . 0.0 109.134 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.1 m -104.09 130.03 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.059 -1.026 . . . . 0.0 110.593 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.558 HG21 ' NE2' ' A' ' 82' ' ' GLN . 9.5 t -139.94 150.08 44.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.58 -172.04 41.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.277 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 72' ' ' SER . 93.8 m -115.63 167.32 11.02 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.884 -0.774 . . . . 0.0 109.703 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 71' ' ' THR . 97.3 p -145.22 151.26 38.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.786 -0.571 . . . . 0.0 109.632 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -132.03 -175.73 3.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.649 -0.657 . . . . 0.0 109.757 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -52.92 -66.19 2.86 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -111.57 9.53 21.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.425 -1.044 . . . . 0.0 111.699 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.3 tt0 -130.0 129.41 43.69 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.996 -1.065 . . . . 0.0 110.609 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 21' ' ' CYS . 9.2 m -115.18 134.52 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -110.99 112.58 24.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.844 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.935 HD13 ' CG2' ' A' ' 36' ' ' VAL . 95.7 mt -107.31 129.66 54.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 18' ' ' SER . 58.6 m -124.05 136.69 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.249 -0.907 . . . . 0.0 110.777 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.78 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -103.52 137.29 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.675 . . . . 0.0 109.957 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.558 ' NE2' HG21 ' A' ' 69' ' ' THR . 30.7 mt-30 -119.97 120.71 37.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.041 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.03 40.07 1.74 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.78 HD21 HG21 ' A' ' 81' ' ' ILE . 76.3 mt -80.37 137.83 36.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.996 . . . . 0.0 111.445 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -117.03 176.15 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.9 93.04 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.31 -39.07 93.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.738 -0.601 . . . . 0.0 110.748 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.11 -23.94 64.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.566 -0.709 . . . . 0.0 111.195 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 115' ' ' ILE . 25.3 m -52.43 137.77 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 155.96 -164.26 32.2 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.51 HD23 ' NE2' ' A' ' 39' ' ' GLN . 14.6 tp -88.42 126.22 35.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.884 . . . . 0.0 112.733 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 31.5 m-85 -106.89 158.13 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -123.7 140.18 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.887 . . . . 0.0 111.723 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.581 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 13.9 p -98.64 133.54 42.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.7 tttt -135.95 123.11 21.65 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 106' ' ' LEU . 2.6 p -132.36 118.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.8 mm-40 -139.58 142.68 37.11 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.273 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 106' ' ' LEU . 6.5 mt -90.44 81.87 5.95 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.845 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 2.8 ttm -80.13 -48.99 12.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.264 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.46 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 80.6 m-85 -70.87 -41.92 12.23 Favored Pre-proline 0 N--CA 1.508 2.467 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.4 Cg_endo -86.58 119.82 1.69 Allowed 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.558 1.505 . . . . 0.0 109.34 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 65.5 Cg_endo -84.77 161.71 12.18 Favored 'Trans proline' 2 CA--C 1.685 8.042 0 CA-C-O 113.188 -2.921 . . . . 0.0 106.18 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 38.6 Cg_endo -86.45 174.8 30.84 Favored 'Cis proline' 1 C--N 1.423 4.468 1 C-N-CA 98.673 -11.803 . . . . 0.0 114.9 -11.624 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' GLU 0.313 3.0 t80 -80.16 133.0 36.02 Favored 'General case' 0 N--CA 1.529 3.513 0 O-C-N 118.319 -2.738 . . . . 0.0 115.727 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 14.0 p90 -162.47 107.7 1.19 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.149 -1.595 . . . . 0.0 111.695 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 96' ' ' VAL . 2.3 tp -157.59 -147.11 0.17 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.623 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.548 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -160.66 169.57 36.41 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 118.689 -1.719 . . . . 0.0 112.102 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.4 mp -117.16 159.76 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.537 -0.978 . . . . 0.0 109.576 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -103.39 143.57 15.78 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -59.92 -39.71 86.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -1.089 . . . . 0.0 110.188 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 137.01 158.67 8.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.257 -1.449 . . . . 0.0 113.004 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.627 HG21 HG23 ' A' ' 9' ' ' VAL . 85.1 m -125.77 139.96 53.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.858 ' HB3' HG23 ' A' ' 8' ' ' VAL . 27.5 tt0 -85.24 142.36 29.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.162 -1.415 . . . . 0.0 108.251 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 76.4 mt -109.18 130.03 62.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 8' ' ' VAL . 15.1 m-30 -110.87 150.35 29.3 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.914 -0.491 . . . . 0.0 110.391 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 75.6 m80 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.47 0.652 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.601 HG11 ' CA ' ' A' ' 110' ' ' GLY . 66.6 t -142.22 132.6 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -123.95 134.43 53.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.318 -0.864 . . . . 0.0 111.165 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.133 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 65.5 mt-30 -146.81 147.95 31.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.653 -0.655 . . . . 0.0 110.697 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.02 140.7 42.33 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.438 1.23 . . . . 0.0 109.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.18 71.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.978 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -155.49 161.41 2.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.35 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.5 t -137.94 156.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.529 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' A' ' 116' ' ' TYR . 84.8 mt -122.79 124.23 42.85 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.07 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 141.3 38.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.509 -0.744 . . . . 0.0 109.32 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -80.3 -59.78 2.57 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.221 -0.924 . . . . 0.0 111.884 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 16' ' ' ILE . 15.2 t -152.32 165.93 33.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.535 -0.728 . . . . 0.0 109.462 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.875 ' HG2' HD11 ' A' ' 16' ' ' ILE . 6.3 ttt180 57.67 19.51 5.56 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.544 -0.722 . . . . 0.0 110.733 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' HD12 ' A' ' 84' ' ' LEU . . . 56.65 44.31 91.18 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.875 HD11 ' HG2' ' A' ' 14' ' ' ARG . 29.1 mm -106.78 104.66 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.75 120.67 42.89 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.335 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.613 ' OG ' HG23 ' A' ' 80' ' ' THR . 13.7 m -116.28 121.93 43.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.763 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.5 p90 -132.03 163.96 27.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.683 . . . . 0.0 110.392 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 78' ' ' ASN . 36.3 t -122.03 130.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.171 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.081 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 48.7 t -117.9 131.92 56.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.4 tt0 -102.53 136.36 42.5 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 111.821 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.78 ' CG ' HG11 ' A' ' 96' ' ' VAL . 40.2 p90 -127.3 179.53 5.41 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' HD21 ' A' ' 106' ' ' LEU . . . -132.47 127.29 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.719 -0.613 . . . . 0.0 110.477 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.35 149.9 59.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.594 -0.691 . . . . 0.0 109.97 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.81 -16.11 45.33 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.362 1.191 . . . . 0.0 111.446 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.96 -171.92 37.4 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -108.05 130.1 55.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.602 -0.94 . . . . 0.0 109.959 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.62 -178.63 5.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 110.623 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.088 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -79.96 -14.19 58.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 112.266 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.717 ' OE1' HG21 ' A' ' 51' ' ' THR . 3.1 mm-40 -128.82 130.73 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.497 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.0 t -139.68 84.91 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -64.49 115.24 4.96 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.458 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -117.3 147.41 20.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 49' ' ' ALA . 90.7 m -147.12 140.03 25.1 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.339 0.59 . . . . 0.0 111.101 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.882 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -102.66 132.1 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -121.91 170.3 9.94 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.847 -1.158 . . . . 0.0 112.019 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 47' ' ' VAL . 15.6 mmm180 -116.0 115.66 26.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HA ' HG13 ' A' ' 44' ' ' VAL . 7.4 tt0 -103.01 140.02 37.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.206 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.774 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -141.28 155.34 46.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.16 -44.0 92.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.355 -0.841 . . . . 0.0 110.263 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.0 m -70.1 -44.04 69.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.656 -0.652 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.774 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 12.4 tp60 -162.65 161.33 26.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 111.078 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 39' ' ' GLN . 62.1 t -118.25 141.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 160.31 33.99 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.161 -0.962 . . . . 0.0 111.885 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.922 ' HA ' HD23 ' A' ' 37' ' ' LEU . 80.4 mt-10 -87.97 158.53 18.63 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.702 -0.624 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 38' ' ' ARG . 94.0 t -139.17 -83.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.609 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 1.118 ' SG ' ' N ' ' A' ' 68' ' ' CYS . 83.4 m -105.21 149.52 25.88 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.085 -1.01 . . . . 0.0 111.792 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -163.94 145.34 8.87 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB2' ' CD1' ' A' ' 60' ' ' PHE . . . -171.79 158.0 4.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.717 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -97.62 109.92 22.59 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.327 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.633 ' CD1' HD21 ' A' ' 58' ' ' LEU . 29.1 t80 -68.97 123.99 22.52 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 1.088 ' SD ' ' O ' ' A' ' 30' ' ' THR . 40.0 mmm -111.92 39.23 2.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.414 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 16.4 mmt 59.9 35.57 21.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.58 174.66 28.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.03 -18.93 45.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.597 -0.943 . . . . 0.0 112.126 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.95 124.65 28.27 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.312 0.577 . . . . 0.0 112.027 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' A' ' 52' ' ' TYR . 75.7 mt -131.9 151.82 51.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.589 -0.695 . . . . 0.0 109.139 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 p -87.12 95.63 10.02 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.967 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 67' ' ' ILE . 20.6 m-85 -115.06 99.54 7.52 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.441 ' N ' HG13 ' A' ' 67' ' ' ILE . 96.0 mt -135.01 -0.13 2.81 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.63 -1.294 . . . . 0.0 114.155 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 56.6 t0 -110.65 130.17 55.64 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.51 -1.369 . . . . 0.0 112.872 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 53.12 44.28 30.53 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.761 -1.212 . . . . 0.0 111.333 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 5.8 t 72.15 -42.25 0.53 Allowed 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.417 -0.802 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.966 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 25.8 mm 61.13 168.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.874 -1.142 . . . . 0.0 110.592 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.118 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 4.1 m -110.25 -179.74 3.86 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -130.22 149.79 51.76 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.3 -172.66 40.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.97 -1.586 . . . . 0.0 111.369 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 72' ' ' SER . 59.7 m -131.85 168.88 17.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 122.157 -0.614 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 71' ' ' THR . 19.0 t -140.24 129.83 24.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -130.99 131.99 44.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.55 -123.78 24.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 78.7 m-20 -99.75 11.53 38.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.769 -0.842 . . . . 0.0 110.919 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -114.34 131.92 56.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 21' ' ' CYS . 11.4 m -111.52 118.2 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.614 ' CG ' HG22 ' A' ' 20' ' ' VAL . 4.1 m120 -89.9 114.21 25.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.545 -0.722 . . . . 0.0 110.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 36' ' ' VAL . 69.7 mt -114.24 124.32 51.74 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.613 HG23 ' OG ' ' A' ' 18' ' ' SER . 88.1 m -115.31 132.41 56.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.34 -0.85 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -107.06 135.78 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.294 -0.879 . . . . 0.0 110.17 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.849 ' HG2' HD12 ' A' ' 16' ' ' ILE . 82.9 mt-30 -119.97 120.32 36.01 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.204 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.02 51.74 0.72 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 81' ' ' ILE . 80.7 mt -92.32 113.53 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.682 -0.893 . . . . 0.0 111.439 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' HB2' ' HG2' ' A' ' 87' ' ' MET . 71.9 mmt-85 -81.32 166.16 20.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.02 -28.48 57.51 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.215 -0.928 . . . . 0.0 109.066 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 22.2 ptm -69.91 -36.07 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.507 0.67 . . . . 0.0 110.005 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.13 -25.74 65.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.799 -0.563 . . . . 0.0 111.397 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.1 m -51.2 132.01 28.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.43 -165.72 31.99 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.457 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 12.9 tp -86.8 130.07 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.705 -0.879 . . . . 0.0 112.798 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 115' ' ' ILE . 59.1 m-85 -111.58 140.09 46.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.704 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.6 mp -110.14 122.95 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.133 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -79.67 120.17 23.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 175.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HE3' HD11 ' A' ' 109' ' ' ILE . 8.0 tttt -103.47 143.97 32.02 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.78 HG11 ' CG ' ' A' ' 23' ' ' TYR . 20.3 t -140.77 106.62 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.768 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG2' ' OH ' ' A' ' 104' ' ' TYR . 59.0 mt-10 -140.17 122.21 15.68 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.908 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.5 mp -72.94 83.7 1.23 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 13.2 mmt -79.28 -50.92 10.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 97.6 m-85 -69.17 -40.3 15.05 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.407 -0.808 . . . . 0.0 112.618 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 14.8 Cg_endo -88.8 119.6 1.06 Allowed 'Trans proline' 0 C--O 1.177 -2.551 0 C-N-CA 122.14 1.893 . . . . 0.0 109.881 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.885 ' CB ' ' HA ' ' A' ' 103' ' ' PRO 0.479 88.9 Cg_endo -100.46 173.7 0.34 Allowed 'Trans proline' 2 C--O 1.08 -7.38 0 CA-C-O 114.3 -2.459 . . . . 0.0 113.482 173.563 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.885 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.408 52.0 Cg_endo -72.69 176.64 39.37 Favored 'Cis proline' 3 N--CA 1.586 6.96 1 C-N-CA 96.736 -12.61 . . . . 0.0 112.6 -5.491 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.422 ' OH ' ' HG2' ' A' ' 97' ' ' GLU . 14.7 t80 -79.55 135.72 36.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 116.327 -3.983 . . . . 0.0 111.352 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.33 30.4 t80 -158.73 91.76 1.08 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.104 0.411 . . . . 0.0 111.464 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -159.35 -157.29 0.57 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.119 -1.432 . . . . 0.0 112.57 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.715 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.5 -177.01 36.82 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.966 -1.112 . . . . 0.0 111.295 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.715 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -121.29 153.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.601 ' CA ' HG11 ' A' ' 3' ' ' VAL . . . -92.99 165.2 27.91 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -62.54 -34.03 76.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -1.094 . . . . 0.0 111.694 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.54 160.57 11.52 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.688 -1.244 . . . . 0.0 111.921 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.563 HG21 HG23 ' A' ' 9' ' ' VAL . 60.6 m -120.04 145.04 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.978 ' HB3' HG23 ' A' ' 8' ' ' VAL . 30.5 tt0 -88.98 145.56 25.43 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.612 -1.235 . . . . 0.0 107.954 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 92' ' ' TYR . 45.6 mt -117.99 131.31 71.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.87 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -113.93 155.97 24.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.83 -0.544 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.826 0.822 . . . . 0.0 110.047 178.631 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.5 m170 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.288 0.566 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.738 HG11 ' HA2' ' A' ' 110' ' ' GLY . 83.8 t -80.13 137.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.745 -0.597 . . . . 0.0 109.895 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -122.12 135.69 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.538 -0.726 . . . . 0.0 110.72 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 41.5 mt-30 -148.51 150.07 32.95 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.526 -0.734 . . . . 0.0 111.694 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 113' ' ' THR . 41.7 Cg_endo -71.02 139.97 37.0 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.284 -1.468 . . . . 0.0 108.284 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.21 -27.5 67.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.497 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.926 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -152.34 171.99 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 118.491 -1.284 . . . . 0.0 110.983 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -149.85 155.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.567 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -112.12 131.95 55.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.05 135.93 39.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.529 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -69.88 173.46 6.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.688 -0.632 . . . . 0.0 110.256 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.4 p -60.32 -30.53 69.57 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.555 -0.715 . . . . 0.0 109.992 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.69 ' CG ' HD13 ' A' ' 16' ' ' ILE . 7.7 tpm_? -60.07 -30.13 69.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 0.0 109.926 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.648 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.68 26.01 8.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.69 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -109.72 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.565 -0.962 . . . . 0.0 110.507 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -110.41 128.88 55.8 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.7 t -126.59 134.83 50.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 111.728 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -140.07 163.99 31.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 93.5 t -124.92 124.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.468 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 77' ' ' VAL . 51.2 t -100.81 117.12 34.26 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.0 tt0 -90.75 137.56 32.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 111.282 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.695 ' HB3' HG11 ' A' ' 96' ' ' VAL . 31.8 p90 -131.29 180.0 5.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.85 123.57 18.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.707 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 98' ' ' LEU . 92.8 p -134.53 143.39 46.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.558 -0.714 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.13 144.24 29.59 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.296 1.156 . . . . 0.0 110.742 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.87 30.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 150.05 51.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.881 . . . . 0.0 109.92 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.77 154.75 37.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 110.41 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.5 p -92.62 10.46 30.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.603 -0.685 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' OE1' HG21 ' A' ' 51' ' ' THR . 13.1 mm-40 -132.19 84.92 2.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.279 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 34' ' ' VAL . 11.8 m -103.35 89.13 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 19.6 tpt85 -53.72 102.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.3 m -110.17 131.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.86 0.838 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 99.9 m -135.56 148.15 49.0 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.828 ' CG2' HD13 ' A' ' 79' ' ' LEU . 95.9 t -116.08 133.83 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.8 mt -121.35 170.18 9.87 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.231 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.2 ttt180 -123.21 119.91 31.6 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.607 ' HA ' HG22 ' A' ' 44' ' ' VAL . 14.2 tt0 -97.15 148.56 22.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 110.166 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.43 -175.66 3.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.848 -0.533 . . . . 0.0 110.055 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.74 -40.47 88.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.67 -0.643 . . . . 0.0 111.385 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.0 m -126.8 -21.55 4.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.19 -0.944 . . . . 0.0 112.57 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 98.1 mt-30 -131.96 163.98 27.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.06 -1.025 . . . . 0.0 111.775 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 39' ' ' GLN . 61.0 t -134.84 143.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.2 p -129.99 160.18 34.44 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.842 ' HA ' HD23 ' A' ' 37' ' ' LEU . 58.2 tt0 -80.15 157.31 26.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 109.876 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.75 -64.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.782 -0.574 . . . . 0.0 110.392 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.3 m -140.1 141.08 36.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.105 -0.997 . . . . 0.0 109.846 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -151.1 135.1 16.64 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.698 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.01 149.57 2.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.564 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -81.17 111.24 17.42 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.06 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.606 ' O ' HG22 ' A' ' 32' ' ' VAL . 23.3 t80 -74.92 112.99 11.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.769 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 2.0 mtp -82.63 161.54 22.17 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 35.6 mmt -61.04 -23.91 65.79 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.659 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.37 41.49 0.75 Allowed Glycine 0 N--CA 1.501 3.027 0 C-N-CA 119.042 -1.551 . . . . 0.0 112.658 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 79.6 m-20 -135.55 160.06 39.67 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 119.067 1.434 . . . . 0.0 110.241 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -89.12 135.63 33.46 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.492 -0.755 . . . . 0.0 110.283 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.677 HD22 ' N ' ' A' ' 58' ' ' LEU . 1.3 mm? -103.04 156.12 17.91 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.492 -0.755 . . . . 0.0 110.086 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 p -102.2 123.15 45.53 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.388 -0.82 . . . . 0.0 111.706 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 42.3 m-85 -114.12 30.5 7.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -53.72 -44.03 69.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.532 -0.73 . . . . 0.0 111.899 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -66.54 145.45 55.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.264 -0.897 . . . . 0.0 110.749 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 52.13 55.58 9.0 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.388 -0.82 . . . . 0.0 110.498 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 60.17 163.87 0.06 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.798 -0.564 . . . . 0.0 109.938 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -99.92 142.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.591 0.71 . . . . 0.0 111.229 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.4 m -121.99 153.77 38.11 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.406 HG21 ' NE2' ' A' ' 82' ' ' GLN . 10.2 t -132.63 150.08 52.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.95 -172.01 43.52 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.41 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 72' ' ' SER . 92.5 m -129.1 168.78 15.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.0 -0.706 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 71' ' ' THR . 70.1 m -159.98 127.39 4.59 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -155.83 155.93 33.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 110.344 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.76 -124.04 25.67 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -109.32 11.05 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.774 -0.839 . . . . 0.0 110.914 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.1 mt-30 -118.46 124.76 48.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 21' ' ' CYS . 4.0 m -107.17 124.01 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.924 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' THR . 46.6 t-20 -101.97 116.21 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.71 . . . . 0.0 111.077 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.828 HD13 ' CG2' ' A' ' 36' ' ' VAL . 96.6 mt -115.98 131.98 56.78 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.297 -0.877 . . . . 0.0 109.164 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.3 m -124.47 147.21 48.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.184 -0.948 . . . . 0.0 111.075 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.635 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -113.53 131.53 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.711 -0.618 . . . . 0.0 110.072 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG2' HG13 ' A' ' 16' ' ' ILE . 10.5 mt-30 -110.22 120.76 43.48 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.667 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.58 0.99 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -85.76 125.55 33.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.656 -0.908 . . . . 0.0 111.082 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -107.44 175.85 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.21 94.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.302 -0.873 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.1 ttm -62.14 -36.06 80.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.756 -0.59 . . . . 0.0 110.169 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -66.97 -26.92 67.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.647 . . . . 0.0 111.143 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.9 m -51.4 132.07 29.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.5 -143.96 8.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.466 HD23 ' NE2' ' A' ' 39' ' ' GLN . 10.6 tp -110.04 131.94 54.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.737 -0.861 . . . . 0.0 111.611 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.876 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.1 m-85 -113.28 132.03 55.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -107.97 129.36 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.728 -0.607 . . . . 0.0 112.144 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.076 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 20.1 p -79.88 161.99 25.27 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.3 tttt -152.34 77.49 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 23' ' ' TYR . 7.4 p -95.1 113.63 29.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 68.2 mt-10 -130.16 129.65 43.72 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.426 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.658 ' CD2' HD22 ' A' ' 106' ' ' LEU . 19.1 mt -76.99 76.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.4 tpp -80.63 -50.15 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.034 -0.667 . . . . 0.0 112.45 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 89.1 m-85 -68.6 -41.21 21.41 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 112.926 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 46.9 Cg_endo -86.25 109.44 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-O 117.875 -0.969 . . . . 0.0 111.098 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.3 Cg_endo -77.39 158.02 32.93 Favored 'Trans proline' 1 CA--C 1.609 4.236 0 CA-C-O 113.892 -2.628 . . . . 0.0 110.001 177.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 56.3 Cg_endo -88.54 -177.68 12.56 Favored 'Cis proline' 1 C--N 1.484 7.662 1 C-N-CA 93.031 -14.154 . . . . 0.0 114.475 -10.125 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 4.6 t80 -88.04 125.51 34.59 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-O 122.76 1.267 . . . . 0.0 109.888 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -149.7 74.42 1.22 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 120.943 -1.098 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.3 tp -142.48 -150.68 0.32 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.352 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.1 -173.04 34.99 Favored Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.902 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.472 HG23 ' O ' ' A' ' 94' ' ' CYS . 71.7 mt -110.96 149.18 13.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.847 -0.796 . . . . 0.0 109.938 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 1.076 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -74.53 144.14 32.47 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.07 -30.34 69.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.398 -1.06 . . . . 0.0 110.283 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.0 140.03 7.08 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.319 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.3 m -113.53 149.97 33.64 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.843 ' HB3' HG23 ' A' ' 8' ' ' VAL . 13.7 tp60 -89.87 137.29 32.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.876 HD12 ' CD1' ' A' ' 92' ' ' TYR . 56.4 mt -109.92 128.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.926 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.3 m-30 -101.95 139.86 37.02 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.646 0.736 . . . . 0.0 111.748 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 C--N 1.304 -1.399 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.287 0.565 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG12 ' OE1' ' A' ' 5' ' ' GLN . 74.8 t -129.69 131.47 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.564 -0.71 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 131.78 56.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.449 -0.782 . . . . 0.0 110.56 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.47 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.7 134.7 18.42 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.649 . . . . 0.0 110.475 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.48 136.57 24.01 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.11 1.058 . . . . 0.0 109.696 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.43 -32.95 64.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.484 -0.76 . . . . 0.0 109.666 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.0 157.35 6.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.992 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.8 t -139.72 153.36 23.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.45 0.643 . . . . 0.0 110.038 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.0 mt -110.83 124.1 51.38 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.71 140.77 46.24 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.496 -0.752 . . . . 0.0 110.724 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -91.61 -168.99 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.598 -0.689 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -49.98 159.04 0.45 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.48 -0.763 . . . . 0.0 110.529 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.817 ' HG3' HD11 ' A' ' 16' ' ' ILE . 40.8 tpt85 62.43 13.27 5.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.556 -0.715 . . . . 0.0 110.655 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.07 46.01 93.17 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' HG2' ' A' ' 82' ' ' GLN . 34.6 mm -104.92 106.7 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.729 -0.865 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.08 123.58 48.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.803 -0.56 . . . . 0.0 109.772 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -130.0 130.95 45.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.663 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.678 ' HB3' HG21 ' A' ' 9' ' ' VAL . 27.2 p90 -142.39 164.06 31.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.807 -0.558 . . . . 0.0 109.724 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 99.5 t -120.66 116.21 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.852 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.8 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -100.12 103.77 15.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 90.1 mt-10 -79.67 165.11 23.21 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 111.933 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.7 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.8 p90 -148.07 178.14 8.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.4 130.34 32.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.689 -0.632 . . . . 0.0 110.009 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -139.95 150.11 61.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.405 -0.809 . . . . 0.0 110.45 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 140.06 33.81 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.44 1.232 . . . . 0.0 110.299 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.65 -145.71 23.28 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -130.11 149.92 51.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.937 . . . . 0.0 110.141 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 147.69 45.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.617 -0.677 . . . . 0.0 109.926 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.142 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 32.8 p -79.97 -59.65 2.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.712 0.767 . . . . 0.0 111.679 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.0 mt-10 -80.99 80.52 7.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG11 ' OH ' ' A' ' 52' ' ' TYR . 97.0 t -88.5 96.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 51' ' ' THR . 55.6 ttt85 -70.53 124.25 23.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.572 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 50' ' ' ALA . 27.3 m -121.1 142.14 38.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 49' ' ' ALA . 88.8 m -135.32 142.35 45.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.726 -0.608 . . . . 0.0 110.625 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.897 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -112.77 131.23 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.0 mt -120.94 173.76 7.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 110.958 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.651 ' O ' HG13 ' A' ' 44' ' ' VAL . 39.5 ttm180 -122.42 121.28 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 44' ' ' VAL . 24.4 tt0 -97.9 148.65 23.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 111.151 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -132.15 168.65 17.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.47 -28.24 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 110.722 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -108.49 -53.14 2.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.474 -0.766 . . . . 0.0 112.153 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.747 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 63.3 mt-30 -136.64 170.01 16.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.12 -0.988 . . . . 0.0 111.997 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 39' ' ' GLN . 62.0 t -122.56 147.96 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -127.65 160.42 31.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.341 -0.849 . . . . 0.0 110.678 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.1 mt-10 -80.4 145.58 31.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 110.651 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -117.18 -75.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.305 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.922 ' SG ' ' HB3' ' A' ' 63' ' ' ASP . 70.2 m -139.83 149.15 43.11 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -153.88 145.48 23.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.488 -0.757 . . . . 0.0 111.294 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -165.28 148.02 8.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.618 -0.677 . . . . 0.0 109.714 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.568 HG21 ' HB3' ' A' ' 31' ' ' GLU . 6.2 m -98.42 130.19 45.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.685 ' OH ' HG11 ' A' ' 32' ' ' VAL . 52.1 p90 -102.09 133.44 46.93 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.521 -1.272 . . . . 0.0 110.631 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.477 ' HE1' ' HG2' ' A' ' 31' ' ' GLU . 6.6 mmt -78.41 168.17 20.21 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.142 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.96 90.03 0.17 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.673 -1.267 . . . . 0.0 109.2 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.39 -117.48 0.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -129.9 137.77 50.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.307 -1.113 . . . . 0.0 110.379 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 58' ' ' LEU . 17.6 tt0 -178.73 138.33 0.16 Allowed 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 70' ' ' GLY . 94.3 mt -142.14 87.72 2.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.435 ' N ' ' HB1' ' A' ' 50' ' ' ALA . 46.1 p -89.58 72.2 7.85 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.425 -0.797 . . . . 0.0 111.384 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.482 ' HE2' HD22 ' A' ' 58' ' ' LEU . 78.4 m-85 -89.89 109.76 20.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.36 -37.3 82.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.425 -0.797 . . . . 0.0 110.48 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -139.98 172.19 13.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.634 -0.666 . . . . 0.0 110.026 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.922 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 84.5 m-20 52.6 49.95 19.24 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -53.91 -21.11 7.1 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.659 -0.651 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.97 -20.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.264 -0.897 . . . . 0.0 110.627 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 30.7 m -86.07 137.78 32.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 110.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 80' ' ' THR . 9.0 t -129.95 131.01 45.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.705 ' CA ' HD23 ' A' ' 79' ' ' LEU . . . -125.63 116.8 2.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.2 m -103.87 159.0 16.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.726 -0.867 . . . . 0.0 108.673 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 63.0 m -148.15 129.97 15.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.969 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 122.04 25.88 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.04 -124.07 34.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.93 16.59 25.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.964 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 35.7 mt-30 -116.46 122.25 44.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.197 -0.939 . . . . 0.0 110.502 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 21' ' ' CYS . 1.9 m -103.74 122.2 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.866 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -104.21 109.96 21.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 0.0 111.462 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.897 HD13 HG22 ' A' ' 36' ' ' VAL . 53.1 mt -98.06 130.02 44.88 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 69' ' ' THR . 93.9 m -123.75 145.44 49.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.0 110.41 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 84' ' ' LEU . 95.5 mt -119.91 135.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.83 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.851 ' HG2' HD12 ' A' ' 16' ' ' ILE . 76.5 mt-30 -120.02 120.31 35.94 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.927 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.66 40.5 1.1 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 81' ' ' ILE . 80.8 mt -89.81 121.19 31.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.952 . . . . 0.0 111.464 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -103.32 179.66 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.85 93.91 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.926 0.869 . . . . 0.0 109.872 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.7 -34.66 78.34 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.331 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.54 -19.96 66.14 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.479 -0.763 . . . . 0.0 111.238 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 115' ' ' ILE . 30.0 m -50.65 136.88 20.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.84 -159.99 32.85 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.59 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 113' ' ' THR . 13.8 tp -110.2 130.05 55.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.7 -0.882 . . . . 0.0 111.961 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.699 ' CD2' HD12 ' A' ' 115' ' ' ILE . 83.9 m-85 -116.29 146.98 41.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -103.53 139.96 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.44 -0.788 . . . . 0.0 111.683 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.769 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.7 p -98.16 127.59 44.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 109' ' ' ILE . 4.6 tttm -120.39 141.72 49.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.741 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.8 t -138.05 108.85 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 99' ' ' MET . 5.9 mm-40 -134.4 128.26 33.24 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.841 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.79 HD23 HD13 ' A' ' 106' ' ' LEU 0.26 2.8 mm? -76.51 87.68 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.456 ' HE1' ' HB3' ' A' ' 97' ' ' GLU . 2.7 mmt -81.15 -58.45 3.06 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.498 -1.281 . . . . 0.0 111.687 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.6 m-85 -71.7 -40.45 8.4 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 48.6 Cg_endo -82.05 117.36 2.88 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.229 0.594 . . . . 0.0 110.658 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 73.0 Cg_endo -92.41 156.97 3.05 Favored 'Trans proline' 1 CA--C 1.701 8.859 0 CA-C-O 114.534 -2.361 . . . . 0.0 109.835 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 55.7 Cg_endo -87.65 178.62 19.91 Favored 'Cis proline' 2 C--N 1.46 6.408 1 C-N-CA 96.668 -12.638 . . . . 0.0 116.727 -8.039 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 13.3 t80 -85.93 119.68 26.5 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.043 2.09 . . . . 0.0 113.12 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 106' ' ' LEU . 25.7 t80 -162.16 107.74 1.25 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.272 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.79 HD13 HD23 ' A' ' 98' ' ' LEU . 1.4 tp -157.16 -143.49 0.11 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.921 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.73 178.55 35.77 Favored Glycine 0 N--CA 1.504 3.227 0 O-C-N 120.682 -1.261 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 95' ' ' LYS . 97.4 mt -126.17 160.82 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.987 . . . . 0.0 109.814 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.769 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 143.47 16.68 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -60.43 -36.08 77.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.479 -1.013 . . . . 0.0 110.271 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 131.56 158.4 9.1 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.017 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.553 ' C ' HD12 ' A' ' 91' ' ' LEU . 97.0 m -123.33 127.67 48.84 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 1.002 ' HB3' HG23 ' A' ' 8' ' ' VAL . 36.1 tp60 -73.64 137.12 43.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.699 HD12 ' CD2' ' A' ' 92' ' ' TYR . 75.4 mt -110.0 129.19 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.894 -1.129 . . . . 0.0 108.422 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.808 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.9 m-85 -110.15 142.67 41.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.874 -0.516 . . . . 0.0 111.044 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.055 0.455 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -135.78 132.48 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.68 131.09 57.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.581 -0.699 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.089 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 87.0 mm-40 -140.0 139.69 22.12 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.224 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.33 147.66 42.16 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.284 1.15 . . . . 0.0 109.835 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.5 -29.61 25.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.44 156.99 4.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.017 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.0 t -134.98 157.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 116' ' ' TYR . 66.1 mt -111.04 130.18 55.68 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.702 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.71 147.78 23.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.863 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -78.27 168.85 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.647 -0.658 . . . . 0.0 110.153 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -59.76 -37.91 80.35 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.446 -0.783 . . . . 0.0 109.969 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -57.46 -24.06 53.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.535 -0.728 . . . . 0.0 110.397 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.8 28.02 8.6 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.2 mp -103.63 101.67 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.56 124.35 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.0 p -136.37 150.03 48.62 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.922 ' HB3' HG21 ' A' ' 9' ' ' VAL . 22.2 p90 -154.62 161.48 41.57 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 79.8 t -118.79 117.69 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.499 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.089 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 53.6 t -100.1 107.42 19.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.51 144.95 29.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.911 . . . . 0.0 111.186 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CG ' HG11 ' A' ' 96' ' ' VAL . 50.0 p90 -131.64 -179.97 5.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.75 131.92 39.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.691 -0.631 . . . . 0.0 110.093 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.4 t -127.29 150.42 72.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.475 -0.766 . . . . 0.0 111.101 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.34 -14.77 37.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.735 1.387 . . . . 0.0 111.362 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.89 -165.43 16.79 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -110.1 132.16 54.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.97 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 153.76 39.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.1 p -80.03 -35.08 37.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.794 ' OE1' HG21 ' A' ' 51' ' ' THR . 42.7 mm-40 -79.89 97.07 6.55 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.3 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 34' ' ' VAL . 97.5 t -113.56 85.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 99' ' ' MET . 72.1 ttt-85 -61.25 116.19 4.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.114 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 32' ' ' VAL . 28.4 m -122.46 133.98 67.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.712 0.767 . . . . 0.0 110.157 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.483 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 61.3 m -120.06 123.98 44.75 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.086 0.469 . . . . 0.0 109.967 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.689 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -100.54 130.23 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 95' ' ' LYS . 71.2 mt -124.76 167.66 14.28 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.351 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.3 ttt180 -127.71 124.04 36.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.564 ' NE2' HD23 ' A' ' 91' ' ' LEU . 22.0 mt-30 -109.13 132.01 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.954 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -125.01 162.6 24.17 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.03 -42.98 95.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.2 m -70.09 -55.92 8.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.727 . . . . 0.0 110.694 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 58.7 mm-40 -150.42 -177.27 5.86 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.964 0.888 . . . . 0.0 111.399 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.8 136.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -134.27 161.6 34.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 37' ' ' LEU . 75.5 mt-10 -80.2 155.54 27.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 48' ' ' CYS . 96.3 t -118.77 -95.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.869 -0.519 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 47' ' ' VAL . 99.2 m -120.14 145.12 47.24 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.705 -1.247 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.76 138.57 14.28 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.38 -0.825 . . . . 0.0 111.796 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -175.4 157.06 2.1 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.794 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -80.1 119.88 23.49 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 72' ' ' SER . 19.6 t80 -80.83 109.98 15.91 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.445 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.16 146.06 33.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -15.81 63.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.07 -1.018 . . . . 0.0 110.661 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.83 -15.03 5.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -130.02 160.06 34.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -1.221 . . . . 0.0 110.911 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -123.2 125.2 44.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.506 -0.746 . . . . 0.0 110.052 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 51' ' ' THR . 79.8 mt -85.2 170.17 13.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.474 -0.766 . . . . 0.0 111.349 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -110.2 159.95 16.93 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.8 m-85 -99.93 132.08 45.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.492 -0.755 . . . . 0.0 109.696 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.87 -44.13 94.35 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -140.82 -165.76 2.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.028 -1.045 . . . . 0.0 111.995 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 56.0 57.15 5.32 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.221 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.3 m 56.61 167.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.322 0.582 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -91.39 84.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 110.018 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 59.7 m -68.08 151.39 47.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.1 t -132.62 149.96 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 109.336 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.1 176.49 39.33 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.9 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 94.3 m -131.96 166.41 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 122.005 -0.703 . . . . 0.0 109.721 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 34.7 t -151.16 80.32 1.31 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.706 -0.621 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -129.97 145.11 51.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.486 -0.759 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.01 37.75 87.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.5 m120 56.96 24.22 9.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.609 -0.936 . . . . 0.0 110.387 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -127.37 124.1 37.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.552 -0.717 . . . . 0.0 109.17 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -102.19 117.55 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.553 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 57.4 t-20 -99.76 104.77 16.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.322 -0.861 . . . . 0.0 111.156 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.689 HD13 ' CG2' ' A' ' 36' ' ' VAL . 75.1 mt -93.27 131.86 37.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 0.0 109.819 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.577 ' HB ' HG23 ' A' ' 69' ' ' THR . 58.9 m -121.89 139.93 53.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 84' ' ' LEU . 72.2 mt -120.02 138.82 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.711 . . . . 0.0 109.905 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.0 mt-30 -124.92 121.24 33.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.983 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.38 25.1 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 81' ' ' ILE . 75.7 mt -81.67 129.99 34.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -1.044 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 85' ' ' ARG . 22.9 mtp-105 -104.19 179.93 4.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.05 94.55 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.835 0.826 . . . . 0.0 109.614 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.9 mmt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -67.75 -16.93 64.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.761 . . . . 0.0 111.807 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.3 m -52.96 139.96 26.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 166.31 -164.96 37.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.564 HD23 ' NE2' ' A' ' 39' ' ' GLN . 18.0 tp -94.12 132.01 39.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.752 -0.852 . . . . 0.0 112.483 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.798 ' CD1' HD12 ' A' ' 115' ' ' ILE . 72.9 m-85 -118.39 134.58 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -99.95 139.91 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 111.762 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.859 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.8 p -108.07 107.98 18.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.712 ' HE3' HD12 ' A' ' 37' ' ' LEU . 17.1 mttt -105.17 141.39 36.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 109.202 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.6 ' O ' HD23 ' A' ' 106' ' ' LEU . 9.8 t -135.96 111.42 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.947 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 86.6 mt-10 -131.98 131.7 42.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.539 -0.725 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.717 ' CD2' HD22 ' A' ' 106' ' ' LEU . 11.2 mt -85.43 80.01 9.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 33' ' ' ARG . 2.5 ttm -80.65 -39.67 26.92 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.631 -173.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 68.6 m-85 -70.8 -45.7 16.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.401 -0.92 . . . . 0.0 112.773 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 71.9 Cg_endo -80.29 133.42 9.72 Favored 'Trans proline' 0 CA--C 1.597 3.648 0 O-C-N 122.877 0.935 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 86.0 Cg_endo -90.88 143.11 3.32 Favored 'Trans proline' 1 N--CA 1.54 4.207 1 CA-C-O 110.185 -4.173 . . . . 0.0 114.945 177.088 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.2 Cg_endo -110.7 57.07 0.77 Allowed 'Cis proline' 2 C--N 1.453 6.051 1 C-N-CA 97.123 -12.449 . . . . 0.0 110.505 11.41 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.469 ' O ' ' O ' ' A' ' 103' ' ' PRO . 5.1 t80 50.72 120.95 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.836 0 O-C-N 120.556 -1.34 . . . . 0.0 111.843 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -160.18 106.98 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.428 -2.045 . . . . 0.0 107.378 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD22 ' CD2' ' A' ' 98' ' ' LEU . 3.2 tp -159.41 -148.91 0.19 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.979 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.46 -176.38 30.44 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 ' HD3' ' A' ' 95' ' ' LYS . 76.8 mt -126.63 162.75 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.355 -1.086 . . . . 0.0 110.978 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.859 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 134.81 11.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -59.8 -35.89 75.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -1.17 . . . . 0.0 110.64 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 130.6 136.73 4.02 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.68 -1.248 . . . . 0.0 111.874 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.492 HG21 HG23 ' A' ' 9' ' ' VAL . 96.3 m -108.63 139.09 43.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.564 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.5 tt0 -89.56 120.2 30.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.207 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.798 HD12 ' CD1' ' A' ' 92' ' ' TYR . 97.0 mt -81.48 123.66 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.609 ' CE2' HG21 ' A' ' 8' ' ' VAL . 2.8 m-30 -94.93 161.66 14.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.633 0.73 . . . . 0.0 111.531 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.44 ' C ' HG23 ' A' ' 3' ' ' VAL . 77.8 m80 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.434 0.635 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.468 HG12 ' OE1' ' A' ' 5' ' ' GLN . 61.3 t -149.77 132.03 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -110.2 132.74 53.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.377 -0.827 . . . . 0.0 110.606 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.468 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.75 138.79 22.34 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.814 -0.554 . . . . 0.0 110.503 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.48 133.89 27.19 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.259 1.137 . . . . 0.0 109.535 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.49 76.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.994 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -149.16 155.96 7.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.118 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.6 t -137.62 155.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.989 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 116' ' ' TYR . 82.1 mt -116.01 132.72 56.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.07 131.76 35.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.384 -0.823 . . . . 0.0 110.974 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -60.64 172.73 0.85 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.62 -0.675 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -59.83 -35.94 75.77 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.577 -0.702 . . . . 0.0 110.088 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.762 ' CG ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -53.55 -24.95 15.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.97 24.97 13.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.762 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -112.6 111.64 37.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 84' ' ' LEU . . . -98.69 119.72 37.9 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.503 ' HB2' HG23 ' A' ' 80' ' ' THR . 46.4 t -122.31 131.1 53.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.21 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.725 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.2 p90 -139.92 164.03 31.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 77' ' ' VAL . 55.3 t -131.6 130.77 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.956 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' VAL . 29.5 t -112.84 110.75 21.05 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -82.06 151.73 26.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.723 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CD2' HG21 ' A' ' 96' ' ' VAL . 19.6 p90 -134.36 169.44 17.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.63 134.72 43.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.583 -0.698 . . . . 0.0 110.898 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 t -140.2 149.47 58.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.634 . . . . 0.0 110.651 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.67 -20.44 52.99 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.727 1.383 . . . . 0.0 111.54 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.02 165.91 25.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.61 133.54 55.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.573 -0.957 . . . . 0.0 110.548 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -131.93 163.0 29.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 109.536 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' MET . 25.6 p -80.1 -38.03 32.49 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.39 -0.818 . . . . 0.0 110.201 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 10.5 mm-40 -79.35 93.11 5.26 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.225 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 34' ' ' VAL . 96.4 t -109.76 102.6 14.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -82.83 106.37 14.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.343 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 34.0 m -106.04 141.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.487 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.0 m -132.0 156.88 45.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.728 0.775 . . . . 0.0 110.175 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 79' ' ' LEU . 98.4 t -125.57 136.24 61.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 46' ' ' GLU . 7.7 mt -131.92 160.1 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.058 -1.026 . . . . 0.0 111.216 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 47' ' ' VAL . 77.4 mtt180 -112.66 113.79 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.921 ' NE2' HD11 ' A' ' 93' ' ' ILE . 26.3 mt-30 -93.67 131.82 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.895 . . . . 0.0 110.818 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -130.9 158.69 39.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.65 85.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 110.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.7 p -73.71 -56.09 5.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.615 -0.678 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.663 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.6 mt-30 -154.15 171.99 18.28 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.302 -0.874 . . . . 0.0 111.353 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.8 t -122.35 142.11 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.0 p -128.22 160.16 32.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.206 -0.934 . . . . 0.0 111.603 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.87 ' HA ' HD23 ' A' ' 37' ' ' LEU . 59.1 mt-10 -80.25 162.04 24.83 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.67 -0.643 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 48' ' ' CYS . 38.7 t -130.25 -64.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.342 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.776 ' SG ' ' O ' ' A' ' 64' ' ' SER . 57.9 m -149.56 151.89 34.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.441 -0.787 . . . . 0.0 110.153 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -167.59 137.89 2.84 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.148 -0.97 . . . . 0.0 112.387 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -169.1 148.11 3.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.529 -0.732 . . . . 0.0 109.917 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.437 ' HG1' ' HE1' ' A' ' 100' ' ' TYR . 2.9 m -95.87 115.3 27.23 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.137 -0.977 . . . . 0.0 108.784 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 54' ' ' MET . 46.1 p90 -109.57 145.31 36.57 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.388 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 1.068 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -73.23 158.71 34.67 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.464 ' HE2' ' CD1' ' A' ' 52' ' ' TYR . 27.5 mmt -67.14 130.46 43.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.837 -1.164 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.5 30.46 18.84 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -149.26 175.61 11.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -1.124 . . . . 0.0 110.909 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -137.84 150.07 46.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.819 -0.551 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 51' ' ' THR . 80.1 mt -134.15 179.63 6.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.304 -0.873 . . . . 0.0 111.577 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.7 p -113.8 159.81 19.38 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.963 -0.461 . . . . 0.0 110.081 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 36.2 m-85 -110.2 123.38 49.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.63 -35.87 75.63 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.48 -0.762 . . . . 0.0 112.359 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -67.15 -147.75 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.241 -0.912 . . . . 0.0 111.187 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -46.57 -19.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.896 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.776 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 29.0 m 57.51 -132.62 1.32 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.654 -0.654 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.5 mt 56.56 22.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.77 -1.206 . . . . 0.0 110.27 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 64' ' ' SER . 20.7 m -137.36 155.18 49.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.413 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 9.9 t -120.31 140.06 51.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.43 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.58 96.1 1.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 m -123.79 156.03 36.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.538 -0.978 . . . . 0.0 109.024 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.2 p -156.52 160.24 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.177 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -140.36 107.92 5.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.15 32.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -93.69 9.71 35.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.454 -1.027 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.528 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 36.5 tt0 -111.7 136.07 51.44 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.239 -0.913 . . . . 0.0 110.226 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 20' ' ' VAL . 11.3 m -112.77 141.85 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.008 -1.058 . . . . 0.0 111.287 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.438 ' CG ' HG22 ' A' ' 20' ' ' VAL . 64.1 t-20 -112.76 118.01 33.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.769 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD13 HG22 ' A' ' 36' ' ' VAL . 90.4 mt -112.22 129.97 56.08 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.719 . . . . 0.0 109.376 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 18' ' ' SER . 81.8 m -130.65 154.52 47.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.272 -0.892 . . . . 0.0 110.808 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 91.0 mt -120.43 139.41 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.78 -0.575 . . . . 0.0 109.846 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 67' ' ' ILE . 40.2 mt-30 -119.48 123.22 43.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.143 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.57 56.84 0.76 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 17' ' ' ALA . 91.4 mt -80.85 126.03 30.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.792 -0.828 . . . . 0.0 111.805 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -105.93 170.14 8.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.22 90.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -65.64 -37.72 87.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.755 -0.591 . . . . 0.0 110.325 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.28 -36.47 75.61 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.619 -0.676 . . . . 0.0 111.228 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 115' ' ' ILE . 20.3 m -51.11 133.75 27.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.6 -143.69 9.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.499 HD23 HE21 ' A' ' 39' ' ' GLN . 34.8 tp -109.23 123.71 49.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.733 -0.863 . . . . 0.0 111.709 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.767 ' CD1' HD12 ' A' ' 115' ' ' ILE . 53.7 m-85 -110.18 115.87 30.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.469 -0.769 . . . . 0.0 110.05 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.921 HD11 ' NE2' ' A' ' 39' ' ' GLN . 40.8 mm -78.21 133.51 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.6 -0.687 . . . . 0.0 111.984 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.3 p -85.47 149.82 25.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.2 tttt -147.31 127.93 14.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 108.495 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.704 HG21 ' CD2' ' A' ' 23' ' ' TYR . 2.4 p -134.95 113.11 15.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.614 0.721 . . . . 0.0 109.297 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 74.3 mm-40 -134.56 132.2 38.83 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.553 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.6 mm? -81.54 85.2 6.55 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 51.0 tpp -82.52 -46.92 12.77 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.779 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 59.0 m-85 -71.42 -42.98 11.9 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 49.1 Cg_endo -81.76 113.06 2.47 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 121.194 1.263 . . . . 0.0 112.576 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 50.5 Cg_endo -77.02 166.87 26.05 Favored 'Trans proline' 1 CA--C 1.642 5.913 0 CA-C-O 111.834 -3.486 . . . . 0.0 108.246 177.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.43 68.2 Cg_endo -81.95 -171.97 10.0 Favored 'Cis proline' 1 C--N 1.47 6.944 1 C-N-CA 98.741 -11.774 . . . . 0.0 116.704 -15.862 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.1 t80 -99.19 125.16 44.7 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 118.365 -2.709 . . . . 0.0 109.243 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.536 ' O ' HD22 ' A' ' 106' ' ' LEU . 22.5 p90 -169.42 108.1 0.42 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.005 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.553 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.91 -148.02 0.24 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.1 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.65 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -154.8 165.35 32.06 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.357 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -122.25 149.18 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' HA2' ' OE1' ' A' ' 5' ' ' GLN . . . -88.14 -177.68 47.46 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.84 21.33 17.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -1.19 . . . . 0.0 111.803 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.682 ' CA ' HD13 ' A' ' 93' ' ' ILE . . . 83.53 146.89 7.17 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-O 122.793 1.218 . . . . 0.0 114.074 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.593 HG21 HG23 ' A' ' 9' ' ' VAL . 57.7 m -116.16 128.88 56.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 8' ' ' VAL . 35.3 tp60 -68.36 136.59 53.6 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 118.354 -1.339 . . . . 0.0 107.86 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 92' ' ' TYR . 61.6 mt -113.67 125.1 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.957 -1.09 . . . . 0.0 108.635 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.819 ' CE2' HG21 ' A' ' 8' ' ' VAL . 24.8 m-85 -109.69 159.79 16.85 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 88.4 t . . . . . 0 N--CA 1.492 1.641 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.331 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.301 0.572 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 22' ' ' GLU . 95.4 t -102.06 134.97 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.773 -0.58 . . . . 0.0 110.114 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.36 54.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.508 -0.745 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.417 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.3 pt20 -157.57 156.05 28.15 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.572 -0.705 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.57 46.75 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.55 1.29 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.13 -23.66 23.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.582 -0.699 . . . . 0.0 109.731 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.2 156.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.567 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.711 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -136.86 156.8 35.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.86 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 116' ' ' TYR . 86.8 mt -114.61 127.77 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.629 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.93 165.14 18.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.456 -0.778 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 160.02 43.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.255 -0.903 . . . . 0.0 111.1 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t 55.5 -132.87 1.66 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.509 -0.745 . . . . 0.0 110.737 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 16' ' ' ILE . 6.1 ttt180 -52.02 -23.84 5.77 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.764 -1.21 . . . . 0.0 111.461 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.576 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 119.56 46.19 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.8 mp -103.78 113.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.93 0.872 . . . . 0.0 109.893 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -112.92 126.48 55.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.3 p -123.49 139.99 53.46 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.59 0.709 . . . . 0.0 110.902 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.711 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.7 p90 -150.15 162.24 40.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 71.9 t -125.29 121.03 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.713 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.864 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.04 103.72 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 3' ' ' VAL . 57.2 tt0 -80.04 142.43 34.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.817 . . . . 0.0 111.0 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.3 p90 -121.96 176.36 5.83 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.64 137.01 41.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.661 -0.649 . . . . 0.0 110.584 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 106' ' ' LEU . 95.4 p -142.95 152.91 59.88 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.649 -0.657 . . . . 0.0 110.43 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HG2' ' CE2' ' A' ' 105' ' ' TYR . 44.0 Cg_endo -69.23 -13.47 36.07 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.461 1.242 . . . . 0.0 110.929 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.13 -179.84 33.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -117.98 140.08 50.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -1.035 . . . . 0.0 110.602 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.54 172.27 13.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.0 109.486 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 p -80.06 -46.55 16.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.638 ' OE1' HG21 ' A' ' 51' ' ' THR . 5.3 mm-40 -80.09 109.96 15.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.795 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 34' ' ' VAL . 96.7 t -119.83 82.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -60.22 103.58 0.24 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.739 HG23 ' HZ ' ' A' ' 60' ' ' PHE . 27.2 m -114.44 143.66 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.325 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 49' ' ' ALA . 69.1 m -140.03 132.9 29.22 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.217 0.532 . . . . 0.0 111.04 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -98.99 130.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -119.97 160.01 23.59 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.749 -1.219 . . . . 0.0 111.735 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -117.03 129.68 56.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.406 ' HG3' ' CG2' ' A' ' 44' ' ' VAL . 15.8 tt0 -106.81 149.31 27.51 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.712 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.62 -172.6 2.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.858 -0.526 . . . . 0.0 109.761 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.18 -44.4 95.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.502 -0.749 . . . . 0.0 111.138 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.1 m -132.73 -13.74 2.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.295 -0.878 . . . . 0.0 112.294 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.746 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 tt0 -122.88 142.7 50.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 111.168 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 39' ' ' GLN . 50.7 t -132.03 133.81 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -131.17 165.84 22.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HA ' HD23 ' A' ' 37' ' ' LEU . 64.3 mt-10 -79.98 149.91 30.63 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.441 0.638 . . . . 0.0 110.55 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.314 HG12 ' SG ' ' A' ' 68' ' ' CYS . 95.4 t -112.33 -67.99 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 63' ' ' ASP . 57.0 m -133.34 150.08 51.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.547 -0.721 . . . . 0.0 109.526 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.853 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -166.87 135.27 2.71 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.378 -0.929 . . . . 0.0 112.007 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.02 157.54 4.4 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.638 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -85.69 124.81 32.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 72' ' ' SER . 28.7 t80 -87.82 110.41 20.48 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.592 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.425 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 2.2 mmt -80.04 165.58 22.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 54' ' ' MET . 31.2 mmt -59.54 -30.34 68.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.6 -1.312 . . . . 0.0 109.604 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.16 -139.75 7.9 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.68 133.75 55.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -1.154 . . . . 0.0 110.668 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 178.02 159.22 0.48 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 38.3 mt 51.04 78.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.977 . . . . 0.0 111.308 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -96.79 163.26 13.06 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.728 -0.608 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.739 ' HZ ' HG23 ' A' ' 34' ' ' VAL . 8.6 m-30 -90.53 10.01 27.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.565 -0.709 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.71 -30.21 68.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.273 -0.892 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.07 -28.55 62.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.396 -0.815 . . . . 0.0 111.019 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.724 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 26.3 m-20 -84.11 -6.58 59.43 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 122.082 -0.386 . . . . 0.0 111.667 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p 42.25 28.5 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.8 mt -137.04 -47.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.306 -0.871 . . . . 0.0 110.79 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.314 ' SG ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -118.76 131.41 56.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 0.0 111.486 -179.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -139.85 147.49 40.75 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.99 -171.74 37.26 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.275 -1.441 . . . . 0.0 111.16 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 72' ' ' SER . 59.9 m -130.08 169.6 15.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 122.019 -0.695 . . . . 0.0 109.821 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 71' ' ' THR . 31.0 t -134.74 130.02 35.56 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -135.07 129.95 34.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 50.61 -122.84 14.09 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 27.4 m120 -100.03 12.07 37.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.759 -0.847 . . . . 0.0 110.46 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -116.27 128.49 55.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 109.853 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 21' ' ' CYS . 16.7 m -105.42 118.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.399 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.31 110.05 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 111.112 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 HG22 ' A' ' 36' ' ' VAL . 77.4 mt -111.08 131.96 54.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -131.26 144.08 51.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -124.02 140.02 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.502 -0.749 . . . . 0.0 110.481 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 16' ' ' ILE . 30.4 mt-30 -120.34 122.56 41.06 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.402 0.62 . . . . 0.0 109.589 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.92 37.75 1.65 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 94.9 mt -80.12 85.72 5.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.893 . . . . 0.0 110.77 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.96 168.38 20.14 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -41.73 67.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.234 -0.917 . . . . 0.0 109.732 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.76 -36.07 79.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.393 0.616 . . . . 0.0 109.78 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.25 -23.48 67.07 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 110.859 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 115' ' ' ILE . 50.7 m -53.43 139.98 29.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.23 -146.8 10.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.004 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.6 tm? -107.33 134.93 49.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.859 -0.789 . . . . 0.0 110.752 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.813 ' N ' HD13 ' A' ' 91' ' ' LEU . 57.2 m-85 -121.1 125.07 46.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.744 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -98.75 123.97 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.396 -0.815 . . . . 0.0 112.578 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.9 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.6 p -85.11 111.29 19.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HB3' ' H ' ' A' ' 35' ' ' THR . 7.8 tttt -103.56 139.99 38.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.536 -0.727 . . . . 0.0 109.076 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' HD23 ' A' ' 106' ' ' LEU . 21.2 t -140.13 105.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.41 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.937 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 36.8 mt-10 -131.93 130.69 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.238 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.728 ' HG ' HD22 ' A' ' 106' ' ' LEU . 13.5 mt -84.62 78.84 9.77 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.937 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -80.03 -41.67 25.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.195 -0.941 . . . . 0.0 113.016 -174.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.475 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 62.8 m-85 -65.17 -46.84 72.83 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.884 -1.135 . . . . 0.0 113.145 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 61.3 Cg_endo -77.0 110.1 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.204 1.107 . . . . 0.0 111.349 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 44.6 Cg_endo -89.24 145.92 5.18 Favored 'Trans proline' 0 CA--C 1.598 3.724 0 CA-C-O 110.666 -3.972 . . . . 0.0 110.432 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 37.6 Cg_endo -88.3 -168.37 4.44 Favored 'Cis proline' 2 N--CA 1.629 9.478 2 C-N-CA 92.29 -14.463 . . . . 0.0 111.927 -0.064 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -88.17 137.79 32.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.644 -1.285 . . . . 0.0 113.975 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 12.4 p90 -153.59 92.71 1.6 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.496 -0.752 . . . . 0.0 111.905 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.6 tp -160.13 -149.67 0.2 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.616 -0.678 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.695 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.02 176.35 40.03 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.339 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.0 mp -117.55 158.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.718 -0.872 . . . . 0.0 109.338 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.9 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -87.45 146.82 20.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.31 78.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.439 -1.036 . . . . 0.0 110.135 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 121.4 129.96 3.74 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.101 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.706 HG21 HG23 ' A' ' 9' ' ' VAL . 94.8 m -94.63 129.98 41.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.987 -0.713 . . . . 0.0 109.089 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.774 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 tp60 -79.87 132.01 36.0 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 89' ' ' THR . 81.3 mt -98.85 125.06 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.865 -1.147 . . . . 0.0 108.767 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.888 ' CE2' HG21 ' A' ' 8' ' ' VAL . 11.9 m-30 -103.44 151.21 23.08 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.108 0.48 . . . . 0.0 111.122 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.516 HG23 ' OG1' ' A' ' 89' ' ' THR . 95.8 t . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.459 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.144 0.497 . . . . 0.0 110.292 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 97.6 t -149.25 147.73 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 109.679 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.71 130.6 55.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.443 -0.785 . . . . 0.0 110.607 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.591 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 13.1 mm100 -143.5 139.97 17.0 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.668 -0.645 . . . . 0.0 111.49 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.63 139.92 38.29 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.82 66.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.909 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.03 162.41 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.679 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG23 HG21 ' A' ' 113' ' ' THR . 8.9 t -141.94 153.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -107.91 129.78 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 143.98 25.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.483 -0.761 . . . . 0.0 110.624 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -75.87 170.05 16.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.655 -0.653 . . . . 0.0 110.13 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -60.14 -34.63 73.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.712 . . . . 0.0 110.124 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.444 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 5.6 ttt180 -60.17 -26.63 66.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.0 110.034 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.93 30.67 6.63 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.1 mp -105.3 103.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.646 -0.914 . . . . 0.0 109.32 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.85 124.07 50.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.763 ' HB3' HG23 ' A' ' 80' ' ' THR . 92.9 p -136.26 149.83 48.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.738 0.78 . . . . 0.0 111.243 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -155.95 164.1 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 89.1 t -126.66 123.98 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.596 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' VAL . 36.8 t -102.89 108.07 19.14 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.895 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 17.1 pt-20 -79.79 160.03 26.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 111.296 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.96 179.89 6.35 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.68 125.76 29.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.702 . . . . 0.0 110.961 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -149.73 158.81 37.11 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.653 . . . . 0.0 109.966 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.81 124.91 11.52 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.354 1.186 . . . . 0.0 110.168 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.98 -131.38 52.02 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -126.03 143.31 51.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.617 -0.931 . . . . 0.0 109.956 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.18 145.17 42.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 110.04 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 2.7 p -80.9 -59.74 2.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 112.067 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 51' ' ' THR . 9.8 mm-40 -84.27 75.82 10.17 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.279 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 34' ' ' VAL . 15.4 m -85.78 87.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.613 ' N ' HG23 ' A' ' 51' ' ' THR . 7.2 ttp85 -55.97 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.53 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.6 m -103.56 129.59 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.819 0.819 . . . . 0.0 111.046 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.5 m -131.45 145.83 51.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.611 -0.68 . . . . 0.0 109.655 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.883 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.5 t -114.04 132.39 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.821 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.25 167.16 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.979 -1.076 . . . . 0.0 111.293 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.9 ttt-85 -127.61 120.86 29.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.591 HE21 HD23 ' A' ' 91' ' ' LEU . 34.5 mt-30 -105.9 130.28 53.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.395 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -126.78 156.12 41.73 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.24 -43.62 95.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.443 -0.786 . . . . 0.0 110.644 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -68.33 -49.95 56.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.549 -0.719 . . . . 0.0 111.145 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 71.2 mt-30 -155.47 164.02 39.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.382 -0.824 . . . . 0.0 111.084 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.9 t -124.77 137.27 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -139.96 166.11 25.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.494 -0.754 . . . . 0.0 110.959 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.821 ' HA ' HD23 ' A' ' 37' ' ' LEU . 62.5 tt0 -79.99 157.42 26.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 109.47 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 38' ' ' ARG . 97.3 t -121.03 -72.17 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.843 -0.536 . . . . 0.0 110.445 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 47' ' ' VAL . 81.0 m -129.95 148.08 51.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.339 -0.85 . . . . 0.0 109.411 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -155.95 136.47 13.24 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.17 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -173.84 149.58 1.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.587 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 ' N ' ' A' ' 33' ' ' ARG . 3.2 m -94.33 119.94 33.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.214 -0.928 . . . . 0.0 109.278 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 53' ' ' MET . 25.6 t80 -77.91 116.7 18.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.077 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -84.23 169.93 14.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.5 mmt -65.44 -28.26 69.1 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.687 -1.258 . . . . 0.0 111.27 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.76 44.3 0.83 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.218 -1.468 . . . . 0.0 112.361 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 74.1 m-20 -132.73 162.14 32.21 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 118.867 1.333 . . . . 0.0 110.158 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' HD22 ' A' ' 58' ' ' LEU . 59.0 tt0 -104.68 126.54 51.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.561 -0.712 . . . . 0.0 110.13 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.804 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mm? -98.29 139.98 33.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.009 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.6 p -100.18 142.87 31.07 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.676 -0.64 . . . . 0.0 110.581 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 96.0 m-85 -103.72 133.64 48.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.51 -0.743 . . . . 0.0 109.25 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.83 -44.27 94.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.516 -0.74 . . . . 0.0 112.762 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -168.39 -149.45 0.09 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.909 -1.119 . . . . 0.0 111.21 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 47' ' ' VAL . 76.8 m-20 59.01 54.27 5.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.462 -0.774 . . . . 0.0 110.242 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p 65.47 9.72 6.02 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.899 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.0 mt 48.27 68.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.16 -0.962 . . . . 0.0 111.354 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.413 ' O ' ' CE1' ' A' ' 60' ' ' PHE . 11.5 m -59.89 133.41 56.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 80' ' ' THR . 9.1 t -80.08 128.93 34.09 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.286 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.68 ' HA2' HD23 ' A' ' 79' ' ' LEU . . . -106.68 107.69 2.75 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.48 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -113.8 149.69 34.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.737 -0.861 . . . . 0.0 108.943 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 69.3 m -150.71 131.42 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -139.98 138.53 35.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.664 -0.648 . . . . 0.0 109.265 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.54 -123.92 33.31 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -108.92 16.68 22.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.905 . . . . 0.0 110.544 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 36.8 mt-30 -121.8 128.8 52.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.218 -0.926 . . . . 0.0 111.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -100.5 128.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.133 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 20' ' ' VAL . 51.0 t-20 -108.02 118.12 35.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' CG2' ' A' ' 36' ' ' VAL . 86.7 mt -112.13 129.96 56.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.525 -0.734 . . . . 0.0 109.541 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.763 HG23 ' HB3' ' A' ' 18' ' ' SER . 61.3 m -125.89 138.98 53.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.296 -0.878 . . . . 0.0 110.641 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.705 HG21 HD21 ' A' ' 84' ' ' LEU . 72.9 mt -113.7 139.74 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.734 -0.604 . . . . 0.0 110.273 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.431 ' HG2' HG13 ' A' ' 16' ' ' ILE . 63.3 mt-30 -124.81 121.98 36.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.259 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.61 36.99 1.49 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.705 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -92.81 121.09 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.986 . . . . 0.0 111.33 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' O ' HG21 ' A' ' 117' ' ' VAL . 73.4 mmt-85 -98.02 176.96 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.08 84.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 16.9 tpt -67.89 -34.54 76.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.514 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -67.53 -16.34 64.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.665 -0.647 . . . . 0.0 111.465 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 115' ' ' ILE . 22.8 m -50.36 135.5 21.81 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.213 -0.929 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.55 -159.43 24.02 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.871 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.591 HD23 HE21 ' A' ' 39' ' ' GLN . 15.6 tp -109.55 128.65 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.676 -0.897 . . . . 0.0 111.531 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 62.1 m-85 -109.94 139.94 44.48 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -115.31 130.22 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.608 -0.683 . . . . 0.0 111.881 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.114 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.8 p -80.1 146.87 31.66 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 6.8 tttt -142.55 77.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.776 HG22 HD23 ' A' ' 106' ' ' LEU . 3.6 p -98.84 113.99 35.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.783 0.801 . . . . 0.0 110.482 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.661 ' OE2' HD11 ' A' ' 109' ' ' ILE . 54.9 mt-10 -128.19 129.14 46.02 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.721 -0.612 . . . . 0.0 110.63 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 106' ' ' LEU . 67.4 mt -77.64 76.16 4.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.6 tpp -81.8 -44.21 17.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.431 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 90.3 m-85 -70.19 -42.1 15.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.405 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 58.7 Cg_endo -87.51 111.76 0.81 Allowed 'Trans proline' 0 CA--C 1.561 1.868 0 CA-C-O 117.362 -1.183 . . . . 0.0 111.324 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.591 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 76.0 Cg_endo -85.23 155.15 10.95 Favored 'Trans proline' 0 CA--C 1.597 3.629 0 CA-C-O 111.592 -3.587 . . . . 0.0 110.249 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.591 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.286 48.0 Cg_endo -86.46 -178.99 17.33 Favored 'Cis proline' 2 C--N 1.5 8.512 1 C-N-CA 91.179 -14.925 . . . . 0.0 115.914 -5.951 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.28 128.43 34.69 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.399 -1.438 . . . . 0.0 110.33 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -145.09 69.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.385 0.612 . . . . 0.0 111.552 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.776 HD23 HG22 ' A' ' 96' ' ' VAL . 3.5 tp -144.9 -154.87 0.56 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -167.74 -171.22 33.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.063 -1.541 . . . . 0.0 111.838 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.2 mp -115.15 150.03 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.7 -0.882 . . . . 0.0 109.639 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 1.114 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -79.91 148.65 30.45 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -59.82 -38.63 82.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.351 -1.087 . . . . 0.0 110.227 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 125.42 148.5 7.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.549 HG21 HG23 ' A' ' 9' ' ' VAL . 98.8 m -119.79 134.57 55.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.813 ' HB3' HG23 ' A' ' 8' ' ' VAL . 38.3 tp60 -80.38 129.51 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 75.5 mt -98.2 120.82 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.0 108.537 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 8' ' ' VAL . 9.5 m-30 -97.02 132.36 42.9 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.095 0.474 . . . . 0.0 111.414 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 85' ' ' ARG . 96.4 t . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.073 0.463 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.48 HG12 ' OE1' ' A' ' 5' ' ' GLN . 66.5 t -129.89 126.04 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.609 -0.682 . . . . 0.0 109.607 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 130.81 56.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.506 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.48 ' OE1' HG12 ' A' ' 3' ' ' VAL . 2.7 mp0 -135.02 131.29 19.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 110.601 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.78 136.03 24.69 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.064 1.034 . . . . 0.0 109.515 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.1 -28.78 57.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.813 . . . . 0.0 110.209 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.97 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -153.01 163.01 2.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.045 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.4 t -138.51 151.63 24.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.57 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 116' ' ' TYR . 85.9 mt -119.19 121.26 39.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.603 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 140.08 45.53 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -110.12 -69.38 0.87 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.226 -0.921 . . . . 0.0 112.647 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 m -120.03 151.32 39.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.241 -0.912 . . . . 0.0 111.075 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HG2' HD11 ' A' ' 16' ' ' ILE . 4.0 tpt180 56.9 18.8 4.09 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.606 -0.684 . . . . 0.0 110.577 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.64 44.02 53.91 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.618 HD11 ' HG2' ' A' ' 14' ' ' ARG . 21.6 mm -110.25 108.97 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 121.606 -0.938 . . . . 0.0 108.941 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -101.79 126.11 48.59 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.793 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' HG23 ' A' ' 80' ' ' THR . 38.3 t -133.17 135.0 44.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' VAL . 26.7 p90 -146.23 161.33 40.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.77 -0.581 . . . . 0.0 109.796 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 96.1 t -117.72 119.06 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.225 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.881 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.18 103.18 14.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 85.1 mt-10 -80.4 164.3 23.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 111.789 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.662 ' CG ' HG11 ' A' ' 96' ' ' VAL . 44.0 p90 -147.9 178.46 8.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.489 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.59 27.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.636 . . . . 0.0 109.891 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -131.44 147.82 67.65 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 0.0 110.585 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.44 142.53 26.69 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.379 1.199 . . . . 0.0 110.372 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.61 -150.34 38.62 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.07 140.91 50.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.924 . . . . 0.0 110.21 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.81 144.82 31.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.273 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 1.149 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 82.7 p -78.6 -46.83 18.42 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.952 0.882 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.686 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.2 mm-40 -79.04 112.56 16.37 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.538 0.685 . . . . 0.0 112.847 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.684 HG11 ' OH ' ' A' ' 52' ' ' TYR . 94.2 t -124.04 96.09 3.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 99' ' ' MET . 24.0 ttt180 -77.89 124.03 27.5 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 0.0 111.184 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 28.3 m -121.75 141.81 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.58 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.5 m -129.92 130.1 44.7 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.238 0.542 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD13 ' A' ' 79' ' ' LEU . 95.6 t -103.77 132.02 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 46' ' ' GLU . 18.7 mt -127.34 169.03 14.0 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.185 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HG3' HG21 ' A' ' 47' ' ' VAL . 87.7 mtm180 -122.1 115.66 22.85 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.791 ' HA ' HG22 ' A' ' 44' ' ' VAL . 9.5 tt0 -83.95 150.37 25.71 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.733 0.778 . . . . 0.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.86 -162.05 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.18 -46.15 90.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.444 -0.785 . . . . 0.0 110.392 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.1 p -134.77 -3.88 2.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.473 -0.767 . . . . 0.0 112.031 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.5 mt-30 -137.32 161.52 36.05 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.007 -1.058 . . . . 0.0 111.133 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 39' ' ' GLN . 94.0 t -125.17 156.0 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.1 p -124.13 157.67 34.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.386 -0.822 . . . . 0.0 110.628 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.806 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.2 mt-10 -87.31 143.18 27.38 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.608 0.718 . . . . 0.0 111.017 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -116.3 -71.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.932 -0.48 . . . . 0.0 109.98 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HG12 ' A' ' 47' ' ' VAL . 30.8 m -140.06 153.38 46.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.381 -0.824 . . . . 0.0 110.589 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 135.27 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.492 -0.755 . . . . 0.0 110.912 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.844 ' HB3' ' C ' ' A' ' 59' ' ' THR . . . -171.15 155.96 4.57 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.424 -0.797 . . . . 0.0 110.212 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.6 m -102.17 131.04 48.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.684 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.4 p90 -110.05 141.12 43.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.669 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.977 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -77.0 164.1 26.08 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.149 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -71.29 79.96 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.904 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.05 -134.27 2.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -99.16 135.67 40.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.293 -1.122 . . . . 0.0 110.573 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -177.08 174.94 1.62 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.07 137.76 46.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.107 -0.996 . . . . 0.0 110.055 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.844 ' C ' ' HB3' ' A' ' 50' ' ' ALA . 73.4 p -90.77 8.27 35.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.976 -0.452 . . . . 0.0 110.046 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 59' ' ' THR . 13.5 m-85 -131.59 113.54 13.76 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.57 -35.91 81.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.537 -0.727 . . . . 0.0 109.521 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -141.16 -169.92 2.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.792 -0.567 . . . . 0.0 109.684 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.695 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 81.6 m-20 54.33 58.15 5.22 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.344 -0.848 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 t -49.26 -21.53 0.84 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.749 -0.595 . . . . 0.0 112.013 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -49.1 -26.72 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 63' ' ' ASP . 4.2 p -95.57 129.62 42.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -0.764 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -139.08 148.41 43.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.787 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.92 -173.77 38.94 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 72' ' ' SER . 94.5 m -130.12 163.92 25.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.951 -0.734 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 62.8 m -148.08 127.16 12.84 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -155.93 140.0 16.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 110.589 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.86 -124.19 33.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -107.76 16.14 23.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.741 -0.858 . . . . 0.0 110.824 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.423 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.5 mt-30 -119.83 120.09 35.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.209 -0.932 . . . . 0.0 110.958 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -103.96 124.33 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -103.0 111.25 23.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 111.946 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.768 HD13 HG22 ' A' ' 36' ' ' VAL . 81.1 mt -100.52 135.87 41.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.297 -0.877 . . . . 0.0 109.011 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 18' ' ' SER . 94.1 m -135.81 144.5 45.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.313 -0.867 . . . . 0.0 110.812 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.821 HG21 HD21 ' A' ' 84' ' ' LEU . 91.1 mt -119.12 131.45 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 96.9 mt-30 -113.78 119.42 37.29 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.155 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.07 47.85 0.86 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.821 HD21 HG21 ' A' ' 81' ' ' ILE . 80.2 mt -89.11 129.82 35.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.958 . . . . 0.0 111.755 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -119.21 179.99 4.01 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.88 82.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.188 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -65.4 -32.93 74.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.982 -0.449 . . . . 0.0 111.74 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.23 -20.02 64.78 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.345 -0.847 . . . . 0.0 111.4 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 115' ' ' ILE . 26.4 m -51.79 136.46 27.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.61 29.93 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.631 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.571 HD11 ' C ' ' A' ' 112' ' ' GLY . 58.4 tp -109.9 133.12 53.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.912 . . . . 0.0 111.775 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD2' HD12 ' A' ' 115' ' ' ILE . 46.8 m-85 -116.5 128.79 55.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.3 mp -95.37 127.02 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.612 -0.68 . . . . 0.0 112.112 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.064 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 29.9 p -93.13 112.25 24.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.867 ' HD3' HD12 ' A' ' 109' ' ' ILE . 5.6 mttt -105.55 146.62 29.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.662 HG11 ' CG ' ' A' ' 23' ' ' TYR . 21.9 t -141.75 106.3 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.54 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.688 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 85.9 mt-10 -132.69 127.4 34.74 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.057 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.539 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.7 mm? -77.53 83.73 3.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 5.0 mmm -80.58 -51.3 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.578 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 78.0 m-85 -66.29 -41.25 41.14 Favored Pre-proline 0 N--CA 1.503 2.195 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 56.4 Cg_endo -86.48 114.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.442 1.233 . . . . 0.0 111.927 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.752 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 90.3 Cg_endo -91.96 151.38 3.28 Favored 'Trans proline' 2 CA--C 1.675 7.545 0 CA-C-O 113.269 -2.888 . . . . 0.0 112.679 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.752 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 22.3 Cg_endo -84.95 177.39 27.9 Favored 'Cis proline' 1 N--CA 1.579 6.526 1 C-N-CA 92.828 -14.238 . . . . 0.0 114.271 -1.203 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -85.53 128.06 34.63 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.475 ' O ' HD22 ' A' ' 106' ' ' LEU . 43.2 t80 -160.21 111.19 1.9 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.522 -1.361 . . . . 0.0 109.708 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.539 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.15 -144.67 0.14 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.693 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.98 175.82 31.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.867 HD12 ' HD3' ' A' ' 95' ' ' LYS . 48.9 mm -124.24 165.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.367 -1.078 . . . . 0.0 109.79 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 1.064 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -96.12 139.33 14.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -60.09 -26.25 66.05 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.633 -0.922 . . . . 0.0 110.558 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.571 ' C ' HD11 ' A' ' 91' ' ' LEU . . . 110.89 135.65 6.93 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 9' ' ' VAL . 94.0 m -107.63 129.82 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.888 -0.772 . . . . 0.0 109.993 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.97 ' HB3' HG23 ' A' ' 8' ' ' VAL . 37.0 tp60 -79.05 146.46 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.709 ' O ' HG23 ' A' ' 89' ' ' THR . 40.9 mt -117.46 129.91 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.848 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -109.95 140.21 44.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.689 -0.632 . . . . 0.0 111.3 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.9 t . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.42 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.448 ' C ' HG23 ' A' ' 3' ' ' VAL . 97.9 m-70 . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 121.132 0.492 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.834 HG11 ' HA2' ' A' ' 110' ' ' GLY . 90.9 t -147.69 151.29 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.618 -0.676 . . . . 0.0 109.604 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.881 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -130.55 133.86 46.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.449 -0.782 . . . . 0.0 111.562 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.122 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 49.1 mt-30 -150.69 149.92 27.01 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.597 . . . . 0.0 111.141 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.91 139.99 37.41 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 N-CA-C 108.337 -1.447 . . . . 0.0 108.337 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.47 66.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.271 -0.893 . . . . 0.0 110.891 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.873 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.93 166.61 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.931 ' HB ' HD13 ' A' ' 115' ' ' ILE . 25.7 t -138.1 154.72 28.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.319 0.581 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.24 130.04 55.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.24 132.69 46.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.733 . . . . 0.0 110.789 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.07 175.5 4.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.786 -0.571 . . . . 0.0 109.527 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -60.18 -35.23 74.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.582 ' CG ' HD13 ' A' ' 16' ' ' ILE . 22.7 tpt180 -60.37 -32.63 71.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.6 -0.687 . . . . 0.0 110.163 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.05 33.92 5.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.582 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.3 mp -105.34 101.78 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.921 . . . . 0.0 109.247 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.852 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -107.39 122.98 47.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.6 t -131.92 131.72 42.93 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.381 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HD11 ' A' ' 115' ' ' ILE . 34.8 p90 -144.42 159.99 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 92.1 t -116.73 125.47 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.699 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.819 ' O ' HG22 ' A' ' 77' ' ' VAL . 49.6 t -107.02 105.81 16.01 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.881 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 16.7 pt-20 -80.22 152.15 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.05 . . . . 0.0 111.098 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -139.94 178.86 6.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.47 127.79 38.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.664 -0.648 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 106' ' ' LEU . 97.9 p -139.86 148.68 56.28 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.548 -0.72 . . . . 0.0 110.206 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.88 140.03 28.26 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.392 1.207 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.54 -156.92 8.83 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -129.97 149.93 51.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.938 . . . . 0.0 110.127 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 155.48 40.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.526 -0.734 . . . . 0.0 109.98 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 70.7 p -80.46 -43.17 21.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.456 -0.777 . . . . 0.0 110.513 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG21 ' A' ' 51' ' ' THR . 33.2 mm-40 -80.4 114.4 19.27 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.597 0.713 . . . . 0.0 112.334 -176.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.634 ' CG1' HG23 ' A' ' 96' ' ' VAL . 93.3 t -128.48 87.2 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 52.6 ttt85 -58.67 110.99 1.11 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.389 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.1 m -113.91 127.59 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.628 0.728 . . . . 0.0 110.178 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 93.2 m -128.75 140.45 51.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.713 -0.617 . . . . 0.0 109.574 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD13 ' A' ' 79' ' ' LEU . 96.7 t -109.79 136.94 44.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.9 mt -122.94 159.94 27.22 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.853 -1.154 . . . . 0.0 111.31 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -120.85 118.09 29.07 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' HG22 ' A' ' 44' ' ' VAL . 75.4 mt-30 -99.93 132.64 45.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.435 -0.791 . . . . 0.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.42 161.82 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.69 -41.31 90.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.503 -0.748 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 m -70.58 -57.19 4.99 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 110.83 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 mt-30 -154.29 169.57 23.36 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.4 -0.813 . . . . 0.0 110.734 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 39' ' ' GLN . 80.9 t -117.35 137.53 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.655 -0.653 . . . . 0.0 109.28 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.2 p -132.55 162.4 31.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.472 -0.767 . . . . 0.0 110.89 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.82 ' HA ' HD23 ' A' ' 37' ' ' LEU . 36.9 tt0 -80.02 158.1 26.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.582 -0.699 . . . . 0.0 109.937 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 93.8 t -119.38 -82.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.675 ' SG ' ' O ' ' A' ' 64' ' ' SER . 92.8 m -120.15 154.09 35.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.909 -1.119 . . . . 0.0 109.978 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -161.23 132.89 5.61 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.397 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.38 159.67 4.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.659 ' O ' HD13 ' A' ' 58' ' ' LEU . 3.0 m -93.4 110.2 21.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 109.869 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 23.7 t80 -72.67 124.44 25.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.384 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 1.4 mmt -86.07 144.51 27.51 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.431 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 34.1 mmt -59.79 -28.09 67.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.82 -22.59 9.31 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.694 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -129.9 158.21 40.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.177 -1.19 . . . . 0.0 111.467 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -113.57 135.47 53.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.031 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 51' ' ' THR . 9.6 mp -96.32 167.43 11.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.729 0.776 . . . . 0.0 111.742 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -114.79 160.0 19.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m-85 -96.36 124.43 40.36 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.6 tp -59.81 -44.19 94.12 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -144.04 -166.44 2.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.0 111.705 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 55.82 59.27 3.89 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.46 0.648 . . . . 0.0 110.12 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.675 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 70.1 m 57.39 105.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.408 0.623 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.78 92.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.783 -0.573 . . . . 0.0 110.287 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 76.1 m -69.99 163.34 26.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.631 HG21 ' NE2' ' A' ' 82' ' ' GLN . 8.8 t -138.24 150.38 46.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.414 -0.804 . . . . 0.0 109.218 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.92 43.24 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.872 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 72' ' ' SER . 99.4 m -130.1 166.41 20.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.045 -0.679 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 65.5 m -152.87 122.77 6.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.755 -0.591 . . . . 0.0 109.554 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.6 p -148.94 148.15 29.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.96 -125.53 27.49 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.23 19.06 20.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.909 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.8 mt-30 -123.98 122.72 38.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.237 -0.915 . . . . 0.0 110.876 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.4 m -105.57 123.78 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -99.61 114.03 26.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.185 -0.947 . . . . 0.0 111.225 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 HG22 ' A' ' 36' ' ' VAL . 81.2 mt -101.81 129.53 48.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' HG23 ' A' ' 69' ' ' THR . 60.7 m -119.55 132.58 55.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 96.0 mt -110.16 129.89 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.449 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.631 ' NE2' HG21 ' A' ' 69' ' ' THR . 76.6 mt-30 -122.1 121.87 37.93 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.62 45.75 0.89 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 75.9 mt -79.86 133.55 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.788 0.804 . . . . 0.0 111.836 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -120.05 167.54 12.09 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.39 84.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.268 -0.895 . . . . 0.0 109.842 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -68.09 -39.14 82.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.708 -0.62 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.2 -22.6 66.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.536 -0.728 . . . . 0.0 111.345 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -51.52 136.48 26.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.41 -164.81 34.68 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.575 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 26.9 tp -84.27 131.7 34.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.723 -0.869 . . . . 0.0 112.784 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 72.1 m-85 -113.55 127.15 55.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -110.09 130.33 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.617 -0.677 . . . . 0.0 112.792 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.194 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -80.06 148.64 30.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.823 ' HD2' HD12 ' A' ' 109' ' ' ILE . 7.8 tttt -142.79 82.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 106' ' ' LEU . 3.2 p -93.95 115.28 32.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 122.181 0.991 . . . . 0.0 111.078 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 62.0 mt-10 -131.9 131.04 42.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.729 ' HG ' HD22 ' A' ' 106' ' ' LEU . 49.1 mt -80.99 75.78 7.96 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.415 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 2.5 ttm -80.26 -34.58 36.94 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.471 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.438 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 16.8 m-85 -69.0 -44.36 28.54 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 119.389 -0.924 . . . . 0.0 113.144 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 37.1 Cg_endo -90.42 105.49 0.32 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 N-CA-C 114.958 1.099 . . . . 0.0 114.958 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.7 Cg_endo -74.88 155.82 43.54 Favored 'Trans proline' 1 CA--C 1.659 6.759 0 CA-C-O 112.825 -3.073 . . . . 0.0 109.081 177.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 48.1 Cg_endo -87.98 172.81 30.98 Favored 'Cis proline' 3 C--N 1.494 8.196 1 C-N-CA 90.435 -15.235 . . . . 0.0 116.032 -12.051 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 2.7 t80 -90.8 134.98 34.03 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.518 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -160.5 113.5 2.05 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.679 1.191 . . . . 0.0 109.583 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.729 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.8 tp -158.26 -146.32 0.15 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.014 -1.054 . . . . 0.0 110.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.17 170.66 32.72 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.979 -1.581 . . . . 0.0 112.389 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.823 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.8 mm -109.69 152.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 122.189 -0.595 . . . . 0.0 109.69 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 1.194 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -80.53 148.41 29.24 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -60.46 -38.65 84.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.988 . . . . 0.0 110.327 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.96 136.62 5.94 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.295 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.7 HG21 HG23 ' A' ' 9' ' ' VAL . 60.2 m -119.93 141.75 49.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.3 tt0 -89.88 124.04 34.35 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.596 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.931 HD13 ' HB ' ' A' ' 9' ' ' VAL . 23.9 mm -87.85 123.98 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.873 ' CE2' HG21 ' A' ' 8' ' ' VAL . 4.4 m-30 -95.02 151.08 19.49 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.854 0.835 . . . . 0.0 111.536 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 C--N 1.304 -1.374 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.613 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.085 0.469 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.46 125.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.637 -0.664 . . . . 0.0 109.246 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -122.08 137.73 54.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.444 -0.785 . . . . 0.0 110.651 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -150.55 144.47 17.4 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.667 . . . . 0.0 111.117 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.87 147.58 50.17 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.324 1.171 . . . . 0.0 109.745 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.86 -26.55 29.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 109.45 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -153.61 155.99 5.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.043 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.701 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -138.05 151.45 25.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.222 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.6 mt -105.32 126.61 52.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.97 154.11 42.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.47 -0.769 . . . . 0.0 110.561 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 m -97.37 -179.93 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.802 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 m -53.36 160.97 1.04 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.83 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 58.8 18.12 5.79 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.747 -0.596 . . . . 0.0 111.401 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.71 39.06 86.38 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.163 -0.96 . . . . 0.0 111.213 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.447 HG13 ' HG2' ' A' ' 82' ' ' GLN . 1.4 mp -99.52 99.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.152 -1.205 . . . . 0.0 108.854 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 108.907 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.66 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.6 p -135.56 149.98 49.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.672 0.748 . . . . 0.0 111.237 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.701 ' HB3' HG21 ' A' ' 9' ' ' VAL . 35.5 p90 -157.17 163.95 38.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 59.0 t -125.06 113.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.548 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 47.3 t -100.08 109.95 22.24 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.2 pt-20 -80.77 164.03 23.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.958 . . . . 0.0 111.77 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.975 ' CG ' HG11 ' A' ' 96' ' ' VAL . 46.5 p90 -145.83 178.28 8.29 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.12 131.31 53.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.4 p -142.34 160.65 53.78 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.747 -0.596 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.06 -10.37 28.17 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.46 1.242 . . . . 0.0 111.503 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.44 27.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 44.1 mtpt 52.01 -155.01 0.17 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.265 -1.138 . . . . 0.0 110.063 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 28' ' ' LYS . . . 60.6 117.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 53' ' ' MET . 47.7 p -79.91 -35.69 37.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.661 ' OE1' HG21 ' A' ' 51' ' ' THR . 39.1 mm-40 -80.04 120.09 23.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.091 0.948 . . . . 0.0 112.779 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 34' ' ' VAL . 92.1 t -132.05 83.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.724 ' HD3' ' SD ' ' A' ' 99' ' ' MET . 12.4 ttt180 -59.04 114.9 2.81 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.384 0.611 . . . . 0.0 111.664 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 50' ' ' ALA . 35.6 m -112.16 152.8 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 59.0 m -147.64 140.09 24.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.7 -0.625 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.829 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -115.96 131.64 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.98 160.02 25.75 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.696 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp-105 -116.93 129.94 56.38 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HA ' HG13 ' A' ' 44' ' ' VAL . 38.3 tt0 -102.92 140.02 37.73 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.3 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -133.27 155.25 49.73 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.09 -43.98 95.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.82 -44.09 67.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.549 -0.72 . . . . 0.0 111.055 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.83 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.6 tt0 -164.43 167.92 19.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.4 -0.813 . . . . 0.0 110.95 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 39' ' ' GLN . 59.6 t -119.16 137.27 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.1 p -130.04 168.23 17.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.29 -0.881 . . . . 0.0 111.224 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.792 ' HA ' HD23 ' A' ' 37' ' ' LEU . 52.5 mt-10 -79.92 154.07 28.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.706 -0.621 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 48' ' ' CYS . 89.8 t -118.05 -75.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.765 -0.585 . . . . 0.0 110.391 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.977 ' SG ' ' CG ' ' A' ' 63' ' ' ASP . 85.2 m -130.31 165.66 22.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.387 -0.821 . . . . 0.0 110.622 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.11 3.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.218 -0.926 . . . . 0.0 111.677 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -174.19 140.49 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.661 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -85.52 105.65 16.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.579 ' HA ' HD23 ' A' ' 58' ' ' LEU . 32.1 t80 -60.23 127.93 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.596 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.5 ' CG ' HD21 ' A' ' 58' ' ' LEU . 2.3 mmt -95.72 134.31 38.79 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.441 ' CG ' ' HA ' ' A' ' 30' ' ' THR . 34.8 mmt -56.96 -20.38 23.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.101 -0.999 . . . . 0.0 111.077 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.11 -12.83 8.06 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.249 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -129.98 159.94 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.985 -1.303 . . . . 0.0 111.223 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -109.85 131.95 54.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.698 -0.626 . . . . 0.0 110.264 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -93.95 153.88 17.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.486 -0.759 . . . . 0.0 110.861 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.6 p -101.72 140.62 35.77 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.545 0.688 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 50' ' ' ALA . 72.0 m-85 -100.2 30.97 3.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -60.0 -35.83 75.89 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.531 -0.731 . . . . 0.0 111.331 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -52.08 -25.93 9.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.977 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 2.8 p30 -113.66 11.54 18.21 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.611 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 59.0 137.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.057 0.932 . . . . 0.0 111.877 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 68' ' ' CYS . 19.0 mt 58.86 -131.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.306 -0.872 . . . . 0.0 110.315 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.556 ' H ' HG22 ' A' ' 67' ' ' ILE . 69.1 m 51.61 67.82 0.9 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.248 -1.533 . . . . 0.0 111.31 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 80' ' ' THR . 10.0 t -132.72 149.89 52.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.1 -140.02 4.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 72' ' ' SER . 71.2 m -129.01 164.92 22.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.723 -0.869 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 22.0 m -166.38 120.15 1.1 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -158.25 153.51 25.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.22 -124.36 35.61 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.26 12.09 26.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.748 -0.854 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -120.8 122.09 39.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.182 -0.949 . . . . 0.0 110.63 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.5 m -107.41 123.74 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.422 -0.799 . . . . 0.0 109.713 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.54 113.43 27.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 111.194 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 36' ' ' VAL . 91.5 mt -105.7 129.23 53.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.454 -0.779 . . . . 0.0 109.217 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 18' ' ' SER . 62.1 m -124.53 137.67 54.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 110.738 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 84' ' ' LEU . 59.5 mt -111.62 139.58 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.707 -0.621 . . . . 0.0 110.144 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 16' ' ' ILE . 82.1 mt-30 -120.02 120.53 36.6 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.997 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.68 51.91 0.73 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 81' ' ' ILE . 80.9 mt -99.69 130.03 45.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.987 . . . . 0.0 111.504 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -105.39 179.97 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 117' ' ' VAL . . . -59.97 -47.07 87.33 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.776 0.798 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.7 mtp -60.37 -39.94 89.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.147 0.498 . . . . 0.0 110.82 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -57.95 -27.11 63.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.6 -0.688 . . . . 0.0 111.018 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.4 m -50.0 140.02 12.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.62 -161.85 33.0 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.635 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.8 tm? -88.68 139.91 29.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.888 0.852 . . . . 0.0 112.086 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.884 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -127.58 128.19 45.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.73 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.7 mp -100.77 129.9 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.302 -0.874 . . . . 0.0 112.182 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.932 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.2 p -91.07 126.24 36.1 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.76 ' HD2' HD12 ' A' ' 109' ' ' ILE . 5.5 mtmt -116.72 145.75 43.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.137 -0.977 . . . . 0.0 110.145 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' A' ' 23' ' ' TYR . 26.6 t -142.6 104.57 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.964 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.5 mm-40 -133.23 140.09 47.32 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.599 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 106' ' ' LEU . 8.0 mt -93.01 81.14 4.56 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 103.779 -2.675 . . . . 0.0 103.779 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.724 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 1.4 mtt -80.51 -30.58 37.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.411 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.461 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 71.5 m-85 -75.45 -49.08 3.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.29 -0.881 . . . . 0.0 111.853 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 98' ' ' LEU . 41.3 Cg_endo -74.76 120.74 6.27 Favored 'Trans proline' 0 N--CA 1.518 2.924 0 C-N-CA 121.841 1.694 . . . . 0.0 114.813 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.45 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 63.1 Cg_endo -82.2 148.13 14.83 Favored 'Trans proline' 1 CA--C 1.659 6.758 0 CA-C-O 114.187 -2.505 . . . . 0.0 111.06 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.329 58.0 Cg_endo -116.39 58.25 0.38 Allowed 'Cis proline' 0 C--N 1.398 3.156 1 C-N-CA 95.048 -13.313 . . . . 0.0 109.053 10.955 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.2 t80 55.67 118.85 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.093 0 O-C-N 120.942 -1.099 . . . . 0.0 112.629 172.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 4.3 p90 -165.71 105.55 0.72 Allowed 'General case' 0 N--CA 1.529 3.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.0 tp -158.87 -149.38 0.21 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 118.692 0.678 . . . . 0.0 111.415 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.22 174.13 34.08 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.281 -1.438 . . . . 0.0 110.753 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.8 mm -120.26 163.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.954 -0.733 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.932 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -94.04 140.04 14.85 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.99 -38.26 82.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.479 -1.013 . . . . 0.0 110.393 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.77 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 128.87 148.53 6.68 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.011 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.626 HG21 HG23 ' A' ' 9' ' ' VAL . 98.0 m -118.15 140.01 50.42 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 8' ' ' VAL . 23.3 tt0 -89.28 129.99 35.75 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.221 -1.392 . . . . 0.0 108.741 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 89' ' ' THR . 88.8 mt -94.35 131.95 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.857 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.9 m-30 -106.71 149.92 26.8 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.139 0.495 . . . . 0.0 111.491 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' A' ' 86' ' ' ALA . 96.4 t . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.9 m80 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.373 0.606 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 71.0 t -125.76 129.68 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.8 132.14 52.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 110.558 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.512 ' NE2' HG12 ' A' ' 3' ' ' VAL . 17.2 mp0 -135.82 131.93 19.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.641 -0.662 . . . . 0.0 110.851 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.52 139.86 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.132 1.069 . . . . 0.0 109.799 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.18 -32.28 64.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.808 . . . . 0.0 109.443 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.51 157.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.916 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.3 t -139.91 136.64 38.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.666 0.746 . . . . 0.0 110.594 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 10' ' ' LEU . 2.8 mm? -97.63 125.13 42.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -86.4 151.25 23.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.425 -0.797 . . . . 0.0 110.245 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -75.82 172.24 13.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.552 -0.717 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -59.65 -29.0 67.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.01 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.702 ' CG ' HD13 ' A' ' 16' ' ' ILE . 3.0 tpt180 -59.93 -27.78 67.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.597 -0.689 . . . . 0.0 109.867 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.662 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.41 23.36 12.65 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.702 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -110.25 109.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 O-C-N 121.5 -1.0 . . . . 0.0 110.534 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -100.47 118.32 36.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB3' HG23 ' A' ' 80' ' ' THR . 81.7 p -123.95 140.58 52.84 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.531 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.0 p90 -149.92 164.86 34.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.891 -0.505 . . . . 0.0 109.895 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 97.1 t -122.65 114.16 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.134 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.833 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.05 107.49 19.42 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 3' ' ' VAL . 82.9 mt-10 -79.98 165.03 23.0 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 111.678 -176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.673 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.4 p90 -149.88 -179.95 7.55 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 106' ' ' LEU . . . -128.9 128.52 43.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -112.6 150.42 42.66 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.425 -0.797 . . . . 0.0 111.116 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.27 -19.31 38.65 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.712 1.375 . . . . 0.0 111.34 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.13 -165.81 29.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.77 126.5 38.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.638 -0.919 . . . . 0.0 110.728 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.65 38.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.682 -0.636 . . . . 0.0 109.588 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' MET . 62.8 p -79.9 -37.88 33.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 110.675 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -79.93 112.48 17.27 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.861 -0.735 . . . . 0.0 112.331 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 34' ' ' VAL . 85.3 t -131.97 82.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ttp85 -60.17 121.42 11.9 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.392 0.615 . . . . 0.0 111.43 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -124.34 132.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 49' ' ' ALA . 58.6 m -125.55 131.27 52.79 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.236 0.541 . . . . 0.0 110.66 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.991 HG22 HD13 ' A' ' 79' ' ' LEU . 87.9 t -104.54 139.15 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 46' ' ' GLU . 19.6 mt -125.12 164.02 21.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 111.587 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HG3' HG21 ' A' ' 47' ' ' VAL . 10.4 mtt-85 -116.51 91.64 3.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.606 ' HA ' HG13 ' A' ' 44' ' ' VAL . 6.5 tt0 -93.63 140.05 30.07 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.29 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -150.53 154.53 37.77 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.1 -42.88 91.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 96.4 p -70.21 -43.61 70.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.599 -0.688 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 11.5 mp0 -156.88 160.69 39.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.385 -0.822 . . . . 0.0 111.09 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 39' ' ' GLN . 60.3 t -130.35 130.39 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.3 p -139.91 165.88 26.14 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.452 -0.78 . . . . 0.0 111.416 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.808 ' HA ' HD23 ' A' ' 37' ' ' LEU . 72.0 mt-10 -81.07 160.3 24.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.631 -0.668 . . . . 0.0 109.832 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.525 HG12 ' OD2' ' A' ' 63' ' ' ASP . 60.1 t -123.75 -85.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.621 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 1.217 ' SG ' ' CG ' ' A' ' 60' ' ' PHE . 18.5 t -118.79 152.69 35.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.959 -1.088 . . . . 0.0 110.112 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 62' ' ' ASP . . . -167.81 128.52 1.41 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.391 -0.818 . . . . 0.0 112.654 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.0 161.42 5.66 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 58' ' ' LEU . 2.9 m -83.11 119.98 25.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.017 -1.052 . . . . 0.0 109.596 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 72' ' ' SER . 12.8 t80 -78.99 109.58 13.43 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.243 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 53' ' ' MET . 6.1 mmm -84.82 138.61 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.1 mmt -58.15 -20.2 38.8 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.16 -0.963 . . . . 0.0 110.921 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.73 -93.17 1.67 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -80.43 164.18 23.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.526 -0.985 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 40.3 tp10 -110.12 130.11 55.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.812 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 51' ' ' THR . 71.5 mt -76.03 169.49 18.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.465 -0.772 . . . . 0.0 110.467 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 p -96.53 164.27 12.68 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.217 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 49.4 m-85 -116.16 92.61 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.532 -0.73 . . . . 0.0 110.218 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.66 -28.79 67.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 49' ' ' ALA . 82.2 m-20 -61.3 -42.0 97.92 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.567 -0.708 . . . . 0.0 111.38 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.905 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . 23.9 t0 -100.02 11.99 37.98 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 122.038 -0.414 . . . . 0.0 112.035 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t 62.02 -67.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.998 -0.439 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.1 mt -132.1 73.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.98 . . . . 0.0 111.668 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 1.115 ' SG ' ' CB ' ' A' ' 60' ' ' PHE . 1.8 p -113.07 158.08 20.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.208 -0.932 . . . . 0.0 109.176 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 80' ' ' THR . 8.8 t -130.65 150.03 52.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.491 -0.756 . . . . 0.0 109.836 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.66 148.95 19.54 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.777 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 75.3 m -129.86 160.29 33.97 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 32.9 t -146.96 108.31 4.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -120.17 123.78 44.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.614 -0.678 . . . . 0.0 109.46 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 -120.55 23.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.88 19.21 20.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.982 . . . . 0.0 110.682 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.439 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.8 mt-30 -116.78 120.16 37.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -104.52 123.94 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.05 -1.031 . . . . 0.0 109.416 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 54.2 t-20 -103.79 108.03 19.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 111.372 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.991 HD13 HG22 ' A' ' 36' ' ' VAL . 68.0 mt -104.49 139.95 38.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.451 -0.78 . . . . 0.0 109.536 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.482 ' HB ' HG23 ' A' ' 69' ' ' THR . 59.6 m -140.84 152.02 44.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.816 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -120.01 139.87 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.441 ' HG2' HG13 ' A' ' 16' ' ' ILE . 38.7 mt-30 -115.79 121.54 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.658 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 51.96 0.7 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.816 HD21 HG21 ' A' ' 81' ' ' ILE . 77.7 mt -97.2 117.34 31.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.609 -0.936 . . . . 0.0 111.246 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -102.44 -179.73 4.06 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.05 92.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -38.52 89.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.724 -0.61 . . . . 0.0 110.523 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.38 -26.91 66.69 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.644 -0.66 . . . . 0.0 110.735 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.2 m -51.51 134.27 29.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.863 . . . . 0.0 110.557 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.8 -150.29 13.83 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.406 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 113' ' ' THR . 13.6 tp -107.57 134.48 50.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.664 -0.903 . . . . 0.0 111.833 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.896 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.9 m-85 -116.24 145.31 43.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.7 mp -112.68 129.73 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.357 -0.839 . . . . 0.0 111.96 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 94' ' ' CYS . 31.3 p -92.46 123.99 36.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HB3' ' H ' ' A' ' 35' ' ' THR . 8.4 tttt -117.79 138.79 51.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -0.802 . . . . 0.0 108.9 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.797 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.6 t -135.96 112.81 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.584 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 77.4 mt-10 -138.56 123.94 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.864 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 106' ' ' LEU . 8.9 mp -76.2 81.85 3.0 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 40.5 tpp -79.03 -52.17 8.6 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 88.5 m-85 -69.09 -38.24 10.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.37 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 29.1 Cg_endo -83.08 112.02 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 CA-C-N 119.832 0.976 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 58.9 Cg_endo -83.25 150.77 13.62 Favored 'Trans proline' 1 CA--C 1.665 7.065 1 CA-C-O 110.57 -4.012 . . . . 0.0 113.244 176.023 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' PRO 0.253 37.4 Cg_endo -89.69 174.38 23.49 Favored 'Cis proline' 0 C--N 1.403 3.396 1 C-N-CA 95.287 -13.214 . . . . 0.0 118.711 -8.782 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.9 t80 -82.05 127.49 33.15 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.562 -2.563 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -160.79 105.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.375 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 98' ' ' LEU . 3.4 tp -158.23 -144.17 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.757 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.29 174.44 39.55 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.726 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -123.85 168.76 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 122.082 -0.658 . . . . 0.0 109.732 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -112.18 144.93 17.88 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.76 -38.99 87.07 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.605 1.202 . . . . 0.0 110.345 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 138.86 163.73 9.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.025 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.537 HG21 HG23 ' A' ' 9' ' ' VAL . 98.3 m -124.01 133.84 53.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.988 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.5 tp60 -75.98 139.76 41.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 92' ' ' TYR . 52.3 mt -116.21 124.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.897 -1.127 . . . . 0.0 108.642 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.84 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.8 m-85 -104.42 140.13 38.37 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 t . . . . . 0 N--CA 1.49 1.571 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.831 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.438 ' C ' HG23 ' A' ' 3' ' ' VAL . 65.1 m170 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.339 0.59 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.1 t -147.95 144.84 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -117.01 117.7 30.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 111.552 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.02 ' OE1' ' SG ' ' A' ' 94' ' ' CYS . 1.2 mm-40 -142.34 141.36 20.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.617 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.27 138.11 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.216 1.114 . . . . 0.0 109.549 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.35 -30.21 67.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -149.57 156.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.951 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 113' ' ' THR . 13.9 t -140.18 151.27 21.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.31 0.576 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 116' ' ' TYR . 77.8 mt -110.06 130.03 55.6 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.472 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 135.34 33.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.507 -0.746 . . . . 0.0 110.595 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.02 173.34 6.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.714 -0.616 . . . . 0.0 110.513 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -60.12 -29.4 68.59 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.631 -0.668 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.713 ' HG3' HD13 ' A' ' 16' ' ' ILE . 23.6 tpp180 -60.33 -29.73 69.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.547 -0.721 . . . . 0.0 109.905 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.75 25.28 10.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 15' ' ' GLY . 1.8 mp -114.18 115.61 50.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.97 . . . . 0.0 110.271 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.03 127.4 53.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -127.22 133.59 50.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 111.617 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' HB3' HG21 ' A' ' 9' ' ' VAL . 51.1 p90 -143.63 167.02 23.24 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 88.6 t -128.89 124.38 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.475 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.702 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -99.99 109.04 21.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.2 tt0 -86.49 140.56 29.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.479 -0.763 . . . . 0.0 110.939 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -129.62 161.94 29.41 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.16 130.54 18.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.0 p -159.99 160.0 27.04 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 0.0 110.388 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.13 148.23 49.89 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.391 1.206 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.6 167.47 8.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.98 149.58 51.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.943 . . . . 0.0 110.318 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 149.96 33.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HE2' ' A' ' 54' ' ' MET . 43.3 p -79.99 -33.4 39.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.38 -0.825 . . . . 0.0 110.76 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 23.2 mm-40 -80.17 74.29 6.98 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.268 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 34' ' ' VAL . 14.5 m -91.98 87.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.551 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 72.3 ttt-85 -53.1 105.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.693 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -107.55 131.21 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.79 0.805 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.6 m -135.94 150.21 49.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 0.0 109.409 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.959 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.2 t -117.51 140.03 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 46' ' ' GLU . 17.4 mt -127.87 164.51 22.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.887 -1.133 . . . . 0.0 110.915 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -127.4 117.28 21.87 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.642 HE21 HD23 ' A' ' 91' ' ' LEU . 35.3 mt-30 -105.24 123.96 48.73 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.44 154.28 39.28 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.74 -43.8 94.07 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.467 -0.771 . . . . 0.0 110.422 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.3 m -68.0 -49.79 59.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.579 -0.7 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.3 mt-30 -154.5 160.75 41.74 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 111.096 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.3 t -125.97 134.23 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.592 -0.692 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -140.76 164.02 31.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.788 ' HA ' HD23 ' A' ' 37' ' ' LEU . 30.5 tt0 -79.91 156.9 27.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 109.841 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 98.4 t -113.64 -89.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.895 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 93.4 m -122.68 149.94 43.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.801 -1.187 . . . . 0.0 110.28 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -150.22 140.01 21.78 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.819 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -172.0 153.54 3.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -91.89 120.62 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.791 ' CA ' HD21 ' A' ' 58' ' ' LEU . 16.1 t80 -79.16 109.15 13.21 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.983 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.46 169.96 17.0 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 30' ' ' THR . 34.4 mmt -67.63 -28.77 68.01 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.001 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.91 35.63 1.48 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.297 -1.43 . . . . 0.0 112.57 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 81.6 m-20 -130.32 159.95 35.42 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 119.151 1.476 . . . . 0.0 110.272 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -83.41 139.98 32.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.791 HD21 ' CA ' ' A' ' 52' ' ' TYR . 6.6 mp -89.17 129.97 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 110.242 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 p -99.98 135.57 41.2 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.494 -0.754 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 95.2 m-85 -107.99 114.91 29.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.26 -43.72 95.91 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.565 -0.709 . . . . 0.0 112.833 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -149.38 -161.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.024 -1.047 . . . . 0.0 111.632 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 56.75 58.07 4.33 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.473 0.654 . . . . 0.0 110.088 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 57.74 164.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.62 85.75 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 110.465 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 60' ' ' PHE . 97.5 m -68.07 153.24 44.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.577 -0.702 . . . . 0.0 109.462 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -140.0 150.01 43.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 109.305 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.9 179.98 43.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 72' ' ' SER . 91.1 m -130.19 169.25 15.61 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.12 -0.635 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.482 ' N ' HG22 ' A' ' 71' ' ' THR . 44.5 m -155.04 124.57 6.43 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.2 p -141.09 145.53 35.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.464 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.8 -122.37 16.35 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -105.72 11.98 31.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.801 -0.823 . . . . 0.0 111.016 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -116.69 126.68 53.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.873 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -107.89 123.48 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.899 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -100.61 118.62 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.0 111.435 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 ' CG2' ' A' ' 36' ' ' VAL . 76.1 mt -111.84 137.22 50.09 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.2 m -128.32 140.21 51.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.253 -0.905 . . . . 0.0 110.927 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 84' ' ' LEU . 88.5 mt -116.85 132.79 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.638 -0.664 . . . . 0.0 110.102 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 16' ' ' ILE . 19.7 mt-30 -118.94 121.39 39.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.589 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.86 54.19 0.57 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 81' ' ' ILE . 76.2 mt -90.85 120.01 31.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.601 -0.941 . . . . 0.0 110.953 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -98.07 178.95 4.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.66 90.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.281 -0.887 . . . . 0.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -66.79 -37.44 84.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.696 -0.627 . . . . 0.0 110.565 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.88 -33.5 71.9 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -51.99 130.92 30.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.27 -142.02 7.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.642 HD23 HE21 ' A' ' 39' ' ' GLN . 18.0 tp -109.05 129.19 55.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.672 -0.899 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.801 ' CD1' HD12 ' A' ' 115' ' ' ILE . 73.3 m-85 -109.99 132.06 54.5 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -110.07 130.05 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.732 -0.605 . . . . 0.0 111.731 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.088 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 19.9 p -79.9 155.78 27.59 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 5.3 tptm -147.15 79.09 1.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 108.759 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 106' ' ' LEU . 3.6 p -95.79 115.24 34.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.147 0.975 . . . . 0.0 110.614 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 67.8 mm-40 -135.17 137.24 42.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.787 -0.571 . . . . 0.0 111.703 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.768 ' CD2' HD22 ' A' ' 106' ' ' LEU . 13.8 mt -83.98 75.46 10.13 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.4 ttm -79.9 -32.42 40.25 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.472 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.2 m-85 -87.03 -39.55 0.52 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.332 -0.855 . . . . 0.0 112.426 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 59.0 Cg_endo -92.59 118.71 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-O 121.556 0.565 . . . . 0.0 110.698 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.599 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 60.7 Cg_endo -91.13 156.01 3.84 Favored 'Trans proline' 1 CA--C 1.655 6.562 0 CA-C-O 113.372 -2.845 . . . . 0.0 111.123 177.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.599 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 44.2 Cg_endo -89.94 175.47 21.15 Favored 'Cis proline' 3 N--CA 1.644 10.334 1 C-N-CA 91.289 -14.88 . . . . 0.0 116.263 1.059 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 4.0 t80 -82.58 129.57 34.96 Favored 'General case' 0 C--N 1.266 -3.025 0 O-C-N 119.626 -1.921 . . . . 0.0 109.167 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -166.7 104.9 0.6 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.426 -1.421 . . . . 0.0 108.376 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.768 HD22 ' CD2' ' A' ' 98' ' ' LEU . 4.3 tp -157.71 -147.96 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.484 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.48 170.96 34.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.249 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.471 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.0 mm -115.22 146.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -1.087 . . . . 0.0 109.187 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 1.088 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -73.63 141.58 29.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -60.07 -30.59 69.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -1.046 . . . . 0.0 109.709 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.72 138.77 5.93 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.492 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 9' ' ' VAL . 94.5 m -111.64 139.78 46.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 1.012 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.1 tp60 -83.45 120.72 26.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.258 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.801 HD12 ' CD1' ' A' ' 92' ' ' TYR . 53.8 mt -96.79 114.23 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.619 -1.301 . . . . 0.0 108.592 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.78 ' CE2' HG21 ' A' ' 8' ' ' VAL . 12.4 m-85 -87.81 139.11 30.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.389 0.614 . . . . 0.0 111.552 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.4 t . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.603 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.293 0.568 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 128.11 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.329 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.884 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.21 128.83 56.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.453 -0.78 . . . . 0.0 110.737 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.087 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 27.1 mm100 -139.45 131.95 15.27 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.729 -0.607 . . . . 0.0 111.214 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.51 139.21 25.39 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.119 1.063 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -33.41 71.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.789 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 116' ' ' TYR . 3.1 p -152.72 156.26 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.529 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -131.84 155.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.845 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.9 mt -112.33 129.99 56.11 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.928 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.03 27.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.616 -0.677 . . . . 0.0 110.29 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.3 t -89.58 176.93 6.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.554 -0.716 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG3' HD13 ' A' ' 16' ' ' ILE . 7.8 tpm_? -59.97 -28.77 67.94 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.076 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.29 22.59 21.84 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.74 HD13 ' HG3' ' A' ' 14' ' ' ARG . 1.8 mp -114.73 114.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.501 -0.999 . . . . 0.0 109.877 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.76 124.02 49.92 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.642 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.1 p -132.8 150.01 52.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.008 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.685 ' HB3' HG21 ' A' ' 9' ' ' VAL . 32.4 p90 -152.06 163.11 40.0 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 87.2 t -119.4 122.71 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.301 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.087 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 41.4 t -100.78 100.54 11.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.884 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.4 pt-20 -79.95 149.97 30.66 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.318 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -132.68 173.56 11.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.04 120.59 22.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.391 -0.818 . . . . 0.0 111.154 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 106' ' ' LEU . 28.7 t -151.62 149.95 25.32 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 111.053 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.84 147.95 31.52 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.694 1.365 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.51 -176.15 0.44 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.89 160.05 36.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.845 . . . . 0.0 109.73 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 1.018 ' O ' ' SD ' ' A' ' 54' ' ' MET . . . -148.4 171.94 15.23 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.312 -0.867 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.833 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.8 p -86.26 -5.39 59.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.611 -0.681 . . . . 0.0 112.622 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -129.16 76.44 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.914 -1.514 . . . . 0.0 112.91 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HB ' ' CD2' ' A' ' 52' ' ' TYR . 92.0 t -91.94 86.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -63.16 123.33 18.35 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.366 0.603 . . . . 0.0 111.618 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.99 161.24 34.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.6 m -152.73 138.95 18.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.985 HG22 HD13 ' A' ' 79' ' ' LEU . 88.2 t -108.84 128.9 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 46' ' ' GLU . 11.0 mt -124.82 165.01 18.79 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.491 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB2' HG21 ' A' ' 47' ' ' VAL . 62.4 ttp180 -128.3 121.25 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.58 HE21 HD23 ' A' ' 91' ' ' LEU . 34.6 mt-30 -103.3 131.96 49.93 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.974 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -99.74 -174.17 2.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.94 -0.475 . . . . 0.0 109.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.43 -43.69 96.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 m -130.08 -3.28 4.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.814 . . . . 0.0 111.88 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.632 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 37.2 mt-30 -132.31 152.35 51.43 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.061 -1.024 . . . . 0.0 110.988 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 89.4 t -135.33 138.62 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.617 . . . . 0.0 109.864 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.1 p -136.9 162.8 32.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.584 -0.697 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.879 ' HA ' HD23 ' A' ' 37' ' ' LEU . 85.8 mt-10 -79.91 153.73 28.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.605 -0.684 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.189 HG12 ' SG ' ' A' ' 48' ' ' CYS . 86.5 t -120.72 -50.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.636 -0.665 . . . . 0.0 110.646 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 1.189 ' SG ' HG12 ' A' ' 47' ' ' VAL . 1.3 m -155.96 132.29 10.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.239 -0.913 . . . . 0.0 110.201 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -139.61 138.46 36.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.444 -0.785 . . . . 0.0 111.188 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.63 156.48 6.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.644 -0.66 . . . . 0.0 109.656 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -90.64 124.08 34.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 109.575 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.582 ' HA ' HD11 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.89 90.06 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.833 ' SD ' ' O ' ' A' ' 30' ' ' THR . 61.8 mmm -88.13 122.52 31.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 1.018 ' SD ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -59.83 -27.96 67.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.035 -1.04 . . . . 0.0 110.265 -178.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.45 -42.1 7.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -110.48 151.02 28.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.245 -1.15 . . . . 0.0 111.554 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -77.04 150.23 35.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.58 -0.7 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' TYR . 4.7 mp -71.15 136.93 48.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.514 -0.741 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.1 p -118.28 139.61 51.06 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.525 -0.734 . . . . 0.0 110.999 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 75.2 m-85 -107.63 112.0 24.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -68.0 -43.39 78.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.448 -0.782 . . . . 0.0 112.031 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' HB3' HD23 ' A' ' 61' ' ' LEU . 55.3 p-10 -142.51 -158.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.262 -0.899 . . . . 0.0 111.339 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.65 57.01 4.5 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.412 0.625 . . . . 0.0 110.271 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p 57.13 166.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.325 0.583 . . . . 0.0 110.95 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.95 131.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.739 -0.601 . . . . 0.0 110.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 82.8 m -130.05 165.42 22.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.709 -0.619 . . . . 0.0 109.667 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 80' ' ' THR . 8.2 t -136.05 141.37 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.2 153.74 25.25 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.8 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 59.2 m -139.99 157.36 45.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD2' ' A' ' 52' ' ' TYR . 15.3 t -146.0 108.04 4.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.772 . . . . 0.0 110.512 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.7 t -148.28 148.1 30.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.831 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.74 38.58 96.7 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.06 27.42 13.3 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.692 -0.887 . . . . 0.0 110.227 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -132.12 128.62 38.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.591 -0.693 . . . . 0.0 109.814 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.9 m -104.45 120.29 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.34 -0.85 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -100.97 110.1 22.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -0.899 . . . . 0.0 111.175 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.985 HD13 HG22 ' A' ' 36' ' ' VAL . 86.9 mt -103.01 131.98 49.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.726 . . . . 0.0 109.242 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.642 HG23 ' HB3' ' A' ' 18' ' ' SER . 94.8 m -130.88 150.33 52.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.335 -0.853 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 HD21 ' A' ' 84' ' ' LEU . 62.4 mt -124.47 141.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.809 -0.557 . . . . 0.0 109.977 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.434 ' CG ' HG13 ' A' ' 16' ' ' ILE . 24.0 mt-30 -120.01 122.06 40.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.745 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.46 41.38 1.14 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 81' ' ' ILE . 80.1 mt -89.35 129.95 35.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.956 . . . . 0.0 111.421 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -116.15 179.81 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.03 81.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.5 ttp -68.14 -35.86 78.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.64 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.522 -0.736 . . . . 0.0 111.387 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 115' ' ' ILE . 19.7 m -49.65 142.51 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.7 -165.24 35.02 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.58 HD23 HE21 ' A' ' 39' ' ' GLN . 21.1 tp -98.76 131.37 44.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.959 . . . . 0.0 112.75 -178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CE1' HD12 ' A' ' 115' ' ' ILE . 86.1 m-85 -114.23 139.2 49.59 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -108.91 141.45 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.386 -0.822 . . . . 0.0 111.818 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.038 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 17.3 p -104.66 112.72 25.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -100.87 143.08 31.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.22 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.74 106.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.465 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CG ' ' OH ' ' A' ' 104' ' ' TYR . 22.1 mp0 -131.32 130.13 42.35 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.566 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.7 ' CD1' HD23 ' A' ' 106' ' ' LEU . 12.1 mt -84.61 80.36 9.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.7 tpp -79.74 -52.85 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.186 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.451 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 94.0 m-85 -68.75 -44.25 30.85 Favored Pre-proline 0 N--CA 1.508 2.464 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.3 Cg_endo -79.14 110.46 2.74 Favored 'Trans proline' 0 N--CA 1.518 2.932 0 C-N-CA 121.136 1.224 . . . . 0.0 110.885 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.4 Cg_endo -83.18 155.22 14.63 Favored 'Trans proline' 1 CA--C 1.676 7.599 0 CA-C-O 111.686 -3.548 . . . . 0.0 105.643 -177.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 52.4 Cg_endo -88.07 -179.08 15.31 Favored 'Cis proline' 1 C--N 1.492 8.082 1 C-N-CA 95.527 -13.114 . . . . 0.0 116.297 -10.356 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' OH ' ' CG ' ' A' ' 97' ' ' GLU . 4.4 t80 -87.37 132.15 34.06 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 117.469 -3.27 . . . . 0.0 110.467 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 106' ' ' LEU . 51.4 t80 -163.43 92.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.042 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.7 HD23 ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -145.57 -148.36 0.24 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.074 -179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.61 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.1 179.0 38.58 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.8 mp -119.81 158.79 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 O-C-N 121.67 -0.9 . . . . 0.0 109.109 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.81 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -85.52 145.22 20.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.15 -34.54 73.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.297 -1.119 . . . . 0.0 110.727 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 122.95 135.27 4.56 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 9' ' ' VAL . 94.7 m -106.78 130.99 54.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' VAL . 44.7 tt0 -85.11 123.99 31.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.835 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 92' ' ' TYR . 82.3 mt -85.85 125.59 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.731 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.845 ' HB2' HD23 ' A' ' 10' ' ' LEU . 4.6 m-30 -95.84 158.87 15.25 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.209 0.528 . . . . 0.0 110.38 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.596 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 71.1 m80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.363 0.601 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.2 t -149.26 137.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.826 -0.546 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.47 127.33 53.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.557 -0.714 . . . . 0.0 109.876 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.004 ' CD ' ' SG ' ' A' ' 94' ' ' CYS . 14.0 mm-40 -139.95 131.52 14.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.658 -0.651 . . . . 0.0 111.745 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.65 139.93 28.79 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.141 1.074 . . . . 0.0 109.434 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.77 -33.81 74.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.725 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.68 155.77 7.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.615 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.64 HG23 HG21 ' A' ' 113' ' ' THR . 8.6 t -133.01 148.2 31.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.135 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.1 mt -104.52 127.48 52.25 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.81 175.18 6.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.465 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -109.45 175.81 5.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.42 -37.54 81.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.745 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HB3' HD13 ' A' ' 16' ' ' ILE . 19.8 mmt85 -59.63 -30.22 68.56 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.682 -0.636 . . . . 0.0 110.312 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.14 27.03 9.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.3 mp -102.74 100.4 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.65 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.22 118.4 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.676 ' HB2' HG23 ' A' ' 80' ' ' THR . 45.7 t -131.19 132.58 44.8 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.5 p90 -131.92 163.95 27.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.547 HG22 ' CG ' ' A' ' 78' ' ' ASN . 58.0 t -118.47 122.67 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.685 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.737 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 42.3 t -101.12 108.1 19.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -85.51 141.13 30.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.815 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.914 ' CB ' HG11 ' A' ' 96' ' ' VAL . 45.1 p90 -125.57 178.22 5.78 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -133.54 123.87 25.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.705 -0.622 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -116.18 132.71 23.13 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 109.941 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.51 -12.17 32.77 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.192 1.101 . . . . 0.0 112.159 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.03 27.2 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.358 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.82 136.47 44.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.694 -0.886 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.06 163.99 38.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.625 -0.672 . . . . 0.0 109.931 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 64.3 p -86.2 12.38 9.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.511 -0.743 . . . . 0.0 111.308 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' HG21 ' A' ' 51' ' ' THR . 34.0 mm-40 -137.22 97.6 3.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.002 -1.479 . . . . 0.0 113.216 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 40.0 t -122.4 79.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -58.99 131.62 51.59 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.254 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -129.26 164.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 49' ' ' ALA . 87.1 m -160.0 157.97 29.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 110.084 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.001 HG22 HD13 ' A' ' 79' ' ' LEU . 96.8 t -122.14 134.06 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.876 HD23 ' HA ' ' A' ' 46' ' ' GLU . 8.4 mt -130.03 163.96 25.37 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.523 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.724 ' HG3' HG21 ' A' ' 47' ' ' VAL . 39.0 mtm105 -123.68 119.99 31.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.573 HE21 HD23 ' A' ' 91' ' ' LEU . 26.2 mt-30 -106.01 129.7 54.08 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.512 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.39 154.97 44.35 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.68 -43.19 94.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 0.0 110.621 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.1 m -68.85 -49.99 53.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.9 mt-30 -155.0 162.89 40.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.343 -0.848 . . . . 0.0 111.284 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 39' ' ' GLN . 87.8 t -126.42 135.13 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.2 159.97 38.63 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.462 -0.774 . . . . 0.0 111.626 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.876 ' HA ' HD23 ' A' ' 37' ' ' LEU . 54.9 mt-10 -80.86 161.09 24.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.618 . . . . 0.0 110.71 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.724 HG21 ' HG3' ' A' ' 38' ' ' ARG . 96.1 t -127.64 -67.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.698 -0.626 . . . . 0.0 110.663 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 67.8 m -138.03 154.12 49.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.903 . . . . 0.0 111.77 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -160.56 136.13 8.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.787 -0.57 . . . . 0.0 110.579 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -155.38 146.56 22.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.575 -0.703 . . . . 0.0 109.12 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.554 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.4 m -80.05 127.55 32.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.241 -0.912 . . . . 0.0 110.116 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 1.2 t80 -79.99 103.47 9.9 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.3 mtp -95.81 131.09 42.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 21.0 mmt -59.76 -34.96 73.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.957 . . . . 0.0 110.733 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.18 -51.89 25.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.17 159.95 35.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.428 -1.042 . . . . 0.0 110.724 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -103.86 130.85 51.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 51' ' ' THR . 60.9 tp -95.41 150.21 20.53 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.518 -0.738 . . . . 0.0 109.656 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 p -104.86 167.39 9.75 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.63 -0.669 . . . . 0.0 110.61 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 34.8 m-85 -92.9 100.6 13.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.664 -0.648 . . . . 0.0 109.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -103.85 2.35 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.531 -0.731 . . . . 0.0 111.77 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -67.92 -41.78 82.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -109.92 7.49 23.89 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 33.63 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 67' ' ' ILE . 26.8 mm -141.98 10.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 0.0 111.246 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 16.8 p -127.92 138.96 52.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.669 -1.269 . . . . 0.0 111.069 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -139.93 156.14 46.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.19 -179.83 43.33 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 72' ' ' SER . 94.6 m -117.43 163.57 16.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.034 -0.686 . . . . 0.0 109.579 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 71' ' ' THR . 1.3 p -153.18 113.8 4.05 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.2 m -143.66 146.94 33.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.053 -1.029 . . . . 0.0 110.948 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.63 -123.95 27.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -110.11 19.88 18.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.813 -0.816 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -125.79 129.95 50.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.7 m -110.05 126.95 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.723 . . . . 0.0 109.806 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.547 ' CG ' HG22 ' A' ' 20' ' ' VAL . 39.4 t-20 -107.2 120.78 43.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.926 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.001 HD13 HG22 ' A' ' 36' ' ' VAL . 80.6 mt -108.09 132.01 54.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.387 -0.821 . . . . 0.0 109.269 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.676 HG23 ' HB2' ' A' ' 18' ' ' SER . 60.9 m -119.99 139.9 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.248 -0.907 . . . . 0.0 110.907 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.718 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -117.31 132.57 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.0 110.158 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.1 mt-30 -120.16 121.12 38.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.218 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.94 39.67 0.95 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 81' ' ' ILE . 80.4 mt -94.83 120.08 34.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.509 -0.994 . . . . 0.0 111.365 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' O ' HG21 ' A' ' 117' ' ' VAL . 19.1 mmt85 -102.27 178.86 4.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.09 83.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.232 -0.917 . . . . 0.0 109.819 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 ttm -68.02 -33.76 75.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.74 -0.6 . . . . 0.0 110.824 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.04 -17.3 64.36 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.589 -0.694 . . . . 0.0 111.67 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 115' ' ' ILE . 24.5 m -51.16 135.17 26.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.84 -155.26 19.22 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.778 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.573 HD23 HE21 ' A' ' 39' ' ' GLN . 15.1 tp -109.77 128.68 55.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.738 -0.86 . . . . 0.0 112.061 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.941 ' CD1' HD12 ' A' ' 115' ' ' ILE . 44.9 m-85 -112.29 144.88 40.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -111.59 143.32 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 111.432 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.004 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 17.5 p -105.82 117.23 33.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.5 tptt -102.11 141.15 35.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.505 -0.747 . . . . 0.0 109.652 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.914 HG11 ' CB ' ' A' ' 23' ' ' TYR . 16.5 t -145.14 103.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -136.56 125.46 24.18 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.269 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 HD23 ' A' ' 106' ' ' LEU . 7.6 mp -79.73 77.22 6.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.8 tpp -80.47 -51.36 8.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.977 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 92.6 m-85 -67.17 -40.21 26.42 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 111.737 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 39.6 Cg_endo -86.99 120.74 1.66 Allowed 'Trans proline' 0 N--CA 1.504 2.109 0 N-CA-C 110.201 -0.73 . . . . 0.0 110.201 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -97.8 159.21 0.9 Allowed 'Trans proline' 1 CA--C 1.662 6.879 0 CA-C-O 112.144 -3.357 . . . . 0.0 108.086 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.474 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 71.9 Cg_endo -92.54 171.11 21.06 Favored 'Cis proline' 2 C--N 1.464 6.616 1 C-N-CA 95.217 -13.243 . . . . 0.0 119.232 -6.178 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -74.31 125.15 27.82 Favored 'General case' 0 N--CA 1.527 3.418 0 O-C-N 120.303 -1.498 . . . . 0.0 111.338 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 105' ' ' TYR 0.262 52.9 t80 -152.82 59.97 0.8 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.499 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.834 HD23 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -130.78 -152.8 0.53 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.36 24.98 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.333 -1.413 . . . . 0.0 109.919 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -122.26 154.66 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.574 -0.957 . . . . 0.0 110.391 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.726 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -81.08 138.75 19.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 177.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -60.31 -29.69 69.01 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -1.169 . . . . 0.0 110.285 -179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.42 145.85 7.28 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.6 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.64 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -114.02 131.54 56.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.2 tp60 -80.83 119.94 24.04 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.166 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.941 HD12 ' CD1' ' A' ' 92' ' ' TYR . 86.8 mt -86.86 119.99 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.053 . . . . 0.0 109.112 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' HD23 ' A' ' 10' ' ' LEU . 7.6 m-30 -91.74 120.09 32.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.145 -0.347 . . . . 0.0 110.328 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 85' ' ' ARG . 96.3 t . . . . . 0 N--CA 1.491 1.598 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.834 178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.207 0.527 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' GLU . 93.3 t -123.85 134.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.517 -0.74 . . . . 0.0 110.075 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.38 54.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.108 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 25.9 mm100 -137.95 139.95 27.76 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.566 -0.709 . . . . 0.0 111.91 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.1 140.28 25.01 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 O-C-N 123.324 1.17 . . . . 0.0 109.109 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -151.7 159.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.713 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -137.82 156.02 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.374 0.607 . . . . 0.0 109.713 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.1 mt -117.08 126.6 53.09 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.705 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.92 138.18 40.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.428 -0.795 . . . . 0.0 109.22 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -75.98 -65.29 0.93 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.422 -0.798 . . . . 0.0 111.547 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -160.02 168.22 26.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.473 -0.767 . . . . 0.0 110.369 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.414 ' HB2' HD13 ' A' ' 16' ' ' ILE . 6.2 mtt180 54.16 21.05 2.83 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.674 -0.641 . . . . 0.0 111.252 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.12 35.59 64.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 16' ' ' ILE . 1.2 mp -99.14 97.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 0.0 108.906 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.27 114.36 28.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 80' ' ' THR . 32.8 t -121.07 131.97 54.6 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.689 0.757 . . . . 0.0 111.246 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.855 ' HB3' HG21 ' A' ' 9' ' ' VAL . 24.3 p90 -140.47 161.63 37.25 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 85.4 t -120.4 125.33 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.455 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.108 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.5 t -104.38 130.0 52.27 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.1 tt0 -102.83 138.75 39.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 111.378 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.873 ' CD2' HG11 ' A' ' 96' ' ' VAL . 19.7 p90 -137.32 -177.73 4.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.96 113.93 15.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.585 -0.697 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.5 p -141.75 164.37 34.93 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.542 -0.723 . . . . 0.0 110.151 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.678 ' HD2' HD21 ' A' ' 98' ' ' LEU . 43.4 Cg_endo -69.96 155.95 64.02 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.389 1.205 . . . . 0.0 110.095 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.2 19.96 51.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -119.93 32.61 5.97 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.212 -1.17 . . . . 0.0 110.775 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.11 140.04 47.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.652 -0.655 . . . . 0.0 110.342 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.512 ' O ' ' HE2' ' A' ' 53' ' ' MET . 40.3 p -92.03 10.72 27.9 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.528 -0.732 . . . . 0.0 110.572 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.579 ' OE1' HG21 ' A' ' 51' ' ' THR . 16.1 mm-40 -130.29 122.34 27.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.572 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 95.9 t -138.89 83.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 6.6 ttm180 -63.41 116.88 5.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.767 -0.583 . . . . 0.0 111.343 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 35.9 m -113.85 131.91 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.1 m -122.47 131.91 54.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.694 -0.629 . . . . 0.0 110.624 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.936 HG22 HD13 ' A' ' 79' ' ' LEU . 97.9 t -109.6 129.71 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.771 HD12 ' HE3' ' A' ' 95' ' ' LYS . 46.9 mt -125.46 165.14 18.98 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.87 ' HG3' HG21 ' A' ' 47' ' ' VAL . 75.0 mtm180 -121.31 119.92 33.59 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.718 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.8 tt0 -97.45 141.46 30.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -136.91 157.03 47.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.79 -40.17 87.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.5 m -75.61 -53.36 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.776 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.2 mt-30 -154.47 174.59 14.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.718 HG22 ' HA ' ' A' ' 39' ' ' GLN . 99.8 t -128.77 139.93 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -130.1 161.46 30.99 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.706 ' HA ' HD23 ' A' ' 37' ' ' LEU . 49.6 mt-10 -80.1 158.95 26.26 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 110.844 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 ' HG3' ' A' ' 38' ' ' ARG . 46.0 t -135.16 -66.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.226 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.683 ' SG ' HG12 ' A' ' 47' ' ' VAL . 71.3 m -129.93 142.65 50.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.26 -0.9 . . . . 0.0 111.22 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.85 131.97 14.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.657 -0.652 . . . . 0.0 110.278 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.9 157.61 14.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 0.0 110.334 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.579 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -102.21 116.01 31.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.578 ' N ' HD21 ' A' ' 58' ' ' LEU . 20.6 t80 -77.87 123.96 27.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.225 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 30' ' ' THR . 2.8 mtp -95.58 157.62 15.82 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.5 mmt -60.03 -27.63 67.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.843 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.04 48.01 0.99 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.971 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' A' ' 53' ' ' MET . 9.0 t-20 -157.81 -179.49 8.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.265 -1.138 . . . . 0.0 110.701 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -115.08 156.03 25.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 110.406 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' N ' ' A' ' 52' ' ' TYR . 85.3 mt -72.82 136.16 45.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.561 -0.712 . . . . 0.0 111.136 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.2 p -104.76 129.36 53.02 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.705 -0.622 . . . . 0.0 109.565 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 99.1 m-85 -119.99 66.2 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.761 . . . . 0.0 110.099 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.07 -39.48 90.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.536 -0.727 . . . . 0.0 110.767 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.58 131.27 44.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.434 -0.791 . . . . 0.0 110.728 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 52.17 49.01 21.51 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.492 -0.755 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -59.03 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.908 -0.495 . . . . 0.0 110.43 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 67' ' ' ILE . 49.0 mm 52.36 22.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.386 -1.446 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -160.03 160.65 33.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -123.88 139.92 53.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.55 121.72 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.978 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -130.06 155.12 46.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 68.9 m -160.06 137.95 9.94 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.857 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -140.27 140.06 35.65 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.89 -124.02 34.84 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -107.32 11.92 28.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.948 . . . . 0.0 110.927 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.0 mt-30 -116.65 129.29 56.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.122 -0.986 . . . . 0.0 111.016 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.7 m -110.12 126.23 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.433 -0.792 . . . . 0.0 110.221 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -98.64 117.89 34.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 111.585 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 36' ' ' VAL . 76.4 mt -110.38 130.47 55.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.615 -0.678 . . . . 0.0 109.52 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.488 HG23 ' HB2' ' A' ' 18' ' ' SER . 60.1 m -129.69 138.15 51.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.388 -0.82 . . . . 0.0 110.803 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 92' ' ' TYR . 84.3 mt -108.06 130.1 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 75.4 mt-30 -118.99 119.74 35.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.086 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.84 35.96 3.1 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.571 HD11 ' CG2' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -99.35 131.3 45.46 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.689 -0.889 . . . . 0.0 110.105 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 84' ' ' LEU . 72.3 mtt85 -86.26 160.6 19.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 109.921 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -29.03 66.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 26.1 ptm -66.52 -30.04 70.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.46 0.648 . . . . 0.0 109.526 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -77.48 -4.03 43.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.751 -0.593 . . . . 0.0 111.387 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 115' ' ' ILE . 59.4 m -55.31 140.01 40.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.958 -1.089 . . . . 0.0 109.62 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.63 -148.04 11.55 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.793 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 113' ' ' THR . 17.3 tp -106.93 130.23 54.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.741 -0.858 . . . . 0.0 111.754 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.866 ' CD1' HD12 ' A' ' 115' ' ' ILE . 50.8 m-85 -112.57 135.17 53.6 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -100.67 140.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 0.0 111.678 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 1.108 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 13.7 p -106.68 122.6 46.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.925 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.1 mttt -120.04 146.12 46.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.148 -0.97 . . . . 0.0 110.056 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 23' ' ' TYR . 2.7 t -140.44 107.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.529 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 99' ' ' MET . 2.5 mp0 -132.52 125.18 29.98 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.598 -0.841 . . . . 0.0 113.216 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 106' ' ' LEU . 9.4 mp -74.34 80.2 1.86 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 12.9 mmt -79.58 -48.15 14.29 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.556 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 87.0 m-85 -66.66 -42.92 48.36 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.955 -1.091 . . . . 0.0 113.531 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 51.4 Cg_endo -86.07 113.68 1.27 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 O-C-N 122.657 0.819 . . . . 0.0 112.697 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 60.1 Cg_endo -83.06 141.03 10.27 Favored 'Trans proline' 1 CA--C 1.654 6.515 0 CA-C-O 110.774 -3.928 . . . . 0.0 107.861 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.433 55.2 Cg_endo -102.61 179.54 3.91 Favored 'Cis proline' 3 C--N 1.524 9.813 1 C-N-CA 91.932 -14.612 . . . . 0.0 116.815 6.991 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.402 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 5.9 t80 -82.2 126.9 32.61 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 116.795 -3.691 . . . . 0.0 108.847 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.25 47.8 t80 -158.63 101.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.985 -0.447 . . . . 0.0 110.374 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 98' ' ' LEU . 2.8 tp -160.31 -143.46 0.1 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.542 -0.724 . . . . 0.0 110.454 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.27 -173.79 23.64 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.43 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.925 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.251 46.8 mm -131.46 168.87 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.406 -1.055 . . . . 0.0 110.347 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.833 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -105.95 134.13 11.95 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -60.1 -36.4 77.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.094 -1.239 . . . . 0.0 110.519 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.5 153.1 8.1 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.318 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.757 HG21 HG23 ' A' ' 9' ' ' VAL . 89.1 m -121.84 139.42 53.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.906 ' HB3' HG23 ' A' ' 8' ' ' VAL . 16.3 tp60 -79.95 138.21 37.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.866 HD12 ' CD1' ' A' ' 92' ' ' TYR . 46.8 mt -110.07 124.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CE2' HG21 ' A' ' 8' ' ' VAL . 16.7 m-30 -100.84 133.63 45.03 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.084 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 84' ' ' LEU . 98.0 t . . . . . 0 N--CA 1.49 1.545 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.063 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.453 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.325 0.583 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -148.29 144.34 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.85 -0.531 . . . . 0.0 109.862 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.65 127.07 51.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.589 -0.694 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.926 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 15.1 mm100 -142.12 130.65 11.89 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.642 -0.661 . . . . 0.0 111.3 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.64 139.97 31.87 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.175 1.092 . . . . 0.0 109.367 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.01 69.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.954 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -154.23 162.9 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.26 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' A' ' 113' ' ' THR . 8.3 t -141.74 151.86 19.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.954 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.4 mt -110.61 127.03 55.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.26 148.98 23.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.413 -0.805 . . . . 0.0 110.984 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -69.41 172.16 7.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.603 -0.686 . . . . 0.0 110.521 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -60.1 -36.05 76.57 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.557 -0.714 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.653 ' CG ' HD13 ' A' ' 16' ' ' ILE . 27.1 tpt180 -57.16 -25.49 59.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.556 -0.715 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.603 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 101.14 26.44 7.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.653 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -108.06 112.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 121.626 -0.926 . . . . 0.0 110.52 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -110.54 124.74 52.39 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.794 ' OG ' HG23 ' A' ' 80' ' ' THR . 53.0 m -126.97 140.09 52.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.583 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.6 p90 -148.55 163.5 37.02 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 77' ' ' VAL . 63.2 t -130.31 123.73 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.731 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 77' ' ' VAL . 37.6 t -100.01 108.04 20.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 tt0 -84.97 139.45 31.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 0.0 110.519 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 96' ' ' VAL . 41.1 p90 -130.6 177.6 7.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 0.0 109.6 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.94 138.1 35.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.85 -0.532 . . . . 0.0 110.157 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.7 p -125.83 149.83 66.95 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.95 -13.98 34.89 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.462 1.243 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.6 -170.13 18.02 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.99 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.542 -0.975 . . . . 0.0 110.52 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -139.43 151.67 46.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.62 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' MET . 32.4 p -79.9 -43.59 21.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 111.097 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.4 mm-40 -79.68 84.77 5.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.021 -0.671 . . . . 0.0 112.713 -175.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.719 HG11 ' OH ' ' A' ' 52' ' ' TYR . 48.1 t -97.79 89.38 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.705 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -67.15 123.42 20.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.915 -0.491 . . . . 0.0 110.703 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -118.48 134.75 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.58 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.4 m -134.41 159.71 40.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.411 -0.805 . . . . 0.0 110.025 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.97 HG22 HD13 ' A' ' 79' ' ' LEU . 84.5 t -128.84 139.24 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 46' ' ' GLU . 6.2 mt -131.16 171.0 13.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.687 -1.258 . . . . 0.0 111.67 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 47' ' ' VAL . 89.9 mtt180 -125.72 118.39 25.48 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.624 HE21 HD23 ' A' ' 91' ' ' LEU . 21.8 mt-30 -101.78 126.25 48.61 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.391 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -97.16 -171.57 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.21 -43.81 95.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 111.019 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -131.96 -0.16 3.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 111.949 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 62.8 mt-30 -135.1 155.59 50.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.06 -1.025 . . . . 0.0 110.943 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.8 139.73 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.604 -0.685 . . . . 0.0 109.629 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.9 p -127.03 160.1 32.13 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.437 -0.789 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 37' ' ' LEU . 77.0 mt-10 -86.45 160.04 19.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.647 -0.658 . . . . 0.0 110.742 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 71.5 t -123.41 -71.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.807 -0.558 . . . . 0.0 110.232 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' CB ' ' A' ' 63' ' ' ASP . 80.7 m -147.17 153.71 40.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.31 30.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.508 -0.745 . . . . 0.0 111.258 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 59' ' ' THR . . . -170.44 155.68 5.21 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.601 -0.687 . . . . 0.0 109.658 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' N ' ' A' ' 33' ' ' ARG . 2.8 m -116.27 122.76 45.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.719 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.1 p90 -94.05 124.39 38.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.307 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 3.2 mmt -60.62 -44.7 96.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 166.44 102.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.46 63.0 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.93 159.86 23.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -1.026 . . . . 0.0 110.472 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -70.72 151.6 44.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -90.16 123.89 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.577 -0.702 . . . . 0.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 53.9 p -92.57 131.91 37.3 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 67.9 m-85 -113.86 123.92 50.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.764 . . . . 0.0 110.363 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.74 -36.06 77.93 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.485 -0.759 . . . . 0.0 109.79 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -140.07 174.46 10.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 109.671 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CB ' ' SG ' ' A' ' 48' ' ' CYS . 85.8 m-20 52.65 51.02 16.89 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.1 m -52.36 -21.8 3.95 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.622 -0.674 . . . . 0.0 111.382 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.69 -21.88 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.271 -0.893 . . . . 0.0 110.811 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.3 m -72.43 126.36 29.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.342 -0.849 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.58 HG21 ' NE2' ' A' ' 82' ' ' GLN . 9.2 t -139.98 149.93 43.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.99 -171.52 42.95 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 72' ' ' SER . 94.4 m -129.73 168.46 16.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.939 -0.742 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 71' ' ' THR . 97.2 p -138.33 152.51 48.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.505 -0.747 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -133.7 -173.64 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.746 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -49.67 76.09 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.6 3.86 6.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.463 -1.022 . . . . 0.0 111.272 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 19.2 tt0 -124.27 129.62 51.08 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.09 -1.006 . . . . 0.0 110.851 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.8 m -113.23 132.84 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 64.8 t-20 -110.11 115.97 30.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.97 HD13 HG22 ' A' ' 36' ' ' VAL . 86.6 mt -111.47 133.05 54.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 109.752 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.794 HG23 ' OG ' ' A' ' 18' ' ' SER . 94.5 m -130.87 145.06 51.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.34 -0.85 . . . . 0.0 110.811 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -119.92 140.08 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.611 -0.681 . . . . 0.0 109.874 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.58 ' NE2' HG21 ' A' ' 69' ' ' THR . 6.7 mt-30 -123.83 121.93 36.68 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.803 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.36 46.37 1.0 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.813 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -90.03 122.79 33.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.635 -0.92 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -102.59 178.0 4.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.69 95.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.325 -0.86 . . . . 0.0 109.401 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.8 ttm -63.45 -39.98 95.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.753 -0.592 . . . . 0.0 110.742 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.79 -21.06 62.71 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.598 -0.689 . . . . 0.0 111.025 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.9 m -51.84 140.01 20.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.921 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.88 -158.59 31.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD23 HE21 ' A' ' 39' ' ' GLN . 17.2 tp -108.2 123.99 49.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.637 -0.919 . . . . 0.0 111.97 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.938 ' CD1' HD12 ' A' ' 115' ' ' ILE . 51.0 m-85 -103.18 140.02 37.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.862 HG23 ' O ' ' A' ' 110' ' ' GLY . 4.2 mp -111.33 130.59 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.665 -0.647 . . . . 0.0 111.775 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.926 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 20.2 p -79.97 157.91 26.71 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.782 ' HG3' HD12 ' A' ' 109' ' ' ILE . 7.9 tttt -153.65 97.2 2.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.93 -1.106 . . . . 0.0 109.457 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.868 HG22 ' CD2' ' A' ' 106' ' ' LEU . 4.0 p -111.17 116.78 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.9 0.857 . . . . 0.0 111.37 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -135.7 124.15 23.46 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.914 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.858 HD23 HD13 ' A' ' 106' ' ' LEU . 4.1 mm? -75.47 76.48 2.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.9 ttm -78.73 -40.42 33.56 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 83.4 m-85 -62.97 -45.72 86.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.234 -0.986 . . . . 0.0 112.446 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 56.2 Cg_endo -81.3 129.62 6.79 Favored 'Trans proline' 0 C--O 1.284 2.805 0 O-C-N 122.776 0.882 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 72.1 Cg_endo -83.86 166.14 13.32 Favored 'Trans proline' 1 CA--C 1.656 6.601 0 CA-C-O 113.526 -2.781 . . . . 0.0 108.966 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.349 56.6 Cg_endo -96.47 50.54 1.46 Allowed 'Cis proline' 2 C--N 1.477 7.331 1 C-N-CA 89.174 -15.761 . . . . 0.0 115.439 -7.756 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.0 t80 67.36 122.26 0.02 OUTLIER 'General case' 1 N--CA 1.554 4.727 1 O-C-N 115.783 -4.323 . . . . 0.0 112.965 179.931 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.476 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.1 p90 -159.84 100.3 1.42 Allowed 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.31 -1.494 . . . . 0.0 109.91 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.868 ' CD2' HG22 ' A' ' 96' ' ' VAL . 1.4 tp -160.24 -146.66 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.654 ' O ' HD13 ' A' ' 109' ' ' ILE . . . -159.71 170.69 35.96 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.049 -1.548 . . . . 0.0 111.254 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.782 HD12 ' HG3' ' A' ' 95' ' ' LYS . 22.8 mm -124.18 149.68 28.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.685 -0.891 . . . . 0.0 109.25 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.862 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -91.41 144.71 17.34 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -68.12 -24.71 65.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.242 . . . . 0.0 110.592 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 126.53 165.79 12.05 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.137 -1.506 . . . . 0.0 113.849 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 59.5 m -129.28 127.63 41.58 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.954 ' HB3' HG23 ' A' ' 8' ' ' VAL . 8.8 tp-100 -67.98 142.72 55.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.93 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.938 HD12 ' CD1' ' A' ' 92' ' ' TYR . 64.6 mt -118.5 126.38 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.85 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.1 m-85 -110.16 139.98 44.74 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.834 -0.541 . . . . 0.0 110.328 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 84.8 t . . . . . 0 N--CA 1.491 1.585 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.449 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.9 m80 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.439 0.638 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.833 HG12 ' OE1' ' A' ' 5' ' ' GLN . 53.3 t -147.04 148.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -135.02 135.81 41.63 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.051 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.833 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -140.0 146.49 46.85 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.648 -0.658 . . . . 0.0 110.095 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 42.6 Cg_endo -69.87 147.95 63.31 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.254 1.134 . . . . 0.0 109.565 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.93 -20.77 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.835 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.7 p -160.6 160.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.029 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 113' ' ' THR . 33.6 t -137.13 159.6 36.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.155 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.698 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.8 mt -120.0 130.37 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.289 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -100.89 133.37 45.46 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -135.81 162.43 32.81 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.289 -0.882 . . . . 0.0 112.476 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t 59.31 -115.87 0.78 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.728 -0.608 . . . . 0.0 110.827 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 16' ' ' ILE . 5.9 mtt180 -59.93 -13.06 9.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 111.346 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.22 43.47 5.91 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.3 mm -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -98.59 124.1 43.16 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.998 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 80' ' ' THR . 15.0 t -126.2 131.29 52.01 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 28.2 p90 -139.73 165.82 26.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.742 -0.599 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 57.5 t -123.92 127.27 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.859 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.675 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -110.03 119.79 40.41 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -93.16 154.25 18.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.935 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' HG11 ' A' ' 96' ' ' VAL . 45.8 p90 -134.01 -175.99 4.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.64 116.95 20.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.351 -0.843 . . . . 0.0 111.799 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 106' ' ' LEU . 69.8 m -161.68 155.89 18.97 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.712 -0.618 . . . . 0.0 109.696 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.97 -19.94 45.4 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.286 1.151 . . . . 0.0 110.733 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.98 35.9 33.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -102.64 26.86 7.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.366 -1.079 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -148.19 144.74 27.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 53' ' ' MET . 16.1 p -80.28 -39.11 29.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.731 0.777 . . . . 0.0 111.655 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.694 ' OE1' HG21 ' A' ' 51' ' ' THR . 4.7 mm-40 -80.19 82.85 6.16 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.918 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 86.8 t -93.67 84.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.798 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 60.1 ttt180 -59.98 123.17 16.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.676 -0.64 . . . . 0.0 111.084 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 32' ' ' VAL . 31.9 m -123.4 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.8 m -120.92 131.61 54.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.236 0.541 . . . . 0.0 110.636 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.837 HG22 HD13 ' A' ' 79' ' ' LEU . 86.4 t -107.76 130.39 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD12 ' HE3' ' A' ' 95' ' ' LYS . 78.9 mt -124.62 169.93 11.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.992 -1.068 . . . . 0.0 111.958 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -130.26 121.39 26.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.576 HE21 HD23 ' A' ' 91' ' ' LEU . 32.7 mt-30 -110.24 131.98 54.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.346 -0.846 . . . . 0.0 111.061 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.36 152.77 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.57 -44.21 93.38 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 0.0 110.543 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.44 -44.87 66.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.3 mt-30 -154.89 160.16 40.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.469 -0.769 . . . . 0.0 111.263 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 92.2 t -126.86 139.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -145.21 160.38 41.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.453 -0.779 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 13.7 mt-10 -80.71 156.16 26.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.691 -0.631 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 48' ' ' CYS . 85.4 t -114.49 -83.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.345 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' ' OD2' ' A' ' 63' ' ' ASP . 80.8 m -122.0 160.9 23.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 110.866 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.37 135.55 6.03 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.91 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 59' ' ' THR . . . -172.1 165.34 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.419 -0.8 . . . . 0.0 110.594 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.694 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.9 m -97.9 123.94 42.1 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 27.6 t80 -88.31 106.79 18.46 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.135 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -76.17 157.86 32.29 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.4 mmt -59.64 -28.5 67.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.852 -1.155 . . . . 0.0 110.084 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.84 -79.04 0.17 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 58' ' ' LEU . 25.1 t30 -154.15 178.49 9.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.39 -1.065 . . . . 0.0 110.665 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.715 ' C ' HD22 ' A' ' 58' ' ' LEU . 7.2 tp10 -120.07 120.15 35.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.65 -0.656 . . . . 0.0 109.746 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 58' ' ' LEU . 2.4 mm? -124.28 46.22 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.571 HG21 ' HB1' ' A' ' 50' ' ' ALA 0.285 36.8 p -116.4 -132.14 0.32 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.791 -0.568 . . . . 0.0 110.909 -178.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 57' ' ' GLU . 39.8 m-85 60.57 25.12 14.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.825 -1.172 . . . . 0.0 109.426 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.72 -36.42 80.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 111.402 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -59.63 -43.28 93.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.413 -0.805 . . . . 0.0 111.812 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 1.045 ' OD2' ' SG ' ' A' ' 48' ' ' CYS . 95.9 m-20 -92.88 -13.2 29.29 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.164 0.507 . . . . 0.0 110.78 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t 42.4 24.93 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -144.85 -43.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.018 -1.051 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 22.9 p -67.82 134.64 51.29 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -0.857 . . . . 0.0 111.344 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -130.02 139.98 50.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA3' HD23 ' A' ' 79' ' ' LEU . . . -139.05 158.02 25.08 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.357 -1.401 . . . . 0.0 111.111 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.1 m -130.05 159.92 35.26 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 53.4 m -145.93 127.24 14.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -139.96 129.99 24.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.774 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.84 -124.07 35.08 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -106.45 16.43 24.7 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.933 . . . . 0.0 110.715 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.3 mt-30 -119.95 123.92 44.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 111.09 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -104.54 121.82 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.661 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.415 ' OD1' HG22 ' A' ' 20' ' ' VAL . 55.5 t30 -101.43 107.8 19.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.119 -0.988 . . . . 0.0 111.391 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.837 HD13 HG22 ' A' ' 36' ' ' VAL . 61.6 mt -97.34 131.92 43.56 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.449 -0.782 . . . . 0.0 109.673 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 18' ' ' SER . 59.2 m -124.42 139.2 54.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 0.0 111.034 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.622 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -113.55 129.94 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.728 -0.608 . . . . 0.0 109.618 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 16' ' ' ILE . 35.2 mt-30 -112.54 118.26 34.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.282 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.67 51.37 0.75 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 81' ' ' ILE . 76.6 mt -84.59 129.79 34.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.546 -0.973 . . . . 0.0 111.381 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -112.21 175.48 5.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.06 94.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.875 0.845 . . . . 0.0 109.855 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.2 mmt -66.17 -32.94 74.68 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.191 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.11 -24.91 67.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.44 -0.787 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 115' ' ' ILE . 42.4 m -51.88 137.85 25.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.52 -163.83 34.76 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.576 HD23 HE21 ' A' ' 39' ' ' GLN . 15.7 tp -94.77 129.94 41.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.886 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CD2' HD12 ' A' ' 115' ' ' ILE . 78.5 m-85 -113.44 136.35 52.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -104.16 133.05 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.429 -0.795 . . . . 0.0 112.117 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.822 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.6 p -97.49 122.34 40.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.907 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.7 mttt -119.1 143.86 46.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.363 -0.836 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' CD1' ' A' ' 106' ' ' LEU . 11.1 t -136.51 111.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.889 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -132.39 130.22 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.34 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 31.7 mt -86.94 82.84 7.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.798 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 3.4 ttm -82.67 -45.92 13.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.904 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 91.0 m-85 -69.71 -42.89 20.17 Favored Pre-proline 0 N--CA 1.508 2.456 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HG3' ' HB1' ' A' ' 29' ' ' ALA . 60.7 Cg_endo -82.36 143.09 12.25 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.734 -1.295 . . . . 0.0 108.734 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.431 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 53.1 Cg_endo -92.88 173.04 2.04 Favored 'Trans proline' 1 CA--C 1.658 6.72 0 CA-C-O 113.417 -2.826 . . . . 0.0 107.536 177.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 88.5 Cg_endo -92.18 49.39 1.24 Allowed 'Cis proline' 2 C--N 1.503 8.698 1 C-N-CA 91.326 -14.864 . . . . 0.0 115.228 -14.585 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 2.3 t80 55.82 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 118.692 -2.505 . . . . 0.0 111.692 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -147.19 105.74 3.8 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 119.617 -1.927 . . . . 0.0 108.777 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.731 ' CD1' HG12 ' A' ' 96' ' ' VAL . 1.7 mt -159.3 -157.97 0.63 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.829 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -151.22 -167.61 14.94 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.907 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.258 46.6 mm -134.93 169.39 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.561 -0.964 . . . . 0.0 110.5 -178.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.822 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -104.48 139.49 14.61 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.26 -36.81 78.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.388 -1.066 . . . . 0.0 110.536 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.81 144.49 5.92 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.691 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -115.5 137.45 52.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.589 ' HB3' HG23 ' A' ' 8' ' ' VAL . 12.8 tt0 -89.92 124.05 34.38 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.371 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.697 HD12 ' CD2' ' A' ' 92' ' ' TYR . 82.7 mt -90.45 129.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.835 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.7 m-30 -100.35 140.0 35.21 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.422 0.63 . . . . 0.0 111.976 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.026 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.142 0.496 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.2 132.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 110.001 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.41 54.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.632 -0.668 . . . . 0.0 109.722 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 1.079 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 96.3 mm-40 -137.34 148.02 60.35 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.785 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.0 152.83 68.22 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.429 1.226 . . . . 0.0 109.146 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.98 -12.17 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 110.792 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' HE2' ' A' ' 116' ' ' TYR . 2.3 p -139.95 137.62 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.67 ' CG2' HG21 ' A' ' 113' ' ' THR . 8.9 t -137.85 145.66 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.127 -1.608 . . . . 0.0 110.846 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 116' ' ' TYR . 70.8 mt -114.84 148.31 38.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.465 -0.772 . . . . 0.0 110.539 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.88 -171.5 1.84 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.513 -0.742 . . . . 0.0 110.413 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 t -123.84 172.87 8.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -60.79 -39.13 87.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.469 -0.769 . . . . 0.0 109.744 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.471 ' CB ' HD13 ' A' ' 16' ' ' ILE . 22.4 mmt85 -60.51 -28.04 68.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.0 109.854 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 27.14 8.25 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' CB ' ' A' ' 14' ' ' ARG . 1.3 mp -97.73 99.89 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.3 126.11 51.74 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -133.83 149.55 51.39 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.092 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.11 163.94 39.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 68.9 t -119.91 124.04 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.033 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.079 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.3 t -102.78 107.91 18.94 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -86.96 141.55 28.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 112.358 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -127.38 174.72 8.76 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.34 131.87 21.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.843 . . . . 0.0 111.483 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 106' ' ' LEU . 6.4 t -164.64 153.05 10.89 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.676 -0.64 . . . . 0.0 110.555 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.86 149.86 48.47 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.654 1.344 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.85 -179.19 5.34 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -132.83 151.06 52.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.71 -0.876 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.07 48.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.599 -0.688 . . . . 0.0 109.615 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 54' ' ' MET . 57.9 p -79.81 -39.06 31.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.335 -0.853 . . . . 0.0 110.649 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 38.0 mm-40 -79.76 76.72 6.42 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.447 -175.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 34' ' ' VAL . 91.3 t -94.25 82.03 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HE ' ' HE3' ' A' ' 99' ' ' MET . 18.7 ttp85 -59.5 121.53 11.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.821 -0.549 . . . . 0.0 110.955 -178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -125.35 139.86 50.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.571 0.7 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 72.1 m -135.22 133.06 38.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.033 -0.417 . . . . 0.0 109.982 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 79' ' ' LEU . 95.4 t -105.11 132.35 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.544 -0.723 . . . . 0.0 109.123 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.751 HD12 ' HE3' ' A' ' 95' ' ' LYS . 83.1 mt -126.41 168.01 14.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.128 -0.982 . . . . 0.0 111.176 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -129.61 128.54 42.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.553 HE21 HD23 ' A' ' 91' ' ' LEU . 30.8 mt-30 -109.86 132.05 54.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.322 -0.861 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.36 178.76 5.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.932 -0.48 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.33 -40.12 89.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.0 111.514 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.4 m -118.37 -19.96 8.68 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 112.112 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' C ' HG23 ' A' ' 44' ' ' VAL . 83.9 mm-40 -131.79 179.29 6.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.14 -0.975 . . . . 0.0 112.142 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.464 HG23 ' C ' ' A' ' 43' ' ' GLN . 84.5 t -149.88 143.52 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.81 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -138.72 156.13 47.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.455 -0.778 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 68.6 mt-10 -80.16 147.57 31.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 111.54 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.1 t -102.89 -73.92 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.952 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 14.5 p -159.92 164.65 33.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 110.133 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -169.39 161.01 9.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.205 -0.934 . . . . 0.0 111.603 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . . . -172.0 157.68 4.47 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -84.58 119.82 25.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.681 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 71' ' ' THR . 44.2 t80 -79.96 99.52 7.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.682 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 mmt -71.78 138.11 48.14 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 8.8 tpp -68.03 -19.99 64.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.73 -21.12 8.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.94 161.3 28.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -1.151 . . . . 0.0 110.701 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -121.75 124.39 44.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.408 -0.808 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 51' ' ' THR . 69.3 mt -93.16 166.14 12.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 p -119.75 135.04 55.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.784 -0.572 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.952 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 5.3 m-30 -67.2 136.71 55.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.4 tt -68.97 -42.06 77.1 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -118.25 -172.12 2.2 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.915 -1.115 . . . . 0.0 112.615 -177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 56.18 56.77 5.55 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.444 0.64 . . . . 0.0 110.88 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.1 m 52.09 26.64 3.95 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.551 -0.718 . . . . 0.0 110.705 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt 53.98 76.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.503 -0.748 . . . . 0.0 110.762 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.524 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -64.74 149.98 48.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.29 -0.882 . . . . 0.0 108.735 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -119.11 143.57 47.1 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.57 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -130.17 140.91 12.13 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 61.4 m -116.1 160.9 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.856 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 46.4 t -143.75 109.8 5.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.75 -0.594 . . . . 0.0 110.487 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -151.77 140.63 20.98 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.517 -0.74 . . . . 0.0 110.319 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.81 99.67 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.21 21.23 6.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.621 -0.929 . . . . 0.0 110.354 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -124.65 125.68 44.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.584 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -102.7 124.11 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.174 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 47.7 t-20 -102.41 115.95 31.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.0 111.15 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 36' ' ' VAL . 84.2 mt -100.61 137.95 38.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.509 -0.745 . . . . 0.0 109.586 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 m -127.72 131.97 49.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.826 . . . . 0.0 110.78 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -110.68 138.3 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 109.872 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 62.6 mt-30 -124.02 122.15 37.14 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.093 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.54 2.83 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 76.0 mt -87.14 129.93 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.499 -1.001 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -102.6 177.19 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.863 0.839 . . . . 0.0 109.747 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -67.61 -29.96 69.42 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.353 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -66.4 -16.49 64.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 111.451 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 115' ' ' ILE . 23.0 m -49.8 150.03 2.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 110.415 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.09 -168.62 32.48 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD23 HE21 ' A' ' 39' ' ' GLN . 9.4 tp -88.91 130.11 35.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.716 -0.873 . . . . 0.0 112.691 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 115' ' ' ILE . 67.7 m-85 -118.5 140.84 49.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.5 mp -98.14 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.412 -0.805 . . . . 0.0 111.903 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.896 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 18.7 p -109.02 116.4 31.91 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.751 ' HE3' HD12 ' A' ' 37' ' ' LEU . 15.5 mttt -111.61 142.7 43.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.018 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.622 HG12 ' CD2' ' A' ' 106' ' ' LEU . 8.2 t -142.17 105.62 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -128.76 125.27 37.52 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.948 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.727 ' HG ' HD22 ' A' ' 106' ' ' LEU . 52.7 mt -81.65 76.35 8.57 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.437 ' HE3' ' HE ' ' A' ' 33' ' ' ARG . 5.8 ttm -80.89 -52.48 7.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.5 m-85 -62.46 -41.83 76.11 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.091 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 55.9 Cg_endo -85.71 113.79 1.37 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 120.831 1.021 . . . . 0.0 111.233 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 71.7 Cg_endo -90.72 150.99 4.14 Favored 'Trans proline' 1 CA--C 1.688 8.215 0 C-N-CA 123.042 2.495 . . . . 0.0 108.671 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.302 69.7 Cg_endo -83.56 176.09 34.75 Favored 'Cis proline' 2 C--N 1.469 6.892 1 C-N-CA 95.565 -13.098 . . . . 0.0 118.149 -8.53 . . . . . . . . 5 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.17 127.26 32.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.182 -1.574 . . . . 0.0 109.687 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -148.48 87.61 1.59 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.93 -1.106 . . . . 0.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.727 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.2 tp -155.0 -145.95 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.256 -0.903 . . . . 0.0 110.767 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.37 -172.45 31.86 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.586 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.429 HG21 ' HE2' ' A' ' 95' ' ' LYS . 84.5 mt -126.87 160.31 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.76 -0.847 . . . . 0.0 110.492 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.896 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.9 130.09 10.11 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.116 -2.393 . . . . 0.0 107.116 177.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.61 -32.39 70.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.324 -1.103 . . . . 0.0 111.051 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 135.14 151.54 6.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.934 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.67 HG21 ' CG2' ' A' ' 9' ' ' VAL . 65.5 m -124.76 149.81 46.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.423 ' HG2' ' CE1' ' A' ' 116' ' ' TYR . 58.2 tt0 -97.13 119.83 36.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.446 -1.301 . . . . 0.0 110.004 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 92' ' ' TYR . 96.0 mt -81.28 140.1 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.685 ' HB2' HD23 ' A' ' 10' ' ' LEU . 48.4 m-85 -120.92 152.58 38.32 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.318 0.58 . . . . 0.0 112.236 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' A ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.262 0.553 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 mtp 54.04 21.97 3.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.508 -0.745 . . . . 0.0 111.354 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.455 ' C ' HG23 ' A' ' 3' ' ' VAL . 69.1 m-70 -108.11 26.1 10.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 110.303 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -149.6 118.87 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.767 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -106.81 128.45 54.27 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.403 -0.811 . . . . 0.0 111.008 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.568 ' HB2' ' SG ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -149.83 143.64 16.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.85 136.24 32.26 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.323 1.17 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.95 -30.63 69.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.806 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.929 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -144.83 165.32 12.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.755 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.925 ' HB ' HD13 ' A' ' 115' ' ' ILE . 8.3 t -139.33 130.56 33.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-O 121.753 0.787 . . . . 0.0 111.181 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 10' ' ' LEU . 3.6 mm? -87.59 129.9 34.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.531 ' O ' HD13 ' A' ' 118' ' ' ILE . . . -106.41 154.77 20.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.386 -0.821 . . . . 0.0 110.815 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.0 m -75.2 172.47 12.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.727 -0.608 . . . . 0.0 109.732 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.5 m -59.79 -40.08 87.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.442 -0.786 . . . . 0.0 109.992 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.778 ' HB3' HD13 ' A' ' 16' ' ' ILE . 0.3 OUTLIER -61.01 -29.58 69.79 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.486 -0.759 . . . . 0.0 110.029 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.405 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 109.03 41.49 1.41 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.778 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.5 mp -100.5 102.11 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.672 -0.899 . . . . 0.0 108.85 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.917 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -108.75 114.16 27.72 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.87 ' OG ' HG23 ' A' ' 80' ' ' THR . 52.8 m -130.8 131.72 44.83 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.554 0.692 . . . . 0.0 110.886 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' HB3' HG21 ' A' ' 9' ' ' VAL . 38.5 p90 -150.07 163.97 36.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.781 -0.574 . . . . 0.0 109.476 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.6 t -123.45 122.36 64.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.692 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -103.84 108.5 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 15.2 pt-20 -81.66 162.57 22.99 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.19 -0.944 . . . . 0.0 110.867 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.2 p90 -140.13 176.36 8.82 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.735 -0.603 . . . . 0.0 109.581 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.76 130.85 45.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.795 -0.566 . . . . 0.0 110.409 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.5 p -132.77 155.94 80.62 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.558 -0.714 . . . . 0.0 110.081 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.15 -16.89 45.21 Favored 'Trans proline' 0 C--N 1.317 -1.131 0 O-C-N 123.391 1.206 . . . . 0.0 111.216 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.11 -171.99 37.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -100.63 137.3 39.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.598 -0.942 . . . . 0.0 110.127 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.96 170.67 15.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.537 -0.727 . . . . 0.0 110.271 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.076 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -81.15 -8.64 59.8 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.583 -0.698 . . . . 0.0 112.494 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.824 ' OE1' HG21 ' A' ' 51' ' ' THR . 18.6 mm-40 -129.46 108.26 10.13 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.944 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 78.0 t -125.89 80.45 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.76 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 67.8 ttt180 -59.97 124.59 20.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 111.427 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -114.73 153.98 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' A' ' 95' ' ' LYS . 20.3 m -144.0 141.41 30.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.635 ' CG2' HD13 ' A' ' 79' ' ' LEU . 85.6 t -116.86 124.07 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.6 mt -120.07 153.36 36.2 Favored 'General case' 0 N--CA 1.501 2.078 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.518 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 47' ' ' VAL . 69.0 mtm180 -111.28 123.96 51.26 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.529 ' HA ' HG22 ' A' ' 44' ' ' VAL . 20.0 tt0 -96.25 139.99 31.6 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.853 0.835 . . . . 0.0 110.937 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -134.04 156.98 47.27 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.83 -43.86 94.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.42 -0.8 . . . . 0.0 110.137 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 54.4 m -70.0 -47.28 62.82 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.648 -0.657 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.777 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.2 tt0 -165.15 169.48 16.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 111.241 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.3 t -116.73 140.2 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -130.03 160.58 33.25 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.326 -0.859 . . . . 0.0 111.32 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.822 ' HA ' HD23 ' A' ' 37' ' ' LEU . 96.9 mt-10 -80.03 154.85 27.9 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.635 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.9 HG21 ' HG3' ' A' ' 38' ' ' ARG . 45.8 t -130.89 -83.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.705 -0.622 . . . . 0.0 111.181 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.655 ' SG ' HG12 ' A' ' 47' ' ' VAL . 83.2 m -110.14 149.45 30.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.076 -1.015 . . . . 0.0 110.925 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.04 141.41 15.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.538 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' HB3' HD22 ' A' ' 58' ' ' LEU . . . -165.79 163.35 18.83 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 109.842 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.824 HG21 ' OE1' ' A' ' 31' ' ' GLU . 5.5 m -97.45 116.31 29.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.7 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.703 ' CZ ' ' SD ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -72.9 91.94 1.57 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 1.076 ' SD ' ' O ' ' A' ' 30' ' ' THR . 35.8 mmm -85.0 129.96 34.7 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.703 ' SD ' ' CZ ' ' A' ' 52' ' ' TYR . 18.0 mmt -59.43 -27.98 66.54 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.618 -177.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -104.72 18.66 43.41 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.242 -0.98 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 53' ' ' MET . 11.2 t30 -149.8 -179.99 7.57 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.0 -1.294 . . . . 0.0 110.846 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -108.61 156.39 19.59 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.656 -0.653 . . . . 0.0 110.65 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 50' ' ' ALA . 80.4 mt -70.28 139.93 52.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.603 -0.686 . . . . 0.0 110.972 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 p -104.55 118.33 36.32 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.718 . . . . 0.0 110.102 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -109.87 37.85 2.55 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.472 -0.768 . . . . 0.0 110.307 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.1 tp -59.91 -40.04 87.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.436 -0.79 . . . . 0.0 110.662 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -85.7 127.12 34.42 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.355 -0.841 . . . . 0.0 109.86 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 52.24 47.52 24.56 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.318 -0.864 . . . . 0.0 109.932 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p -57.53 -106.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.983 -0.448 . . . . 0.0 110.823 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.8 mt 52.04 22.38 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 120.342 -1.473 . . . . 0.0 110.534 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.05 158.21 24.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.12 -0.988 . . . . 0.0 110.339 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.712 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.0 t -132.75 139.95 47.83 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -142.82 154.12 25.09 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.411 -1.376 . . . . 0.0 111.066 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 72' ' ' SER . 94.2 m -130.04 163.51 26.34 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' ' CD2' ' A' ' 52' ' ' TYR . 32.8 t -143.39 130.02 20.24 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.773 -0.58 . . . . 0.0 109.961 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.1 p -142.42 133.85 26.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -0.783 . . . . 0.0 109.744 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.5 -123.99 27.54 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -105.9 16.43 25.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.674 -0.897 . . . . 0.0 110.441 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -119.87 123.94 44.85 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.248 -0.907 . . . . 0.0 111.013 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.0 m -99.49 130.44 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -107.97 118.38 36.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 111.459 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD13 ' CG2' ' A' ' 36' ' ' VAL . 74.0 mt -108.95 132.05 54.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 0.0 110.189 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.87 HG23 ' OG ' ' A' ' 18' ' ' SER . 86.6 m -121.14 132.2 54.71 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.481 -0.762 . . . . 0.0 110.173 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.789 HG21 HD21 ' A' ' 84' ' ' LEU . 94.9 mt -116.38 130.16 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.642 -0.661 . . . . 0.0 110.312 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.5 mt-30 -124.54 120.86 33.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.648 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.28 48.68 0.69 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.789 HD21 HG21 ' A' ' 81' ' ' ILE . 81.2 mt -96.0 108.41 20.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.488 -1.007 . . . . 0.0 111.308 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -82.85 -176.62 6.4 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.21 92.43 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.32 -0.862 . . . . 0.0 109.44 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.5 mtm -67.8 -38.84 83.85 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.117 0.484 . . . . 0.0 111.103 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -60.0 -35.39 74.95 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.544 -0.723 . . . . 0.0 111.177 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 115' ' ' ILE . 35.7 m -51.46 135.96 26.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.281 -0.887 . . . . 0.0 110.094 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.97 -144.03 7.83 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.616 -1.278 . . . . 0.0 110.908 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.868 HD13 ' N ' ' A' ' 92' ' ' TYR . 2.1 tm? -106.62 139.42 41.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.779 -0.836 . . . . 0.0 110.816 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.868 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -124.53 125.3 43.97 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.741 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -97.94 120.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.365 -0.834 . . . . 0.0 111.949 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.701 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 30.8 p -84.15 122.4 28.79 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.757 ' HD2' HD12 ' A' ' 109' ' ' ILE . 10.5 mtmt -113.9 150.59 33.45 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.304 -0.873 . . . . 0.0 109.986 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.704 HG11 ' CG ' ' A' ' 23' ' ' TYR . 24.6 t -141.39 103.99 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.03 117.34 18.26 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.759 HD13 HD23 ' A' ' 106' ' ' LEU . 8.7 mp -75.6 75.35 2.61 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 175.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.76 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 22.9 ttm -78.39 -38.31 42.04 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.932 -174.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.429 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 92.8 m-85 -67.51 -44.96 46.87 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 55.7 Cg_endo -80.8 137.18 11.06 Favored 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 120.463 0.776 . . . . 0.0 110.469 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 73.6 Cg_endo -89.98 143.81 4.17 Favored 'Trans proline' 2 CA--C 1.708 9.188 0 CA-C-O 112.032 -3.403 . . . . 0.0 110.923 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.305 51.0 Cg_endo -114.41 64.67 0.26 Allowed 'Cis proline' 2 C--N 1.443 5.526 1 C-N-CA 93.233 -14.07 . . . . 0.0 113.31 5.111 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' PRO . 4.3 t80 48.14 111.85 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 119.092 -2.255 . . . . 0.0 111.8 174.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.467 ' O ' HD22 ' A' ' 106' ' ' LEU . 28.9 t80 -160.64 107.99 1.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.83 1.3 . . . . 0.0 111.525 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.759 HD23 HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.45 -142.83 0.11 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.562 -179.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -153.99 167.41 32.23 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.0 mm -119.82 157.15 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.946 -0.737 . . . . 0.0 109.082 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.701 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -86.32 141.55 18.3 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.424 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 9.2 m120 -60.01 -36.24 76.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.508 -0.995 . . . . 0.0 110.11 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.797 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 129.64 143.14 5.4 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.866 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 98.1 m -111.42 131.94 54.83 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.833 ' HB3' HG23 ' A' ' 8' ' ' VAL . 32.8 tp60 -79.97 131.88 35.91 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.925 HD13 ' HB ' ' A' ' 9' ' ' VAL . 22.1 mm -99.74 121.17 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.883 -1.135 . . . . 0.0 108.61 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.929 ' CE2' HG21 ' A' ' 8' ' ' VAL . 13.2 m-30 -101.37 147.15 26.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.794 -0.566 . . . . 0.0 110.555 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.532 ' C ' HD12 ' A' ' 118' ' ' ILE . 86.4 t -133.91 164.02 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.89 0.852 . . . . 0.0 110.008 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.655 HD12 ' N ' ' A' ' 118' ' ' ILE 0.258 3.5 mp -111.53 138.62 39.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.206 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.51 108.05 51.31 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.499 -0.751 . . . . 0.0 109.556 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.15 149.85 64.99 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.185 1.097 . . . . 0.0 110.748 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -129.98 139.84 36.85 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.626 -0.671 . . . . 0.0 110.053 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.83 -12.03 31.94 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.215 1.113 . . . . 0.0 111.208 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.4 m -112.29 156.17 42.49 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.273 -0.892 . . . . 0.0 110.286 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.83 -20.0 46.19 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.392 1.206 . . . . 0.0 110.85 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -139.99 163.97 31.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.323 -0.861 . . . . 0.0 110.276 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.6 p -100.6 12.03 38.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.717 . . . . 0.0 111.016 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -60.07 -36.33 77.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.229 -0.919 . . . . 0.0 110.402 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -127.77 148.81 50.44 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.583 -0.698 . . . . 0.0 110.257 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 61.4 mt-10 52.08 49.98 7.6 Favored Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.518 -0.739 . . . . 0.0 111.047 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.8 Cg_endo -69.99 150.06 66.28 Favored 'Trans proline' 0 N--CA 1.486 1.035 0 O-C-N 123.186 1.098 . . . . 0.0 110.414 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.609 -0.682 . . . . 0.0 110.207 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.498 ' H83' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.509 ' H82' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.509 ' O2 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.442 ' H61' ' C1 ' ' A' ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . 0.442 ' C1 ' ' H61' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.916 0.389 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.3 mtm 57.03 113.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 121.467 0.651 . . . . 0.0 111.007 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 72.7 m80 -94.44 22.92 5.62 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.291 -0.881 . . . . 0.0 111.019 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 ' C ' ' A' ' 2' ' ' HIS . 67.1 t -150.15 132.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.66 -0.65 . . . . 0.0 109.279 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.755 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -108.02 130.69 55.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.405 -0.809 . . . . 0.0 110.319 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -130.43 124.99 21.46 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.688 -0.632 . . . . 0.0 111.07 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.63 139.87 31.75 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 N-CA-C 109.053 -1.172 . . . . 0.0 109.053 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.16 64.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.939 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.33 162.86 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 118.935 -1.106 . . . . 0.0 110.445 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.638 HG21 ' HB3' ' A' ' 19' ' ' PHE . 10.7 t -139.68 155.92 25.56 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 116' ' ' TYR . 92.4 mt -114.32 131.9 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.605 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.08 -163.82 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.579 -0.7 . . . . 0.0 110.245 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -128.87 -178.8 4.76 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.518 -0.739 . . . . 0.0 110.566 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.31 -39.53 87.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.497 -0.752 . . . . 0.0 109.475 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.567 ' HG3' HD11 ' A' ' 16' ' ' ILE . 21.6 tpp180 -59.15 -21.48 59.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.729 -0.607 . . . . 0.0 109.656 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.606 ' C ' HD13 ' A' ' 16' ' ' ILE . . . 83.64 35.03 17.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.606 HD13 ' C ' ' A' ' 15' ' ' GLY . 5.1 mm -114.69 109.91 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.503 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -104.55 127.35 52.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.755 -0.591 . . . . 0.0 110.221 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.696 ' HB2' HG23 ' A' ' 80' ' ' THR . 34.1 t -127.07 129.96 49.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 110.842 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.638 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.7 p90 -138.08 160.16 40.11 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 77' ' ' VAL . 61.5 t -125.67 123.32 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.297 -178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -105.52 109.94 22.09 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.6 pt-20 -82.77 149.49 27.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.198 -0.939 . . . . 0.0 111.419 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' CD2' HG21 ' A' ' 96' ' ' VAL . 7.6 p90 -131.89 164.0 27.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -131.32 133.4 45.31 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.399 -0.813 . . . . 0.0 111.19 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -139.9 150.46 62.57 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.648 -0.658 . . . . 0.0 110.717 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.77 -10.09 27.71 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 O-C-N 123.688 1.362 . . . . 0.0 111.852 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -146.48 -178.77 22.12 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.383 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -121.87 150.06 42.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.676 -0.896 . . . . 0.0 110.599 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.51 162.63 39.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.604 -0.685 . . . . 0.0 109.795 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 71.0 p -80.25 -46.09 16.83 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.46 -0.775 . . . . 0.0 110.647 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.575 ' HB3' HG21 ' A' ' 51' ' ' THR . 5.7 mm-40 -80.26 112.04 17.21 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.999 -175.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.23 95.75 3.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.845 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 68.9 ttt180 -75.78 115.3 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.431 -178.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.5 m -118.78 138.91 47.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.917 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 85.2 m -129.6 143.73 50.96 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.474 0.654 . . . . 0.0 110.338 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.935 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -114.32 139.48 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.841 HD23 ' HA ' ' A' ' 46' ' ' GLU . 9.5 mt -130.22 172.33 11.92 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 118.39 -1.324 . . . . 0.0 112.049 -178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HG3' ' CG2' ' A' ' 47' ' ' VAL . 91.5 mtt180 -126.72 123.6 37.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.517 ' HG3' HD11 ' A' ' 93' ' ' ILE . 24.7 mt-30 -106.32 132.01 52.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.939 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -104.87 -172.31 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -60.41 -43.6 96.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.493 -0.754 . . . . 0.0 110.791 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.0 p -132.06 0.06 3.79 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.331 -0.855 . . . . 0.0 111.878 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.624 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 74.9 mt-30 -137.3 154.98 49.98 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.031 -1.043 . . . . 0.0 110.816 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -133.21 145.16 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.661 -0.649 . . . . 0.0 109.732 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.9 p -129.8 156.06 44.95 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.343 -0.848 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.841 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.8 mp0 -86.34 159.99 19.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.563 -0.711 . . . . 0.0 111.194 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 63.9 t -122.25 -80.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.822 -0.549 . . . . 0.0 110.194 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.407 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 85.9 m -131.66 156.6 45.56 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.979 -1.076 . . . . 0.0 110.834 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -160.03 121.8 3.23 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.462 -0.774 . . . . 0.0 111.275 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -158.29 143.02 16.24 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.4 -0.812 . . . . 0.0 110.196 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.575 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.0 m -92.7 119.95 32.61 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.285 -0.884 . . . . 0.0 108.728 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HE1' ' A' ' 54' ' ' MET . 46.0 p90 -110.06 146.87 34.63 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.967 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 1.05 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -75.99 160.78 29.5 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.459 ' HE1' ' CE1' ' A' ' 52' ' ' TYR . 31.7 mmt -70.66 127.45 32.73 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.893 -1.129 . . . . 0.0 110.131 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.85 27.77 23.09 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -150.03 175.77 11.4 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.213 -1.169 . . . . 0.0 111.163 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.31 152.01 48.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.8 -0.562 . . . . 0.0 109.859 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 51' ' ' THR . 96.3 mt -136.42 -171.82 2.99 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 122.157 0.979 . . . . 0.0 112.136 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.7 p -109.48 159.97 16.61 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 95.0 m-85 -111.35 127.89 55.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.382 -0.824 . . . . 0.0 109.418 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.94 -44.07 94.6 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.587 -0.695 . . . . 0.0 112.344 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -94.88 131.44 40.78 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.227 -0.921 . . . . 0.0 109.898 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 67' ' ' ILE . 81.9 m-20 53.05 57.77 5.98 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m -60.86 64.35 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.238 0 CA-C-O 121.362 0.601 . . . . 0.0 112.098 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 67' ' ' ILE . 67.3 mt -140.98 16.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.419 -0.801 . . . . 0.0 109.134 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.1 m -104.09 130.03 51.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.059 -1.026 . . . . 0.0 110.593 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.558 HG21 ' NE2' ' A' ' 82' ' ' GLN . 9.5 t -139.94 150.08 44.09 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -177.58 -172.04 41.68 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.277 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 72' ' ' SER . 93.8 m -115.63 167.32 11.02 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.884 -0.774 . . . . 0.0 109.703 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 71' ' ' THR . 97.3 p -145.22 151.26 38.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.786 -0.571 . . . . 0.0 109.632 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 52.8 m -132.03 -175.73 3.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.649 -0.657 . . . . 0.0 109.757 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -52.92 -66.19 2.86 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -111.57 9.53 21.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.425 -1.044 . . . . 0.0 111.699 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 19.3 tt0 -130.0 129.41 43.69 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.996 -1.065 . . . . 0.0 110.609 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.713 HG22 ' O ' ' A' ' 21' ' ' CYS . 9.2 m -115.18 134.52 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -110.99 112.58 24.51 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.844 . . . . 0.0 110.892 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.935 HD13 ' CG2' ' A' ' 36' ' ' VAL . 95.7 mt -107.31 129.66 54.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.447 -0.783 . . . . 0.0 109.295 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.696 HG23 ' HB2' ' A' ' 18' ' ' SER . 58.6 m -124.05 136.69 54.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.249 -0.907 . . . . 0.0 110.777 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.78 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -103.52 137.29 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.675 . . . . 0.0 109.957 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.558 ' NE2' HG21 ' A' ' 69' ' ' THR . 30.7 mt-30 -119.97 120.71 37.16 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.929 -0.708 . . . . 0.0 110.041 178.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.03 40.07 1.74 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.78 HD21 HG21 ' A' ' 81' ' ' ILE . 76.3 mt -80.37 137.83 36.59 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.996 . . . . 0.0 111.445 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -117.03 176.15 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.9 93.04 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 109.69 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.31 -39.07 93.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.738 -0.601 . . . . 0.0 110.748 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.11 -23.94 64.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.566 -0.709 . . . . 0.0 111.195 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 115' ' ' ILE . 25.3 m -52.43 137.77 28.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.103 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 155.96 -164.26 32.2 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.51 HD23 ' NE2' ' A' ' 39' ' ' GLN . 14.6 tp -88.42 126.22 35.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.884 . . . . 0.0 112.733 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 31.5 m-85 -106.89 158.13 17.24 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -123.7 140.18 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.887 . . . . 0.0 111.723 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.581 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 13.9 p -98.64 133.54 42.83 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.7 tttt -135.95 123.11 21.65 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 106' ' ' LEU . 2.6 p -132.36 118.41 35.68 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.8 mm-40 -139.58 142.68 37.11 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.273 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 106' ' ' LEU . 6.5 mt -90.44 81.87 5.95 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.845 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 2.8 ttm -80.13 -48.99 12.33 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.264 -174.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.46 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 80.6 m-85 -70.87 -41.92 12.23 Favored Pre-proline 0 N--CA 1.508 2.467 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.4 Cg_endo -86.58 119.82 1.69 Allowed 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.558 1.505 . . . . 0.0 109.34 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 65.5 Cg_endo -84.77 161.71 12.18 Favored 'Trans proline' 2 CA--C 1.685 8.042 0 CA-C-O 113.188 -2.921 . . . . 0.0 106.18 -178.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 38.6 Cg_endo -86.45 174.8 30.84 Favored 'Cis proline' 1 C--N 1.423 4.468 1 C-N-CA 98.673 -11.803 . . . . 0.0 114.9 -11.624 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 97' ' ' GLU 0.313 3.0 t80 -80.16 133.0 36.02 Favored 'General case' 0 N--CA 1.529 3.513 0 O-C-N 118.319 -2.738 . . . . 0.0 115.727 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.477 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 14.0 p90 -162.47 107.7 1.19 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.149 -1.595 . . . . 0.0 111.695 175.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 96' ' ' VAL . 2.3 tp -157.59 -147.11 0.17 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.623 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.548 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -160.66 169.57 36.41 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 118.689 -1.719 . . . . 0.0 112.102 -178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.4 mp -117.16 159.76 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.537 -0.978 . . . . 0.0 109.576 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.581 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -103.39 143.57 15.78 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 5.2 m120 -59.92 -39.71 86.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -1.089 . . . . 0.0 110.188 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 137.01 158.67 8.03 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.257 -1.449 . . . . 0.0 113.004 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.627 HG21 HG23 ' A' ' 9' ' ' VAL . 85.1 m -125.77 139.96 53.08 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.858 ' HB3' HG23 ' A' ' 8' ' ' VAL . 27.5 tt0 -85.24 142.36 29.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.162 -1.415 . . . . 0.0 108.251 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 76.4 mt -109.18 130.03 62.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.939 ' CE2' HG21 ' A' ' 8' ' ' VAL . 15.1 m-30 -110.87 150.35 29.3 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.914 -0.491 . . . . 0.0 110.391 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 118' ' ' ILE . 95.9 t -98.65 166.49 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 117' ' ' VAL 0.253 44.2 mm -109.22 134.01 52.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.809 -0.557 . . . . 0.0 110.834 -179.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -131.24 107.13 14.78 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.667 -0.646 . . . . 0.0 109.557 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.71 139.95 41.66 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 O-C-N 123.202 1.106 . . . . 0.0 110.899 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.83 140.81 39.8 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.631 -0.668 . . . . 0.0 110.04 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -69.2 -12.23 33.45 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 O-C-N 123.256 1.135 . . . . 0.0 111.227 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 42.3 t -91.02 138.33 26.08 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.287 -0.883 . . . . 0.0 110.386 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.5 163.96 36.1 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 O-C-N 123.279 1.147 . . . . 0.0 110.545 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -104.85 157.63 17.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.55 -0.718 . . . . 0.0 110.374 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -66.93 -30.08 70.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.631 -0.668 . . . . 0.0 110.351 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.55 134.3 54.11 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.588 -0.695 . . . . 0.0 110.306 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -130.13 157.02 43.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.618 -0.676 . . . . 0.0 110.164 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 86.1 mt-10 52.87 49.89 7.09 Favored Pre-proline 0 N--CA 1.501 2.092 0 O-C-N 121.484 -0.76 . . . . 0.0 111.043 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.3 Cg_endo -69.92 150.04 66.71 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 O-C-N 123.139 1.073 . . . . 0.0 110.427 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.6 tptt . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.608 -0.682 . . . . 0.0 110.234 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.627 ' O6 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.627 ' H82' ' O6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.221 0.534 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm -130.34 -176.29 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.735 . . . . 0.0 109.941 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -97.71 25.1 6.11 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.512 -0.743 . . . . 0.0 110.518 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.601 HG11 ' CA ' ' A' ' 110' ' ' GLY . 66.6 t -142.22 132.6 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -123.95 134.43 53.5 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.318 -0.864 . . . . 0.0 111.165 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.133 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 65.5 mt-30 -146.81 147.95 31.5 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.653 -0.655 . . . . 0.0 110.697 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.02 140.7 42.33 Favored 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.438 1.23 . . . . 0.0 109.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.18 71.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.326 -0.859 . . . . 0.0 109.967 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.978 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -155.49 161.41 2.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 C-N-CA 118.84 -1.144 . . . . 0.0 111.35 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.763 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.5 t -137.94 156.07 30.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.529 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' A' ' 116' ' ' TYR . 84.8 mt -122.79 124.23 42.85 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.07 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.7 ' O ' HD13 ' A' ' 118' ' ' ILE . . . -78.49 141.3 38.32 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.509 -0.744 . . . . 0.0 109.32 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.3 m -80.3 -59.78 2.57 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.221 -0.924 . . . . 0.0 111.884 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.478 ' O ' HG12 ' A' ' 16' ' ' ILE . 15.2 t -152.32 165.93 33.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.535 -0.728 . . . . 0.0 109.462 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.875 ' HG2' HD11 ' A' ' 16' ' ' ILE . 6.3 ttt180 57.67 19.51 5.56 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.544 -0.722 . . . . 0.0 110.733 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' HD12 ' A' ' 84' ' ' LEU . . . 56.65 44.31 91.18 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.875 HD11 ' HG2' ' A' ' 14' ' ' ARG . 29.1 mm -106.78 104.66 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.75 120.67 42.89 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.335 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.613 ' OG ' HG23 ' A' ' 80' ' ' THR . 13.7 m -116.28 121.93 43.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.763 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.5 p90 -132.03 163.96 27.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.608 -0.683 . . . . 0.0 110.392 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 78' ' ' ASN . 36.3 t -122.03 130.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.171 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.081 ' SG ' ' HG2' ' A' ' 5' ' ' GLN . 48.7 t -117.9 131.92 56.47 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.4 tt0 -102.53 136.36 42.5 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 111.821 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.78 ' CG ' HG11 ' A' ' 96' ' ' VAL . 40.2 p90 -127.3 179.53 5.41 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.532 ' O ' HD21 ' A' ' 106' ' ' LEU . . . -132.47 127.29 34.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.719 -0.613 . . . . 0.0 110.477 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.35 149.9 59.14 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.594 -0.691 . . . . 0.0 109.97 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.81 -16.11 45.33 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.362 1.191 . . . . 0.0 111.446 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -171.96 -171.92 37.4 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -108.05 130.1 55.1 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.602 -0.94 . . . . 0.0 109.959 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.62 -178.63 5.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 110.623 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.088 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.9 p -79.96 -14.19 58.78 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.651 -0.655 . . . . 0.0 112.266 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.717 ' OE1' HG21 ' A' ' 51' ' ' THR . 3.1 mm-40 -128.82 130.73 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.45 -1.3 . . . . 0.0 112.497 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.0 t -139.68 84.91 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -64.49 115.24 4.96 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.458 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -117.3 147.41 20.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 49' ' ' ALA . 90.7 m -147.12 140.03 25.1 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.339 0.59 . . . . 0.0 111.101 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.882 ' CG2' HD13 ' A' ' 79' ' ' LEU . 96.1 t -102.66 132.1 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.922 HD23 ' HA ' ' A' ' 46' ' ' GLU . 4.9 mt -121.91 170.3 9.94 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.847 -1.158 . . . . 0.0 112.019 -177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 47' ' ' VAL . 15.6 mmm180 -116.0 115.66 26.54 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.459 ' HA ' HG13 ' A' ' 44' ' ' VAL . 7.4 tt0 -103.01 140.02 37.82 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.206 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.774 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -141.28 155.34 46.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -59.16 -44.0 92.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.355 -0.841 . . . . 0.0 110.263 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.0 m -70.1 -44.04 69.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.656 -0.652 . . . . 0.0 111.144 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.774 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 12.4 tp60 -162.65 161.33 26.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 111.078 -178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 39' ' ' GLN . 62.1 t -118.25 141.91 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.3 p -129.95 160.31 33.99 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.161 -0.962 . . . . 0.0 111.885 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.922 ' HA ' HD23 ' A' ' 37' ' ' LEU . 80.4 mt-10 -87.97 158.53 18.63 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.702 -0.624 . . . . 0.0 110.668 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 38' ' ' ARG . 94.0 t -139.17 -83.5 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.609 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.118 ' SG ' ' N ' ' A' ' 68' ' ' CYS . 83.4 m -105.21 149.52 25.88 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.085 -1.01 . . . . 0.0 111.792 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.615 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -163.94 145.34 8.87 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' HB2' ' CD1' ' A' ' 60' ' ' PHE . . . -171.79 158.0 4.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.717 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -97.62 109.92 22.59 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.327 179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.633 ' CD1' HD21 ' A' ' 58' ' ' LEU . 29.1 t80 -68.97 123.99 22.52 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 1.088 ' SD ' ' O ' ' A' ' 30' ' ' THR . 40.0 mmm -111.92 39.23 2.44 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.414 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 16.4 mmt 59.9 35.57 21.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.58 174.66 28.17 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.03 -18.93 45.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.597 -0.943 . . . . 0.0 112.126 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.95 124.65 28.27 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.312 0.577 . . . . 0.0 112.027 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.633 HD21 ' CD1' ' A' ' 52' ' ' TYR . 75.7 mt -131.9 151.82 51.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.589 -0.695 . . . . 0.0 109.139 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.9 p -87.12 95.63 10.02 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.205 -0.934 . . . . 0.0 110.967 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.684 ' CD1' HG21 ' A' ' 67' ' ' ILE . 20.6 m-85 -115.06 99.54 7.52 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.441 ' N ' HG13 ' A' ' 67' ' ' ILE . 96.0 mt -135.01 -0.13 2.81 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 120.63 -1.294 . . . . 0.0 114.155 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 67' ' ' ILE . 56.6 t0 -110.65 130.17 55.64 Favored 'General case' 0 N--CA 1.51 2.547 0 O-C-N 120.51 -1.369 . . . . 0.0 112.872 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 53.12 44.28 30.53 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.761 -1.212 . . . . 0.0 111.333 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 67' ' ' ILE . 5.8 t 72.15 -42.25 0.53 Allowed 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.417 -0.802 . . . . 0.0 112.43 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.966 ' HA ' ' SG ' ' A' ' 48' ' ' CYS . 25.8 mm 61.13 168.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.874 -1.142 . . . . 0.0 110.592 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.118 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 4.1 m -110.25 -179.74 3.86 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -130.22 149.79 51.76 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -175.3 -172.66 40.39 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.97 -1.586 . . . . 0.0 111.369 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 72' ' ' SER . 59.7 m -131.85 168.88 17.08 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 122.157 -0.614 . . . . 0.0 109.581 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 71' ' ' THR . 19.0 t -140.24 129.83 24.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.4 m -130.99 131.99 44.73 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.55 -123.78 24.06 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 78.7 m-20 -99.75 11.53 38.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.769 -0.842 . . . . 0.0 110.919 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -114.34 131.92 56.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.148 -0.97 . . . . 0.0 110.076 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 21' ' ' CYS . 11.4 m -111.52 118.2 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.865 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.614 ' CG ' HG22 ' A' ' 20' ' ' VAL . 4.1 m120 -89.9 114.21 25.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.545 -0.722 . . . . 0.0 110.912 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 36' ' ' VAL . 69.7 mt -114.24 124.32 51.74 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.094 -1.004 . . . . 0.0 109.574 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.613 HG23 ' OG ' ' A' ' 18' ' ' SER . 88.1 m -115.31 132.41 56.62 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.34 -0.85 . . . . 0.0 110.703 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.82 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -107.06 135.78 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.294 -0.879 . . . . 0.0 110.17 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.849 ' HG2' HD12 ' A' ' 16' ' ' ILE . 82.9 mt-30 -119.97 120.32 36.01 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.204 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.02 51.74 0.72 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.82 HD21 HG21 ' A' ' 81' ' ' ILE . 80.7 mt -92.32 113.53 25.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.682 -0.893 . . . . 0.0 111.439 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' HB2' ' HG2' ' A' ' 87' ' ' MET . 71.9 mmt-85 -81.32 166.16 20.74 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.02 -28.48 57.51 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.215 -0.928 . . . . 0.0 109.066 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 22.2 ptm -69.91 -36.07 75.1 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.507 0.67 . . . . 0.0 110.005 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.13 -25.74 65.72 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.799 -0.563 . . . . 0.0 111.397 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.1 m -51.2 132.01 28.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.271 -0.893 . . . . 0.0 110.13 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.43 -165.72 31.99 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.964 -1.255 . . . . 0.0 109.964 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.457 ' CD2' ' NE2' ' A' ' 39' ' ' GLN . 12.9 tp -86.8 130.07 34.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.705 -0.879 . . . . 0.0 112.798 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD2' HD12 ' A' ' 115' ' ' ILE . 59.1 m-85 -111.58 140.09 46.48 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.704 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.6 mp -110.14 122.95 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.218 -0.926 . . . . 0.0 112.576 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.133 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -79.67 120.17 23.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 175.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HE3' HD11 ' A' ' 109' ' ' ILE . 8.0 tttt -103.47 143.97 32.02 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.78 HG11 ' CG ' ' A' ' 23' ' ' TYR . 20.3 t -140.77 106.62 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.768 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.422 ' HG2' ' OH ' ' A' ' 104' ' ' TYR . 59.0 mt-10 -140.17 122.21 15.68 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.908 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 98' ' ' LEU . 9.5 mp -72.94 83.7 1.23 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 13.2 mmt -79.28 -50.92 10.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.86 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.444 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 97.6 m-85 -69.17 -40.3 15.05 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.407 -0.808 . . . . 0.0 112.618 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 14.8 Cg_endo -88.8 119.6 1.06 Allowed 'Trans proline' 0 C--O 1.177 -2.551 0 C-N-CA 122.14 1.893 . . . . 0.0 109.881 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.885 ' CB ' ' HA ' ' A' ' 103' ' ' PRO 0.479 88.9 Cg_endo -100.46 173.7 0.34 Allowed 'Trans proline' 2 C--O 1.08 -7.38 0 CA-C-O 114.3 -2.459 . . . . 0.0 113.482 173.563 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.885 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.408 52.0 Cg_endo -72.69 176.64 39.37 Favored 'Cis proline' 3 N--CA 1.586 6.96 1 C-N-CA 96.736 -12.61 . . . . 0.0 112.6 -5.491 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.422 ' OH ' ' HG2' ' A' ' 97' ' ' GLU . 14.7 t80 -79.55 135.72 36.68 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 116.327 -3.983 . . . . 0.0 111.352 175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.33 30.4 t80 -158.73 91.76 1.08 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 118.104 0.411 . . . . 0.0 111.464 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.733 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -159.35 -157.29 0.57 Allowed 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.119 -1.432 . . . . 0.0 112.57 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.715 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.5 -177.01 36.82 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.966 -1.112 . . . . 0.0 111.295 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.715 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -121.29 153.9 25.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.659 ' O ' ' H83' ' A' ' 132' ' ' NAG . . . -92.99 165.2 27.91 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.376 -1.89 . . . . 0.0 108.376 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -62.54 -34.03 76.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.341 -1.094 . . . . 0.0 111.694 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.54 160.57 11.52 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.688 -1.244 . . . . 0.0 111.921 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.563 HG21 HG23 ' A' ' 9' ' ' VAL . 60.6 m -120.04 145.04 47.21 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.978 ' HB3' HG23 ' A' ' 8' ' ' VAL . 30.5 tt0 -88.98 145.56 25.43 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.612 -1.235 . . . . 0.0 107.954 176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.469 HD12 ' CD2' ' A' ' 92' ' ' TYR . 45.6 mt -117.99 131.31 71.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.87 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -113.93 155.97 24.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.83 -0.544 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.568 ' C ' HD12 ' A' ' 118' ' ' ILE . 76.6 t -124.02 163.98 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.826 0.822 . . . . 0.0 110.047 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' 11' ' ' ALA 0.259 3.3 mp -111.44 132.55 59.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.314 -179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -108.0 109.83 62.1 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.579 -0.701 . . . . 0.0 109.418 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.74 146.39 60.13 Favored 'Trans proline' 0 N--CA 1.485 1.029 0 O-C-N 123.144 1.076 . . . . 0.0 110.938 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -129.85 132.93 24.47 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 110.014 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.37 -18.99 44.09 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.105 1.055 . . . . 0.0 110.911 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 78.7 m -119.84 153.5 54.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.36 -0.837 . . . . 0.0 110.394 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.91 158.09 57.91 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.39 1.205 . . . . 0.0 110.452 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -148.07 172.08 14.84 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.555 -0.716 . . . . 0.0 110.488 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.6 p -131.96 160.0 37.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.638 -0.664 . . . . 0.0 110.166 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -106.14 120.17 41.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.606 -0.684 . . . . 0.0 110.317 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -121.42 153.61 37.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.586 -0.696 . . . . 0.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 85.7 mt-10 53.03 50.12 7.32 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 121.472 -0.768 . . . . 0.0 111.011 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.8 Cg_endo -70.25 159.66 52.26 Favored 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.205 1.108 . . . . 0.0 110.338 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt . . . . . 0 N--CA 1.496 1.873 0 O-C-N 121.599 -0.688 . . . . 0.0 110.246 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.659 ' H83' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.571 ' H83' ' H2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.571 ' H2 ' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.54 ' H83' HG23 ' A' ' 20' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.424 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.152 0.501 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.3 mtp 53.39 22.97 3.07 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.469 -0.77 . . . . 0.0 110.937 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -129.4 36.63 4.11 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.469 -0.769 . . . . 0.0 110.151 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.738 HG11 ' HA2' ' A' ' 110' ' ' GLY . 83.8 t -80.13 137.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.745 -0.597 . . . . 0.0 109.895 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.66 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -122.12 135.69 54.83 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.538 -0.726 . . . . 0.0 110.72 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.403 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 41.5 mt-30 -148.51 150.07 32.95 Favored Pre-proline 0 N--CA 1.497 1.918 0 O-C-N 121.526 -0.734 . . . . 0.0 111.694 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' HG23 ' A' ' 113' ' ' THR . 41.7 Cg_endo -71.02 139.97 37.0 Favored 'Trans proline' 0 C--N 1.319 -0.993 0 N-CA-C 108.284 -1.468 . . . . 0.0 108.284 176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.21 -27.5 67.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.293 -0.879 . . . . 0.0 110.497 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.926 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -152.34 171.99 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 C-N-CA 118.491 -1.284 . . . . 0.0 110.983 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.735 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -149.85 155.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.567 178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -112.12 131.95 55.15 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.05 135.93 39.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.529 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -69.88 173.46 6.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.688 -0.632 . . . . 0.0 110.256 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.4 p -60.32 -30.53 69.57 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.555 -0.715 . . . . 0.0 109.992 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.69 ' CG ' HD13 ' A' ' 16' ' ' ILE . 7.7 tpm_? -60.07 -30.13 69.02 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.582 -0.699 . . . . 0.0 109.926 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.648 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.68 26.01 8.3 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.69 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -109.72 110.41 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 O-C-N 121.565 -0.962 . . . . 0.0 110.507 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -110.41 128.88 55.8 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.433 ' HB3' ' H82' ' A' ' 136' ' ' NAG . 32.7 t -126.59 134.83 50.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.376 -0.828 . . . . 0.0 111.728 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.735 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -140.07 163.99 31.24 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 93.5 t -124.92 124.46 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 119.712 -0.795 . . . . 0.0 111.468 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 77' ' ' VAL . 51.2 t -100.81 117.12 34.26 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.0 tt0 -90.75 137.56 32.26 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 111.282 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.695 ' HB3' HG11 ' A' ' 96' ' ' VAL . 31.8 p90 -131.29 180.0 5.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.85 123.57 18.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.653 -0.654 . . . . 0.0 110.707 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 98' ' ' LEU . 92.8 p -134.53 143.39 46.45 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.558 -0.714 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -75.13 144.24 29.59 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.296 1.156 . . . . 0.0 110.742 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.24 -153.87 30.58 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 150.05 51.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.881 . . . . 0.0 109.92 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.77 154.75 37.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.513 -0.742 . . . . 0.0 110.41 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' MET . 57.5 p -92.62 10.46 30.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.603 -0.685 . . . . 0.0 110.764 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' OE1' HG21 ' A' ' 51' ' ' THR . 13.1 mm-40 -132.19 84.92 2.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.279 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.729 ' O ' HG13 ' A' ' 34' ' ' VAL . 11.8 m -103.35 89.13 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 19.6 tpt85 -53.72 102.35 0.06 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.403 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.3 m -110.17 131.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.86 0.838 . . . . 0.0 111.199 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 99.9 m -135.56 148.15 49.0 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.828 ' CG2' HD13 ' A' ' 79' ' ' LEU . 95.9 t -116.08 133.83 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.842 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.8 mt -121.35 170.18 9.87 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.231 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.2 ttt180 -123.21 119.91 31.6 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.607 ' HA ' HG22 ' A' ' 44' ' ' VAL . 14.2 tt0 -97.15 148.56 22.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.54 -0.725 . . . . 0.0 110.166 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.43 -175.66 3.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.848 -0.533 . . . . 0.0 110.055 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.74 -40.47 88.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.67 -0.643 . . . . 0.0 111.385 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.0 m -126.8 -21.55 4.03 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.19 -0.944 . . . . 0.0 112.57 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.722 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 98.1 mt-30 -131.96 163.98 27.17 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.06 -1.025 . . . . 0.0 111.775 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' HA ' ' A' ' 39' ' ' GLN . 61.0 t -134.84 143.58 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.2 p -129.99 160.18 34.44 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.366 -0.834 . . . . 0.0 110.557 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.842 ' HA ' HD23 ' A' ' 37' ' ' LEU . 58.2 tt0 -80.15 157.31 26.63 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.584 -0.698 . . . . 0.0 109.876 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -124.75 -64.3 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.782 -0.574 . . . . 0.0 110.392 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 68.3 m -140.1 141.08 36.18 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.105 -0.997 . . . . 0.0 109.846 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -151.1 135.1 16.64 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.698 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.01 149.57 2.42 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.564 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -81.17 111.24 17.42 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.06 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.606 ' O ' HG22 ' A' ' 32' ' ' VAL . 23.3 t80 -74.92 112.99 11.71 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.769 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 2.0 mtp -82.63 161.54 22.17 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 35.6 mmt -61.04 -23.91 65.79 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.659 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.37 41.49 0.75 Allowed Glycine 0 N--CA 1.501 3.027 0 C-N-CA 119.042 -1.551 . . . . 0.0 112.658 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 79.6 m-20 -135.55 160.06 39.67 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 119.067 1.434 . . . . 0.0 110.241 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -89.12 135.63 33.46 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.492 -0.755 . . . . 0.0 110.283 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.677 HD22 ' N ' ' A' ' 58' ' ' LEU . 1.3 mm? -103.04 156.12 17.91 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.492 -0.755 . . . . 0.0 110.086 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.6 p -102.2 123.15 45.53 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.388 -0.82 . . . . 0.0 111.706 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 42.3 m-85 -114.12 30.5 7.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -53.72 -44.03 69.54 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.532 -0.73 . . . . 0.0 111.899 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 46.8 p-10 -66.54 145.45 55.61 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.264 -0.897 . . . . 0.0 110.749 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 52.13 55.58 9.0 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.388 -0.82 . . . . 0.0 110.498 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 60.17 163.87 0.06 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.798 -0.564 . . . . 0.0 109.938 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -99.92 142.17 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-O 121.591 0.71 . . . . 0.0 111.229 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.4 m -121.99 153.77 38.11 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.406 HG21 ' NE2' ' A' ' 82' ' ' GLN . 10.2 t -132.63 150.08 52.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.492 -0.755 . . . . 0.0 109.856 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.95 -172.01 43.52 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.41 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 72' ' ' SER . 92.5 m -129.1 168.78 15.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 122.0 -0.706 . . . . 0.0 109.47 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.469 ' N ' HG22 ' A' ' 71' ' ' THR . 70.1 m -159.98 127.39 4.59 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.0 p -155.83 155.93 33.82 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.239 -0.913 . . . . 0.0 110.344 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.76 -124.04 25.67 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -109.32 11.05 25.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.774 -0.839 . . . . 0.0 110.914 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.1 mt-30 -118.46 124.76 48.41 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 21' ' ' CYS . 4.0 m -107.17 124.01 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.924 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 71' ' ' THR . 46.6 t-20 -101.97 116.21 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.565 -0.71 . . . . 0.0 111.077 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.828 HD13 ' CG2' ' A' ' 36' ' ' VAL . 96.6 mt -115.98 131.98 56.78 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.297 -0.877 . . . . 0.0 109.164 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.3 m -124.47 147.21 48.48 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.184 -0.948 . . . . 0.0 111.075 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.635 HG21 HD21 ' A' ' 84' ' ' LEU . 62.3 mt -113.53 131.53 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.711 -0.618 . . . . 0.0 110.072 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HG2' HG13 ' A' ' 16' ' ' ILE . 10.5 mt-30 -110.22 120.76 43.48 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.667 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.58 0.99 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -85.76 125.55 33.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.656 -0.908 . . . . 0.0 111.082 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -107.44 175.85 5.35 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.21 94.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.302 -0.873 . . . . 0.0 109.521 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.1 ttm -62.14 -36.06 80.65 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.756 -0.59 . . . . 0.0 110.169 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -66.97 -26.92 67.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.666 -0.647 . . . . 0.0 111.143 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.9 m -51.4 132.07 29.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.231 -0.918 . . . . 0.0 110.275 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.5 -143.96 8.47 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.466 HD23 ' NE2' ' A' ' 39' ' ' GLN . 10.6 tp -110.04 131.94 54.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.737 -0.861 . . . . 0.0 111.611 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.876 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.1 m-85 -113.28 132.03 55.7 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -107.97 129.36 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.728 -0.607 . . . . 0.0 112.144 -176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.076 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 20.1 p -79.88 161.99 25.27 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.56 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 7.3 tttt -152.34 77.49 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.096 -1.003 . . . . 0.0 108.349 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 23' ' ' TYR . 7.4 p -95.1 113.63 29.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-O 121.495 0.664 . . . . 0.0 110.726 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 68.2 mt-10 -130.16 129.65 43.72 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.919 -0.712 . . . . 0.0 111.426 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.658 ' CD2' HD22 ' A' ' 106' ' ' LEU . 19.1 mt -76.99 76.91 3.54 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 104.243 -2.502 . . . . 0.0 104.243 176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.4 tpp -80.63 -50.15 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 120.034 -0.667 . . . . 0.0 112.45 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 89.1 m-85 -68.6 -41.21 21.41 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.464 -0.773 . . . . 0.0 112.926 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 46.9 Cg_endo -86.25 109.44 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-O 117.875 -0.969 . . . . 0.0 111.098 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.3 Cg_endo -77.39 158.02 32.93 Favored 'Trans proline' 1 CA--C 1.609 4.236 0 CA-C-O 113.892 -2.628 . . . . 0.0 110.001 177.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 56.3 Cg_endo -88.54 -177.68 12.56 Favored 'Cis proline' 1 C--N 1.484 7.662 1 C-N-CA 93.031 -14.154 . . . . 0.0 114.475 -10.125 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 4.6 t80 -88.04 125.51 34.59 Favored 'General case' 0 C--N 1.274 -2.696 0 CA-C-O 122.76 1.267 . . . . 0.0 109.888 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -149.7 74.42 1.22 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 120.943 -1.098 . . . . 0.0 111.076 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.3 tp -142.48 -150.68 0.32 Allowed 'General case' 0 N--CA 1.503 2.175 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.352 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -167.1 -173.04 34.99 Favored Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.388 -1.387 . . . . 0.0 111.902 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.533 HG22 ' C8 ' ' A' ' 132' ' ' NAG . 71.7 mt -110.96 149.18 13.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 O-C-N 121.847 -0.796 . . . . 0.0 109.938 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 1.076 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -74.53 144.14 32.47 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.426 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 4.0 t-20 -60.07 -30.34 69.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.398 -1.06 . . . . 0.0 110.283 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.0 140.03 7.08 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.319 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 6' ' ' PRO . 85.3 m -113.53 149.97 33.64 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.843 ' HB3' HG23 ' A' ' 8' ' ' VAL . 13.7 tp60 -89.87 137.29 32.46 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.876 HD12 ' CD1' ' A' ' 92' ' ' TYR . 56.4 mt -109.92 128.18 66.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.926 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.3 m-30 -101.95 139.86 37.02 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.646 0.736 . . . . 0.0 111.748 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 118' ' ' ILE . 97.1 t -125.64 166.12 22.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' N ' HG12 ' A' ' 117' ' ' VAL . 27.1 mm -100.06 120.01 48.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.477 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -146.33 141.03 15.93 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.628 -0.67 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.11 159.98 51.21 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.243 1.128 . . . . 0.0 110.322 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -86.68 114.84 59.98 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.547 -0.72 . . . . 0.0 110.178 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.0 -11.92 31.44 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 O-C-N 123.2 1.105 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.9 m -100.51 135.77 20.1 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.249 -0.907 . . . . 0.0 110.41 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.6 -12.06 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.224 1.118 . . . . 0.0 111.157 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -148.05 172.19 14.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.5 p -136.43 159.91 40.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.239 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -74.58 132.03 41.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.555 -0.716 . . . . 0.0 110.269 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -120.18 146.36 46.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.599 -0.688 . . . . 0.0 110.24 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 65.7 mm-40 52.3 50.17 7.77 Favored Pre-proline 0 N--CA 1.501 2.115 0 O-C-N 121.407 -0.808 . . . . 0.0 111.05 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.9 Cg_endo -70.22 148.14 61.43 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.197 1.104 . . . . 0.0 110.306 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.501 2.12 0 O-C-N 121.363 -0.836 . . . . 0.0 110.957 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.894 ' H61' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.894 ' H83' ' H61' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.425 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.433 ' H82' ' HB3' ' A' ' 18' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.121 0.486 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 57.9 mtt -134.2 156.96 47.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.581 -0.699 . . . . 0.0 110.225 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -110.26 132.02 54.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.644 -0.66 . . . . 0.0 110.783 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG12 ' OE1' ' A' ' 5' ' ' GLN . 74.8 t -129.69 131.47 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.564 -0.71 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.83 131.78 56.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.449 -0.782 . . . . 0.0 110.56 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.47 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.7 134.7 18.42 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.662 -0.649 . . . . 0.0 110.475 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.48 136.57 24.01 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 123.11 1.058 . . . . 0.0 109.696 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.43 -32.95 64.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.484 -0.76 . . . . 0.0 109.666 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.002 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.0 157.35 6.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.992 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.678 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.8 t -139.72 153.36 23.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 121.45 0.643 . . . . 0.0 110.038 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.0 mt -110.83 124.1 51.38 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.71 140.77 46.24 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.496 -0.752 . . . . 0.0 110.724 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.0 m -91.61 -168.99 2.16 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.598 -0.689 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.0 m -49.98 159.04 0.45 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.48 -0.763 . . . . 0.0 110.529 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.817 ' HG3' HD11 ' A' ' 16' ' ' ILE . 40.8 tpt85 62.43 13.27 5.97 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.556 -0.715 . . . . 0.0 110.655 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 58.07 46.01 93.17 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.851 HD12 ' HG2' ' A' ' 82' ' ' GLN . 34.6 mm -104.92 106.7 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.729 -0.865 . . . . 0.0 109.545 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.08 123.58 48.23 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.803 -0.56 . . . . 0.0 109.772 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.1 t -130.0 130.95 45.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.64 -0.663 . . . . 0.0 110.455 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.678 ' HB3' HG21 ' A' ' 9' ' ' VAL . 27.2 p90 -142.39 164.06 31.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.807 -0.558 . . . . 0.0 109.724 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG23 ' O7 ' ' A' ' 136' ' ' NAG . 99.5 t -120.66 116.21 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.852 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.8 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -100.12 103.77 15.28 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 90.1 mt-10 -79.67 165.11 23.21 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 111.933 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.7 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.8 p90 -148.07 178.14 8.78 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.426 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 1' ' ' MET . . . -136.4 130.34 32.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.689 -0.632 . . . . 0.0 110.009 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -139.95 150.11 61.18 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.405 -0.809 . . . . 0.0 110.45 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.08 140.06 33.81 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 O-C-N 123.44 1.232 . . . . 0.0 110.299 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 53.65 -145.71 23.28 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.4 mttp -130.11 149.92 51.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.607 -0.937 . . . . 0.0 110.141 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.6 147.69 45.24 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.617 -0.677 . . . . 0.0 109.926 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.142 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 32.8 p -79.97 -59.65 2.64 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.712 0.767 . . . . 0.0 111.679 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.0 mt-10 -80.99 80.52 7.45 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.631 -175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG11 ' OH ' ' A' ' 52' ' ' TYR . 97.0 t -88.5 96.5 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' N ' HG23 ' A' ' 51' ' ' THR . 55.6 ttt85 -70.53 124.25 23.76 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.572 -177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 50' ' ' ALA . 27.3 m -121.1 142.14 38.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.707 HG23 ' HB2' ' A' ' 49' ' ' ALA . 88.8 m -135.32 142.35 45.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.726 -0.608 . . . . 0.0 110.625 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.897 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -112.77 131.23 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.797 HD23 ' HA ' ' A' ' 46' ' ' GLU . 14.0 mt -120.94 173.76 7.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.09 -1.006 . . . . 0.0 110.958 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.651 ' O ' HG13 ' A' ' 44' ' ' VAL . 39.5 ttm180 -122.42 121.28 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 44' ' ' VAL . 24.4 tt0 -97.9 148.65 23.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 111.151 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -132.15 168.65 17.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.47 -28.24 66.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.556 -0.715 . . . . 0.0 110.722 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.5 t -108.49 -53.14 2.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.474 -0.766 . . . . 0.0 112.153 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.747 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 63.3 mt-30 -136.64 170.01 16.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.12 -0.988 . . . . 0.0 111.997 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 39' ' ' GLN . 62.0 t -122.56 147.96 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.2 p -127.65 160.42 31.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.341 -0.849 . . . . 0.0 110.678 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.797 ' HA ' HD23 ' A' ' 37' ' ' LEU . 40.1 mt-10 -80.4 145.58 31.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.586 -0.696 . . . . 0.0 110.651 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.509 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -117.18 -75.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.846 -0.534 . . . . 0.0 110.305 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.922 ' SG ' ' HB3' ' A' ' 63' ' ' ASP . 70.2 m -139.83 149.15 43.11 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.248 -0.907 . . . . 0.0 110.383 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.707 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -153.88 145.48 23.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.488 -0.757 . . . . 0.0 111.294 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -165.28 148.02 8.0 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.618 -0.677 . . . . 0.0 109.714 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.568 HG21 ' HB3' ' A' ' 31' ' ' GLU . 6.2 m -98.42 130.19 45.05 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.324 -0.86 . . . . 0.0 108.952 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.685 ' OH ' HG11 ' A' ' 32' ' ' VAL . 52.1 p90 -102.09 133.44 46.93 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.521 -1.272 . . . . 0.0 110.631 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.477 ' HE1' ' HG2' ' A' ' 31' ' ' GLU . 6.6 mmt -78.41 168.17 20.21 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.142 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -66.96 90.03 0.17 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.673 -1.267 . . . . 0.0 109.2 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.39 -117.48 0.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.05 -2.42 . . . . 0.0 107.05 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -129.9 137.77 50.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.307 -1.113 . . . . 0.0 110.379 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' O ' HD23 ' A' ' 58' ' ' LEU . 17.6 tt0 -178.73 138.33 0.16 Allowed 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' O ' ' A' ' 70' ' ' GLY . 94.3 mt -142.14 87.72 2.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.352 -0.843 . . . . 0.0 110.034 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.435 ' N ' ' HB1' ' A' ' 50' ' ' ALA . 46.1 p -89.58 72.2 7.85 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.425 -0.797 . . . . 0.0 111.384 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.482 ' HE2' HD22 ' A' ' 58' ' ' LEU . 78.4 m-85 -89.89 109.76 20.75 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 0.0 110.056 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.4 mt -61.36 -37.3 82.84 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.425 -0.797 . . . . 0.0 110.48 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 p-10 -139.98 172.19 13.11 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.634 -0.666 . . . . 0.0 110.026 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.922 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 84.5 m-20 52.6 49.95 19.24 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.388 -0.82 . . . . 0.0 110.495 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 42.6 t -53.91 -21.11 7.1 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.659 -0.651 . . . . 0.0 111.215 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 mm -55.97 -20.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.264 -0.897 . . . . 0.0 110.627 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 30.7 m -86.07 137.78 32.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 110.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 80' ' ' THR . 9.0 t -129.95 131.01 45.81 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.705 ' CA ' HD23 ' A' ' 79' ' ' LEU . . . -125.63 116.8 2.74 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.864 HG21 ' O5 ' ' A' ' 138' ' ' FUC . 59.2 m -103.87 159.0 16.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.726 -0.867 . . . . 0.0 108.673 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 63.0 m -148.15 129.97 15.19 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.969 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 122.04 25.88 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.04 -124.07 34.98 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -101.93 16.59 25.5 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.964 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.44 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 35.7 mt-30 -116.46 122.25 44.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.197 -0.939 . . . . 0.0 110.502 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 21' ' ' CYS . 1.9 m -103.74 122.2 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.866 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -104.21 109.96 21.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 0.0 111.462 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.897 HD13 HG22 ' A' ' 36' ' ' VAL . 53.1 mt -98.06 130.02 44.88 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.495 -0.753 . . . . 0.0 109.53 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 69' ' ' THR . 93.9 m -123.75 145.44 49.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.469 -0.769 . . . . 0.0 110.41 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 84' ' ' LEU . 95.5 mt -119.91 135.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.567 -0.708 . . . . 0.0 109.83 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.851 ' HG2' HD12 ' A' ' 16' ' ' ILE . 76.5 mt-30 -120.02 120.31 35.94 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.927 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.66 40.5 1.1 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 81' ' ' ILE . 80.8 mt -89.81 121.19 31.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.581 -0.952 . . . . 0.0 111.464 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -103.32 179.66 4.21 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.85 93.91 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.926 0.869 . . . . 0.0 109.872 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 65.9 mtt -66.7 -34.66 78.34 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.331 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -65.54 -19.96 66.14 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.479 -0.763 . . . . 0.0 111.238 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 115' ' ' ILE . 30.0 m -50.65 136.88 20.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 0.0 110.6 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.84 -159.99 32.85 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.59 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD12 ' C ' ' A' ' 113' ' ' THR . 13.8 tp -110.2 130.05 55.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.7 -0.882 . . . . 0.0 111.961 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.699 ' CD2' HD12 ' A' ' 115' ' ' ILE . 83.9 m-85 -116.29 146.98 41.99 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.691 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.9 mp -103.53 139.96 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.44 -0.788 . . . . 0.0 111.683 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.769 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.7 p -98.16 127.59 44.18 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HE3' HD11 ' A' ' 109' ' ' ILE . 4.6 tttm -120.39 141.72 49.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.176 -0.952 . . . . 0.0 109.916 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.741 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.8 t -138.05 108.85 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB3' ' HE1' ' A' ' 99' ' ' MET . 5.9 mm-40 -134.4 128.26 33.24 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.841 -178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD23 HD13 ' A' ' 106' ' ' LEU 0.26 2.8 mm? -76.51 87.68 3.24 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 176.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.456 ' HE1' ' HB3' ' A' ' 97' ' ' GLU . 2.7 mmt -81.15 -58.45 3.06 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.498 -1.281 . . . . 0.0 111.687 -175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.6 m-85 -71.7 -40.45 8.4 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 48.6 Cg_endo -82.05 117.36 2.88 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 O-C-N 122.229 0.594 . . . . 0.0 110.658 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.474 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 73.0 Cg_endo -92.41 156.97 3.05 Favored 'Trans proline' 1 CA--C 1.701 8.859 0 CA-C-O 114.534 -2.361 . . . . 0.0 109.835 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 55.7 Cg_endo -87.65 178.62 19.91 Favored 'Cis proline' 2 C--N 1.46 6.408 1 C-N-CA 96.668 -12.638 . . . . 0.0 116.727 -8.039 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CZ ' ' HE1' ' A' ' 99' ' ' MET . 13.3 t80 -85.93 119.68 26.5 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 126.043 2.09 . . . . 0.0 113.12 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 106' ' ' LEU . 25.7 t80 -162.16 107.74 1.25 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.272 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.79 HD13 HD23 ' A' ' 98' ' ' LEU . 1.4 tp -157.16 -143.49 0.11 Allowed 'General case' 0 N--CA 1.508 2.461 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.921 177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.73 178.55 35.77 Favored Glycine 0 N--CA 1.504 3.227 0 O-C-N 120.682 -1.261 . . . . 0.0 110.604 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.482 HD11 ' HE3' ' A' ' 95' ' ' LYS . 97.4 mt -126.17 160.82 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.987 . . . . 0.0 109.814 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.769 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 143.47 16.68 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -60.43 -36.08 77.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.479 -1.013 . . . . 0.0 110.271 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 131.56 158.4 9.1 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.071 -1.062 . . . . 0.0 111.017 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.553 ' C ' HD12 ' A' ' 91' ' ' LEU . 97.0 m -123.33 127.67 48.84 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 1.002 ' HB3' HG23 ' A' ' 8' ' ' VAL . 36.1 tp60 -73.64 137.12 43.97 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.699 HD12 ' CD2' ' A' ' 92' ' ' TYR . 75.4 mt -110.0 129.19 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.894 -1.129 . . . . 0.0 108.422 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.808 ' CE2' HG21 ' A' ' 8' ' ' VAL . 14.9 m-85 -110.15 142.67 41.34 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.874 -0.516 . . . . 0.0 111.044 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.6 t -96.02 166.21 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 117' ' ' VAL . 46.8 mm -105.96 134.29 47.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.843 -0.536 . . . . 0.0 110.592 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -77.33 141.57 66.4 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 109.858 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.82 148.07 63.89 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.214 1.112 . . . . 0.0 110.338 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -91.75 126.06 55.18 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.573 -0.704 . . . . 0.0 110.142 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.69 -12.2 32.53 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.117 1.061 . . . . 0.0 111.043 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 1.057 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 49.3 t -138.73 156.38 72.94 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 109.863 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 1.057 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 41.9 Cg_endo -66.57 -17.79 53.4 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.344 1.181 . . . . 0.0 111.551 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.7 p30 -83.96 -175.07 5.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.278 -0.889 . . . . 0.0 110.418 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 47.6 t -89.81 129.87 36.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.453 -0.78 . . . . 0.0 110.299 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -67.87 -35.95 79.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.71 . . . . 0.0 110.188 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -101.48 143.79 31.06 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.616 -0.678 . . . . 0.0 110.119 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 64.9 mm-40 52.72 49.74 6.96 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.472 -0.767 . . . . 0.0 111.161 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 45.1 Cg_endo -69.75 154.05 68.25 Favored 'Trans proline' 0 N--CA 1.486 1.04 0 O-C-N 123.194 1.102 . . . . 0.0 110.546 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp . . . . . 0 N--CA 1.493 1.715 0 O-C-N 121.537 -0.727 . . . . 0.0 110.133 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.435 ' C8 ' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.489 ' O7 ' HG23 ' A' ' 20' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.458 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.864 ' O5 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt -99.23 21.44 11.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.59 -0.694 . . . . 0.0 110.517 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -110.04 131.08 55.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.396 -0.815 . . . . 0.0 110.455 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -135.78 132.48 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.68 131.09 57.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.581 -0.699 . . . . 0.0 110.146 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.089 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 87.0 mm-40 -140.0 139.69 22.12 Favored Pre-proline 0 N--CA 1.496 1.853 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.224 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.33 147.66 42.16 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.284 1.15 . . . . 0.0 109.835 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.5 -29.61 25.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 109.346 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.609 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -154.44 156.99 4.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.435 -0.906 . . . . 0.0 111.017 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.922 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.0 t -134.98 157.55 40.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 116' ' ' TYR . 66.1 mt -111.04 130.18 55.68 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.702 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' O ' HD13 ' A' ' 118' ' ' ILE . . . -90.71 147.78 23.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.571 -0.706 . . . . 0.0 110.863 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -78.27 168.85 19.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.647 -0.658 . . . . 0.0 110.153 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -59.76 -37.91 80.35 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.446 -0.783 . . . . 0.0 109.969 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.6 mtt-85 -57.46 -24.06 53.47 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.535 -0.728 . . . . 0.0 110.397 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.8 28.02 8.6 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.2 mp -103.63 101.67 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.56 124.35 49.42 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.0 p -136.37 150.03 48.62 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.875 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.922 ' HB3' HG21 ' A' ' 9' ' ' VAL . 22.2 p90 -154.62 161.48 41.57 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 79.8 t -118.79 117.69 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.499 -178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.089 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 53.6 t -100.1 107.42 19.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -83.51 144.95 29.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.242 -0.911 . . . . 0.0 111.186 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CG ' HG11 ' A' ' 96' ' ' VAL . 50.0 p90 -131.64 -179.97 5.7 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.75 131.92 39.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.691 -0.631 . . . . 0.0 110.093 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.4 t -127.29 150.42 72.42 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.475 -0.766 . . . . 0.0 111.101 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.34 -14.77 37.98 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 O-C-N 123.735 1.387 . . . . 0.0 111.362 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.89 -165.43 16.79 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -110.1 132.16 54.41 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.552 -0.97 . . . . 0.0 110.375 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 153.76 39.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.583 -0.698 . . . . 0.0 109.842 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.1 p -80.03 -35.08 37.78 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.394 -0.816 . . . . 0.0 110.408 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.794 ' OE1' HG21 ' A' ' 51' ' ' THR . 42.7 mm-40 -79.89 97.07 6.55 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.3 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' O ' HG13 ' A' ' 34' ' ' VAL . 97.5 t -113.56 85.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.521 ' CD ' ' SD ' ' A' ' 99' ' ' MET . 72.1 ttt-85 -61.25 116.19 4.41 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.114 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 32' ' ' VAL . 28.4 m -122.46 133.98 67.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.712 0.767 . . . . 0.0 110.157 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.483 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 61.3 m -120.06 123.98 44.75 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.086 0.469 . . . . 0.0 109.967 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.689 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -100.54 130.23 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.712 HD12 ' HE3' ' A' ' 95' ' ' LYS . 71.2 mt -124.76 167.66 14.28 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.351 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.3 ttt180 -127.71 124.04 36.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.564 ' NE2' HD23 ' A' ' 91' ' ' LEU . 22.0 mt-30 -109.13 132.01 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.954 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -125.01 162.6 24.17 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.03 -42.98 95.57 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.2 m -70.09 -55.92 8.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.727 . . . . 0.0 110.694 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 58.7 mm-40 -150.42 -177.27 5.86 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.964 0.888 . . . . 0.0 111.399 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.8 136.97 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.476 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -134.27 161.6 34.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.61 ' HA ' HD23 ' A' ' 37' ' ' LEU . 75.5 mt-10 -80.2 155.54 27.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.584 -0.697 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 48' ' ' CYS . 96.3 t -118.77 -95.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.869 -0.519 . . . . 0.0 110.089 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 47' ' ' VAL . 99.2 m -120.14 145.12 47.24 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.705 -1.247 . . . . 0.0 110.281 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -156.76 138.57 14.28 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.38 -0.825 . . . . 0.0 111.796 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -175.4 157.06 2.1 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.794 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -80.1 119.88 23.49 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 72' ' ' SER . 19.6 t80 -80.83 109.98 15.91 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.667 -0.813 . . . . 0.0 109.445 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.2 mmt -79.16 146.06 33.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -15.81 63.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.07 -1.018 . . . . 0.0 110.661 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -118.83 -15.03 5.89 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 120.242 -0.98 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -130.02 160.06 34.83 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.124 -1.221 . . . . 0.0 110.911 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -123.2 125.2 44.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.506 -0.746 . . . . 0.0 110.052 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 51' ' ' THR . 79.8 mt -85.2 170.17 13.11 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.474 -0.766 . . . . 0.0 111.349 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.5 p -110.2 159.95 16.93 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 68' ' ' CYS . 29.8 m-85 -99.93 132.08 45.51 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.492 -0.755 . . . . 0.0 109.696 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.7 tp -59.87 -44.13 94.35 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -140.82 -165.76 2.01 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.028 -1.045 . . . . 0.0 111.995 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 56.0 57.15 5.32 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.455 0.645 . . . . 0.0 110.221 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.3 m 56.61 167.84 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.322 0.582 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.7 mt -91.39 84.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.58 -0.7 . . . . 0.0 110.018 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 59.7 m -68.08 151.39 47.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 109.385 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.577 HG23 ' HB ' ' A' ' 80' ' ' THR . 9.1 t -132.62 149.96 52.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.571 -0.705 . . . . 0.0 109.336 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -163.1 176.49 39.33 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.9 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 94.3 m -131.96 166.41 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 122.005 -0.703 . . . . 0.0 109.721 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' A' ' 52' ' ' TYR . 34.7 t -151.16 80.32 1.31 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.706 -0.621 . . . . 0.0 110.356 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -129.97 145.11 51.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.486 -0.759 . . . . 0.0 110.463 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.01 37.75 87.9 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.5 m120 56.96 24.22 9.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.609 -0.936 . . . . 0.0 110.387 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.407 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -127.37 124.1 37.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.552 -0.717 . . . . 0.0 109.17 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -102.19 117.55 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.553 -179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 57.4 t-20 -99.76 104.77 16.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.322 -0.861 . . . . 0.0 111.156 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.689 HD13 ' CG2' ' A' ' 36' ' ' VAL . 75.1 mt -93.27 131.86 37.99 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 0.0 109.819 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.644 HG21 ' O7 ' ' A' ' 137' ' ' NAG . 58.9 m -121.89 139.93 53.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 84' ' ' LEU . 72.2 mt -120.02 138.82 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.562 -0.711 . . . . 0.0 109.905 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' HG2' HG13 ' A' ' 16' ' ' ILE . 35.0 mt-30 -124.92 121.24 33.92 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.983 177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.38 25.1 3.88 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 81' ' ' ILE . 75.7 mt -81.67 129.99 34.9 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.426 -1.044 . . . . 0.0 111.335 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 85' ' ' ARG . 22.9 mtp-105 -104.19 179.93 4.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -44.05 94.55 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.835 0.826 . . . . 0.0 109.614 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.9 mmt -65.55 -30.5 71.26 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.452 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -67.75 -16.93 64.36 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.483 -0.761 . . . . 0.0 111.807 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.3 m -52.96 139.96 26.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 166.31 -164.96 37.96 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.564 HD23 ' NE2' ' A' ' 39' ' ' GLN . 18.0 tp -94.12 132.01 39.08 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.752 -0.852 . . . . 0.0 112.483 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.798 ' CD1' HD12 ' A' ' 115' ' ' ILE . 72.9 m-85 -118.39 134.58 54.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -99.95 139.91 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 111.762 -178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.859 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.8 p -108.07 107.98 18.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 176.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.712 ' HE3' HD12 ' A' ' 37' ' ' LEU . 17.1 mttt -105.17 141.39 36.79 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.521 -0.737 . . . . 0.0 109.202 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.6 ' O ' HD23 ' A' ' 106' ' ' LEU . 9.8 t -135.96 111.42 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.947 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.405 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 86.6 mt-10 -131.98 131.7 42.81 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.539 -0.725 . . . . 0.0 111.835 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.717 ' CD2' HD22 ' A' ' 106' ' ' LEU . 11.2 mt -85.43 80.01 9.25 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.852 -2.648 . . . . 0.0 103.852 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.521 ' SD ' ' CD ' ' A' ' 33' ' ' ARG . 2.5 ttm -80.65 -39.67 26.92 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.216 -0.994 . . . . 0.0 112.631 -173.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 68.6 m-85 -70.8 -45.7 16.37 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.401 -0.92 . . . . 0.0 112.773 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 102' ' ' PRO . 71.9 Cg_endo -80.29 133.42 9.72 Favored 'Trans proline' 0 CA--C 1.597 3.648 0 O-C-N 122.877 0.935 . . . . 0.0 111.019 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 86.0 Cg_endo -90.88 143.11 3.32 Favored 'Trans proline' 1 N--CA 1.54 4.207 1 CA-C-O 110.185 -4.173 . . . . 0.0 114.945 177.088 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 21.2 Cg_endo -110.7 57.07 0.77 Allowed 'Cis proline' 2 C--N 1.453 6.051 1 C-N-CA 97.123 -12.449 . . . . 0.0 110.505 11.41 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' O ' ' O ' ' A' ' 103' ' ' PRO . 5.1 t80 50.72 120.95 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.836 0 O-C-N 120.556 -1.34 . . . . 0.0 111.843 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -160.18 106.98 1.59 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 119.428 -2.045 . . . . 0.0 107.378 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD22 ' CD2' ' A' ' 98' ' ' LEU . 3.2 tp -159.41 -148.91 0.19 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 120.079 -0.649 . . . . 0.0 110.979 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -158.46 -176.38 30.44 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.55 HG21 ' H81' ' A' ' 132' ' ' NAG . 76.8 mt -126.63 162.75 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.355 -1.086 . . . . 0.0 110.978 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.859 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.36 134.81 11.85 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.059 -2.416 . . . . 0.0 107.059 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -59.8 -35.89 75.61 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.211 -1.17 . . . . 0.0 110.64 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 130.6 136.73 4.02 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.68 -1.248 . . . . 0.0 111.874 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.492 HG21 HG23 ' A' ' 9' ' ' VAL . 96.3 m -108.63 139.09 43.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.564 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.5 tt0 -89.56 120.2 30.65 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.207 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.798 HD12 ' CD1' ' A' ' 92' ' ' TYR . 97.0 mt -81.48 123.66 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.609 ' CE2' HG21 ' A' ' 8' ' ' VAL . 2.8 m-30 -94.93 161.66 14.06 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.633 0.73 . . . . 0.0 111.531 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p -123.28 148.0 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 118' ' ' ILE . 1.9 mp -79.99 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.381 0.61 . . . . 0.0 110.123 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -132.03 126.4 20.61 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.769 -0.582 . . . . 0.0 109.711 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.55 150.02 68.99 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 O-C-N 123.101 1.053 . . . . 0.0 110.748 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -120.01 150.07 50.26 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.626 -0.671 . . . . 0.0 109.953 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.98 -27.93 35.98 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.353 1.186 . . . . 0.0 110.738 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 1.118 ' HG ' ' CG ' ' A' ' 125' ' ' ASP . 42.3 t -140.0 135.64 16.58 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.463 -0.773 . . . . 0.0 110.202 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.99 -19.3 35.22 Favored 'Trans proline' 0 N--CA 1.488 1.188 0 O-C-N 123.158 1.083 . . . . 0.0 111.312 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 1.118 ' CG ' ' HG ' ' A' ' 123' ' ' CYS . 56.3 p30 -86.04 -172.1 3.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.294 -0.879 . . . . 0.0 111.008 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.3 p -122.68 150.45 42.69 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.641 -0.662 . . . . 0.0 109.927 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -142.11 160.1 40.91 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.54 -0.725 . . . . 0.0 110.295 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -60.38 -30.42 69.56 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.595 -0.69 . . . . 0.0 110.041 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -70.03 140.84 88.72 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.617 -0.677 . . . . 0.0 109.974 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.92 149.98 66.62 Favored 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.286 1.151 . . . . 0.0 110.495 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.606 -0.684 . . . . 0.0 110.262 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.55 ' H81' HG21 ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.814 ' H82' ' C1 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.814 ' C1 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.489 ' H5 ' ' C8 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.644 ' O7 ' HG21 ' A' ' 80' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.109 0.481 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mmm -122.47 -164.04 1.14 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.626 -0.671 . . . . 0.0 109.858 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.44 ' C ' HG23 ' A' ' 3' ' ' VAL . 77.8 m80 -96.52 22.92 7.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.511 -0.743 . . . . 0.0 110.818 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.468 HG12 ' OE1' ' A' ' 5' ' ' GLN . 61.3 t -149.77 132.03 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.811 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -110.2 132.74 53.9 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.377 -0.827 . . . . 0.0 110.606 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.468 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.75 138.79 22.34 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.814 -0.554 . . . . 0.0 110.503 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.48 133.89 27.19 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.259 1.137 . . . . 0.0 109.535 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.16 -34.49 76.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.994 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -149.16 155.96 7.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.118 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.6 t -137.62 155.6 31.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.989 178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.699 HD23 ' HB2' ' A' ' 116' ' ' TYR . 82.1 mt -116.01 132.72 56.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.07 131.76 35.08 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.384 -0.823 . . . . 0.0 110.974 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -60.64 172.73 0.85 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.62 -0.675 . . . . 0.0 110.762 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.9 t -59.83 -35.94 75.77 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.577 -0.702 . . . . 0.0 110.088 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.762 ' CG ' HD13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -53.55 -24.95 15.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.706 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.97 24.97 13.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.762 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -112.6 111.64 37.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 84' ' ' LEU . . . -98.69 119.72 37.9 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.503 ' HB2' HG23 ' A' ' 80' ' ' THR . 46.4 t -122.31 131.1 53.74 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.21 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.725 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.2 p90 -139.92 164.03 31.09 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 77' ' ' VAL . 55.3 t -131.6 130.77 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.956 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' VAL . 29.5 t -112.84 110.75 21.05 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.811 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -82.06 151.73 26.93 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.723 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.704 ' CD2' HG21 ' A' ' 96' ' ' VAL . 19.6 p90 -134.36 169.44 17.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.63 134.72 43.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.583 -0.698 . . . . 0.0 110.898 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.0 t -140.2 149.47 58.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.685 -0.634 . . . . 0.0 110.651 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.67 -20.44 52.99 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 O-C-N 123.727 1.383 . . . . 0.0 111.54 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.02 165.91 25.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.61 133.54 55.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.573 -0.957 . . . . 0.0 110.548 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -131.93 163.0 29.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 109.536 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' MET . 25.6 p -80.1 -38.03 32.49 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.39 -0.818 . . . . 0.0 110.201 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 10.5 mm-40 -79.35 93.11 5.26 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.567 -0.853 . . . . 0.0 112.225 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 34' ' ' VAL . 96.4 t -109.76 102.6 14.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -82.83 106.37 14.62 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.343 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 34.0 m -106.04 141.34 21.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.487 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.535 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.0 m -132.0 156.88 45.44 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.728 0.775 . . . . 0.0 110.175 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.96 HG22 HD13 ' A' ' 79' ' ' LEU . 98.4 t -125.57 136.24 61.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 46' ' ' GLU . 7.7 mt -131.92 160.1 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.058 -1.026 . . . . 0.0 111.216 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 47' ' ' VAL . 77.4 mtt180 -112.66 113.79 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.921 ' NE2' HD11 ' A' ' 93' ' ' ILE . 26.3 mt-30 -93.67 131.82 38.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.895 . . . . 0.0 110.818 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -130.9 158.69 39.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -58.97 -40.65 85.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.422 -0.799 . . . . 0.0 110.557 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.7 p -73.71 -56.09 5.44 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.615 -0.678 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.663 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.6 mt-30 -154.15 171.99 18.28 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.302 -0.874 . . . . 0.0 111.353 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.63 HG22 ' HA ' ' A' ' 39' ' ' GLN . 63.8 t -122.35 142.11 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.0 p -128.22 160.16 32.97 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.206 -0.934 . . . . 0.0 111.603 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.87 ' HA ' HD23 ' A' ' 37' ' ' LEU . 59.1 mt-10 -80.25 162.04 24.83 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.67 -0.643 . . . . 0.0 110.581 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG12 ' SG ' ' A' ' 48' ' ' CYS . 38.7 t -130.25 -64.93 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.342 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.776 ' SG ' ' O ' ' A' ' 64' ' ' SER . 57.9 m -149.56 151.89 34.6 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.441 -0.787 . . . . 0.0 110.153 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -167.59 137.89 2.84 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.148 -0.97 . . . . 0.0 112.387 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -169.1 148.11 3.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.529 -0.732 . . . . 0.0 109.917 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.437 ' HG1' ' HE1' ' A' ' 100' ' ' TYR . 2.9 m -95.87 115.3 27.23 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.137 -0.977 . . . . 0.0 108.784 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 54' ' ' MET . 46.1 p90 -109.57 145.31 36.57 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.774 -0.77 . . . . 0.0 111.388 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 1.068 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -73.23 158.71 34.67 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.464 ' HE2' ' CD1' ' A' ' 52' ' ' TYR . 27.5 mmt -67.14 130.46 43.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.837 -1.164 . . . . 0.0 109.824 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.5 30.46 18.84 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -149.26 175.61 11.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.289 -1.124 . . . . 0.0 110.909 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -137.84 150.07 46.85 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.819 -0.551 . . . . 0.0 110.129 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' CD1' ' O ' ' A' ' 51' ' ' THR . 80.1 mt -134.15 179.63 6.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.304 -0.873 . . . . 0.0 111.577 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 78.7 p -113.8 159.81 19.38 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.963 -0.461 . . . . 0.0 110.081 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 36.2 m-85 -110.2 123.38 49.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.619 -0.675 . . . . 0.0 109.668 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.63 -35.87 75.63 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.48 -0.762 . . . . 0.0 112.359 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -67.15 -147.75 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.241 -0.912 . . . . 0.0 111.187 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -46.57 -19.15 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.143 -0.973 . . . . 0.0 112.896 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.776 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 29.0 m 57.51 -132.62 1.32 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.654 -0.654 . . . . 0.0 110.631 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.633 ' O ' HG22 ' A' ' 67' ' ' ILE . 87.5 mt 56.56 22.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.77 -1.206 . . . . 0.0 110.27 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.562 ' SG ' ' O ' ' A' ' 64' ' ' SER . 20.7 m -137.36 155.18 49.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.413 ' CG2' ' HB ' ' A' ' 80' ' ' THR . 9.9 t -120.31 140.06 51.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.512 -0.742 . . . . 0.0 109.43 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -100.58 96.1 1.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 m -123.79 156.03 36.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.538 -0.978 . . . . 0.0 109.024 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 97.2 p -156.52 160.24 39.33 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.177 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -140.36 107.92 5.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.15 32.99 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -93.69 9.71 35.85 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.454 -1.027 . . . . 0.0 110.708 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.528 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 36.5 tt0 -111.7 136.07 51.44 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.239 -0.913 . . . . 0.0 110.226 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.711 ' O ' HG13 ' A' ' 20' ' ' VAL . 11.3 m -112.77 141.85 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.008 -1.058 . . . . 0.0 111.287 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.438 ' CG ' HG22 ' A' ' 20' ' ' VAL . 64.1 t-20 -112.76 118.01 33.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.469 -0.769 . . . . 0.0 110.784 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD13 HG22 ' A' ' 36' ' ' VAL . 90.4 mt -112.22 129.97 56.08 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.719 . . . . 0.0 109.376 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 18' ' ' SER . 81.8 m -130.65 154.52 47.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.272 -0.892 . . . . 0.0 110.808 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' ILE . 91.0 mt -120.43 139.41 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.78 -0.575 . . . . 0.0 109.846 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 67' ' ' ILE . 40.2 mt-30 -119.48 123.22 43.51 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.143 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.57 56.84 0.76 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.521 HD11 ' CB ' ' A' ' 17' ' ' ALA . 91.4 mt -80.85 126.03 30.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.792 -0.828 . . . . 0.0 111.805 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -105.93 170.14 8.08 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.22 90.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.268 -0.895 . . . . 0.0 109.454 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.9 ttm -65.64 -37.72 87.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.755 -0.591 . . . . 0.0 110.325 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -59.28 -36.47 75.61 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.619 -0.676 . . . . 0.0 111.228 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 115' ' ' ILE . 20.3 m -51.11 133.75 27.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.6 -143.69 9.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.499 HD23 HE21 ' A' ' 39' ' ' GLN . 34.8 tp -109.23 123.71 49.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.733 -0.863 . . . . 0.0 111.709 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.767 ' CD1' HD12 ' A' ' 115' ' ' ILE . 53.7 m-85 -110.18 115.87 30.5 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.469 -0.769 . . . . 0.0 110.05 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.921 HD11 ' NE2' ' A' ' 39' ' ' GLN . 40.8 mm -78.21 133.51 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.6 -0.687 . . . . 0.0 111.984 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 17.3 p -85.47 149.82 25.13 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.2 tttt -147.31 127.93 14.21 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 108.495 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.704 HG21 ' CD2' ' A' ' 23' ' ' TYR . 2.4 p -134.95 113.11 15.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-O 121.614 0.721 . . . . 0.0 109.297 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 74.3 mm-40 -134.56 132.2 38.83 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.553 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.6 mm? -81.54 85.2 6.55 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 104.166 -2.531 . . . . 0.0 104.166 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 51.0 tpp -82.52 -46.92 12.77 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.779 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.446 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 59.0 m-85 -71.42 -42.98 11.9 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 49.1 Cg_endo -81.76 113.06 2.47 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 C-N-CA 121.194 1.263 . . . . 0.0 112.576 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 50.5 Cg_endo -77.02 166.87 26.05 Favored 'Trans proline' 1 CA--C 1.642 5.913 0 CA-C-O 111.834 -3.486 . . . . 0.0 108.246 177.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.43 68.2 Cg_endo -81.95 -171.97 10.0 Favored 'Cis proline' 1 C--N 1.47 6.944 1 C-N-CA 98.741 -11.774 . . . . 0.0 116.704 -15.862 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.1 t80 -99.19 125.16 44.7 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 118.365 -2.709 . . . . 0.0 109.243 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.536 ' O ' HD22 ' A' ' 106' ' ' LEU . 22.5 p90 -169.42 108.1 0.42 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.005 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.553 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.91 -148.02 0.24 Allowed 'General case' 0 N--CA 1.504 2.273 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.1 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.65 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -154.8 165.35 32.06 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.357 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.6 mp -122.25 149.18 25.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' HA2' ' OE1' ' A' ' 5' ' ' GLN . . . -88.14 -177.68 47.46 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.84 21.33 17.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -1.19 . . . . 0.0 111.803 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.682 ' CA ' HD13 ' A' ' 93' ' ' ILE . . . 83.53 146.89 7.17 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-O 122.793 1.218 . . . . 0.0 114.074 175.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.593 HG21 HG23 ' A' ' 9' ' ' VAL . 57.7 m -116.16 128.88 56.01 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 176.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.994 ' HB3' HG23 ' A' ' 8' ' ' VAL . 35.3 tp60 -68.36 136.59 53.6 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 118.354 -1.339 . . . . 0.0 107.86 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.767 HD12 ' CD1' ' A' ' 92' ' ' TYR . 61.6 mt -113.67 125.1 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.957 -1.09 . . . . 0.0 108.635 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.819 ' CE2' HG21 ' A' ' 8' ' ' VAL . 24.8 m-85 -109.69 159.79 16.85 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 118' ' ' ILE . 88.4 t -103.61 164.71 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.331 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 117' ' ' VAL 0.272 38.8 mm -117.95 140.07 42.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.156 0.503 . . . . 0.0 110.672 -178.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -105.98 116.09 60.22 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.619 -0.676 . . . . 0.0 109.276 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.81 140.07 41.58 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.101 1.053 . . . . 0.0 110.76 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -130.0 142.15 44.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.606 -0.684 . . . . 0.0 110.112 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.64 -12.11 32.43 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.244 1.129 . . . . 0.0 111.241 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 42.3 t -128.03 144.48 51.7 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.94 . . . . 0.0 110.389 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.61 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 49.1 Cg_endo -69.08 161.92 43.87 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.38 1.2 . . . . 0.0 110.691 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -80.22 -173.7 4.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.588 -0.695 . . . . 0.0 110.457 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -60.12 -29.98 68.98 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.568 -0.707 . . . . 0.0 110.785 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -84.14 119.96 25.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.452 -0.78 . . . . 0.0 110.427 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -120.67 142.05 49.83 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.6 -0.687 . . . . 0.0 110.05 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 52.37 49.49 6.76 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.492 -0.755 . . . . 0.0 111.259 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 47.4 Cg_endo -69.34 149.94 70.17 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.24 1.126 . . . . 0.0 110.663 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.3 tptt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 110.073 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.068 0.461 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt 56.09 166.63 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.695 -0.628 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -124.08 37.08 4.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 22' ' ' GLU . 95.4 t -102.06 134.97 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.773 -0.58 . . . . 0.0 110.114 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.36 54.65 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.508 -0.745 . . . . 0.0 110.217 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.417 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.3 pt20 -157.57 156.05 28.15 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.572 -0.705 . . . . 0.0 111.277 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.06 149.57 46.75 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.55 1.29 . . . . 0.0 110.323 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.13 -23.66 23.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.582 -0.699 . . . . 0.0 109.731 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.888 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.2 156.51 4.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.567 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.711 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -136.86 156.8 35.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.86 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.796 HD23 ' HB2' ' A' ' 116' ' ' TYR . 86.8 mt -114.61 127.77 55.96 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.629 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.93 165.14 18.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.456 -0.778 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -152.18 160.02 43.47 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.255 -0.903 . . . . 0.0 111.1 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.2 t 55.5 -132.87 1.66 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.509 -0.745 . . . . 0.0 110.737 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 16' ' ' ILE . 6.1 ttt180 -52.02 -23.84 5.77 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.764 -1.21 . . . . 0.0 111.461 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.576 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 119.56 46.19 0.41 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.58 HD13 ' HB3' ' A' ' 14' ' ' ARG . 1.8 mp -103.78 113.48 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.93 0.872 . . . . 0.0 109.893 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -112.92 126.48 55.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 79.3 p -123.49 139.99 53.46 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.59 0.709 . . . . 0.0 110.902 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.711 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.7 p90 -150.15 162.24 40.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 71.9 t -125.29 121.03 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.713 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.864 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.04 103.72 15.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.683 -0.635 . . . . 0.0 109.3 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' O ' HG13 ' A' ' 3' ' ' VAL . 57.2 tt0 -80.04 142.43 34.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.392 -0.817 . . . . 0.0 111.0 -179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CG ' HG11 ' A' ' 96' ' ' VAL . 38.3 p90 -121.96 176.36 5.83 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.64 137.01 41.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.661 -0.649 . . . . 0.0 110.584 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.456 ' HB3' HD11 ' A' ' 106' ' ' LEU . 95.4 p -142.95 152.91 59.88 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.649 -0.657 . . . . 0.0 110.43 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HG2' ' CE2' ' A' ' 105' ' ' TYR . 44.0 Cg_endo -69.23 -13.47 36.07 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.461 1.242 . . . . 0.0 110.929 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.13 -179.84 33.3 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -117.98 140.08 50.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.441 -1.035 . . . . 0.0 110.602 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.54 172.27 13.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.0 109.486 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.3 p -80.06 -46.55 16.33 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.366 -0.834 . . . . 0.0 110.765 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.638 ' OE1' HG21 ' A' ' 51' ' ' THR . 5.3 mm-40 -80.09 109.96 15.05 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.795 -176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.536 HG12 HG13 ' A' ' 34' ' ' VAL . 96.7 t -119.83 82.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -60.22 103.58 0.24 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.643 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.739 HG23 ' HZ ' ' A' ' 60' ' ' PHE . 27.2 m -114.44 143.66 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 119.653 -0.819 . . . . 0.0 109.325 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.853 HG23 ' HB2' ' A' ' 49' ' ' ALA . 69.1 m -140.03 132.9 29.22 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.217 0.532 . . . . 0.0 111.04 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 79' ' ' LEU . 96.3 t -98.99 130.63 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 46' ' ' GLU . 13.6 mt -119.97 160.01 23.59 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.749 -1.219 . . . . 0.0 111.735 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -117.03 129.68 56.17 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.406 ' HG3' ' CG2' ' A' ' 44' ' ' VAL . 15.8 tt0 -106.81 149.31 27.51 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.712 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.62 -172.6 2.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.858 -0.526 . . . . 0.0 109.761 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.18 -44.4 95.09 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.502 -0.749 . . . . 0.0 111.138 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.1 m -132.73 -13.74 2.87 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.295 -0.878 . . . . 0.0 112.294 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.746 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 tt0 -122.88 142.7 50.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 111.168 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 39' ' ' GLN . 50.7 t -132.03 133.81 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.7 p -131.17 165.84 22.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.982 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.785 ' HA ' HD23 ' A' ' 37' ' ' LEU . 64.3 mt-10 -79.98 149.91 30.63 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.441 0.638 . . . . 0.0 110.55 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.314 HG12 ' SG ' ' A' ' 68' ' ' CYS . 95.4 t -112.33 -67.99 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 63' ' ' ASP . 57.0 m -133.34 150.08 51.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.547 -0.721 . . . . 0.0 109.526 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.853 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -166.87 135.27 2.71 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.378 -0.929 . . . . 0.0 112.007 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.896 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -172.02 157.54 4.4 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.638 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -85.69 124.81 32.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.206 -0.934 . . . . 0.0 109.516 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 72' ' ' SER . 28.7 t80 -87.82 110.41 20.48 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.592 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.425 ' O ' ' CD1' ' A' ' 52' ' ' TYR . 2.2 mmt -80.04 165.58 22.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.414 ' N ' ' HE2' ' A' ' 54' ' ' MET . 31.2 mmt -59.54 -30.34 68.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.6 -1.312 . . . . 0.0 109.604 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.16 -139.75 7.9 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 107.912 -2.075 . . . . 0.0 107.912 178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -115.68 133.75 55.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.238 -1.154 . . . . 0.0 110.668 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 178.02 159.22 0.48 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.896 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 38.3 mt 51.04 78.55 0.11 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.136 -0.977 . . . . 0.0 111.308 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.8 p -96.79 163.26 13.06 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.728 -0.608 . . . . 0.0 110.169 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.739 ' HZ ' HG23 ' A' ' 34' ' ' VAL . 8.6 m-30 -90.53 10.01 27.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.565 -0.709 . . . . 0.0 110.411 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.71 -30.21 68.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.273 -0.892 . . . . 0.0 111.003 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -57.07 -28.55 62.69 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.396 -0.815 . . . . 0.0 111.019 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.724 ' HB2' ' SG ' ' A' ' 48' ' ' CYS . 26.3 m-20 -84.11 -6.58 59.43 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 122.082 -0.386 . . . . 0.0 111.667 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.4 p 42.25 28.5 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.8 mt -137.04 -47.71 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.306 -0.871 . . . . 0.0 110.79 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.314 ' SG ' HG12 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -118.76 131.41 56.12 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.374 -0.829 . . . . 0.0 111.486 -179.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -139.85 147.49 40.75 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.99 -171.74 37.26 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.275 -1.441 . . . . 0.0 111.16 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.514 HG21 ' H62' ' A' ' 138' ' ' FUC . 59.9 m -130.08 169.6 15.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 122.019 -0.695 . . . . 0.0 109.821 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 71' ' ' THR . 31.0 t -134.74 130.02 35.56 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 m -135.07 129.95 34.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.013 -1.054 . . . . 0.0 110.871 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 50.61 -122.84 14.09 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 110.116 -1.193 . . . . 0.0 110.116 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.477 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 27.4 m120 -100.03 12.07 37.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.759 -0.847 . . . . 0.0 110.46 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -116.27 128.49 55.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 109.853 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.864 HG22 ' O ' ' A' ' 21' ' ' CYS . 16.7 m -105.42 118.18 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.399 -179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.31 110.05 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 111.112 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 HG22 ' A' ' 36' ' ' VAL . 77.4 mt -111.08 131.96 54.65 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.292 -0.88 . . . . 0.0 109.538 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.3 m -131.26 144.08 51.03 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.336 -0.853 . . . . 0.0 110.744 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -124.02 140.02 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.502 -0.749 . . . . 0.0 110.481 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.43 ' HG2' HG13 ' A' ' 16' ' ' ILE . 30.4 mt-30 -120.34 122.56 41.06 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.402 0.62 . . . . 0.0 109.589 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.92 37.75 1.65 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 94.9 mt -80.12 85.72 5.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.893 . . . . 0.0 110.77 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.96 168.38 20.14 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -41.73 67.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.234 -0.917 . . . . 0.0 109.732 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 15.4 tpt -67.76 -36.07 79.85 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.393 0.616 . . . . 0.0 109.78 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -65.25 -23.48 67.07 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.687 -0.633 . . . . 0.0 110.859 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 115' ' ' ILE . 50.7 m -53.43 139.98 29.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.23 -146.8 10.79 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.414 -1.374 . . . . 0.0 111.004 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.6 tm? -107.33 134.93 49.67 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.859 -0.789 . . . . 0.0 110.752 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.813 ' N ' HD13 ' A' ' 91' ' ' LEU . 57.2 m-85 -121.1 125.07 46.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.744 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.6 mp -98.75 123.97 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.396 -0.815 . . . . 0.0 112.578 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.9 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 22.6 p -85.11 111.29 19.64 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HB3' ' H ' ' A' ' 35' ' ' THR . 7.8 tttt -103.56 139.99 38.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.536 -0.727 . . . . 0.0 109.076 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.608 ' O ' HD23 ' A' ' 106' ' ' LEU . 21.2 t -140.13 105.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.41 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.937 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 36.8 mt-10 -131.93 130.69 41.87 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.549 -0.86 . . . . 0.0 112.238 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.728 ' HG ' HD22 ' A' ' 106' ' ' LEU . 13.5 mt -84.62 78.84 9.77 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.937 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -80.03 -41.67 25.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.195 -0.941 . . . . 0.0 113.016 -174.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.475 ' O ' ' HD3' ' A' ' 102' ' ' PRO . 62.8 m-85 -65.17 -46.84 72.83 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 120.884 -1.135 . . . . 0.0 113.145 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 61.3 Cg_endo -77.0 110.1 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.204 1.107 . . . . 0.0 111.349 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.527 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 44.6 Cg_endo -89.24 145.92 5.18 Favored 'Trans proline' 0 CA--C 1.598 3.724 0 CA-C-O 110.666 -3.972 . . . . 0.0 110.432 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 37.6 Cg_endo -88.3 -168.37 4.44 Favored 'Cis proline' 2 N--CA 1.629 9.478 2 C-N-CA 92.29 -14.463 . . . . 0.0 111.927 -0.064 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -88.17 137.79 32.02 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.644 -1.285 . . . . 0.0 113.975 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.458 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 12.4 p90 -153.59 92.71 1.6 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.496 -0.752 . . . . 0.0 111.905 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.6 tp -160.13 -149.67 0.2 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.616 -0.678 . . . . 0.0 110.446 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.695 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -164.02 176.35 40.03 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.339 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.0 mp -117.55 158.11 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.718 -0.872 . . . . 0.0 109.338 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.9 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -87.45 146.82 20.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.31 78.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.439 -1.036 . . . . 0.0 110.135 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.773 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 121.4 129.96 3.74 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 120.282 -0.961 . . . . 0.0 111.101 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.706 HG21 HG23 ' A' ' 9' ' ' VAL . 94.8 m -94.63 129.98 41.27 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.987 -0.713 . . . . 0.0 109.089 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.774 ' HB3' HG23 ' A' ' 8' ' ' VAL . 21.4 tp60 -79.87 132.01 36.0 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.784 ' O ' HG23 ' A' ' 89' ' ' THR . 81.3 mt -98.85 125.06 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.865 -1.147 . . . . 0.0 108.767 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.888 ' CE2' HG21 ' A' ' 8' ' ' VAL . 11.9 m-30 -103.44 151.21 23.08 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.108 0.48 . . . . 0.0 111.122 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 118' ' ' ILE . 95.8 t -100.13 166.43 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' N ' HG12 ' A' ' 117' ' ' VAL . 45.8 mm -101.67 120.22 50.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 O-C-N 121.848 -0.533 . . . . 0.0 111.035 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -119.97 148.41 46.63 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 0.0 109.824 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.89 147.99 63.23 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 O-C-N 123.346 1.182 . . . . 0.0 110.437 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -129.91 144.24 52.28 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.502 -0.749 . . . . 0.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.31 160.07 50.83 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.341 1.18 . . . . 0.0 110.365 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.6 m -81.35 140.03 48.59 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.528 -0.732 . . . . 0.0 109.92 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.05 -35.97 10.86 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 O-C-N 123.237 1.125 . . . . 0.0 110.975 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.89 -39.84 87.59 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.44 -0.787 . . . . 0.0 110.637 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.2 p -65.1 -31.98 73.45 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.549 -0.719 . . . . 0.0 110.419 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -107.99 124.11 49.66 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.55 -0.719 . . . . 0.0 110.446 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -73.69 155.29 39.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.593 -0.692 . . . . 0.0 109.906 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 54.0 mt-10 53.48 50.17 7.06 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 121.443 -0.785 . . . . 0.0 110.741 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.4 Cg_endo -69.98 167.6 24.26 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 O-C-N 123.273 1.144 . . . . 0.0 110.541 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? . . . . . 0 N--CA 1.499 2.018 0 O-C-N 121.562 -0.711 . . . . 0.0 110.557 -179.92 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.424 ' C8 ' ' H2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.424 ' H2 ' ' C8 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.55 ' C6 ' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.55 ' C1 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.514 ' H62' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.063 0.459 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt -137.3 78.45 1.69 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.67 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.459 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 -100.1 118.73 37.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.292 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' CG1' ' SG ' ' A' ' 21' ' ' CYS . 97.6 t -149.25 147.73 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 109.679 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.895 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.71 130.6 55.73 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.443 -0.785 . . . . 0.0 110.607 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.591 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 13.1 mm100 -143.5 139.97 17.0 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.668 -0.645 . . . . 0.0 111.49 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.63 139.92 38.29 Favored 'Trans proline' 0 N--CA 1.485 1.009 0 N-CA-C 109.003 -1.191 . . . . 0.0 109.003 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.71 -27.82 66.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.36 -0.838 . . . . 0.0 110.233 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.909 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -154.03 162.41 2.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.679 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG23 HG21 ' A' ' 113' ' ' THR . 8.9 t -141.94 153.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 116' ' ' TYR . 91.6 mt -107.91 129.78 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.6 143.98 25.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.483 -0.761 . . . . 0.0 110.624 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.2 m -75.87 170.05 16.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.655 -0.653 . . . . 0.0 110.13 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -60.14 -34.63 73.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.56 -0.712 . . . . 0.0 110.124 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' HG2' ' CD1' ' A' ' 16' ' ' ILE . 5.6 ttt180 -60.17 -26.63 66.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.535 -0.728 . . . . 0.0 110.034 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.93 30.67 6.63 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.1 mp -105.3 103.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.646 -0.914 . . . . 0.0 109.32 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.551 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.85 124.07 50.05 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.763 ' HB3' HG23 ' A' ' 80' ' ' THR . 92.9 p -136.26 149.83 48.67 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.738 0.78 . . . . 0.0 111.243 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' HB3' HG21 ' A' ' 9' ' ' VAL . 46.4 p90 -155.95 164.1 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 89.1 t -126.66 123.98 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.596 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' VAL . 36.8 t -102.89 108.07 19.14 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.895 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 17.1 pt-20 -79.79 160.03 26.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 111.296 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.96 179.89 6.35 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.68 125.76 29.35 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.576 -0.702 . . . . 0.0 110.961 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.8 p -149.73 158.81 37.11 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.656 -0.653 . . . . 0.0 109.966 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.81 124.91 11.52 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.354 1.186 . . . . 0.0 110.168 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 57.98 -131.38 52.02 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -126.03 143.31 51.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.617 -0.931 . . . . 0.0 109.956 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -115.18 145.17 42.65 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 110.04 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 2.7 p -80.9 -59.74 2.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.557 -0.714 . . . . 0.0 112.067 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 51' ' ' THR . 9.8 mm-40 -84.27 75.82 10.17 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 120.241 -0.584 . . . . 0.0 112.279 -175.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.652 ' O ' HG13 ' A' ' 34' ' ' VAL . 15.4 m -85.78 87.13 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.613 ' N ' HG23 ' A' ' 51' ' ' THR . 7.2 ttp85 -55.97 97.52 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.53 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.6 m -103.56 129.59 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.819 0.819 . . . . 0.0 111.046 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.701 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.5 m -131.45 145.83 51.97 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.611 -0.68 . . . . 0.0 109.655 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.883 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.5 t -114.04 132.39 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.821 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.25 167.16 13.02 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.979 -1.076 . . . . 0.0 111.293 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.554 ' HB2' HG21 ' A' ' 47' ' ' VAL . 76.9 ttt-85 -127.61 120.86 29.07 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.591 HE21 HD23 ' A' ' 91' ' ' LEU . 34.5 mt-30 -105.9 130.28 53.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.395 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -126.78 156.12 41.73 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.24 -43.62 95.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.443 -0.786 . . . . 0.0 110.644 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 t -68.33 -49.95 56.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.549 -0.719 . . . . 0.0 111.145 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.59 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 71.2 mt-30 -155.47 164.02 39.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.382 -0.824 . . . . 0.0 111.084 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.9 t -124.77 137.27 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.2 p -139.96 166.11 25.51 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.494 -0.754 . . . . 0.0 110.959 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.821 ' HA ' HD23 ' A' ' 37' ' ' LEU . 62.5 tt0 -79.99 157.42 26.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.655 -0.653 . . . . 0.0 109.47 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 38' ' ' ARG . 97.3 t -121.03 -72.17 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.843 -0.536 . . . . 0.0 110.445 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.527 ' SG ' HG12 ' A' ' 47' ' ' VAL . 81.0 m -129.95 148.08 51.77 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.339 -0.85 . . . . 0.0 109.411 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.701 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -155.95 136.47 13.24 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.083 -1.047 . . . . 0.0 112.17 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.804 ' HB1' ' HB3' ' A' ' 58' ' ' LEU . . . -173.84 149.58 1.56 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.587 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 ' N ' ' A' ' 33' ' ' ARG . 3.2 m -94.33 119.94 33.84 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.214 -0.928 . . . . 0.0 109.278 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 53' ' ' MET . 25.6 t80 -77.91 116.7 18.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.077 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.471 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 1.0 OUTLIER -84.23 169.93 14.25 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 177.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.5 mmt -65.44 -28.26 69.1 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.687 -1.258 . . . . 0.0 111.27 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.76 44.3 0.83 Allowed Glycine 0 N--CA 1.5 2.931 0 C-N-CA 119.218 -1.468 . . . . 0.0 112.361 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 74.1 m-20 -132.73 162.14 32.21 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 118.867 1.333 . . . . 0.0 110.158 178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' C ' HD22 ' A' ' 58' ' ' LEU . 59.0 tt0 -104.68 126.54 51.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.561 -0.712 . . . . 0.0 110.13 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.804 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 3.6 mm? -98.29 139.98 33.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.009 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.6 p -100.18 142.87 31.07 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.676 -0.64 . . . . 0.0 110.581 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 48' ' ' CYS . 96.0 m-85 -103.72 133.64 48.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.51 -0.743 . . . . 0.0 109.25 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.9 tp -59.83 -44.27 94.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.516 -0.74 . . . . 0.0 112.762 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -168.39 -149.45 0.09 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.909 -1.119 . . . . 0.0 111.21 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' HG13 ' A' ' 47' ' ' VAL . 76.8 m-20 59.01 54.27 5.1 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.462 -0.774 . . . . 0.0 110.242 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 p 65.47 9.72 6.02 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.899 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.0 mt 48.27 68.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.16 -0.962 . . . . 0.0 111.354 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.413 ' O ' ' CE1' ' A' ' 60' ' ' PHE . 11.5 m -59.89 133.41 56.07 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.447 -0.783 . . . . 0.0 109.682 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 80' ' ' THR . 9.1 t -80.08 128.93 34.09 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.591 -0.844 . . . . 0.0 109.286 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.68 ' HA2' HD23 ' A' ' 79' ' ' LEU . . . -106.68 107.69 2.75 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.993 -1.099 . . . . 0.0 110.48 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -113.8 149.69 34.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.737 -0.861 . . . . 0.0 108.943 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.443 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 69.3 m -150.71 131.42 14.03 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.54 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.3 p -139.98 138.53 35.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.664 -0.648 . . . . 0.0 109.265 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 56.54 -123.92 33.31 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -108.92 16.68 22.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.905 . . . . 0.0 110.544 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 36.8 mt-30 -121.8 128.8 52.09 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.218 -0.926 . . . . 0.0 111.245 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -100.5 128.47 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.133 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.42 ' HA ' HG22 ' A' ' 20' ' ' VAL . 51.0 t-20 -108.02 118.12 35.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.282 -0.886 . . . . 0.0 111.487 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.883 HD13 ' CG2' ' A' ' 36' ' ' VAL . 86.7 mt -112.13 129.96 56.06 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.525 -0.734 . . . . 0.0 109.541 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.763 HG23 ' HB3' ' A' ' 18' ' ' SER . 61.3 m -125.89 138.98 53.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.296 -0.878 . . . . 0.0 110.641 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.705 HG21 HD21 ' A' ' 84' ' ' LEU . 72.9 mt -113.7 139.74 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.734 -0.604 . . . . 0.0 110.273 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.431 ' HG2' HG13 ' A' ' 16' ' ' ILE . 63.3 mt-30 -124.81 121.98 36.11 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.259 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.61 36.99 1.49 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.705 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -92.81 121.09 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.523 -0.986 . . . . 0.0 111.33 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' O ' HG21 ' A' ' 117' ' ' VAL . 73.4 mmt-85 -98.02 176.96 5.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.08 84.28 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 16.9 tpt -67.89 -34.54 76.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.514 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -67.53 -16.34 64.14 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.665 -0.647 . . . . 0.0 111.465 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 115' ' ' ILE . 22.8 m -50.36 135.5 21.81 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.213 -0.929 . . . . 0.0 110.439 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.55 -159.43 24.02 Favored Glycine 0 N--CA 1.498 2.826 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.871 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.591 HD23 HE21 ' A' ' 39' ' ' GLN . 15.6 tp -109.55 128.65 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.676 -0.897 . . . . 0.0 111.531 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.822 ' CD1' HD12 ' A' ' 115' ' ' ILE . 62.1 m-85 -109.94 139.94 44.48 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.716 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -115.31 130.22 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.608 -0.683 . . . . 0.0 111.881 -177.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.114 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.8 p -80.1 146.87 31.66 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 6.8 tttt -142.55 77.76 1.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.776 HG22 HD23 ' A' ' 106' ' ' LEU . 3.6 p -98.84 113.99 35.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-O 121.783 0.801 . . . . 0.0 110.482 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.661 ' OE2' HD11 ' A' ' 109' ' ' ILE . 54.9 mt-10 -128.19 129.14 46.02 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.721 -0.612 . . . . 0.0 110.63 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.748 ' HG ' HD22 ' A' ' 106' ' ' LEU . 67.4 mt -77.64 76.16 4.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 104.143 -2.539 . . . . 0.0 104.143 176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 47.6 tpp -81.8 -44.21 17.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.431 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 90.3 m-85 -70.19 -42.1 15.73 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.405 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 58.7 Cg_endo -87.51 111.76 0.81 Allowed 'Trans proline' 0 CA--C 1.561 1.868 0 CA-C-O 117.362 -1.183 . . . . 0.0 111.324 -178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.591 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 76.0 Cg_endo -85.23 155.15 10.95 Favored 'Trans proline' 0 CA--C 1.597 3.629 0 CA-C-O 111.592 -3.587 . . . . 0.0 110.249 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.591 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.286 48.0 Cg_endo -86.46 -178.99 17.33 Favored 'Cis proline' 2 C--N 1.5 8.512 1 C-N-CA 91.179 -14.925 . . . . 0.0 115.914 -5.951 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.28 128.43 34.69 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 120.399 -1.438 . . . . 0.0 110.33 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -145.09 69.86 1.26 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.385 0.612 . . . . 0.0 111.552 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.776 HD23 HG22 ' A' ' 96' ' ' VAL . 3.5 tp -144.9 -154.87 0.56 Allowed 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.604 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -167.74 -171.22 33.48 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.063 -1.541 . . . . 0.0 111.838 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.2 mp -115.15 150.03 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.7 -0.882 . . . . 0.0 109.639 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 1.114 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -79.91 148.65 30.45 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.4 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 12.1 t-20 -59.82 -38.63 82.53 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.351 -1.087 . . . . 0.0 110.227 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 125.42 148.5 7.27 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.549 HG21 HG23 ' A' ' 9' ' ' VAL . 98.8 m -119.79 134.57 55.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.813 ' HB3' HG23 ' A' ' 8' ' ' VAL . 38.3 tp60 -80.38 129.51 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.822 HD12 ' CD1' ' A' ' 92' ' ' TYR . 75.5 mt -98.2 120.82 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.818 -1.176 . . . . 0.0 108.537 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.909 ' CE2' HG21 ' A' ' 8' ' ' VAL . 9.5 m-30 -97.02 132.36 42.9 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.095 0.474 . . . . 0.0 111.414 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.4 t -98.82 166.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.504 ' N ' HG12 ' A' ' 117' ' ' VAL . 45.6 mm -100.03 116.7 43.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 121.772 -0.58 . . . . 0.0 110.74 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -140.09 125.06 11.26 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.581 -0.7 . . . . 0.0 110.08 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.72 149.94 67.78 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.075 1.04 . . . . 0.0 110.513 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -123.92 145.52 48.08 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.506 -0.746 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.35 -17.44 44.35 Favored 'Trans proline' 0 N--CA 1.487 1.121 0 O-C-N 123.418 1.22 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.1 m -125.91 148.91 64.38 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.346 -0.846 . . . . 0.0 110.343 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.8 -11.94 31.8 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.463 1.244 . . . . 0.0 111.36 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -147.95 179.24 7.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.223 -0.923 . . . . 0.0 110.645 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.8 p -132.44 163.95 27.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.146 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.18 122.2 27.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.534 -0.729 . . . . 0.0 110.38 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -89.87 169.77 10.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.642 -0.661 . . . . 0.0 110.331 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 53.67 50.67 7.53 Favored Pre-proline 0 N--CA 1.501 2.102 0 O-C-N 121.471 -0.768 . . . . 0.0 110.996 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.5 Cg_endo -70.13 159.99 51.18 Favored 'Trans proline' 0 C--N 1.318 -1.063 0 O-C-N 123.209 1.11 . . . . 0.0 110.224 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.502 2.162 0 O-C-N 121.454 -0.779 . . . . 0.0 110.613 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.718 ' H62' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.718 ' H83' ' H62' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' A ALA . . . . . 0.589 ' HB3' ' NE2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.041 0.448 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.611 ' SD ' ' HE1' ' A' ' 105' ' ' TYR . 66.3 mtt -93.94 95.29 8.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.562 -0.711 . . . . 0.0 110.283 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.589 ' NE2' ' HB3' ' A' ' 1' A ALA . 97.7 m-70 -109.92 132.02 54.53 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.671 -0.643 . . . . 0.0 110.586 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.48 HG12 ' OE1' ' A' ' 5' ' ' GLN . 66.5 t -129.89 126.04 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.609 -0.682 . . . . 0.0 109.607 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.07 130.81 56.9 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.513 -0.742 . . . . 0.0 110.506 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' OE1' HG12 ' A' ' 3' ' ' VAL . 2.7 mp0 -135.02 131.29 19.79 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.62 -0.675 . . . . 0.0 110.601 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.78 136.03 24.69 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 O-C-N 123.064 1.034 . . . . 0.0 109.515 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.1 -28.78 57.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.813 . . . . 0.0 110.209 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.97 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -153.01 163.01 2.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.045 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.68 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.4 t -138.51 151.63 24.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.57 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 116' ' ' TYR . 85.9 mt -119.19 121.26 39.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.603 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.83 140.08 45.53 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.8 t -110.12 -69.38 0.87 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.226 -0.921 . . . . 0.0 112.647 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 m -120.03 151.32 39.17 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.241 -0.912 . . . . 0.0 111.075 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.618 ' HG2' HD11 ' A' ' 16' ' ' ILE . 4.0 tpt180 56.9 18.8 4.09 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.606 -0.684 . . . . 0.0 110.577 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 51.64 44.02 53.91 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.618 HD11 ' HG2' ' A' ' 14' ' ' ARG . 21.6 mm -110.25 108.97 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 121.606 -0.938 . . . . 0.0 108.941 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -101.79 126.11 48.59 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.159 -0.616 . . . . 0.0 109.793 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.521 ' HB2' HG23 ' A' ' 80' ' ' THR . 38.3 t -133.17 135.0 44.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.621 -0.674 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' HB3' HG21 ' A' ' 9' ' ' VAL . 26.7 p90 -146.23 161.33 40.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.77 -0.581 . . . . 0.0 109.796 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 96.1 t -117.72 119.06 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.225 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.881 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.18 103.18 14.64 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 177.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 76' ' ' GLN . 85.1 mt-10 -80.4 164.3 23.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 111.789 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.662 ' CG ' HG11 ' A' ' 96' ' ' VAL . 44.0 p90 -147.9 178.46 8.49 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.489 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.64 132.59 27.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.683 -0.636 . . . . 0.0 109.891 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -131.44 147.82 67.65 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 0.0 110.585 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -75.44 142.53 26.69 Favored 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.379 1.199 . . . . 0.0 110.372 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.61 -150.34 38.62 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.07 140.91 50.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.924 . . . . 0.0 110.21 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.81 144.82 31.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.511 -0.743 . . . . 0.0 110.273 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 1.149 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 82.7 p -78.6 -46.83 18.42 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.952 0.882 . . . . 0.0 111.197 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.686 ' HB3' HG21 ' A' ' 51' ' ' THR . 2.2 mm-40 -79.04 112.56 16.37 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.538 0.685 . . . . 0.0 112.847 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.684 HG11 ' OH ' ' A' ' 52' ' ' TYR . 94.2 t -124.04 96.09 3.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 99' ' ' MET . 24.0 ttt180 -77.89 124.03 27.5 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.181 0.515 . . . . 0.0 111.184 -177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 28.3 m -121.75 141.81 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.58 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.5 m -129.92 130.1 44.7 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.238 0.542 . . . . 0.0 110.536 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD13 ' A' ' 79' ' ' LEU . 95.6 t -103.77 132.02 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.806 HD23 ' HA ' ' A' ' 46' ' ' GLU . 18.7 mt -127.34 169.03 14.0 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 118.804 -1.158 . . . . 0.0 111.185 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.589 ' HG3' HG21 ' A' ' 47' ' ' VAL . 87.7 mtm180 -122.1 115.66 22.85 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.791 ' HA ' HG22 ' A' ' 44' ' ' VAL . 9.5 tt0 -83.95 150.37 25.71 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.733 0.778 . . . . 0.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.86 -162.05 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -60.18 -46.15 90.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.444 -0.785 . . . . 0.0 110.392 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.1 p -134.77 -3.88 2.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.473 -0.767 . . . . 0.0 112.031 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 79.5 mt-30 -137.32 161.52 36.05 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.007 -1.058 . . . . 0.0 111.133 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 39' ' ' GLN . 94.0 t -125.17 156.0 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.1 p -124.13 157.67 34.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.386 -0.822 . . . . 0.0 110.628 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.806 ' HA ' HD23 ' A' ' 37' ' ' LEU . 50.2 mt-10 -87.31 143.18 27.38 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.608 0.718 . . . . 0.0 111.017 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.0 t -116.3 -71.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.932 -0.48 . . . . 0.0 109.98 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.75 ' SG ' HG12 ' A' ' 47' ' ' VAL . 30.8 m -140.06 153.38 46.76 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.381 -0.824 . . . . 0.0 110.589 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.83 135.27 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.492 -0.755 . . . . 0.0 110.912 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.844 ' HB3' ' C ' ' A' ' 59' ' ' THR . . . -171.15 155.96 4.57 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.424 -0.797 . . . . 0.0 110.212 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.686 HG21 ' HB3' ' A' ' 31' ' ' GLU . 3.6 m -102.17 131.04 48.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.394 -0.816 . . . . 0.0 109.3 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.684 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.4 p90 -110.05 141.12 43.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.669 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.977 ' N ' ' SD ' ' A' ' 53' ' ' MET . 0.0 OUTLIER -77.0 164.1 26.08 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.149 ' SD ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -71.29 79.96 0.73 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.904 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.05 -134.27 2.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.86 -2.096 . . . . 0.0 107.86 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -99.16 135.67 40.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.293 -1.122 . . . . 0.0 110.573 179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -177.08 174.94 1.62 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.07 137.76 46.48 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.107 -0.996 . . . . 0.0 110.055 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.844 ' C ' ' HB3' ' A' ' 50' ' ' ALA . 73.4 p -90.77 8.27 35.51 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.976 -0.452 . . . . 0.0 110.046 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 59' ' ' THR . 13.5 m-85 -131.59 113.54 13.76 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.23 -0.919 . . . . 0.0 110.702 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.9 mt -66.57 -35.91 81.37 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.537 -0.727 . . . . 0.0 109.521 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -141.16 -169.92 2.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.792 -0.567 . . . . 0.0 109.684 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.695 ' O ' ' SG ' ' A' ' 68' ' ' CYS . 81.6 m-20 54.33 58.15 5.22 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.344 -0.848 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 t -49.26 -21.53 0.84 Allowed 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.749 -0.595 . . . . 0.0 112.013 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.6 mt -49.1 -26.72 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 121.186 -0.946 . . . . 0.0 110.811 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.695 ' SG ' ' O ' ' A' ' 63' ' ' ASP . 4.2 p -95.57 129.62 42.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -0.764 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -139.08 148.41 43.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.511 -0.743 . . . . 0.0 109.787 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.92 -173.77 38.94 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.465 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.666 HG21 ' H3 ' ' A' ' 138' ' ' FUC . 94.5 m -130.12 163.92 25.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.951 -0.734 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 52' ' ' TYR . 62.8 m -148.08 127.16 12.84 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -155.93 140.0 16.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.228 -0.92 . . . . 0.0 110.589 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.86 -124.19 33.14 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -107.76 16.14 23.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.741 -0.858 . . . . 0.0 110.824 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.423 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.5 mt-30 -119.83 120.09 35.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.209 -0.932 . . . . 0.0 110.958 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -103.96 124.33 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.088 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -103.0 111.25 23.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 111.946 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.768 HD13 HG22 ' A' ' 36' ' ' VAL . 81.1 mt -100.52 135.87 41.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.297 -0.877 . . . . 0.0 109.011 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 18' ' ' SER . 94.1 m -135.81 144.5 45.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.313 -0.867 . . . . 0.0 110.812 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.821 HG21 HD21 ' A' ' 84' ' ' LEU . 91.1 mt -119.12 131.45 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 109.893 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 16' ' ' ILE . 96.9 mt-30 -113.78 119.42 37.29 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.155 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.07 47.85 0.86 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.821 HD21 HG21 ' A' ' 81' ' ' ILE . 80.2 mt -89.11 129.82 35.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.958 . . . . 0.0 111.755 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -119.21 179.99 4.01 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.88 82.3 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.42 -0.8 . . . . 0.0 110.188 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -65.4 -32.93 74.81 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.982 -0.449 . . . . 0.0 111.74 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -68.23 -20.02 64.78 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.345 -0.847 . . . . 0.0 111.4 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 115' ' ' ILE . 26.4 m -51.79 136.46 27.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.15 -157.61 29.93 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.631 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.571 HD11 ' C ' ' A' ' 112' ' ' GLY . 58.4 tp -109.9 133.12 53.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.65 -0.912 . . . . 0.0 111.775 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' CD2' HD12 ' A' ' 115' ' ' ILE . 46.8 m-85 -116.5 128.79 55.77 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.3 mp -95.37 127.02 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.612 -0.68 . . . . 0.0 112.112 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.064 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 29.9 p -93.13 112.25 24.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.867 ' HD3' HD12 ' A' ' 109' ' ' ILE . 5.6 mttt -105.55 146.62 29.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 0.0 109.536 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.662 HG11 ' CG ' ' A' ' 23' ' ' TYR . 21.9 t -141.75 106.3 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.54 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.688 ' HB3' ' SD ' ' A' ' 99' ' ' MET . 85.9 mt-10 -132.69 127.4 34.74 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.691 -0.804 . . . . 0.0 113.057 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.539 HD23 ' CD2' ' A' ' 106' ' ' LEU . 1.7 mm? -77.53 83.73 3.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 97' ' ' GLU . 5.0 mmm -80.58 -51.3 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.77 -0.772 . . . . 0.0 112.578 -175.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.458 ' HE1' ' HG1' ' A' ' 51' ' ' THR . 78.0 m-85 -66.29 -41.25 41.14 Favored Pre-proline 0 N--CA 1.503 2.195 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 56.4 Cg_endo -86.48 114.27 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.442 1.233 . . . . 0.0 111.927 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.752 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 90.3 Cg_endo -91.96 151.38 3.28 Favored 'Trans proline' 2 CA--C 1.675 7.545 0 CA-C-O 113.269 -2.888 . . . . 0.0 112.679 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.752 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 22.3 Cg_endo -84.95 177.39 27.9 Favored 'Cis proline' 1 N--CA 1.579 6.526 1 C-N-CA 92.828 -14.238 . . . . 0.0 114.271 -1.203 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 0.8 OUTLIER -85.53 128.06 34.63 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.611 ' HE1' ' SD ' ' A' ' 1' ' ' MET . 43.2 t80 -160.21 111.19 1.9 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.522 -1.361 . . . . 0.0 109.708 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.539 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -156.15 -144.67 0.14 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.693 -179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.98 175.82 31.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.867 HD12 ' HD3' ' A' ' 95' ' ' LYS . 48.9 mm -124.24 165.76 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.367 -1.078 . . . . 0.0 109.79 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 1.064 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -96.12 139.33 14.43 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.9 ' OD1' ' H61' ' A' ' 134' ' ' FUL . 10.1 m120 -60.09 -26.25 66.05 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.633 -0.922 . . . . 0.0 110.558 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.571 ' C ' HD11 ' A' ' 91' ' ' LEU . . . 110.89 135.65 6.93 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.666 HG21 HG23 ' A' ' 9' ' ' VAL . 94.0 m -107.63 129.82 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.888 -0.772 . . . . 0.0 109.993 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.97 ' HB3' HG23 ' A' ' 8' ' ' VAL . 37.0 tp60 -79.05 146.46 33.28 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.709 ' O ' HG23 ' A' ' 89' ' ' THR . 40.9 mt -117.46 129.91 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.848 ' CE2' HG21 ' A' ' 8' ' ' VAL . 23.0 m-85 -109.95 140.21 44.2 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.689 -0.632 . . . . 0.0 111.3 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.9 147.2 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.6 mm -78.57 131.66 34.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-O 121.221 0.534 . . . . 0.0 110.45 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -98.27 126.33 40.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.708 -0.62 . . . . 0.0 110.145 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.88 151.91 68.51 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 O-C-N 123.083 1.044 . . . . 0.0 110.495 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -120.06 149.89 49.99 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.263 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.27 -10.09 28.03 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.392 1.206 . . . . 0.0 111.323 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.915 ' SG ' ' CG ' ' A' ' 125' ' ' ASP . 42.3 t -85.54 131.19 48.48 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 0.0 110.084 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.68 -12.99 37.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 O-C-N 123.185 1.097 . . . . 0.0 111.384 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.915 ' CG ' ' SG ' ' A' ' 123' ' ' CYS . 56.9 p-10 -76.54 169.92 17.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.7 p -70.92 159.88 33.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.553 -0.717 . . . . 0.0 110.198 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -63.47 -35.92 82.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.592 -0.692 . . . . 0.0 110.305 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -142.24 162.13 36.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.531 -0.73 . . . . 0.0 109.981 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 81.0 mm-40 54.69 50.42 6.45 Favored Pre-proline 0 N--CA 1.502 2.156 0 O-C-N 121.36 -0.838 . . . . 0.0 110.798 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 42.3 Cg_endo -70.63 157.52 58.45 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.198 1.104 . . . . 0.0 110.135 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm . . . . . 0 N--CA 1.496 1.845 0 O-C-N 121.623 -0.673 . . . . 0.0 110.171 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.482 ' H82' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.444 ' C6 ' ' H2 ' ' A' ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.9 ' H61' ' OD1' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . 0.444 ' H2 ' ' C6 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.408 ' H61' ' C1 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.408 ' C1 ' ' H61' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.666 ' H3 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' A ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.096 0.474 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' SD ' ' O ' ' A' ' 106' ' ' LEU . 22.1 mmt 52.7 82.57 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.415 -0.803 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.548 ' CD2' ' HB1' ' A' ' 1' A ALA . 97.9 m-70 -109.98 130.1 55.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.513 -0.742 . . . . 0.0 110.437 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.834 HG11 ' HA2' ' A' ' 110' ' ' GLY . 90.9 t -147.69 151.29 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.618 -0.676 . . . . 0.0 109.604 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.881 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -130.55 133.86 46.56 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.449 -0.782 . . . . 0.0 111.562 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.122 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 49.1 mt-30 -150.69 149.92 27.01 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.746 -0.597 . . . . 0.0 111.141 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.91 139.99 37.41 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 N-CA-C 108.337 -1.447 . . . . 0.0 108.337 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.17 -20.47 66.15 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.271 -0.893 . . . . 0.0 110.891 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.873 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -155.93 166.61 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.382 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.931 ' HB ' HD13 ' A' ' 115' ' ' ILE . 25.7 t -138.1 154.72 28.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.319 0.581 . . . . 0.0 109.513 178.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.24 130.04 55.62 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.24 132.69 46.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.528 -0.733 . . . . 0.0 110.789 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.07 175.5 4.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.786 -0.571 . . . . 0.0 109.527 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -60.18 -35.23 74.89 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.582 ' CG ' HD13 ' A' ' 16' ' ' ILE . 22.7 tpt180 -60.37 -32.63 71.48 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.6 -0.687 . . . . 0.0 110.163 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 100.05 33.92 5.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.582 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.3 mp -105.34 101.78 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.634 -0.921 . . . . 0.0 109.247 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.852 ' HB1' HD12 ' A' ' 115' ' ' ILE . . . -107.39 122.98 47.7 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.745 ' O ' ' H83' ' A' ' 136' ' ' NAG . 32.6 t -131.92 131.72 42.93 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.381 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CD1' HD11 ' A' ' 115' ' ' ILE . 34.8 p90 -144.42 159.99 41.82 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 92.1 t -116.73 125.47 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 C-N-CA 119.804 -0.759 . . . . 0.0 111.699 -178.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.819 ' O ' HG22 ' A' ' 77' ' ' VAL . 49.6 t -107.02 105.81 16.01 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.881 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 16.7 pt-20 -80.22 152.15 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.05 . . . . 0.0 111.098 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -139.94 178.86 6.96 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.47 127.79 38.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.664 -0.648 . . . . 0.0 110.504 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.583 ' HB3' HD11 ' A' ' 106' ' ' LEU . 97.9 p -139.86 148.68 56.28 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.548 -0.72 . . . . 0.0 110.206 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.88 140.03 28.26 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.392 1.207 . . . . 0.0 110.653 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.54 -156.92 8.83 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -129.97 149.93 51.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.606 -0.938 . . . . 0.0 110.127 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 155.48 40.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.526 -0.734 . . . . 0.0 109.98 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 54' ' ' MET . 70.7 p -80.46 -43.17 21.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.456 -0.777 . . . . 0.0 110.513 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' HG21 ' A' ' 51' ' ' THR . 33.2 mm-40 -80.4 114.4 19.27 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.597 0.713 . . . . 0.0 112.334 -176.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.634 ' CG1' HG23 ' A' ' 96' ' ' VAL . 93.3 t -128.48 87.2 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 52.6 ttt85 -58.67 110.99 1.11 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.389 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.1 m -113.91 127.59 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.628 0.728 . . . . 0.0 110.178 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 93.2 m -128.75 140.45 51.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.713 -0.617 . . . . 0.0 109.574 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.898 HG22 HD13 ' A' ' 79' ' ' LEU . 96.7 t -109.79 136.94 44.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.82 HD23 ' HA ' ' A' ' 46' ' ' GLU . 12.9 mt -122.94 159.94 27.22 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.853 -1.154 . . . . 0.0 111.31 -178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -120.85 118.09 29.07 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' HG22 ' A' ' 44' ' ' VAL . 75.4 mt-30 -99.93 132.64 45.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.435 -0.791 . . . . 0.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.42 161.82 27.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.69 -41.31 90.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.503 -0.748 . . . . 0.0 110.88 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 m -70.58 -57.19 4.99 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 110.83 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 65.9 mt-30 -154.29 169.57 23.36 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.4 -0.813 . . . . 0.0 110.734 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 39' ' ' GLN . 80.9 t -117.35 137.53 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.655 -0.653 . . . . 0.0 109.28 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.2 p -132.55 162.4 31.36 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.472 -0.767 . . . . 0.0 110.89 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.82 ' HA ' HD23 ' A' ' 37' ' ' LEU . 36.9 tt0 -80.02 158.1 26.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.582 -0.699 . . . . 0.0 109.937 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 93.8 t -119.38 -82.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.675 ' SG ' ' O ' ' A' ' 64' ' ' SER . 92.8 m -120.15 154.09 35.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.909 -1.119 . . . . 0.0 109.978 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -161.23 132.89 5.61 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.017 -1.073 . . . . 0.0 112.397 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.521 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.38 159.67 4.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.659 ' O ' HD13 ' A' ' 58' ' ' LEU . 3.0 m -93.4 110.2 21.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.172 -0.955 . . . . 0.0 109.869 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.456 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 23.7 t80 -72.67 124.44 25.31 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.384 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 1.4 mmt -86.07 144.51 27.51 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.431 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 34.1 mmt -59.79 -28.09 67.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.222 -0.924 . . . . 0.0 110.6 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -102.82 -22.59 9.31 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.694 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -129.9 158.21 40.13 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.177 -1.19 . . . . 0.0 111.467 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -113.57 135.47 53.87 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.679 -0.638 . . . . 0.0 110.031 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 51' ' ' THR . 9.6 mp -96.32 167.43 11.19 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.729 0.776 . . . . 0.0 111.742 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.3 p -114.79 160.0 19.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 50' ' ' ALA . 29.9 m-85 -96.36 124.43 40.36 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.6 tp -59.81 -44.19 94.12 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -144.04 -166.44 2.36 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.068 -1.02 . . . . 0.0 111.705 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 55.82 59.27 3.89 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.46 0.648 . . . . 0.0 110.12 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.675 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 70.1 m 57.39 105.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.408 0.623 . . . . 0.0 110.598 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.78 92.16 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.783 -0.573 . . . . 0.0 110.287 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 60' ' ' PHE . 76.1 m -69.99 163.34 26.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.623 -0.673 . . . . 0.0 109.431 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.631 HG21 ' NE2' ' A' ' 82' ' ' GLN . 8.8 t -138.24 150.38 46.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.414 -0.804 . . . . 0.0 109.218 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -176.32 -174.92 43.24 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.872 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.529 HG21 ' H5 ' ' A' ' 138' ' ' FUC . 99.4 m -130.1 166.41 20.24 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 122.045 -0.679 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 65.5 m -152.87 122.77 6.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.755 -0.591 . . . . 0.0 109.554 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 81.6 p -148.94 148.15 29.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.283 -0.886 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.96 -125.53 27.49 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -108.23 19.06 20.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.655 -0.909 . . . . 0.0 110.386 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.8 mt-30 -123.98 122.72 38.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.237 -0.915 . . . . 0.0 110.876 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.4 m -105.57 123.78 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.525 -0.734 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -99.61 114.03 26.82 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.185 -0.947 . . . . 0.0 111.225 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.898 HD13 HG22 ' A' ' 36' ' ' VAL . 81.2 mt -101.81 129.53 48.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.297 -0.877 . . . . 0.0 109.776 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.433 ' HB ' HG23 ' A' ' 69' ' ' THR . 60.7 m -119.55 132.58 55.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.423 -0.798 . . . . 0.0 110.073 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.692 HG21 HD21 ' A' ' 84' ' ' LEU . 96.0 mt -110.16 129.89 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.501 -0.749 . . . . 0.0 110.449 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.631 ' NE2' HG21 ' A' ' 69' ' ' THR . 76.6 mt-30 -122.1 121.87 37.93 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.808 178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.62 45.75 0.89 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 81' ' ' ILE . 75.9 mt -79.86 133.55 36.26 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.788 0.804 . . . . 0.0 111.836 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -120.05 167.54 12.09 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.416 ' HB1' ' OD2' ' A' ' 119' ' ' ASP . . . -59.84 -39.39 84.99 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.268 -0.895 . . . . 0.0 109.842 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -68.09 -39.14 82.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.708 -0.62 . . . . 0.0 111.096 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.2 -22.6 66.35 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.536 -0.728 . . . . 0.0 111.345 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -51.52 136.48 26.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.318 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.41 -164.81 34.68 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.799 -1.191 . . . . 0.0 110.575 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 26.9 tp -84.27 131.7 34.7 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.723 -0.869 . . . . 0.0 112.784 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 72.1 m-85 -113.55 127.15 55.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.671 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.4 mp -110.09 130.33 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.617 -0.677 . . . . 0.0 112.792 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.194 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 0.8 OUTLIER -80.06 148.64 30.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 175.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.823 ' HD2' HD12 ' A' ' 109' ' ' ILE . 7.8 tttt -142.79 82.78 1.78 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.68 ' O ' HD23 ' A' ' 106' ' ' LEU . 3.2 p -93.95 115.28 32.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 122.181 0.991 . . . . 0.0 111.078 -177.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 104' ' ' TYR . 62.0 mt-10 -131.9 131.04 42.36 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.69 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.729 ' HG ' HD22 ' A' ' 106' ' ' LEU . 49.1 mt -80.99 75.78 7.96 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.415 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 2.5 ttm -80.26 -34.58 36.94 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.471 -175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.438 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 16.8 m-85 -69.0 -44.36 28.54 Favored Pre-proline 0 N--CA 1.5 2.04 0 C-N-CA 119.389 -0.924 . . . . 0.0 113.144 -178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 37.1 Cg_endo -90.42 105.49 0.32 Allowed 'Trans proline' 0 C--O 1.2 -1.379 0 N-CA-C 114.958 1.099 . . . . 0.0 114.958 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.7 Cg_endo -74.88 155.82 43.54 Favored 'Trans proline' 1 CA--C 1.659 6.759 0 CA-C-O 112.825 -3.073 . . . . 0.0 109.081 177.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 48.1 Cg_endo -87.98 172.81 30.98 Favored 'Cis proline' 3 C--N 1.494 8.196 1 C-N-CA 90.435 -15.235 . . . . 0.0 116.032 -12.051 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 97' ' ' GLU . 2.7 t80 -90.8 134.98 34.03 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.518 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -160.5 113.5 2.05 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 124.679 1.191 . . . . 0.0 109.583 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.729 HD22 ' HG ' ' A' ' 98' ' ' LEU . 2.8 tp -158.26 -146.32 0.15 Allowed 'General case' 0 N--CA 1.508 2.432 0 O-C-N 121.014 -1.054 . . . . 0.0 110.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.17 170.66 32.72 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 118.979 -1.581 . . . . 0.0 112.389 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.823 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.8 mm -109.69 152.07 11.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 122.189 -0.595 . . . . 0.0 109.69 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 1.194 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -80.53 148.41 29.24 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 8.9 t-20 -60.46 -38.65 84.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.521 -0.988 . . . . 0.0 110.327 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 115.96 136.62 5.94 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.295 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.7 HG21 HG23 ' A' ' 9' ' ' VAL . 60.2 m -119.93 141.75 49.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.661 ' HB3' HG23 ' A' ' 8' ' ' VAL . 33.3 tt0 -89.88 124.04 34.35 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.596 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.931 HD13 ' HB ' ' A' ' 9' ' ' VAL . 23.9 mm -87.85 123.98 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.873 ' CE2' HG21 ' A' ' 8' ' ' VAL . 4.4 m-30 -95.02 151.08 19.49 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.854 0.835 . . . . 0.0 111.536 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 118' ' ' ILE . 99.1 t -131.98 166.92 27.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.51 ' N ' HG12 ' A' ' 117' ' ' VAL . 26.4 mm -99.9 114.89 39.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 121.787 -0.571 . . . . 0.0 110.311 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.416 ' OD2' ' HB1' ' A' ' 86' ' ' ALA . 64.3 t0 -139.96 128.5 13.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.58 -0.7 . . . . 0.0 110.548 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -68.41 164.01 34.32 Favored 'Trans proline' 0 N--CA 1.487 1.147 0 O-C-N 123.097 1.051 . . . . 0.0 110.025 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -79.66 128.27 75.22 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.0 110.283 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.9 -15.2 36.47 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 O-C-N 123.192 1.101 . . . . 0.0 111.298 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.3 m -104.09 119.99 52.46 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 110.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.9 -11.44 29.35 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 123.1 1.053 . . . . 0.0 111.424 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -75.91 170.03 17.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.191 -0.943 . . . . 0.0 110.677 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.6 p -92.05 3.8 54.48 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.65 -0.656 . . . . 0.0 111.22 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -64.09 136.61 57.42 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.122 -0.986 . . . . 0.0 110.187 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -117.66 143.76 45.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.627 -0.67 . . . . 0.0 110.209 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 65.6 mm-40 52.44 49.91 7.33 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.423 -0.798 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.0 Cg_endo -69.95 150.06 66.52 Favored 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.203 1.107 . . . . 0.0 110.422 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.549 -0.719 . . . . 0.0 110.172 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.829 ' H61' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.829 ' H83' ' H61' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.423 ' O2 ' ' C6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.745 ' H83' ' O ' ' A' ' 18' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.529 ' H5 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 120.945 0.402 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.6 mtm -87.38 -79.86 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.785 . . . . 0.0 110.485 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -123.5 119.98 31.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.258 -0.901 . . . . 0.0 110.855 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -129.46 125.66 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.637 -0.664 . . . . 0.0 109.246 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.725 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -122.08 137.73 54.71 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.444 -0.785 . . . . 0.0 110.651 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -150.55 144.47 17.4 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.667 . . . . 0.0 111.117 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.87 147.58 50.17 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 O-C-N 123.324 1.171 . . . . 0.0 109.745 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.86 -26.55 29.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.0 109.45 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.857 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.8 p -153.61 155.99 5.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.043 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.701 HG21 ' HB3' ' A' ' 19' ' ' PHE . 9.1 t -138.05 151.45 25.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.222 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.687 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.6 mt -105.32 126.61 52.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' O ' HD11 ' A' ' 118' ' ' ILE . . . -67.97 154.11 42.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.47 -0.769 . . . . 0.0 110.561 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 m -97.37 -179.93 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.614 -0.679 . . . . 0.0 109.802 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.6 m -53.36 160.97 1.04 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.373 -0.83 . . . . 0.0 110.602 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 58.8 18.12 5.79 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.747 -0.596 . . . . 0.0 111.401 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.71 39.06 86.38 Favored Glycine 0 N--CA 1.496 2.652 0 O-C-N 121.163 -0.96 . . . . 0.0 111.213 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.447 HG13 ' HG2' ' A' ' 82' ' ' GLN . 1.4 mp -99.52 99.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.152 -1.205 . . . . 0.0 108.854 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 84' ' ' LEU . . . -103.96 124.51 49.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 108.907 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.66 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.6 p -135.56 149.98 49.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.672 0.748 . . . . 0.0 111.237 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.701 ' HB3' HG21 ' A' ' 9' ' ' VAL . 35.5 p90 -157.17 163.95 38.31 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 59.0 t -125.06 113.32 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.548 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.674 ' O ' HG22 ' A' ' 77' ' ' VAL . 47.3 t -100.08 109.95 22.24 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.725 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.2 pt-20 -80.77 164.03 23.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.166 -0.958 . . . . 0.0 111.77 -178.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.975 ' CG ' HG11 ' A' ' 96' ' ' VAL . 46.5 p90 -145.83 178.28 8.29 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.12 131.31 53.53 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.601 -0.687 . . . . 0.0 110.984 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.4 p -142.34 160.65 53.78 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.747 -0.596 . . . . 0.0 109.983 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -70.06 -10.37 28.17 Favored 'Trans proline' 0 N--CA 1.488 1.186 0 O-C-N 123.46 1.242 . . . . 0.0 111.503 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.44 27.96 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 44.1 mtpt 52.01 -155.01 0.17 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.265 -1.138 . . . . 0.0 110.063 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 28' ' ' LYS . . . 60.6 117.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.218 -0.926 . . . . 0.0 110.224 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 53' ' ' MET . 47.7 p -79.91 -35.69 37.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.661 ' OE1' HG21 ' A' ' 51' ' ' THR . 39.1 mm-40 -80.04 120.09 23.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.091 0.948 . . . . 0.0 112.779 -175.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 34' ' ' VAL . 92.1 t -132.05 83.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.724 ' HD3' ' SD ' ' A' ' 99' ' ' MET . 12.4 ttt180 -59.04 114.9 2.81 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.384 0.611 . . . . 0.0 111.664 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 50' ' ' ALA . 35.6 m -112.16 152.8 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.495 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 59.0 m -147.64 140.09 24.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.7 -0.625 . . . . 0.0 110.359 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.829 ' CG2' HD13 ' A' ' 79' ' ' LEU . 93.7 t -115.96 131.64 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.792 HD23 ' HA ' ' A' ' 46' ' ' GLU . 15.2 mt -121.98 160.02 25.75 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.696 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 25.0 ttp-105 -116.93 129.94 56.38 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HA ' HG13 ' A' ' 44' ' ' VAL . 38.3 tt0 -102.92 140.02 37.73 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.3 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.83 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -133.27 155.25 49.73 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.09 -43.98 95.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.399 -0.813 . . . . 0.0 110.614 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.82 -44.09 67.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.549 -0.72 . . . . 0.0 111.055 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.83 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 55.6 tt0 -164.43 167.92 19.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.4 -0.813 . . . . 0.0 110.95 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 39' ' ' GLN . 59.6 t -119.16 137.27 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.1 p -130.04 168.23 17.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.29 -0.881 . . . . 0.0 111.224 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.792 ' HA ' HD23 ' A' ' 37' ' ' LEU . 52.5 mt-10 -79.92 154.07 28.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.706 -0.621 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.52 HG12 ' SG ' ' A' ' 48' ' ' CYS . 89.8 t -118.05 -75.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.765 -0.585 . . . . 0.0 110.391 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.977 ' SG ' ' CG ' ' A' ' 63' ' ' ASP . 85.2 m -130.31 165.66 22.01 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.387 -0.821 . . . . 0.0 110.622 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -170.07 148.11 3.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.218 -0.926 . . . . 0.0 111.677 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -174.19 140.49 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.661 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -85.52 105.65 16.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.579 ' HA ' HD23 ' A' ' 58' ' ' LEU . 32.1 t80 -60.23 127.93 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.596 -179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.5 ' CG ' HD21 ' A' ' 58' ' ' LEU . 2.3 mmt -95.72 134.31 38.79 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.441 ' CG ' ' HA ' ' A' ' 30' ' ' THR . 34.8 mmt -56.96 -20.38 23.39 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.101 -0.999 . . . . 0.0 111.077 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.11 -12.83 8.06 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 120.037 -1.078 . . . . 0.0 111.249 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -129.98 159.94 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.985 -1.303 . . . . 0.0 111.223 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -109.85 131.95 54.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.698 -0.626 . . . . 0.0 110.264 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.683 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -93.95 153.88 17.97 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.486 -0.759 . . . . 0.0 110.861 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.6 p -101.72 140.62 35.77 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.545 0.688 . . . . 0.0 111.348 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.562 ' CZ ' ' HB3' ' A' ' 50' ' ' ALA . 72.0 m-85 -100.2 30.97 3.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -60.0 -35.83 75.89 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.531 -0.731 . . . . 0.0 111.331 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 p-10 -52.08 -25.93 9.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.271 -0.893 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.977 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 2.8 p30 -113.66 11.54 18.21 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.611 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t 59.0 137.33 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 122.057 0.932 . . . . 0.0 111.877 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.556 HG22 ' H ' ' A' ' 68' ' ' CYS . 19.0 mt 58.86 -131.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 121.306 -0.872 . . . . 0.0 110.315 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.556 ' H ' HG22 ' A' ' 67' ' ' ILE . 69.1 m 51.61 67.82 0.9 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.248 -1.533 . . . . 0.0 111.31 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 80' ' ' THR . 10.0 t -132.72 149.89 52.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.307 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.1 -140.02 4.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 72' ' ' SER . 71.2 m -129.01 164.92 22.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.723 -0.869 . . . . 0.0 110.499 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.457 ' HB2' ' CE2' ' A' ' 52' ' ' TYR . 22.0 m -166.38 120.15 1.1 Allowed 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -158.25 153.51 25.72 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.074 -1.016 . . . . 0.0 110.796 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.22 -124.36 35.61 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -108.26 12.09 26.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.748 -0.854 . . . . 0.0 110.805 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -120.8 122.09 39.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.182 -0.949 . . . . 0.0 110.63 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.5 m -107.41 123.74 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.422 -0.799 . . . . 0.0 109.713 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -104.54 113.43 27.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.369 -0.832 . . . . 0.0 111.194 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 36' ' ' VAL . 91.5 mt -105.7 129.23 53.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.454 -0.779 . . . . 0.0 109.217 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 18' ' ' SER . 62.1 m -124.53 137.67 54.39 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 110.738 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.86 HG21 HD21 ' A' ' 84' ' ' LEU . 59.5 mt -111.62 139.58 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.707 -0.621 . . . . 0.0 110.144 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 16' ' ' ILE . 82.1 mt-30 -120.02 120.53 36.6 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.997 177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.68 51.91 0.73 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.86 HD21 HG21 ' A' ' 81' ' ' ILE . 80.9 mt -99.69 130.03 45.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.522 -0.987 . . . . 0.0 111.504 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -105.39 179.97 4.11 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.636 ' HA ' HG21 ' A' ' 117' ' ' VAL . . . -59.97 -47.07 87.33 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.776 0.798 . . . . 0.0 109.533 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.7 mtp -60.37 -39.94 89.01 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.147 0.498 . . . . 0.0 110.82 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -57.95 -27.11 63.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.6 -0.688 . . . . 0.0 111.018 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.4 m -50.0 140.02 12.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.418 -0.801 . . . . 0.0 110.555 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.62 -161.85 33.0 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.635 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.884 HD13 ' N ' ' A' ' 92' ' ' TYR . 1.8 tm? -88.68 139.91 29.99 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.888 0.852 . . . . 0.0 112.086 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.884 ' N ' HD13 ' A' ' 91' ' ' LEU . 42.3 m-85 -127.58 128.19 45.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.73 ' CD1' HD12 ' A' ' 91' ' ' LEU . 3.7 mp -100.77 129.9 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.302 -0.874 . . . . 0.0 112.182 -177.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.932 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.2 p -91.07 126.24 36.1 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.76 ' HD2' HD12 ' A' ' 109' ' ' ILE . 5.5 mtmt -116.72 145.75 43.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.137 -0.977 . . . . 0.0 110.145 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' A' ' 23' ' ' TYR . 26.6 t -142.6 104.57 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.964 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 70.5 mm-40 -133.23 140.09 47.32 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.599 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.728 ' CD2' HD22 ' A' ' 106' ' ' LEU . 8.0 mt -93.01 81.14 4.56 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 103.779 -2.675 . . . . 0.0 103.779 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.724 ' SD ' ' HD3' ' A' ' 33' ' ' ARG . 1.4 mtt -80.51 -30.58 37.26 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.411 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.461 ' N ' ' HD2' ' A' ' 101' ' ' PRO . 71.5 m-85 -75.45 -49.08 3.92 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.29 -0.881 . . . . 0.0 111.853 -179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' HG2' ' HB3' ' A' ' 98' ' ' LEU . 41.3 Cg_endo -74.76 120.74 6.27 Favored 'Trans proline' 0 N--CA 1.518 2.924 0 C-N-CA 121.841 1.694 . . . . 0.0 114.813 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.45 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 63.1 Cg_endo -82.2 148.13 14.83 Favored 'Trans proline' 1 CA--C 1.659 6.758 0 CA-C-O 114.187 -2.505 . . . . 0.0 111.06 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 102' ' ' PRO 0.329 58.0 Cg_endo -116.39 58.25 0.38 Allowed 'Cis proline' 0 C--N 1.398 3.156 1 C-N-CA 95.048 -13.313 . . . . 0.0 109.053 10.955 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.2 t80 55.67 118.85 0.01 OUTLIER 'General case' 0 C--N 1.265 -3.093 0 O-C-N 120.942 -1.099 . . . . 0.0 112.629 172.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 105' ' ' TYR . 4.3 p90 -165.71 105.55 0.72 Allowed 'General case' 0 N--CA 1.529 3.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.728 HD22 ' CD2' ' A' ' 98' ' ' LEU . 2.0 tp -158.87 -149.38 0.21 Allowed 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 118.692 0.678 . . . . 0.0 111.415 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -156.22 174.13 34.08 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.281 -1.438 . . . . 0.0 110.753 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HD2' ' A' ' 95' ' ' LYS . 48.8 mm -120.26 163.76 17.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.954 -0.733 . . . . 0.0 109.518 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.932 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -94.04 140.04 14.85 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.309 -1.916 . . . . 0.0 108.309 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -59.99 -38.26 82.05 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.479 -1.013 . . . . 0.0 110.393 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.77 ' HA3' HD11 ' A' ' 91' ' ' LEU . . . 128.87 148.53 6.68 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.011 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.626 HG21 HG23 ' A' ' 9' ' ' VAL . 98.0 m -118.15 140.01 50.42 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.678 ' HB3' HG23 ' A' ' 8' ' ' VAL . 23.3 tt0 -89.28 129.99 35.75 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.221 -1.392 . . . . 0.0 108.741 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.708 ' O ' HG23 ' A' ' 89' ' ' THR . 88.8 mt -94.35 131.95 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.857 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.9 m-30 -106.71 149.92 26.8 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.139 0.495 . . . . 0.0 111.491 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' A' ' 86' ' ' ALA . 96.4 t -83.23 168.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.533 ' N ' HG12 ' A' ' 117' ' ' VAL . 36.3 mm -102.72 140.04 22.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.783 0.801 . . . . 0.0 111.289 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -117.56 145.49 36.41 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 149.95 88.8 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 O-C-N 123.107 1.056 . . . . 0.0 110.164 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -66.61 142.24 97.47 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.609 -0.682 . . . . 0.0 111.167 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 123' ' ' CYS . 52.1 Cg_endo -77.03 0.23 9.91 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 O-C-N 123.492 1.259 . . . . 0.0 111.43 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 1.112 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 0.5 OUTLIER 76.17 173.52 0.09 OUTLIER Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 121.42 -0.8 . . . . 0.0 110.001 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 1.112 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 44.2 Cg_endo -69.95 -8.9 24.77 Favored 'Trans proline' 0 N--CA 1.489 1.252 0 O-C-N 123.367 1.193 . . . . 0.0 112.157 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -65.77 -13.09 58.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.115 -0.99 . . . . 0.0 110.969 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -114.13 155.42 26.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.181 -0.949 . . . . 0.0 110.173 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -69.93 139.94 52.99 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.55 -0.719 . . . . 0.0 110.514 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -118.13 151.1 38.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.624 -0.673 . . . . 0.0 110.134 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 53.3 mt-10 53.25 50.19 7.25 Favored Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.414 -0.804 . . . . 0.0 110.918 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 43.1 Cg_endo -67.8 -20.01 46.3 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 O-C-N 123.241 1.127 . . . . 0.0 111.0 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.392 -0.817 . . . . 0.0 110.163 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.744 ' O6 ' ' H83' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.744 ' H83' ' O6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.596 ' H5 ' ' H83' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.596 ' H83' ' H5 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.148 0.499 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt -81.06 -148.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.578 -0.701 . . . . 0.0 109.587 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -97.02 30.21 2.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.063 -1.023 . . . . 0.0 110.594 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 71.0 t -125.76 129.68 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.8 132.14 52.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 110.558 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.512 ' NE2' HG12 ' A' ' 3' ' ' VAL . 17.2 mp0 -135.82 131.93 19.27 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.641 -0.662 . . . . 0.0 110.851 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.52 139.86 35.2 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.132 1.069 . . . . 0.0 109.799 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.18 -32.28 64.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.808 . . . . 0.0 109.443 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -150.51 157.9 5.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.916 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.584 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.3 t -139.91 136.64 38.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-O 121.666 0.746 . . . . 0.0 110.594 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 10' ' ' LEU . 2.8 mm? -97.63 125.13 42.21 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -86.4 151.25 23.7 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.425 -0.797 . . . . 0.0 110.245 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.6 t -75.82 172.24 13.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.552 -0.717 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.7 p -59.65 -29.0 67.73 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.01 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.702 ' CG ' HD13 ' A' ' 16' ' ' ILE . 3.0 tpt180 -59.93 -27.78 67.06 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.597 -0.689 . . . . 0.0 109.867 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.662 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 98.41 23.36 12.65 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.702 HD13 ' CG ' ' A' ' 14' ' ' ARG . 1.8 mp -110.25 109.64 29.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 O-C-N 121.5 -1.0 . . . . 0.0 110.534 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -100.47 118.32 36.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' HB3' HG23 ' A' ' 80' ' ' THR . 81.7 p -123.95 140.58 52.84 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.531 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' HB3' HG21 ' A' ' 9' ' ' VAL . 43.0 p90 -149.92 164.86 34.3 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.891 -0.505 . . . . 0.0 109.895 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 97.1 t -122.65 114.16 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.134 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.833 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.2 t -100.05 107.49 19.42 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' O ' HG13 ' A' ' 3' ' ' VAL . 82.9 mt-10 -79.98 165.03 23.0 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 111.678 -176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.673 ' CG ' HG11 ' A' ' 96' ' ' VAL . 43.4 p90 -149.88 -179.95 7.55 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.614 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 106' ' ' LEU . . . -128.9 128.52 43.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.703 -0.623 . . . . 0.0 109.82 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.9 t -112.6 150.42 42.66 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.425 -0.797 . . . . 0.0 111.116 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.27 -19.31 38.65 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.712 1.375 . . . . 0.0 111.34 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.13 -165.81 29.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -93.77 126.5 38.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.638 -0.919 . . . . 0.0 110.728 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.85 154.65 38.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.682 -0.636 . . . . 0.0 109.588 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 53' ' ' MET . 62.8 p -79.9 -37.88 33.76 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.361 -0.837 . . . . 0.0 110.675 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -79.93 112.48 17.27 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.861 -0.735 . . . . 0.0 112.331 -175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 34' ' ' VAL . 85.3 t -131.97 82.25 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 176.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 8.7 ttp85 -60.17 121.42 11.9 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.392 0.615 . . . . 0.0 111.43 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.2 m -124.34 132.05 71.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.551 HG23 ' HB2' ' A' ' 49' ' ' ALA . 58.6 m -125.55 131.27 52.79 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.236 0.541 . . . . 0.0 110.66 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.991 HG22 HD13 ' A' ' 79' ' ' LEU . 87.9 t -104.54 139.15 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 46' ' ' GLU . 19.6 mt -125.12 164.02 21.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.919 -1.113 . . . . 0.0 111.587 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HG3' HG21 ' A' ' 47' ' ' VAL . 10.4 mtt-85 -116.51 91.64 3.65 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.606 ' HA ' HG13 ' A' ' 44' ' ' VAL . 6.5 tt0 -93.63 140.05 30.07 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.29 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -150.53 154.53 37.77 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.1 -42.88 91.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.466 -0.771 . . . . 0.0 110.64 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 96.4 p -70.21 -43.61 70.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.599 -0.688 . . . . 0.0 110.872 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.642 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 11.5 mp0 -156.88 160.69 39.37 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.385 -0.822 . . . . 0.0 111.09 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 ' HA ' ' A' ' 39' ' ' GLN . 60.3 t -130.35 130.39 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.3 p -139.91 165.88 26.14 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.452 -0.78 . . . . 0.0 111.416 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.808 ' HA ' HD23 ' A' ' 37' ' ' LEU . 72.0 mt-10 -81.07 160.3 24.53 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.631 -0.668 . . . . 0.0 109.832 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.525 HG12 ' OD2' ' A' ' 63' ' ' ASP . 60.1 t -123.75 -85.58 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.621 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.217 ' SG ' ' CG ' ' A' ' 60' ' ' PHE . 18.5 t -118.79 152.69 35.74 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.959 -1.088 . . . . 0.0 110.112 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.606 ' HB3' ' OD2' ' A' ' 62' ' ' ASP . . . -167.81 128.52 1.41 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.391 -0.818 . . . . 0.0 112.654 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -172.0 161.42 5.66 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.739 ' O ' HD12 ' A' ' 58' ' ' LEU . 2.9 m -83.11 119.98 25.19 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.017 -1.052 . . . . 0.0 109.596 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 72' ' ' SER . 12.8 t80 -78.99 109.58 13.43 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.243 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 53' ' ' MET . 6.1 mmm -84.82 138.61 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 30' ' ' THR . 32.1 mmt -58.15 -20.2 38.8 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.16 -0.963 . . . . 0.0 110.921 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -94.73 -93.17 1.67 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -80.43 164.18 23.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.526 -0.985 . . . . 0.0 110.416 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' CE2' ' A' ' 52' ' ' TYR . 40.3 tp10 -110.12 130.11 55.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 110.812 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.739 HD12 ' O ' ' A' ' 51' ' ' THR . 71.5 mt -76.03 169.49 18.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.465 -0.772 . . . . 0.0 110.467 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.6 p -96.53 164.27 12.68 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.217 ' CG ' ' SG ' ' A' ' 48' ' ' CYS . 49.4 m-85 -116.16 92.61 3.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.532 -0.73 . . . . 0.0 110.218 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.66 -28.79 67.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.682 -0.636 . . . . 0.0 110.604 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.606 ' OD2' ' HB3' ' A' ' 49' ' ' ALA . 82.2 m-20 -61.3 -42.0 97.92 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.567 -0.708 . . . . 0.0 111.38 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.905 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . 23.9 t0 -100.02 11.99 37.98 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 122.038 -0.414 . . . . 0.0 112.035 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t 62.02 -67.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.998 -0.439 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 67' ' ' ILE . 89.1 mt -132.1 73.87 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.131 -0.98 . . . . 0.0 111.668 -179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 1.115 ' SG ' ' CB ' ' A' ' 60' ' ' PHE . 1.8 p -113.07 158.08 20.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.208 -0.932 . . . . 0.0 109.176 178.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 80' ' ' THR . 8.8 t -130.65 150.03 52.03 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.491 -0.756 . . . . 0.0 109.836 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -156.66 148.95 19.54 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.727 -1.225 . . . . 0.0 110.777 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 75.3 m -129.86 160.29 33.97 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.459 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 32.9 t -146.96 108.31 4.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.6 t -120.17 123.78 44.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.614 -0.678 . . . . 0.0 109.46 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.29 -120.55 23.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -106.88 19.21 20.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.53 -0.982 . . . . 0.0 110.682 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.439 ' HG2' ' HG2' ' A' ' 22' ' ' GLU . 26.8 mt-30 -116.78 120.16 37.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 111.111 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.6 m -104.52 123.94 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.05 -1.031 . . . . 0.0 109.416 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.547 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 54.2 t-20 -103.79 108.03 19.17 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 111.372 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.991 HD13 HG22 ' A' ' 36' ' ' VAL . 68.0 mt -104.49 139.95 38.67 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.451 -0.78 . . . . 0.0 109.536 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.517 ' HB ' ' H82' ' A' ' 137' ' ' NAG . 59.6 m -140.84 152.02 44.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.0 111.406 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.816 HG21 HD21 ' A' ' 84' ' ' LEU . 62.5 mt -120.01 139.87 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.854 -0.529 . . . . 0.0 109.779 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.441 ' HG2' HG13 ' A' ' 16' ' ' ILE . 38.7 mt-30 -115.79 121.54 42.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.621 -0.832 . . . . 0.0 109.658 177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 51.96 0.7 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.816 HD21 HG21 ' A' ' 81' ' ' ILE . 77.7 mt -97.2 117.34 31.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.609 -0.936 . . . . 0.0 111.246 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -102.44 -179.73 4.06 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.05 92.72 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.265 -0.897 . . . . 0.0 109.492 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.6 ttt -62.14 -38.52 89.32 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.724 -0.61 . . . . 0.0 110.523 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.38 -26.91 66.69 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.644 -0.66 . . . . 0.0 110.735 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 115' ' ' ILE . 21.2 m -51.51 134.27 29.29 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.863 . . . . 0.0 110.557 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.8 -150.29 13.83 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.406 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.483 HD12 ' C ' ' A' ' 113' ' ' THR . 13.6 tp -107.57 134.48 50.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.664 -0.903 . . . . 0.0 111.833 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.896 ' CD1' HD12 ' A' ' 115' ' ' ILE . 74.9 m-85 -116.24 145.31 43.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.7 mp -112.68 129.73 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.357 -0.839 . . . . 0.0 111.96 -177.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 94' ' ' CYS . 31.3 p -92.46 123.99 36.18 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.486 ' HB3' ' H ' ' A' ' 35' ' ' THR . 8.4 tttt -117.79 138.79 51.82 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.416 -0.802 . . . . 0.0 108.9 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.797 ' O ' HD23 ' A' ' 106' ' ' LEU . 4.6 t -135.96 112.81 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.584 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 77.4 mt-10 -138.56 123.94 19.39 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.864 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 106' ' ' LEU . 8.9 mp -76.2 81.85 3.0 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 175.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 40.5 tpp -79.03 -52.17 8.6 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 88.5 m-85 -69.09 -38.24 10.59 Favored Pre-proline 0 N--CA 1.492 1.643 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.37 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 29.1 Cg_endo -83.08 112.02 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 CA-C-N 119.832 0.976 . . . . 0.0 112.464 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 58.9 Cg_endo -83.25 150.77 13.62 Favored 'Trans proline' 1 CA--C 1.665 7.065 1 CA-C-O 110.57 -4.012 . . . . 0.0 113.244 176.023 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.504 ' O ' ' HD2' ' A' ' 103' ' ' PRO 0.253 37.4 Cg_endo -89.69 174.38 23.49 Favored 'Cis proline' 0 C--N 1.403 3.396 1 C-N-CA 95.287 -13.214 . . . . 0.0 118.711 -8.782 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 4.9 t80 -82.05 127.49 33.15 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 111.562 -2.563 . . . . 0.0 109.483 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -160.79 105.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.375 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.992 HD13 HD13 ' A' ' 98' ' ' LEU . 3.4 tp -158.23 -144.17 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.712 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.757 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.29 174.44 39.55 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.05 -1.548 . . . . 0.0 110.726 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.757 HD12 ' C ' ' A' ' 108' ' ' GLY . 3.2 mp -123.85 168.76 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 122.082 -0.658 . . . . 0.0 109.732 -178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.595 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -112.18 144.93 17.88 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 107.689 -2.164 . . . . 0.0 107.689 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -60.76 -38.99 87.07 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 118.605 1.202 . . . . 0.0 110.345 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 138.86 163.73 9.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.683 -1.246 . . . . 0.0 112.025 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.537 HG21 HG23 ' A' ' 9' ' ' VAL . 98.3 m -124.01 133.84 53.58 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.988 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.5 tp60 -75.98 139.76 41.69 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.896 HD12 ' CD1' ' A' ' 92' ' ' TYR . 52.3 mt -116.21 124.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.897 -1.127 . . . . 0.0 108.642 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.84 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.8 m-85 -104.42 140.13 38.37 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.491 ' HA ' ' HB3' ' A' ' 11' ' ' ALA . 86.8 t -109.95 157.09 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.831 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . 0.27 43.9 mm -103.94 140.03 23.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.189 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -116.81 97.53 50.61 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.429 -0.794 . . . . 0.0 109.95 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.03 147.26 60.71 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.349 1.184 . . . . 0.0 110.697 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -130.06 155.08 81.25 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.679 -0.638 . . . . 0.0 110.18 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -66.85 -20.34 51.9 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 O-C-N 123.398 1.209 . . . . 0.0 111.358 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 81.7 m -83.44 146.85 51.45 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.36 -0.837 . . . . 0.0 109.904 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.12 -21.46 42.52 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.363 1.191 . . . . 0.0 110.934 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -151.93 150.14 29.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.426 -0.796 . . . . 0.0 110.052 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.8 p -152.88 157.79 41.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.459 -0.776 . . . . 0.0 110.357 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -139.97 83.62 1.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.558 -0.714 . . . . 0.0 110.039 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -137.93 144.46 41.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.562 -0.712 . . . . 0.0 109.999 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 85.8 mt-10 51.56 49.68 7.41 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.527 -0.733 . . . . 0.0 111.563 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 45.9 Cg_endo -69.26 150.07 70.84 Favored 'Trans proline' 0 N--CA 1.486 1.063 0 O-C-N 123.171 1.09 . . . . 0.0 110.599 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.2 mttp . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.547 -0.72 . . . . 0.0 110.148 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.658 ' H61' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.658 ' H82' ' H61' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.467 ' H5 ' ' C7 ' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.517 ' H82' ' HB ' ' A' ' 80' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.491 ' H5 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.041 0.448 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.2 mmm -64.4 138.4 58.4 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.578 -0.701 . . . . 0.0 110.046 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.438 ' C ' HG23 ' A' ' 3' ' ' VAL . 65.1 m170 -110.27 129.91 55.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.471 -0.768 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.1 t -147.95 144.84 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -117.01 117.7 30.38 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.315 -0.866 . . . . 0.0 111.552 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.02 ' OE1' ' SG ' ' A' ' 94' ' ' CYS . 1.2 mm-40 -142.34 141.36 20.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.617 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.27 138.11 32.49 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 O-C-N 123.216 1.114 . . . . 0.0 109.549 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.35 -30.21 67.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.379 -0.826 . . . . 0.0 109.954 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 1.012 HG23 ' HB3' ' A' ' 114' ' ' GLN . 2.9 p -149.57 156.81 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.951 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 113' ' ' THR . 13.9 t -140.18 151.27 21.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-O 121.31 0.576 . . . . 0.0 109.457 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.69 HD23 ' HB2' ' A' ' 116' ' ' TYR . 77.8 mt -110.06 130.03 55.6 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.472 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 135.34 33.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.507 -0.746 . . . . 0.0 110.595 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.7 p -70.02 173.34 6.6 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.714 -0.616 . . . . 0.0 110.513 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.2 p -60.12 -29.4 68.59 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.631 -0.668 . . . . 0.0 110.196 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.713 ' HG3' HD13 ' A' ' 16' ' ' ILE . 23.6 tpp180 -60.33 -29.73 69.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.547 -0.721 . . . . 0.0 109.905 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.745 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.75 25.28 10.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 15' ' ' GLY . 1.8 mp -114.18 115.61 50.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 O-C-N 121.551 -0.97 . . . . 0.0 110.271 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -108.03 127.4 53.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.8 t -127.22 133.59 50.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.414 -0.804 . . . . 0.0 111.617 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' HB3' HG21 ' A' ' 9' ' ' VAL . 51.1 p90 -143.63 167.02 23.24 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 88.6 t -128.89 124.38 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.475 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.702 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -99.99 109.04 21.38 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 60.2 tt0 -86.49 140.56 29.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.479 -0.763 . . . . 0.0 110.939 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -129.62 161.94 29.41 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.16 130.54 18.7 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.0 p -159.99 160.0 27.04 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.595 -0.691 . . . . 0.0 110.388 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.13 148.23 49.89 Favored 'Trans proline' 0 C--N 1.317 -1.108 0 O-C-N 123.391 1.206 . . . . 0.0 110.57 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.6 167.47 8.62 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.98 149.58 51.64 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.597 -0.943 . . . . 0.0 110.318 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.99 149.96 33.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 109.658 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.545 ' HA ' ' HE2' ' A' ' 54' ' ' MET . 43.3 p -79.99 -33.4 39.41 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.38 -0.825 . . . . 0.0 110.76 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 23.2 mm-40 -80.17 74.29 6.98 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.268 -175.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 34' ' ' VAL . 14.5 m -91.98 87.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 118.352 -1.339 . . . . 0.0 107.551 176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 72.3 ttt-85 -53.1 105.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.693 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.705 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -107.55 131.21 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.79 0.805 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.723 HG23 ' HB2' ' A' ' 49' ' ' ALA . 94.6 m -135.94 150.21 49.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 0.0 109.409 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.959 ' CG2' HD13 ' A' ' 79' ' ' LEU . 94.2 t -117.51 140.03 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.788 HD23 ' HA ' ' A' ' 46' ' ' GLU . 17.4 mt -127.87 164.51 22.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.887 -1.133 . . . . 0.0 110.915 -179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -127.4 117.28 21.87 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.642 HE21 HD23 ' A' ' 91' ' ' LEU . 35.3 mt-30 -105.24 123.96 48.73 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.612 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -123.44 154.28 39.28 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -59.74 -43.8 94.07 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.467 -0.771 . . . . 0.0 110.422 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.3 m -68.0 -49.79 59.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.579 -0.7 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.691 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.3 mt-30 -154.5 160.75 41.74 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.366 -0.834 . . . . 0.0 111.096 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 39' ' ' GLN . 96.3 t -125.97 134.23 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.592 -0.692 . . . . 0.0 109.294 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -140.76 164.02 31.34 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.543 -0.723 . . . . 0.0 111.138 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.788 ' HA ' HD23 ' A' ' 37' ' ' LEU . 30.5 tt0 -79.91 156.9 27.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 109.841 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 98.4 t -113.64 -89.64 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.895 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.454 ' HB3' ' CD1' ' A' ' 60' ' ' PHE . 93.4 m -122.68 149.94 43.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.801 -1.187 . . . . 0.0 110.28 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.723 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -150.22 140.01 21.78 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.819 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -172.0 153.54 3.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 3.0 m -91.89 120.62 32.74 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.791 ' CA ' HD21 ' A' ' 58' ' ' LEU . 16.1 t80 -79.16 109.15 13.21 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.43 -0.908 . . . . 0.0 108.983 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.8 OUTLIER -80.46 169.96 17.0 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 30' ' ' THR . 34.4 mmt -67.63 -28.77 68.01 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.001 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -144.91 35.63 1.48 Allowed Glycine 0 N--CA 1.499 2.846 0 C-N-CA 119.297 -1.43 . . . . 0.0 112.57 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 53' ' ' MET . 81.6 m-20 -130.32 159.95 35.42 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 119.151 1.476 . . . . 0.0 110.272 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -83.41 139.98 32.66 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.55 -0.719 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.791 HD21 ' CA ' ' A' ' 52' ' ' TYR . 6.6 mp -89.17 129.97 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 110.242 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 p -99.98 135.57 41.2 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.494 -0.754 . . . . 0.0 110.981 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 95.2 m-85 -107.99 114.91 29.18 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.4 tp -60.26 -43.72 95.91 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.565 -0.709 . . . . 0.0 112.833 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -149.38 -161.81 1.42 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.024 -1.047 . . . . 0.0 111.632 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 56.75 58.07 4.33 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.473 0.654 . . . . 0.0 110.088 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 57.74 164.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.359 0.6 . . . . 0.0 110.553 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.62 85.75 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.58 -0.7 . . . . 0.0 110.465 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' O ' ' CE2' ' A' ' 60' ' ' PHE . 97.5 m -68.07 153.24 44.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.577 -0.702 . . . . 0.0 109.462 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -140.0 150.01 43.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.579 -0.701 . . . . 0.0 109.305 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.9 179.98 43.23 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.641 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 72' ' ' SER . 91.1 m -130.19 169.25 15.61 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 122.12 -0.635 . . . . 0.0 109.444 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.482 ' N ' HG22 ' A' ' 71' ' ' THR . 44.5 m -155.04 124.57 6.43 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.2 p -141.09 145.53 35.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.168 -0.958 . . . . 0.0 110.464 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 51.8 -122.37 16.35 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -105.72 11.98 31.51 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.801 -0.823 . . . . 0.0 111.016 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -116.69 126.68 53.53 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.093 -1.004 . . . . 0.0 110.873 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.2 m -107.89 123.48 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.899 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -100.61 118.62 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.752 . . . . 0.0 111.435 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.959 HD13 ' CG2' ' A' ' 36' ' ' VAL . 76.1 mt -111.84 137.22 50.09 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.255 -0.903 . . . . 0.0 109.216 178.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.2 m -128.32 140.21 51.99 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.253 -0.905 . . . . 0.0 110.927 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 84' ' ' LEU . 88.5 mt -116.85 132.79 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.638 -0.664 . . . . 0.0 110.102 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 16' ' ' ILE . 19.7 mt-30 -118.94 121.39 39.83 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.806 -0.757 . . . . 0.0 109.589 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.86 54.19 0.57 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 81' ' ' ILE . 76.2 mt -90.85 120.01 31.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.601 -0.941 . . . . 0.0 110.953 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -98.07 178.95 4.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.66 90.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.281 -0.887 . . . . 0.0 109.639 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.9 ttt -66.79 -37.44 84.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.696 -0.627 . . . . 0.0 110.565 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -59.88 -33.5 71.9 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.576 -0.702 . . . . 0.0 111.153 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.4 m -51.99 130.92 30.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.27 -142.02 7.27 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.642 HD23 HE21 ' A' ' 39' ' ' GLN . 18.0 tp -109.05 129.19 55.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.672 -0.899 . . . . 0.0 111.518 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.801 ' CD1' HD12 ' A' ' 115' ' ' ILE . 73.3 m-85 -109.99 132.06 54.5 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -110.07 130.05 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.732 -0.605 . . . . 0.0 111.731 -176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.088 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 19.9 p -79.9 155.78 27.59 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 5.3 tptm -147.15 79.09 1.5 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 108.759 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.616 HG22 ' CD2' ' A' ' 106' ' ' LEU . 3.6 p -95.79 115.24 34.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 122.147 0.975 . . . . 0.0 110.614 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.448 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 67.8 mm-40 -135.17 137.24 42.51 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.787 -0.571 . . . . 0.0 111.703 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' CD2' HD22 ' A' ' 106' ' ' LEU . 13.8 mt -83.98 75.46 10.13 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 176.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.4 ttm -79.9 -32.42 40.25 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.472 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 96.2 m-85 -87.03 -39.55 0.52 Allowed Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.332 -0.855 . . . . 0.0 112.426 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 59.0 Cg_endo -92.59 118.71 0.42 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 CA-C-O 121.556 0.565 . . . . 0.0 110.698 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.599 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 60.7 Cg_endo -91.13 156.01 3.84 Favored 'Trans proline' 1 CA--C 1.655 6.562 0 CA-C-O 113.372 -2.845 . . . . 0.0 111.123 177.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.599 ' C ' ' HA ' ' A' ' 102' ' ' PRO . 44.2 Cg_endo -89.94 175.47 21.15 Favored 'Cis proline' 3 N--CA 1.644 10.334 1 C-N-CA 91.289 -14.88 . . . . 0.0 116.263 1.059 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 4.0 t80 -82.58 129.57 34.96 Favored 'General case' 0 C--N 1.266 -3.025 0 O-C-N 119.626 -1.921 . . . . 0.0 109.167 -173.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -166.7 104.9 0.6 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.426 -1.421 . . . . 0.0 108.376 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.768 HD22 ' CD2' ' A' ' 98' ' ' LEU . 4.3 tp -157.71 -147.96 0.19 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.484 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -157.48 170.96 34.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 118.541 -1.79 . . . . 0.0 112.249 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.471 HD12 ' HD2' ' A' ' 95' ' ' LYS . 50.0 mm -115.22 146.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.352 -1.087 . . . . 0.0 109.187 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 1.088 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -73.63 141.58 29.83 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.467 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 11.1 t-20 -60.07 -30.59 69.31 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.421 -1.046 . . . . 0.0 109.709 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 118.72 138.77 5.93 Favored Glycine 0 N--CA 1.489 2.174 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.492 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.529 HG21 HG23 ' A' ' 9' ' ' VAL . 94.5 m -111.64 139.78 46.8 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 1.012 ' HB3' HG23 ' A' ' 8' ' ' VAL . 34.1 tp60 -83.45 120.72 26.26 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 118.844 -1.142 . . . . 0.0 108.258 178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.801 HD12 ' CD1' ' A' ' 92' ' ' TYR . 53.8 mt -96.79 114.23 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.619 -1.301 . . . . 0.0 108.592 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.78 ' CE2' HG21 ' A' ' 8' ' ' VAL . 12.4 m-85 -87.81 139.11 30.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.389 0.614 . . . . 0.0 111.552 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 118' ' ' ILE . 89.4 t -125.45 165.26 23.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.492 ' N ' HG12 ' A' ' 117' ' ' VAL . 28.2 mm -99.98 119.88 48.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 121.954 -0.466 . . . . 0.0 110.323 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -137.65 126.52 14.78 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.597 -0.689 . . . . 0.0 110.203 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.03 159.99 51.22 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.09 1.048 . . . . 0.0 110.314 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -114.9 150.19 43.72 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.534 -0.729 . . . . 0.0 110.273 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.28 -19.81 43.64 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.38 1.2 . . . . 0.0 110.863 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.7 m -102.83 123.59 41.77 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.349 -0.844 . . . . 0.0 109.991 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.43 -17.66 38.98 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.129 1.068 . . . . 0.0 111.394 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -90.0 178.68 6.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.24 -0.912 . . . . 0.0 110.831 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.3 p -83.41 169.93 15.05 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.623 -0.673 . . . . 0.0 110.142 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -89.68 106.35 18.4 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.599 -0.688 . . . . 0.0 110.104 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -130.03 160.02 34.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.554 -0.716 . . . . 0.0 110.251 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.423 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 80.9 mm-40 53.01 50.05 7.24 Favored Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.414 -0.804 . . . . 0.0 110.986 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.3 Cg_endo -69.95 149.93 66.34 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.214 1.113 . . . . 0.0 110.435 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.607 -0.683 . . . . 0.0 110.217 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.467 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.428 ' O2 ' ' H62' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.498 ' O3 ' ' H82' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.498 ' H82' ' O3 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' A ALA . . . . . 0.597 ' HB1' ' CD2' ' A' ' 2' ' ' HIS . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.105 0.478 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt 52.85 77.35 0.17 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.445 -0.784 . . . . 0.0 110.739 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.597 ' CD2' ' HB1' ' A' ' 1' A ALA . 84.8 m-70 -110.04 130.55 55.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.562 -0.711 . . . . 0.0 110.888 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 128.11 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.576 -0.703 . . . . 0.0 109.329 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.884 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -111.21 128.83 56.04 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.453 -0.78 . . . . 0.0 110.737 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.087 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 27.1 mm100 -139.45 131.95 15.27 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.729 -0.607 . . . . 0.0 111.214 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -74.51 139.21 25.39 Favored 'Trans proline' 0 N--CA 1.486 1.03 0 O-C-N 123.119 1.063 . . . . 0.0 109.485 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.43 -33.41 71.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.437 -0.789 . . . . 0.0 109.768 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.605 HG21 ' CZ ' ' A' ' 116' ' ' TYR . 3.1 p -152.72 156.26 5.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.529 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.685 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -131.84 155.94 42.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.845 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.9 mt -112.33 129.99 56.11 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.92 -0.712 . . . . 0.0 109.928 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.8 149.03 27.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.616 -0.677 . . . . 0.0 110.29 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.3 t -89.58 176.93 6.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.629 -0.669 . . . . 0.0 110.664 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.6 t -59.84 -31.65 69.94 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.554 -0.716 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.74 ' HG3' HD13 ' A' ' 16' ' ' ILE . 7.8 tpm_? -59.97 -28.77 67.94 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.618 -0.676 . . . . 0.0 110.076 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 95.29 22.59 21.84 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.74 HD13 ' HG3' ' A' ' 14' ' ' ARG . 1.8 mp -114.73 114.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 121.501 -0.999 . . . . 0.0 109.877 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.508 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -108.76 124.02 49.92 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.642 ' HB3' HG23 ' A' ' 80' ' ' THR . 97.1 p -132.8 150.01 52.21 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.008 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.685 ' HB3' HG21 ' A' ' 9' ' ' VAL . 32.4 p90 -152.06 163.11 40.0 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 87.2 t -119.4 122.71 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.301 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.087 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 41.4 t -100.78 100.54 11.22 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.884 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.4 pt-20 -79.95 149.97 30.66 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.318 -178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -132.68 173.56 11.22 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.04 120.59 22.6 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.391 -0.818 . . . . 0.0 111.154 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB2' HD21 ' A' ' 106' ' ' LEU . 28.7 t -151.62 149.95 25.32 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.5 -0.75 . . . . 0.0 111.053 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.84 147.95 31.52 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 O-C-N 123.694 1.365 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 54.51 -176.15 0.44 Allowed Glycine 0 N--CA 1.497 2.753 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -131.89 160.05 36.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.764 -0.845 . . . . 0.0 109.73 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 1.018 ' O ' ' SD ' ' A' ' 54' ' ' MET . . . -148.4 171.94 15.23 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.312 -0.867 . . . . 0.0 111.039 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.833 ' O ' ' SD ' ' A' ' 53' ' ' MET . 2.8 p -86.26 -5.39 59.19 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.611 -0.681 . . . . 0.0 112.622 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 6.4 mm-40 -129.16 76.44 1.72 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 117.914 -1.514 . . . . 0.0 112.91 -175.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' HB ' ' CD2' ' A' ' 52' ' ' TYR . 92.0 t -91.94 86.21 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 176.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.9 ttm-85 -63.16 123.33 18.35 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.366 0.603 . . . . 0.0 111.618 -177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 m -126.99 161.24 34.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.6 m -152.73 138.95 18.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.764 -0.585 . . . . 0.0 110.104 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.985 HG22 HD13 ' A' ' 79' ' ' LEU . 88.2 t -108.84 128.9 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.879 HD23 ' HA ' ' A' ' 46' ' ' GLU . 11.0 mt -124.82 165.01 18.79 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.279 -0.968 . . . . 0.0 111.491 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' HB2' HG21 ' A' ' 47' ' ' VAL . 62.4 ttp180 -128.3 121.25 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.58 HE21 HD23 ' A' ' 91' ' ' LEU . 34.6 mt-30 -103.3 131.96 49.93 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.974 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -99.74 -174.17 2.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.94 -0.475 . . . . 0.0 109.814 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.43 -43.69 96.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.54 -0.725 . . . . 0.0 110.764 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.5 m -130.08 -3.28 4.52 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.398 -0.814 . . . . 0.0 111.88 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.632 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 37.2 mt-30 -132.31 152.35 51.43 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.061 -1.024 . . . . 0.0 110.988 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 89.4 t -135.33 138.62 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.712 -0.617 . . . . 0.0 109.864 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 79.1 p -136.9 162.8 32.27 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.584 -0.697 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.879 ' HA ' HD23 ' A' ' 37' ' ' LEU . 85.8 mt-10 -79.91 153.73 28.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.605 -0.684 . . . . 0.0 110.146 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.189 HG12 ' SG ' ' A' ' 48' ' ' CYS . 86.5 t -120.72 -50.46 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.636 -0.665 . . . . 0.0 110.646 -179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.189 ' SG ' HG12 ' A' ' 47' ' ' VAL . 1.3 m -155.96 132.29 10.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.239 -0.913 . . . . 0.0 110.201 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.417 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -139.61 138.46 36.19 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.444 -0.785 . . . . 0.0 111.188 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.63 156.48 6.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.644 -0.66 . . . . 0.0 109.656 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -90.64 124.08 34.77 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.299 -0.876 . . . . 0.0 109.575 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.582 ' HA ' HD11 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -69.89 90.06 0.61 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.833 ' SD ' ' O ' ' A' ' 30' ' ' THR . 61.8 mmm -88.13 122.52 31.79 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 1.018 ' SD ' ' O ' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -59.83 -27.96 67.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.035 -1.04 . . . . 0.0 110.265 -178.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.45 -42.1 7.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -110.48 151.02 28.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.245 -1.15 . . . . 0.0 111.554 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -77.04 150.23 35.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.58 -0.7 . . . . 0.0 110.544 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' TYR . 4.7 mp -71.15 136.93 48.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.514 -0.741 . . . . 0.0 110.388 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.1 p -118.28 139.61 51.06 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.525 -0.734 . . . . 0.0 110.999 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 75.2 m-85 -107.63 112.0 24.5 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.5 tt -68.0 -43.39 78.99 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.448 -0.782 . . . . 0.0 112.031 -178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' HB3' HD23 ' A' ' 61' ' ' LEU . 55.3 p-10 -142.51 -158.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.262 -0.899 . . . . 0.0 111.339 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 57.65 57.01 4.5 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.412 0.625 . . . . 0.0 110.271 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 p 57.13 166.49 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.325 0.583 . . . . 0.0 110.95 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.95 131.96 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.739 -0.601 . . . . 0.0 110.558 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 82.8 m -130.05 165.42 22.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.709 -0.619 . . . . 0.0 109.667 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 80' ' ' THR . 8.2 t -136.05 141.37 44.27 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -150.2 153.74 25.25 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.8 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.829 HG21 ' C6 ' ' A' ' 138' ' ' FUC . 59.2 m -139.99 157.36 45.8 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.455 ' CB ' ' CD2' ' A' ' 52' ' ' TYR . 15.3 t -146.0 108.04 4.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.464 -0.772 . . . . 0.0 110.512 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.7 t -148.28 148.1 30.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.831 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.74 38.58 96.7 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 29.2 m120 57.06 27.42 13.3 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.692 -0.887 . . . . 0.0 110.227 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.404 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -132.12 128.62 38.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.591 -0.693 . . . . 0.0 109.814 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.9 m -104.45 120.29 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.34 -0.85 . . . . 0.0 110.427 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -100.97 110.1 22.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.262 -0.899 . . . . 0.0 111.175 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.985 HD13 HG22 ' A' ' 36' ' ' VAL . 86.9 mt -103.01 131.98 49.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.539 -0.726 . . . . 0.0 109.242 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.642 HG23 ' HB3' ' A' ' 18' ' ' SER . 94.8 m -130.88 150.33 52.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.335 -0.853 . . . . 0.0 111.188 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.585 HG21 HD21 ' A' ' 84' ' ' LEU . 62.4 mt -124.47 141.57 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.809 -0.557 . . . . 0.0 109.977 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.434 ' CG ' HG13 ' A' ' 16' ' ' ILE . 24.0 mt-30 -120.01 122.06 40.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.745 177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.46 41.38 1.14 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 81' ' ' ILE . 80.1 mt -89.35 129.95 35.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.575 -0.956 . . . . 0.0 111.421 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -116.15 179.81 3.88 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.11 -38.03 81.8 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.327 -0.858 . . . . 0.0 109.865 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.5 ttp -68.14 -35.86 78.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.675 -0.64 . . . . 0.0 111.045 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -64.97 -20.02 66.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.522 -0.736 . . . . 0.0 111.387 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 115' ' ' ILE . 19.7 m -49.65 142.51 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.28 -0.888 . . . . 0.0 110.357 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 160.7 -165.24 35.02 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.58 HD23 HE21 ' A' ' 39' ' ' GLN . 21.1 tp -98.76 131.37 44.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.569 -0.959 . . . . 0.0 112.75 -178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CE1' HD12 ' A' ' 115' ' ' ILE . 86.1 m-85 -114.23 139.2 49.59 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.0 mp -108.91 141.45 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.386 -0.822 . . . . 0.0 111.818 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.038 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 17.3 p -104.66 112.72 25.91 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -100.87 143.08 31.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.22 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.74 106.61 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.678 -0.639 . . . . 0.0 109.465 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.417 ' CG ' ' OH ' ' A' ' 104' ' ' TYR . 22.1 mp0 -131.32 130.13 42.35 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.566 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.7 ' CD1' HD23 ' A' ' 106' ' ' LEU . 12.1 mt -84.61 80.36 9.27 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 103.919 -2.623 . . . . 0.0 103.919 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 44.7 tpp -79.74 -52.85 7.42 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.186 -174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.451 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 94.0 m-85 -68.75 -44.25 30.85 Favored Pre-proline 0 N--CA 1.508 2.464 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 31' ' ' GLU . 60.3 Cg_endo -79.14 110.46 2.74 Favored 'Trans proline' 0 N--CA 1.518 2.932 0 C-N-CA 121.136 1.224 . . . . 0.0 110.885 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 57.4 Cg_endo -83.18 155.22 14.63 Favored 'Trans proline' 1 CA--C 1.676 7.599 0 CA-C-O 111.686 -3.548 . . . . 0.0 105.643 -177.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 102' ' ' PRO . 52.4 Cg_endo -88.07 -179.08 15.31 Favored 'Cis proline' 1 C--N 1.492 8.082 1 C-N-CA 95.527 -13.114 . . . . 0.0 116.297 -10.356 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' OH ' ' CG ' ' A' ' 97' ' ' GLU . 4.4 t80 -87.37 132.15 34.06 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 117.469 -3.27 . . . . 0.0 110.467 177.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.4 ' O ' HD22 ' A' ' 106' ' ' LEU . 51.4 t80 -163.43 92.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.042 178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.7 HD23 ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -145.57 -148.36 0.24 Allowed 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.412 -0.805 . . . . 0.0 110.074 -179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.61 ' C ' HD12 ' A' ' 109' ' ' ILE . . . -163.1 179.0 38.58 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 109' ' ' ILE . 3.8 mp -119.81 158.79 21.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 O-C-N 121.67 -0.9 . . . . 0.0 109.109 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.81 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -85.52 145.22 20.99 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 107.471 -2.252 . . . . 0.0 107.471 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -60.15 -34.54 73.69 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.297 -1.119 . . . . 0.0 110.727 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 122.95 135.27 4.56 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.612 HG21 HG23 ' A' ' 9' ' ' VAL . 94.7 m -106.78 130.99 54.4 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' VAL . 44.7 tt0 -85.11 123.99 31.27 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.551 -1.26 . . . . 0.0 108.835 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 92' ' ' TYR . 82.3 mt -85.85 125.59 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.731 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.845 ' HB2' HD23 ' A' ' 10' ' ' LEU . 4.6 m-30 -95.84 158.87 15.25 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.209 0.528 . . . . 0.0 110.38 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.4 t -110.55 167.01 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.51 ' N ' HG12 ' A' ' 117' ' ' VAL . 30.7 mm -99.54 115.14 39.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-O 121.303 0.573 . . . . 0.0 110.451 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -140.01 125.41 11.53 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.736 -0.603 . . . . 0.0 109.819 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.49 149.99 69.29 Favored 'Trans proline' 0 N--CA 1.487 1.102 0 O-C-N 123.058 1.031 . . . . 0.0 110.298 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -87.14 129.98 49.78 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.502 -0.749 . . . . 0.0 110.266 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.36 -12.3 33.36 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 O-C-N 123.184 1.097 . . . . 0.0 111.235 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.888 ' SG ' ' O ' ' A' ' 125' ' ' ASP . 42.3 t -102.44 120.74 52.26 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.237 -0.914 . . . . 0.0 110.194 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.13 -19.88 44.44 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.12 1.063 . . . . 0.0 110.986 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.888 ' O ' ' SG ' ' A' ' 123' ' ' CYS . 55.0 p-10 -140.59 169.97 16.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.361 -0.837 . . . . 0.0 110.602 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -94.37 170.06 9.77 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.656 -0.653 . . . . 0.0 110.27 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -79.31 124.03 28.01 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.008 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 28.0 mm100 -67.51 -36.35 80.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.586 -0.696 . . . . 0.0 110.567 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -110.05 124.07 34.46 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 0.0 110.412 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.93 159.91 51.57 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.19 1.1 . . . . 0.0 110.529 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 64.3 mttm . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.565 -0.709 . . . . 0.0 110.196 179.775 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.686 ' O6 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.686 ' H82' ' O6 ' ' A' ' 132' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.829 ' C6 ' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.053 0.454 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm -105.01 -32.93 8.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.615 -0.678 . . . . 0.0 110.253 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . 71.1 m80 -110.06 31.45 5.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.551 -0.718 . . . . 0.0 110.293 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' C ' ' A' ' 2' ' ' HIS . 87.2 t -149.26 137.98 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.826 -0.546 . . . . 0.0 110.043 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.47 127.33 53.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.557 -0.714 . . . . 0.0 109.876 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.004 ' CD ' ' SG ' ' A' ' 94' ' ' CYS . 14.0 mm-40 -139.95 131.52 14.53 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.658 -0.651 . . . . 0.0 111.745 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.65 139.93 28.79 Favored 'Trans proline' 0 N--CA 1.486 1.071 0 O-C-N 123.141 1.074 . . . . 0.0 109.434 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.77 -33.81 74.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 109.725 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.689 HG21 ' CE2' ' A' ' 116' ' ' TYR . 3.0 p -150.68 155.77 7.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.615 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.64 HG23 HG21 ' A' ' 113' ' ' THR . 8.6 t -133.01 148.2 31.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.135 177.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.1 mt -104.52 127.48 52.25 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.684 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.81 175.18 6.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.623 -0.673 . . . . 0.0 110.465 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -109.45 175.81 5.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.657 -0.652 . . . . 0.0 110.22 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -60.42 -37.54 81.19 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.524 -0.735 . . . . 0.0 109.745 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HB3' HD13 ' A' ' 16' ' ' ILE . 19.8 mmt85 -59.63 -30.22 68.56 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.682 -0.636 . . . . 0.0 110.312 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 97.14 27.03 9.67 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 16' ' ' ILE . 1.3 mp -102.74 100.4 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.975 . . . . 0.0 108.65 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.22 118.4 33.2 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.676 ' HB2' HG23 ' A' ' 80' ' ' THR . 45.7 t -131.19 132.58 44.8 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.924 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' HB3' HG21 ' A' ' 9' ' ' VAL . 37.5 p90 -131.92 163.95 27.19 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.547 HG22 ' CG ' ' A' ' 78' ' ' ASN . 58.0 t -118.47 122.67 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.685 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.737 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 42.3 t -101.12 108.1 19.7 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -85.51 141.13 30.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.815 . . . . 0.0 110.713 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.914 ' CB ' HG11 ' A' ' 96' ' ' VAL . 45.1 p90 -125.57 178.22 5.78 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' A' ' 2' ' ' HIS . . . -133.54 123.87 25.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.705 -0.622 . . . . 0.0 110.41 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.0 m -116.18 132.71 23.13 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 109.941 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.51 -12.17 32.77 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.192 1.101 . . . . 0.0 112.159 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.03 27.2 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.358 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.82 136.47 44.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.694 -0.886 . . . . 0.0 110.25 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.06 163.99 38.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.625 -0.672 . . . . 0.0 109.931 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 53' ' ' MET . 64.3 p -86.2 12.38 9.94 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.511 -0.743 . . . . 0.0 111.308 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' OE1' HG21 ' A' ' 51' ' ' THR . 34.0 mm-40 -137.22 97.6 3.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 118.002 -1.479 . . . . 0.0 113.216 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 40.0 t -122.4 79.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 175.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -58.99 131.62 51.59 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.254 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 32.7 m -129.26 164.04 32.78 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.544 HG23 ' HB2' ' A' ' 49' ' ' ALA . 87.1 m -160.0 157.97 29.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.679 -0.638 . . . . 0.0 110.084 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.001 HG22 HD13 ' A' ' 79' ' ' LEU . 96.8 t -122.14 134.06 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.876 HD23 ' HA ' ' A' ' 46' ' ' GLU . 8.4 mt -130.03 163.96 25.37 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 118.808 -1.157 . . . . 0.0 111.523 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.724 ' HG3' HG21 ' A' ' 47' ' ' VAL . 39.0 mtm105 -123.68 119.99 31.42 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.573 HE21 HD23 ' A' ' 91' ' ' LEU . 26.2 mt-30 -106.01 129.7 54.08 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.512 -178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -127.39 154.97 44.35 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -59.68 -43.19 94.11 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 0.0 110.621 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.1 m -68.85 -49.99 53.73 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.567 -0.708 . . . . 0.0 110.975 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.623 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 32.9 mt-30 -155.0 162.89 40.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.343 -0.848 . . . . 0.0 111.284 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 39' ' ' GLN . 87.8 t -126.42 135.13 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -133.2 159.97 38.63 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.462 -0.774 . . . . 0.0 111.626 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.876 ' HA ' HD23 ' A' ' 37' ' ' LEU . 54.9 mt-10 -80.86 161.09 24.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.712 -0.618 . . . . 0.0 110.71 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.724 HG21 ' HG3' ' A' ' 38' ' ' ARG . 96.1 t -127.64 -67.22 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.698 -0.626 . . . . 0.0 110.663 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB3' ' CG ' ' A' ' 60' ' ' PHE . 67.8 m -138.03 154.12 49.32 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.254 -0.903 . . . . 0.0 111.77 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.544 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -160.56 136.13 8.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.787 -0.57 . . . . 0.0 110.579 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . . . -155.38 146.56 22.67 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.575 -0.703 . . . . 0.0 109.12 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.554 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.4 m -80.05 127.55 32.43 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.241 -0.912 . . . . 0.0 110.116 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 1.2 t80 -79.99 103.47 9.9 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.3 mtp -95.81 131.09 42.49 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 21.0 mmt -59.76 -34.96 73.66 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.957 . . . . 0.0 110.733 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.18 -51.89 25.53 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -130.17 159.95 35.3 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.428 -1.042 . . . . 0.0 110.724 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -103.86 130.85 51.48 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.533 HD23 ' H ' ' A' ' 51' ' ' THR . 60.9 tp -95.41 150.21 20.53 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.518 -0.738 . . . . 0.0 109.656 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 p -104.86 167.39 9.75 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.63 -0.669 . . . . 0.0 110.61 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.732 ' HB2' ' SG ' ' A' ' 68' ' ' CYS . 34.8 m-85 -92.9 100.6 13.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.664 -0.648 . . . . 0.0 109.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 95.8 mt -103.85 2.35 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.531 -0.731 . . . . 0.0 111.77 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -67.92 -41.78 82.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.02 -1.05 . . . . 0.0 110.411 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -109.92 7.49 23.89 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.209 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.0 m 33.63 33.77 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 67' ' ' ILE . 26.8 mm -141.98 10.44 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 0.0 111.246 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 16.8 p -127.92 138.96 52.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.669 -1.269 . . . . 0.0 111.069 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.9 t -139.93 156.14 46.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -172.19 -179.83 43.33 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.618 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 72' ' ' SER . 94.6 m -117.43 163.57 16.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 122.034 -0.686 . . . . 0.0 109.579 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.421 ' N ' HG22 ' A' ' 71' ' ' THR . 1.3 p -153.18 113.8 4.05 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.2 m -143.66 146.94 33.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.053 -1.029 . . . . 0.0 110.948 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.63 -123.95 27.72 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -110.11 19.88 18.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.813 -0.816 . . . . 0.0 110.636 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -125.79 129.95 50.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.225 -0.922 . . . . 0.0 110.079 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.7 m -110.05 126.95 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 O-C-N 121.543 -0.723 . . . . 0.0 109.806 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.547 ' CG ' HG22 ' A' ' 20' ' ' VAL . 39.4 t-20 -107.2 120.78 43.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.926 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.001 HD13 HG22 ' A' ' 36' ' ' VAL . 80.6 mt -108.09 132.01 54.02 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.387 -0.821 . . . . 0.0 109.269 179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.676 HG23 ' HB2' ' A' ' 18' ' ' SER . 60.9 m -119.99 139.9 51.78 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.248 -0.907 . . . . 0.0 110.907 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.718 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -117.31 132.57 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.0 110.158 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' HG2' HG13 ' A' ' 16' ' ' ILE . 78.1 mt-30 -120.16 121.12 38.08 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.218 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 114.94 39.67 0.95 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.718 HD21 HG21 ' A' ' 81' ' ' ILE . 80.4 mt -94.83 120.08 34.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.509 -0.994 . . . . 0.0 111.365 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' O ' HG21 ' A' ' 117' ' ' VAL . 19.1 mmt85 -102.27 178.86 4.48 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.09 83.44 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.232 -0.917 . . . . 0.0 109.819 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.5 ttm -68.02 -33.76 75.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.74 -0.6 . . . . 0.0 110.824 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -68.04 -17.3 64.36 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.589 -0.694 . . . . 0.0 111.67 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.602 HG23 ' O ' ' A' ' 115' ' ' ILE . 24.5 m -51.16 135.17 26.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.161 -0.962 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.84 -155.26 19.22 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.778 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.573 HD23 HE21 ' A' ' 39' ' ' GLN . 15.1 tp -109.77 128.68 55.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.738 -0.86 . . . . 0.0 112.061 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.941 ' CD1' HD12 ' A' ' 115' ' ' ILE . 44.9 m-85 -112.29 144.88 40.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.632 ' N ' HD12 ' A' ' 93' ' ' ILE . 4.2 mp -111.59 143.32 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.588 -0.695 . . . . 0.0 111.432 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.004 ' SG ' ' CD ' ' A' ' 5' ' ' GLN . 17.5 p -105.82 117.23 33.5 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 176.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.5 tptt -102.11 141.15 35.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.505 -0.747 . . . . 0.0 109.652 -178.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.914 HG11 ' CB ' ' A' ' 23' ' ' TYR . 16.5 t -145.14 103.96 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -136.56 125.46 24.18 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.847 -1.141 . . . . 0.0 113.269 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 HD23 ' A' ' 106' ' ' LEU . 7.6 mp -79.73 77.22 6.37 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.8 tpp -80.47 -51.36 8.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.977 -175.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 92.6 m-85 -67.17 -40.21 26.42 Favored Pre-proline 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 111.737 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 39.6 Cg_endo -86.99 120.74 1.66 Allowed 'Trans proline' 0 N--CA 1.504 2.109 0 N-CA-C 110.201 -0.73 . . . . 0.0 110.201 -177.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -97.8 159.21 0.9 Allowed 'Trans proline' 1 CA--C 1.662 6.879 0 CA-C-O 112.144 -3.357 . . . . 0.0 108.086 -177.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.474 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 71.9 Cg_endo -92.54 171.11 21.06 Favored 'Cis proline' 2 C--N 1.464 6.616 1 C-N-CA 95.217 -13.243 . . . . 0.0 119.232 -6.178 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -74.31 125.15 27.82 Favored 'General case' 0 N--CA 1.527 3.418 0 O-C-N 120.303 -1.498 . . . . 0.0 111.338 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.422 ' O ' ' CD2' ' A' ' 105' ' ' TYR 0.262 52.9 t80 -152.82 59.97 0.8 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.499 -179.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.834 HD23 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -130.78 -152.8 0.53 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -163.14 -168.36 24.98 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.333 -1.413 . . . . 0.0 109.919 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.534 ' CG2' ' H81' ' A' ' 132' ' ' NAG . 93.7 mt -122.26 154.66 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 O-C-N 121.574 -0.957 . . . . 0.0 110.391 -179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.726 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -81.08 138.75 19.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 177.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 9.7 m120 -60.31 -29.69 69.01 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -1.169 . . . . 0.0 110.285 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 121.42 145.85 7.28 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 120.104 -1.046 . . . . 0.0 111.6 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.64 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -114.02 131.54 56.32 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 8' ' ' VAL . 11.2 tp60 -80.83 119.94 24.04 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.002 -1.079 . . . . 0.0 108.166 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.941 HD12 ' CD1' ' A' ' 92' ' ' TYR . 86.8 mt -86.86 119.99 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.014 -1.053 . . . . 0.0 109.112 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' HD23 ' A' ' 10' ' ' LEU . 7.6 m-30 -91.74 120.09 32.16 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 122.145 -0.347 . . . . 0.0 110.328 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 118' ' ' ILE . 96.3 t -84.39 166.32 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.512 -0.875 . . . . 0.0 108.834 178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.519 ' N ' HG12 ' A' ' 117' ' ' VAL . 45.3 mm -102.86 139.91 22.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.21 0.529 . . . . 0.0 110.607 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -111.68 123.12 35.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.636 -0.665 . . . . 0.0 109.724 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.07 149.94 65.61 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 O-C-N 123.069 1.036 . . . . 0.0 110.697 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -124.37 151.21 66.2 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.621 -0.674 . . . . 0.0 109.981 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.95 -27.53 36.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.289 1.152 . . . . 0.0 110.873 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 82.0 m -136.86 130.04 17.49 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.51 -20.07 27.66 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 O-C-N 123.143 1.075 . . . . 0.0 111.041 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -99.98 139.53 35.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.326 -0.859 . . . . 0.0 110.875 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 79.5 p -90.03 -0.56 57.65 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.642 -0.661 . . . . 0.0 111.265 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -62.84 -25.79 68.44 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.185 -0.947 . . . . 0.0 110.725 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -87.86 0.5 55.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 111.527 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.491 ' N ' ' HD2' ' A' ' 130' ' ' PRO . 77.3 mt-10 -59.52 -46.0 98.78 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.041 -1.037 . . . . 0.0 112.086 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 129' ' ' GLU . 43.9 Cg_endo -71.41 152.92 61.06 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 122.763 0.875 . . . . 0.0 110.692 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.584 -0.698 . . . . 0.0 110.208 -179.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.559 ' H83' ' O ' ' A' ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.412 ' H82' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.412 ' O2 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.441 ' C6 ' ' O2 ' ' A' ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.472 ' H61' ' C1 ' ' A' ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.441 ' O2 ' ' C6 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . 0.472 ' C1 ' ' H61' ' A' ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.121 0.486 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt -109.74 160.68 16.11 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.545 -0.722 . . . . 0.0 110.21 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -130.07 74.19 1.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.585 -0.697 . . . . 0.0 110.061 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' GLU . 93.3 t -123.85 134.11 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.517 -0.74 . . . . 0.0 110.075 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . . . -108.02 131.38 54.63 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.601 -0.687 . . . . 0.0 109.842 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.108 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 25.9 mm100 -137.95 139.95 27.76 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.566 -0.709 . . . . 0.0 111.91 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.1 140.28 25.01 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 O-C-N 123.324 1.17 . . . . 0.0 109.109 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.47 -30.16 62.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.01 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.948 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.9 p -151.7 159.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.713 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 19' ' ' PHE . 8.9 t -137.82 156.02 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 121.374 0.607 . . . . 0.0 109.713 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.1 mt -117.08 126.6 53.09 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.705 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.92 138.18 40.86 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.428 -0.795 . . . . 0.0 109.22 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.5 t -75.98 -65.29 0.93 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.422 -0.798 . . . . 0.0 111.547 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 97.5 p -160.02 168.22 26.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.473 -0.767 . . . . 0.0 110.369 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.414 ' HB2' HD13 ' A' ' 16' ' ' ILE . 6.2 mtt180 54.16 21.05 2.83 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.674 -0.641 . . . . 0.0 111.252 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.12 35.59 64.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 16' ' ' ILE . 1.2 mp -99.14 97.92 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.206 -1.173 . . . . 0.0 108.906 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.27 114.36 28.45 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB2' HG23 ' A' ' 80' ' ' THR . 32.8 t -121.07 131.97 54.6 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.689 0.757 . . . . 0.0 111.246 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.855 ' HB3' HG21 ' A' ' 9' ' ' VAL . 24.3 p90 -140.47 161.63 37.25 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 85.4 t -120.4 125.33 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.629 -0.829 . . . . 0.0 111.455 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.108 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.5 t -104.38 130.0 52.27 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 4' ' ' ALA . 57.1 tt0 -102.83 138.75 39.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.202 -0.936 . . . . 0.0 111.378 -178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.873 ' CD2' HG11 ' A' ' 96' ' ' VAL . 19.7 p90 -137.32 -177.73 4.9 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.96 113.93 15.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.585 -0.697 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.5 p -141.75 164.37 34.93 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.542 -0.723 . . . . 0.0 110.151 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.678 ' HD2' HD21 ' A' ' 98' ' ' LEU . 43.4 Cg_endo -69.96 155.95 64.02 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 O-C-N 123.389 1.205 . . . . 0.0 110.095 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.2 19.96 51.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -119.93 32.61 5.97 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.212 -1.17 . . . . 0.0 110.775 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.11 140.04 47.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.652 -0.655 . . . . 0.0 110.342 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.512 ' O ' ' HE2' ' A' ' 53' ' ' MET . 40.3 p -92.03 10.72 27.9 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.528 -0.732 . . . . 0.0 110.572 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' OE1' HG21 ' A' ' 51' ' ' THR . 16.1 mm-40 -130.29 122.34 27.8 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.572 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 52' ' ' TYR . 95.9 t -138.89 83.68 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 6.6 ttm180 -63.41 116.88 5.96 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.767 -0.583 . . . . 0.0 111.343 -178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 35.9 m -113.85 131.91 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.1 m -122.47 131.91 54.09 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.694 -0.629 . . . . 0.0 110.624 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.936 HG22 HD13 ' A' ' 79' ' ' LEU . 97.9 t -109.6 129.71 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.771 HD12 ' HE3' ' A' ' 95' ' ' LYS . 46.9 mt -125.46 165.14 18.98 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.707 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.87 ' HG3' HG21 ' A' ' 47' ' ' VAL . 75.0 mtm180 -121.31 119.92 33.59 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.718 ' HA ' HG22 ' A' ' 44' ' ' VAL . 4.8 tt0 -97.45 141.46 30.49 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.945 0.878 . . . . 0.0 110.971 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -136.91 157.03 47.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -59.79 -40.17 87.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.5 m -75.61 -53.36 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 111.061 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.776 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 73.2 mt-30 -154.47 174.59 14.69 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.319 -0.863 . . . . 0.0 111.473 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.718 HG22 ' HA ' ' A' ' 39' ' ' GLN . 99.8 t -128.77 139.93 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.1 p -130.1 161.46 30.99 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.706 ' HA ' HD23 ' A' ' 37' ' ' LEU . 49.6 mt-10 -80.1 158.95 26.26 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.58 -0.7 . . . . 0.0 110.844 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.87 HG21 ' HG3' ' A' ' 38' ' ' ARG . 46.0 t -135.16 -66.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.226 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.683 ' SG ' HG12 ' A' ' 47' ' ' VAL . 71.3 m -129.93 142.65 50.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.26 -0.9 . . . . 0.0 111.22 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.85 131.97 14.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.657 -0.652 . . . . 0.0 110.278 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.9 157.61 14.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 0.0 110.334 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.579 HG21 ' OE1' ' A' ' 31' ' ' GLU . 2.9 m -102.21 116.01 31.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.578 ' N ' HD21 ' A' ' 58' ' ' LEU . 20.6 t80 -77.87 123.96 27.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.225 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 30' ' ' THR . 2.8 mtp -95.58 157.62 15.82 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 36.5 mmt -60.03 -27.63 67.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.843 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -128.04 48.01 0.99 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.971 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' A' ' 53' ' ' MET . 9.0 t-20 -157.81 -179.49 8.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.265 -1.138 . . . . 0.0 110.701 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -115.08 156.03 25.94 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.667 -0.646 . . . . 0.0 110.406 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.578 HD21 ' N ' ' A' ' 52' ' ' TYR . 85.3 mt -72.82 136.16 45.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.561 -0.712 . . . . 0.0 111.136 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.2 p -104.76 129.36 53.02 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 121.705 -0.622 . . . . 0.0 109.565 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 99.1 m-85 -119.99 66.2 0.82 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.482 -0.761 . . . . 0.0 110.099 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.07 -39.48 90.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.536 -0.727 . . . . 0.0 110.767 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.58 131.27 44.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.434 -0.791 . . . . 0.0 110.728 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 52.17 49.01 21.51 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.492 -0.755 . . . . 0.0 110.527 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -59.03 -107.55 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.908 -0.495 . . . . 0.0 110.43 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.614 ' O ' HG22 ' A' ' 67' ' ' ILE . 49.0 mm 52.36 22.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 120.386 -1.446 . . . . 0.0 110.921 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 27.3 p -160.03 160.65 33.47 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.228 -0.92 . . . . 0.0 110.455 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.549 HG21 ' H81' ' A' ' 137' ' ' NAG . 9.1 t -123.88 139.92 53.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -116.55 121.72 5.27 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.978 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -130.06 155.12 46.66 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 68.9 m -160.06 137.95 9.94 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.857 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 96.9 p -140.27 140.06 35.65 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.89 -124.02 34.84 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -107.32 11.92 28.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.589 -0.948 . . . . 0.0 110.927 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.417 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.0 mt-30 -116.65 129.29 56.06 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.122 -0.986 . . . . 0.0 111.016 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 21' ' ' CYS . 5.7 m -110.12 126.23 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.433 -0.792 . . . . 0.0 110.221 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -98.64 117.89 34.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.345 -0.847 . . . . 0.0 111.585 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.936 HD13 HG22 ' A' ' 36' ' ' VAL . 76.4 mt -110.38 130.47 55.55 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.615 -0.678 . . . . 0.0 109.52 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.512 HG21 ' H83' ' A' ' 137' ' ' NAG . 60.1 m -129.69 138.15 51.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.388 -0.82 . . . . 0.0 110.803 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 92' ' ' TYR . 84.3 mt -108.06 130.1 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.629 -0.669 . . . . 0.0 109.523 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 75.4 mt-30 -118.99 119.74 35.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.086 178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.84 35.96 3.1 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.571 HD11 ' CG2' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -99.35 131.3 45.46 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.689 -0.889 . . . . 0.0 110.105 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 84' ' ' LEU . 72.3 mtt85 -86.26 160.6 19.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 109.921 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.73 -29.03 66.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.454 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 26.1 ptm -66.52 -30.04 70.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.46 0.648 . . . . 0.0 109.526 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -77.48 -4.03 43.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.751 -0.593 . . . . 0.0 111.387 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 115' ' ' ILE . 59.4 m -55.31 140.01 40.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.958 -1.089 . . . . 0.0 109.62 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 169.63 -148.04 11.55 Favored Glycine 0 N--CA 1.496 2.643 0 C-N-CA 119.625 -1.274 . . . . 0.0 110.793 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 113' ' ' THR . 17.3 tp -106.93 130.23 54.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.741 -0.858 . . . . 0.0 111.754 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.866 ' CD1' HD12 ' A' ' 115' ' ' ILE . 50.8 m-85 -112.57 135.17 53.6 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -100.67 140.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.639 -0.663 . . . . 0.0 111.678 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 1.108 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 13.7 p -106.68 122.6 46.68 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.925 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.1 mttt -120.04 146.12 46.19 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.148 -0.97 . . . . 0.0 110.056 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.873 HG11 ' CD2' ' A' ' 23' ' ' TYR . 2.7 t -140.44 107.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.529 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.412 ' HB3' ' HE2' ' A' ' 99' ' ' MET . 2.5 mp0 -132.52 125.18 29.98 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 119.598 -0.841 . . . . 0.0 113.216 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 106' ' ' LEU . 9.4 mp -74.34 80.2 1.86 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 175.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HE2' ' HB3' ' A' ' 97' ' ' GLU . 12.9 mmt -79.58 -48.15 14.29 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.556 -175.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.451 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 87.0 m-85 -66.66 -42.92 48.36 Favored Pre-proline 0 N--CA 1.497 1.917 0 O-C-N 120.955 -1.091 . . . . 0.0 113.531 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 51.4 Cg_endo -86.07 113.68 1.27 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 O-C-N 122.657 0.819 . . . . 0.0 112.697 -177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 60.1 Cg_endo -83.06 141.03 10.27 Favored 'Trans proline' 1 CA--C 1.654 6.515 0 CA-C-O 110.774 -3.928 . . . . 0.0 107.861 178.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 102' ' ' PRO 0.433 55.2 Cg_endo -102.61 179.54 3.91 Favored 'Cis proline' 3 C--N 1.524 9.813 1 C-N-CA 91.932 -14.612 . . . . 0.0 116.815 6.991 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.402 ' CZ ' ' HE2' ' A' ' 99' ' ' MET . 5.9 t80 -82.2 126.9 32.61 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 116.795 -3.691 . . . . 0.0 108.847 -176.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . 0.25 47.8 t80 -158.63 101.34 1.66 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.985 -0.447 . . . . 0.0 110.374 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 98' ' ' LEU . 2.8 tp -160.31 -143.46 0.1 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.542 -0.724 . . . . 0.0 110.454 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.27 -173.79 23.64 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.43 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.925 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.251 46.8 mm -131.46 168.87 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.406 -1.055 . . . . 0.0 110.347 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.833 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -105.95 134.13 11.95 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.677 -2.169 . . . . 0.0 107.677 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -60.1 -36.4 77.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.094 -1.239 . . . . 0.0 110.519 -178.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.5 153.1 8.1 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.318 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.757 HG21 HG23 ' A' ' 9' ' ' VAL . 89.1 m -121.84 139.42 53.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.906 ' HB3' HG23 ' A' ' 8' ' ' VAL . 16.3 tp60 -79.95 138.21 37.04 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.866 HD12 ' CD1' ' A' ' 92' ' ' TYR . 46.8 mt -110.07 124.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.948 ' CE2' HG21 ' A' ' 8' ' ' VAL . 16.7 m-30 -100.84 133.63 45.03 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.084 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 84' ' ' LEU . 98.0 t -96.94 165.96 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.063 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.522 ' N ' HG12 ' A' ' 117' ' ' VAL . 41.2 mm -105.21 132.01 53.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.993 -0.442 . . . . 0.0 110.048 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -97.35 119.97 61.91 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.486 -0.759 . . . . 0.0 109.909 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -74.16 68.03 5.06 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.095 1.05 . . . . 0.0 110.871 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -87.05 132.93 40.23 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.462 -0.773 . . . . 0.0 109.986 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.26 -19.88 43.68 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 O-C-N 123.136 1.072 . . . . 0.0 111.008 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.4 m -129.92 141.84 43.27 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 110.329 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.03 160.05 51.0 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.293 1.154 . . . . 0.0 110.405 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -82.8 120.03 25.11 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.578 -0.701 . . . . 0.0 110.125 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.4 p -66.94 -29.99 70.0 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.617 -0.677 . . . . 0.0 110.353 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -70.07 132.01 45.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.507 -0.745 . . . . 0.0 110.233 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -84.54 148.84 26.28 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.601 -0.687 . . . . 0.0 110.09 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 22.0 mp0 52.5 49.89 7.26 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.406 -0.809 . . . . 0.0 111.005 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.8 Cg_endo -69.79 155.96 64.5 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.203 1.107 . . . . 0.0 110.517 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 N--CA 1.497 1.906 0 O-C-N 121.602 -0.687 . . . . 0.0 110.099 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.434 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.587 ' H83' ' H3 ' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.411 ' C1 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.549 ' H81' HG21 ' A' ' 69' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.041 0.448 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mtm 56.09 167.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.73 -0.607 . . . . 0.0 110.844 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.453 ' C ' HG23 ' A' ' 3' ' ' VAL . 73.7 m80 -120.08 29.43 7.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.453 HG23 ' C ' ' A' ' 2' ' ' HIS . 91.8 t -148.29 144.34 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.85 -0.531 . . . . 0.0 109.862 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.65 127.07 51.73 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.589 -0.694 . . . . 0.0 110.074 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.926 ' NE2' ' SG ' ' A' ' 94' ' ' CYS . 15.1 mm100 -142.12 130.65 11.89 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.642 -0.661 . . . . 0.0 111.3 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.64 139.97 31.87 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.175 1.092 . . . . 0.0 109.367 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 -31.01 69.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 109.776 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.954 HG23 ' HB3' ' A' ' 114' ' ' GLN . 3.0 p -154.23 162.9 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.26 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' A' ' 113' ' ' THR . 8.3 t -141.74 151.86 19.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.954 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 116' ' ' TYR . 89.4 mt -110.61 127.03 55.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -89.26 148.98 23.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.413 -0.805 . . . . 0.0 110.984 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.6 t -69.41 172.16 7.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.603 -0.686 . . . . 0.0 110.521 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 t -60.1 -36.05 76.57 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.557 -0.714 . . . . 0.0 109.95 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.653 ' CG ' HD13 ' A' ' 16' ' ' ILE . 27.1 tpt180 -57.16 -25.49 59.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.556 -0.715 . . . . 0.0 110.194 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.603 ' C ' HD12 ' A' ' 16' ' ' ILE . . . 101.14 26.44 7.83 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.693 HG21 ' H82' ' A' ' 137' ' ' NAG . 1.8 mp -108.06 112.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 O-C-N 121.626 -0.926 . . . . 0.0 110.52 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.68 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . . . -110.54 124.74 52.39 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.794 ' OG ' HG23 ' A' ' 80' ' ' THR . 53.0 m -126.97 140.09 52.57 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.583 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' HB3' HG21 ' A' ' 9' ' ' VAL . 50.6 p90 -148.55 163.5 37.02 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 77' ' ' VAL . 63.2 t -130.31 123.73 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.731 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.845 ' O ' HG22 ' A' ' 77' ' ' VAL . 37.6 t -100.01 108.04 20.13 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.618 -0.676 . . . . 0.0 109.742 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' GLN . 25.8 tt0 -84.97 139.45 31.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.856 . . . . 0.0 110.519 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB3' HG11 ' A' ' 96' ' ' VAL . 41.1 p90 -130.6 177.6 7.26 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.295 0.569 . . . . 0.0 109.6 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.94 138.1 35.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.85 -0.532 . . . . 0.0 110.157 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.7 p -125.83 149.83 66.95 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.553 -0.717 . . . . 0.0 110.381 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.95 -13.98 34.89 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.462 1.243 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -151.6 -170.13 18.02 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -109.99 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.542 -0.975 . . . . 0.0 110.52 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 98' ' ' LEU . . . -139.43 151.67 46.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.629 -0.669 . . . . 0.0 109.62 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 53' ' ' MET . 32.4 p -79.9 -43.59 21.93 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.425 -0.797 . . . . 0.0 111.097 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.4 mm-40 -79.68 84.77 5.46 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 120.021 -0.671 . . . . 0.0 112.713 -175.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.719 HG11 ' OH ' ' A' ' 52' ' ' TYR . 48.1 t -97.79 89.38 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.705 ' N ' HG23 ' A' ' 51' ' ' THR . 0.0 OUTLIER -67.15 123.42 20.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.915 -0.491 . . . . 0.0 110.703 -177.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 95' ' ' LYS . 27.3 m -118.48 134.75 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.58 178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 95' ' ' LYS . 94.4 m -134.41 159.71 40.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.411 -0.805 . . . . 0.0 110.025 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.97 HG22 HD13 ' A' ' 79' ' ' LEU . 84.5 t -128.84 139.24 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.887 HD23 ' HA ' ' A' ' 46' ' ' GLU . 6.2 mt -131.16 171.0 13.79 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.687 -1.258 . . . . 0.0 111.67 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 47' ' ' VAL . 89.9 mtt180 -125.72 118.39 25.48 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.624 HE21 HD23 ' A' ' 91' ' ' LEU . 21.8 mt-30 -101.78 126.25 48.61 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.391 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -97.16 -171.57 2.25 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.799 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.21 -43.81 95.67 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.503 -0.748 . . . . 0.0 111.019 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -131.96 -0.16 3.81 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 0.0 111.949 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 62.8 mt-30 -135.1 155.59 50.46 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.06 -1.025 . . . . 0.0 110.943 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -135.8 139.73 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.604 -0.685 . . . . 0.0 109.629 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.9 p -127.03 160.1 32.13 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.437 -0.789 . . . . 0.0 110.952 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.887 ' HA ' HD23 ' A' ' 37' ' ' LEU . 77.0 mt-10 -86.45 160.04 19.14 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.647 -0.658 . . . . 0.0 110.742 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 71.5 t -123.41 -71.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.807 -0.558 . . . . 0.0 110.232 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' CB ' ' A' ' 63' ' ' ASP . 80.7 m -147.17 153.71 40.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.31 30.35 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.508 -0.745 . . . . 0.0 111.258 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 59' ' ' THR . . . -170.44 155.68 5.21 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.601 -0.687 . . . . 0.0 109.658 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.705 HG23 ' N ' ' A' ' 33' ' ' ARG . 2.8 m -116.27 122.76 45.9 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.21 -0.931 . . . . 0.0 109.251 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.719 ' OH ' HG11 ' A' ' 32' ' ' VAL . 55.1 p90 -94.05 124.39 38.03 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.661 -1.216 . . . . 0.0 109.307 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 53' ' ' MET . 3.2 mmt -60.62 -44.7 96.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 166.44 102.63 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.13 32.46 63.0 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -119.93 159.86 23.85 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -1.026 . . . . 0.0 110.472 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -70.72 151.6 44.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.67 -0.644 . . . . 0.0 110.397 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.7 mt -90.16 123.89 34.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.577 -0.702 . . . . 0.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 53.9 p -92.57 131.91 37.3 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.429 ' CD1' ' HB3' ' A' ' 48' ' ' CYS . 67.9 m-85 -113.86 123.92 50.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.764 . . . . 0.0 110.363 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.6 mt -60.74 -36.06 77.93 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.485 -0.759 . . . . 0.0 109.79 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -140.07 174.46 10.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 109.671 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CB ' ' SG ' ' A' ' 48' ' ' CYS . 85.8 m-20 52.65 51.02 16.89 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.265 -0.897 . . . . 0.0 110.398 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.1 m -52.36 -21.8 3.95 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.622 -0.674 . . . . 0.0 111.382 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.69 -21.88 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.271 -0.893 . . . . 0.0 110.811 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 78.3 m -72.43 126.36 29.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.342 -0.849 . . . . 0.0 109.932 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.58 HG21 ' NE2' ' A' ' 82' ' ' GLN . 9.2 t -139.98 149.93 43.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.652 -0.655 . . . . 0.0 109.47 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 179.99 -171.52 42.95 Favored Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.414 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.471 HG22 ' N ' ' A' ' 72' ' ' SER . 94.4 m -129.73 168.46 16.49 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.939 -0.742 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 71' ' ' THR . 97.2 p -138.33 152.51 48.55 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.505 -0.747 . . . . 0.0 110.015 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.2 t -133.7 -173.64 3.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.593 -0.692 . . . . 0.0 109.746 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -49.67 76.09 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -126.6 3.86 6.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.463 -1.022 . . . . 0.0 111.272 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.427 ' HG2' ' CG1' ' A' ' 20' ' ' VAL . 19.2 tt0 -124.27 129.62 51.08 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.09 -1.006 . . . . 0.0 110.851 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.845 HG22 ' O ' ' A' ' 21' ' ' CYS . 3.8 m -113.23 132.84 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 64.8 t-20 -110.11 115.97 30.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.97 HD13 HG22 ' A' ' 36' ' ' VAL . 86.6 mt -111.47 133.05 54.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 109.752 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.794 HG23 ' OG ' ' A' ' 18' ' ' SER . 94.5 m -130.87 145.06 51.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.34 -0.85 . . . . 0.0 110.811 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.813 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -119.92 140.08 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.611 -0.681 . . . . 0.0 109.874 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.58 ' NE2' HG21 ' A' ' 69' ' ' THR . 6.7 mt-30 -123.83 121.93 36.68 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.803 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.36 46.37 1.0 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.813 HD21 HG21 ' A' ' 81' ' ' ILE . 80.3 mt -90.03 122.79 33.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.635 -0.92 . . . . 0.0 111.182 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -102.59 178.0 4.7 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.69 95.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.325 -0.86 . . . . 0.0 109.401 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 57.8 ttm -63.45 -39.98 95.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.753 -0.592 . . . . 0.0 110.742 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -60.79 -21.06 62.71 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.598 -0.689 . . . . 0.0 111.025 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 115' ' ' ILE . 58.9 m -51.84 140.01 20.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.921 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.88 -158.59 31.54 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD23 HE21 ' A' ' 39' ' ' GLN . 17.2 tp -108.2 123.99 49.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.637 -0.919 . . . . 0.0 111.97 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.938 ' CD1' HD12 ' A' ' 115' ' ' ILE . 51.0 m-85 -103.18 140.02 37.91 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.862 HG23 ' O ' ' A' ' 110' ' ' GLY . 4.2 mp -111.33 130.59 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.665 -0.647 . . . . 0.0 111.775 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.926 ' SG ' ' NE2' ' A' ' 5' ' ' GLN . 20.2 p -79.97 157.91 26.71 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.782 ' HG3' HD12 ' A' ' 109' ' ' ILE . 7.9 tttt -153.65 97.2 2.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.93 -1.106 . . . . 0.0 109.457 -177.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.868 HG22 ' CD2' ' A' ' 106' ' ' LEU . 4.0 p -111.17 116.78 53.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-O 121.9 0.857 . . . . 0.0 111.37 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 104' ' ' TYR . 3.1 mp0 -135.7 124.15 23.46 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.914 -178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.858 HD23 HD13 ' A' ' 106' ' ' LEU . 4.1 mm? -75.47 76.48 2.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.9 ttm -78.73 -40.42 33.56 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 83.4 m-85 -62.97 -45.72 86.98 Favored Pre-proline 0 N--CA 1.493 1.709 0 C-N-CA 119.234 -0.986 . . . . 0.0 112.446 -178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 100' ' ' TYR . 56.2 Cg_endo -81.3 129.62 6.79 Favored 'Trans proline' 0 C--O 1.284 2.805 0 O-C-N 122.776 0.882 . . . . 0.0 111.602 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.403 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 72.1 Cg_endo -83.86 166.14 13.32 Favored 'Trans proline' 1 CA--C 1.656 6.601 0 CA-C-O 113.526 -2.781 . . . . 0.0 108.966 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.349 56.6 Cg_endo -96.47 50.54 1.46 Allowed 'Cis proline' 2 C--N 1.477 7.331 1 C-N-CA 89.174 -15.761 . . . . 0.0 115.439 -7.756 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 97' ' ' GLU . 5.0 t80 67.36 122.26 0.02 OUTLIER 'General case' 1 N--CA 1.554 4.727 1 O-C-N 115.783 -4.323 . . . . 0.0 112.965 179.931 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.476 ' O ' HD12 ' A' ' 106' ' ' LEU . 1.1 p90 -159.84 100.3 1.42 Allowed 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.31 -1.494 . . . . 0.0 109.91 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.868 ' CD2' HG22 ' A' ' 96' ' ' VAL . 1.4 tp -160.24 -146.66 0.14 Allowed 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.654 ' O ' HD13 ' A' ' 109' ' ' ILE . . . -159.71 170.69 35.96 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 119.049 -1.548 . . . . 0.0 111.254 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.782 HD12 ' HG3' ' A' ' 95' ' ' LYS . 22.8 mm -124.18 149.68 28.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.685 -0.891 . . . . 0.0 109.25 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.862 ' O ' HG23 ' A' ' 93' ' ' ILE . . . -91.41 144.71 17.34 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HA ' ' HN2' ' A' ' 132' ' ' NAG . 6.8 m120 -68.12 -24.71 65.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.089 -1.242 . . . . 0.0 110.592 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 126.53 165.79 12.05 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.137 -1.506 . . . . 0.0 113.849 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 59.5 m -129.28 127.63 41.58 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.954 ' HB3' HG23 ' A' ' 8' ' ' VAL . 8.8 tp-100 -67.98 142.72 55.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.93 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.938 HD12 ' CD1' ' A' ' 92' ' ' TYR . 64.6 mt -118.5 126.38 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.85 ' CE2' HG21 ' A' ' 8' ' ' VAL . 28.1 m-85 -110.16 139.98 44.74 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.834 -0.541 . . . . 0.0 110.328 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 118' ' ' ILE . 84.8 t -99.98 165.14 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.671 -0.811 . . . . 0.0 109.449 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.53 ' N ' HG12 ' A' ' 117' ' ' VAL 0.264 42.4 mm -112.83 130.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-O 121.046 0.451 . . . . 0.0 110.53 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -108.07 110.03 62.05 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.528 -0.732 . . . . 0.0 109.604 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.02 139.1 38.55 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 O-C-N 123.143 1.075 . . . . 0.0 110.693 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -133.9 150.5 74.66 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.679 -0.638 . . . . 0.0 110.138 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.92 -11.49 31.99 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 O-C-N 123.433 1.228 . . . . 0.0 110.884 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.672 ' SG ' ' HD2' ' A' ' 124' ' ' PRO . 42.3 t -112.77 146.65 35.49 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.672 ' HD2' ' SG ' ' A' ' 123' ' ' CYS . 41.7 Cg_endo -68.22 147.89 73.49 Favored 'Trans proline' 0 C--N 1.316 -1.152 0 O-C-N 123.325 1.171 . . . . 0.0 110.405 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.9 p-10 -89.94 -179.98 5.83 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.649 -0.657 . . . . 0.0 110.676 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.7 p -92.98 9.87 33.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.627 -0.671 . . . . 0.0 111.015 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.77 139.96 57.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -110.16 149.99 29.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.62 -0.675 . . . . 0.0 110.118 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 130' ' ' PRO . 96.3 mt-10 52.82 49.88 7.1 Favored Pre-proline 0 N--CA 1.501 2.085 0 O-C-N 121.445 -0.784 . . . . 0.0 111.119 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 129' ' ' GLU . 44.8 Cg_endo -69.85 150.87 68.22 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 O-C-N 123.241 1.127 . . . . 0.0 110.54 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.0 tptm . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.51 -0.744 . . . . 0.0 110.221 -179.999 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.533 ' H81' ' CG2' ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.406 ' H62' ' C2 ' ' A' ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . 0.406 ' C2 ' ' H62' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.693 ' H82' HG21 ' A' ' 16' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.144 0.497 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 ttp 53.89 98.51 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.46 -0.775 . . . . 0.0 110.781 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -104.04 30.88 4.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.56 -0.712 . . . . 0.0 110.27 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.833 HG12 ' OE1' ' A' ' 5' ' ' GLN . 53.3 t -147.04 148.55 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . . . -135.02 135.81 41.63 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.337 -0.852 . . . . 0.0 111.051 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.833 ' OE1' HG12 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -140.0 146.49 46.85 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.648 -0.658 . . . . 0.0 110.095 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 19' ' ' PHE . 42.6 Cg_endo -69.87 147.95 63.31 Favored 'Trans proline' 0 C--N 1.317 -1.128 0 O-C-N 123.254 1.134 . . . . 0.0 109.565 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.93 -20.77 28.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 110.245 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.835 HG21 ' CE2' ' A' ' 116' ' ' TYR . 2.7 p -160.6 160.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 118.723 -1.191 . . . . 0.0 109.029 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.691 HG23 HG21 ' A' ' 113' ' ' THR . 33.6 t -137.13 159.6 36.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.155 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.698 HD23 ' HB2' ' A' ' 116' ' ' TYR . 90.8 mt -120.0 130.37 54.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.289 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . . . -100.89 133.37 45.46 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.5 m -135.81 162.43 32.81 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.289 -0.882 . . . . 0.0 112.476 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t 59.31 -115.87 0.78 Allowed 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.728 -0.608 . . . . 0.0 110.827 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.503 ' HB2' HG12 ' A' ' 16' ' ' ILE . 5.9 mtt180 -59.93 -13.06 9.31 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.675 -1.266 . . . . 0.0 111.346 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.22 43.47 5.91 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.601 HG23 ' HG2' ' A' ' 82' ' ' GLN . 8.3 mm -109.67 108.15 24.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB3' HD11 ' A' ' 84' ' ' LEU . . . -98.59 124.1 43.16 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.998 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB2' HG23 ' A' ' 80' ' ' THR . 15.0 t -126.2 131.29 52.01 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 28.2 p90 -139.73 165.82 26.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.742 -0.599 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.877 HG23 ' H83' ' A' ' 136' ' ' NAG . 57.5 t -123.92 127.27 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.859 -178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.675 ' O ' HG22 ' A' ' 77' ' ' VAL . 42.3 t -110.03 119.79 40.41 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 177.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.74 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 14.9 pt-20 -93.16 154.25 18.17 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.935 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.601 ' CG ' HG11 ' A' ' 96' ' ' VAL . 45.8 p90 -134.01 -175.99 4.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -128.64 116.95 20.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.351 -0.843 . . . . 0.0 111.799 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.706 ' OG ' HD21 ' A' ' 106' ' ' LEU . 69.8 m -161.68 155.89 18.97 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.712 -0.618 . . . . 0.0 109.696 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.97 -19.94 45.4 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 O-C-N 123.286 1.151 . . . . 0.0 110.733 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.98 35.9 33.59 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 13.4 mttp -102.64 26.86 7.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.366 -1.079 . . . . 0.0 110.649 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.577 ' HB1' ' HG3' ' A' ' 101' ' ' PRO . . . -148.19 144.74 27.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.684 -0.635 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 53' ' ' MET . 16.1 p -80.28 -39.11 29.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.731 0.777 . . . . 0.0 111.655 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.694 ' OE1' HG21 ' A' ' 51' ' ' THR . 4.7 mm-40 -80.19 82.85 6.16 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.918 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 86.8 t -93.67 84.73 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.798 ' NH1' ' SD ' ' A' ' 99' ' ' MET . 60.1 ttt180 -59.98 123.17 16.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.676 -0.64 . . . . 0.0 111.084 -177.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 32' ' ' VAL . 31.9 m -123.4 132.02 72.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.432 ' H ' ' HB2' ' A' ' 95' ' ' LYS . 60.8 m -120.92 131.61 54.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.236 0.541 . . . . 0.0 110.636 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.837 HG22 HD13 ' A' ' 79' ' ' LEU . 86.4 t -107.76 130.39 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD12 ' HE3' ' A' ' 95' ' ' LYS . 78.9 mt -124.62 169.93 11.45 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.992 -1.068 . . . . 0.0 111.958 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -130.26 121.39 26.04 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.576 HE21 HD23 ' A' ' 91' ' ' LEU . 32.7 mt-30 -110.24 131.98 54.57 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.346 -0.846 . . . . 0.0 111.061 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 43' ' ' GLN . . . -128.36 152.77 47.78 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -59.57 -44.21 93.38 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.45 -0.781 . . . . 0.0 110.543 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 97.6 p -70.44 -44.87 66.96 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 111.025 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.807 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 77.3 mt-30 -154.89 160.16 40.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.469 -0.769 . . . . 0.0 111.263 -179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 39' ' ' GLN . 92.2 t -126.86 139.76 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 74.5 p -145.21 160.38 41.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.453 -0.779 . . . . 0.0 110.836 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.457 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 13.7 mt-10 -80.71 156.16 26.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.691 -0.631 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG12 ' SG ' ' A' ' 48' ' ' CYS . 85.4 t -114.49 -83.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.345 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 1.045 ' SG ' ' OD2' ' A' ' 63' ' ' ASP . 80.8 m -122.0 160.9 23.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.19 -0.944 . . . . 0.0 110.866 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -162.37 135.55 6.03 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.91 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' A' ' 59' ' ' THR . . . -172.1 165.34 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.419 -0.8 . . . . 0.0 110.594 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.694 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.9 m -97.9 123.94 42.1 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.436 ' CD1' ' HB2' ' A' ' 72' ' ' SER . 27.6 t80 -88.31 106.79 18.46 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.135 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -76.17 157.86 32.29 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 37.4 mmt -59.64 -28.5 67.29 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.852 -1.155 . . . . 0.0 110.084 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.84 -79.04 0.17 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 58' ' ' LEU . 25.1 t30 -154.15 178.49 9.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.39 -1.065 . . . . 0.0 110.665 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.715 ' C ' HD22 ' A' ' 58' ' ' LEU . 7.2 tp10 -120.07 120.15 35.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.65 -0.656 . . . . 0.0 109.746 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.733 HD22 ' N ' ' A' ' 58' ' ' LEU . 2.4 mm? -124.28 46.22 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.571 HG21 ' HB1' ' A' ' 50' ' ' ALA 0.285 36.8 p -116.4 -132.14 0.32 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.791 -0.568 . . . . 0.0 110.909 -178.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.436 ' CZ ' ' HG2' ' A' ' 57' ' ' GLU . 39.8 m-85 60.57 25.12 14.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.825 -1.172 . . . . 0.0 109.426 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.5 tp -67.72 -36.42 80.58 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.513 -0.742 . . . . 0.0 111.402 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -59.63 -43.28 93.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.413 -0.805 . . . . 0.0 111.812 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 1.045 ' OD2' ' SG ' ' A' ' 48' ' ' CYS . 95.9 m-20 -92.88 -13.2 29.29 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.164 0.507 . . . . 0.0 110.78 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t 42.4 24.93 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.8 mt -144.85 -43.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.018 -1.051 . . . . 0.0 110.774 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 22.9 p -67.82 134.64 51.29 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.328 -0.857 . . . . 0.0 111.344 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.0 t -130.02 139.98 50.94 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' HA3' HD23 ' A' ' 79' ' ' LEU . . . -139.05 158.02 25.08 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.357 -1.401 . . . . 0.0 111.111 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.853 HG21 ' H63' ' A' ' 138' ' ' FUC . 61.1 m -130.05 159.92 35.26 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.436 ' HB2' ' CD1' ' A' ' 52' ' ' TYR . 53.4 m -145.93 127.24 14.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -139.96 129.99 24.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.567 -0.708 . . . . 0.0 109.774 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.84 -124.07 35.08 Favored Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -106.45 16.43 24.7 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.613 -0.933 . . . . 0.0 110.715 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.416 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 29.3 mt-30 -119.95 123.92 44.71 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 111.09 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -104.54 121.82 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.661 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.429 ' OD1' ' N2 ' ' A' ' 136' ' ' NAG . 55.5 t30 -101.43 107.8 19.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.119 -0.988 . . . . 0.0 111.391 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.837 HD13 HG22 ' A' ' 36' ' ' VAL . 61.6 mt -97.34 131.92 43.56 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.449 -0.782 . . . . 0.0 109.673 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 18' ' ' SER . 59.2 m -124.42 139.2 54.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 0.0 111.034 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.622 HG21 HD21 ' A' ' 84' ' ' LEU . 95.6 mt -113.55 129.94 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.728 -0.608 . . . . 0.0 109.618 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.601 ' HG2' HG23 ' A' ' 16' ' ' ILE . 35.2 mt-30 -112.54 118.26 34.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.282 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.67 51.37 0.75 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 81' ' ' ILE . 76.6 mt -84.59 129.79 34.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.546 -0.973 . . . . 0.0 111.381 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -112.21 175.48 5.41 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.76 -44.06 94.03 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.875 0.845 . . . . 0.0 109.855 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.2 mmt -66.17 -32.94 74.68 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.191 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.11 -24.91 67.56 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.44 -0.787 . . . . 0.0 111.042 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 115' ' ' ILE . 42.4 m -51.88 137.85 25.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.255 -0.903 . . . . 0.0 110.29 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.52 -163.83 34.76 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.576 HD23 HE21 ' A' ' 39' ' ' GLN . 15.7 tp -94.77 129.94 41.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.693 -0.886 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.697 ' CD2' HD12 ' A' ' 115' ' ' ILE . 78.5 m-85 -113.44 136.35 52.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.713 ' N ' HD12 ' A' ' 93' ' ' ILE . 3.9 mp -104.16 133.05 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.429 -0.795 . . . . 0.0 112.117 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.822 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 31.6 p -97.49 122.34 40.44 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.907 ' HD3' HD12 ' A' ' 109' ' ' ILE . 17.7 mttt -119.1 143.86 46.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.363 -0.836 . . . . 0.0 109.446 -178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' CD1' ' A' ' 106' ' ' LEU . 11.1 t -136.51 111.32 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.889 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -132.39 130.22 40.37 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.34 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 31.7 mt -86.94 82.84 7.65 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 102.394 -3.187 . . . . 0.0 102.394 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.798 ' SD ' ' NH1' ' A' ' 33' ' ' ARG . 3.4 ttm -82.67 -45.92 13.89 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.904 -173.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.454 ' HB2' ' HD3' ' A' ' 101' ' ' PRO . 91.0 m-85 -69.71 -42.89 20.17 Favored Pre-proline 0 N--CA 1.508 2.456 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.577 ' HG3' ' HB1' ' A' ' 29' ' ' ALA . 60.7 Cg_endo -82.36 143.09 12.25 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 N-CA-C 108.734 -1.295 . . . . 0.0 108.734 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.431 ' CB ' ' HA ' ' A' ' 103' ' ' PRO . 53.1 Cg_endo -92.88 173.04 2.04 Favored 'Trans proline' 1 CA--C 1.658 6.72 0 CA-C-O 113.417 -2.826 . . . . 0.0 107.536 177.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 102' ' ' PRO . 88.5 Cg_endo -92.18 49.39 1.24 Allowed 'Cis proline' 2 C--N 1.503 8.698 1 C-N-CA 91.326 -14.864 . . . . 0.0 115.228 -14.585 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 98' ' ' LEU . 2.3 t80 55.82 110.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 118.692 -2.505 . . . . 0.0 111.692 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -147.19 105.74 3.8 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 119.617 -1.927 . . . . 0.0 108.777 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.731 ' CD1' HG12 ' A' ' 96' ' ' VAL . 1.7 mt -159.3 -157.97 0.63 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.759 -1.176 . . . . 0.0 113.829 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -151.22 -167.61 14.94 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 -177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.907 HD12 ' HD3' ' A' ' 95' ' ' LYS 0.258 46.6 mm -134.93 169.39 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.561 -0.964 . . . . 0.0 110.5 -178.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.822 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -104.48 139.49 14.61 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HA ' ' N2 ' ' A' ' 132' ' ' NAG . 10.8 t-20 -60.26 -36.81 78.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.388 -1.066 . . . . 0.0 110.536 -179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 127.81 144.49 5.92 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.691 HG21 HG23 ' A' ' 9' ' ' VAL . 94.3 m -115.5 137.45 52.05 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.589 ' HB3' HG23 ' A' ' 8' ' ' VAL . 12.8 tt0 -89.92 124.05 34.38 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.395 -1.322 . . . . 0.0 109.371 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.697 HD12 ' CD2' ' A' ' 92' ' ' TYR . 82.7 mt -90.45 129.8 40.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.835 ' CE2' HG21 ' A' ' 8' ' ' VAL . 7.7 m-30 -100.35 140.0 35.21 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.422 0.63 . . . . 0.0 111.976 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 118' ' ' ILE . 7.2 p -94.0 168.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.501 ' N ' HG22 ' A' ' 117' ' ' VAL . 41.0 mm -98.9 119.89 47.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 110.844 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -136.11 126.84 16.71 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.681 -0.637 . . . . 0.0 109.972 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.68 159.88 51.81 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 123.122 1.064 . . . . 0.0 110.558 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -109.86 143.85 28.77 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.546 -0.721 . . . . 0.0 110.299 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.91 -20.17 45.48 Favored 'Trans proline' 0 N--CA 1.487 1.131 0 O-C-N 123.315 1.166 . . . . 0.0 111.336 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 79.8 m -129.31 140.06 37.51 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.293 -0.88 . . . . 0.0 110.425 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.72 -19.48 36.28 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 O-C-N 123.224 1.118 . . . . 0.0 110.987 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -149.79 175.12 11.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.354 -0.841 . . . . 0.0 110.519 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.0 p -75.83 163.91 26.76 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.583 -0.698 . . . . 0.0 110.29 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -63.27 137.58 58.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.13 -35.91 78.86 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.632 -0.667 . . . . 0.0 110.28 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -109.74 130.34 22.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.57 -0.706 . . . . 0.0 110.203 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.56 159.96 51.07 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.151 1.08 . . . . 0.0 110.311 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.599 -0.688 . . . . 0.0 110.243 179.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.408 ' N2 ' ' HA ' ' A' ' 111' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.787 ' H82' ' O4 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.787 ' O4 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . 0.877 ' H83' HG23 ' A' ' 20' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . 0.436 ' N2 ' ' H3 ' ' A' ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . 0.853 ' H63' HG21 ' A' ' 71' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' A ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.218 0.532 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp 52.98 38.59 27.57 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.379 -0.825 . . . . 0.0 110.637 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -110.1 130.14 55.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.589 -0.694 . . . . 0.0 109.931 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.2 132.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.574 -0.704 . . . . 0.0 110.001 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.0 132.41 54.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.632 -0.668 . . . . 0.0 109.722 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 1.079 ' OE1' ' SG ' ' A' ' 21' ' ' CYS . 96.3 mm-40 -137.34 148.02 60.35 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.445 -0.785 . . . . 0.0 111.208 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.0 152.83 68.22 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 O-C-N 123.429 1.226 . . . . 0.0 109.146 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.98 -12.17 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.506 -0.746 . . . . 0.0 110.792 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' HE2' ' A' ' 116' ' ' TYR . 2.3 p -139.95 137.62 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.2 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.67 ' CG2' HG21 ' A' ' 113' ' ' THR . 8.9 t -137.85 145.66 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 O-C-N 120.127 -1.608 . . . . 0.0 110.846 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 116' ' ' TYR . 70.8 mt -114.84 148.31 38.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.465 -0.772 . . . . 0.0 110.539 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.88 -171.5 1.84 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.513 -0.742 . . . . 0.0 110.413 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.2 t -123.84 172.87 8.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.523 -0.736 . . . . 0.0 110.072 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.1 t -60.79 -39.13 87.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.469 -0.769 . . . . 0.0 109.744 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' CB ' HD13 ' A' ' 16' ' ' ILE . 22.4 mmt85 -60.51 -28.04 68.08 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.659 -0.651 . . . . 0.0 109.854 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 27.14 8.25 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' CB ' ' A' ' 14' ' ' ARG . 1.3 mp -97.73 99.89 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HB3' ' CD1' ' A' ' 84' ' ' LEU . . . -105.3 126.11 51.74 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.4 p -133.83 149.55 51.39 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.092 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -155.11 163.94 39.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 76' ' ' GLN . 68.9 t -119.91 124.04 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.384 -0.926 . . . . 0.0 112.033 -178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.079 ' SG ' ' OE1' ' A' ' 5' ' ' GLN . 42.3 t -102.78 107.91 18.94 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -86.96 141.55 28.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.2 -0.938 . . . . 0.0 112.358 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -127.38 174.72 8.76 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.34 131.87 21.03 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.352 -0.843 . . . . 0.0 111.483 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 106' ' ' LEU . 6.4 t -164.64 153.05 10.89 Favored Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 121.676 -0.64 . . . . 0.0 110.555 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.86 149.86 48.47 Favored 'Trans proline' 0 C--N 1.316 -1.184 0 O-C-N 123.654 1.344 . . . . 0.0 110.825 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.85 -179.19 5.34 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -132.83 151.06 52.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.71 -0.876 . . . . 0.0 110.332 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.38 154.07 48.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.599 -0.688 . . . . 0.0 109.615 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' A' ' 54' ' ' MET . 57.9 p -79.81 -39.06 31.6 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.335 -0.853 . . . . 0.0 110.649 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.822 ' OE1' HG21 ' A' ' 51' ' ' THR . 38.0 mm-40 -79.76 76.72 6.42 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.447 -175.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 34' ' ' VAL . 91.3 t -94.25 82.03 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.437 ' HE ' ' HE3' ' A' ' 99' ' ' MET . 18.7 ttp85 -59.5 121.53 11.76 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.821 -0.549 . . . . 0.0 110.955 -178.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 32' ' ' VAL . 27.2 m -125.35 139.86 50.0 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.571 0.7 . . . . 0.0 109.802 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.706 HG23 ' HB2' ' A' ' 49' ' ' ALA . 72.1 m -135.22 133.06 38.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 122.033 -0.417 . . . . 0.0 109.982 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.982 HG22 HD13 ' A' ' 79' ' ' LEU . 95.4 t -105.11 132.35 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.544 -0.723 . . . . 0.0 109.123 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.751 HD12 ' HE3' ' A' ' 95' ' ' LYS . 83.1 mt -126.41 168.01 14.77 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.128 -0.982 . . . . 0.0 111.176 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -129.61 128.54 42.86 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.553 HE21 HD23 ' A' ' 91' ' ' LEU . 30.8 mt-30 -109.86 132.05 54.51 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.322 -0.861 . . . . 0.0 111.397 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.36 178.76 5.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.932 -0.48 . . . . 0.0 109.888 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -60.33 -40.12 89.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.623 -0.673 . . . . 0.0 111.514 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.4 m -118.37 -19.96 8.68 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 112.112 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' C ' HG23 ' A' ' 44' ' ' VAL . 83.9 mm-40 -131.79 179.29 6.15 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.14 -0.975 . . . . 0.0 112.142 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.464 HG23 ' C ' ' A' ' 43' ' ' GLN . 84.5 t -149.88 143.52 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.81 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -138.72 156.13 47.64 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.455 -0.778 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.485 ' HA ' ' CD2' ' A' ' 37' ' ' LEU . 68.6 mt-10 -80.16 147.57 31.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.528 -0.732 . . . . 0.0 111.54 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG12 ' SG ' ' A' ' 48' ' ' CYS . 96.1 t -102.89 -73.92 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.952 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 14.5 p -159.92 164.65 33.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.33 -0.856 . . . . 0.0 110.133 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 35' ' ' THR . . . -169.39 161.01 9.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.205 -0.934 . . . . 0.0 111.603 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 60' ' ' PHE . . . -172.0 157.68 4.47 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.822 HG21 ' OE1' ' A' ' 31' ' ' GLU . 3.0 m -84.58 119.82 25.63 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.148 -0.97 . . . . 0.0 109.681 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 71' ' ' THR . 44.2 t80 -79.96 99.52 7.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.682 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' THR . 1.2 mmt -71.78 138.11 48.14 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.432 ' HB2' ' HA ' ' A' ' 30' ' ' THR . 8.8 tpp -68.03 -19.99 64.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.999 -1.063 . . . . 0.0 110.017 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.73 -21.12 8.86 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -126.94 161.3 28.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.244 -1.151 . . . . 0.0 110.701 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -121.75 124.39 44.11 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.408 -0.808 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 51' ' ' THR . 69.3 mt -93.16 166.14 12.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.44 -0.788 . . . . 0.0 110.843 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.2 p -119.75 135.04 55.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 121.784 -0.572 . . . . 0.0 110.239 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.952 ' HD2' ' SG ' ' A' ' 48' ' ' CYS . 5.3 m-30 -67.2 136.71 55.43 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.581 -0.699 . . . . 0.0 109.305 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 61' ' ' LEU . 10.4 tt -68.97 -42.06 77.1 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -118.25 -172.12 2.2 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.915 -1.115 . . . . 0.0 112.615 -177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 56.18 56.77 5.55 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.444 0.64 . . . . 0.0 110.88 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 70.1 m 52.09 26.64 3.95 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.551 -0.718 . . . . 0.0 110.705 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt 53.98 76.44 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.503 -0.748 . . . . 0.0 110.762 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.524 ' SG ' ' HD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -64.74 149.98 48.21 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.29 -0.882 . . . . 0.0 108.735 179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.2 t -119.11 143.57 47.1 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.57 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -130.17 140.91 12.13 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 78' ' ' ASN . 61.4 m -116.1 160.9 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.746 -0.856 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.425 ' HB3' ' CE1' ' A' ' 52' ' ' TYR . 46.4 t -143.75 109.8 5.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.75 -0.594 . . . . 0.0 110.487 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -151.77 140.63 20.98 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.517 -0.74 . . . . 0.0 110.319 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.75 40.81 99.67 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.21 21.23 6.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.621 -0.929 . . . . 0.0 110.354 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.414 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . 36.8 mt-30 -124.65 125.68 44.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.416 -0.803 . . . . 0.0 109.584 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 21' ' ' CYS . 2.8 m -102.7 124.11 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.174 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 47.7 t-20 -102.41 115.95 31.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.267 -0.896 . . . . 0.0 111.15 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.982 HD13 HG22 ' A' ' 36' ' ' VAL . 84.2 mt -100.61 137.95 38.32 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.509 -0.745 . . . . 0.0 109.586 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 60.3 m -127.72 131.97 49.67 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.378 -0.826 . . . . 0.0 110.78 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.509 HG21 HD21 ' A' ' 84' ' ' LEU . 69.8 mt -110.68 138.3 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.622 -0.674 . . . . 0.0 109.872 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.406 ' HG2' HG13 ' A' ' 16' ' ' ILE . 62.6 mt-30 -124.02 122.15 37.14 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.586 -0.845 . . . . 0.0 110.093 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.1 28.54 2.83 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 17' ' ' ALA . 76.0 mt -87.14 129.93 34.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.499 -1.001 . . . . 0.0 111.474 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -102.6 177.19 4.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.98 94.43 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.863 0.839 . . . . 0.0 109.747 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.3 mmt -67.61 -29.96 69.42 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.353 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -66.4 -16.49 64.13 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 111.451 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 115' ' ' ILE . 23.0 m -49.8 150.03 2.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 110.415 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' GLN . . . 154.09 -168.62 32.48 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD23 HE21 ' A' ' 39' ' ' GLN . 9.4 tp -88.91 130.11 35.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.716 -0.873 . . . . 0.0 112.691 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.703 ' CD1' HD12 ' A' ' 115' ' ' ILE . 67.7 m-85 -118.5 140.84 49.25 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 177.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.685 HG23 ' O ' ' A' ' 110' ' ' GLY . 3.5 mp -98.14 143.55 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.412 -0.805 . . . . 0.0 111.903 -178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.896 ' SG ' ' HA3' ' A' ' 110' ' ' GLY . 18.7 p -109.02 116.4 31.91 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.751 ' HE3' HD12 ' A' ' 37' ' ' LEU . 15.5 mttt -111.61 142.7 43.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.131 -0.981 . . . . 0.0 110.018 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.622 HG12 ' CD2' ' A' ' 106' ' ' LEU . 8.2 t -142.17 105.62 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -128.76 125.27 37.52 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.948 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.727 ' HG ' HD22 ' A' ' 106' ' ' LEU . 52.7 mt -81.65 76.35 8.57 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.437 ' HE3' ' HE ' ' A' ' 33' ' ' ARG . 5.8 ttm -80.89 -52.48 7.42 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.456 ' N ' ' CD ' ' A' ' 101' ' ' PRO . 94.5 m-85 -62.46 -41.83 76.11 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.091 -178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 100' ' ' TYR . 55.9 Cg_endo -85.71 113.79 1.37 Allowed 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 120.831 1.021 . . . . 0.0 111.233 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.549 ' HA ' ' C ' ' A' ' 103' ' ' PRO . 71.7 Cg_endo -90.72 150.99 4.14 Favored 'Trans proline' 1 CA--C 1.688 8.215 0 C-N-CA 123.042 2.495 . . . . 0.0 108.671 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.549 ' C ' ' HA ' ' A' ' 102' ' ' PRO 0.302 69.7 Cg_endo -83.56 176.09 34.75 Favored 'Cis proline' 2 C--N 1.469 6.892 1 C-N-CA 95.565 -13.098 . . . . 0.0 118.149 -8.53 . . . . . . . . 5 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -82.17 127.26 32.98 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.182 -1.574 . . . . 0.0 109.687 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -148.48 87.61 1.59 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.93 -1.106 . . . . 0.0 110.987 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.727 HD22 ' HG ' ' A' ' 98' ' ' LEU . 4.2 tp -155.0 -145.95 0.17 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.256 -0.903 . . . . 0.0 110.767 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -164.37 -172.45 31.86 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.586 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.544 HG22 ' C8 ' ' A' ' 132' ' ' NAG . 84.5 mt -126.87 160.31 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.76 -0.847 . . . . 0.0 110.492 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.896 ' HA3' ' SG ' ' A' ' 94' ' ' CYS . . . -98.9 130.09 10.11 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.116 -2.393 . . . . 0.0 107.116 177.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HA ' ' H82' ' A' ' 132' ' ' NAG . 3.6 m120 -59.61 -32.39 70.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.324 -1.103 . . . . 0.0 111.051 -178.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 93' ' ' ILE . . . 135.14 151.54 6.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.162 -1.494 . . . . 0.0 112.934 177.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.67 HG21 ' CG2' ' A' ' 9' ' ' VAL . 65.5 m -124.76 149.81 46.94 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.423 ' HG2' ' CE1' ' A' ' 116' ' ' TYR . 58.2 tt0 -97.13 119.83 36.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.446 -1.301 . . . . 0.0 110.004 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.703 HD12 ' CD1' ' A' ' 92' ' ' TYR . 96.0 mt -81.28 140.1 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.685 ' HB2' HD23 ' A' ' 10' ' ' LEU . 48.4 m-85 -120.92 152.58 38.32 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.318 0.58 . . . . 0.0 112.236 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 118' ' ' ILE . 7.1 p -86.15 168.67 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 10' ' ' LEU . 39.9 mm -96.71 114.29 33.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 O-C-N 121.34 -0.85 . . . . 0.0 110.891 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -140.05 124.01 10.75 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.831 -0.543 . . . . 0.0 109.766 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.99 158.19 57.49 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.095 1.05 . . . . 0.0 110.644 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -99.43 120.05 58.77 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.535 -0.728 . . . . 0.0 110.025 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.9 -19.87 34.89 Favored 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.126 1.066 . . . . 0.0 111.184 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.774 ' SG ' ' O ' ' A' ' 125' ' ' ASP . 42.3 t -111.26 119.95 44.21 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 0.0 110.59 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.64 -12.3 32.83 Favored 'Trans proline' 0 N--CA 1.487 1.139 0 O-C-N 123.118 1.062 . . . . 0.0 111.086 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.774 ' O ' ' SG ' ' A' ' 123' ' ' CYS . 55.8 p-10 -145.33 -171.06 3.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 110.421 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 97.2 p -70.14 166.37 20.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.57 -0.706 . . . . 0.0 110.136 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -140.01 159.97 40.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.579 -0.7 . . . . 0.0 110.325 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -64.63 -34.28 77.91 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.596 -0.69 . . . . 0.0 110.371 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -77.82 130.32 73.61 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.506 -0.747 . . . . 0.0 110.205 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.08 159.97 51.28 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 O-C-N 123.158 1.083 . . . . 0.0 110.464 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 0.0 110.114 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' NAG . . . . . 0.544 ' C8 ' HG22 ' A' ' 109' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' NAG . . . . . 0.685 ' H82' ' O2 ' ' A' ' 134' ' ' FUL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' FUL . . . . . 0.685 ' O2 ' ' H82' ' A' ' 133' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' BMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_